Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),-0.7931295563083957,-2.054975871643429,0.0,0.11973829700211037,0.112,3/12,2.24%,FOXP1;SMARCA4;NCOR1
prerank,positive regulation of BMP signaling pathway (GO:0030513),-0.5971009868308851,-2.0052468142245745,0.0,0.12410830784160344,0.223,10/25,13.87%,CDH5;BMPR1A;FOXD1;BMP4;SULF1;ZNF423;ACVRL1;SMAD4;CCN1;UBE2O
prerank,positive regulation of T cell proliferation (GO:0042102),0.8108510216963155,2.0005663221980403,0.0,0.0010259844431380436,0.001,17/55,9.75%,NCKAP1L;PTPRC;CD86;CD3E;SYK;CCR2;PDCD1LG2;NCK2;PYCARD;CCDC88B;IL18;HMGB1;ANXA1;AIF1;CD80;PNP;CD274
prerank,neutrophil chemotaxis (GO:0030593),0.8109350412451332,1.991465882637583,0.0,0.0005129922215690218,0.001,12/53,3.98%,NCKAP1L;PF4;LGALS3;PIK3CG;SYK;ITGB2;CXCL5;PIK3CD;CXCL2;CCL8;FCER1G;PIP5K1C
prerank,regulation of immune response (GO:0050776),0.7758508206157498,1.9910269999109615,0.0,0.00034199481437934784,0.001,33/135,6.55%,SLAMF7;CD300LB;CD22;CD226;LILRB1;TREM2;ITGAL;TREML2;FGR;LYN;SLAMF6;KLRK1;IRF4;NCR1;TREML4;CD3E;SYK;ITGB2;FCGR2B;ADCY7;PDCD1;TREML1;ITGA4;CD300A;CD200R1;CRTAM;FCGR1A;LAIR1;CD300LF;TRAF3;SAMHD1;TYROBP;RAET1E
prerank,regulation of T cell proliferation (GO:0042129),0.8082969484156179,1.987435937129165,0.0,0.0002564961107845109,0.001,19/61,11.69%,NCKAP1L;PTPRC;CD86;LILRB1;GPNMB;LGALS3;CD3E;PDCD1LG2;NCK2;TNFSF8;CCDC88B;ANXA1;AIF1;CD80;CEBPB;PNP;CD274;TNFRSF21;TNFRSF1B
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.8847544108977755,1.985346116033996,0.0,0.00020519688862760872,0.001,7/23,2.20%,ARRB2;CD226;LILRB1;SLAMF6;KLRK1;NCR1;CRTAM
prerank,positive regulation of T cell activation (GO:0050870),0.7977331530569318,1.9792583490086175,0.0,0.00017099740718967392,0.001,19/62,8.29%,NCKAP1L;PTPRC;CD86;DOCK8;CD3E;CCR2;PDCD1LG2;SIRPA;CYRIB;THY1;MDK;NCK2;PYCARD;CCDC88B;ANXA1;AIF1;CD80;PRKCQ;PNP
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.894880101330924,1.9705715072412595,0.0,0.00014656920616257766,0.001,9/22,2.44%,CD22;LGALS3;FCGR2B;DGKZ;CD300A;LAPTM5;PTPRJ;THY1;DUSP3
prerank,B cell receptor signaling pathway (GO:0050853),0.8544816973653399,1.9663785567893992,0.0,0.00012824805539225545,0.001,13/32,6.13%,NCKAP1L;PTPRC;BTK;BLNK;SYK;RFTN1;PIK3CD;PLCG2;TEC;LAT2;VAV3;NFAM1;PRKCB
prerank,regulation of interleukin-2 production (GO:0032663),0.8130553452022022,1.9631586376262997,0.0,0.0001139982714597826,0.001,18/43,8.56%,PTPRC;CD86;RUNX1;CARD11;IRF4;CCR2;IL1A;LAPTM5;HAVCR2;PLCG2;PRKD2;TRAF2;TNFAIP3;ANXA1;CD80;MALT1;PNP;TRIM27
prerank,positive regulation of phagocytosis (GO:0050766),0.7993660925358721,1.9597760447292163,0.0,0.00010259844431380436,0.001,14/47,5.11%,NCKAP1L;PTPRC;DOCK2;TREM2;SLC11A1;FCGR2B;STAP1;SIRPA;PTPRJ;CAMK1D;TNF;FCER1G;PYCARD;CD300LF
prerank,negative regulation of T cell activation (GO:0050868),0.8378751476868388,1.9595091085780347,0.0,9.327131301254941e-05,0.001,15/35,10.64%,NCKAP1L;CD86;LILRB1;GPNMB;LGALS3;FCGR2B;PDCD1LG2;LAPTM5;HAVCR2;DUSP3;RIPOR2;CD80;CEBPB;CD274;TNFRSF21
prerank,neutrophil migration (GO:1990266),0.7932888394889411,1.9589774067645573,0.0,8.549870359483696e-05,0.001,12/58,3.98%,NCKAP1L;PF4;LGALS3;PIK3CG;SYK;ITGB2;CXCL5;PIK3CD;CXCL2;CCL8;FCER1G;PIP5K1C
prerank,dendritic cell differentiation (GO:0097028),0.8729063927890361,1.9516136925503618,0.0,7.892188024138796e-05,0.001,6/22,1.15%,BATF3;LILRB1;TREM2;LYN;IRF8;FLT3
prerank,regulation of phagocytosis (GO:0050764),0.7976650715983784,1.948187255857851,0.0,0.0002198538092438665,0.002,14/53,4.78%,PTPRC;DOCK2;TREM2;FGR;HCK;SLC11A1;SYK;FCGR2B;SIRPA;TLR2;CAMK1D;TNF;FCER1G;PYCARD
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.8323796306373574,1.945761137119891,0.0,0.00020519688862760872,0.002,11/33,4.09%,CD226;LGALS3;CARD11;DGKZ;CD300A;LAPTM5;KCNN4;PTPRJ;THY1;DUSP3;PRKD2
prerank,regulation of immunoglobulin production (GO:0002637),0.8668396088725646,1.9439615018787146,0.0,0.00019237208308838319,0.002,5/23,1.94%,PTPRC;CD86;CD22;FCGR2B;VAMP3
prerank,positive regulation of interleukin-12 production (GO:0032735),0.8511546012660072,1.9418732855211227,0.0,0.00018105607820083122,0.002,9/31,5.85%,IRF5;SCIMP;SYK;LAPTM5;PLCG2;TLR2;MDK;MAPK14;HMGB1
prerank,granulocyte chemotaxis (GO:0071621),0.7870572776463515,1.9386153091802751,0.0,0.0002279965429195652,0.003,12/55,3.98%,NCKAP1L;PF4;LGALS3;PIK3CG;SYK;ITGB2;CXCL5;PIK3CD;CXCL2;CCL8;FCER1G;PIP5K1C
prerank,regulation of interleukin-17 production (GO:0032660),0.8393380763180089,1.9376949174207825,0.0,0.0002699959060889588,0.003,10/31,5.08%,NCKAP1L;SLAMF6;LY9;TGFB1;RFTN1;VSIR;OSM;NR1H4;DDIT3;IL18
prerank,T cell activation (GO:0042110),0.7769830003391289,1.9371457959046756,0.0,0.00025649611078451084,0.003,18/69,6.22%,PTPRC;TREML2;PIK3CG;IRF4;CD3E;LCP1;CD7;CD74;LAT;PIK3CD;CRTAM;LFNG;MDK;NCK2;NLRC3;CTPS1;CD44;CHD7
prerank,positive regulation of interferon-gamma production (GO:0032729),0.8074427458578007,1.9329585106146836,0.0,0.0005862768246503107,0.005,13/48,5.10%,CD226;LILRB1;SLAMF6;SLC11A1;CCR2;CYRIB;CRTAM;TLR8;TLR7;IL12RB2;PYCARD;IL18;CD14
prerank,regulation of mast cell degranulation (GO:0043304),0.9153733217638198,1.9296865904263985,0.0,0.0006062635345815712,0.006,6/14,1.54%,CD84;FGR;LYN;SYK;UNC13D;CD300A
prerank,regulation of interferon-gamma production (GO:0032649),0.7769319107713869,1.923165442371168,0.0,0.0006245122697362004,0.006,21/71,5.85%,CD226;LILRB1;SLAMF6;SLC11A1;CCR2;PDCD1LG2;SIRPA;VSIR;LAPTM5;CYRIB;HAVCR2;CRTAM;TLR8;TLR7;IL12RB2;NR1H4;PYCARD;DDIT3;IL18;CD14;HMGB1
prerank,positive regulation of interleukin-2 production (GO:0032743),0.8511223883779592,1.918043765054782,0.0,0.0007267389805561142,0.008,14/25,8.29%,PTPRC;CD86;RUNX1;CARD11;IRF4;CCR2;IL1A;PLCG2;PRKD2;TRAF2;ANXA1;CD80;MALT1;PNP
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.7708367319207479,1.9146776904831806,0.0,0.0008207875545104348,0.011,17/63,9.75%,NCKAP1L;PTPRC;CD86;CD3E;PDCD1LG2;CD74;NCK2;CCDC88B;VAV3;IL18;ANXA1;AIF1;CD80;MEF2C;PNP;GPR183;CD274
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.8989230011762345,1.9125058358485227,0.0,0.0007892188024138795,0.011,3/16,1.91%,PTPRC;LILRB1;CYRIB
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.9702243363163797,1.9119743662263702,0.0,0.0007599884763985507,0.011,5/10,1.05%,ARRB2;PTPRC;LILRB1;CX3CR1;FCGR2B
prerank,hematopoietic progenitor cell differentiation (GO:0002244),0.8281166492743064,1.9069695376132867,0.0,0.000879415236975466,0.014,9/30,3.16%,PTPRC;PLD4;MEOX1;SHH;TGFB1;PLEK;FLT3;CSF1R;SP7
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.7552500463255466,1.9064217505716252,0.0,0.0008844693475327962,0.015,32/71,11.38%,NCKAP1L;VAV1;FGR;LYN;MYO1G;HCK;SYK;FCGR2B;PLCG2;PRKCD;GRB2;NCKIPSD;PIK3CB;ELMO1;VAV2;FCGR1A;WIPF1;FCER1G;VAV3;ARPC2;PLD2;WIPF2;ACTB;ARPC3;WASF2;ABI1;ACTG1;ACTR2;ACTR3;YES1;CYFIP1;ARPC4
prerank,regulation of B cell proliferation (GO:0030888),0.7941208037122579,1.9057357478732684,0.0,0.0008891865173863044,0.016,14/44,11.79%,NCKAP1L;PTPRC;CD22;LYN;FCGR2B;CD74;CD300A;VAV3;TYROBP;MEF2C;RC3H1;GPR183;TNFRSF21;SASH3
prerank,B cell activation (GO:0042113),0.7726283032566399,1.9053939919685163,0.0,0.0008605030813415849,0.016,22/68,9.95%,PTPRC;CD86;CD22;BTK;BLNK;FLT3;ITGA4;PIK3CD;TPD52;PLCG2;PTPRJ;LAT2;CTPS1;NFAM1;HDAC5;ADGRG3;PRKCB;KLF6;MALT1;MEF2C;GPR183;HDAC4
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.8918911696911478,1.9047372724854992,0.0,0.0008336123600496604,0.016,6/17,2.44%,LGALS3;DGKZ;LAPTM5;PTPRJ;THY1;DUSP3
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.7525415204958252,1.902839512564293,0.0,0.0008394418171129446,0.017,32/73,11.38%,NCKAP1L;VAV1;FGR;LYN;MYO1G;HCK;SYK;FCGR2B;PLCG2;PRKCD;GRB2;NCKIPSD;PIK3CB;ELMO1;VAV2;FCGR1A;WIPF1;FCER1G;VAV3;ARPC2;PLD2;WIPF2;ACTB;ARPC3;WASF2;ABI1;ACTG1;ACTR2;ACTR3;YES1;CYFIP1;ARPC4
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.7527238215198736,1.9015880861092402,0.0,0.0008751043779706841,0.019,31/70,11.38%,NCKAP1L;VAV1;FGR;LYN;MYO1G;HCK;SYK;FCGR2B;PLCG2;PRKCD;GRB2;NCKIPSD;PIK3CB;ELMO1;VAV2;FCGR1A;WIPF1;VAV3;ARPC2;PLD2;WIPF2;ACTB;ARPC3;WASF2;ABI1;ACTG1;ACTR2;ACTR3;YES1;CYFIP1;ARPC4
prerank,regulation of interleukin-6 production (GO:0032675),0.7521450339369725,1.9009037226118612,0.0,0.000879415236975466,0.02,26/96,6.55%,NCKAP1L;SLAMF1;TREM2;SCIMP;SYK;CD74;IL1A;SIRPA;POU2F2;LPL;CD200R1;TLR1;PLCG2;TLR2;DHX9;TLR8;TLR7;NLRC3;TNF;IL6R;PYCARD;TNFAIP3;RAB7B;HMGB1;AIF1;TYROBP
prerank,regulation of B cell activation (GO:0050864),0.8532643697200873,1.9007729104654603,0.0,0.0008549870359483696,0.02,8/25,7.56%,THEMIS2;CD22;FCGR2B;LAPTM5;SLAMF8;TNFAIP3;SAMSN1;SH3KBP1
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.8249859875809842,1.8938433635436915,0.0,0.0009705258245900411,0.025,13/31,10.64%,CD86;LILRB1;GPNMB;LYN;FCGR2B;PDCD1LG2;CD300A;TYROBP;CD80;CEBPB;RC3H1;CD274;TNFRSF21
prerank,regulation of T cell activation (GO:0050863),0.790665239995097,1.8871477308660425,0.0,0.0011609823961825228,0.032,17/42,12.01%,GPNMB;LGALS3;CCR2;LAT;SIRPA;LAPTM5;CYRIB;CRTAM;THY1;DUSP3;TNFSF8;PYCARD;CCDC88B;PRKCQ;CCL2;TNFRSF1B;METTL3
prerank,regulation of myeloid cell differentiation (GO:0045637),0.7453618192408179,1.8717952745506854,0.0,0.001973047006034699,0.057,22/62,12.44%,RUNX1;NFE2;PTK2B;PF4;LYN;LGALS3;ITGA2B;GP1BA;GATA1;SPI1;PRKCB;TNRC6A;LEO1;DPY30;PRKCQ;MEF2C;MOV10;AGO4;RBBP5;THBS1;AGO3;CDK6
prerank,positive regulation of leukocyte migration (GO:0002687),0.836514381740546,1.8684609604288065,0.0,0.002077618497354538,0.062,8/27,6.51%,NCKAP1L;LGALS3;ADAM8;THY1;MDK;TNF;IL6R;AIF1
prerank,toll-like receptor signaling pathway (GO:0002224),0.7459579593735619,1.8670026493896408,0.0,0.0022521609727420466,0.07,30/84,9.31%,CTSS;BTK;SCIMP;RFTN1;ITGB2;CTSB;LGMN;MAPKAPK3;IRAK2;TLR1;PIK3AP1;PLCG2;UNC93B1;TLR2;CTSK;CTSL;TLR8;TLR7;SFTPA1;SFTPA2;NR1H4;UBE2D3;CD14;TRAF3;HMGB1;TICAM1;CNPY3;MAP3K1;LY96;ITGAM
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.93918064092897,1.8662499562214703,0.0,0.002247394494492857,0.072,3/10,0.52%,LILRB1;FGR;LYN
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.8052739327516194,1.8579025741141413,0.0,0.0030779533294141305,0.098,9/29,6.55%,CD226;SLAMF6;KLRK1;STAP1;CYRIB;CRTAM;SPI1;TYROBP;RAET1E
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.7385312798186265,1.853728448422637,0.0,0.003451038581464328,0.111,18/73,6.55%,PTPRC;CD86;PF4;SYK;CCR2;IL1A;LPL;TLR1;HAVCR2;PLCG2;ADAM8;PTPRJ;TLR2;DHX9;PYCARD;CD14;HMGB1;TYROBP
prerank,regulation of interleukin-12 production (GO:0032655),0.7761780872197387,1.8526129082668663,0.0,0.0035111467609613045,0.117,11/47,3.05%,SLAMF1;LILRB1;IRF5;SCIMP;SYK;LAPTM5;PLCG2;TLR2;TLR8;MDK;MAPK14
prerank,positive regulation of interleukin-6 production (GO:0032755),0.7456677155866748,1.8479763752028568,0.0,0.00381398564731751,0.131,19/68,6.55%,SCIMP;SYK;CD74;IL1A;POU2F2;LPL;TLR1;PLCG2;TLR2;DHX9;TLR8;TLR7;TNF;IL6R;PYCARD;RAB7B;HMGB1;AIF1;TYROBP
prerank,platelet aggregation (GO:0070527),0.7923498654738792,1.8447324450945406,0.0,0.003972961035130296,0.138,18/33,10.21%,FERMT3;PIK3CG;UBASH3B;GP1BA;PLEK;GATA1;ITGB3;PIK3CB;MYH9;MYL12A;ACTB;CLIC1;STXBP3;P2RY12;RAP2B;ACTG1;VCL;ACTN1
prerank,T cell activation involved in immune response (GO:0002286),0.9366058219088215,1.8442786280415557,0.0,0.00395431504126121,0.141,7/12,3.89%,LILRB1;ITGAL;SLC11A1;LCP1;CD74;MDK;FCER1G
prerank,natural killer cell activation (GO:0030101),0.8197639351186552,1.8437923230760385,0.0,0.003915491650343146,0.143,7/23,2.82%,SLAMF7;PTPRC;KLRK1;NCR1;PIK3CD;IL21R;ELF4
prerank,ethanol metabolic process (GO:0006067),-0.7294051907289844,-1.8428006781802675,0.0,0.5826681119324105,0.817,7/12,21.56%,ALDH2;ALDH1A1;ACSS2;SULT1A1;ADH5;ACSS1;ADH1A
prerank,T cell proliferation (GO:0042098),0.9024657849594296,1.8416501024661955,0.0,0.004144977150277697,0.152,6/13,4.13%,LILRB1;DOCK8;PIK3CG;SLC11A1;CRTAM;CTPS1
prerank,positive regulation of lymphocyte activation (GO:0051251),0.8087940655078916,1.8412054734874157,0.0,0.004184407140641433,0.158,13/28,12.25%,NCKAP1L;CCR2;SIRPA;CYRIB;THY1;PYCARD;CCDC88B;TYROBP;TICAM1;SH3KBP1;PRKCQ;CCL2;NOD2
prerank,embryonic organ morphogenesis (GO:0048562),-0.49053672953116034,-1.8401024039314913,0.0,0.44858161267396457,0.823,23/42,26.10%,RYR2;NIPBL;EFEMP1;HOXC4;ACVR1;HOXB9;DSCAML1;HOXA3;MFAP5;PDGFRA;FBN1;SIX1;HES1;TBX1;HOXC9;SOX17;FUZ;RBP4;FOXE1;HOXD4;FGFR2;HOXD3;MFAP2
prerank,neurotransmitter biosynthetic process (GO:0042136),0.8953207032129962,1.839428225547016,0.0,0.004498547173759113,0.173,4/14,3.73%,SLC6A3;SLC6A4;DAGLB;ALDH9A1
prerank,regulation of interleukin-4 production (GO:0032673),0.8380131854199651,1.8377151631058677,0.0,0.0046459672896817066,0.182,8/21,8.09%,CD86;IRF4;SYK;HAVCR2;FCER1G;DDIT3;CEBPB;PRKCQ
prerank,mononuclear cell differentiation (GO:1903131),0.8320814894738124,1.8367015772720825,0.0,0.0046929288417610505,0.184,8/24,2.01%,BATF3;LILRB1;TREM2;LYN;IRF8;IKZF1;FLT3;CSF1R
prerank,natural killer cell mediated immunity (GO:0002228),0.8806804382728289,1.8363452124808417,0.0,0.00470087417583249,0.189,5/15,1.19%,SLAMF7;TUBB;KLRK1;PLEKHM2;LYST
prerank,homotypic cell-cell adhesion (GO:0034109),0.7761081978399468,1.8361168507154477,0.0,0.004726856898743129,0.193,18/39,10.21%,FERMT3;PIK3CG;UBASH3B;GP1BA;PLEK;GATA1;ITGB3;PIK3CB;MYH9;MYL12A;ACTB;CLIC1;STXBP3;P2RY12;RAP2B;ACTG1;VCL;ACTN1
prerank,regulation of cytokine production (GO:0001817),0.7137485806781908,1.8354994715950779,0.0,0.004715928493020481,0.193,27/126,6.34%,CLEC9A;PTPRC;PLD4;TREM2;GPNMB;FGR;LYN;PIK3CG;IRF8;SLC11A1;FCGR2B;CCR2;IL1A;SIRPA;SRGN;PIK3CD;CRTAM;MAPK14;TNF;RGCC;CCDC88B;TRAF3;NFAM1;PPP1R11;BTN3A3;PLD3;ANXA1
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.7864699884815379,1.8333995586995264,0.0,0.004758445089726444,0.197,5/33,0.95%,NCKAP1L;FERMT3;LYN;PIK3CG;SYK
prerank,negative regulation of lymphocyte activation (GO:0051250),0.8269942236748276,1.8312519134692729,0.0,0.004973416114194584,0.209,7/21,5.42%,GPNMB;LGALS3;FCGR2B;LAPTM5;DUSP3;TNFAIP3;SAMSN1
prerank,vasculature development (GO:0001944),-0.631780169421141,-1.830356147556886,0.0,0.3966221837923918,0.853,11/16,25.06%,ERRFI1;CDH5;ACVRL1;PDGFRA;FBXW7;STRA6;NOTCH4;FLT4;BMPR2;SOX18;ACVR2B
prerank,myeloid dendritic cell activation (GO:0001773),0.9092613516681326,1.8303524134563296,0.0,0.005095722734252282,0.218,6/12,6.68%,DOCK2;BATF3;SLAMF1;PYCARD;HMGB1;TGFBR2
prerank,regulation of B cell differentiation (GO:0045577),0.8551019237703872,1.8275091518720423,0.0,0.005516768809004562,0.236,4/17,1.96%,NCKAP1L;BTK;SYK;SLAMF8
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.8694517521324574,1.8262865043770695,0.0,0.0056594625734388854,0.242,6/16,1.76%,SLAMF7;TUBB;KLRK1;PLEKHM2;LYST;CORO1A
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.7480502706942114,1.824608783836481,0.0,0.0057650554423947205,0.249,16/49,11.72%,RUNX1;NFE2;PF4;ITGA2B;GP1BA;GATA1;RAB7B;TNRC6A;DPY30;PRKCQ;MEF2C;MOV10;AGO4;RBBP5;THBS1;AGO3
prerank,regulation of cytokine production involved in immune response (GO:0002718),0.8245640673085346,1.8232073354330178,0.0,0.005915441554967782,0.257,7/22,3.81%,BTK;LILRB1;SCIMP;CCR2;LAPTM5;FFAR2;TNF
prerank,negative regulation of T cell proliferation (GO:0042130),0.8078942569321683,1.8215876923367311,0.0,0.00609276915463515,0.268,10/28,10.64%,CD86;LILRB1;GPNMB;PDCD1LG2;CRTAM;CD80;CEBPB;RC3H1;CD274;TNFRSF21
prerank,neuron fate commitment (GO:0048663),0.8813097403904455,1.8215867177359917,0.0,0.006000454470474011,0.268,4/14,5.19%,ASCL1;SHH;TGFBR1;MYT1L
prerank,positive regulation of interleukin-4 production (GO:0032753),0.8478645985937214,1.8193629096197221,0.0012531328320802004,0.0062937254646229235,0.281,7/17,8.09%,CD86;IRF4;SYK;HAVCR2;FCER1G;CEBPB;PRKCQ
prerank,lymphocyte proliferation (GO:0046651),0.8342374842371273,1.816412386605978,0.0,0.006774514926014433,0.304,6/22,8.10%,PTPRC;PIK3CG;FLT3;ELF4;CTPS1;MEF2C
prerank,negative regulation of B cell activation (GO:0050869),0.8220330331041392,1.81593339719599,0.0,0.006795288268320084,0.308,10/21,10.64%,LYN;FCGR2B;CD300A;LAPTM5;TNFAIP3;SAMSN1;TYROBP;RC3H1;INHBA;TNFRSF21
prerank,outflow tract septum morphogenesis (GO:0003148),-0.5509962743428893,-1.8076030038390327,0.0053475935828877,0.4141313605559608,0.911,11/24,13.22%,ZFPM2;PARVA;BMPR1A;ROBO2;BMP4;ACVR1;ROBO1;SEMA3C;SMAD4;TBX1;SMAD6
prerank,positive regulation of immune response (GO:0050778),0.7261505301508311,1.8064900869869231,0.0,0.008764838528522143,0.385,10/64,4.78%,PTPRC;CD226;LILRB1;ITGB2;FCGR2B;CD74;ADAM8;DHX9;TLR8;PYCARD
prerank,regulation of interleukin-10 production (GO:0032653),0.7508925856538491,1.8034496623320113,0.0,0.0095951221161079,0.421,13/44,12.25%,LILRB1;IRF4;SYK;FCGR2B;PDCD1LG2;VSIR;PLCG2;PYCARD;HMGB1;TYROBP;CD274;TNFRSF21;NOD2
prerank,defense response to fungus (GO:0050832),0.86789044154607,1.8033092946612825,0.0,0.009490356099026901,0.422,3/17,2.02%,CLEC4D;CX3CR1;PLCG2
prerank,positive regulation of cytokine production (GO:0001819),0.6944756705894207,1.802502968052656,0.0,0.00955711536073794,0.431,71/292,8.85%,CLEC9A;PTPRC;CD86;RUNX1;CD226;LILRB1;IRF5;SCIMP;FGR;SLAMF6;PIK3CG;LY9;CARD11;IRF4;HPSE;SLC11A1;TGFB1;SYK;RFTN1;CCR2;CD74;IL1A;POU2F2;LPL;PIK3CD;LAPTM5;TLR1;CYRIB;HAVCR2;CSF1R;PLCG2;CRTAM;TLR2;DHX9;TLR8;TLR7;MDK;MAPK14;OSM;IL12RB2;FFAR2;NR1H4;TNF;FCER1G;RGCC;PRKD2;TRAF2;IL6R;PYCARD;LRRFIP1;DDIT3;CCDC88B;IL18;CD14;RAB7B;NFAM1;HMGB1;XRCC5;CTNNB1;ANXA1;AIF1;TYROBP;CD80;TICAM1;CEBPB;MALT1;PRKCQ;PNP;TRIM27;LURAP1;SULF2
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.736848017752229,1.799233315557202,0.0,0.010481678905572443,0.452,21/56,8.92%,CTSS;CTSB;LGMN;MAPKAPK3;IRAK2;TLR1;PLCG2;UNC93B1;TLR2;CTSK;CTSL;TLR8;TLR7;SFTPA1;SFTPA2;FFAR2;CD14;TRAF3;HMGB1;CNPY3;LY96
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.8915727239236518,1.7970178159916144,0.0014577259475218659,0.010998553230439828,0.475,4/11,5.09%,TREM2;LYN;TLR1;TNFAIP3
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.7632661740595923,1.7959509143184837,0.0,0.011177830512082895,0.484,6/34,3.52%,PTPRC;CD86;SCIMP;LAPTM5;VAMP3;FFAR2
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.7785994919078747,1.7957777246629107,0.0,0.011099286248493379,0.485,7/33,3.90%,RUNX1;PF4;HCLS1;CD74;ACIN1;TNF;OCSTAMP
prerank,inflammatory response (GO:0006954),0.6964176447407646,1.794411231509042,0.0,0.01141736534158746,0.495,54/195,14.09%,ITGAL;BLNK;PF4;CIITA;PIK3CG;CYBB;SLC11A1;TGFB1;ITGB2;CXCL5;FCGR2B;CCR2;TMIGD3;NRROS;LAT;IL1A;PIK3CD;IL10RB;TLR1;CSF1R;ADAM8;CXCL2;TLR2;ADGRE5;CCL8;TNF;CXCR4;IL18;CD14;NFAM1;HDAC5;CD44;HMGB1;ANXA1;AIF1;CEBPB;CCL14;HDAC4;NFX1;F11R;CMKLR1;CCL13;THBS1;CCL2;TACR1;TPST1;HDAC9;LTB4R2;IKBKG;ITCH;NFKB1;ADCY8;C3AR1;SIGLEC1
prerank,regulation of microglial cell activation (GO:1903978),0.8612226860702883,1.7935197835313508,0.0,0.011441674612716661,0.5,4/15,3.45%,PTPRC;TREM2;STAP1;CST7
prerank,cellular response to lipopolysaccharide (GO:0071222),0.7023811384966445,1.792842592152559,0.0,0.011478200957606861,0.504,34/101,13.46%,CD86;LILRB1;PF4;LYN;HCK;TGFB1;CX3CR1;CXCL5;STAP1;PDCD1LG2;IL1A;SIRPA;CXCL2;MAPK14;TNF;PYCARD;CD68;IL18;TNFAIP3;CD14;CASP1;HMGB1;CD80;TICAM1;CD180;MEF2C;LY96;CD274;CCL2;TNFRSF1B;NOD2;DEFA6;SHPK;NFKB1
prerank,regulation of calcium-mediated signaling (GO:0050848),0.7947748832013323,1.7927748348194865,0.0,0.011336494772945049,0.504,5/25,5.57%,CD22;TREM2;PLEK;PLCG2;P2RX4
prerank,organophosphate catabolic process (GO:0046434),0.9084278481910406,1.791990435365192,0.0,0.011448484944772071,0.513,3/11,3.09%,PLBD1;ABHD12;ANGPTL3
prerank,negative regulation of immune response (GO:0050777),0.6901703140671327,1.7910752391788003,0.0,0.011533054041539693,0.521,41/154,13.50%,TSHB;LILRB1;TREM2;FGR;LYN;LGALS3;CALCR;HCK;SYK;FCGR2B;CCR2;ADCY7;PDCD1;CD300A;PRKAR2B;HAVCR2;PLCG2;CYSLTR2;MAPK14;FCGR1A;NLRC3;ADCY6;RHBDF2;TRAFD1;SPI1;TNFAIP3;MYH9;SAMSN1;RAMP1;PLK2;TRIM27;RC3H1;CYSLTR1;YES1;PRKACB;IAPP;FYN;CREB1;ITCH;ADCY8;ADCY3
prerank,positive regulation of immune system process (GO:0002684),0.8537293608827938,1.787751339511235,0.0,0.012421740222278457,0.552,4/16,6.34%,NCKAP1L;PIK3CD;PIK3CB;ANXA1
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",0.91130260698278,1.7868499817136465,0.0,0.01251701020628413,0.558,4/10,1.54%,NCKAP1L;TREM2;STAP1;CD300A
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.7442333615572495,1.7852330459313899,0.0,0.012884455797547522,0.576,12/45,5.81%,IRF5;PTAFR;CIITA;HCK;IRF4;IRF8;TRIM25;PRKCD;FCGR1A;TRIM5;CD44;IFNGR2
prerank,superoxide anion generation (GO:0042554),0.8738114150822229,1.7841486040095966,0.0013513513513513514,0.01303118172031653,0.585,4/13,2.52%,CYBB;NCF4;ALOX12;NCF2
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.8249486957584808,1.7837238951358874,0.0012468827930174563,0.013069642735883485,0.591,6/20,6.62%,MRAP;PLEK;GRK3;SNCA;MGRN1;YWHAB
prerank,negative regulation of cytokine production (GO:0001818),0.6892633169558738,1.7823702892179791,0.0,0.013395437336251759,0.599,51/163,13.54%,NCKAP1L;CD84;PTPRC;SLAMF1;LILRB1;TREM2;GPNMB;SLC11A1;FCGR2B;ADCY7;PDCD1LG2;SIRPA;VSIR;SRGN;CD200R1;NLRC5;LAPTM5;HAVCR2;TRIM25;TLR8;NLRC3;NR1H4;TNF;RGCC;PYCARD;DDIT3;TNFAIP3;HMGB1;PPP1R11;ANXA1;TYROBP;ABCD1;TAX1BP1;TMSB4X;ATP2B1;TRIM27;CD274;ANXA4;INHBA;TNFRSF21;CMKLR1;THBS1;RPS6KA4;HDAC9;RNF216;NLRX1;RNF135;ITCH;NPTN;GAS6;GPATCH3
prerank,innate immune response (GO:0045087),0.696599282529066,1.782259640296827,0.0,0.013280798625064674,0.599,56/217,13.13%,CD300LB;SLA;CLEC4D;PTK2B;BTK;TREM2;IRF5;FGR;LYN;CIITA;PIK3CG;HCK;CYBB;SLC11A1;CX3CR1;SYK;CLEC5A;NRROS;TREML1;CD74;PIK3CD;CORO1A;NLRC5;PLCG2;TRIM25;TLR2;NCF2;S100B;TLR8;MASP1;TRIM5;SNCA;FCER1G;GCH1;OTULIN;DMBT1;HMGB1;TYROBP;KYNU;CAPZA1;MALT1;TRIM27;ADAR;SETD2;TRIM8;TRIM56;YES1;MID2;TRIM35;NOD2;DEFA6;FYN;ALPK1;IKBKG;RNF135;B2M
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.6949531523430311,1.7796665299546384,0.0,0.013878976368164082,0.614,29/121,7.60%,PTPRC;PTK2B;TREM2;LYN;TGFB1;CASS4;HCLS1;FLT3;GATA1;CD74;ITGB3;CSF1R;PLCG2;GPRC5B;PTPRJ;ANGPT4;PTPN1;TEC;OSM;FCGR1A;SEMA4D;TNF;IL6R;IL18;CD44;TP53;CD80;NEDD9;EPO
prerank,positive regulation of interleukin-17 production (GO:0032740),0.8079936150234346,1.7769179566506905,0.0,0.014664886333983992,0.642,8/22,8.09%,SLAMF6;LY9;TGFB1;RFTN1;OSM;NR1H4;IL18;PRKCQ
prerank,positive regulation of immune effector process (GO:0002699),0.7765091174943716,1.7746336239924299,0.0012224938875305623,0.01552215173650782,0.668,4/27,2.35%,PTPRC;LILRB1;CCR2;PTPRJ
prerank,negative regulation of interleukin-6 production (GO:0032715),0.7896178333659821,1.7742237024840002,0.0,0.01550982865637404,0.669,7/27,5.09%,NCKAP1L;SLAMF1;SIRPA;CD200R1;NLRC3;TNF;TNFAIP3
prerank,plasma membrane invagination (GO:0099024),0.7583215461669172,1.7739241576781248,0.0011737089201877935,0.015411366319557768,0.671,11/29,6.51%,ARHGAP25;BIN2;ITGB2;FCGR2B;ELMO1;MSR1;FCGR1A;SNX9;SNX33;MYH9;AIF1
prerank,negative regulation of interleukin-10 production (GO:0032693),0.8426980301713375,1.771353881811798,0.0013192612137203166,0.016052381599930637,0.691,7/16,10.64%,LILRB1;FCGR2B;PDCD1LG2;VSIR;TYROBP;CD274;TNFRSF21
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.6956517427349753,1.7712706324277745,0.0,0.01590804744824348,0.691,15/72,5.08%,TREM2;FGR;LYN;PIK3CG;PIK3R5;HCLS1;FLT3;PIK3CD;CBL;PIK3AP1;PIK3CB;OSM;SEMA4D;TNF;IL18
prerank,B cell differentiation (GO:0030183),0.7490045026543002,1.7702427413573956,0.0,0.016133081906895153,0.702,12/46,6.73%,PTPRC;BLNK;FLT3;ITGA4;TPD52;PLCG2;PTPRJ;FNIP1;NFAM1;HDAC5;ADGRG3;KLF6
prerank,cholesterol biosynthetic process (GO:0006695),-0.5033343049579676,-1.769145605736961,0.006289308176100629,0.5247758730968403,0.968,20/31,31.51%,HMGCR;ACAA2;ACLY;NSDHL;CYP51A1;INSIG2;INSIG1;ACAT2;SQLE;LSS;PMVK;LBR;IDI1;MVK;HSD17B7;FDPS;DHCR7;EBP;SC5D;TM7SF2
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.7070396360995699,1.7678761769353601,0.0,0.016685201550022725,0.723,16/69,6.55%,PTPRC;PF4;SYK;CCR2;IL1A;LPL;TLR1;HAVCR2;PLCG2;PTPRJ;TLR2;DHX9;PYCARD;CD14;HMGB1;TYROBP
prerank,phagosome maturation (GO:0090382),0.7656658913750672,1.766469197203786,0.001145475372279496,0.016969782689503242,0.729,16/35,10.51%,ATP6V0D2;CORO1A;SLAMF8;ATP6V0E1;RAB39A;RAB34;TCIRG1;RAB32;ATP6V1C1;ATP6V1E1;RAB14;ATP6V0A2;RAB7A;ATP6V0D1;RAB31;ATP6V0A1
prerank,leukocyte cell-cell adhesion (GO:0007159),0.7867154435236722,1.765732783577784,0.0,0.017157304202575798,0.734,6/24,3.56%,ITGAL;FERMT3;SYK;ITGB2;ITGA4;SEMA4D
prerank,positive regulation of chemokine production (GO:0032722),0.7410654645684173,1.7655714881429694,0.0,0.01706956470593392,0.736,13/44,6.51%,SYK;CD74;LPL;CSF1R;TLR2;TLR7;FFAR2;TNF;IL6R;PYCARD;IL18;HMGB1;AIF1
prerank,negative regulation of interleukin-17 production (GO:0032700),0.9111794559255477,1.763059148486923,0.0,0.017969669275932333,0.757,3/10,4.84%,NCKAP1L;VSIR;DDIT3
prerank,myeloid cell differentiation (GO:0030099),0.7185164983543401,1.7606792255935777,0.0010799136069114472,0.018901790317812417,0.774,15/47,12.56%,RUNX1;LYN;IKZF1;HCLS1;GATA1;ACIN1;CEBPA;SPI1;TAL1;EPO;ATP5IF1;SLC25A38;INHBA;PRDX3;RPS14
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.876286284960566,1.7606196233327316,0.0014144271570014145,0.018731544547577424,0.774,4/12,1.54%,PTPRC;RUNX1;LYN;CD300A
prerank,regulation of mast cell activation (GO:0033003),0.8922645227498898,1.7603835481935595,0.0,0.01863226465132768,0.776,4/10,5.11%,CD84;CD226;LYN;CD300LF
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.6936717928472184,1.7588236363410348,0.0,0.019138924752369484,0.792,32/95,13.46%,CD86;LILRB1;PF4;CX3CR1;CXCL5;FCGR2B;STAP1;PDCD1LG2;IL1A;SIRPA;CYRIB;CXCL2;TLR2;MAPK14;PYCARD;CD68;TNFAIP3;CD14;CASP1;HMGB1;CD80;TICAM1;CD180;MEF2C;LY96;CD274;CCL2;TNFRSF1B;NOD2;DEFA6;SHPK;NFKB1
prerank,T cell differentiation (GO:0030217),0.7366593910231132,1.7571261439764412,0.0011148272017837235,0.019702701250632428,0.809,8/40,6.34%,PTPRC;SHH;PIK3CD;LFNG;FCER1G;SPI1;CHD7;ANXA1
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.7714259806366118,1.756802549238722,0.0011947431302270011,0.019672545744573493,0.809,11/27,8.09%,ITGB2;CCR2;SIRPA;CYRIB;THY1;MDK;TNF;PYCARD;CCDC88B;CD44;PRKCQ
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.8538155818481548,1.7563854361333153,0.0,0.01968957417694918,0.81,3/14,6.74%,CD84;IL18;CD80
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.7369687544458743,1.756326040293685,0.0,0.019530676831988163,0.81,11/37,7.53%,PLD4;TREM2;ADCY7;SIRPA;MAPK14;NLRC3;TNF;PYCARD;PLD3;ABCD1;TICAM1
prerank,regulation of lymphocyte activation (GO:0051249),0.8900288580376096,1.756121174990123,0.0,0.019457062118082184,0.812,3/12,2.20%,THEMIS2;LAT;CRTAM
prerank,regulation of lymphocyte differentiation (GO:0045619),0.8336362592065555,1.7560852905624698,0.0,0.019312114252695738,0.813,4/18,2.20%,NCKAP1L;CCR2;SLAMF8;CRTAM
prerank,peptidyl-tyrosine modification (GO:0018212),0.7115250465646542,1.7529644047606963,0.0,0.02059168777105126,0.832,9/56,2.77%,PTK2B;BTK;FGR;LYN;HCK;SYK;FLT3;CSF1R;TEC
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.8492689232395843,1.7508228815836755,0.0,0.021402927644244923,0.845,6/14,7.53%,LILRB1;CD74;LAPTM5;PLCG2;GPRC5B;TICAM1
prerank,integrin-mediated signaling pathway (GO:0007229),0.7101459004587162,1.749645187311414,0.0,0.021766790642782117,0.85,17/73,3.11%,PTK2B;FERMT3;FGR;FYB1;ITGA2B;HCK;PLEK;SYK;ITGB2;LAT;ITGB3;ITGB5;THY1;ITGA2;TEC;ANGPTL3;CCM2
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.6840276609798142,1.7481112182842031,0.0,0.02236996849953119,0.858,55/163,15.62%,NCKAP1L;THEMIS2;PTPRC;LCP2;GRAP2;BTK;BLNK;INPP5D;FYB1;CARD11;CD3E;SYK;RFTN1;LAT;PIK3CD;PLCG2;PTPRJ;THY1;PIK3CB;TEC;THEMIS;LAT2;PRKD2;VAV3;NFAM1;BTN3A3;PRKCB;PSMB10;WNK1;NFKBID;RC3H2;MALT1;PRKCQ;MEF2C;DENND1B;RC3H1;SPPL3;BCAR1;EIF2B2;TNFRSF21;PSMA2;TXK;FYN;PSME3;TAB2;IKBKG;NFKB1;PSMB5;BMX;PSMD8;PLEKHA1;PAG1;ICOSLG;PSMD7;PSMB9
prerank,cellular lipid catabolic process (GO:0044242),0.7746506873144835,1.74785181529901,0.0,0.022345593380209933,0.86,7/27,7.03%,PLBD1;LPIN2;ABHD12;ANGPTL3;CEL;NUDT19;ACADL
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.8695054220393404,1.7472730327526047,0.0,0.02245095369690307,0.864,6/11,9.31%,ITGB2;STAP1;SPI1;TYROBP;TICAM1;ITGAM
prerank,regulation of tumor necrosis factor production (GO:0032680),0.6851684453699521,1.746979314145857,0.0,0.022434859823285216,0.866,24/112,6.55%,PTPRC;SLAMF1;LILRB1;PF4;CX3CR1;SYK;CCR2;IL1A;SIRPA;VSIR;LPL;TLR1;HAVCR2;PLCG2;PTPRJ;TLR2;DHX9;NLRC3;NR1H4;PYCARD;TNFAIP3;CD14;HMGB1;TYROBP
prerank,myeloid cell activation involved in immune response (GO:0002275),0.8131532710271353,1.7452396465711555,0.002621231979030144,0.02309736878601678,0.875,7/18,6.55%,DOCK2;SLAMF1;SYK;PLCG2;FCER1G;PYCARD;TYROBP
prerank,chemokine-mediated signaling pathway (GO:0070098),0.7317566667745737,1.7452232458181713,0.0,0.022924865508150056,0.876,11/42,11.55%,PTK2B;PF4;CXCL5;CCR2;CXCL2;CCL8;WNK1;CCL14;SH2B3;CCL13;CCL2
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.8206383597976606,1.7442641997118549,0.0,0.023113844649882264,0.881,5/17,6.55%,CD226;SLAMF6;KLRK1;CRTAM;RAET1E
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),0.8749456384182859,1.7438900571617477,0.0,0.023150842515324562,0.881,3/12,5.08%,SLC11A1;CCR2;IL18
prerank,defense response to protozoan (GO:0042832),0.866823264512357,1.7430283294757614,0.0013831258644536654,0.023392445303547393,0.882,4/12,1.19%,PF4;IRF4;SLC11A1;LYST
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.8541877321301081,1.7417118510850769,0.002699055330634278,0.023858209669797358,0.888,7/13,3.89%,SYK;ITGB2;LPL;ABCA1;CD9;SREBF2;FCER1G
prerank,mature B cell differentiation involved in immune response (GO:0002313),0.862905174643086,1.739964597493795,0.002824858757062147,0.024672098341288067,0.895,6/12,9.45%,PTK2B;FCGR2B;LFNG;DOCK11;DOCK10;GPR183
prerank,neutrophil activation (GO:0042119),0.8759466995849616,1.7384808837709302,0.0,0.0253530374503565,0.903,5/12,6.55%,PREX1;SYK;PRKCD;FCER1G;TYROBP
prerank,positive regulation of B cell proliferation (GO:0030890),0.7573112149101076,1.7377264688311416,0.0,0.025625750975122298,0.905,7/29,11.79%,NCKAP1L;PTPRC;CD74;VAV3;MEF2C;GPR183;SASH3
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.82293872648128,1.7358135963771597,0.0,0.02642304550481669,0.913,5/16,6.55%,CD226;SLAMF6;KLRK1;CRTAM;RAET1E
prerank,secondary alcohol biosynthetic process (GO:1902653),-0.5009912260527046,-1.735717810840389,0.0,0.619121285685182,0.99,18/30,28.67%,HMGCR;ACAA2;ACLY;NSDHL;CYP51A1;INSIG2;INSIG1;ACAT2;SQLE;LSS;PMVK;LBR;IDI1;MVK;HSD17B7;FDPS;DHCR7;EBP
prerank,regulation of macrophage cytokine production (GO:0010935),0.8628673607380228,1.734935535914432,0.0,0.026714755233159283,0.915,6/13,2.16%,LILRB1;TGFB1;CD74;LAPTM5;PLCG2;GPRC5B
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.6724916773731014,1.734790388309047,0.0,0.026605642036829715,0.915,27/116,13.50%,TSHB;TREM2;FGR;LYN;CALCR;HCK;SYK;FCGR2B;ADCY7;PRKAR2B;PLCG2;CYSLTR2;MAPK14;FCGR1A;ADCY6;RHBDF2;MYH9;RAMP1;PLK2;CYSLTR1;YES1;PRKACB;IAPP;FYN;CREB1;ADCY8;ADCY3
prerank,cortical actin cytoskeleton organization (GO:0030866),0.7820299101771426,1.7331810404060886,0.0025477707006369425,0.02726958651498484,0.918,6/20,5.71%,NCKAP1L;PLEK;LCP1;TNF;FHOD1;FMNL3
prerank,lymphocyte differentiation (GO:0030098),0.6963406361585528,1.7327769657700116,0.0,0.02733406314927474,0.921,15/68,6.73%,PTPRC;BLNK;IKZF1;FLT3;ITGA4;PIK3CD;TPD52;PLCG2;PTPRJ;LFNG;NFAM1;HDAC5;ADGRG3;CHD7;KLF6
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.6033696391976995,-1.7320157768792197,0.0,0.5676158523741566,0.991,5/16,20.47%,CLDN5;CLDN11;CLDN14;CLDN12;CLDN1
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.7867026070027431,1.7309794833494672,0.0050568900126422255,0.02809677397245442,0.927,7/20,7.53%,LYN;HCK;TGFB1;TNF;IL18;CD14;TICAM1
prerank,arachidonic acid metabolic process (GO:0019369),0.7421647352189243,1.7304922898707578,0.0,0.028184396173262724,0.93,6/35,3.21%,TBXAS1;CYP1A1;ALOX12;DAGLB;PTGES3;HPGDS
prerank,B cell proliferation (GO:0042100),0.8292819649975074,1.7302573394350962,0.0012970168612191958,0.028105982591949467,0.93,4/17,8.10%,PTPRC;CTPS1;CD180;MEF2C
prerank,negative regulation of organelle assembly (GO:1902116),-0.48425447097181124,-1.7292014925652814,0.006622516556291391,0.5245761011727491,0.992,23/35,27.03%,MTM1;FEZ1;TRIM37;SMAD4;CCP110;TMEM39A;EVI5L;CEP97;CDK5RAP2;PINK1;RBM14;CHMP4B;CHMP4A;NUPR1;CDK10;TBC1D7;PHF23;KAT2B;SMCR8;FEZ2;KAT2A;TESK1;STYXL1
prerank,positive regulation of B cell activation (GO:0050871),0.714961618430877,1.7286282855456305,0.0,0.0287796070970099,0.936,12/50,12.25%,NCKAP1L;PTPRC;BTK;SYK;CD74;MAD2L2;VAV3;SH3KBP1;MEF2C;GPR183;SASH3;NOD2
prerank,cellular response to chemokine (GO:1990869),0.7153943494125797,1.7275815304139706,0.0,0.029273771953132955,0.941,13/46,11.55%,PTK2B;DOCK8;PF4;CXCL5;CCR2;CXCL2;CCL8;RIPOR2;WNK1;CCL14;SH2B3;CCL13;CCL2
prerank,positive regulation of interleukin-8 production (GO:0032757),0.7163179438687867,1.727409950321607,0.0010822510822510823,0.029159943566044823,0.941,13/49,5.85%,SYK;CD74;TLR1;TLR2;TLR8;TLR7;FFAR2;TNF;PRKD2;PYCARD;DDIT3;CD14;HMGB1
prerank,response to thyroid hormone (GO:0097066),0.8468820083857055,1.726112228845115,0.001392757660167131,0.029724442909353957,0.944,6/13,2.62%,CTSS;CTSB;GATA1;BRD8;GAS2L1;CTSL
prerank,negative regulation of interferon-gamma production (GO:0032689),0.7768220502632023,1.7257831008952402,0.0012077294685990338,0.0297824498212325,0.945,10/23,10.54%,LILRB1;PDCD1LG2;VSIR;LAPTM5;HAVCR2;NR1H4;DDIT3;HMGB1;CD274;INHBA
prerank,B cell homeostasis (GO:0001782),0.8946895494287272,1.7238452680657723,0.0,0.030801057443298047,0.947,6/10,8.10%,NCKAP1L;LYN;TNFAIP3;DOCK11;DOCK10;MEF2C
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.8044625069517843,1.7230720142677582,0.001282051282051282,0.031093028540655706,0.948,6/18,8.71%,RUNX1;TGFB1;RGCC;COLGALT1;RB1;SMAD3
prerank,T cell differentiation in thymus (GO:0033077),0.8392262238018722,1.7224410294268957,0.0013550135501355014,0.03127483612875968,0.948,2/14,0.68%,PTPRC;SHH
prerank,regulation of tissue remodeling (GO:0034103),0.8044719017152006,1.7215894085611145,0.0025575447570332483,0.03167199921385727,0.951,5/18,5.08%,RUNX1;GPNMB;TGFB1;MDK;IL18
prerank,positive regulation of neutrophil migration (GO:1902624),0.8172063629420533,1.7176881450183075,0.002551020408163265,0.03391332251161737,0.962,6/18,5.96%,NCKAP1L;CD74;ADAM8;CAMK1D;MDK;RIPOR2
prerank,positive regulation of calcium-mediated signaling (GO:0050850),0.861488939104066,1.7173777258948804,0.0014285714285714286,0.033878283605510935,0.962,3/11,5.57%,TREM2;PLCG2;P2RX4
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.6781473592556013,1.717053849932624,0.0,0.03387125822681903,0.962,24/86,8.95%,PTPRC;PTK2B;TREM2;TGFB1;ITGB2;HCLS1;GATA1;CD74;ITGB3;PLCG2;PRKCD;PTPRJ;ANGPT4;TEC;OSM;SEMA4D;PDCL3;IL6R;SAMSN1;CD44;TP53;CD80;RAP2B;NTF3
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),0.7993679113345381,1.7151870876481263,0.0012484394506866417,0.0350339487850204,0.967,5/19,5.96%,NCKAP1L;CD74;CAMK1D;MDK;RIPOR2
prerank,positive regulation of superoxide anion generation (GO:0032930),0.8305428555280169,1.7149632354057562,0.004231311706629055,0.034931033259421734,0.967,6/13,9.31%,TGFB1;SYK;ITGB2;PRKCD;TYROBP;ITGAM
prerank,regulation of mononuclear cell migration (GO:0071675),0.7729090944713352,1.7148559875034746,0.001226993865030675,0.034734973318344554,0.967,10/23,11.25%,LYN;LGALS3;CSF1R;MDK;TNF;AIF1;STK10;AKIRIN1;CMKLR1;THBS1
prerank,cellular response to interferon-gamma (GO:0071346),0.6763493025599798,1.7133034629461443,0.0,0.035580872256800386,0.969,24/88,11.55%,IRF5;PTAFR;CIITA;HCK;IRF4;IRF8;SIRPA;TRIM25;PRKCD;TLR2;FCGR1A;CCL8;TRIM5;CASP1;CD44;IFNGR2;AIF1;IRF2;CCL14;EPRS1;TRIM8;CCL13;GBP3;CCL2
prerank,superoxide metabolic process (GO:0006801),0.7482746050527588,1.713186020037133,0.001182033096926714,0.03540978776155001,0.969,8/29,4.06%,CYBB;PREX1;NRROS;NCF4;SH3PXD2B;ALOX12;NCF2;ATP7A
prerank,positive regulation of calcium ion import (GO:0090280),0.8419039009637941,1.712758690204841,0.0,0.035419630678914,0.97,2/12,0.54%,LGALS3;CALCR
prerank,positive regulation of immunoglobulin production (GO:0002639),0.7439136773475864,1.71256388331165,0.0023094688221709007,0.03531754140802112,0.97,4/31,2.40%,PTPRC;CD86;VAMP3;MAD2L2
prerank,neutrophil activation involved in immune response (GO:0002283),0.6590361933703934,1.7097013826964942,0.0,0.037177232465046686,0.974,126/428,12.58%,ARHGAP45;NCKAP1L;PTPRC;CTSS;HK3;DOCK2;TUBB;CLEC4D;LILRB3;ITGAL;FGR;LGALS3;GMFG;PTAFR;P2RX1;CYBB;MGAM;ITGAX;HPSE;SLC11A1;ARHGAP9;BIN2;SYK;ITGB2;CLEC5A;CTSB;HEXB;TMC6;GUSB;ATP8B4;UNC13D;SIRPA;CD300A;CTSD;IQGAP2;TBC1D10C;CTSC;CTSA;ADAM8;PRKCD;PTPRJ;TLR2;TCIRG1;LPCAT1;OSTF1;ARSB;ADGRE5;MAPK14;GNS;PFKL;ATP8A1;GM2A;PSAP;NPC2;ATG7;FCER1G;SLC2A3;TTR;PPIE;DNAJC3;LAIR1;PYCARD;RAB14;CD68;GYG1;NBEAL2;CD14;CPPED1;RAP1B;RAB7A;NFAM1;CD44;ADGRG3;HMGB1;XRCC5;APAF1;ARL8A;B4GALT1;CDA;TYROBP;STK10;FUCA1;VPS35L;IRAG2;STXBP3;SVIP;EPX;RAP2B;FABP5;DNAJC13;CAP1;PNP;TSPAN14;ACTR10;TMEM179B;RAB31;SLC44A2;PAFAH1B2;CCT8;CTSZ;MAN2B1;FTL;SNAP29;ITGAM;ATP6AP2;VCL;SYNGR1;FGL2;ACTR2;TMEM63A;ATP6V0A1;DIAPH1;PSMA2;CD53;CYFIP1;GPI;CD63;GRN;TNFRSF1B;CD93;GGH;PRDX6;DYNC1H1;SDCBP;ARSA;COTL1
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.7876433137219594,1.708771206977993,0.001226993865030675,0.03755232933333738,0.975,7/19,9.31%,SCIMP;ITGB2;PIK3AP1;NR1H4;CD14;LY96;ITGAM
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.794179744099034,1.7076145491069332,0.0025252525252525255,0.03827115554875305,0.978,4/19,3.02%,NCKAP1L;BTK;SYK;MDK
prerank,defense response to bacterium (GO:0042742),0.6756524420749329,1.7073359740075733,0.0,0.03828845693735786,0.978,19/105,7.68%,TREM2;FGR;SLC11A1;SYK;LYST;AQP1;MPEG1;SLAMF8;PRKCD;TLR2;FCER1G;IL6R;PYCARD;DMBT1;STAB2;PPP1R11;STAB1;EPX;CEBPB
prerank,sterol biosynthetic process (GO:0016126),-0.483728773743551,-1.7068290283895797,0.013888888888888888,0.584389631354029,0.998,20/33,31.51%,HMGCR;ACAA2;ACLY;NSDHL;CYP51A1;INSIG2;INSIG1;ACAT2;SQLE;LSS;PMVK;LBR;IDI1;MVK;HSD17B7;FDPS;DHCR7;EBP;SC5D;TM7SF2
prerank,immunoglobulin mediated immune response (GO:0016064),0.8940028791865717,1.7053099904727618,0.0014534883720930232,0.039516332496267126,0.98,4/10,3.89%,FCGR2B;CD74;TLR8;FCER1G
prerank,regulation of superoxide anion generation (GO:0032928),0.815595608528371,1.7050330593366896,0.001379310344827586,0.03951306753542132,0.98,6/14,9.31%,TGFB1;SYK;ITGB2;PRKCD;TYROBP;ITGAM
prerank,dendritic cell chemotaxis (GO:0002407),0.8243507245133143,1.7048078937113489,0.0027397260273972603,0.03947837072001109,0.981,5/14,9.45%,PIK3CG;CCR2;CXCR4;HMGB1;GPR183
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.660594544747063,1.704280661985997,0.0,0.039594241101345594,0.982,26/117,13.50%,TSHB;TREM2;FGR;LYN;CALCR;HCK;SYK;ADCY7;PRKAR2B;PLCG2;CYSLTR2;MAPK14;FCGR1A;ADCY6;RHBDF2;MYH9;RAMP1;PLK2;CYSLTR1;YES1;PRKACB;IAPP;FYN;CREB1;ADCY8;ADCY3
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),0.8548679206680204,1.7037542065486466,0.004379562043795621,0.03975845169348272,0.983,5/11,8.10%,LYN;PIK3CD;PIK3CB;ANXA1;MEF2C
prerank,neutrophil degranulation (GO:0043312),0.6567858676770374,1.7034572742432166,0.0,0.03981561314876672,0.985,125/425,12.58%,ARHGAP45;NCKAP1L;PTPRC;CTSS;HK3;DOCK2;TUBB;CLEC4D;LILRB3;ITGAL;FGR;LGALS3;GMFG;PTAFR;P2RX1;CYBB;MGAM;ITGAX;HPSE;SLC11A1;ARHGAP9;BIN2;ITGB2;CLEC5A;CTSB;HEXB;TMC6;GUSB;ATP8B4;UNC13D;SIRPA;CD300A;CTSD;IQGAP2;TBC1D10C;CTSC;CTSA;ADAM8;PRKCD;PTPRJ;TLR2;TCIRG1;LPCAT1;OSTF1;ARSB;ADGRE5;MAPK14;GNS;PFKL;ATP8A1;GM2A;PSAP;NPC2;ATG7;FCER1G;SLC2A3;TTR;PPIE;DNAJC3;LAIR1;PYCARD;RAB14;CD68;GYG1;NBEAL2;CD14;CPPED1;RAP1B;RAB7A;NFAM1;CD44;ADGRG3;HMGB1;XRCC5;APAF1;ARL8A;B4GALT1;CDA;TYROBP;STK10;FUCA1;VPS35L;IRAG2;STXBP3;SVIP;EPX;RAP2B;FABP5;DNAJC13;CAP1;PNP;TSPAN14;ACTR10;TMEM179B;RAB31;SLC44A2;PAFAH1B2;CCT8;CTSZ;MAN2B1;FTL;SNAP29;ITGAM;ATP6AP2;VCL;SYNGR1;FGL2;ACTR2;TMEM63A;ATP6V0A1;DIAPH1;PSMA2;CD53;CYFIP1;GPI;CD63;GRN;TNFRSF1B;CD93;GGH;PRDX6;DYNC1H1;SDCBP;ARSA;COTL1
prerank,receptor metabolic process (GO:0043112),0.6967211845874878,1.7027606421034782,0.0010741138560687433,0.04006868585716359,0.985,29/53,18.53%,ARRB2;LILRB1;TGFB1;SYK;ITGB2;LGMN;GRB2;CD9;GRK3;SNCA;FCER1G;LDLRAP1;DNM2;RAMP1;RAB31;UVRAG;ARFGEF2;CLTC;BECN1;SNX25;GRK4;LRP1;AP2M1;CD36;SMURF1;PIK3R4;ADM;PICALM;ITGB1
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.6805840229623212,1.7025980870930475,0.0,0.03992789457878886,0.985,23/67,11.23%,NCKAP1L;VAV1;PTK2B;CYBB;MAPKAPK3;NCF4;ITGB3;NCF2;PIK3CB;ELMO1;VAV2;MAPK14;NCK2;PRKD2;VAV3;SHC2;VEGFB;WASF2;PDCD6;ABI1;BCAR1;CYFIP1;NRP1
prerank,regulation of platelet activation (GO:0010543),0.7805972981178901,1.702395285167522,0.003694581280788177,0.03986162043576564,0.985,8/21,11.00%,LYN;PLEK;SYK;TEC;FCER1G;APOE;PRKCQ;TXK
prerank,negative regulation of B cell proliferation (GO:0030889),0.8497674189167952,1.7022196447505853,0.00411522633744856,0.03971766835465567,0.985,6/11,10.64%,LYN;FCGR2B;CD300A;TYROBP;RC3H1;TNFRSF21
prerank,cellular response to thyroid hormone stimulus (GO:0097067),0.8510050303681249,1.701571085993878,0.0028368794326241137,0.04004939273652889,0.985,6/12,2.62%,CTSS;CTSB;GATA1;BRD8;GAS2L1;CTSL
prerank,regulation of osteoclast differentiation (GO:0045670),0.7346907912622332,1.700510434466666,0.003393665158371041,0.04065761607226107,0.987,8/33,7.68%,LILRB3;UBASH3B;MTOR;TNF;OCSTAMP;GPR137B;TMEM178A;CEBPB
prerank,negative regulation of T cell mediated immunity (GO:0002710),0.8584130639486238,1.7001252510968066,0.0,0.04079622534304394,0.987,2/11,0.34%,PTPRC;LILRB1
prerank,erythrocyte differentiation (GO:0030218),0.7046194181712276,1.6995926647493982,0.0033222591362126247,0.04099220602698666,0.987,13/44,12.56%,NCKAP1L;LYN;IKZF1;HCLS1;GATA1;ACIN1;TAL1;EPO;ATP5IF1;SLC25A38;INHBA;SH2B3;RPS14
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.7389213504050847,1.6993920230345685,0.0,0.04088108298286616,0.987,8/29,8.34%,LGALS3;CCR2;LGMN;CREB3;TNF;HMGB1;AIF1;PLA2G7
prerank,activation of phospholipase C activity (GO:0007202),0.7460441957411518,1.6982322216460812,0.0011467889908256881,0.04140080406344537,0.988,7/29,7.66%,GNA15;CD86;PLCB2;P2RY6;GNAQ;S1PR4;P2RY12
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.826685419851714,1.697237840767305,0.010854816824966078,0.04204797260182694,0.991,5/13,9.31%,FGR;SYK;ITGB2;GAB2;ITGAM
prerank,B cell mediated immunity (GO:0019724),0.8798969144607387,1.6959804005418133,0.002967359050445104,0.04272821728641751,0.993,4/10,3.89%,FCGR2B;CD74;TLR8;FCER1G
prerank,neutrophil mediated immunity (GO:0002446),0.6534574118252648,1.6956426204725052,0.0,0.042735977698532136,0.993,125/432,12.58%,ARHGAP45;NCKAP1L;PTPRC;CTSS;HK3;DOCK2;TUBB;CLEC4D;LILRB3;ITGAL;FGR;LGALS3;GMFG;PTAFR;P2RX1;CYBB;MGAM;ITGAX;HPSE;SLC11A1;ARHGAP9;BIN2;ITGB2;CLEC5A;CTSB;HEXB;TMC6;GUSB;ATP8B4;UNC13D;SIRPA;CD300A;CTSD;IQGAP2;TBC1D10C;CTSC;CTSA;ADAM8;PRKCD;PTPRJ;TLR2;TCIRG1;LPCAT1;OSTF1;ARSB;ADGRE5;MAPK14;GNS;PFKL;ATP8A1;GM2A;PSAP;NPC2;ATG7;FCER1G;SLC2A3;TTR;PPIE;DNAJC3;LAIR1;PYCARD;RAB14;CD68;GYG1;NBEAL2;CD14;CPPED1;RAP1B;RAB7A;NFAM1;CD44;ADGRG3;HMGB1;XRCC5;APAF1;ARL8A;B4GALT1;CDA;TYROBP;STK10;FUCA1;VPS35L;IRAG2;STXBP3;SVIP;EPX;RAP2B;FABP5;DNAJC13;CAP1;PNP;TSPAN14;ACTR10;TMEM179B;RAB31;SLC44A2;PAFAH1B2;CCT8;CTSZ;MAN2B1;FTL;SNAP29;ITGAM;ATP6AP2;VCL;SYNGR1;FGL2;ACTR2;TMEM63A;ATP6V0A1;DIAPH1;PSMA2;CD53;CYFIP1;GPI;CD63;GRN;TNFRSF1B;CD93;GGH;PRDX6;DYNC1H1;SDCBP;ARSA;COTL1
prerank,microglial cell activation (GO:0001774),0.7742663111976082,1.694958257992272,0.0024875621890547263,0.04301154782177598,0.993,10/21,11.65%,TREM2;CX3CR1;ITGB2;TNF;SNCA;AIF1;TYROBP;C1QA;ITGAM;GRN
prerank,prostaglandin metabolic process (GO:0006693),0.7449612637167539,1.6947190791993514,0.0035629453681710215,0.04296664132036668,0.993,6/26,4.51%,TBXAS1;CD74;DAGLB;PTGES3;HPGDS;HPGD
prerank,negative regulation of phagocytosis (GO:0050765),0.7884922306051415,1.6944334826561314,0.005263157894736842,0.042984238345755946,0.993,6/17,5.85%,FCGR2B;SIRPA;CD300A;TLR2;CD300LF;HMGB1
prerank,negative regulation of complement activation (GO:0045916),-0.6698151960573793,-1.6940963852345574,0.006230529595015576,0.5951226428249657,0.999,4/10,8.07%,CD55;SERPING1;CR1L;CD46
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),0.8486895764917237,1.692043081498459,0.0,0.04447614528641584,0.993,5/13,8.29%,NCKAP1L;RUNX1;SHH;TGFBR2;PNP
prerank,dendritic cell migration (GO:0036336),0.8013440310492311,1.6914065529517222,0.006657789613848202,0.04476972333671386,0.996,5/16,9.45%,PIK3CG;CCR2;CXCR4;HMGB1;GPR183
prerank,cholesterol efflux (GO:0033344),0.7812795504799088,1.6913241662952019,0.0050062578222778474,0.044616458621867895,0.996,6/20,5.56%,ABCA1;NPC2;ABCG1;APOE;NPC1;SOAT2
prerank,macrophage migration (GO:1905517),0.8275519818663782,1.687306067494093,0.009887005649717515,0.04766966428816652,0.998,6/13,11.55%,LGALS3;CCR2;EDNRB;P2RX4;P2RY12;CCL2
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.8649236305138748,1.6870422807661216,0.002894356005788712,0.04765615440158848,0.998,4/10,5.85%,NCKAP1L;RUNX1;IRF4;HMGB1
prerank,regulation of interferon-alpha production (GO:0032647),0.7798024319437529,1.683905621289581,0.006024096385542169,0.04995671059832792,1.0,6/23,3.58%,IRF5;HAVCR2;DHX9;TLR8;TLR7;NLRC3
prerank,negative regulation of leukocyte activation (GO:0002695),0.8042226915770998,1.6826427078747184,0.007022471910112359,0.05057180461520642,1.0,5/15,5.11%,CD84;FCGR2B;CD300A;HAVCR2;CD300LF
prerank,monocyte chemotaxis (GO:0002548),0.7307563018612092,1.6825946401817968,0.0011574074074074073,0.05034343664934726,1.0,9/32,11.55%,LGALS3;TNFRSF11A;CCL8;IL6R;ANXA1;CCL14;CCL13;PTPRO;CCL2
prerank,phagolysosome assembly (GO:0001845),0.8411749846424841,1.6824205378592525,0.0013812154696132596,0.050230264543370914,1.0,7/12,5.43%,CORO1A;RAB39A;RAB34;CLN3;RAB14;RAB7A;RAB7B
prerank,regulation of chemokine production (GO:0032642),0.7204214313252421,1.6820716723462854,0.0022727272727272726,0.05026789404478945,1.0,12/36,6.51%,TREM2;CD74;LPL;CSF1R;TLR2;TLR7;FFAR2;TNF;IL6R;PYCARD;IL18;AIF1
prerank,positive regulation of lipid kinase activity (GO:0090218),0.7320398085049558,1.6801294027817193,0.002328288707799767,0.05175108059040857,1.0,5/29,1.24%,PTK2B;FGR;TGFB1;FLT3;DGKZ
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.8501716573000796,1.679394652806572,0.0,0.05214539489351087,1.0,4/12,5.08%,TREM2;STAP1;TNF;IL18
prerank,positive regulation of macrophage migration (GO:1905523),0.7811369018530006,1.67873219227679,0.00625,0.052388344104233334,1.0,8/19,11.25%,TREM2;CSF1R;MDK;P2RX4;P2RY12;AKIRIN1;CMKLR1;THBS1
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.848360431549072,1.677506340421871,0.005633802816901409,0.05313133723393439,1.0,3/11,5.06%,ARRB2;GRK3;SAG
prerank,regulation of lymphocyte proliferation (GO:0050670),0.7882732335669669,1.674999880559696,0.002677376171352075,0.055189630172253035,1.0,3/16,4.38%,CD22;LGALS3;TNFSF8
prerank,defense response to Gram-negative bacterium (GO:0050829),0.6980928913159059,1.6739345529661362,0.0,0.0559368791094706,1.0,7/42,5.04%,TREM2;SLC11A1;AQP1;MPEG1;IL6R;PYCARD;DMBT1
prerank,myeloid leukocyte differentiation (GO:0002573),0.6691670397243668,1.6732176152043305,0.0,0.05647554567906597,1.0,15/65,6.68%,RUNX1;BATF3;TREM2;PIK3CD;CBFA2T3;CSF1R;TNFRSF11A;MAPK14;CEBPA;SPI1;MYH9;EFNA2;TYROBP;GAB2;TGFBR2
prerank,intracellular pH reduction (GO:0051452),0.7303378694799206,1.6713857361814546,0.005807200929152149,0.05800403049280929,1.0,11/33,7.43%,ATP6V0D2;SLC11A1;SLAMF8;ATP6V0E1;RAB39A;TCIRG1;ATP6V1C1;ATP6V1E1;ATP6V0A2;RAB7A;ATP6V0D1
prerank,T cell homeostasis (GO:0043029),0.8491707835535688,1.6707992526295115,0.005797101449275362,0.05826672844985456,1.0,1/10,0.04%,NCKAP1L
prerank,catecholamine biosynthetic process (GO:0042423),0.8519340275136686,1.6704284431877865,0.00821917808219178,0.05831858106985651,1.0,3/11,4.50%,SNCA;GCH1;DDC
prerank,receptor internalization (GO:0031623),0.6924108846363309,1.669513229127236,0.0010869565217391304,0.05896125376181485,1.0,15/44,9.24%,ARRB2;LILRB1;SYK;ITGB2;GRB2;CD9;GRK3;SNCA;FCER1G;LDLRAP1;SAG;DNM2;RAMP1;RAB31;SCYL2
prerank,negative regulation of immune effector process (GO:0002698),0.8046274244190752,1.6689231401757494,0.007132667617689016,0.059155044216616014,1.0,5/13,1.96%,LILRB1;LGALS3;CD300A;HAVCR2;SLAMF8
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.7031176164528538,1.6684505425929028,0.0011049723756906078,0.059296896011217265,1.0,8/41,5.09%,SLAMF1;LILRB1;SIRPA;VSIR;HAVCR2;NLRC3;NR1H4;TNFAIP3
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),0.7882264203265764,1.6684331084967257,0.006720430107526882,0.05902398852247064,1.0,5/17,9.61%,NCKAP1L;CD3E;SYK;P2RY12;PODXL
prerank,muscle organ development (GO:0007517),-0.4201540171395392,-1.6671004939322087,0.0,0.6853521615044992,1.0,21/54,18.19%,SGCD;UTRN;TCF12;FHL1;CHD2;MRAS;DMD;VAMP5;COL6A3;MKX;SRI;TEAD4;EVC;SGCE;ITGA11;TBX1;MAPK12;EMD;MEF2B;TAGLN;HBEGF
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.8088781271053962,1.6664718413619544,0.012016021361815754,0.06079577381416058,1.0,4/14,4.09%,CD226;CARD11;KCNN4;PRKD2
prerank,positive regulation of T cell differentiation (GO:0045582),0.7119199132030517,1.6656927172500655,0.002244668911335578,0.06135682927016405,1.0,7/36,8.91%,NCKAP1L;SHH;VSIR;ADAM8;MDK;PNP;DUSP10
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.813685153801729,1.6655510131819853,0.002797202797202797,0.06121543543507847,1.0,4/14,3.45%,PTPRC;TREM2;CD200R1;CST7
prerank,hyaluronan catabolic process (GO:0030214),0.7887501861503406,1.6647785911795057,0.006544502617801047,0.061647008111980164,1.0,7/18,7.37%,TGFB1;HEXB;GUSB;HEXA;CD44;STAB2;SLC9A1
prerank,pinocytosis (GO:0006907),0.8596713499536499,1.6643819425792756,0.0072254335260115606,0.061690353697120184,1.0,6/10,4.90%,DOCK2;MAPKAPK3;SNX5;RAB34;PYCARD;SNX33
prerank,regulation of chemotaxis (GO:0050920),0.720407477392375,1.663940504041695,0.00591016548463357,0.06184459999462764,1.0,12/30,13.68%,TREM2;TGFB1;CYRIB;DUSP3;CXCR4;P2RX4;AIF1;P2RY12;GPR183;THBS1;STX3;ZSWIM6
prerank,phagosome acidification (GO:0090383),0.7459047112951528,1.6608186728037748,0.007142857142857143,0.06481524256744373,1.0,11/26,10.51%,ATP6V0D2;SLAMF8;ATP6V0E1;RAB39A;TCIRG1;ATP6V1C1;ATP6V1E1;ATP6V0A2;RAB7A;ATP6V0D1;ATP6V0A1
prerank,positive regulation of bone resorption (GO:0045780),0.8474585709491953,1.6599422162903952,0.009708737864077669,0.06542808268927514,1.0,6/11,11.03%,SYK;ADAM8;TNFRSF11A;SPP1;PLEKHM1;ATP6AP1
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),0.803137540217031,1.6598874091633782,0.003931847968545216,0.06520966239758774,1.0,5/17,5.96%,NCKAP1L;CD74;CAMK1D;MDK;RIPOR2
prerank,prostaglandin biosynthetic process (GO:0001516),0.7717350982085976,1.659128336907897,0.002531645569620253,0.06580075227218203,1.0,5/18,3.21%,TBXAS1;CD74;DAGLB;PTGES3;HPGDS
prerank,vesicle transport along actin filament (GO:0030050),0.7754190444500497,1.6585947555768992,0.0140485312899106,0.06613108021277334,1.0,7/19,8.47%,MYO1F;MYO1G;MYO1E;MYO5A;ACTN4;MYO7A;MYO19
prerank,T cell receptor signaling pathway (GO:0050852),0.6498082898484178,1.6583034318398924,0.0,0.06612893307583784,1.0,44/138,15.62%,THEMIS2;PTPRC;LCP2;GRAP2;INPP5D;FYB1;CARD11;CD3E;RFTN1;LAT;PIK3CD;PLCG2;PTPRJ;THY1;PIK3CB;TEC;THEMIS;PRKD2;BTN3A3;PSMB10;WNK1;NFKBID;RC3H2;MALT1;PRKCQ;DENND1B;RC3H1;SPPL3;BCAR1;EIF2B2;TNFRSF21;PSMA2;TXK;FYN;PSME3;TAB2;IKBKG;NFKB1;PSMB5;PSMD8;PAG1;ICOSLG;PSMD7;PSMB9
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.8210474104289531,1.657478192807757,0.010958904109589041,0.06668430394350187,1.0,5/14,6.68%,SYK;RASAL3;CCR2;IL18;TGFBR2
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.8247916799245344,1.6573270299679268,0.004213483146067416,0.06654441826880338,1.0,3/12,8.09%,SLC11A1;CCR2;PRKCQ
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.7297482344069148,1.6570098291264825,0.009411764705882352,0.06660078199664422,1.0,10/25,13.48%,CD226;SCIMP;LAPTM5;PLCG2;FFAR2;TRAF2;MALT1;NOD2;B2M;LACC1
prerank,presynapse organization (GO:0099172),-0.6733067507659093,-1.6567863881966836,0.015432098765432098,0.6890258519355016,1.0,4/10,17.63%,NLGN1;WNT5A;LRRTM3;FZD1
prerank,regulation of macrophage chemotaxis (GO:0010758),0.7617853007296069,1.6566066913650925,0.008484848484848486,0.06674444742252084,1.0,8/21,11.25%,PTK2B;STAP1;SLAMF8;CSF1R;MDK;AKIRIN1;CMKLR1;THBS1
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.7652982896342798,1.6563531445516153,0.0049261083743842365,0.0667487995562634,1.0,8/21,6.13%,PTPRC;CD226;CARD11;STAP1;KCNN4;PRKD2;NFAM1;PRKCB
prerank,regulation of interleukin-8 production (GO:0032677),0.6635800550007633,1.6554026200829033,0.0,0.06749053915017443,1.0,16/69,7.46%,PTPRC;SYK;CD74;TLR1;TLR2;TLR8;TLR7;FFAR2;TNF;PRKD2;PYCARD;DDIT3;CD14;HMGB1;ANXA1;TMSB4X
prerank,embryo development ending in birth or egg hatching (GO:0009792),-0.5979744514333426,-1.6549712961865273,0.019455252918287938,0.6522969513083335,1.0,10/15,32.99%,RAI2;STOX2;RICTOR;UBR3;USP22;TGFB2;CELF4;SCEL;NR5A2;BRCA1
prerank,regulation of T cell differentiation (GO:0045580),0.7174476711043988,1.6549418067227437,0.005649717514124294,0.0676967335236773,1.0,4/33,3.02%,RUNX1;CCR2;CRTAM;MDK
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.7645694902065883,1.6539957942386485,0.0049079754601227,0.06837777735639475,1.0,8/21,6.13%,RUNX1;CD22;LYN;FCGR2B;STAP1;CD300A;NFAM1;PRKCB
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.6659367358809988,1.653828855439187,0.0,0.06822118583579571,1.0,9/67,2.77%,PTK2B;BTK;FGR;LYN;HCK;SYK;FLT3;CSF1R;TEC
prerank,vitamin D metabolic process (GO:0042359),0.8264071868203762,1.6530835182177446,0.006765899864682003,0.06879495687146671,1.0,2/13,1.26%,CYP1A1;LGMN
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.8386573266018857,1.653007297346288,0.004379562043795621,0.06860206896650532,1.0,4/11,9.75%,RUNX1;VSIR;HMGB1;CD274
prerank,negative regulation of type I interferon production (GO:0032480),0.6918539609827944,1.6491785640729892,0.0011248593925759281,0.07240327607205906,1.0,15/40,13.54%,LILRB1;SIRPA;NLRC5;HAVCR2;TRIM25;NLRC3;PYCARD;TNFAIP3;YY1;TAX1BP1;RNF216;NLRX1;RNF135;ITCH;GPATCH3
prerank,macrophage activation involved in immune response (GO:0002281),0.8038319715027095,1.6463556242779036,0.011267605633802818,0.07532768898537323,1.0,7/13,11.65%,TREM2;CX3CR1;SYK;PLCG2;TYROBP;DYSF;GRN
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.6882328792266497,1.6430478260936898,0.0010964912280701754,0.07896100100099038,1.0,10/43,9.75%,SLAMF1;LILRB1;SIRPA;VSIR;HAVCR2;NLRC3;NR1H4;TNFAIP3;TRIM27;CD274
prerank,positive regulation of leukocyte proliferation (GO:0070665),0.8175228904436622,1.6412589998466365,0.006811989100817439,0.08078856900538063,1.0,3/12,3.90%,LYN;CSF1R;OCSTAMP
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.777532856570259,1.637608577408791,0.007926023778071334,0.08507778690021624,1.0,6/16,7.24%,TREM2;ADCY7;SIRPA;NLRC3;PYCARD;ABCD1
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.6395049833326965,1.6372658453398448,0.0,0.08515670878045761,1.0,27/150,7.98%,CD86;VAV1;CALCR;PIK3CG;PIK3R5;HPSE;TGFB1;CX3CR1;CASS4;HCLS1;FLT3;F10;PIK3CD;PIK3AP1;TGFBR1;ADAM8;PTPRJ;GRB2;PIK3CB;OSM;TNF;IL18;P2RX4;GAB2;CD80;P2RY12;FLT3LG
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.8358869987462171,1.636803649883441,0.01276595744680851,0.08536103619074359,1.0,2/11,0.65%,PF4;CIITA
prerank,interleukin-2-mediated signaling pathway (GO:0038110),0.8354913312115246,1.6361970453551318,0.007022471910112359,0.08539811688472539,1.0,3/11,1.35%,PTK2B;SYK;STAT5A
prerank,cellular response to interleukin-2 (GO:0071352),0.8354913312115246,1.6361970453551318,0.007022471910112359,0.08539811688472539,1.0,3/11,1.35%,PTK2B;SYK;STAT5A
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),0.768580181079998,1.6347960966096742,0.010230179028132993,0.08696398681627818,1.0,1/17,0.08%,PLBD1
prerank,negative regulation of interleukin-12 production (GO:0032695),0.7955851518112989,1.6346961874719426,0.006747638326585695,0.08674698466732157,1.0,5/14,11.25%,SLAMF1;LILRB1;TLR8;CMKLR1;THBS1
prerank,prostanoid biosynthetic process (GO:0046457),0.7772557377581328,1.6330053857735418,0.007957559681697613,0.08860503823664771,1.0,4/15,2.88%,TBXAS1;CD74;DAGLB;PTGES3
prerank,hyaluronan metabolic process (GO:0030212),0.7465656391875498,1.6322506828086096,0.006242197253433208,0.08935391786602233,1.0,7/23,7.37%,TGFB1;HEXB;GUSB;HEXA;CD44;STAB2;SLC9A1
prerank,mesoderm development (GO:0007498),0.7812817274536662,1.6321143783098253,0.006377551020408163,0.08914242612334777,1.0,4/18,2.20%,BTK;HCK;IKZF1;HES7
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.6684142290339253,1.6313579460297079,0.005422993492407809,0.0898030727545049,1.0,13/47,11.25%,TGFB1;SYK;ITGB2;PLCG2;PRKCD;GRB2;MAPK14;XDH;TYROBP;TGFBR2;TP53;ITGAM;THBS1
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.6738590394019089,1.6299248166621656,0.003246753246753247,0.0913879938881695,1.0,9/49,7.60%,LYN;HCLS1;FLT3;CSF1R;OSM;TNF;IL6R;IL18;EPO
prerank,negative regulation of inflammatory response (GO:0050728),0.6303562573774549,1.629724517128317,0.0,0.09130010343388176,1.0,42/182,13.50%,TSHB;TREM2;FGR;LYN;CALCR;HCK;SYK;ADCY7;SIRPA;CD200R1;METRNL;PRKAR2B;SLAMF8;PLCG2;CYSLTR2;PRKCD;MDK;MAPK14;FCGR1A;NLRC3;NR1H4;APOE;OTULIN;ADCY6;RHBDF2;TNFAIP3;MYH9;RAMP1;PLK2;RB1;CYSLTR1;YES1;PRKACB;GRN;TNFRSF1B;IAPP;FYN;CREB1;GPS2;FNDC4;ADCY8;ADCY3
prerank,regulation of monocyte chemotaxis (GO:0090025),0.7269304067065436,1.6292689121156387,0.012150668286755772,0.09152445838098644,1.0,8/24,8.34%,LYN;CCR2;LGMN;SLAMF8;CREB3;HMGB1;AIF1;PLA2G7
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.7681434695545915,1.6291924768226862,0.014304291287386216,0.09126297103074694,1.0,6/17,8.34%,CCR2;LGMN;CREB3;HMGB1;AIF1;PLA2G7
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.6323960042787209,1.6286322084017208,0.0,0.09166285109256593,1.0,28/138,11.30%,LCP2;SLA;PTK2B;GP6;BLNK;FGR;LYN;HCK;CD3E;SYK;CASS4;STAP1;FLT3;CD7;CSF1R;PIK3CB;GUCY2F;CLNK;SHC2;MTSS1;NEDD9;NTF3;ABI1;BCAR1;NPR2;YES1;RAPGEF1;PTPRU
prerank,regulation of leukocyte chemotaxis (GO:0002688),0.7757235942659982,1.628294397039612,0.011320754716981131,0.09170248952767833,1.0,5/18,4.50%,PTK2B;LYN;CAMK1D;MDK;IL6R
prerank,protein autoprocessing (GO:0016540),0.7657721814396998,1.6282690288302413,0.01032258064516129,0.09139027960032023,1.0,4/17,5.12%,PCSK9;FAM111A;CTSL;CASP1
prerank,negative regulation of interleukin-2 production (GO:0032703),0.7570549903284103,1.6279591736363608,0.009259259259259259,0.0913736859418536,1.0,5/18,8.56%,PTPRC;LAPTM5;HAVCR2;TNFAIP3;TRIM27
prerank,regulation of protein processing (GO:0070613),0.737882604526384,1.6262142677322506,0.010935601458080195,0.0932713130125494,1.0,4/21,4.53%,RUNX1;BAG2;ADAM8;CLN3
prerank,regulation of platelet aggregation (GO:0090330),0.7659769185887851,1.625720590242311,0.00796812749003984,0.0935544318406308,1.0,8/17,10.93%,LYN;SYK;ALOX12;PRKCD;CD9;PRKCQ;F11R;SH2B3
prerank,positive regulation of phospholipase C activity (GO:0010863),0.6852155469684799,1.6234634327387856,0.0033259423503325942,0.09627757545039312,1.0,9/40,11.00%,GNA15;CD86;PLCB2;P2RY6;GNAQ;S1PR4;P2RY12;NTF3;TXK
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.6860550887935464,1.6214996464039872,0.009163802978235968,0.09853859181029327,1.0,10/34,8.92%,TREM2;LYN;CD300A;TNFAIP3;CD14;CD300LF;RAB7B;TICAM1;GRAMD4;LY96
prerank,response to interferon-gamma (GO:0034341),0.6548977271183066,1.6209893422713022,0.0010449320794148381,0.09894562032364361,1.0,17/67,11.55%,CIITA;IRF8;SLC11A1;CD74;SIRPA;TLR2;CCL8;SNCA;GCH1;CASP1;AIF1;KYNU;CCL14;EPRS1;CCL13;GBP3;CCL2
prerank,regulation of acute inflammatory response (GO:0002673),0.7635121813552337,1.6201136556007645,0.013140604467805518,0.09977897543711879,1.0,3/18,3.52%,ADAM8;OSM;FFAR2
prerank,negative regulation of transport (GO:0051051),0.670722388813317,1.6200879948691411,0.0021482277121374865,0.09942938039677564,1.0,10/51,5.43%,LILRB1;LGALS3;FCGR2B;SIRPA;ITGB3;TLR2;SNCA;MCTP1;SNX33;RAB7A
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.7703532464834442,1.619328168012656,0.0174496644295302,0.10002953711194718,1.0,3/15,1.16%,SHH;SYK;CCR2
prerank,stem cell differentiation (GO:0048863),0.6728219530468409,1.6181835186025773,0.00778642936596218,0.10115184555872848,1.0,10/39,12.32%,PTPRC;MEOX1;SHH;SP7;EEF1AKMT4-ECE2;TP53;SETD6;MEF2C;SETD2;MTF2
prerank,regulation of cholesterol storage (GO:0010885),0.7825473661232447,1.6178489804092688,0.020053475935828877,0.10126701412041911,1.0,6/15,4.11%,TREM2;LPL;ABCA1;MSR1;SREBF2;ABCG1
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.7122304296916637,1.61660906899336,0.00589622641509434,0.10253212592774598,1.0,4/27,1.15%,PTK2B;FGR;TGFB1;FLT3
prerank,response to lipopolysaccharide (GO:0032496),0.6313405471217219,1.616382194492343,0.0,0.1024507647348678,1.0,38/138,13.46%,CD86;LILRB1;PF4;SLC11A1;CX3CR1;CXCL5;STAP1;PDCD1LG2;MAPKAPK3;IL1A;SIRPA;CXCL2;TNFRSF11A;MAPK14;SNCA;GCH1;IFNAR1;PYCARD;CD68;TNFAIP3;CD14;CASP1;HMGB1;CD80;TICAM1;ERBIN;CD180;MEF2C;LY96;CD274;CCL2;TNFRSF1B;PRDX3;NOD2;DEFA6;TAB2;SHPK;NFKB1
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.7308656281726786,1.6163130606227731,0.01376720901126408,0.10218030725773299,1.0,7/22,11.85%,NCKAP1L;LGALS3;MGAT5;TNF;PPP1R11;BOD1L1;PPP4R4
prerank,cellular response to zinc ion (GO:0071294),0.7612060459603238,1.616040226633229,0.018469656992084433,0.10225516380463412,1.0,13/15,22.29%,P2RX4;GLRA2;HVCN1;ATP13A2;MT3;MT1G;MT1B;MT1E;MT1F;MT1A;MT1X;MT1M;MT1H
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.6305780042226772,1.6138711345767374,0.0010152284263959391,0.10511152980373799,1.0,18/100,5.08%,TREM2;FGR;LYN;PIK3CG;PIK3R5;HCLS1;FLT3;PIK3CD;CBL;PIK3AP1;PIK3CB;OSM;SEMA4D;NLRC3;TNF;PIP5K1C;PIP4K2A;IL18
prerank,regulation of erythrocyte differentiation (GO:0045646),0.6725041389940623,1.6132233520304715,0.008938547486033519,0.10565725614241367,1.0,10/35,12.44%,NCKAP1L;LYN;GATA1;MAPK14;FOXO3;SPI1;TAL1;STAT5B;INHBA;CDK6
prerank,negative regulation of interferon-beta production (GO:0032688),0.8192543181597968,1.6130246607314567,0.008670520231213872,0.10558485999773404,1.0,5/10,7.16%,LILRB1;SIRPA;NLRC3;PYCARD;YY1
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.7887701833778644,1.6109476219284788,0.01544943820224719,0.10837815667681533,1.0,3/14,7.31%,PTK2B;CCR2;WNK1
prerank,"phagocytosis, engulfment (GO:0006911)",0.6806368111972082,1.6107391084125222,0.012359550561797753,0.10825460947265393,1.0,11/36,11.25%,ARHGAP25;BIN2;ITGB2;FCGR2B;ELMO1;MSR1;FCGR1A;MYH9;AIF1;ITGAM;THBS1
prerank,keratan sulfate catabolic process (GO:0042340),0.8143653338701887,1.6103447434287317,0.016877637130801686,0.10846390684718543,1.0,5/11,6.81%,HEXB;PRELP;GNS;HEXA;FMOD
prerank,triglyceride catabolic process (GO:0019433),0.7546108092153189,1.6097931057434118,0.0076824583866837385,0.1088032073746868,1.0,4/19,8.57%,LPL;FABP4;FABP5;LIPC
prerank,receptor-mediated endocytosis (GO:0006898),0.6280277625521461,1.609790896967915,0.0,0.10840611537696895,1.0,48/132,18.53%,CLEC9A;ARRB2;LILRB1;SYK;ITGB2;FCGR2B;GRB2;CTSL;CD9;MSR1;FCGR1A;MASP1;GRK3;SNX9;SNCA;FCER1G;PIP5K1C;APOE;LDLRAP1;CLN3;STAB2;STAB1;DNM2;MICALL1;AP2S1;RAMP1;GPR107;DNAJC13;RAB31;ITGAM;CLTC;ARHGAP27;GRK4;SORL1;FNBP1L;CUBN;GAK;EPS15;LRP1;AP2M1;CD36;CXCL16;HSP90AA1;VLDLR;ADM;PICALM;LRP1B;ITGB1
prerank,lymphocyte migration (GO:0072676),0.6970500328152858,1.609779380327032,0.0057273768613974796,0.10803056558365522,1.0,7/32,11.55%,MYO1G;CRTAM;ADAM8;CCL8;CCL14;CCL13;CCL2
prerank,macrophage activation (GO:0042116),0.683462506833684,1.6087552497078605,0.011363636363636364,0.10901828175329493,1.0,13/34,11.80%,TREM2;SLC11A1;SYK;ITGB2;TLR1;PLCG2;TNF;SNCA;AIF1;C1QA;ITGAM;DYSF;CD93
prerank,vacuolar acidification (GO:0007035),0.7404859280001195,1.6075664335106352,0.006150061500615006,0.11045444793797689,1.0,10/21,11.65%,ATP6V0D2;SLC11A1;ATP6V0E1;TCIRG1;CLN3;ATP6V0A2;ATP6V0D1;ATP6AP2;ATP6V0A1;GRN
prerank,fibrinolysis (GO:0042730),0.7912361794618082,1.6064488249483209,0.016643550624133148,0.11174742069703893,1.0,1/13,0.82%,GP1BA
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.6256930669266546,1.6061014278050987,0.0,0.11190952893755177,1.0,21/151,5.85%,ARRB2;PTPRC;PTK2B;SLAMF1;TREM2;SCIMP;GPNMB;CALCR;TGFB1;CD74;P2RY6;CSF1R;DSTYK;TNFRSF11A;CCL8;TNF;PRKD2;APOE;PYCARD;CD44;HMGB1
prerank,response to amyloid-beta (GO:1904645),0.6648942490087605,1.6057604078948207,0.007633587786259542,0.11198620196851745,1.0,6/44,1.53%,TREM2;MMP12;CALCR;FCGR2B;LGMN;ITGA4
prerank,regulation of BMP signaling pathway (GO:0030510),-0.37725018586796377,-1.6049068372846362,0.0,0.8962345980445369,1.0,21/73,13.87%,FSTL1;CDH5;CRIM1;BMPR1A;BMPER;FOXD1;NBL1;BMP4;SULF1;ZNF423;ACVRL1;SMAD9;XIAP;PCSK6;SMAD4;SMAD5;SMAD1;TWSG1;CCN1;SMAD6;UBE2O
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.7520504719932163,1.6044664886049302,0.0136986301369863,0.11367980653773305,1.0,4/18,7.06%,GNA15;RGS10;GNAQ;AGRN
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.7270189581800446,1.6015534828162215,0.02383939774153074,0.11793727556298872,1.0,5/23,7.72%,PTK2B;IL10RA;IL10RB;TNF;OCIAD1
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),0.7864651628641708,1.6011818702124556,0.006925207756232687,0.11812960104314492,1.0,3/11,9.57%,TREM2;KCNIP2;NOS1AP
prerank,cellular response to cytokine stimulus (GO:0071345),0.6133031545172712,1.6008162240487027,0.0,0.11837114881641243,1.0,121/416,16.89%,CD86;SLA;GRAP2;VAV1;DOCK8;IRF5;INPP5D;PTPN7;PF4;PTAFR;IL10RA;HCK;ITGAX;IRF4;IRF8;TGFB1;SYK;ITGB2;HCLS1;FLT3;CCR2;CSF3R;AIM2;STAT5A;NFE2L2;IL1A;SIRPA;IRAK2;CSF2RB;PIK3CD;IL10RB;CBL;CSF1R;F13A1;TYK2;CXCL2;PTPRJ;TLR2;GRB2;PIK3CB;TEC;DHX9;OSM;PTPN18;IL12RB2;CCL8;TNF;OCSTAMP;LDLRAP1;MYLK3;TANK;IL6R;CEBPA;IFNAR1;CXCR4;FOXO3;PYCARD;IL18;CASP1;TIMP1;IFNGR2;RIPOR2;ANXA1;BCL2L1;AIF1;GAB2;TP53;CD80;PIM1;WNK1;STAT4;ERBIN;FLT3LG;SMAD3;RC3H1;CCL14;ITGAM;EPRS1;STAT5B;TPR;NPR2;TNFRSF21;IL18BP;SH2B3;CCL13;RAPGEF1;SOX9;GBP3;CCL2;TNFRSF1B;CDC34;FYN;STX3;LRP8;PRLR;SHPK;UBE2G2;GAS6;NFKB1;TRADD;IRF1;PID1;IL2RG;PTPRT;SOX2;RO60;MAOA;IL3RA;SELPLG;GSK3A;IL13RA1;CD36;IRGM;HIF1A;SBNO2;CD47;HSP90AA1;ASAH1;PTPN12;CCL25;IL20RB
prerank,positive regulation of T-helper cell differentiation (GO:0045624),0.7796380881903849,1.6004778547369953,0.01643835616438356,0.11852820277305291,1.0,6/14,7.90%,CD86;IL18;ANXA1;CD80;NFKBID;MALT1
prerank,response to peptide (GO:1901652),0.6938310314785836,1.6003311702772103,0.005656108597285068,0.11833977206376844,1.0,14/33,13.81%,IRF5;MMP12;CALCR;STAT5A;ANXA1;STAT4;CACNA1A;ERBIN;STAT5B;EIF2B2;NOD2;FYN;KAT7;CACNA1B
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.7530940109166416,1.6002866584214674,0.01171875,0.11799178581956189,1.0,3/17,2.52%,PTPRC;CD300A;MTOR
prerank,actin filament-based transport (GO:0099515),0.741155863513826,1.6002544372052014,0.021464646464646464,0.11762484147059694,1.0,7/21,8.47%,MYO1F;MYO1G;MYO1E;MYO5A;ACTN4;MYO7A;MYO19
prerank,regulation of interferon-beta production (GO:0032648),0.6740219709756854,1.5989920682668857,0.0022002200220022,0.11913844957532735,1.0,15/46,13.89%,LILRB1;IRF5;SIRPA;TLR2;DHX9;TLR8;TLR7;NLRC3;PYCARD;TRAF3;YY1;TRIM56;RNF216;RNF135;IRF1
prerank,cellular response to copper ion (GO:0071280),0.7470316978803033,1.5981217023050833,0.023809523809523808,0.12017461918797608,1.0,12/16,22.29%,AQP1;SNCA;HSF1;MT3;MT1G;MT1B;MT1E;MT1F;MT1A;MT1X;MT1M;MT1H
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.7361844804466308,1.5948248137840437,0.020050125313283207,0.12517362778257718,1.0,11/20,19.16%,MRAP;TGFB1;BCL2L1;CLTC;NUMB;PPFIA1;PID1;AP2M1;PICALM;CSK;TMEM59
prerank,glycosaminoglycan catabolic process (GO:0006027),0.6579843766078008,1.5941745317078466,0.003194888178913738,0.12577796270894706,1.0,16/55,9.07%,HPSE;TGFB1;HEXB;GUSB;PRELP;ARSB;GNS;IDS;HEXA;CD44;STAB2;FUCA1;FMOD;AGRN;SLC9A1;BCAN
prerank,pyroptosis (GO:0070269),0.7732946951909945,1.5923874629713088,0.012032085561497326,0.12829707853970912,1.0,4/15,5.12%,TREM2;AIM2;DHX9;CASP1
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.7343988370339962,1.590753187118759,0.018915510718789406,0.13063154986389924,1.0,10/20,19.16%,MRAP;TGFB1;BCL2L1;CLTC;NUMB;PPFIA1;PID1;AP2M1;PICALM;TMEM59
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.6180057170572787,1.5906547617947813,0.0,0.13034523715229693,1.0,27/140,9.01%,ARHGAP45;ARHGAP30;FGD2;VAV1;ARHGAP25;PREX1;ARHGAP9;ABR;ARHGAP15;ARHGAP39;ARHGAP22;CYRIB;ARHGAP24;NUP62;VAV2;ARHGEF18;ARAP1;VAV3;FAM13B;TAGAP;MYO9B;GNA13;FLCN;ITSN1;ARHGAP21;ARHGAP10;ARHGAP1
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.7880160341372693,1.5905658515512342,0.024216524216524215,0.13004006200408774,1.0,3/11,8.09%,LYN;SYK;PRKCQ
prerank,negative regulation of immune system process (GO:0002683),0.762348208252575,1.5896923186768401,0.014608233731739707,0.13097710492114115,1.0,3/16,1.25%,LYN;FCGR2B;PDCD1
prerank,negative regulation of macrophage activation (GO:0043031),0.7646115403562443,1.5894083895077311,0.02197802197802198,0.1309610612351842,1.0,3/16,3.45%,PTPRC;FCGR2B;CST7
prerank,positive regulation of interleukin-10 production (GO:0032733),0.6904056441378874,1.5875614217299074,0.011507479861910242,0.1337863125535424,1.0,7/30,12.25%,IRF4;SYK;PLCG2;PYCARD;HMGB1;CD274;NOD2
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),0.807482733915464,1.5864269341625439,0.02599388379204893,0.13532392810176416,1.0,4/10,9.61%,FERMT3;CD3E;WNK1;PODXL
prerank,regulation of neutrophil migration (GO:1902622),0.8146472915186149,1.586396930864915,0.01849217638691323,0.13494933584145608,1.0,3/10,8.45%,NCKAP1L;SLAMF8;MPP1
prerank,lipid translocation (GO:0034204),0.7226949872033304,1.5863086578243877,0.022249690976514216,0.13464177301472496,1.0,8/21,12.70%,ATP8B4;ABCA1;RFT1;ATP8A1;ATP8A2;ABCB4;ABCC1;ABCA4
prerank,positive regulation of erythrocyte differentiation (GO:0045648),0.689747441160764,1.5861649781839222,0.017942583732057416,0.13447168379650537,1.0,7/25,10.54%,NCKAP1L;GATA1;MAPK14;FOXO3;TAL1;STAT5B;INHBA
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.7329434233629093,1.585357608115201,0.021628498727735368,0.13540632185243898,1.0,4/18,7.31%,GPNMB;LAPTM5;DUSP3;WNK1
prerank,regulation of adaptive immune response (GO:0002819),0.7460476967136073,1.5852174346481225,0.019404915912031046,0.1351810191211325,1.0,7/18,13.89%,FCGR2B;ADCY7;PYCARD;SAMSN1;TRIM27;SASH3;IRF1
prerank,lipid modification (GO:0030258),0.6750909255038378,1.5845387613772794,0.012585812356979404,0.1357853528699493,1.0,9/37,8.67%,CYP1A1;DGKZ;ALOX12;DGKK;DGKE;DGKG;DGKD;PLA2G7;PLPPR1
prerank,odontogenesis of dentin-containing tooth (GO:0042475),-0.5626227236855768,-1.5841914592503354,0.04924242424242424,0.9791908993998256,1.0,6/15,12.21%,FOXC1;EDA;GLI2;WNT6;HDAC2;TBX1
prerank,positive chemotaxis (GO:0050918),0.7417832047009805,1.5830815670172225,0.031007751937984496,0.13771585320140878,1.0,4/17,2.35%,GPNMB;LGALS3;CORO1A;PTPRJ
prerank,platelet degranulation (GO:0002576),0.629082300358011,1.581943467450848,0.0,0.1392174280261956,1.0,33/118,13.41%,FERMT3;PF4;LYN;MMRN1;ITGA2B;LY6G6F;TGFB1;PLEK;SRGN;ITGB3;CYRIB;F13A1;CD9;PSAP;TUBA4A;TTN;CYB5R1;TIMP1;LHFPL2;ACTN4;VEGFB;TMSB4X;SYTL4;VCL;ACTN1;BRPF3;THBS1;CD63;TLN1;F5;TEX264;NHLRC2;GAS6
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.7880477451189076,1.5816399372771874,0.01445466491458607,0.1393014606065161,1.0,5/13,7.46%,GATA1;MAD2L2;DDIT3;TAF1;TMSB4X
prerank,cellular defense response (GO:0006968),0.667634547837114,1.5807802459992786,0.011198208286674132,0.14018588083225195,1.0,6/40,2.52%,PTK2B;NCR1;CX3CR1;CLEC5A;TCIRG1;NCF2
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.6939261934169523,1.5803539375448858,0.011641443538998836,0.1404477032080898,1.0,4/29,6.35%,PLBD1;DBI;LPCAT1;LPCAT2
prerank,positive regulation of chemotaxis (GO:0050921),0.6670703455136068,1.580078709312627,0.009966777408637873,0.14043162065451972,1.0,16/43,13.52%,TREM2;TGFB1;CCR2;LGMN;SMOC2;MDK;PRKD2;IL6R;P2RX4;AIF1;TMSB4X;P2RY12;NRP1;THBS1;STX3;MEGF8
prerank,Fc receptor signaling pathway (GO:0038093),0.6151293936668508,1.579475666977169,0.0,0.14102860920629773,1.0,22/110,8.63%,LCP2;GRAP2;VAV1;BTK;LYN;CARD11;SYK;LAT;PLCG2;NFATC1;GRB2;PIK3CB;TEC;VAV2;LAT2;FCER1G;VAV3;GAB2;PSMB10;MALT1;PRKCQ;MAP3K1
prerank,inorganic ion transmembrane transport (GO:0098660),0.7710273772767615,1.5786950519502154,0.027065527065527065,0.14183418059788597,1.0,2/12,4.10%,KCNJ11;PKD2
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.7378990061437543,1.5786113904917014,0.02727272727272727,0.14153373965752553,1.0,1/16,0.06%,MRAP
prerank,regulation of sequestering of triglyceride (GO:0010889),0.7612031796752619,1.578219096126183,0.024869109947643978,0.1418683235535342,1.0,5/15,8.24%,TREM2;LPL;PLIN2;OSBPL11;PLIN3
prerank,positive regulation of interferon-alpha production (GO:0032727),0.7485600255477655,1.5770195007847436,0.018656716417910446,0.14346628520813898,1.0,4/19,2.91%,IRF5;DHX9;TLR8;TLR7
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.6141668644852548,1.576911106569984,0.0,0.14319258350739825,1.0,22/109,8.63%,LCP2;GRAP2;VAV1;BTK;LYN;CARD11;SYK;LAT;PLCG2;NFATC1;GRB2;PIK3CB;TEC;VAV2;LAT2;FCER1G;VAV3;GAB2;PSMB10;MALT1;PRKCQ;MAP3K1
prerank,T cell migration (GO:0072678),0.7723489734925835,1.5763407810113517,0.02188782489740082,0.14376003962189424,1.0,3/13,1.59%,MYO1G;PIK3CG;PIK3CD
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.7151698229509726,1.5763324553039786,0.02360248447204969,0.14333002670638467,1.0,5/22,7.72%,IL10RA;IL10RB;MGAT5;TNF;OCIAD1
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.7590891526515134,1.5761029392831045,0.026281208935611037,0.14330541586460224,1.0,4/15,7.81%,LILRB1;TGFB1;TNF;HFE
prerank,iron ion transport (GO:0006826),0.6651852581178772,1.5760883917457544,0.008898776418242492,0.14288904457306073,1.0,18/47,15.44%,ATP6V0D2;SLC11A1;ATP6V0E1;TCIRG1;ATP6V1C1;ATP6V1E1;ATP6V0A2;IREB2;DNM2;ATP6V0D1;HFE;ARHGAP1;ATP6V0A1;ATP6AP1;CLTC;FTH1;ATP6V0B;STEAP3
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.7163235269464219,1.5755780556071115,0.018315018315018316,0.14330112126232106,1.0,2/22,1.26%,CYP1A1;LGMN
prerank,stem cell development (GO:0048864),0.74578795666432,1.5735297765315315,0.026881720430107527,0.1464054467408775,1.0,2/16,0.68%,PTPRC;SHH
prerank,transepithelial transport (GO:0070633),-0.5558190408115108,-1.5734903379358467,0.05019305019305019,0.9950029124765796,1.0,4/15,8.42%,SLC12A2;ABCG2;CXADR;GPLD1
prerank,lipid oxidation (GO:0034440),0.7887555091584707,1.5726789606342721,0.019099590723055934,0.14756497480013755,1.0,5/12,16.65%,ALOX12;PLA2G7;PPARGC1A;ADIPOR1;ADIPOR2
prerank,response to acidic pH (GO:0010447),0.7655899685045853,1.5721838492615137,0.0332409972299169,0.14804074300849826,1.0,5/13,12.59%,CTSS;LGMN;SLC9A1;IMPACT;RAB11FIP5
prerank,erythrocyte development (GO:0048821),0.8083450610335124,1.5720429272258716,0.03367496339677892,0.14785784979474098,1.0,2/10,1.17%,NCKAP1L;GATA1
prerank,positive regulation of locomotion (GO:0040017),0.6976254925653878,1.5716539597800947,0.015457788347205707,0.1481046079685978,1.0,7/27,12.76%,TREM2;TGFB1;CSF1R;AIF1;P2RY12;THBS1;STX3
prerank,negative regulation of autophagosome assembly (GO:1902902),-0.5986538261719264,-1.571391495543513,0.045774647887323945,0.9551003690567873,1.0,10/13,23.07%,MTM1;FEZ1;TMEM39A;PINK1;CHMP4B;CHMP4A;NUPR1;PHF23;SMCR8;FEZ2
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),0.6868313003002439,1.5712929854569053,0.026869158878504672,0.14827190374906205,1.0,7/27,5.08%,PF4;LPL;ABCA1;ITGB3;MSR1;ABCG1;IL18
prerank,regulation of triglyceride biosynthetic process (GO:0010866),-0.5526013457508836,-1.5711371758010546,0.031496062992125984,0.9091807551565348,1.0,12/15,30.69%,SIK1;GPLD1;FBXW7;SCARB1;CTDNEP1;SLC27A1;NR1H2;NR1H3;MFSD2A;LDLR;CNEP1R1;FITM2
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.7208822287592681,1.5696398551737802,0.017241379310344827,0.15078551365985446,1.0,3/22,3.02%,RUNX1;VSIR;MDK
prerank,negative regulation of cholesterol transport (GO:0032375),0.7977914582974144,1.568831268276017,0.02695035460992908,0.15175270805786203,1.0,2/10,3.88%,SHH;SREBF2
prerank,eosinophil migration (GO:0072677),0.763510529760136,1.5681261490489165,0.03234501347708895,0.15219693550190114,1.0,4/14,11.55%,LGALS3;CCL8;CCL13;CCL2
prerank,eosinophil chemotaxis (GO:0048245),0.763510529760136,1.5681261490489165,0.03234501347708895,0.15219693550190114,1.0,4/14,11.55%,LGALS3;CCL8;CCL13;CCL2
prerank,response to ATP (GO:0033198),0.7314043326628981,1.5680997983589104,0.023255813953488372,0.15178733319994056,1.0,6/18,7.66%,KCNJ11;P2RX7;P2RY2;P2RX4;TAF1;P2RY12
prerank,negative regulation of bone mineralization (GO:0030502),0.7838464237123971,1.568099167495806,0.028288543140028287,0.1513342366829258,1.0,2/13,1.55%,PTK2B;SRGN
prerank,negative regulation of endocytosis (GO:0045806),0.6978247858524036,1.5680707636376403,0.015568862275449102,0.15090826537001562,1.0,5/24,4.90%,LILRB1;LGALS3;CD300A;MCTP1;SNX33
prerank,inositol lipid-mediated signaling (GO:0048017),0.6419596786155121,1.567922093187165,0.009594882729211088,0.15072533475038058,1.0,9/50,6.59%,PTAFR;PIK3CG;PLCB2;PLCL2;PIK3CD;CSF1R;PIK3CB;ADAP2;GAB2
prerank,positive regulation of dendrite development (GO:1900006),-0.6419682355157217,-1.5675536504575749,0.05144694533762058,0.8881526791884028,1.0,6/10,11.30%,COBL;PTN;ALK;DAB2IP;BMP5;PACSIN1
prerank,positive regulation of response to external stimulus (GO:0032103),0.6084872975424366,1.565979627627017,0.0010111223458038423,0.15384909915978875,1.0,31/128,13.66%,TREM2;SCIMP;TGFB1;CCR2;LPL;GPRC5B;ADAM8;TLR2;DHX9;TLR8;TLR7;LY86;MDK;OSM;TNF;SNCA;CEBPA;IL18;AIF1;USF1;P2RY12;CD180;PLA2G7;LY96;PUM2;ABCC1;THBS1;GRN;STX3;NINJ1;TRADD
prerank,transferrin transport (GO:0033572),0.6851338051116413,1.5653179093275138,0.01647058823529412,0.15461494763006853,1.0,13/33,11.11%,ATP6V0D2;ATP6V0E1;TCIRG1;ATP6V1C1;ATP6V1E1;ATP6V0A2;DNM2;ATP6V0D1;HFE;ARHGAP1;ATP6V0A1;ATP6AP1;CLTC
prerank,positive regulation of endocytosis (GO:0045807),0.6544342257165203,1.5649383593775745,0.008830022075055188,0.15484519327995755,1.0,18/45,18.33%,NCKAP1L;TREM2;STAP1;CBL;SNCA;APOE;LDLRAP1;CLN3;HFE;RAB31;NEDD4L;B2M;TOR1A;LRP1;APPL2;VPS28;CDC42;FLOT1
prerank,macrophage chemotaxis (GO:0048246),0.7994213933984042,1.5633782550906268,0.03215926493108729,0.15730658252371357,1.0,2/10,2.42%,LGALS3;EDNRB
prerank,phagosome-lysosome fusion (GO:0090385),0.7992522390096949,1.563275944410748,0.021246458923512748,0.15704461875389894,1.0,5/10,5.43%,RAB39A;RAB34;CLN3;RAB7A;RAB7B
prerank,positive regulation of actin filament polymerization (GO:0030838),0.6462750849818575,1.56226252484692,0.013201320132013201,0.15845028548661352,1.0,6/44,4.78%,NCKAP1L;PTK2B;HCK;NCK2;SNX9;PYCARD
prerank,phospholipid catabolic process (GO:0009395),0.6948355256366281,1.561991781266744,0.014302741358760428,0.1585145964648277,1.0,3/24,3.09%,PLBD1;ABHD12;ANGPTL3
prerank,positive regulation of lipid transport (GO:0032370),0.7811293384400307,1.561181008543881,0.02789400278940028,0.1595747803894037,1.0,6/12,15.27%,DBI;APOE;SPP1;ABCB4;LRP1;ABCA3
prerank,regulation of neutrophil chemotaxis (GO:0090022),0.7234605686081987,1.5611424756079018,0.008557457212713936,0.1591817828801632,1.0,6/23,8.45%,NCKAP1L;CD74;CAMK1D;MDK;RIPOR2;MPP1
prerank,regulation of collagen biosynthetic process (GO:0032965),0.7172163512119136,1.5607165973515056,0.024296675191815855,0.1594415305366542,1.0,5/19,7.23%,RUNX1;CIITA;TGFB1;RGCC;CREB3L1
prerank,regulation of dendritic cell apoptotic process (GO:2000668),0.7944725518905241,1.5602401413424614,0.03566121842496285,0.15981476640570094,1.0,2/10,0.52%,LILRB1;LYN
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.7427316103360907,1.559679724995747,0.017743979721166033,0.1603651901810323,1.0,4/18,7.29%,LILRB1;LILRB3;GPR137B;TMEM178A
prerank,renal water homeostasis (GO:0003091),0.6924419342454703,1.5594461909286257,0.031862745098039214,0.16042292752906448,1.0,10/23,14.22%,ADCY7;PRKAR2B;AQP1;ADCY6;TFAP2B;RAB11A;PRKACB;ADCY8;ADCY3;WFS1
prerank,positive regulation of lipid storage (GO:0010884),0.7124486814201838,1.5593234287723394,0.02252816020025031,0.16015295623798692,1.0,8/21,13.46%,LPL;MSR1;SREBF2;PLIN2;OSBPL11;PLIN3;VSTM2A;NFKB1
prerank,negative regulation of bone remodeling (GO:0046851),0.7908075340969174,1.5591488543771443,0.017118402282453638,0.16007980568631955,1.0,4/11,5.09%,UBASH3B;P2RX7;GPR137B;TNFAIP3
prerank,somite development (GO:0061053),0.7892866061417949,1.5584066918958162,0.015827338129496403,0.16105339932908008,1.0,2/11,0.68%,MEOX1;SHH
prerank,regulation of protein kinase B signaling (GO:0051896),0.6028779737879271,1.5573289080678159,0.0,0.16256636553688134,1.0,34/193,9.56%,ARRB2;CD86;VAV1;CALCR;PIK3CG;PIK3R5;HPSE;TGFB1;CX3CR1;CASS4;HCLS1;FLT3;F10;PIK3CD;PIK3AP1;TGFBR1;ADAM8;PTPRJ;GRB2;PIK3CB;OSM;TNF;DDIT3;IL18;XDH;P2RX4;OTUD3;GAB2;CD80;P2RY12;FLT3LG;FLCN;PDCD6;STRN
prerank,positive regulation of acute inflammatory response (GO:0002675),0.7672337758515012,1.5564436655657177,0.023351648351648352,0.1636806448933045,1.0,4/14,3.81%,ADAM8;OSM;FFAR2;TNF
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.6669263916991844,1.5556432518391834,0.013574660633484163,0.16473678863543176,1.0,11/35,11.23%,PTK2B;HCK;HCLS1;STAP1;IQGAP2;CSF1R;MDK;NTF3;ARHGDIB;F11R;NRP1
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.6894305815486885,1.5547008179155601,0.022871664548919948,0.16604566714618135,1.0,5/22,9.17%,TREM2;LYN;TNFAIP3;RAB7B;WDFY1
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),0.7131760762902056,1.554524212438816,0.01982651796778191,0.1659572824950777,1.0,8/21,12.98%,CX3CR1;MDK;FZD9;FZD3;CTNNB1;DISC1;NAP1L1;SMARCD3
prerank,positive regulation of macrophage differentiation (GO:0045651),0.7984679521627848,1.5541307300154186,0.020086083213773313,0.16618947452066957,1.0,4/11,12.90%,PF4;TGFB1;HSF1;CASP8
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.6237625864491239,1.553936665285405,0.00102880658436214,0.16602993251081388,1.0,22/76,12.91%,ARRB2;TMIGD3;AIM2;IRAK2;NLRC5;HAVCR2;NLRC3;OTULIN;PYCARD;DDIT3;SPI1;TNFAIP3;TRAF3;SETD6;TAX1BP1;TMSB4X;ERBIN;ANXA4;CMKLR1;USP7;DAP;ITCH
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.6817652820716112,1.5534368409152461,0.03361344537815126,0.16650505425397621,1.0,3/27,5.93%,GNA15;LPAR6;GPR17
prerank,positive regulation of type 2 immune response (GO:0002830),0.7713658580617201,1.5533450407511882,0.02571041948579161,0.1662491587447275,1.0,5/14,12.25%,CD86;CD74;IL18;DENND1B;NOD2
prerank,response to copper ion (GO:0046688),0.7095341934901259,1.5529112983199866,0.024265644955300127,0.16659952346096096,1.0,13/20,22.29%,IL1A;AQP1;SNCA;HSF1;MT3;MT1G;MT1B;MT1E;MT1F;MT1A;MT1X;MT1M;MT1H
prerank,regulation of macrophage differentiation (GO:0045649),0.7555032584792879,1.5521429501392436,0.030065359477124184,0.16759343133116736,1.0,5/15,12.90%,PF4;C1QC;HSF1;INHBA;CASP8
prerank,negative regulation of ossification (GO:0030279),0.7042753887324299,1.5510144909244803,0.022388059701492536,0.16927056762008175,1.0,6/23,12.22%,PTK2B;SRGN;MDK;MEF2C;SOX9;CHSY1
prerank,lymphocyte chemotaxis (GO:0048247),0.6560054416524714,1.5503750471644189,0.023076923076923078,0.1700863554300568,1.0,12/34,18.57%,PIK3CG;PIK3CD;ADAM8;CCL8;CCL14;GPR183;CCL13;CCL2;GAS6;CXCL16;CCL25;CKLF
prerank,excitatory postsynaptic potential (GO:0060079),0.712542714501246,1.549934079740041,0.03416557161629435,0.1705454521897448,1.0,2/19,0.45%,ARRB2;NPAS4
prerank,regulation of MAP kinase activity (GO:0043405),0.6099208247703425,1.5491111435367249,0.0030737704918032786,0.17169626615818825,1.0,13/92,4.14%,LYN;PIK3CG;PIK3R5;TGFB1;FLT3;CD300A;ADAM8;PRKCD;PTPRJ;PTPN1;PIK3CB;TNF;APOE
prerank,regulation of hemopoiesis (GO:1903706),0.7945395741613273,1.548532352970224,0.027941176470588237,0.17233202109944698,1.0,3/10,6.13%,RUNX1;LGALS3;PRKCB
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.660257144323117,1.5479135531622874,0.019144144144144143,0.17316676348520996,1.0,10/35,11.48%,PTPRC;IL10RA;IL10RB;TNF;OCIAD1;DOT1L;SH2B3;NF2;NLK;ADIPOR1
prerank,response to molecule of bacterial origin (GO:0002237),0.6277366628044766,1.547594440436592,0.006269592476489028,0.17334988903952864,1.0,14/69,8.92%,IRF5;SLC11A1;FCGR2B;MAPKAPK3;CYRIB;CXCL2;TNFRSF11A;SNCA;GCH1;IFNAR1;TNFAIP3;CD14;ERBIN;LY96
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.6889584288619665,1.547180099430496,0.019753086419753086,0.1736975114096528,1.0,2/25,0.45%,ARRB2;NPAS4
prerank,regulation of innate immune response (GO:0045088),0.6317969391468159,1.5461098928314927,0.011752136752136752,0.1753910778344617,1.0,18/57,13.89%,TREM2;FGR;FCGR2B;ADAM8;PTPN1;DHX9;TLR8;NLRC3;TRAFD1;TNFAIP3;SAMHD1;RNASEL;USP18;RNF135;CASP8;LRP8;ERAP1;IRF1
prerank,regulation of protein kinase activity (GO:0045859),0.6099824888572288,1.5454416322453792,0.003054989816700611,0.17631021433283972,1.0,27/106,14.55%,PTPRC;LCP2;PTK2B;FGR;UBASH3B;LAT;MMD;THY1;GNAQ;SNX9;TNF;SNCA;TTN;XRCC5;MAP2K3;RAP2B;RB1;TRIM27;UVRAG;QARS1;DUSP19;DTNBP1;TAB2;CAMKK2;GAS6;RTRAF;RAP1A
prerank,negative regulation of lipid storage (GO:0010888),0.7181576732354452,1.5451205357837547,0.019455252918287938,0.17648300401231864,1.0,5/19,4.11%,TREM2;ABCA1;ITGB3;TNF;ABCG1
prerank,tryptophan metabolic process (GO:0006568),0.7764316999828852,1.545084839930409,0.038834951456310676,0.17607639400747782,1.0,4/11,7.82%,ATP7A;HAAO;KYNU;KMO
prerank,leukocyte tethering or rolling (GO:0050901),0.7447135419991993,1.5446823404681003,0.026455026455026454,0.17639312378364833,1.0,4/17,3.81%,CX3CR1;ITGA4;GCNT1;TNF
prerank,heterotypic cell-cell adhesion (GO:0034113),0.6902607590561921,1.5410528374517458,0.025703794369645042,0.18306765274161804,1.0,6/25,3.69%,ITGAX;ITGB2;ITGA4;CD200R1;ITGB3;PKP2
prerank,zymogen activation (GO:0031638),0.6510258827424449,1.540939242002905,0.01905829596412556,0.18282555501786518,1.0,7/39,8.96%,KLK3;LGMN;VSIR;CTSL;ASPH;TBC1D10A;BAK1
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.6714267600928652,1.5407348734817616,0.027446300715990454,0.1827440290772509,1.0,4/29,4.28%,TGFB1;MYL3;PKP2;TTN
prerank,regulation of leukocyte migration (GO:0002685),0.7440067896147801,1.5403996742471104,0.02442159383033419,0.1829753043106136,1.0,2/16,6.34%,NCKAP1L;ANXA1
prerank,regulation of activated T cell proliferation (GO:0046006),0.6631446646889462,1.540095822076579,0.023255813953488372,0.1830871924602988,1.0,7/30,9.75%,PDCD1LG2;CRTAM;PYCARD;IL18;HMGB1;RC3H1;CD274
prerank,melanocyte differentiation (GO:0030318),0.7841258849759645,1.539940523455104,0.036619718309859155,0.18289579074477785,1.0,3/11,8.10%,LRMDA;MITF;MEF2C
prerank,positive regulation of leukocyte activation (GO:0002696),0.7169640207566074,1.538907234188693,0.03398692810457516,0.18451956153009486,1.0,3/18,4.57%,CLEC4D;CD226;CEBPA
prerank,regulation of neuroinflammatory response (GO:0150077),0.7129462499553691,1.537747211363511,0.028132992327365727,0.18621484398222615,1.0,4/19,5.08%,TREM2;CD200R1;TNF;IL18
prerank,phospholipid homeostasis (GO:0055091),0.7901179559338106,1.5376782380439342,0.02556818181818182,0.1859131654800271,1.0,3/11,4.11%,ABCA1;ANGPTL3;ABCG1
prerank,regulation of granulocyte chemotaxis (GO:0071622),0.7188160934957435,1.5355999574707404,0.03444034440344403,0.18963745013464442,1.0,7/19,11.25%,CSF1R;CAMK1D;MDK;MPP1;AKIRIN1;CMKLR1;THBS1
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.6128920309932416,1.5350719171455087,0.009259259259259259,0.19024607408765382,1.0,18/76,12.21%,NCKAP1L;PTK2B;HCK;PLEK;HCLS1;STAP1;P2RX7;NUP62;NCK2;SNX9;MYLK3;PYCARD;PLK4;NTF3;PFN2;PFN1;NRP1;DYNC1H1
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.7765131717525233,1.5350628179952983,0.0361794500723589,0.1897807470591206,1.0,3/10,7.53%,TREM2;CD68;TICAM1
prerank,regulation of defense response (GO:0031347),0.6190263760578522,1.5348775435934354,0.004162330905306972,0.18975450739371047,1.0,27/76,14.52%,TREM2;FGR;HCK;FCGR2B;CCR2;PIK3AP1;DAGLB;APOE;CASP1;TRAF3;SAMHD1;ANXA1;SETD6;AKNA;TMSB4X;ZMPSTE24;GRN;USP18;NOD2;RNF135;CASP8;LRP8;SHPK;LACC1;ERAP1;IRF1;AREL1
prerank,regulation of calcium ion import (GO:0090279),0.6869649515801467,1.5340119524715445,0.03745318352059925,0.19092757046447653,1.0,6/21,12.34%,LGALS3;PKD2;CTNNB1;TRIM27;CCL2;FYN
prerank,positive regulation of protein kinase activity (GO:0045860),0.5943526802949546,1.534004042183183,0.0,0.19046406610101674,1.0,44/148,16.75%,PTPRC;LCP2;PTK2B;SLC11A1;CASS4;LAT;ITGB3;TAOK3;CSF1R;GPRC5B;MMD;PRKCD;PTPN1;FCGR1A;SNX9;TNF;SNCA;IL6R;XRCC5;MAP2K3;TGFBR2;NEDD9;TNIK;KIF14;STRADB;DUSP19;MAP2K2;PARP16;PPP2CA;TAB2;LRP8;GAS6;STK3;RAP1A;PIH1D1;SRC;STRADA;SYAP1;ALS2;INCENP;IRGM;EPHA4;HSP90AA1;STK4
prerank,anterior/posterior axis specification (GO:0009948),0.7403147109124252,1.5334595059207055,0.017379679144385027,0.1910393475712789,1.0,3/15,4.84%,SHH;SKI;DDIT3
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.698797648655339,1.5328951770082004,0.03209242618741977,0.19116817476080217,1.0,5/21,6.37%,PF4;GATA1;IL1A;TNF;BCL2L1
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),0.698797648655339,1.5328951770082004,0.03209242618741977,0.19116817476080217,1.0,5/21,6.37%,PF4;GATA1;IL1A;TNF;BCL2L1
prerank,lysosome localization (GO:0032418),0.6466400736573115,1.532451177920222,0.025755879059350503,0.19166736650117724,1.0,13/37,12.68%,PIK3CG;PLEKHM2;PIK3CD;RAB34;KLC2;PLEKHM1;MYH9;TFEB;FLCN;SYTL4;HDAC6;BORCS5;PIP4P1
prerank,negative regulation of ion transport (GO:0043271),0.6908211717951177,1.532281548240425,0.02909090909090909,0.1915282948750719,1.0,4/24,7.31%,PTK2B;LILRB1;SNCA;WNK1
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.6192839532771606,1.5321960373196502,0.005154639175257732,0.19119916117474545,1.0,22/72,15.15%,PTPRC;RUNX1;SYK;CD74;IRAK2;PTPN1;TNF;OTULIN;TRAF2;PYCARD;TNFAIP3;IFNGR2;CFLAR;TAX1BP1;RNASEL;USP18;IKBKG;CASP8;GAS6;TRADD;SPPL2A;PIAS1
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.7187199847123112,1.531800130963632,0.040973111395646605,0.19148109659828957,1.0,3/17,1.83%,SCIMP;LYN;TAOK3
prerank,retinol metabolic process (GO:0042572),0.7419673648847039,1.5316974013618438,0.042119565217391304,0.1912204155509607,1.0,2/14,3.05%,CYP1A1;DHRS3
prerank,positive regulation of MAP kinase activity (GO:0043406),0.6161722100732769,1.531302914203507,0.008359456635318705,0.19149833324466334,1.0,11/66,6.91%,PIK3CG;PIK3R5;TGFB1;FLT3;TAOK3;FZD10;ADAM8;TNFRSF11A;TNF;TRAF2;MAP3K5
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),-0.567283442006985,-1.5306542943688806,0.04198473282442748,1.0,1.0,8/13,25.26%,CPSF6;FIP1L1;CPSF7;CSTF2;TUT1;CSTF2T;NCBP2;CPSF1
prerank,negative regulation of cell development (GO:0010721),0.6908184820276636,1.5296117636250015,0.026282853566958697,0.19458994498163432,1.0,9/25,16.66%,HOOK3;LILRB1;TNF;PCM1;SORL1;B2M;RFLNA;GSK3A;APPL2
prerank,positive regulation of collagen metabolic process (GO:0010714),0.7176636758260899,1.5293901388744473,0.03871829105473965,0.1945755310673806,1.0,5/17,7.23%,RUNX1;TGFB1;VSIR;RGCC;CREB3L1
prerank,intracellular cholesterol transport (GO:0032367),0.7439946387896124,1.5293602938116055,0.03810775295663601,0.19414977890570156,1.0,7/15,14.53%,ABCA1;NPC2;ABCG1;LDLRAP1;NPC1;OSBP;STARD4
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.6748559353109015,1.5285053951589187,0.027644230769230768,0.1953930372820674,1.0,4/26,1.40%,HPSE;TGFB1;CCR2;IL1A
prerank,heart process (GO:0003015),-0.561310204212249,-1.5275129225580444,0.056451612903225805,1.0,1.0,4/14,9.66%,SGCD;SGCZ;SOD1;ACE
prerank,negative regulation of biomineral tissue development (GO:0070168),0.707608071507913,1.527374430129033,0.03333333333333333,0.19723666449981356,1.0,3/21,1.55%,PTK2B;TGFB1;SRGN
prerank,secretory granule organization (GO:0033363),0.8033609233887276,1.5270019133790043,0.03111111111111111,0.19751839080500802,1.0,3/10,1.71%,LYST;SRGN;ABCA1
prerank,base conversion or substitution editing (GO:0016553),0.763545989563796,1.5267889349508952,0.03486750348675035,0.19746177062002873,1.0,4/11,13.05%,APOBEC1;ADAR;METTL3;ADARB1
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.6433573402593754,1.5257033091337568,0.02569832402234637,0.19917895053692858,1.0,10/38,8.02%,PTPRC;CASS4;CSF1R;GPRC5B;THY1;PTPN1;FCGR1A;NCK2;NEDD9;RAP2B
prerank,negative regulation of protein localization to membrane (GO:1905476),0.6877125547433156,1.52531155935753,0.04744958481613286,0.1994363613395507,1.0,11/24,19.95%,MRAP;TGFB1;BCL2L1;CLTC;NUMB;PPFIA1;PID1;AP2M1;PICALM;TMEM59;INPP5K
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),-0.5645123904553656,-1.5250382046628321,0.04081632653061224,1.0,1.0,7/13,15.60%,NFIB;BMP4;REST;PPARA;NFATC4;RELA;PPARG
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.7338856122457398,1.5240114531239757,0.033602150537634407,0.2017444884211369,1.0,7/15,16.04%,PF4;LPL;MSR1;IL18;PRKCH;NFKB1;CD36
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.6827466124438006,1.5230204421877254,0.02491103202846975,0.20332919850053702,1.0,6/25,8.46%,TGFB1;GATA1;MAD2L2;NSD1;DOT1L;RB1
prerank,negative regulation of signaling (GO:0023057),0.6857534815033757,1.5227208073199698,0.036231884057971016,0.20344054237749104,1.0,4/25,3.12%,UBASH3B;PCSK9;PTPN1;OSM
prerank,phosphatidylinositol metabolic process (GO:0046488),0.6004387807133458,1.522644776049424,0.0010152284263959391,0.20310278994535835,1.0,15/109,4.84%,PLBD1;INPP5D;PIK3CG;PLCB2;PIK3R5;PLEK;PIK3CD;CSF1R;PLCG2;PIK3CB;PIP5K1C;INPP4B;PIP4K2A;PI4K2A;RAB14
prerank,regulated exocytosis (GO:0045055),0.5982885611965839,1.5218333601754552,0.0,0.20428215550963022,1.0,44/173,13.41%,FERMT3;PF4;LYN;MMRN1;ITGA2B;LY6G6F;SYT17;TGFB1;PLEK;SRGN;ITGB3;CYRIB;F13A1;SDF4;CD9;PSAP;SNCA;PIP5K1C;TUBA4A;TTN;CYB5R1;TIMP1;MYH9;LHFPL2;ACTN4;SYT2;VEGFB;TMSB4X;RAB31;SYTL4;SYT10;VCL;SYNGR1;ACTN1;SYNGR2;BRPF3;THBS1;CD63;TLN1;F5;RAB11FIP5;TEX264;NHLRC2;GAS6
prerank,intracellular sterol transport (GO:0032366),0.765229699002393,1.5214803369236127,0.03351206434316354,0.20455318204188988,1.0,7/13,14.80%,ABCA1;NPC2;ABCG1;NPC1;OSBP;STARD4;ARV1
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.613284061769297,1.5213663822282757,0.009433962264150943,0.20429392390187331,1.0,8/69,2.72%,PTAFR;PIK3CG;PLCB2;PIK3R5;PLCL2;PIK3CD;CSF1R;PIK3CB
prerank,calcium-mediated signaling (GO:0019722),0.6012152690094603,1.5211235725658294,0.0040609137055837565,0.20432308369517532,1.0,17/93,7.66%,PTPRC;BTK;CX3CR1;CCR2;LAT;PLCG2;PTPRJ;EDNRB;P2RX7;SLC8A1;LAT2;CXCR4;MCTP1;P2RX4;NUDT4;SLC9A1;P2RY12
prerank,extracellular matrix disassembly (GO:0022617),0.6183798307556619,1.5202920914279756,0.01079913606911447,0.20552011045695054,1.0,9/53,5.65%,CTSS;MMP12;LCP1;SH3PXD2B;ADAM8;CTSK;CTSL;TIMP1;CD44
prerank,cellular component disassembly (GO:0022411),0.6186328629628891,1.5196985055305228,0.008658008658008658,0.20627417229290365,1.0,9/53,5.65%,CTSS;MMP12;LCP1;SH3PXD2B;ADAM8;CTSK;CTSL;TIMP1;CD44
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),0.7201569839979578,1.5189197219443402,0.038860103626943004,0.20742675980450015,1.0,4/18,3.81%,CX3CR1;ITGA4;GCNT1;TNF
prerank,lysosome organization (GO:0007040),0.6422287739770085,1.5180312492680454,0.0257847533632287,0.20887535891781692,1.0,15/36,17.35%,HOOK3;ABCA1;CORO1A;MTOR;ARSB;CLN3;VPS18;TFEB;MYO7A;GRN;HOOK2;LRRK2;GNPTAB;TMEM165;LAMTOR1
prerank,regulation of amyloid-beta clearance (GO:1900221),0.7148730702491629,1.5178723008817656,0.04227212681638045,0.20870658009148751,1.0,4/16,6.92%,TREM2;TNF;APOE;MYOCD
prerank,negative regulation of cilium assembly (GO:1902018),-0.5869279763233781,-1.5177465684164126,0.0472972972972973,1.0,1.0,6/12,18.91%,MAP4;CCP110;EVI5L;CEP97;CDK10;TBC1D7
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.6211708314259994,1.5177376198896462,0.010718113612004287,0.2085240787439172,1.0,12/57,12.34%,LYN;HCLS1;FLT3;CSF1R;OSM;TNF;IL6R;IL18;EPO;SH2B3;NF2;PPP2CA
prerank,cellular component maintenance (GO:0043954),0.74130343225733,1.5151459097386062,0.049575070821529746,0.21371859470826113,1.0,1/12,0.36%,TREM2
prerank,cellular protein catabolic process (GO:0044257),0.6192143459444217,1.5141459729246731,0.012644889357218124,0.21534594600644374,1.0,22/59,16.53%,CTSS;CTSB;PCSK9;LGMN;CTSC;MYLIP;TCIRG1;CTSK;CTSL;RAB7A;LONP1;AP2S1;MALT1;CHEK2;CTSZ;CLTC;CASP8;UBE2G2;CAPN2;AP2M1;IDE;YME1L1
prerank,hemopoiesis (GO:0030097),0.606876729316358,1.5139561038662468,0.002061855670103093,0.2152645111492677,1.0,17/87,11.97%,PTPRC;RUNX1;PLD4;TGFB1;PLEK;FLT3;CSF1R;CEBPA;TGFBR2;TP53;TAL1;FLT3LG;FLCN;INHBA;SH2B3;ETV6;PRDX3
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.46973630397743543,-1.5136671486444508,0.04390243902439024,1.0,1.0,7/21,10.09%,CACNA1C;ANK2;RYR2;DMD;SRI;ATP1A2;CALM3
prerank,regulation of viral entry into host cell (GO:0046596),0.6522460580334899,1.5122451997178714,0.03411764705882353,0.2184052397530541,1.0,8/30,11.21%,CIITA;CD74;TRIM25;TRIM5;P4HB;TRIM27;LGALS1;MID2
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.6410031838740704,1.5121787523120203,0.03103448275862069,0.21804919724631228,1.0,8/33,10.54%,NCKAP1L;GATA1;MAPK14;FOXO3;RAB7B;TAL1;STAT5B;INHBA
prerank,regulation of T cell migration (GO:2000404),0.7083931639547297,1.5119826278159203,0.04516129032258064,0.21797397396017665,1.0,5/18,6.51%,DOCK8;CD200R1;PYCARD;RIPOR2;AIF1
prerank,acylglycerol homeostasis (GO:0055090),0.7040790825223627,1.5115294095731715,0.05093167701863354,0.21846327215802247,1.0,7/20,12.23%,LPL;MLXIPL;ANGPTL3;APOE;IL18;LIPC;ANGPTL4
prerank,vesicle organization (GO:0016050),0.6257278196867786,1.5112263508788333,0.01644736842105263,0.2186201850919981,1.0,23/46,19.71%,HOOK3;SRGN;CORO1A;PI4K2A;SNX33;VPS18;VPS11;DNAJC13;ARFGEF2;WASHC4;EXOC8;PI4K2B;SAR1A;FNBP1L;HOOK2;USP8;EPS15;ALS2;LAMTOR1;SNX10;VPS33B;LAPTM4B;SORT1
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.6295400325645606,1.5108470897790736,0.021574973031283712,0.21894697574892527,1.0,13/48,13.41%,PTPRC;TREM2;STAP1;NLRC5;RFFL;SAMHD1;YTHDF3;SH2B3;TTLL12;USP18;METTL3;GPS2;GAS6
prerank,mesenchyme development (GO:0060485),0.7270402521831528,1.5108047079528104,0.047106325706594884,0.21854887050512867,1.0,3/15,4.10%,MEOX1;TGFBR1;PKD2
prerank,toll-like receptor 9 signaling pathway (GO:0034162),0.7551314837432688,1.5098911086518376,0.03913630229419703,0.21997814036357682,1.0,4/13,2.91%,IRAK2;PIK3AP1;UNC93B1;TLR7
prerank,cellular response to lipid (GO:0071396),0.586332975079729,1.5074799394821161,0.001001001001001001,0.22486708119685386,1.0,48/191,13.92%,CD86;PTK2B;LILRB1;PF4;LYN;CX3CR1;CXCL5;STAP1;PDCD1LG2;IL1A;SIRPA;LPL;MAP4K1;AQP1;FZD10;CXCL2;MAPK14;FFAR2;NR1H4;ADCY6;PYCARD;CD68;SPP1;TNFAIP3;CD14;CASP1;HMGB1;ABCB4;CD80;TICAM1;CD180;MEF2C;LY96;CD274;SOX9;CCL2;TNFRSF1B;NRIP1;TWF2;NOD2;DEFA6;CREB1;SHPK;NFKB1;ADCY8;ADCY3;MGST1;PID1
prerank,angiogenesis involved in wound healing (GO:0060055),0.754036175342915,1.5066225666538626,0.05307262569832402,0.22633639417913032,1.0,2/11,1.74%,HPSE;ITGB3
prerank,positive regulation of MAPK cascade (GO:0043410),0.5816743692782269,1.5062445794679984,0.0,0.22668165874738525,1.0,30/245,5.85%,ARRB2;PTPRC;PTK2B;SLAMF1;TREM2;SCIMP;GPNMB;CALCR;PIK3CG;PIK3R5;TGFB1;FLT3;CD74;P2RY6;LAPTM5;TAOK3;CSF1R;PLCG2;ADAM8;PTPRJ;DSTYK;OSM;CCL8;TRIM5;TNF;PRKD2;APOE;PYCARD;CD44;HMGB1
prerank,regulation of nervous system process (GO:0031644),-0.49938635872845244,-1.5060128388345386,0.03982300884955752,1.0,1.0,7/18,12.61%,APP;DLGAP1;HTR2C;DLGAP2;SLC8A3;CHRNA7;NOS3
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.6664678244887573,1.5053048261126236,0.04047619047619048,0.22828504423981996,1.0,10/27,16.04%,BTK;IRAK2;TLR1;TLR2;CD14;MAP3K1;LY96;TAB2;TAB3;CD36
prerank,regulation of response to external stimulus (GO:0032101),0.5926145478318134,1.5046008414190282,0.0010090817356205853,0.22932617730395521,1.0,41/121,16.66%,TREM2;FGR;HCK;GP1BA;FCGR2B;CCR2;CYRIB;PIK3AP1;DAGLB;TRIM5;GUCY2F;CXCR4;SAG;CASP1;TRAF3;P2RX4;SAMHD1;ANXA1;CNGB1;SETD6;AKNA;TMSB4X;P2RY12;ZMPSTE24;GRN;USP18;NOD2;GRK4;RNF135;CASP8;LRP8;SHPK;LACC1;STK24;ERAP1;IRF1;AREL1;METAP2;CD36;SBNO2;APPL2
prerank,osteoclast differentiation (GO:0030316),0.6787445526437766,1.5045078221666617,0.041044776119402986,0.22898762993266455,1.0,9/22,9.45%,TREM2;CSF1R;TNFRSF11A;MAPK14;OCSTAMP;EFNA2;TYROBP;GAB2;GPR183
prerank,cytokine-mediated signaling pathway (GO:0019221),0.5750378608672376,1.504172423204924,0.0,0.2292100313069369,1.0,118/532,14.02%,CD86;SLA;GRAP2;VAV1;PTK2B;IRF5;INPP5D;PF4;PTAFR;IL10RA;CIITA;HCK;ITGAX;IRF4;IRF8;TGFB1;SYK;ITGB2;CXCL5;LCP1;FLT3;CCR2;CSF3R;AIM2;STAT5A;IL1A;IRAK2;CSF2RB;PIK3CD;IL10RB;CBL;CSF1R;F13A1;TYK2;CXCL2;TRIM25;PRKCD;PTPRJ;IL21R;GRB2;PIK3CB;TEC;TNFRSF11A;OSM;FCGR1A;IL12RB2;CCL8;TRIM5;TNF;FCER1G;AIP;UBE2V1;TNFSF8;TRAF2;IL6R;CEBPA;IFNAR1;FOXO3;PYCARD;SPI1;IL18;CD300LF;CASP1;TRAF3;TIMP1;RAP1B;CD44;MAP3K14;IFNGR2;SAMHD1;ANXA1;BCL2L1;GAB2;TP53;CD80;ACTN4;PSMB10;PIM1;STAT4;TMSB4X;P4HB;EPO;CAPZA1;ST18;FLT3LG;IL18RAP;ADAR;IRF2;CCL14;ITGAM;STAT5B;TRAF5;TRIM8;RNASEL;IL18BP;SH2B3;PSMA2;CCL13;RAPGEF1;LIMS1;RPS6KA4;ADIPOR1;CCL2;TNFRSF1B;NOD2;FYN;PSME3;TAB2;STX3;IKBKG;LRP8;B2M;PRLR;NFKB1;TRADD;PSMB5;IRF1;IL2RG
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.5763145932463085,-1.503832187955694,0.06007067137809187,1.0,1.0,6/12,26.19%,CAV1;SRI;CALM3;GJD3;PDE4D;CALM2
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.6901770327533874,1.5022282280673827,0.05641025641025641,0.23314396374125831,1.0,5/18,8.96%,FCGR2B;ERN1;DDIT3;ATXN3;BAK1
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.6548912466885867,1.5019296219253047,0.02564102564102564,0.23328205737062624,1.0,4/33,2.72%,PIK3CG;PIK3R5;PIK3CD;PIK3CB
prerank,positive regulation of cellular component movement (GO:0051272),0.6700754231043251,1.5011471773213187,0.05143540669856459,0.23447548737684468,1.0,4/24,6.77%,LYN;CSF1R;TGFBR1;ACTN4
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.6342903089493358,1.4996022536505589,0.02824858757062147,0.23761661678264112,1.0,9/38,11.65%,SCIMP;ADAM8;DHX9;TLR8;LY86;CD180;LY96;PUM2;GRN
prerank,Golgi localization (GO:0051645),0.7604679063598209,1.4992724517542,0.038028169014084505,0.23787690317212648,1.0,4/11,9.41%,HOOK3;RIPOR1;ARHGAP21;UVRAG
prerank,endosome organization (GO:0007032),0.6249220178869209,1.4991906465804947,0.030803080308030802,0.23751310844261078,1.0,19/41,19.29%,HOOK3;PI4K2A;SNX33;VPS18;VPS11;DNAJC13;ARFGEF2;WASHC4;TMCC1;EXOC8;PI4K2B;HOOK2;USP8;ALS2;CORO1C;LAMTOR1;SNX10;VPS33B;LAPTM4B
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),-0.5115335704177646,-1.4983530397458253,0.06796116504854369,1.0,1.0,7/19,11.70%,DLG2;CLIC4;PRKCI;SYNJ2BP;PARD3;DLG1;MTCL1
prerank,cellular response to ATP (GO:0071318),0.7220137527376421,1.4976556768257878,0.043184885290148446,0.24050994783530427,1.0,5/14,7.66%,P2RX7;P2RY2;P2RX4;TAF1;P2RY12
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.6857653333187611,1.4972458281979444,0.03814064362336114,0.24095358645368414,1.0,9/21,19.36%,HK3;RPE;GPI;SHPK;HK2;PGLS;GCK;PGD;RBKS
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.7434710485665486,1.4960519026182477,0.06052269601100413,0.24326523379716972,1.0,3/12,3.87%,CBL;PTPRJ;SNCA
prerank,negative regulation of nervous system development (GO:0051961),0.7049231507112415,1.4957989592654697,0.05408970976253298,0.24330358515725797,1.0,6/17,13.13%,HOOK3;TLR2;TNF;PCM1;SORL1;B2M
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.7690085066509273,1.495728642380829,0.04610951008645533,0.2429091777284731,1.0,3/10,8.09%,NCKAP1L;TGFBR2;PRKCQ
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.45518074322079116,-1.4956000530790259,0.045454545454545456,0.9845051753265974,1.0,5/26,2.24%,FOXP1;SMARCA4;KANK2;CLOCK;NCOR1
prerank,positive regulation of transport (GO:0051050),0.5930619342401252,1.4948117274933141,0.007186858316221766,0.24453457849920324,1.0,35/85,22.71%,DOCK2;TREM2;SLC11A1;FCGR2B;SIRPA;CAMK1D;TNF;SNCA;FCER1G;APOE;PYCARD;ANXA1;ACTB;BAK1;NEDD4L;DYNC1H1;MERTK;GAS6;IL2RG;LRP1;GSK3A;CD47;LMAN2;RXRA;FLOT1;PLAA;SMPD1;INPP5K;PLA2G5;GSK3B;CYBA;CDH3;CHP1;BID;SGK1
prerank,regulation of sequestering of calcium ion (GO:0051282),0.7440067714907621,1.4943985989776898,0.049597855227882036,0.2450434185060535,1.0,2/12,0.77%,PTK2B;UBASH3B
prerank,regulation of macrophage migration (GO:1905521),0.7747286297840518,1.494105356909358,0.049635036496350364,0.24521253187587647,1.0,4/10,7.66%,PTK2B;CX3CR1;CD200R1;P2RY12
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.6492133934504851,1.4929843937344642,0.037252619324796274,0.24738797317879746,1.0,6/32,12.31%,PF4;CXCL5;CXCL2;CXCL14;CCL13;DEFA6
prerank,myeloid cell development (GO:0061515),0.6942180168352139,1.4926882092446907,0.07012987012987013,0.24755122894728335,1.0,4/18,2.43%,NCKAP1L;GATA1;NRROS;TLR2
prerank,regulation of response to cytokine stimulus (GO:0060759),0.6888422573489166,1.4924658344807014,0.045454545454545456,0.24758636352885025,1.0,3/19,2.82%,RUNX1;IRAK2;DHX9
prerank,acylglycerol catabolic process (GO:0046464),0.6522884169475098,1.4921912563629938,0.03617269544924154,0.24775739981013076,1.0,8/30,17.09%,LPL;FABP4;ABHD12;FABP5;LIPC;LIPE;ABHD16A;PNPLA3
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.7686220337036711,1.4919038093930892,0.05240793201133145,0.24790321287788186,1.0,4/10,9.75%,PDCD1LG2;CRTAM;RC3H1;CD274
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.7644541876708785,1.491849052814523,0.054570259208731244,0.24750875355208735,1.0,4/11,7.53%,SCIMP;RFTN1;UNC93B1;TICAM1
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.598519519649659,1.4915194032853722,0.020042194092827006,0.2478073742800956,1.0,13/61,13.13%,VAV1;LPAR6;LYN;PIK3CG;GRB2;PIK3CB;GPR17;EPO;ERBIN;F11R;RAPGEF1;ADGRG1;ARHGEF3
prerank,glycoprotein catabolic process (GO:0006516),0.700465708386335,1.4911418398068845,0.043593130779392336,0.24821747769160393,1.0,4/17,6.91%,MMP12;EDEM1;CTSL;OGA
prerank,receptor catabolic process (GO:0032801),0.662916426017157,1.490395823125693,0.05369928400954654,0.24945984328092544,1.0,14/24,17.86%,TGFB1;PCSK9;LGMN;MYLIP;AP2S1;UVRAG;CLTC;BECN1;SNX25;AP2M1;SMURF1;ZNRF3;PIK3R4;VLDLR
prerank,positive regulation of glucose import (GO:0046326),-0.47433264181236057,-1.490078655612424,0.05392156862745098,0.9836189559240937,1.0,6/21,15.10%,SORBS1;PRKCI;IRS1;ARPP19;AKT1;OCLN
prerank,positive regulation of T cell migration (GO:2000406),0.6943041896261861,1.4893084338485718,0.03608247422680412,0.25137499530223817,1.0,5/20,7.31%,DOCK8;CCR2;PYCARD;AIF1;WNK1
prerank,regulation of cellular component size (GO:0032535),0.6393858110906997,1.4885188562987872,0.04032258064516129,0.252741491055768,1.0,6/30,4.99%,VAV1;PEX11A;RIN3;MTOR;VAV2;VAV3
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.7337218038907333,1.4879612204376251,0.058011049723756904,0.2534203497295479,1.0,3/13,8.18%,PTPRC;MGAT5;DOT1L
prerank,lipid phosphorylation (GO:0046834),0.7678650932890448,1.4877351838507906,0.0693815987933635,0.2534137822549128,1.0,6/10,12.73%,DGKZ;DGKK;DGKE;DGKG;DGKD;DGKI
prerank,regulation of Golgi organization (GO:1903358),0.7024745371717449,1.4875344427013186,0.04731457800511509,0.25335921792325694,1.0,9/17,17.71%,MYO5A;ARMH3;RBSN;USP6NL;MAP2K2;STX5;RAB33B;CAMSAP2;AKAP9
prerank,second-messenger-mediated signaling (GO:0019932),0.5957618949935615,1.4859698947096676,0.006191950464396285,0.25650700233910895,1.0,19/82,14.53%,BTK;CX3CR1;CCR2;LAT;PLCG2;EDNRB;LAT2;APOE;CXCR4;MCTP1;P2RX4;NUDT4;P2RY12;DGKD;RCAN1;PPP2CA;CAMKK2;DDAH1;LRRK2
prerank,cellular response to hydrogen peroxide (GO:0070301),0.649338843163296,1.4849529805365325,0.02288329519450801,0.2584524370532063,1.0,9/33,11.27%,NFE2L2;SIRPA;AQP1;PRKCD;TNFAIP3;ANXA1;MAP3K5;IMPACT;HDAC6
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.6796712465620622,1.4848857573287306,0.06398996235884567,0.25808389220602684,1.0,8/20,13.15%,SMOC2;DSTYK;PRKD2;FGFBP3;CREB3L1;SULF2;THBS1;NPTN
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.5746794638297044,1.484542869726087,0.0,0.25831214653934803,1.0,26/214,5.85%,ARRB2;PTPRC;PTK2B;SLAMF1;TREM2;SCIMP;GPNMB;LYN;CALCR;TGFB1;SYK;CD74;SIRPA;P2RY6;CSF1R;DUSP3;PTPN1;DUSP29;DSTYK;CCL8;TNF;PRKD2;APOE;PYCARD;CD44;HMGB1
prerank,phospholipid metabolic process (GO:0006644),0.6000497067824606,1.4838006856332542,0.010362694300518135,0.25959782375366086,1.0,9/71,4.92%,PLBD1;PLCB2;LPL;ABHD12;LPCAT1;ANGPTL3;CLN8;PIP4K2A;SMPD3
prerank,cyclooxygenase pathway (GO:0019371),0.7698403868304283,1.483478086976019,0.052941176470588235,0.25985426994923577,1.0,3/10,3.21%,TBXAS1;PTGES3;HPGDS
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.5983924524001485,1.4834502559091665,0.020105820105820106,0.2593761803219571,1.0,15/57,9.02%,SYK;LGMN;AIM2;CTSD;TNF;PYCARD;CASP1;HMGB1;ASPH;MAP3K5;TBC1D10A;MALT1;GRAMD4;BAK1;PDCD6
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.633691366301342,1.4829125183780405,0.05226480836236934,0.26007203145871166,1.0,10/30,12.34%,PTPRC;CD300A;PRKCD;THY1;SEMA4D;SAMSN1;NTF3;SH2B3;NF2;PPP2CA
prerank,positive regulation of protein maturation (GO:1903319),0.7500654171611125,1.4828257636155755,0.06934812760055478,0.2597732635987096,1.0,4/11,14.61%,BAG2;ADAM8;CCBE1;SOX4
prerank,positive regulation of endothelial cell migration (GO:0010595),0.5946001197998443,1.4824142874851585,0.010309278350515464,0.2601832423770382,1.0,23/84,11.65%,PTK2B;PIK3CG;TGFB1;RIN2;LGMN;STAT5A;SMOC2;PIK3CD;ITGB3;ANGPT4;PIK3CB;MAPK14;PRKD2;P2RX4;HMGB1;MAP2K3;TMSB4X;PDCD6;BCAR1;NRP1;THBS1;GPI;GRN
prerank,regulation of neurogenesis (GO:0050767),0.60767358153296,1.4821018708972078,0.02275189599133261,0.26045073689174153,1.0,12/55,13.13%,HOOK3;ASCL1;CX3CR1;HES7;TNF;BHLHE41;CTNNB1;NAP1L1;PCM1;NUMB;SORL1;B2M
prerank,acetyl-CoA metabolic process (GO:0006084),-0.5315245549902697,-1.4815457580128994,0.06147540983606557,0.9999404177792569,1.0,9/15,24.90%,DIP2A;ACACB;HMGCS2;ACLY;MLYCD;ACSS1;PMVK;MVK;PPCS
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),-0.5015708921923017,-1.4809631004108537,0.04932735426008968,0.973214656412198,1.0,7/17,10.62%,FSTL1;SULF1;XIAP;SLIT2;PCSK6;TMEM204;TWSG1
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.715741512924219,1.4803389512515335,0.06648575305291723,0.26424420906878987,1.0,4/14,11.03%,TNF;OCSTAMP;TYROBP;ATP6AP1
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.6357934571758821,1.4796807494378348,0.03930635838150289,0.26530513249402116,1.0,5/34,3.03%,PTK2B;FGR;TGFB1;FLT3;WDR91
prerank,positive regulation of neuron death (GO:1901216),0.6143386014345481,1.4789984081862766,0.029768467475192944,0.26648038088199055,1.0,16/46,12.48%,ITGB2;FCGR2B;PCSK9;TNF;SNCA;FOXO3;DDIT3;CTNNB1;TYROBP;MAP3K5;C1QA;TFAP2B;ITGAM;GRN;FYN;DDIT4
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),0.7303678980756046,1.4787143737294557,0.05548216644649934,0.26662056757803393,1.0,2/14,2.40%,CD226;MAD2L2
prerank,steroid metabolic process (GO:0008202),0.5905280663634981,1.4786679562615466,0.012269938650306749,0.2662070746496034,1.0,7/72,5.97%,CYP1A1;SHH;LGMN;TSPO;LIPA;NPC1;DHRS11
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.6149174426021108,1.477735683175492,0.02145922746781116,0.26797576012878027,1.0,14/51,13.41%,CCR2;LGMN;CSF1R;MDK;CREB3;IL6R;HMGB1;AIF1;VEGFB;PLA2G7;AKIRIN1;CMKLR1;THBS1;GAS6
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.6265660183229205,1.477272370109571,0.03229398663697105,0.2686018862426848,1.0,14/40,19.20%,ARRB2;PCSK9;CBL;LDLRAP1;HFE;DGKD;NTF3;SCYL2;CD63;B2M;AHI1;GREM1;ANGPT1;TBC1D5
prerank,ganglion development (GO:0061548),0.7442791148318901,1.4772141111932748,0.07050359712230216,0.26821625209201416,1.0,5/11,11.23%,ASCL1;TUBB3;FZD3;CTNNB1;NRP1
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.7560488937488614,1.4757163670471705,0.04680851063829787,0.27128913137791966,1.0,6/11,12.18%,ATF3;DDIT3;TP53;CREB3L1;CEBPB;ATF6B
prerank,chondroitin sulfate catabolic process (GO:0030207),0.7222344537509833,1.4739516387023082,0.061813186813186816,0.275128907687692,1.0,5/13,9.07%,HEXB;ARSB;IDS;HEXA;BCAN
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.7012793130812088,1.4733417872574224,0.0698856416772554,0.2761295325978131,1.0,5/17,8.92%,SCIMP;LY86;TRIM5;CD180;LY96
prerank,negative regulation of protein metabolic process (GO:0051248),0.6039554354273551,1.4731256731322278,0.023758099352051837,0.27617295238668166,1.0,6/48,4.14%,CD84;TREM2;ITGB3;MAD2L2;EDNRB;APOE
prerank,sulfur compound catabolic process (GO:0044273),0.627009318415267,1.473076802248607,0.031496062992125984,0.27571981929804473,1.0,9/38,9.55%,HEXB;PRELP;ARSB;GNS;IDS;HEXA;FMOD;BCAN;TXN2
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.6288025155228171,1.473000844753025,0.034013605442176874,0.2753493521881142,1.0,10/40,8.27%,PTK2B;RPL23;LAPTM5;PDCL3;XPO1;TAF1;GNA12;HFE;CSNK2A2;CSNK2A1
prerank,actin crosslink formation (GO:0051764),0.7284880504169288,1.4722903416764705,0.07042253521126761,0.2766020962427806,1.0,4/12,6.51%,LCP1;GAS2L1;GAS2L3;AIF1
prerank,triglyceride homeostasis (GO:0070328),0.6594723696459297,1.4720909397384534,0.052941176470588235,0.2765678346087185,1.0,8/26,12.23%,LPL;MLXIPL;ANGPTL3;NR1H4;APOE;IL18;LIPC;ANGPTL4
prerank,regulation of B cell apoptotic process (GO:0002902),0.7411270888623772,1.4718380475382187,0.05823863636363636,0.27664084147728957,1.0,3/12,3.86%,BTK;LYN;FNIP1
prerank,acylglycerol metabolic process (GO:0006639),0.6231981323814345,1.4706886092214417,0.043478260869565216,0.27892178677911333,1.0,10/37,8.24%,DGKZ;LPL;ABHD12;APOE;SEL1L;PGS1;DGKK;DGKE;DGKG;DGKD
prerank,regulation of T cell mediated immunity (GO:0002709),0.7488982323331695,1.47023272429197,0.06367583212735166,0.2794617465597128,1.0,3/10,11.69%,CCR2;HMGB1;TNFRSF1B
prerank,regulation of cellular biosynthetic process (GO:0031326),0.6590192039253683,1.4699024641298781,0.048406139315230225,0.27969851346066665,1.0,10/28,16.65%,CX3CR1;SIRPA;NR1H4;MITF;NOS1AP;ADIPOR1;TNFRSF1B;CTNS;CD47;ADIPOR2
prerank,sterol homeostasis (GO:0055092),0.5945068154211345,1.4697913823301858,0.0189873417721519,0.279443826576451,1.0,16/65,12.15%,PCSK9;LPL;ABCA1;ANGPTL3;NPC2;ABCG1;APOE;LDLRAP1;IL18;NPC1;SOAT2;ABCD1;LIPC;LRP5;TTC39B;HDAC9
prerank,regulation of cell killing (GO:0031341),-0.5053725764386939,-1.4683178136285084,0.034934497816593885,1.0,1.0,5/16,8.72%,MAPK8;CD55;WNT5A;CR1L;CFH
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),0.7346267397847708,1.4680187089877086,0.06843575418994413,0.28336752043441266,1.0,4/12,7.03%,WDTC1;ERLIN1;ERLIN2;ACADL
prerank,androgen metabolic process (GO:0008209),0.6871136877804467,1.4669200375298035,0.06290115532734275,0.2856796682782152,1.0,3/18,11.50%,SHH;SPP1;HSD17B11
prerank,central nervous system projection neuron axonogenesis (GO:0021952),-0.5706941741561707,-1.466551780719093,0.05434782608695652,0.9974861884774344,1.0,4/12,4.78%,NFIB;GLI2;PAFAH1B1;EPHB2
prerank,regulation of actin filament polymerization (GO:0030833),0.5851009775549816,1.4662911192839434,0.011434511434511435,0.2866925598505718,1.0,10/69,5.03%,NCKAP1L;PTK2B;HCK;HCLS1;CYRIB;PRKCD;NCK2;SNX9;PYCARD;ARFGEF1
prerank,metanephric mesenchyme development (GO:0072075),0.7535206065728113,1.4661142191790346,0.06321839080459771,0.28653150121179116,1.0,3/10,4.10%,SHH;BASP1;PKD2
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.6256130276988849,1.465949218869528,0.043329532497149374,0.28639940884417725,1.0,8/34,11.88%,IL1A;NUP62;ESPL1;RGCC;CDC23;RB1;LRP5;PHIP
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.6862339409971998,1.4656601996228595,0.06684141546526867,0.28658088295967676,1.0,5/18,13.99%,LYN;FCER1G;BCAR1;CMKLR1;C3AR1
prerank,positive regulation of kinase activity (GO:0033674),0.574254231147211,1.4651874487960181,0.011224489795918367,0.28717082837915675,1.0,14/107,6.25%,PTPRC;LCP2;PTK2B;TREM2;FLT3;CD74;LAT;CSF1R;MMD;DSTYK;SNX9;TNF;XRCC5;MAP2K3
prerank,cellular response to glucagon stimulus (GO:0071377),0.6868376190611347,1.4650771009376995,0.05584415584415584,0.286891402846026,1.0,7/17,13.50%,ADCY7;PRKAR2B;CYSLTR2;ADCY6;PRKACB;ADCY8;ADCY3
prerank,response to glucagon (GO:0033762),0.6801333436546384,1.464605718979533,0.05297157622739018,0.28754067332815164,1.0,8/19,13.50%,ADCY7;PRKAR2B;CYSLTR2;ADCY6;PRKACB;CREB1;ADCY8;ADCY3
prerank,amyloid-beta metabolic process (GO:0050435),-0.5177801986545549,-1.4643021707102226,0.09333333333333334,0.9833981059139258,1.0,9/16,23.91%,MGAT3;BACE1;DYRK1A;MME;ACE;BACE2;PSEN2;APEH;PSENEN
prerank,positive regulation of neuroblast proliferation (GO:0002052),0.750677843789927,1.4642555924230434,0.06628242074927954,0.28779064017608674,1.0,5/10,12.98%,CX3CR1;FZD3;CTNNB1;DISC1;SMARCD3
prerank,positive regulation of nuclear division (GO:0051785),0.6498532982596052,1.4642011008749407,0.057692307692307696,0.2873856424107625,1.0,5/25,11.88%,IL1A;NUP62;RGCC;LRP5;PHIP
prerank,cell projection organization (GO:0030030),0.6322066335710537,1.4628965015738429,0.04513888888888889,0.29013802091028634,1.0,6/30,11.20%,NCKAP1L;PLEK;NEFH;P2RY12;PARVB;CYFIP1
prerank,defense response to symbiont (GO:0140546),0.5824966491554098,1.461373233321655,0.006134969325153374,0.293475379199129,1.0,21/92,13.89%,PTPRC;LILRB1;LYST;NLRC5;TLR2;TLR8;TLR7;TRIM5;ATG7;PYCARD;MAP3K14;SAMHD1;BCL2L1;MOV10;IRF2;SETD2;TRIM56;RNASEL;DDIT4;AGBL5;IRF1
prerank,response to axon injury (GO:0048678),0.6773062097073906,1.4611323923842092,0.0701058201058201,0.2935230144669075,1.0,5/18,7.66%,TREM2;RTN4RL1;P2RX4;TYROBP;P2RY12
prerank,positive regulation of macrophage chemotaxis (GO:0010759),0.7090022237628744,1.4602616009776461,0.06527415143603134,0.29519179870858964,1.0,5/14,11.25%,CSF1R;MDK;AKIRIN1;CMKLR1;THBS1
prerank,positive regulation of interleukin-13 production (GO:0032736),0.7546265279001134,1.4597120530413237,0.08108108108108109,0.2960480091339773,1.0,2/10,5.08%,IRF4;IL18
prerank,positive regulation of phospholipid transport (GO:2001140),0.7568186072505081,1.4589352734434118,0.07860262008733625,0.297432692380855,1.0,3/10,6.00%,DBI;APOE;ABCB4
prerank,ventricular septum morphogenesis (GO:0060412),-0.4266624804499257,-1.4587892656791146,0.05555555555555555,0.9870555294003125,1.0,9/27,7.15%,ZFPM2;BMPR1A;ROBO2;BMP4;ACVR1;TGFBR3;ROBO1;SLIT2;SMAD4
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.6199748871668873,1.4584162566801593,0.05166475315729047,0.29804256159058357,1.0,2/33,0.15%,RUNX1;KLK3
prerank,response to hydrogen peroxide (GO:0042542),0.6134260493886059,1.4583037847582012,0.027412280701754384,0.2977501378465049,1.0,14/45,14.89%,NFE2L2;SIRPA;AQP1;PRKCD;TNFAIP3;ANXA1;MAP3K5;IMPACT;APTX;HDAC6;PRDX3;FYN;STK24;PLEKHA1
prerank,regulation of vesicle-mediated transport (GO:0060627),0.5730236823145377,1.4569090032968635,0.0194672131147541,0.30074906047273514,1.0,15/91,11.64%,PTPRC;CD22;FGR;HCK;SYK;RAB8B;PTPN1;AP2S1;STON2;DNAJC13;RAB11A;MAP2K2;USP7;NRP1;STON1
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.6446840082544316,1.4562382175429567,0.050970873786407765,0.30195134124713346,1.0,5/26,6.37%,PF4;GATA1;IL1A;TNF;BCL2L1
prerank,small GTPase mediated signal transduction (GO:0007264),0.5723393297917636,1.4562350524937109,0.00513347022587269,0.3013829301718003,1.0,19/103,9.01%,ARHGAP30;GRAP2;ABR;RIN2;LAT;RREB1;GRB2;MAPK14;ARHGEF18;RASGRP2;RGS19;PLD2;RGL2;SHC2;TP53;PLK2;RASGRP3;RB1;ARHGAP1
prerank,positive regulation of macrophage activation (GO:0043032),0.6810799725935694,1.4556422897219945,0.060723514211886306,0.30227846802145364,1.0,3/17,4.57%,TREM2;STAP1;CEBPA
prerank,embryonic appendage morphogenesis (GO:0035113),0.7330408120806309,1.4553424591835735,0.07464788732394366,0.30246645556754775,1.0,2/12,4.36%,SHH;SKI
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.6290237447174218,1.4552673787314663,0.061248527679623084,0.30204631574864904,1.0,6/29,11.05%,VAV1;LYN;GRB2;EPO;ERBIN;RAPGEF1
prerank,endothelial cell differentiation (GO:0045446),-0.574038971474094,-1.4548021416851422,0.07011070110701106,0.9845404420807407,1.0,8/12,25.30%,FSTL1;ACVRL1;JAG1;SCUBE1;BMPR2;SOX18;ACVR2B;EDF1
prerank,phosphatidylcholine metabolic process (GO:0046470),0.5876581099658629,1.4547554749122578,0.028242677824267783,0.30284806704703904,1.0,14/70,9.94%,PLBD1;DBI;LPIN2;LPCAT1;PCYT1A;CHKB;LPCAT2;CSNK2A2;CSNK2A1;PLA2G7;LIPC;SLC44A2;ABHD4;STARD10
prerank,cortical cytoskeleton organization (GO:0030865),0.6068436759565758,1.4542840376353388,0.049217002237136466,0.3034159891368654,1.0,6/41,5.71%,NCKAP1L;PLEK;LCP1;TNF;FHOD1;FMNL3
prerank,megakaryocyte differentiation (GO:0030219),0.7393493296711402,1.4539499116490255,0.07443820224719101,0.3037436623008698,1.0,3/11,10.93%,GATA1;TAL1;SH2B3
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.6552283598089134,1.4535334392690633,0.06235011990407674,0.3042169465220314,1.0,11/24,17.01%,NFE2L2;ATF3;DDIT3;TP53;CREB3L1;CEBPB;HSF1;ATF6B;RBPJ;HIF1A;GCN1
prerank,fructose 6-phosphate metabolic process (GO:0006002),0.7500294695479328,1.451807402728439,0.07913669064748201,0.3083237535004729,1.0,2/10,3.12%,HK3;PFKL
prerank,regulation of store-operated calcium entry (GO:2001256),0.7384179098121778,1.4513039742168907,0.07327586206896551,0.3090503833296419,1.0,1/10,0.09%,CD84
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.6374679719397869,1.450805506439612,0.06009615384615385,0.3098261673166882,1.0,4/28,2.00%,TREM2;BAG2;LAPTM5;CTSC
prerank,lytic vacuole organization (GO:0080171),0.6282311163072949,1.4500807431758287,0.049596309111880045,0.31113217954152556,1.0,13/32,17.35%,HOOK3;ABCA1;MTOR;ARSB;CLN3;VPS18;TFEB;MYO7A;GRN;HOOK2;LRRK2;GNPTAB;LAMTOR1
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.6829796478444523,1.4497352907761818,0.0814419225634179,0.3113862784923962,1.0,4/16,7.23%,RUNX1;TGFB1;RGCC;CREB3L1
prerank,reverse cholesterol transport (GO:0043691),0.7265114048543929,1.4491770819383223,0.07313829787234043,0.3122298020150134,1.0,4/13,8.57%,ABCA1;ABCG1;APOE;LIPC
prerank,regulation of epidermal cell differentiation (GO:0045604),0.6692552176097785,1.448795477090729,0.06909547738693467,0.312700225111954,1.0,4/21,5.47%,RUNX1;CTSK;CTSL;MAFG
prerank,cardiac right ventricle morphogenesis (GO:0003215),-0.5847979863688677,-1.448555521945377,0.06296296296296296,0.9931129761647989,1.0,3/11,2.48%,ZFPM2;BMPR1A;BMP4
prerank,response to organic cyclic compound (GO:0014070),0.5978065934695076,1.4483308973303861,0.0367170626349892,0.3132602704854749,1.0,13/52,14.53%,CYP1A1;TGFB1;TNF;SPP1;IL18;ABCB4;CTNNB1;ANXA1;KYNU;STAT5B;CCL2;TIPARP;LRRK2
prerank,regulation of GTPase activity (GO:0043087),0.5614337277068968,1.4482242837493375,0.0020060180541624875,0.3129271551282943,1.0,52/177,17.17%,FGD2;VAV1;DOCK8;RGS10;KLRK1;ARHGAP9;ARHGAP15;FZD10;THY1;PLXNC1;VAV2;RASA4;SNX9;CCL8;ARAP1;SEMA4D;ITGA6;GPR137B;PLXNB2;RASGRP2;VAV3;ARFGEF1;RAB3GAP2;FGD6;USP6NL;DOCK11;DOCK10;AGRN;WNK1;FLCN;CCL14;F11R;TBC1D2;CCL13;RAPGEF1;LIMS1;CCL2;ARHGAP27;ADAP1;MMUT;LRRK2;RAP1A;BCAR3;NF1;GNB5;ALS2;RGS1;EPHA4;CPEB2;SNX13;CCL25;SNX18
prerank,protein trimerization (GO:0070206),-0.529780888647724,-1.4480073605073198,0.08178438661710037,0.9472478129937291,1.0,7/14,28.43%,DISP1;SLC1A5;SCARA5;SIGMAR1;MLKL;MIF;PNPT1
prerank,protein homotrimerization (GO:0070207),-0.529780888647724,-1.4480073605073198,0.08178438661710037,0.9472478129937291,1.0,7/14,28.43%,DISP1;SLC1A5;SCARA5;SIGMAR1;MLKL;MIF;PNPT1
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.6117495740441673,1.4466666605779352,0.03995560488346282,0.3164280153539165,1.0,12/38,16.50%,ARRB2;PTPRJ;PIK3CB;DDIT3;XDH;OTUD3;FLCN;PDCD6;SH2B3;PLEKHA1;PHLPP1;PTEN
prerank,regulation of microtubule polymerization (GO:0031113),-0.3967941735223139,-1.4466061561800105,0.052083333333333336,0.9314365960748107,1.0,15/40,15.12%,CDH5;STMN2;SLAIN2;EML2;CLIP1;PAK1;DYRK1A;ABL1;DRG1;MET;CDK5RAP2;MAPT;NAV3;OCLN;TUBB4A
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.6072379645039596,1.44641095786379,0.05090497737556561,0.3165010570262689,1.0,12/41,16.35%,CASS4;STAP1;CSF1R;GPRC5B;PTPN1;FCGR1A;NEDD9;FYN;LRP8;GAS6;SRC;EPHA4
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.707672966268112,1.4463391158153056,0.06141522029372497,0.31610712956271003,1.0,2/15,3.58%,TREM2;NLRC3
prerank,regulation of leukocyte activation (GO:0002694),0.7040193955328862,1.4462217501591699,0.06919945725915876,0.31585044242053545,1.0,3/14,4.54%,LYN;CD74;GPR137B
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.6533326706089138,1.446065484621612,0.06349206349206349,0.3157038845847579,1.0,6/23,12.71%,PTK2B;UBASH3B;NOS1AP;DIAPH1;FYN;CACNB1
prerank,cholesterol homeostasis (GO:0042632),0.5856872211333671,1.4453985191792802,0.029567053854276663,0.31680933912041154,1.0,15/64,12.15%,PCSK9;LPL;ABCA1;ANGPTL3;NPC2;ABCG1;APOE;LDLRAP1;IL18;NPC1;SOAT2;LIPC;LRP5;TTC39B;HDAC9
prerank,regulation of endocytosis (GO:0030100),0.5873243953873147,1.4446834078272395,0.03171247357293869,0.3181020688007249,1.0,12/61,11.64%,CD22;LILRB1;LGALS3;PTPN1;SNCA;APOE;MCTP1;SNX33;AP2S1;STON2;NEDD4L;STON1
prerank,cell chemotaxis (GO:0060326),0.588156759641117,1.44412840628098,0.026709401709401708,0.3189538498777319,1.0,11/60,11.23%,ARRB2;CX3CR1;BIN2;CCR2;PRKCD;CXCR4;DOCK4;PRKCQ;BCAR1;ABCC1;NRP1
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.6876686990944079,1.4435093491402482,0.08185538881309687,0.32012209685204795,1.0,5/15,11.10%,TREM2;MAPK14;RIPOR2;TYROBP;CD53
prerank,defense response to virus (GO:0051607),0.574107906739201,1.4426684165296002,0.00816326530612245,0.3218382618285825,1.0,24/100,14.25%,PTPRC;LILRB1;LYST;NLRC5;TLR2;TLR8;TLR7;TRIM5;ATG7;PYCARD;MAP3K14;SAMHD1;BCL2L1;MOV10;IRF2;SETD2;TRIM56;RNASEL;DDIT4;RNF135;AGBL5;IRF1;ATAD3A;ZDHHC1
prerank,"wound healing, spreading of cells (GO:0044319)",0.6372194571708649,1.4418963030539567,0.05378973105134474,0.32334895917286877,1.0,5/24,6.17%,MMP12;LCP1;ARHGAP24;CD44;MRTFA
prerank,protein processing (GO:0016485),0.5586121201105321,1.4415350373533864,0.014256619144602852,0.3236572011257247,1.0,19/102,9.46%,CTSS;KLK3;PCSK9;LGMN;FAM111A;VSIR;SRGN;CTSL;ECE2;EEF1AKMT4-ECE2;CLN3;CASP1;DDI2;SPCS2;ATP23;SEC11C;ZMPSTE24;SPPL3;SPCS1
prerank,branched-chain amino acid catabolic process (GO:0009083),-0.4607174457222353,-1.441418883907117,0.05913978494623656,0.9140870855081478,1.0,8/20,16.92%,ACADSB;AUH;MCCC1;HIBCH;DLD;IVD;BCKDK;SLC25A44
prerank,branched-chain amino acid metabolic process (GO:0009081),-0.4607174457222353,-1.441418883907117,0.05913978494623656,0.9140870855081478,1.0,8/20,16.92%,ACADSB;AUH;MCCC1;HIBCH;DLD;IVD;BCKDK;SLC25A44
prerank,estrogen metabolic process (GO:0008210),0.688339950847813,1.440251706532779,0.08695652173913043,0.32646528131627406,1.0,1/15,0.47%,CYP1A1
prerank,phospholipid translocation (GO:0045332),0.627577815263096,1.4402246479549978,0.06549707602339182,0.32598896321106674,1.0,8/28,12.70%,ATP8B4;ABCA1;P2RX7;ATP8A1;ATP8A2;ABCB4;ABCC1;ABCA4
prerank,positive regulation of cation channel activity (GO:2001259),0.599468751963609,1.4401231981865226,0.05561735261401557,0.32568443466438035,1.0,7/40,7.46%,CTSS;CCR2;P2RY6;PKD2;KCNIP2;STAC;TMSB4X
prerank,regulation of cell size (GO:0008361),0.6499201190097387,1.4396589656762442,0.06748466257668712,0.32633317415681734,1.0,5/23,4.99%,VAV1;PLEK;MTOR;VAV2;VAV3
prerank,cholesterol transport (GO:0030301),0.6076583702780449,1.4396220093700516,0.041666666666666664,0.32585413272691643,1.0,10/45,8.57%,ABCA1;MSR1;NPC2;ABCG1;APOE;LDLRAP1;CEL;NPC1;SOAT2;LIPC
prerank,vesicle cytoskeletal trafficking (GO:0099518),0.6191367344062677,1.4395952533076415,0.049162011173184354,0.3253529054280173,1.0,8/39,8.47%,MYO1F;MYO1G;MYO1E;MYO5A;CLN3;ACTN4;MYO7A;MYO19
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.6980423189502388,1.4395582856814788,0.07534246575342465,0.3248718253545729,1.0,2/13,1.20%,ANAPC15;PCID2
prerank,regulation of cell development (GO:0060284),0.6101962706430585,1.4394143937827337,0.06043329532497149,0.3247057551024205,1.0,8/36,12.15%,ASCL1;CX3CR1;SLAMF8;HES7;BHLHE41;CTNNB1;GRN;HDAC9
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.6419369700467457,1.4391088332049091,0.0752157829839704,0.3249627410835464,1.0,3/23,3.69%,TGFB1;MYL3;PKP2
prerank,negative regulation of GTPase activity (GO:0034260),0.6442656152166436,1.4377429382230336,0.06427688504326329,0.3279334724294126,1.0,8/22,16.46%,KLRK1;FZD10;RASA4;ARFGEF1;WNK1;F11R;LRRK2;CPEB2
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.6611905532865666,1.4375998139137676,0.08712121212121213,0.32774462547965844,1.0,8/18,16.03%,CD300A;NLRC3;SKI;MORC3;TP53;B4GALT7;FTH1;NF1
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.5785805964485327,1.4373534405963306,0.026068821689259645,0.32726906244267384,1.0,22/78,12.21%,CTSS;FCGR2B;LGMN;CD74;CTSD;CTSL;KLC2;AP1S3;FCER1G;RAB7A;CAPZB;DNM2;AP2S1;CAPZA1;AP1B1;ACTR10;KIF23;CTSE;CLTC;DCTN5;SEC24D;DYNC1H1
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.5785805964485327,1.4373534405963306,0.026068821689259645,0.32726906244267384,1.0,22/78,12.21%,CTSS;FCGR2B;LGMN;CD74;CTSD;CTSL;KLC2;AP1S3;FCER1G;RAB7A;CAPZB;DNM2;AP2S1;CAPZA1;AP1B1;ACTR10;KIF23;CTSE;CLTC;DCTN5;SEC24D;DYNC1H1
prerank,regulation of neuron death (GO:1901214),0.5678149600835761,1.4369391433385796,0.021920668058455117,0.3278183438228668,1.0,21/82,13.28%,GPNMB;ITGB2;FCGR2B;PCSK9;CD200R1;SNCA;TRAF2;TYROBP;MAP3K5;C1QA;MEF2C;KIF14;CTSZ;PPARGC1A;ITGAM;TNFRSF1B;FYN;DDIT4;SORL1;IKBKG;RRAS2
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.6448817381402412,1.4365727123939465,0.07512315270935961,0.328277022380354,1.0,3/23,4.96%,HOOK3;TUBB;CCDC88B
prerank,regulation of response to biotic stimulus (GO:0002831),0.6295054653426527,1.4365307911273788,0.07611241217798595,0.32778757909749023,1.0,14/28,16.66%,TREM2;FGR;FCGR2B;TRIM5;TRAF3;SAMHD1;ZMPSTE24;RNF135;CASP8;LRP8;ERAP1;IRF1;CD36;APPL2
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.5893953861319942,1.4362292254171174,0.046413502109704644,0.32806258274962324,1.0,17/54,14.82%,SYK;LAPTM5;RFFL;TNF;OTULIN;TRAF2;PYCARD;TNFAIP3;CASP1;CFLAR;TAX1BP1;IKBKG;CASP8;GPS2;GAS6;TRADD;SPPL2A
prerank,water transport (GO:0006833),0.7293874542659362,1.436210920015724,0.08664772727272728,0.327539233567345,1.0,2/12,8.14%,AQP1;AQP11
prerank,negative regulation of receptor binding (GO:1900121),0.7531159484078191,1.4358746284761914,0.07580174927113703,0.3279394863425,1.0,4/10,13.42%,PCSK9;HFE;B2M;ATP2A3
prerank,hematopoietic stem cell differentiation (GO:0060218),0.7227411001126904,1.4349948496254379,0.09829059829059829,0.32956880349255413,1.0,3/10,6.70%,MEOX1;SP7;TP53
prerank,cell proliferation in forebrain (GO:0021846),0.7351150914682684,1.4346503641953379,0.09022556390977443,0.3298871236210591,1.0,5/10,12.62%,HOOK3;AKNA;KIF14;PCM1;NUMB
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.5885714500551574,1.4344298145284526,0.04305705059203445,0.3298825973383761,1.0,20/54,18.48%,TGFB1;STAT5A;ANGPT4;MAPK14;TNF;RGCC;PRKD2;APOE;P2RX4;HMGB1;MAP2K3;TMSB4X;MEF2C;THBS1;ATP5F1A;PRCP;NF1;HIF1A;PDPK1;ANGPT1
prerank,regulation of stem cell proliferation (GO:0072091),0.674764936755854,1.4341450352289271,0.07133243606998654,0.3300672248009766,1.0,1/17,0.11%,PTPRC
prerank,pre-miRNA processing (GO:0031054),0.69906939394621,1.4330076876543818,0.0913978494623656,0.33259530065289045,1.0,11/14,25.05%,ADAR;AGO4;AGO3;PRKRA;TUT7;TARBP2;AGO2;DICER1;LIN28B;DROSHA;AGO1
prerank,positive regulation of cellular metabolic process (GO:0031325),0.5631538487892483,1.4329015275117871,0.017276422764227643,0.3323176058275773,1.0,31/98,19.41%,ARRB2;TGFB1;PCSK9;IL10RB;VAMP3;GRB2;MAPK14;SNCA;APOE;IFNAR1;XDH;TGFBR2;TP53;NTF3;SCYL2;RAB1B;INHBA;THBS1;CD63;PID1;STARD4;FASN;AHI1;ACACA;PPARD;GREM1;ANGPT1;GHITM;TBC1D5;SCRIB;RAB29
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.7124293540785022,1.432816263609282,0.10540915395284327,0.3319698695004044,1.0,2/11,5.65%,CD74;CD44
prerank,negative regulation of MAP kinase activity (GO:0043407),0.5891052966552592,1.4324490908746068,0.04950495049504951,0.33237997571187455,1.0,11/44,12.79%,LYN;CD300A;PRKCD;PTPRJ;PTPN1;PIK3CB;APOE;DUSP10;DUSP19;SH2B3;SORL1
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.6649518788905694,1.4318944432066274,0.06746987951807229,0.33322913349906613,1.0,7/21,16.50%,BAG2;RPL23;MAD2L2;UBE2S;FZR1;RPL11;PTEN
prerank,regulation of cholesterol metabolic process (GO:0090181),0.6629027875848601,1.4314019083766538,0.06265356265356266,0.3339711804468093,1.0,10/20,14.80%,NR1H4;SREBF2;APOE;LDLRAP1;FMO5;ACADL;SEC14L2;TTC39B;SREBF1;ARV1
prerank,positive regulation of receptor internalization (GO:0002092),0.6581280930962635,1.4313231523302554,0.07496977025392987,0.3336088899875821,1.0,9/22,19.20%,ARRB2;PCSK9;NTF3;SCYL2;CD63;AHI1;GREM1;ANGPT1;TBC1D5
prerank,cell projection assembly (GO:0030031),0.6445395392050538,1.431124369407072,0.07169344870210136,0.3335681325464845,1.0,2/22,1.31%,NCKAP1L;NEFH
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.638690126408982,1.4308770611941997,0.07692307692307693,0.3336452218049973,1.0,12/25,20.50%,HK3;PFKL;ALDOB;ENO3;GPI;FOXK1;HK2;GAPDHS;GCK;PGAM1;ENO1;PKM
prerank,canonical glycolysis (GO:0061621),0.639792755008586,1.429869609328315,0.07202881152460984,0.3351222359934584,1.0,12/24,20.50%,HK3;PFKL;ALDOB;ENO3;GPI;FOXK1;HK2;GAPDHS;GCK;PGAM1;ENO1;PKM
prerank,glucose catabolic process to pyruvate (GO:0061718),0.639792755008586,1.429869609328315,0.07202881152460984,0.3351222359934584,1.0,12/24,20.50%,HK3;PFKL;ALDOB;ENO3;GPI;FOXK1;HK2;GAPDHS;GCK;PGAM1;ENO1;PKM
prerank,macromolecule catabolic process (GO:0009057),0.6454208117836274,1.4297874252277176,0.07151230949589683,0.33476281841530886,1.0,13/26,17.56%,TGFB1;LGMN;MTOR;CLN8;UVRAG;TRIM24;BECN1;SNX25;CAPN3;SMURF1;IDE;PIK3R4;USE1
prerank,glycogen catabolic process (GO:0005980),-0.5013787635937139,-1.4279600487553323,0.11654135338345864,0.9625871431827399,1.0,7/15,21.94%,PHKA2;PYGB;PHKG2;PHKB;PYGM;AGL;PHKA1
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.6780679963738685,1.4277414426429884,0.08563899868247694,0.3396497070807466,1.0,3/16,3.81%,ITGB2;MDK;TNF
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),0.7075954988425277,1.4272507806862542,0.10760401721664276,0.34037600021552844,1.0,3/11,8.09%,NFKBID;MALT1;PRKCQ
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.6470720553170117,1.4272453671085912,0.08373786407766991,0.33983387087425254,1.0,3/23,4.51%,CYP1A1;ALOX12;HPGD
prerank,regulation of glucose import (GO:0046324),-0.41605847772456905,-1.427005032618986,0.051094890510948905,0.9462973472215339,1.0,8/30,15.10%,SORBS1;GRB10;PRKCI;IRS1;SELENOS;ARPP19;AKT1;OCLN
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.6917250491036905,1.4269496854114008,0.08718626155878467,0.3400574224359603,1.0,3/15,2.40%,BAG2;RPL23;MAD2L2
prerank,regulation of cell projection organization (GO:0031344),0.6911748918594184,1.4265993061142839,0.09353507565337002,0.34044139536606055,1.0,4/13,8.46%,TREM2;SEMA4D;MACF1;MOV10
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),0.7119265385734144,1.4240483378797146,0.09803921568627451,0.34604866200231915,1.0,8/12,24.42%,TNF;SLC9A1;SPPL3;CHERP;LMCD1;PTBP1;IGF1;CAMTA1
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.7119265385734144,1.4240483378797146,0.09803921568627451,0.34604866200231915,1.0,8/12,24.42%,TNF;SLC9A1;SPPL3;CHERP;LMCD1;PTBP1;IGF1;CAMTA1
prerank,regulation of hormone secretion (GO:0046883),0.6779369320341557,1.422816506806407,0.1126005361930295,0.3487140066148009,1.0,4/15,6.34%,VAMP3;OSM;FFAR2;ANXA1
prerank,response to sterol (GO:0036314),0.7289396695332562,1.4227664489598633,0.08259587020648967,0.3482390888257842,1.0,3/11,6.68%,TGFB1;TGFBR1;TGFBR2
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.4432026680899666,-1.4224762635803752,0.05806451612903226,0.9495568659448301,1.0,12/26,20.43%,STMN2;SLAIN2;CLIP1;PAK1;DRG1;MET;CDK5RAP2;MAPT;NAV3;OCLN;RAC1;TRPV4
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.6916098963119273,1.4224081021303772,0.09820193637621023,0.3486645725431984,1.0,4/13,9.57%,ITGB2;MDK;TNF;FUT9
prerank,activation of GTPase activity (GO:0090630),0.5606054288611997,1.4221143414289883,0.027607361963190184,0.34891363254717617,1.0,19/89,12.63%,ARHGAP45;ARHGAP25;TBC1D9;ABR;SIPA1L2;ARHGAP22;TBC1D10C;ARHGAP24;TBC1D16;TBC1D22A;USP6NL;TBC1D10A;SIPA1;NTF3;RAP1GAP2;TBC1D2;TBC1D17;TBC1D2B;TBC1D8
prerank,defense response to Gram-positive bacterium (GO:0050830),0.5962234951027382,1.422092725056439,0.060335195530726256,0.3483996521551534,1.0,6/40,5.90%,FGR;MPEG1;TLR2;DMBT1;STAB2;PPP1R11
prerank,regulation of nervous system development (GO:0051960),0.6003719636705266,1.4220893991358063,0.06426155580608793,0.34782240601637193,1.0,6/37,8.15%,ASCL1;CX3CR1;HES7;BHLHE41;CTNNB1;KIF14
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.5720472815970374,1.421821405213805,0.028154327424400417,0.34794700366122466,1.0,22/79,12.21%,CTSS;FCGR2B;LGMN;CD74;CTSD;CTSL;KLC2;AP1S3;FCER1G;RAB7A;CAPZB;DNM2;AP2S1;CAPZA1;AP1B1;ACTR10;KIF23;CTSE;CLTC;DCTN5;SEC24D;DYNC1H1
prerank,positive regulation of JUN kinase activity (GO:0043507),0.6260616428944087,1.4217451153094143,0.09518213866039953,0.34759228100074274,1.0,7/23,10.57%,TAOK3;FZD10;TNFRSF11A;TNF;TRAF2;MAP3K5;DUSP19
prerank,mammary gland development (GO:0030879),-0.4673426155049274,-1.4212216961859312,0.058823529411764705,0.9357831961419492,1.0,8/21,16.40%,CAV1;ARHGAP35;WNT4;GLI2;TBX3;GPAT4;TGFB3;NOTCH4
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.65386809647676,1.4205522004470341,0.07477820025348543,0.35027925592767145,1.0,2/19,2.35%,PTPRC;PTPRJ
prerank,granulocyte differentiation (GO:0030851),0.6593247843586143,1.420407729652469,0.08571428571428572,0.3500900128250126,1.0,5/18,6.87%,GATA1;CBFA2T3;CEBPA;SPI1;TAL1
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.6573182956267105,1.4203929691660695,0.08207070707070707,0.3495486601719945,1.0,6/18,8.44%,PTK2B;CYRIB;ARFGEF1;RAP1B;RIPOR2;KIF20B
prerank,dopaminergic neuron differentiation (GO:0071542),0.654649550672283,1.420255806175576,0.09313725490196079,0.3493646333248592,1.0,2/19,6.29%,SHH;CTNNB1
prerank,embryonic digestive tract development (GO:0048566),-0.4721996912913855,-1.420212572897838,0.09417040358744394,0.9218939193436726,1.0,9/18,14.14%,PCSK5;NIPBL;GLI2;SALL1;GLI3;PDGFRA;PKDCC;RARB;STRA6
prerank,type I interferon signaling pathway (GO:0060337),0.6054848967512244,1.4201881635007854,0.05286343612334802,0.3483689677289313,1.0,9/41,10.77%,IRF5;IRF4;IRF8;TYK2;IFNAR1;SAMHD1;ADAR;IRF2;RNASEL
prerank,cellular response to type I interferon (GO:0071357),0.6054848967512244,1.4201881635007854,0.05286343612334802,0.3483689677289313,1.0,9/41,10.77%,IRF5;IRF4;IRF8;TYK2;IFNAR1;SAMHD1;ADAR;IRF2;RNASEL
prerank,cellular response to fluid shear stress (GO:0071498),0.7119183977108734,1.4198882416053635,0.11559888579387187,0.34861064509889317,1.0,5/12,8.10%,NFE2L2;SREBF2;PKD2;MTSS1;MEF2C
prerank,regulation of interleukin-13 production (GO:0032656),0.6897126968338275,1.419733986189069,0.11294765840220386,0.34845795572388083,1.0,3/13,10.64%,IRF4;IL18;TNFRSF21
prerank,sympathetic nervous system development (GO:0048485),0.6841846536678696,1.4197025134014587,0.0850480109739369,0.34796656998427955,1.0,7/15,16.03%,ASCL1;FZD3;CTNNB1;TFAP2B;NRP1;SOX4;NF1
prerank,positive regulation of stem cell proliferation (GO:2000648),0.6623463278350955,1.4196721922570688,0.09018567639257294,0.3474851723062712,1.0,1/17,0.11%,PTPRC
prerank,fluid transport (GO:0042044),0.7113872814370524,1.4189896414970413,0.09686609686609686,0.34873261433572533,1.0,2/12,8.14%,AQP1;AQP11
prerank,regulation of chromatin binding (GO:0035561),-0.5732604460964833,-1.4188575104438688,0.10344827586206896,0.9097138964789531,1.0,5/10,16.92%,WAPL;BTAF1;DTX3L;KDM4D;HMBOX1
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.6292963762941681,1.418686294073282,0.08354114713216958,0.34897674434391646,1.0,4/23,4.53%,PTPRC;CBL;THY1;ZFYVE28
prerank,regulation of postsynaptic membrane potential (GO:0060078),0.6027613374459119,1.4183477921751309,0.07497116493656286,0.3494286138567838,1.0,4/34,8.10%,ARRB2;NPAS4;GABRA5;MEF2C
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.731245646793409,1.4180308235380246,0.09696092619392185,0.3497241192588758,1.0,5/10,13.17%,LYN;STAT5A;PTPN1;STAT5B;PRLR
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.6928114144560609,1.4177581390332106,0.10096818810511757,0.34992055805975353,1.0,3/12,10.47%,CD74;CD44;RPL26
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),0.7170318130670907,1.4172349935302062,0.09156976744186046,0.3508103117791262,1.0,3/11,6.68%,TGFB1;TGFBR1;TGFBR2
prerank,protein-containing complex subunit organization (GO:0043933),0.5530307062035987,1.4171605052494693,0.016293279022403257,0.35047562278116207,1.0,27/109,13.72%,NCKAP1L;PTK2B;CD3E;CD74;VAMP3;SKAP2;SNX9;WIPF1;MITF;TRAF2;TEAD1;TP53;SEH1L;CAPZA1;HFE;PPARGC1A;EPRS1;TUBGCP4;TPR;SOX9;NUP205;DET1;MDN1;RANBP9;IKBKG;DARS1;TSPAN4
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.5486033921391871,1.4165643921584636,0.0020060180541624875,0.35151550872803744,1.0,43/190,12.90%,ARRB2;CD22;TREM2;LYN;ARHGAP25;PLEK;CYRIB;PTPRJ;DUSP3;P2RX7;PIK3CB;RFFL;MAPK14;TSPAN6;NLRC3;NR1H4;FNIP1;HERPUD1;TANK;PYCARD;DDIT3;SPI1;MGRN1;TNFAIP3;WWC2;XDH;ADGRG3;MAP2K3;BCL2L1;OTUD3;TMSB4X;DGKG;DGKD;FLCN;PDCD6;PDE11A;SH2B3;THBS1;ADIPOR1;CDC34;DDIT4;NLRX1;CASP8
prerank,growth hormone receptor signaling pathway (GO:0060396),0.6885820241177469,1.4165198129871408,0.08493150684931507,0.3510568508859697,1.0,3/14,2.55%,LYN;STAT5A;PTPN1
prerank,wound healing (GO:0042060),0.566946258623998,1.4158859137562971,0.04334038054968287,0.3522029747069475,1.0,18/62,17.19%,MMP12;HPSE;SLC11A1;ITGB3;TGFBR1;MYH9;MACF1;CFLAR;SMAD3;SYTL4;DYSF;NRG1;PRCP;DST;AHNAK2;NF1;ARL8B;DCBLD2
prerank,positive regulation of phosphatase activity (GO:0010922),0.6462734045323049,1.4158770799928924,0.08385481852315395,0.35165740301932424,1.0,4/21,8.10%,PLEK;CD300A;MTOR;MEF2C
prerank,indolalkylamine catabolic process (GO:0046218),0.7238884164817809,1.4156386499675875,0.11095505617977527,0.35171864770742217,1.0,3/10,7.82%,HAAO;KYNU;KMO
prerank,release of sequestered calcium ion into cytosol (GO:0051209),0.6226204056098487,1.4156258015749388,0.061248527679623084,0.3511838046479437,1.0,7/26,11.19%,PTPRC;PLCG2;PKD2;ITPR2;IBTK;SLC8B1;CHERP
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.483536964401831,-1.4152783759296224,0.06465517241379311,0.9094249616446244,1.0,6/16,10.09%,CACNA1C;ANK2;RYR2;DMD;ATP1A2;CALM3
prerank,regulation of protein kinase A signaling (GO:0010738),0.6535979616357357,1.4151553347078625,0.09661229611041405,0.35178318672636827,1.0,5/20,14.53%,CALCR;PRKAR2B;AKAP5;IAPP;LRRK2
prerank,regulation of hydrolase activity (GO:0051336),0.5665663506596936,1.4150568666366008,0.03882476390346275,0.35147903420778176,1.0,11/71,5.92%,FGD2;VAV1;ARHGAP9;ARHGAP15;PLXNC1;VAV2;GPR137B;PLXNB2;VAV3;RAB3GAP2;FGD6
prerank,regulation of systemic arterial blood pressure (GO:0003073),0.6584424220633016,1.4145818338755314,0.09733333333333333,0.35218222997265114,1.0,6/16,18.04%,KLK3;DDAH1;KLK2;GSK3A;PRCP;ADM
prerank,regulation of interleukin-1 beta production (GO:0032651),0.5749516828966648,1.414221368774755,0.0423728813559322,0.35258469196228354,1.0,12/66,7.90%,CX3CR1;AIM2;SIRPA;LPL;P2RX7;TLR8;TNF;PYCARD;TNFAIP3;CASP1;TYROBP;MALT1
prerank,negative regulation of cell communication (GO:0010648),0.6594107706494312,1.4139830630761019,0.08782936010037641,0.35258851089143195,1.0,3/21,3.12%,UBASH3B;PTPN1;OSM
prerank,cellular response to drug (GO:0035690),0.6342832942785195,1.4139583232304112,0.0812807881773399,0.35209477217009133,1.0,5/25,8.10%,AIM2;SLAMF8;RAP2A;TP53;MEF2C
prerank,cellular response to amyloid-beta (GO:1904646),0.602977356898703,1.4134071274665918,0.05767012687427912,0.3529776098740365,1.0,11/35,16.35%,TREM2;FCGR2B;LGMN;ITGA4;CACNA1A;ABCC1;FYN;CACNB1;LRP1;CD36;EPHA4
prerank,lipid homeostasis (GO:0055088),0.577863686248481,1.4133370914482848,0.04716981132075472,0.35263069102369515,1.0,12/57,9.00%,TREM2;ABCA1;MLXIPL;ANGPTL3;CLN8;ABCG1;APOE;CEBPA;ABCB4;USF1;ABCD1;ABHD4
prerank,regulation of phospholipase C activity (GO:1900274),-0.5070505784746108,-1.4131935241921747,0.08979591836734693,0.9019702372713715,1.0,4/15,6.80%,NTRK3;PLCG1;ABL1;PDGFRA
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.5914151126517627,1.4128964314862893,0.05147864184008762,0.35325744802197623,1.0,6/46,2.61%,PTPRC;LYN;SIRPA;DUSP3;PTPN1;DUSP29
prerank,high-density lipoprotein particle assembly (GO:0034380),0.7307408303486037,1.4121270607186853,0.12152269399707175,0.3547821889900704,1.0,3/10,11.47%,ABCA1;APOE;PRKACB
prerank,positive regulation of cellular catabolic process (GO:0031331),0.5525494171263465,1.4119972274293813,0.012060301507537688,0.35461313248347637,1.0,48/132,17.02%,LAPTM5;ADAM8;DAGLB;PRKCD;P2RX7;PTPN1;MLXIPL;PIK3CB;SNX9;TRIM5;TNF;SNCA;APOE;CNOT8;FOXO3;SNX33;PFKFB4;HMGB1;TFEB;GTPBP1;ABCD1;PIM2;SVIP;TICAM1;PLK2;GRSF1;VPS11;FLCN;MOV10;TRIM27;RC3H1;AMER1;TRIM8;ZC3H18;MID2;TNFRSF1B;ITCH;LRRK2;RNF152;MTDH;GSK3A;PFKFB3;IRGM;HIF1A;FAF1;HSP90AA1;GAPDHS;FURIN
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.6774986773859759,1.4118679998025296,0.08443271767810026,0.35442366830851885,1.0,5/15,7.46%,LGMN;SMOC2;PRKD2;P2RX4;TMSB4X
prerank,positive regulation of interleukin-1 beta production (GO:0032731),0.5869619363370945,1.4115532732698255,0.05726872246696035,0.3546754246128241,1.0,13/45,16.04%,AIM2;LPL;P2RX7;TLR8;TNF;PYCARD;CASP1;TYROBP;MALT1;NOD2;CASP8;TMEM106A;CD36
prerank,positive regulation of cellular component organization (GO:0051130),0.5586197616570756,1.4098001619173497,0.0121580547112462,0.35874132101773565,1.0,18/107,10.05%,RUNX1;TREM2;LGALS3;PLEKHM2;TGFB1;SYK;FNIP2;TGFBR1;TNF;FNIP1;SNCA;ASAP1;APOE;ABCB4;TAL1;RB1;BAK1;NEDD4L
prerank,regulation of cholesterol efflux (GO:0010874),0.6090252341145296,1.4090441131227711,0.08247422680412371,0.3601878697705342,1.0,12/30,18.31%,TREM2;SHH;SREBF2;APOE;EEPD1;TTC39B;GPS2;LRP1;ABCA3;LAMTOR1;NAXE;RXRA
prerank,response to zinc ion (GO:0010043),0.6167219755649134,1.408881601153313,0.09157509157509157,0.3601125365426769,1.0,15/25,22.29%,HAAO;P2RX4;GLRA2;HVCN1;ATP13A2;SLC30A4;MT3;MT1G;MT1B;MT1E;MT1F;MT1A;MT1X;MT1M;MT1H
prerank,carboxylic acid catabolic process (GO:0046395),0.7170456774399792,1.4082489369853068,0.09562841530054644,0.36134149299091967,1.0,4/12,7.33%,NPL;RENBP;NAGK;PON3
prerank,sensory perception of pain (GO:0019233),0.6494198333436015,1.4079669236411796,0.08596713021491782,0.36155978988003884,1.0,7/21,13.51%,CCR2;P2RX7;PRDM12;P2RX4;CCL2;SCN9A;RETREG1
prerank,interleukin-6-mediated signaling pathway (GO:0070102),0.6485441455502232,1.4072695067402796,0.09922680412371133,0.3628942024537255,1.0,5/18,7.95%,CBL;IL6R;CEBPA;SPI1;ST18
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.6812467942016152,1.4063416275263776,0.09102564102564102,0.36487506279810383,1.0,5/15,4.90%,ADAM8;SNX9;TNF;APOE;SNX33
prerank,regulation of neuroblast proliferation (GO:1902692),0.6686960476548668,1.4061778105667786,0.10386151797603196,0.3647978215616414,1.0,8/15,16.03%,CX3CR1;FZD3;CTNNB1;DISC1;TAFA1;SMARCD3;LRRK2;NF1
prerank,positive regulation of interferon-beta production (GO:0032728),0.6191075991786898,1.4057547900122205,0.07630057803468208,0.36535670744136334,1.0,5/33,2.91%,IRF5;TLR2;DHX9;TLR8;TLR7
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.5520427341727798,-1.405483531756403,0.09554140127388536,0.9194997524501682,1.0,4/11,15.07%,GHR;IRS1;EIF2AK3;AKT1
prerank,activation of protein kinase activity (GO:0032147),0.5472394114257337,1.4051311442799077,0.0262891809908999,0.3665456087856727,1.0,25/106,13.60%,CD86;PTK2B;SLC11A1;ADCY7;PRKAR2B;ITGB3;TAOK3;PRKCD;MTOR;TRAF2;ADCY6;IL18;TGFBR2;TNIK;MALT1;KIF14;STRADB;NTF3;PRKACB;NRG1;PRLR;GAS6;ADCY8;ADCY3;STK3
prerank,regulation of cellular respiration (GO:0043457),0.6782678618289193,1.4051212231968755,0.09220779220779221,0.3660029557400922,1.0,4/17,7.84%,IL10RB;CBFA2T3;IFNAR1;TRAP1
prerank,positive regulation of defense response (GO:0031349),0.5502806633029143,1.4047780390705562,0.02959183673469388,0.36640745652148227,1.0,20/89,13.66%,CCR2;LPL;GPRC5B;ADAM8;TLR2;DHX9;TLR8;TLR7;MDK;OSM;TNF;SNCA;CEBPA;IL18;MEF2C;PLA2G7;ABCC1;GRN;NINJ1;TRADD
prerank,regulation of establishment of protein localization (GO:0070201),0.690049575966543,1.4045438383250524,0.10054347826086957,0.36647502383443725,1.0,3/13,7.13%,TREM2;CTSD;GAPVD1
prerank,positive regulation of proteolysis (GO:0045862),0.5774533260518854,1.4039060807074306,0.05502645502645503,0.36766435767090694,1.0,18/55,14.81%,BAG2;CTSC;ADAM8;SNX9;TNF;AURKAIP1;APOE;TANK;SNX33;ASPH;TBC1D10A;ATP5IF1;BAK1;TNFRSF1B;CCBE1;CASP8;STUB1;CAPN3
prerank,regulation of proteolysis (GO:0030162),0.5782312125329547,1.4035426997719893,0.06175514626218852,0.36806288465640397,1.0,16/48,14.81%,GSAP;SHH;CLN8;AURKAIP1;CLN3;TRAF3;ASPH;TBC1D10A;BAK1;HDAC6;SPOP;PARL;CASP8;ITCH;STUB1;CAPN3
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.6609640937026263,1.4033481603049125,0.11780455153949129,0.36803191499519206,1.0,3/17,7.57%,TREM2;NFE2L2;P4HB
prerank,positive regulation of endopeptidase activity (GO:0010950),0.6161852610606784,1.4032726500366846,0.08982035928143713,0.36769716053604673,1.0,4/26,4.78%,LYN;AIM2;VSIR;PYCARD
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.5516652368740381,1.4029362989901375,0.007035175879396985,0.36800779494807695,1.0,21/152,7.66%,GNA15;CNR2;PF4;CALCR;ADCY7;ABCA1;ADGRE1;ADGRG5;GNAQ;ADGRE5;PSAP;GNAZ;ADCY6;AKAP5;S1PR4;ADGRG3;GNA13;GNA12;RAMP1;WASF2;P2RY12
prerank,regulation of T cell cytokine production (GO:0002724),0.6664905357730428,1.4020135851621103,0.09894459102902374,0.3698556796000873,1.0,6/15,13.13%,CCR2;TRAF2;HFE;MALT1;TNFRSF1B;B2M
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),0.7078770507272121,1.401554662066998,0.12338593974175036,0.37055969736335176,1.0,5/11,13.41%,LILRB1;HCLS1;NOD2;MERTK;GAS6
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),0.6551847007329719,1.4007036849856114,0.09529860228716645,0.3723109161571906,1.0,3/17,1.15%,HCK;HCLS1;STAP1
prerank,T cell mediated immunity (GO:0002456),0.6959569025652068,1.4001391676627801,0.10614525139664804,0.37335262981416695,1.0,3/13,6.12%,MYO1G;CRTAM;BTN3A3
prerank,protein-DNA complex disassembly (GO:0032986),0.6746191610667527,1.3998263967246007,0.10340314136125654,0.3736694324372959,1.0,5/16,13.10%,NFE2;RPL23;ARID1A;SMARCD3;SMARCB1
prerank,response to fatty acid (GO:0070542),0.6647309904936747,1.3996912389553091,0.10225763612217796,0.37341029271352083,1.0,7/17,16.04%,LPL;FFAR2;NR1H4;FOXO3;SOX9;PID1;CD36
prerank,negative regulation of innate immune response (GO:0045824),0.6015700131674406,1.3991694614697332,0.07352941176470588,0.3742816008373149,1.0,11/34,12.01%,NLRC5;SLAMF8;NLRC3;TRAFD1;TNFAIP3;SAMHD1;YTHDF3;TTLL12;GRN;USP18;METTL3
prerank,plasma membrane tubulation (GO:0097320),0.6751243012421885,1.398688191056063,0.12162162162162163,0.3750761169889429,1.0,6/13,13.32%,BIN2;SNX9;SNX33;MICALL1;BIN3;FNBP1L
prerank,positive regulation of lymphocyte migration (GO:2000403),0.7012622560280514,1.3982484296061535,0.11205673758865248,0.3757448169183841,1.0,3/12,6.51%,DOCK8;PYCARD;AIF1
prerank,TOR signaling (GO:0031929),0.612982413731196,1.398041702062795,0.08333333333333333,0.37579222083280955,1.0,7/26,9.29%,CARD11;MTOR;FNIP1;EIF4EBP2;FLCN;LARP1;SMG1
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.6201131518440999,1.3970196246368045,0.08721624850657109,0.3779652854557628,1.0,6/24,11.19%,PTPRC;PLCG2;PKD2;ITPR2;IBTK;CHERP
prerank,regulation of fibroblast proliferation (GO:0048145),0.5807106500736234,1.3964029910869866,0.06263736263736264,0.3790444232598722,1.0,13/45,14.06%,CD74;CD300A;AQP1;DHX9;NLRC3;SKI;MORC3;CTNNB1;TP53;CDK6;B4GALT7;GAS6;FTH1
prerank,negative regulation of neurogenesis (GO:0050768),0.6005772711082498,1.3959535528854263,0.08079625292740047,0.37969399163079687,1.0,14/34,17.75%,HOOK3;THY1;TNF;PCM1;SORL1;B2M;ARHGDIA;EFNB3;YWHAH;NF1;RTN4;PTEN;APPL2;RHOA
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),0.6775814573701524,1.3954396524064816,0.11586206896551725,0.3805544744806086,1.0,4/13,6.47%,PLEK;APOE;ERLIN1;ERLIN2
prerank,positive regulation of GTPase activity (GO:0043547),0.5427576699960821,1.3951383912027946,0.006006006006006006,0.3808466485231763,1.0,55/188,17.23%,ARHGAP45;DOCK8;ARHGAP25;RGS10;TBC1D9;ABR;SIPA1L2;ARHGAP22;FZD10;TBC1D10C;THY1;ARHGAP24;SNX9;CCL8;ARAP1;SEMA4D;ITGA6;RASGRP2;TBC1D16;TBC1D22A;USP6NL;DOCK11;DOCK10;AGRN;TBC1D10A;FLCN;SIPA1;NTF3;CCL14;RAP1GAP2;F11R;TBC1D2;TBC1D17;CCL13;RAPGEF1;LIMS1;CCL2;TBC1D2B;ARHGAP27;TBC1D8;MMUT;RAP1A;TBC1D14;BCAR3;SIPA1L3;TBC1D22B;NF1;GNB5;ALS2;RGS1;ARHGEF26;SNX13;CCL25;SNX18;CORO1C
prerank,digestive tract morphogenesis (GO:0048546),-0.5038375598116566,-1.3951137595123102,0.11929824561403508,0.9522091767002104,1.0,5/14,14.14%,NIPBL;PDGFRA;GLI1;SOX17;STRA6
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.6364815739079772,1.3944820917149352,0.10430247718383312,0.38196851183506253,1.0,2/20,0.51%,PTK2B;PF4
prerank,polyol metabolic process (GO:0019751),0.5799724276308753,1.3938841951273324,0.05984766050054407,0.3829970960848849,1.0,6/46,6.79%,PLD4;INPP5D;PLCB2;PLCG2;INPP4B;NUDT4
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.6341676953341349,1.3938366017221182,0.08700980392156862,0.3825978188995784,1.0,1/23,0.08%,PLBD1
prerank,regulation of T cell differentiation in thymus (GO:0033081),0.6894791241023731,1.393756485610182,0.11684782608695653,0.38224076413550945,1.0,2/13,2.21%,SHH;ADAM8
prerank,diacylglycerol metabolic process (GO:0046339),0.6317838497187964,1.3936917639474231,0.10909090909090909,0.3818802125610836,1.0,8/23,12.80%,DGKZ;PGS1;DGKK;DGKE;DGKG;DGKD;DGKI;LIPE
prerank,cellular response to oxygen-containing compound (GO:1901701),0.5371937874229109,1.3928431747398506,0.002,0.3836181596165719,1.0,66/291,14.55%,CD86;PTK2B;LILRB1;PF4;LYN;CX3CR1;CXCL5;STAP1;PDCD1LG2;IL1A;SIRPA;LPL;P2RY6;AQP1;FZD10;HCN4;CXCL2;PRKCD;TLR2;P2RX7;MTOR;MAPK14;P2RY2;FFAR2;NR1H4;PKD2;ADCY6;PYCARD;CD68;TNFAIP3;CD14;CASP1;RAP1B;P2RX4;HMGB1;TAF1;ABCB4;ACTB;CD80;TICAM1;P2RY12;CD180;MEF2C;LY96;CD274;IMPACT;CPEB3;RAPGEF1;SOX9;GLRA2;CCL2;TNFRSF1B;NRIP1;PRDX3;TWF2;NOD2;DEFA6;CREB1;CAMKK2;SHPK;NFKB1;PID1;LAMTOR3;GNG2;CAPN2;RAP1A
prerank,negative regulation of leukocyte migration (GO:0002686),0.7160829962098098,1.392825002129262,0.12645348837209303,0.38310531492024935,1.0,3/10,1.96%,CD300A;CD200R1;SLAMF8
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),0.7000903274426333,1.392539679911935,0.11220196353436185,0.3832814961606284,1.0,3/11,2.08%,STAP1;SLAMF8;RIN3
prerank,negative regulation of cyclase activity (GO:0031280),0.6778410815615221,1.392528293923502,0.1196808510638298,0.38275556691786056,1.0,6/14,18.16%,CCR2;EDNRB;AKAP5;LTB4R2;GNAI3;GNAI2
prerank,lipoprotein localization (GO:0044872),0.6977202293734697,1.3924601028020562,0.10704225352112676,0.38237882759273295,1.0,5/11,16.04%,PRKCB;VMP1;ZDHHC3;LRP1;CD36
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.5945908332576055,1.3916192527140563,0.09595375722543352,0.38407622322551516,1.0,9/33,11.25%,TGFB1;ANGPT4;TNF;RGCC;APOE;HDAC5;HMGB1;MEF2C;THBS1
prerank,negative regulation of developmental growth (GO:0048640),0.6005307730970031,1.3912609248975267,0.0933806146572104,0.38449180104287584,1.0,5/30,8.91%,SLC6A4;FGF13;DIP2B;WWC2;DUSP10
prerank,cellular response to nutrient levels (GO:0031669),0.564618170848241,1.390275573727215,0.046218487394957986,0.38658613824719545,1.0,12/62,8.33%,PCSK9;LPL;GAS2L1;MTOR;ATG7;FNIP1;SREBF2;MAP1LC3B;CD68;TFEB;RIPOR1;FLCN
prerank,positive regulation of wound healing (GO:0090303),0.5881683086678198,1.3900271284927288,0.08457142857142858,0.386715254537598,1.0,8/36,11.25%,HPSE;SMOC2;RREB1;MTOR;ARFGEF1;ANXA1;ACTG1;THBS1
prerank,response to purine-containing compound (GO:0014074),0.6603820435684892,1.3896451284037368,0.1038961038961039,0.3871685404950269,1.0,5/17,10.39%,KCNJ11;P2RY6;P2RX7;P2RX4;VGF
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.6658714691139067,1.3891038187352114,0.10185185185185185,0.38798042278270534,1.0,6/15,11.25%,LGMN;SMOC2;PRKD2;P2RX4;TMSB4X;THBS1
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.6256251397488439,1.3888751161475523,0.08841843088418432,0.38803984294905564,1.0,3/24,1.40%,HPSE;TGFB1;IL1A
prerank,lipoxygenase pathway (GO:0019372),0.6752400091724166,1.388771230915479,0.11857707509881422,0.3877938267566599,1.0,3/14,7.33%,ALOX12;HPGD;PON3
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),0.720279919552996,1.3885672326885188,0.10579710144927536,0.3877581813452313,1.0,4/10,11.18%,SHH;TGFBR2;LRP5;SOX9
prerank,regulation of inflammatory response (GO:0050727),0.5391192833907413,1.3881126402979835,0.002,0.3884219714816186,1.0,44/190,13.66%,HCK;CCR2;SIRPA;LPL;CD200R1;METRNL;PIK3AP1;VAMP3;GPRC5B;DAGLB;PRKCD;TLR2;DHX9;TLR7;MDK;OSM;FFAR2;NLRC3;NR1H4;TNF;SNCA;APOE;OTULIN;CEBPA;IL18;TNFAIP3;CASP1;ANXA1;SETD6;AKNA;TMSB4X;PLA2G7;RB1;ABCC1;GRN;TNFRSF1B;USP18;NOD2;NINJ1;SHPK;GPS2;FNDC4;LACC1;TRADD
prerank,negative regulation of MAPK cascade (GO:0043409),0.5431664004684437,1.3880618864734173,0.039959016393442626,0.38800151852008175,1.0,12/87,4.14%,PTPRC;LYN;SIRPA;CD300A;PRKCD;PTPRJ;DUSP3;P2RX7;PTPN1;DUSP29;PIK3CB;APOE
prerank,inositol phosphate metabolic process (GO:0043647),0.5795110257613029,1.3880328722131707,0.06256860592755215,0.3875334225849511,1.0,6/46,6.79%,PLD4;INPP5D;PLCB2;PLCG2;INPP4B;NUDT4
prerank,regulation of receptor internalization (GO:0002090),0.5992741120527642,1.3876150634368285,0.056818181818181816,0.38811779225636434,1.0,13/35,19.20%,ARRB2;PCSK9;RIN3;NTF3;SCYL2;CD63;SDCBP;ANKRD13A;AHI1;FLOT1;GREM1;ANGPT1;TBC1D5
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.6209777793067003,1.3862566615681258,0.09904534606205251,0.3912115587600581,1.0,9/24,11.65%,PCSK9;TNF;FOXO3;DDIT3;CTNNB1;TYROBP;TFAP2B;ITGAM;GRN
prerank,regulation of establishment of cell polarity (GO:2000114),0.6501387120438561,1.386182808153262,0.11578947368421053,0.39084553055916343,1.0,6/16,8.44%,PTK2B;CYRIB;ARFGEF1;RAP1B;RIPOR2;KIF20B
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.6530625723253908,1.3861656205889765,0.11594202898550725,0.3903318805901838,1.0,2/18,1.16%,PTK2B;CCR2
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.6310191914437864,1.3860047210837896,0.10902255639097744,0.39021069360374394,1.0,4/22,4.11%,GSAP;LYN;TNF;ABCG1
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.5661552200068973,1.3842410105140555,0.050793650793650794,0.3945607383594662,1.0,18/59,14.64%,CARD11;IRAK2;TLR2;TLR8;TLR7;NLRC3;TNF;TANK;TRAF2;CD14;MAP3K14;TICAM1;LY96;IRAK1BP1;TAB2;IKBKG;TRADD;TAB3
prerank,response to iron ion (GO:0010039),0.6812646584184479,1.3829706804887287,0.13873626373626374,0.39733592667819334,1.0,5/12,16.30%,SNCA;HFE;ACO1;B2M;HIF1A
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.7125940600765042,1.3825721139499343,0.12372634643377002,0.3978258337270771,1.0,2/10,6.71%,SAG;CNGB1
prerank,apoptotic cell clearance (GO:0043277),0.5992292676893886,1.3825492705796716,0.09225512528473805,0.3973146678796585,1.0,13/30,22.31%,TREM2;ITGB3;HMGB1;ANXA1;TYROBP;THBS1;GAS6;LRP1;TXNDC5;XKR4;MEGF10;RHOG;TGM2
prerank,cellular response to steroid hormone stimulus (GO:0071383),-0.46654959585421885,-1.3820675084604184,0.1078838174273859,0.997967457203654,1.0,5/17,13.93%,BMP4;AR;TFPI;ATP1A2;UBE2L3
prerank,positive regulation of defense response to virus by host (GO:0002230),0.6159459192514518,1.3814813607280698,0.10935601458080195,0.399614373134282,1.0,2/24,1.30%,LILRB1;AIM2
prerank,PERK-mediated unfolded protein response (GO:0036499),0.702861418465489,1.3808122417698214,0.14431486880466474,0.40087718859940574,1.0,4/10,11.55%,NFE2L2;HERPUD1;DDIT3;CCL2
prerank,regulation of metal ion transport (GO:0010959),-0.482831095103013,-1.3806858833519333,0.10546875,0.9869669480995118,1.0,6/16,14.13%,ANK2;SRI;CAMK2G;DLG1;CACNA2D1;IL16
prerank,substrate-dependent cell migration (GO:0006929),0.6804376219778331,1.380004294690969,0.12666666666666668,0.4025395389011522,1.0,5/14,12.29%,PTPRC;ITGA2;P2RY12;NRP1;SDCBP
prerank,activation of protein kinase A activity (GO:0034199),0.6518015058985114,1.3798282755342524,0.11584553928095873,0.4025215991695534,1.0,6/16,13.50%,ADCY7;PRKAR2B;ADCY6;PRKACB;ADCY8;ADCY3
prerank,activation of adenylate cyclase activity (GO:0007190),0.5902019872598737,1.3795328027347935,0.08515535097813579,0.40273299666776946,1.0,8/35,15.72%,CALCR;ADCY7;TMIGD3;ADCY6;CAP1;ADCY8;ADCY3;LGR4
prerank,phosphate-containing compound metabolic process (GO:0006796),0.5380299008593133,1.3786186896251542,0.004004004004004004,0.4045929075858931,1.0,46/198,16.82%,PLBD1;PTPRC;HK3;PLD4;INPP5D;PIK3CG;PLCB2;TGFB1;LPL;PIK3CD;PLCG2;DUSP3;MTOR;PIK3CB;ANGPTL3;PFKL;CLN8;ALDOB;INPP4B;PIP4K2A;PFKFB4;NADK;NUDT4;CERK;PLPPR1;DUSP10;PPA2;AGK;FRA10AC1;GPI;SYNJ1;PIP4P1;SHPK;THNSL2;PXYLP1;PLCH1;HK2;LRRK2;GDE1;XYLB;PFKFB3;PTEN;PLAAT3;GCK;GK;PPP3CB
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.5410581607129948,1.3782145965119568,0.02434077079107505,0.40509888716009457,1.0,14/110,7.48%,CNR2;PF4;CALCR;ADCY7;ABCA1;ADGRE1;ADGRG5;GNAQ;ADGRE5;ADCY6;S1PR4;ADGRG3;GNA13;RAMP1
prerank,serine family amino acid metabolic process (GO:0009069),0.6556185277681402,1.377723144700473,0.11889035667107001,0.4059069016271277,1.0,1/16,0.19%,SEPSECS
prerank,endocytic recycling (GO:0032456),0.5626159606578911,1.3776488561148608,0.077502691065662,0.4055596733388848,1.0,15/50,15.19%,DENND1C;MICALL2;CCDC93;RAB14;RAB7A;MICALL1;VPS35L;DENND1A;SNX27;DENND1B;ACAP2;ARF6;VPS29;EPS15;VPS39
prerank,regulation of bicellular tight junction assembly (GO:2000810),0.6303680409240513,1.3775423146452745,0.10438144329896908,0.4052480041562764,1.0,5/19,9.97%,RUNX1;TNF;SNAI1;PRKCH;F11R
prerank,response to cytokine (GO:0034097),0.5401822344209164,1.3773006420573501,0.015045135406218655,0.4053070240904306,1.0,28/141,10.79%,PTPN7;CIITA;SLC11A1;HCLS1;FLT3;MAPKAPK3;CD74;IRAK2;CSF1R;TNFRSF11A;PTPN18;SNCA;GCH1;LDLRAP1;IL6R;CXCR4;CASP1;TIMP1;ANXA1;BCL2L1;KYNU;ADAR;SMAD3;CD274;HDAC4;SETD2;TRIM56;IL18BP
prerank,response to retinoic acid (GO:0032526),0.5575056760189532,1.3772979540122856,0.07799145299145299,0.4047465519589534,1.0,6/59,3.60%,PTK2B;LYN;ASCL1;AQP1;FZD10;RXRB
prerank,positive regulation of protein transport (GO:0051222),0.5530412075752549,1.3772867113202902,0.05919661733615222,0.4042263910501722,1.0,23/67,20.00%,TREM2;TGFB1;IL1A;ADAM8;TNF;ABCG1;TTN;CLN3;RIPOR1;ATP2C1;KIF20B;SYTL4;TPR;EXOC1;PCM1;ARF6;MYH10;CD33;VPS28;GOLPH3;RAB29;DNM1L;ATP13A2
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.5506309598423732,1.377115976763081,0.04041450777202073,0.4041518942464055,1.0,25/88,16.38%,LGALS3;TGFB1;PLEK;SYK;FNIP2;TNF;FNIP1;RGCC;SMPD3;RAB7A;TAL1;SMAD3;BAK1;TPR;PFN2;PFN1;SDCBP;NRG1;SLX4;SYNPO;BMF;SLF2;PIH1D1;PDCD6IP;FAF1
prerank,focal adhesion assembly (GO:0048041),-0.4322484093029748,-1.3765594372685284,0.07936507936507936,0.989631121374466,1.0,7/21,5.31%,SORBS1;PEAK1;TAOK2;ACTN2;PTPRK;BCR;WHAMM
prerank,regulation of calcium ion transport (GO:0051924),0.5629555011773557,1.3764027606188405,0.07243243243243243,0.40561157361649025,1.0,9/54,10.61%,CD84;LILRB1;PKD2;P2RX4;CTNNB1;ATP2B1;EPB41;CACNB2;SLC8B1
prerank,cell differentiation in spinal cord (GO:0021515),0.7090697227535571,1.3763000730435428,0.1546242774566474,0.4053495919010708,1.0,3/10,14.61%,DRAXIN;SOX6;SOX4
prerank,positive regulation of lipid localization (GO:1905954),0.6977499363100047,1.3762163692181228,0.11259259259259259,0.40502412571206237,1.0,4/11,15.03%,LPL;VSTM2A;NFKB1;LRP1
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.6306057584289241,1.3752524854812989,0.10324129651860744,0.40725739981168013,1.0,5/22,10.54%,PLEK;STAP1;CDA;TP53;INHBA
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.6230868647217943,1.3747433021810826,0.10877626699629171,0.40806432297863354,1.0,3/21,1.91%,ARHGAP25;RASAL3;CYRIB
prerank,atrial cardiac muscle cell action potential (GO:0086014),-0.49984909664975063,-1.3744080599511088,0.10526315789473684,0.9830716108512051,1.0,3/13,0.51%,CACNA1C;ANK2;KCNN2
prerank,pancreas development (GO:0031016),-0.5314185794256664,-1.3741730759893072,0.10714285714285714,0.9676240950362303,1.0,5/12,20.28%,TCF7L2;NPHP3;MET;CCDC39;ZIC3
prerank,dendrite morphogenesis (GO:0048813),-0.3856079899617881,-1.3740581120823079,0.06993006993006994,0.9520942616003569,1.0,11/35,11.11%,PTN;DCDC2;BTBD3;TAOK2;FARP1;EPHB2;DIP2A;CHRNA7;MAP6;SHANK3;SHANK1
prerank,protein insertion into membrane (GO:0051205),-0.38770504023701785,-1.374052513375857,0.06349206349206349,0.9365148147599545,1.0,12/32,19.11%,APP;EGFR;OXA1L;ALDH3A2;TRAM1;SEC61G;COX18;EMD;SERP1;SEC61B;GET4;VAPA
prerank,negative regulation of signaling receptor activity (GO:2000272),0.602240370029959,1.3737712562439996,0.11842105263157894,0.41028293683061245,1.0,5/25,7.81%,CALCR;CBL;TNF;ZFYVE28;HFE
prerank,positive regulation of glucose transmembrane transport (GO:0010828),-0.41103807599517855,-1.3736294067725592,0.07222222222222222,0.9233973871940472,1.0,7/26,15.10%,SORBS1;PRKCI;IRS1;C2CD5;ARPP19;AKT1;OCLN
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.5145663462539009,-1.373299337405239,0.11152416356877323,0.9102385752406981,1.0,8/13,28.97%,BMP4;NR3C2;AR;CALCOCO1;GPER1;PLPP1;PGR;BMP7
prerank,inositol phosphate biosynthetic process (GO:0032958),-0.5469614850550986,-1.373184917210203,0.11217948717948718,0.8966169739929926,1.0,5/11,18.57%,PPIP5K2;IP6K1;IP6K2;ITPKC;IPMK
prerank,response to organophosphorus (GO:0046683),0.6521536056497341,1.3728430824999214,0.12419146183699871,0.41229958238265085,1.0,4/16,10.39%,KCNJ11;P2RX7;P2RX4;VGF
prerank,vasoconstriction (GO:0042310),0.6892373203227169,1.372643873246782,0.13199426111908177,0.41231678953330897,1.0,2/11,3.19%,EDNRB;SLC8A1
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.6949984467373227,1.372589609410437,0.11079136690647481,0.4107719943539258,1.0,7/12,21.60%,ESPL1;CDC23;RB1;ANAPC11;CUL3;NSMCE2;CDC16
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.6949984467373227,1.372589609410437,0.11079136690647481,0.4107719943539258,1.0,7/12,21.60%,ESPL1;CDC23;RB1;ANAPC11;CUL3;NSMCE2;CDC16
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.6949984467373227,1.372589609410437,0.11079136690647481,0.4107719943539258,1.0,7/12,21.60%,ESPL1;CDC23;RB1;ANAPC11;CUL3;NSMCE2;CDC16
prerank,negative regulation of adenylate cyclase activity (GO:0007194),0.6813660243436637,1.3724125052415501,0.12837837837837837,0.4107390604812735,1.0,6/13,18.16%,CCR2;EDNRB;AKAP5;LTB4R2;GNAI3;GNAI2
prerank,sterol transport (GO:0015918),0.6332244906548801,1.3723524507540663,0.11764705882352941,0.41034874090106044,1.0,7/19,16.04%,MSR1;NPC2;LDLRAP1;NPC1;OSBP;ARV1;CD36
prerank,cellular response to interleukin-12 (GO:0071349),0.5676426418984032,1.3714641717448555,0.058426966292134834,0.41229676757851724,1.0,9/48,7.75%,LCP1;SIRPA;TYK2;IL12RB2;AIP;RAP1B;STAT4;P4HB;CAPZA1
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.691645310873791,1.3713836042247665,0.14365411436541142,0.41199240417824645,1.0,3/11,8.57%,ABCG1;PLA2G7;LIPC
prerank,cellular response to osmotic stress (GO:0071470),0.6392228283235732,1.3711892021916605,0.10661764705882353,0.4119762040807677,1.0,7/21,17.29%,AQP1;LRRC8D;PKD2;EPO;CAPN3;RCSD1;ARHGEF2
prerank,endoderm development (GO:0007492),-0.5139359698681732,-1.3693818910261326,0.1169811320754717,0.899267553644485,1.0,11/13,48.64%,KIF16B;DUSP1;SOX17;LAMC1;SOX7;LHX1;DUSP4;TBX20;DUSP5;DUSP2;GATA4
prerank,positive regulation of interleukin-1 production (GO:0032732),0.5631381798391806,1.3690763300320516,0.08143322475570032,0.41732652070250625,1.0,14/51,16.04%,AIM2;LPL;P2RX7;TLR8;TNF;PYCARD;CASP1;HMGB1;TYROBP;MALT1;NOD2;CASP8;TMEM106A;CD36
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.5990983298616054,1.368562140397737,0.08710801393728224,0.41812220775400516,1.0,9/29,12.90%,UBE2D3;TANK;CD14;CD300LF;TRAF3;TICAM1;LY96;IKBKG;CASP8
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.595148900777864,1.368253906790312,0.09436133486766399,0.41850533589341493,1.0,9/30,12.90%,UBE2D3;TANK;CD14;CD300LF;TRAF3;TICAM1;LY96;IKBKG;CASP8
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.6493479155330211,1.3679827976991024,0.1272264631043257,0.41872990085571404,1.0,2/19,5.09%,CX3CR1;TNFAIP3
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),0.6831785614190298,1.3674338174041756,0.13445378151260504,0.4197348296479667,1.0,2/12,0.90%,PF4;TGFB1
prerank,tryptophan catabolic process (GO:0006569),0.6841290538855984,1.3667348196970672,0.13598901098901098,0.42115549212558545,1.0,3/11,7.82%,HAAO;KYNU;KMO
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),0.6714987752859864,1.366578494251683,0.1262135922330097,0.42102986226046846,1.0,5/13,12.90%,LGMN;ASPH;TBC1D10A;BAK1;CASP8
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.5258453576644916,1.3661975783097267,0.0,0.42149797915399123,1.0,75/390,12.63%,NCKAP1L;LCP2;SLA;VAV1;PTK2B;BLNK;FGR;LYN;ATP6V0D2;HCK;CYBB;UBASH3B;CD3E;SYK;CASS4;STAP1;FLT3;CD7;MAPKAPK3;NCF4;ITGB3;CBL;CSF1R;ATP6V0E1;PTPRJ;TCIRG1;GRB2;NCF2;PIK3CB;ELMO1;VAV2;MAPK14;ATP6V1C1;NCK2;PRKD2;ATP6V1E1;CLNK;RAB14;ATP6V0A2;VAV3;ARPC2;SHC2;EFNA2;MTSS1;ACTB;NEDD9;AP2S1;VEGFB;ATP6V0D1;ARPC3;WASF2;ITSN1;AP3S1;SULF2;NTF3;ABI1;ACTG1;BCAR1;ACTR2;FLRT1;ATP6V0A1;ACTR3;POLR2L;YES1;ATP6AP1;RAPGEF1;CYFIP1;NRP1;ARPC4;ZNF106;PHIP;SDCBP;FYN;DDIT4;NRG1
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.6959037819340792,1.3661757764153686,0.12305516265912306,0.42097900136829475,1.0,3/12,5.65%,THY1;TNF;CD44
prerank,integrated stress response signaling (GO:0140467),0.6582362497432747,1.3660162423255413,0.15508021390374332,0.4208942164212421,1.0,5/14,11.55%,NFE2L2;HERPUD1;DDIT3;IMPACT;CCL2
prerank,regulation of plasminogen activation (GO:0010755),0.6871106489790606,1.365893213847439,0.1340057636887608,0.4206467173498338,1.0,4/12,15.24%,RUNX1;CTSZ;THBS1;PLGRKT
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.5317196448111144,1.365665671445104,0.03160040774719674,0.4207446364355859,1.0,25/105,15.62%,CLEC4D;LYN;CARD11;SYK;PLCG2;PRKCD;FFAR2;FCER1G;MUC13;TYROBP;PSMB10;MALT1;PSMA2;PRKACB;FYN;PSME3;TAB2;IKBKG;NFKB1;PSMB5;PSMD8;TAB3;SRC;PSMD7;PSMB9
prerank,negative regulation of secretion by cell (GO:1903531),0.5836463704681598,1.3656172750175135,0.09561304836895389,0.42029831432239695,1.0,7/38,6.34%,LILRB1;VAMP3;OSM;SNCA;APOE;RHBDF2;ANXA1
prerank,regulation of transmembrane transport (GO:0034762),0.6052676349781166,1.365598854240106,0.10501750291715285,0.4197816724413572,1.0,7/31,13.74%,KCNJ11;SNCA;PRKCB;ACTB;PIM1;NEDD4L;CTTNBP2NL
prerank,regulation of defense response to virus by host (GO:0050691),0.5927438868897444,1.3652908471209964,0.10409356725146199,0.4200479200273959,1.0,4/30,5.09%,LILRB1;AIM2;DHX9;TNFAIP3
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.5310386977994291,1.3652803093972736,0.02014098690835851,0.41950693319132587,1.0,44/149,17.33%,BTK;CARD11;CX3CR1;AIM2;IRAK2;ADAM8;TRIM25;TLR2;TNFRSF11A;DHX9;TRIM5;TNF;PRKD2;UBE2V1;TRAF2;PYCARD;IL18;RAB7B;PRKCB;CFLAR;TICAM1;MALT1;IL18RAP;PRKCQ;TRIM27;PRKCH;TRAF5;TRIM8;MID2;RPS6KA4;PRDX3;NOD2;TAB2;IKBKG;NFKB1;TRADD;TAB3;CAPN3;MTDH;CD36;UBE2N;TRIM62;ARHGEF2;RPS6KA5
prerank,positive regulation of protein polymerization (GO:0032273),0.5463890182331146,1.3650456095064434,0.07586933614330875,0.41962900704912487,1.0,7/65,6.54%,NCKAP1L;PTK2B;HCK;NCK2;SNX9;PYCARD;MAPRE1
prerank,regulation of fibroblast migration (GO:0010762),0.6209268814448884,1.3648574461866712,0.12547528517110265,0.4195742860524166,1.0,8/20,18.53%,TGFB1;RFFL;CLN3;GNA12;THBS1;APPL2;CORO1C;ITGB1
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.6037567666729641,1.3647237100200524,0.11377245508982035,0.4193789965395302,1.0,7/25,12.29%,NCKAP1L;PTGES3;SNCA;ITGA6;NRP1;THBS1;SDCBP
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.5738334846682501,1.3645306532123278,0.08839779005524862,0.4193615907455716,1.0,5/42,2.38%,PTK2B;CD3E;RIN2;PTPRJ;THY1
prerank,mesonephric tubule development (GO:0072164),-0.48053634925914374,-1.3628140507215043,0.12274368231046931,0.9141135704223264,1.0,6/15,10.33%,ROBO2;FOXC1;BMP4;SALL1;SLIT2;SIX1
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.5913605005606104,1.3623815644071613,0.09977064220183486,0.424640381953028,1.0,5/32,5.57%,CALCR;THY1;P2RX7;SNCA;P2RX4
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.5244384579312201,1.3620778978103254,0.0,0.42494942127146096,1.0,97/509,12.90%,PTPRC;CD86;VAV1;TREM2;FGR;LYN;CALCR;PIK3CG;PIK3R5;CARD11;HPSE;TGFB1;CX3CR1;CASS4;HCLS1;FLT3;F10;CD74;PIK3CD;RPL23;CBL;LAPTM5;PIK3AP1;PLCG2;TGFBR1;GPRC5B;ADAM8;TRIM25;PTPRJ;TLR2;GRB2;PIK3CB;S100B;TLR7;NUP62;OSM;TSPAN6;SEMA4D;TRIM5;NEK6;TNF;FNIP1;PRKD2;UBE2V1;TRAF2;DDIT3;IL18;CD14;CASP1;P2RX4;MAP3K14;HMGB1;PRKCB;CFLAR;BCL2L1;GAB2;TP53;CD80;ACTN4;SEH1L;PIM2;TICAM1;EPO;PLK2;P2RY12;MALT1;FLT3LG;ATP2C1;FLCN;TRIM27;ZDHHC13;SLC44A2;LURAP1;NTF3;PUM2;STRN;NOS1AP;TRAF5;LITAF;TRIM8;DUSP19;RPS20;LGALS1;GPR37;LIMS1;SOX9;MID2;THBS1;BECN1;IAPP;NOD2;FYN;ALPK1;TAB2;NRG1;IKBKG;CASP8
prerank,histone H2A ubiquitination (GO:0033522),-0.4635262677970968,-1.3620261378278122,0.11848341232227488,0.9039400033512623,1.0,7/17,12.26%,DDB2;RYBP;DDB1;UBR2;UBE2B;TRIM37;DTX3L
prerank,regulation of type I interferon production (GO:0032479),0.5414859025468598,1.3616891892494625,0.044012282497441144,0.4255566042969847,1.0,22/84,14.78%,IRF5;IRF8;NLRC5;TRIM25;DHX9;LRRFIP1;TNFAIP3;CD14;TRAF3;XRCC5;CTNNB1;TAX1BP1;TRIM56;POLR2L;RNF216;NLRX1;RNF135;ITCH;NFKB1;GPATCH3;IRF1;DTX4
prerank,eye morphogenesis (GO:0048592),-0.4467028058303014,-1.3614413524417384,0.09205020920502092,0.8931273918079267,1.0,7/19,9.04%,COL5A2;NIPBL;EFEMP1;SHROOM2;MFAP5;FBN1;TENM3
prerank,sodium ion import across plasma membrane (GO:0098719),0.6471491907901175,1.3611247651524514,0.12239583333333333,0.42647974763156027,1.0,5/17,7.37%,HCN4;SLC9A4;SLC8A1;SLC9A9;SLC9A1
prerank,ceramide catabolic process (GO:0046514),0.6596298874384063,1.3611019946246554,0.13451086956521738,0.425971934704925,1.0,4/14,9.80%,HEXB;GM2A;HEXA;ACER3
prerank,early endosome to late endosome transport (GO:0045022),0.6323856490697408,1.3607377269100416,0.11421319796954314,0.42637774861275984,1.0,7/20,14.28%,HOOK3;WDR91;RAB7A;BECN1;WDR81;STX8;HOOK2
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.5415637920448724,1.3601296835185792,0.053830227743271224,0.4274421511641199,1.0,24/78,15.42%,MRAP;TREM2;LGALS3;TGFB1;PLS1;TNF;LDLRAP1;CLN3;AKAP5;STAC;BCL2L1;ACTB;ZDHHC7;PRKCH;CLTC;NUMB;STX3;STAC3;PPFIA1;STX8;PID1;ARF6;LRP1;AP2M1
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-0.43649248946023855,-1.359022096983948,0.09268292682926829,0.8908488763523137,1.0,7/20,10.09%,CACNA1C;ANK2;RYR2;ATP1B1;DMD;ATP1A2;CALM3
prerank,response to laminar fluid shear stress (GO:0034616),0.7104114716849466,1.358980332806242,0.13352685050798258,0.4302668259228952,1.0,3/10,3.88%,NFE2L2;ABCA1;SREBF2
prerank,aminoglycan catabolic process (GO:0006026),0.6012496822399378,1.3586970959872344,0.11072261072261072,0.4304928259783474,1.0,6/28,7.06%,HPSE;GUSB;GNS;IDS;FUCA1;AGRN
prerank,branching involved in blood vessel morphogenesis (GO:0001569),0.6793945012000226,1.3585436211887447,0.13528591352859135,0.4303196877197842,1.0,4/13,11.23%,SHH;CTNNB1;TGFBR2;NRP1
prerank,positive regulation of cellular protein catabolic process (GO:1903364),0.6326638642439573,1.3581780762575044,0.13154533844189017,0.43075882888211864,1.0,9/18,18.54%,PCSK9;CTSC;APOE;VPS11;ATP5IF1;AMER1;FAF1;HSP90AA1;DACT1
prerank,regulation of protein-containing complex assembly (GO:0043254),0.5316850403098843,1.3579074286402384,0.03048780487804878,0.430921523587427,1.0,33/110,16.72%,LGALS3;HCK;TGFB1;SYK;FNIP2;ABCA1;TNF;FNIP1;APOE;TRAF2;TAL1;TFIP11;SVIP;RB1;BAK1;HSF1;ATF7IP;IMPACT;GFAP;HDAC6;IAPP;NRG1;SORL1;SAR1A;HCFC1;BMF;SLF2;PIH1D1;SRC;CD36;IRGM;FAF1;HSP90AA1
prerank,regulation of myelination (GO:0031641),0.5927508258062989,1.3578781165067129,0.12135922330097088,0.430436014533982,1.0,7/25,11.69%,ITGAX;CST7;KIF14;TMEM98;RNF10;TNFRSF21;TNFRSF1B
prerank,regulation of mitochondrion organization (GO:0010821),0.5677174987553231,1.3578077335648528,0.08596300326441784,0.43008973187185573,1.0,22/47,20.78%,TREM2;CYRIB;SREBF2;CSNK2A2;FLCN;MYO19;PPARGC1A;HDAC6;IAPP;PARL;PID1;LRRK2;SREBF1;VDAC1;GSK3A;GOLPH3;DNM1L;FIS1;INF2;ATP13A2;GSK3B;PRKN
prerank,aromatic amino acid family catabolic process (GO:0009074),0.6536367466929296,1.357273074567181,0.12857142857142856,0.4310779981733967,1.0,4/15,9.08%,HAAO;KYNU;KMO;QDPR
prerank,negative regulation of protein kinase activity (GO:0006469),0.534762467635093,1.3567442090777977,0.0581039755351682,0.43193811464387266,1.0,22/88,14.08%,PTPRC;UBASH3B;THY1;DUSP3;PTPN1;GNAQ;SLC8A1;SNCA;PYCARD;RB1;TRIM27;ADAR;DUSP10;QARS1;LRP5;DUSP19;DTNBP1;PTPRO;SORL1;ADARB1;RTRAF;PTPRT
prerank,retina homeostasis (GO:0001895),0.6140008539241933,1.3560805924871624,0.11403508771929824,0.4331922456093694,1.0,11/23,22.05%,WHRN;POTEF;ACTB;CNGB1;ACTG1;PRDX1;B2M;ATP1B2;CCDC66;HSPB1;CDH3
prerank,receptor clustering (GO:0043113),0.5961629130949633,1.3560508675275398,0.11017964071856287,0.43271493490644924,1.0,4/27,2.38%,ITGAL;ITGB2;ITGA4;THY1
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.5637782369962457,1.3560484815324254,0.08743169398907104,0.43216434209275095,1.0,13/48,13.08%,TGFB1;STAT5A;ANGPT4;MAPK14;PRKD2;P2RX4;HMGB1;MAP2K3;ANXA1;TMSB4X;THBS1;HDAC9;ATP5F1A
prerank,positive regulation of myelination (GO:0031643),0.6909323493830266,1.3558364833057766,0.14432989690721648,0.4322677124231048,1.0,4/11,11.69%,ITGAX;CST7;RNF10;TNFRSF1B
prerank,regulation of neuron apoptotic process (GO:0043523),0.5323275001541524,1.3556368573585929,0.042726347914547304,0.43231241515170077,1.0,25/96,16.03%,PTK2B;TREM2;PCSK9;LGMN;ADAM8;MDK;TNF;APOE;CLN3;FOXO3;DDIT3;FZD9;CTNNB1;MEF2C;KIF14;TFAP2B;NTF3;PPARGC1A;CCL2;GRN;RETREG1;WFS1;CPEB4;RASA1;NF1
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.6101279305982048,1.355493864167692,0.12160566706021252,0.4321780515944042,1.0,14/28,17.05%,IRAK2;MAP2K6;UBE2V1;OTULIN;TNFAIP3;NOD2;TAB2;IKBKG;CASP8;ITCH;LACC1;TAB3;IRGM;UBE2N
prerank,positive regulation of JNK cascade (GO:0046330),0.5331518195162855,1.3549949579871383,0.06639004149377593,0.4330382468034448,1.0,14/70,12.29%,PTK2B;SLAMF1;FCGR2B;TAOK3;TRAF2;PYCARD;TRAF3;HMGB1;MAP3K5;GADD45B;TRAF5;DUSP19;NOD2;SDCBP
prerank,glycolytic process (GO:0006096),0.5970193374581122,1.3548977976353251,0.123094958968347,0.43275653610990406,1.0,11/28,16.87%,HK3;PFKL;ALDOB;ENO3;GPI;HK2;GAPDHS;GCK;LDHA;PGAM4;PGAM1
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.5779267662085911,1.3547805682785456,0.09402654867256637,0.43249007541670004,1.0,12/38,18.52%,LGALS3;RFFL;TRAF2;TNFAIP3;CFLAR;BCL2L1;THBS1;CASP8;TRADD;FEM1B;ARHGEF2;TNFSF10
prerank,urogenital system development (GO:0001655),0.6825138160599001,1.353787525100836,0.14756446991404013,0.4347220047706552,1.0,3/11,11.18%,SHH;ANXA1;SOX9
prerank,blood vessel endothelial cell migration (GO:0043534),-0.42002006770388317,-1.3532014584054548,0.07894736842105263,0.9025945245341561,1.0,8/22,8.42%,CDH5;PIK3R3;EPHB4;EFNB2;ID1;ROBO1;SLIT2;GPLD1
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.5314387339553049,1.3527026317663031,0.04378818737270876,0.43724058969286295,1.0,18/93,12.29%,PTK2B;SLAMF1;SCIMP;FCGR2B;TAOK3;TRAF2;PYCARD;SPI1;TRAF3;XDH;HMGB1;MAP3K5;GADD45B;TRAF5;DUSP19;RELL1;NOD2;SDCBP
prerank,filopodium assembly (GO:0046847),0.6453265888433155,1.3526313659150777,0.11734028683181226,0.43688522172290994,1.0,2/16,5.92%,FGD2;FGD6
prerank,negative regulation of cell activation (GO:0050866),0.662252817327758,1.3525067295713813,0.15006821282401092,0.43665424974987743,1.0,2/14,4.14%,TREM2;APOE
prerank,response to organonitrogen compound (GO:0010243),0.5783307957261116,1.3523725268516722,0.10188261351052048,0.4365196445393707,1.0,9/38,15.36%,IRF5;MTOR;NR1H4;SEL1L;KYNU;DERL1;GLRA2;KAT7;CCDC47
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.6962831250066599,1.3520195469824143,0.14574314574314573,0.43689640988217787,1.0,1/10,0.11%,PTPRC
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.6180615483362938,1.3517097668222589,0.14374225526641884,0.43719631217857235,1.0,4/20,7.06%,RGS10;GNAQ;LY6G6D;AGRN
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.6009155570355452,1.3516787886550943,0.14041514041514042,0.4367504680581751,1.0,8/24,16.48%,PTK2B;CTSC;APOE;ATP5IF1;PSME3;RHBDF1;EPHA4;TMF1
prerank,neuronal action potential (GO:0019228),-0.4394767017028206,-1.3515202243088502,0.09289617486338798,0.8967016044846022,1.0,12/22,28.36%,SCN1A;CACNA1G;KCNA1;KCNA2;SCN8A;ANK3;SCN3A;KCNMB2;GPER1;CACNA1H;MYH14;CACNA1I
prerank,keratan sulfate metabolic process (GO:0042339),0.5961606462390668,1.3509086205285605,0.10271546635182999,0.4383094303098614,1.0,7/31,8.51%,HEXB;PRELP;GNS;HEXA;B4GALT1;FMOD;ST3GAL1
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.6768988866559333,1.3507943982535322,0.13096862210095497,0.43806276559214474,1.0,2/12,6.74%,IL18;CD80
prerank,neurotransmitter uptake (GO:0001504),-0.5205722027215718,-1.3505796926003046,0.15064102564102563,0.8882896755599584,1.0,10/12,42.75%,SNAP25;ATP1A2;GLUL;SLC29A1;SLC22A2;SLC1A6;SLC38A1;SLC22A3;SLC29A2;SLC29A4
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.665002588361828,1.3501155671960483,0.1699438202247191,0.4393439854952864,1.0,3/12,4.11%,ABCA1;ITGB3;ABCG1
prerank,ruffle organization (GO:0031529),0.6460094301548248,1.3499471464343242,0.14786967418546365,0.43928648744797305,1.0,9/16,20.37%,PLEK;CSF1R;AIF1;CYFIP1;ARF6;PLEKHA1;ARFIP2;INPP5K;AIF1L
prerank,regulation of Rac protein signal transduction (GO:0035020),0.6418417098905697,1.3499391774124405,0.12627551020408162,0.4387564028928019,1.0,3/16,2.72%,PIK3CG;ARHGAP24;PIK3CB
prerank,positive regulation of integrin activation (GO:0033625),0.6989047245839981,1.3496163006332453,0.13753581661891118,0.4390850236296972,1.0,3/11,7.66%,PLEK;RAP1B;P2RY12
prerank,lipid catabolic process (GO:0016042),0.635325406493914,1.3495480716376724,0.12158808933002481,0.43872234771297336,1.0,6/18,16.78%,LPL;CEL;ACADL;LIPC;LIPE;PLAAT3
prerank,positive regulation of cell adhesion (GO:0045785),0.5441606958724114,1.3494741600883247,0.06308169596690796,0.4383916377211787,1.0,14/74,13.82%,NCKAP1L;SYK;ADAM8;PTPRJ;MDK;TNF;PRKD2;P4HB;P2RY12;FLCN;LIMS1;ADGRG1;STX3;ZFHX3
prerank,cellular response to interferon-beta (GO:0035458),0.6517794771251051,1.349257694436948,0.1341301460823373,0.438440367101957,1.0,7/14,20.52%,AIM2;CDC34;UBE2G2;IRF1;IRGM;UBE2K;IFITM2
prerank,positive regulation of lipid catabolic process (GO:0050996),0.6266641418561033,1.3489362601417385,0.1480099502487562,0.43881935378925335,1.0,4/19,7.24%,DAGLB;PRKCD;ANGPTL3;ABCD1
prerank,bone development (GO:0060348),0.5654633254240345,1.3488895946853816,0.11731843575418995,0.43840727711346145,1.0,6/39,9.91%,PTPRC;SH3PXD2B;SKI;TP53;SULF2;LRP5
prerank,actin nucleation (GO:0045010),0.6188807784257577,1.348324079931915,0.1282367447595561,0.4394264336493106,1.0,7/21,11.38%,IQGAP2;ARPC2;ARPC3;TRIM27;ACTR2;ACTR3;ARPC4
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.6284181880122015,1.3482201170723713,0.12953367875647667,0.4391701980651368,1.0,4/17,5.61%,CCND3;RGCC;PKD2;CCND2
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),0.6731147716247832,1.3478056753700391,0.14464534075104313,0.43978264577849696,1.0,4/12,11.30%,BASP1;MYO1E;PODXL;PTPRO
prerank,positive regulation of TOR signaling (GO:0032008),0.5706112953806349,1.347756052529894,0.11258278145695365,0.4393752728127593,1.0,18/40,21.78%,NCKAP1L;TREM2;FNIP1;GPR137B;SEH1L;FLCN;PIP4P1;GAS6;LAMTOR3;PIH1D1;LAMTOR1;GOLPH3;RPTOR;SEC13;TELO2;RRAGA;PIK3CA;RRAGB
prerank,positive regulation of biosynthetic process (GO:0009891),0.560711829364851,1.3469700757339067,0.10321864594894561,0.44099783006407783,1.0,8/40,7.23%,RUNX1;TGFB1;PLCG2;MTOR;MLXIPL;RGCC;APOE;CREB3L1
prerank,positive regulation of epithelial cell migration (GO:0010634),0.5380733495007148,1.3469664843784865,0.05785123966942149,0.44046202956384156,1.0,22/92,11.65%,PTK2B;PIK3CG;RIN2;SMOC2;PIK3CD;ITGB3;PLCG2;RREB1;ANGPT4;MTOR;PIK3CB;PRKD2;PDCD6;BCAR1;RAB11A;PFN1;SOX9;NRP1;THBS1;HDAC6;GPI;GRN
prerank,positive regulation of inflammatory response (GO:0050729),0.530163490207567,1.3464432818297032,0.061791967044284246,0.44134579859397094,1.0,13/86,5.08%,CCR2;LPL;GPRC5B;ADAM8;TLR2;DHX9;TLR7;MDK;OSM;TNF;SNCA;CEBPA;IL18
prerank,negative regulation of lyase activity (GO:0051350),0.6408153533027966,1.3461934784559366,0.14432989690721648,0.4414999921630942,1.0,5/16,14.14%,CCR2;EDNRB;AKAP5;LTB4R2;GNAI3
prerank,regulation of lipase activity (GO:0060191),0.6629036846551362,1.3461773504932564,0.13934426229508196,0.4410025255613084,1.0,6/13,17.75%,LPL;ANGPTL3;SNCA;LIPC;FURIN;RHOA
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.5236726005408722,1.3448423028137382,0.022199798183652877,0.4442041653373384,1.0,23/140,13.99%,GNA15;LPAR6;CALCR;CX3CR1;CCR2;CD52;P2RX7;SLC8A1;CXCR4;P2RX4;S1PR4;HMGB1;GPR17;CCKBR;CACNA1A;SPPL3;CYSLTR1;CMKLR1;TACR1;IAPP;NPTN;ADCY8;C3AR1
prerank,negative regulation of autophagy (GO:0010507),0.5535887982877469,1.3447917422732873,0.07849462365591398,0.4438037465008489,1.0,15/54,15.13%,TREM2;IL10RA;CTSA;MTOR;ATG7;SNCA;SMG1;EIF4G3;DAP;TAB2;FOXK1;BMF;LRRK2;TAB3;TBC1D14
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.623400743828985,1.3442926794975436,0.13624678663239073,0.4446106123904165,1.0,4/17,8.05%,CD74;RFFL;CD44;SNAI1
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),0.6522277310938126,1.3439687973375636,0.13577023498694518,0.444965267885555,1.0,7/15,11.38%,IQGAP2;ARPC2;ARPC3;TRIM27;ACTR2;ACTR3;ARPC4
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.534806818285068,1.3439374811107276,0.0541922290388548,0.44449826013360233,1.0,11/86,6.54%,NCKAP1L;PTK2B;HCK;PLEK;NCK2;SNX9;APOE;COLGALT1;MYLK3;PYCARD;MAPRE1
prerank,positive regulation of cell migration (GO:0030335),0.5175451285548599,1.343904428360223,0.004004004004004004,0.44403999457913773,1.0,46/253,11.65%,NCKAP1L;PTPRC;PTK2B;FERMT3;GPNMB;FGR;ITGAX;TGFB1;CASS4;CCR2;F10;VSIR;PIK3CD;CSF1R;PLCG2;TGFBR1;MGAT5;RREB1;MTOR;MDK;ANGPTL3;SEMA4D;ITGA6;LGR6;AIF1;MAPRE1;CCAR1;ACTN4;RIPOR1;NEDD9;SNAI1;FAM89B;KIF20B;PTP4A1;NTF3;PODXL;ACTG1;BCAR1;RAB11A;SEMA4A;PFN1;SOX9;NRP1;THBS1;HDAC6;GRN
prerank,protein kinase A signaling (GO:0010737),0.6671097152400419,1.3436423508655626,0.12871287128712872,0.44420830393903554,1.0,3/12,11.47%,LCP1;TTN;PRKACB
prerank,thymus development (GO:0048538),0.6708511612192369,1.3429427101762728,0.12236286919831224,0.445725248909013,1.0,2/13,2.09%,SHH;TGFBR1
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.6068673772528183,1.3428571504668638,0.14177215189873418,0.4453995093673463,1.0,7/22,16.66%,MDK;FZD9;SLC16A2;NAP1L1;TAFA1;LRRK2;APPL2
prerank,carbohydrate catabolic process (GO:0016052),0.5668593038894494,1.3428514071075086,0.12070874861572536,0.4448731489277424,1.0,13/38,16.87%,HK3;PFKL;ALDOB;ENO3;MAN2B1;MAN2B2;GPI;HK2;GAPDHS;GCK;LDHA;PGAM4;PGAM1
prerank,cellular response to lectin (GO:1990858),0.5226663126766273,1.3422817389459774,0.05408163265306123,0.4454291995062679,1.0,27/104,17.85%,CLEC4D;LYN;CARD11;SYK;PLCG2;PRKCD;FCER1G;MUC13;TYROBP;PSMB10;MALT1;PSMA2;PRKACB;FYN;PSME3;TAB2;IKBKG;NFKB1;PSMB5;PSMD8;TAB3;SRC;PSMD7;PSMB9;RPS6KA5;PDPK1;PSMD2
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.5226663126766273,1.3422817389459774,0.05408163265306123,0.4454291995062679,1.0,27/104,17.85%,CLEC4D;LYN;CARD11;SYK;PLCG2;PRKCD;FCER1G;MUC13;TYROBP;PSMB10;MALT1;PSMA2;PRKACB;FYN;PSME3;TAB2;IKBKG;NFKB1;PSMB5;PSMD8;TAB3;SRC;PSMD7;PSMB9;RPS6KA5;PDPK1;PSMD2
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.6975889823380118,1.342059521957031,0.14265129682997119,0.4454892182129749,1.0,4/10,16.80%,PTPRJ;SNCA;LRP1;PTPN12
prerank,negative regulation of stem cell differentiation (GO:2000737),-0.5039089768496,-1.3418220802944714,0.14855072463768115,0.9138470886488431,1.0,4/12,13.17%,REST;HES1;HNRNPU;JAG1
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.5377218607132519,1.341785039106483,0.07525773195876288,0.4456680995383444,1.0,7/76,7.66%,GNA15;LPAR6;CX3CR1;P2RY6;GPR17;CCKBR;P2RY12
prerank,cAMP-mediated signaling (GO:0019933),-0.4109255453927809,-1.3410408272151468,0.12244897959183673,0.9050646773793369,1.0,9/24,16.49%,PDE7A;RAPGEF3;ADGRG6;ADCY2;RIMS2;RAPGEF2;CAP2;DGKQ;PDE2A
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.5730466133894287,1.3408873283279166,0.1310344827586207,0.4476620365519366,1.0,9/36,13.36%,TREM2;SIRPA;TAOK3;DUSP3;DUSP10;QARS1;DUSP19;ITCH;GPS2
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),-0.5219607506688283,-1.3402863350278211,0.14006514657980457,0.8962134763254793,1.0,9/11,30.49%,GPLD1;SCARB1;CTDNEP1;SLC27A1;NR1H2;NR1H3;MFSD2A;LDLR;CNEP1R1
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.6017896363780587,1.3400566233203026,0.1412037037037037,0.4493774370648292,1.0,6/26,12.44%,LILRB3;C1QC;GPR137B;TMEM178A;INHBA;CDK6
prerank,regulation of bone mineralization (GO:0030500),0.5426211349573989,1.339952273124151,0.08090614886731391,0.44911283249923845,1.0,9/55,8.52%,PTK2B;TGFB1;SRGN;P2RX7;BMP2K;SLC8A1;FZD9;MEF2C;ATP2B1
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.5173794626525311,1.3388268391012046,0.003003003003003003,0.4517286085810109,1.0,66/234,17.33%,BTK;SHH;CARD11;CX3CR1;HCLS1;AIM2;IRAK2;PLCG2;ADAM8;TRIM25;TLR2;CAMK1D;TNFRSF11A;DHX9;TRIM5;TNF;RGCC;PRKD2;UBE2V1;TRAF2;PYCARD;DDIT3;IL18;RAB7B;NFAM1;HDAC5;TAF1;PRKCB;CFLAR;CTNNB1;MYOCD;TICAM1;MALT1;IL18RAP;PRKCQ;TRIM27;SMAD3;HSF1;PPARGC1A;PRKCH;TRAF5;HDAC4;TRIM8;MID2;RPS6KA4;PRDX3;NOD2;TAB2;IKBKG;LRP8;SMARCB1;NFKB1;ADCY8;STK3;TRADD;TAB3;CAPN3;BUD31;MTDH;FANK1;CD36;PTEN;UBE2N;TRIM62;ARHGEF2;RPS6KA5
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.5230085053717279,1.3383468229333506,0.010030090270812437,0.4525388275359655,1.0,32/172,9.94%,INPP5D;PIK3CG;PIK3R5;DGKZ;PIK3CD;LPIN2;PLCG2;DDHD1;LPCAT1;PIK3CB;PIP5K1C;INPP4B;CLN3;PIP4K2A;PI4K2A;RAB14;PCYT1A;CHKB;PLD2;PGS1;CDS2;DGKE;LPCAT2;MTMR3;DGKG;DGKD;CSNK2A2;CSNK2A1;SLC44A2;ABHD4;AGK;STARD10
prerank,embryonic skeletal system development (GO:0048706),-0.3621338805550844,-1.3383343315226373,0.07194244604316546,0.8925977140235113,1.0,11/35,14.19%,PCSK5;HOXC4;WNT5A;SULF1;HOXB9;DSCAML1;HOXA3;PDGFRA;SIX1;HOXC9;COL1A1
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.5527676297097446,1.3379774220585654,0.09409190371991247,0.45299762580433633,1.0,14/45,17.78%,PTK2B;TGFB1;CBL;GRB2;NCK2;ERBIN;DGKD;BCAR1;SOX9;BRAF;SRC;IQGAP1;RPS6KA5;PDPK1
prerank,response to cholesterol (GO:0070723),0.6273536144706656,1.3370714373926649,0.1356382978723404,0.4549967740695564,1.0,3/17,6.68%,TGFB1;TGFBR1;TGFBR2
prerank,positive regulation of secretion by cell (GO:1903532),0.5338092090474484,1.3369176668538423,0.08986415882967608,0.4548820506904414,1.0,17/70,14.20%,TREM2;TGFB1;UNC13D;IL1A;ADAM8;SNCA;RGCC;ABCG1;TTN;P2RX4;SYTL4;ATP6AP1;DTNBP1;EXOC1;ARF6;NMB;MYH10
prerank,autonomic nervous system development (GO:0048483),0.6221833915704953,1.3367890036428904,0.1462140992167102,0.45468458394063554,1.0,6/17,16.03%,ASCL1;EDNRB;TFAP2B;NRP1;SOX4;NF1
prerank,retrograde axonal transport (GO:0008090),-0.46378135373882545,-1.3367253895661548,0.12719298245614036,0.8880997093600453,1.0,6/16,10.38%,DLG2;KIF5B;PAFAH1B1;SOD1;NEFL;KIF5A
prerank,negative regulation of cellular metabolic process (GO:0031324),0.5653687831299405,1.336178434227102,0.11858608893956671,0.45587991264563055,1.0,15/37,22.32%,PCSK9;ITGB3;RIN3;EDNRB;APOE;TRAP1;SDCBP;NFKB1;ANKRD13A;OPTN;PRKN;SIRT5;ABCA2;MT3;AATF
prerank,negative regulation of secretion (GO:0051048),0.6873535948979448,1.3361072857464105,0.1702127659574468,0.4555296759982807,1.0,2/10,1.94%,CD74;VAMP3
prerank,regulation of fatty acid metabolic process (GO:0019217),-0.4621115569622151,-1.3358460969088046,0.12350597609561753,0.8803330810378814,1.0,6/17,15.60%,CAV1;PANK2;NCOR1;PPARA;PRKAB2;PPARG
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.5371257629443718,1.3352107493060659,0.0740354535974974,0.45752856436193357,1.0,12/74,6.37%,PF4;LGALS3;GATA1;IL1A;TGFBR1;RFFL;TNF;ITGA6;TRAF2;TNFAIP3;CFLAR;BCL2L1
prerank,glycine transport (GO:0015816),0.7106880511242595,1.3351495363460824,0.14074074074074075,0.4571303282106643,1.0,3/10,9.26%,SLC7A8;SLC36A1;SLC25A38
prerank,catecholamine metabolic process (GO:0006584),0.6530327870921167,1.3349991425805365,0.15353805073431243,0.4570003214669144,1.0,3/14,4.50%,RNF180;ATP7A;DDC
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.5954796746106127,1.334614905220031,0.12845138055222088,0.4575521557243466,1.0,13/26,24.42%,PLCG2;TNF;SLC9A1;SPPL3;CHERP;RCAN1;LMCD1;GSK3B;PTBP1;CHP1;IGF1;ATP2B4;CAMTA1
prerank,ureteric bud development (GO:0001657),-0.4615847981519921,-1.3345873243322326,0.1308016877637131,0.8737809015269958,1.0,7/17,14.63%,ROBO2;FOXC1;BMP4;SALL1;SLIT2;SIX1;GPC3
prerank,chondroitin sulfate metabolic process (GO:0030204),0.5828058987390483,1.334526866002044,0.12311265969802555,0.45725976363865606,1.0,8/30,12.83%,HEXB;ARSB;IDS;HEXA;CHSY3;BCAN;CHSY1;CHST15
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),0.6080061024537621,1.3344036405413882,0.14,0.45703802454032216,1.0,8/20,13.99%,P2RX7;PSTPIP1;PYCARD;IL18;CASP1;P2RX4;ENTPD1;C3AR1
prerank,long-term memory (GO:0007616),0.6093161768205466,1.334384157305571,0.15170670037926676,0.45655081931777775,1.0,3/19,9.89%,NPAS4;APOE;CPEB3
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.6479786533122377,1.3332286675559717,0.13581890812250333,0.4593300519476131,1.0,6/15,12.01%,NLRC5;SAMHD1;YTHDF3;TTLL12;USP18;METTL3
prerank,neurogenesis (GO:0022008),0.5549887379235867,1.3329869824673986,0.09333333333333334,0.4594698293076798,1.0,7/43,6.34%,ASCL1;PCSK9;DAGLB;PRDM12;CXCR4;THOC2;ANXA1
prerank,regulation of extracellular matrix organization (GO:1903053),0.6494791114603137,1.3320390994298559,0.1593625498007968,0.4615745226371382,1.0,2/15,8.46%,RUNX1;RB1
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.6781119120013323,1.3320370354402324,0.15660919540229884,0.4610293424120398,1.0,6/12,20.12%,HOOK3;BICD2;PCM1;NINL;CCDC120;KIF3A
prerank,import into cell (GO:0098657),0.556072356984417,1.3318590093785612,0.12555066079295155,0.4609387424402639,1.0,6/41,7.46%,TREM2;IL10RA;LRRC8D;SLC7A8;SLC36A1;SLC16A2
prerank,regulation of mitotic nuclear division (GO:0007088),0.5423229400489283,1.3316321028511928,0.0944386149003148,0.4610199633539282,1.0,9/55,11.88%,ANAPC15;IL1A;NUP62;NME6;AURKAIP1;RGCC;KIF20B;LRP5;PHIP
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.6431112816162895,1.3315522500068164,0.1469440832249675,0.4607059148530816,1.0,5/16,9.89%,PLEKHN1;ZC3H12D;MOV10;RC3H1;CPEB3
prerank,response to interleukin-1 (GO:0070555),0.5333221430073262,1.3314609558151111,0.06910994764397906,0.4604083940383443,1.0,22/73,16.85%,SIRPA;IRAK2;TNFRSF11A;CCL8;SNCA;MYLK3;TANK;PYCARD;ANXA1;RC3H1;CCL14;HDAC4;CCL13;SOX9;GBP3;CCL2;NFKB1;SRC;TLE5;HIF1A;CD47;CCL25
prerank,cilium-dependent cell motility (GO:0060285),-0.4088352062264188,-1.3312850113053731,0.14285714285714285,0.8760014478576837,1.0,15/22,48.20%,CCDC39;CFAP54;DNAH2;CFAP44;GAS8;DNAH3;DRC1;CCDC65;DNAAF2;TEKT2;DNAH8;DNAH17;TEKT5;EFHC2;DNAH1
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),0.691730136100181,1.3312245170764048,0.1661721068249258,0.45997171972652434,1.0,3/10,4.92%,PRKCD;TNF;SMPD3
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.691730136100181,1.3312245170764048,0.1661721068249258,0.45997171972652434,1.0,3/10,4.92%,PRKCD;TNF;SMPD3
prerank,positive regulation of isotype switching (GO:0045830),0.6476298720118138,1.3312150542284478,0.13743455497382198,0.45945470787933024,1.0,2/15,2.40%,TGFB1;MAD2L2
prerank,regulation of phospholipase activity (GO:0010517),0.6811504436918214,1.3311031508252542,0.16715116279069767,0.45919269103420135,1.0,5/10,20.32%,ANGPTL3;SNCA;LRP1;PDPK1;PLA2G5
prerank,negative regulation of neuron death (GO:1901215),0.5217523189362038,1.3307511927572142,0.07208121827411168,0.4595927489049899,1.0,25/93,15.94%,PTK2B;GPNMB;LGMN;CD200R1;ADAM8;MDK;SNCA;APOE;TRAF2;CLN3;FZD9;MEF2C;KIF14;NTF3;PPARGC1A;CCL2;GRN;TNFRSF1B;SORL1;IKBKG;RETREG1;WFS1;LRRK2;CPEB4;RASA1
prerank,regulation of trans-synaptic signaling (GO:0099177),0.5729808044165359,1.3300640555853194,0.12613636363636363,0.4609467193060062,1.0,10/33,13.81%,CX3CR1;ABR;CEL;BTBD9;CACNA1A;FABP5;EIF4EBP2;NTF3;LRP8;CACNA1B
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.5326173765860783,1.3297506878188967,0.09166666666666666,0.4613293288700683,1.0,16/75,10.93%,LYN;CD300A;PRKAR2B;PRKCD;PTPRJ;PTPN1;PIK3CB;SLC8A1;PKIB;APOE;CEBPA;PYCARD;MYOCD;RB1;LRP5;SH2B3
prerank,actin filament organization (GO:0007015),0.516998450806173,1.3294733783826724,0.03024193548387097,0.4615643003084669,1.0,26/151,11.38%,MYO1F;ARHGAP25;MYO1G;CASS4;LCP1;MYO1E;CORO1A;GAS2L1;MYO5A;MAD2L2;ELMO1;PLS1;TTN;GAS2L3;FHOD1;FLII;AIF1;NEDD9;MYO7A;MYO19;ABI1;TPM4;BCAR1;ACTN1;BIN3;ARPC4
prerank,"synaptic transmission, glutamatergic (GO:0035249)",-0.4522997307328962,-1.3290681912196478,0.16744186046511628,0.8735381914391139,1.0,4/18,4.76%,UNC13B;GRIK4;GRIA2;SLC17A6
prerank,regulation of cholesterol biosynthetic process (GO:0045540),0.6169019047394317,1.3288956384098862,0.1613722998729352,0.4626685256039557,1.0,7/17,14.65%,SREBF2;ABCG1;APOE;ERLIN1;ERLIN2;SEC14L2;SREBF1
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.6305989516864844,1.3286005808298542,0.16732026143790849,0.4629421804709578,1.0,5/16,11.18%,WDTC1;ERLIN1;ERLIN2;ACADL;SOX9
prerank,regulation of cell adhesion (GO:0030155),0.5226002721357416,1.3285488791509545,0.041289023162134945,0.46253679970180317,1.0,34/129,16.80%,PTK2B;LYN;PIK3CG;ADAM8;PTPRJ;PLXNC1;MDK;SEMA4D;TNF;PRKD2;TGFBI;CXCR4;PLXNB2;CYTIP;IL18;RIPOR2;ATXN3;P4HB;KIF14;FLCN;SIPA1;PODXL;ARHGDIB;CYTH1;PPP2CA;ADGRG1;STX3;ARHGDIA;ZFHX3;SRC;RASA1;EPHA4;LPXN;EPHA8
prerank,regulation of lipid storage (GO:0010883),0.6047040816736927,1.3279788303047628,0.1486146095717884,0.46357496854235647,1.0,5/22,13.46%,LPL;ITGB3;TNF;VSTM2A;NFKB1
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.5887064904988796,1.3276257678499888,0.14268867924528303,0.46399010444156963,1.0,9/25,16.38%,RPL23;PDCL3;TAF1;HFE;CSNK2A2;CSNK2A1;PSME3IP1;EPHA4;RPL11
prerank,regulation of JUN kinase activity (GO:0043506),0.5636953997646084,1.326686347914393,0.13683010262257697,0.46605014871196543,1.0,8/33,10.57%,TAOK3;FZD10;TNFRSF11A;TNF;TRAF2;MAP3K5;DUSP10;DUSP19
prerank,ear morphogenesis (GO:0042471),-0.4289894714587358,-1.3265102124363959,0.1095890410958904,0.873128165730717,1.0,7/20,15.27%,NIPBL;MYO6;ZIC1;EPHB2;SIX1;TBX1;PAX2
prerank,negative regulation of amyloid fibril formation (GO:1905907),0.6557503315855695,1.3257523254496573,0.15620641562064155,0.4681495433728906,1.0,4/12,14.96%,TREM2;APOE;IAPP;PFDN1
prerank,receptor signaling pathway via STAT (GO:0097696),0.5865726102237074,1.324986886891503,0.14805825242718446,0.4697864794792434,1.0,7/25,11.55%,CCR2;STAT5A;PKD2;IFNAR1;STAT4;STAT5B;CCL2
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.5120928514579617,-1.324812238450707,0.14492753623188406,0.869590036472718,1.0,6/12,10.73%,CACNA1C;CAV1;RYR2;JUP;DLG1;CTNNA3
prerank,regulation of transposition (GO:0010528),0.650539598629112,1.3245419976412214,0.16158940397350993,0.4705376518447864,1.0,1/13,0.89%,SMYD5
prerank,peptidyl-proline hydroxylation (GO:0019511),0.6606360473853865,1.324528121157643,0.16033755274261605,0.47004472677370096,1.0,3/11,9.78%,CRTAP;P4HB;P3H2
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.5187134753470695,1.3245008665956717,0.052899287894201424,0.4695838172647264,1.0,25/101,17.88%,PIK3CG;PIK3R5;TGFB1;FLT3;CSF1R;ADAM8;CCND3;TNF;SNCA;RGCC;PKD2;CCND2;MAP2K2;PARP16;NOD2;PPP2CA;LRRK2;PIH1D1;SRC;SYAP1;INCENP;IRGM;CEMIP;RHOA;CCNYL1
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.5126896186939893,-1.3244160039252335,0.15942028985507245,0.8609857784695542,1.0,6/12,18.57%,SEC61G;SGTB;CHMP4B;CHMP4A;SEC61B;SEC61A1
prerank,carbohydrate transport (GO:0008643),0.6712395357028267,1.3241651911423937,0.14410480349344978,0.4700289747489683,1.0,2/11,8.14%,AQP1;AQP11
prerank,carbohydrate derivative transport (GO:1901264),0.6192169875645506,1.324151286560975,0.1576923076923077,0.4695193888247869,1.0,4/18,4.53%,SLC15A3;NPC2;ABCG1;CLN3
prerank,sodium ion transport (GO:0006814),0.5253860814806661,1.323758837866734,0.06611570247933884,0.47007009730482335,1.0,7/85,4.10%,SLC6A3;SLC6A4;SCN4B;HCN4;FGF13;SLC8A1;PKD2
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.6751848713331571,1.3234055505867104,0.18409425625920472,0.47054388824877585,1.0,2/10,7.31%,CCR2;WNK1
prerank,cellular response to hormone stimulus (GO:0032870),0.5350266203574303,1.322906278597756,0.09728033472803348,0.4713566158299388,1.0,13/69,11.20%,CTSS;CTSB;GATA1;BRD8;GAS2L1;CTSL;OCSTAMP;RAMP1;LMO2;MEF2C;STAT5B;TRIM24;SRA1
prerank,positive regulation of cell death (GO:0010942),0.5330213006574297,1.3213875950668672,0.10911016949152542,0.475152264296642,1.0,15/59,16.38%,CALCR;ITGB2;FCGR2B;TNF;SNCA;TYROBP;MAP3K5;C1QA;ITGAM;FYN;DDIT4;LRRK2;LRP1;CD36;FAF1
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.658384653926728,1.3212943526936305,0.1623108665749656,0.4748753092894536,1.0,2/12,3.81%,TGFB1;TNF
prerank,negative regulation of protein autophosphorylation (GO:0031953),-0.5300064573494822,-1.3208568884254004,0.1337579617834395,0.8646246387559857,1.0,3/10,7.23%,ERRFI1;CAV1;MVP
prerank,N-acetylneuraminate metabolic process (GO:0006054),0.6904161897800742,1.3203308657519055,0.17587209302325582,0.4770780597085336,1.0,4/10,8.51%,NPL;RENBP;NAGK;ST3GAL1
prerank,cellular response to retinoic acid (GO:0071300),0.5542581076865309,1.3202690122193788,0.12831858407079647,0.4766984626079804,1.0,4/42,1.89%,PTK2B;LYN;AQP1;FZD10
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.6448587800193938,1.3201797262019932,0.19119669876203577,0.4763854722843344,1.0,3/13,5.85%,ITGA4;MDK;HMGB1
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.6723449799435427,1.3201063770881043,0.19264705882352942,0.4760427109722606,1.0,2/10,10.81%,LYN;MAP2K2
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),-0.45994736881003145,-1.320015180843138,0.1380952380952381,0.8579449187674552,1.0,15/18,46.05%,NPHP3;CCDC39;SPEF2;OFD1;NEK10;CABYR;CFAP53;ROPN1L;ADCY10;SPAG17;SPA17;DNAAF2;ODAD4;CCDC40;DNAAF4
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.5558934462151464,1.319784304351869,0.1165158371040724,0.47646904933749573,1.0,11/40,12.94%,TGFB1;TGFBR1;MTOR;MDK;RGCC;CTNNB1;TGFBR2;SNAI1;SMAD3;SDCBP;BAMBI
prerank,amyloid precursor protein metabolic process (GO:0042982),0.6264023479578749,1.3197821016237674,0.14795918367346939,0.4759327743743502,1.0,4/18,4.53%,ABCG1;APOE;LDLRAP1;CLN3
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),0.5561888679470638,1.3197752842701758,0.13785310734463277,0.4754012266358695,1.0,5/34,3.37%,UBASH3B;PTPRJ;DUSP3;PTPN1;PTPN18
prerank,hydrogen peroxide catabolic process (GO:0042744),0.6703784437771139,1.319290118856752,0.1875,0.4761991821872272,1.0,5/11,16.91%,PRDX1;PRDX3;PRDX2;PXDN;PRDX5
prerank,sodium ion transmembrane transport (GO:0035725),0.5238905532768778,1.3192390305749375,0.07556935817805382,0.47579212426537904,1.0,10/84,9.15%,SLC6A3;SLC6A4;SCN4B;HCN4;SLC9A4;SLC8A1;PKD2;SLC9A9;SLC9A1;SLC6A15
prerank,phospholipid transport (GO:0015914),0.5419043238393605,1.3186452585318373,0.11592632719393282,0.4769243848057659,1.0,13/52,15.27%,ATP8B4;ABCA1;ATP8A1;NPC2;ABCG1;APOE;ATP8A2;PRELID3B;ABCB4;ABCC1;ABCA4;OSBPL8;ABCA3
prerank,secondary alcohol metabolic process (GO:1902652),0.5483358417872817,1.3184332623173276,0.12747252747252746,0.47701995068512054,1.0,7/42,5.56%,ABCA1;ANGPTL3;CLN8;ABCG1;APOE;LDLRAP1;SOAT2
prerank,cellular response to interleukin-6 (GO:0071354),0.5835847439254022,1.3177957303739098,0.14130434782608695,0.47836321323511105,1.0,11/26,16.43%,CBL;IL6R;CEBPA;SPI1;ST18;NFKB1;PID1;PTPRT;SRC;SELPLG;SBNO2
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.6560792208009533,1.3176241740290169,0.1643646408839779,0.47833507060007935,1.0,4/12,5.85%,CD74;LPL;TNF;HMGB1
prerank,positive regulation of cardiocyte differentiation (GO:1905209),0.6654158182715368,1.3171250033129407,0.1850282485875706,0.4791671954702209,1.0,3/11,8.10%,TGFB1;MYOCD;MEF2C
prerank,regulation of cell junction assembly (GO:1901888),0.5809383043841633,1.3168914027181264,0.145083932853717,0.4792459025600727,1.0,12/27,21.22%,RUNX1;RAP1B;SNAI1;MEF2C;PRKCH;F11R;RAPGEF1;RAP1A;MYO1C;FLOT1;ROCK2;SETD5
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.5258357032196451,1.316561205406725,0.09278350515463918,0.47957427732245894,1.0,19/69,16.30%,PTK2B;CX3CR1;LGMN;ADAM8;MDK;APOE;CLN3;FZD9;MEF2C;KIF14;NTF3;PPARGC1A;CCL2;GRN;RETREG1;WFS1;CPEB4;RASA1;HIF1A
prerank,cellular response to interleukin-15 (GO:0071350),0.6419279049056918,1.316408200378732,0.16983695652173914,0.47894777265099114,1.0,4/13,14.02%,STAT5A;GRB2;STAT5B;IL2RG
prerank,interleukin-15-mediated signaling pathway (GO:0035723),0.6419279049056918,1.316408200378732,0.16983695652173914,0.47894777265099114,1.0,4/13,14.02%,STAT5A;GRB2;STAT5B;IL2RG
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.5738440568869736,1.3159251880273257,0.13725490196078433,0.47974917281984003,1.0,9/32,12.50%,LPIN2;LPCAT1;PCYT1A;CHKB;CSNK2A2;CSNK2A1;SLC44A2;STARD10;ABHD3
prerank,non-motile cilium assembly (GO:1905515),-0.3836419338947904,-1.3151136544614257,0.125,0.8670905185708657,1.0,15/30,25.28%,TTC8;IFT57;CEP250;BBS4;PIBF1;TBC1D32;CEP89;FUZ;TMEM216;BBS1;VANGL2;RPGRIP1L;GORAB;ARL13B;IFT122
prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.5789669981369319,1.3150059833759826,0.16270337922403003,0.48177627064979706,1.0,9/25,17.39%,CBL;NUP62;ARAP1;DOK1;DGKD;BCAR3;RBPJ;RTN4;PDE6H
prerank,regulation of defense response to virus (GO:0050688),0.6462819570801642,1.3145170385219174,0.16910785619174434,0.48267162077803305,1.0,6/14,12.91%,DHX9;TNFAIP3;TRAF3;ZMPSTE24;RNF216;ITCH
prerank,response to lipid (GO:0033993),0.5174396008658639,1.3135375565607967,0.06896551724137931,0.4848574992358029,1.0,20/105,12.56%,ASCL1;SLC11A1;TGFB1;MAPKAPK3;TNFRSF11A;RXRB;SNCA;GCH1;ABCG1;IFNAR1;FOXO3;SPP1;CTNNB1;ANXA1;ERBIN;LY96;STAT5B;SOX9;PRDX3;TAB2
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.5423566870631465,1.313139447671138,0.15219842164599776,0.48547885351556375,1.0,8/39,7.56%,LGMN;CBL;PTPRJ;DUSP3;GRB2;PTPN18;ZFYVE28;SH3KBP1
prerank,lipoprotein transport (GO:0042953),0.6696805796376069,1.313095910464478,0.17985611510791366,0.4850636640403378,1.0,4/10,16.04%,PRKCB;VMP1;LRP1;CD36
prerank,gas transport (GO:0015669),0.6745699303187127,1.3129310718427456,0.19121813031161472,0.4849803271131222,1.0,2/10,13.10%,AQP1;IPCEF1
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.514887215803567,1.3126365086177436,0.0482897384305835,0.48523230804063794,1.0,28/136,11.74%,ARRB2;TMIGD3;AIM2;IRAK2;NLRC5;HAVCR2;MAD2L2;NLRC3;PKD2;OTULIN;PYCARD;DDIT3;SPI1;TNFAIP3;TRAF3;ADGRG3;TAF1;SETD6;PIM1;TAX1BP1;TMSB4X;ERBIN;RB1;ANXA4;HDAC4;CMKLR1;USP7;DAP
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.6045994708828976,1.3118407782281951,0.15861214374225527,0.48694044286920696,1.0,13/20,28.34%,CNOT8;TNRC6A;MOV10;AGO4;AGO3;NRDE2;AGO2;CNOT7;CNOT1;AGO1;LIMD1;EIF6;TNRC6C
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",-0.33292633309952224,-1.3116619939230538,0.08620689655172414,0.8709431603109706,1.0,14/52,15.39%,RBFOX2;FXR2;YTHDC1;MBNL2;RBFOX3;REST;SRRM4;KHDRBS3;FMR1;HNRNPA1;NOVA2;HNRNPU;KHDRBS2;PUF60
prerank,positive regulation of signal transduction (GO:0009967),0.5092558616337648,1.3113935915375747,0.015015015015015015,0.4876781382172476,1.0,53/238,13.41%,PTPRC;CD226;PTK2B;TREM2;SCIMP;SHH;CD74;SMOC2;P2RY6;ITGB3;SNX5;RAB34;TGFBR1;MGAT5;TLR2;BMP2K;DSTYK;LY86;MAML3;ERN1;PRKD2;PKD2;SKI;TNFAIP3;LGR6;FGFBP3;PRKCB;MACF1;CD80;CRADD;ASXL2;DISC1;CD180;CSNK2A1;TSPAN14;SULF2;LY96;NTF3;BAK1;POGLUT1;ATP6AP2;LIMS1;NRP1;CD63;PHIP;NOD2;CCBE1;SORL1;SMARCB1;TXNDC15;NPTN;GPS2;GAS6
prerank,cytosolic transport (GO:0016482),0.521060642396409,1.311291974106371,0.051934826883910386,0.48741328941887574,1.0,37/108,19.71%,HOOK3;LAPTM5;TBC1D10C;VAMP3;SNX5;WDR91;TMEM87B;HEATR5A;RBSN;CLN3;RAB14;RAB7A;TMEM87A;TBC1D10A;TRIM27;VPS54;TBC1D17;CLTC;BECN1;YKT6;WDR81;STX5;STX8;VPS29;HOOK2;VTI1A;SNX2;GAK;EPS15;HEATR5B;CCDC91;MON2;TBC1D23;DENND5A;TBC1D5;RAB29;SORT1
prerank,cellular response to peptide (GO:1901653),0.5343281353437931,1.311201551652825,0.11978609625668449,0.48715016723764026,1.0,16/56,17.29%,TREM2;FCGR2B;LGMN;ITGA4;RPL23;TP53;CACNA1A;ABCC1;NOD2;FYN;CACNB1;LRP1;SRC;CD36;EPHA4;ARHGEF2
prerank,regulation of protein transport (GO:0051223),0.5744170670409039,1.311182415712872,0.15681544028950542,0.48666013746852754,1.0,5/27,7.13%,LCP1;PTPN1;TNF;RHBDF2;GAPVD1
prerank,triglyceride metabolic process (GO:0006641),0.546378907191627,1.3111693852602235,0.1267605633802817,0.48616437586428696,1.0,14/48,20.90%,LPL;LPIN2;FABP4;APOE;SEL1L;FABP5;LIPC;AGMO;PLAAT3;GK;PNPLA3;DGAT2;MOGAT1;LPIN1
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.526299935387086,1.3105486462439464,0.08627858627858628,0.48736303938435,1.0,20/71,16.53%,CTSS;CTSB;LGMN;CTSC;CTSK;CTSL;TNFAIP3;DDI2;ATXN3;LONP1;MALT1;CTSZ;HDAC6;CASP8;STUB1;USP9X;CAPN2;PDCD6IP;IDE;YME1L1
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.6469062769636783,1.3102846339341925,0.1827956989247312,0.48755914422387386,1.0,4/13,13.92%,TREM2;TMSB4X;PPARGC1A;PID1
prerank,negative regulation of kinase activity (GO:0033673),0.5346251751554134,1.310157677392597,0.12341772151898735,0.4874003645817407,1.0,11/62,11.97%,PTPRC;UBASH3B;THY1;GNAQ;SNCA;RB1;TRIM27;QARS1;DUSP19;DTNBP1;PRDX3
prerank,regulation of autophagy (GO:0010506),0.5080545449744686,1.310143254246472,0.014,0.4869003173072553,1.0,57/216,15.64%,TREM2;ATP6V0D2;IL10RA;ATP6V0E1;SNX5;DRAM2;CTSA;MTOR;PIK3CB;ATP6V1C1;PSAP;ERN1;TRIM5;SREBF2;ATP6V1E1;GPR137B;PIP4K2A;FOXO3;DDIT3;ATP6V0A2;DCAF12;HMGB1;TFEB;PIM2;SVIP;ATP6V0D1;TICAM1;PLK2;MTMR3;CSNK2A2;FLCN;RAB39B;TRIM27;TRIM8;GFAP;ATP6V0A1;EIF4G3;MID2;HDAC6;DAP;EXOC8;EXOC7;EXOC1;TAB2;FOXK1;LAMTOR3;VPS29;BMF;LRRK2;ATP6V0B;TAB3;SREBF1;VDAC1;RNF152;TBC1D14;MTDH;GSK3A
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.6861048855039884,1.3091314957367908,0.13970588235294118,0.48921717898304423,1.0,2/10,6.55%,LILRB1;TYROBP
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.5898560025753905,1.308273401936395,0.1591737545565006,0.49112599866812706,1.0,5/24,8.26%,CD74;CD44;BCL2L1;SNAI1;TPT1
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.582091794635295,1.3077495484185089,0.17543859649122806,0.4920643938398697,1.0,6/23,12.63%,TGFB1;MAPK14;MYLK3;MYOCD;MEF2C;NRG1
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.606315634366974,1.3075818269529034,0.16282051282051282,0.49196348224709685,1.0,4/19,8.10%,RUNX1;TGFBR1;PIM1;MEF2C
prerank,negative regulation of response to stimulus (GO:0048585),0.5317030101320811,1.3075391134392005,0.10421052631578948,0.491543296796138,1.0,14/60,15.37%,LYN;UBASH3B;FCGR2B;PDCD1;THY1;PTPN1;MCTP1;AQP11;CASK;SH2B3;CDK6;DDAH1;WFS1;TLE5
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),0.6736239554097199,1.3064763307059248,0.18061674008810572,0.4940424125168456,1.0,4/10,8.99%,NFKBID;RC3H2;MALT1;RC3H1
prerank,"phototransduction, visible light (GO:0007603)",0.6446225071743633,1.3063261883849178,0.16346153846153846,0.4939183401053438,1.0,4/14,12.70%,GNAQ;SAG;CNGB1;ABCA4
prerank,endocardial cushion development (GO:0003197),-0.42822750135616106,-1.306213233270938,0.1407766990291262,0.8829189540609971,1.0,4/21,5.20%,BMPR1A;BMP4;ACVR1;ACVRL1
prerank,membrane raft organization (GO:0031579),0.6217016341977121,1.306180659254285,0.18783783783783783,0.49379902406826337,1.0,3/15,5.51%,RFTN1;CLN3;NPC1
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.5402423899881827,1.3057849257608136,0.11290322580645161,0.49440465406479045,1.0,7/50,6.77%,CD86;LAPTM5;TLR2;TLR7;TNF;CD14;ACTN4
prerank,ganglioside metabolic process (GO:0001573),0.6105921856458593,1.305664266273301,0.16121212121212122,0.4942369574247218,1.0,5/20,7.47%,HEXB;GM2A;ST8SIA4;HEXA;ST6GALNAC4
prerank,positive regulation of protein phosphorylation (GO:0001934),0.5032606617715413,1.305573262134701,0.003,0.49396792179658633,1.0,60/348,13.41%,PTPRC;LCP2;PTK2B;TREM2;GPNMB;LYN;CALCR;TGFB1;CX3CR1;HCLS1;GATA1;CD74;LAT;FNIP2;ITGB3;CSF1R;PLCG2;NIBAN1;TGFBR1;MMD;PTPRJ;ANGPT4;MAD2L2;TEC;OSM;SNX9;RAP2A;SEMA4D;CCND3;TNF;FNIP1;SNCA;PRKD2;IL6R;BRAT1;CCND2;CD44;XRCC5;MAP2K3;TP53;CD80;VEGFB;TNIK;HFE;FLCN;NTF3;PFN2;INHBA;DUSP19;SOX9;NRP1;RPS6KA4;HDAC6;SDCBP;TAB2;LRP8;CAMKK2;NPTN;BRAF;GAS6
prerank,regulation of ERBB signaling pathway (GO:1901184),0.6257661658326203,1.3055232268923316,0.18701298701298702,0.49357554971368245,1.0,7/15,16.80%,LGMN;PTPN18;RHBDF2;MVB12B;RBPJ;RHBDF1;PTPN12
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.5593639309156524,1.3051703960826533,0.15022935779816513,0.49401708537337624,1.0,7/33,8.71%,TGFB1;TNF;FOXO3;SPI1;TEAD1;TP53;SMAD3
prerank,regulation of keratinocyte differentiation (GO:0045616),0.5795885629622719,1.305167375591713,0.17857142857142858,0.49348626326354167,1.0,3/24,2.62%,RUNX1;CTSK;CTSL
prerank,ERBB signaling pathway (GO:0038127),0.5263200690564892,1.304834494387309,0.09735449735449736,0.4938891034178821,1.0,19/64,17.78%,PTK2B;TGFB1;CBL;GRB2;PTPN18;NCK2;ERBIN;DGKD;BCAR1;SOX9;NRG1;BRAF;STUB1;SRC;HSP90AA1;PTPN12;IQGAP1;RPS6KA5;PDPK1
prerank,microtubule anchoring at centrosome (GO:0034454),0.6796898666566648,1.3044265630404057,0.18577648766328012,0.4944511375911858,1.0,1/10,0.14%,HOOK3
prerank,lymphocyte mediated immunity (GO:0002449),0.6489058925675483,1.3043895268700578,0.1864406779661017,0.4940281649625773,1.0,2/12,6.12%,MYO1G;BTN3A3
prerank,positive regulation of sprouting angiogenesis (GO:1903672),-0.45833662115747587,-1.3042010734309657,0.16942148760330578,0.880508628481861,1.0,4/15,9.80%,TJP1;BMPER;SMAD1;KLF4
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.5963095821653632,1.3040058691141365,0.15151515151515152,0.4946165628993266,1.0,6/22,5.21%,ADAM8;SNX9;TNF;APOE;SNX33;TIMP1
prerank,gene silencing by miRNA (GO:0035195),0.5687465678572879,1.303605106217068,0.14755959137343927,0.49523692923501833,1.0,19/32,26.28%,CNOT8;TNRC6A;MOV10;ADAR;PUM2;AGO4;SNIP1;AGO3;PRKRA;TARBP2;AGO2;ZC3H7A;DICER1;CNOT7;CNOT1;ZC3H7B;AGO1;PUM1;LIMD1
prerank,blood circulation (GO:0008015),-0.3339976590741296,-1.3035136267793164,0.0379746835443038,0.8736083867020901,1.0,15/49,12.61%,SGCD;ELN;SGCZ;SERPING1;COL4A3;ACVRL1;SOD1;HTR7;SCPEP1;ROCK1;ACE;CYB5R3;CXCL12;GUCY1A1;NOS3
prerank,microvillus organization (GO:0032528),0.6403461240040325,1.3033660767047068,0.20196353436185133,0.49534905219678493,1.0,9/13,22.14%,RAP2A;RAP1B;TNIK;RAP2B;RAP1A;FXYD5;MINK1;MAP4K4;RAPGEF6
prerank,regulation of receptor recycling (GO:0001919),0.6252146470710379,1.3032357567458552,0.178335535006605,0.4951812200830801,1.0,4/16,5.41%,PCSK9;VAMP3;SNCA;TBC1D16
prerank,positive regulation of protein localization to cell surface (GO:2000010),0.6368251954050912,1.3029483023002049,0.19463087248322147,0.49543121120267297,1.0,4/13,12.76%,TNF;SNX33;TYROBP;STX3
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.5912177748003868,1.302903553212404,0.15676959619952494,0.4950043975417467,1.0,12/26,17.05%,IRAK2;MAP2K6;UBE2V1;TNFAIP3;NOD2;ALPK1;TAB2;IKBKG;CASP8;ITCH;TAB3;UBE2N
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.5815724304721608,1.302649377891891,0.15096618357487923,0.4952419192858591,1.0,6/26,11.48%,WDTC1;MLXIPL;ERLIN1;ERLIN2;ACADL;ADIPOR1
prerank,morphogenesis of an epithelial sheet (GO:0002011),-0.5202680830279978,-1.3023962165368592,0.1804733727810651,0.868919655291814,1.0,8/10,42.94%,BMP5;LIN7C;ARHGAP12;BMP7;SOX11;DLL4;LRP6;TBX20
prerank,hematopoietic stem cell proliferation (GO:0071425),0.6726739712703821,1.3023950597209444,0.16862170087976538,0.4954437043929879,1.0,1/11,0.13%,RUNX1
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.5356933201011561,1.3010499813058827,0.13062568605927552,0.498736206219781,1.0,18/49,21.16%,TREM2;NLRC3;HMGB1;TFIP11;SVIP;KIF14;HSF1;IMPACT;HDAC6;IAPP;SORL1;SRC;LDLRAD4;CDC42;DACT1;RIOK3;GSK3B;CRYAB
prerank,membrane fusion (GO:0061025),0.5553733319109061,1.3009978893197245,0.14553990610328638,0.498343931901735,1.0,17/33,23.89%,VAMP3;RABEP1;STX11;DNM2;SNAP29;DYSF;SNAP23;HUWE1;VPS33B;UBXN2A;DNM1L;USO1;NSFL1C;RIMS1;CHP1;NAPA;NSF
prerank,regulation of T cell chemotaxis (GO:0010819),0.6575363037046058,1.3008820524472933,0.19359534206695778,0.4981313581322105,1.0,2/11,7.31%,CCR2;WNK1
prerank,protein K63-linked ubiquitination (GO:0070534),0.5521288157885145,1.3005873799519672,0.1385809312638581,0.4984519612717716,1.0,16/41,15.00%,UBE2V2;TRIM5;UBE2V1;TRAF2;TRAF3;HECTD1;UBE2S;TRIM27;UBE2E3;RNF4;TRAF5;TRIM56;RNF135;ITCH;STUB1;RNF152
prerank,regulation of glucose metabolic process (GO:0010906),-0.3660695253883612,-1.2999786884682778,0.10256410256410256,0.8685514016902158,1.0,13/34,21.57%,OGT;IRS1;RORA;PDK3;GPLD1;SELENOS;ZNF692;MLYCD;DGKQ;AKT1;BCKDK;IRS2;PDK2
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.5148502000008129,1.299724201729776,0.09647302904564316,0.500258845806746,1.0,28/87,18.77%,ARRB2;TGFB1;NRROS;CBL;TGFBR1;ITGB5;ARHGEF18;SKI;HPGD;ZMIZ2;TGFBR2;FMOD;TGFBRAP1;ZFYVE9;SMAD3;F11R;NLK;BAMBI;ZYX;USP9X;SRC;SMURF1;LPXN;APPL2;FURIN;RHOA;ITGB1;LTBP2
prerank,regulation of ion transport (GO:0043269),0.5206460381885124,1.299261167153965,0.10718002081165452,0.5010347994662657,1.0,16/76,14.28%,KCNJ11;SYT17;ITGB3;VAMP3;P2RX7;SNCA;P2RX4;WNK1;SYT2;HFE;SYT10;NEDD4L;DTNBP1;B2M;TOR1A;KCNA5
prerank,mitotic nuclear membrane organization (GO:0101024),-0.3302358350256577,-1.297643382031049,0.06349206349206349,0.8590797308845993,1.0,20/51,22.38%,SPAST;NUP93;IST1;NUP188;NUP98;PPP2R2A;AHCTF1;NDC1;NUP37;VPS4A;RCC1;EMD;CHMP4B;CHMP4A;NUP133;LMNA;CHMP2A;RAN;NUP43;LBR
prerank,mitotic nuclear membrane reassembly (GO:0007084),-0.3302358350256577,-1.297643382031049,0.06349206349206349,0.8590797308845993,1.0,20/51,22.38%,SPAST;NUP93;IST1;NUP188;NUP98;PPP2R2A;AHCTF1;NDC1;NUP37;VPS4A;RCC1;EMD;CHMP4B;CHMP4A;NUP133;LMNA;CHMP2A;RAN;NUP43;LBR
prerank,mesoderm formation (GO:0001707),0.6078007313717289,1.2975321834121036,0.20384615384615384,0.5053918511893963,1.0,3/17,8.05%,ITGB3;ITGA2;SNAI1
prerank,regulation of ATP biosynthetic process (GO:2001169),0.6155340470921653,1.2973629894670602,0.16776750330250992,0.5052896979358036,1.0,4/16,9.18%,TREM2;TMSB4X;FLCN;PPARGC1A
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.5677704267472893,1.2970953362310864,0.17139334155363747,0.5055312103635026,1.0,8/26,18.33%,TREML4;TLR1;TLR2;HMGB1;WDFY1;NINJ1;RTN4;FLOT1
prerank,atrial septum development (GO:0003283),-0.4858098790441869,-1.2964141592759444,0.16393442622950818,0.8548469537188377,1.0,6/13,26.25%,ANK2;NPHP3;HEY2;BMPR2;DAND5;TGFB2
prerank,cellular response to organic cyclic compound (GO:0071407),0.5035550609176298,1.2962660941230117,0.04632426988922457,0.507205538611068,1.0,34/141,14.55%,CYP1A1;TGFB1;P2RY6;AQP1;HCN4;P2RX7;P2RY2;NR1H4;TNF;PKD2;ADCY6;SPP1;IL18;RAP1B;P2RX4;TAF1;ABCB4;CTNNB1;ACTB;P2RY12;MEF2C;LARP1;IMPACT;DIAPH1;RAPGEF1;CCL2;CASP7;NRIP1;TIPARP;ADCY8;ADCY3;GNG2;LRRK2;RAP1A
prerank,B cell activation involved in immune response (GO:0002312),0.6446455723374764,1.2957336938689297,0.19553072625698323,0.5081876114938386,1.0,3/13,9.45%,FCGR2B;CD180;GPR183
prerank,positive regulation of multicellular organismal process (GO:0051240),0.49761441686941227,1.2956560574561278,0.009009009009009009,0.507831867611374,1.0,52/308,13.62%,CLEC9A;TREM2;FGR;PIK3CG;SHH;ITGAX;IRF4;SLC11A1;TGFB1;SYK;CCR2;IL1A;PIK3CD;ABCA1;TGFBR1;CRTAM;FABP4;RREB1;MAD2L2;MTOR;MDK;TNF;RGCC;APOE;CXCR4;CCDC88B;IL18;NFAM1;CTNNB1;TGFBR2;ACADL;CEBPB;SNAI1;FABP5;SMAD3;LURAP1;HSF1;PPARGC1A;PRKCH;INHBA;CMKLR1;TXK;SOX9;ADIPOR1;NR2C2;DYNC1H1;SDCBP;SORL1;BAMBI;PRLR;GAS6;SOX6
prerank,chromatin disassembly (GO:0031498),0.6374352554628432,1.295459116536106,0.18304172274562583,0.5073493071317625,1.0,4/14,13.10%,NFE2;ARID1A;SMARCD3;SMARCB1
prerank,nucleosome disassembly (GO:0006337),0.6374352554628432,1.295459116536106,0.18304172274562583,0.5073493071317625,1.0,4/14,13.10%,NFE2;ARID1A;SMARCD3;SMARCB1
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),0.6695416066349524,1.295341044384769,0.18823529411764706,0.5071613363810925,1.0,5/11,18.40%,TGFB1;MYOCD;MEF2C;SOX6;GREM1
prerank,regulation of steroid metabolic process (GO:0019218),0.5931493641595236,1.2949757058726037,0.15782983970406905,0.5076566695598755,1.0,10/23,17.35%,NR1H4;ABCG1;APOE;FMO5;ACADL;TTC39B;STUB1;ARV1;ASAH1;LAMTOR1
prerank,negative regulation of platelet activation (GO:0010544),0.6254397783670133,1.2941185789330407,0.18181818181818182,0.5096364199762922,1.0,4/16,4.14%,ALOX12;PRKCD;CD9;APOE
prerank,RNA polyadenylation (GO:0043631),-0.3924843574148756,-1.2935578161703376,0.14,0.8483617981771002,1.0,10/26,15.25%,WDR33;APP;SCAF8;AHCYL1;FIP1L1;PAPOLA;PAF1;PAPOLG;TUT1;CSTF3
prerank,mRNA polyadenylation (GO:0006378),-0.3924843574148756,-1.2935578161703376,0.14,0.8483617981771002,1.0,10/26,15.25%,WDR33;APP;SCAF8;AHCYL1;FIP1L1;PAPOLA;PAF1;PAPOLG;TUT1;CSTF3
prerank,positive regulation of secretion (GO:0051047),0.6573400306842299,1.293050474741286,0.18355359765051396,0.512009436470858,1.0,1/11,1.86%,AQP1
prerank,lipoprotein catabolic process (GO:0042159),0.646055413780801,1.2926222525334197,0.1887052341597796,0.5126761191065197,1.0,4/11,11.67%,CTSD;APOE;ABHD17B;ABHD17C
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.5202877738861037,1.292334040177543,0.10785340314136126,0.512904926674175,1.0,9/75,8.19%,MRAP;CALCR;PLEK;GUCY2F;MGRN1;SAG;YWHAB;CNGB1;ZDHHC7
prerank,steroid catabolic process (GO:0006706),0.659428538648944,1.2910966500338068,0.206993006993007,0.5157902630881359,1.0,3/10,15.73%,SPP1;HSD17B11;YWHAH
prerank,cellular response to organic substance (GO:0071310),0.5090853238536991,1.2901361547318653,0.07801418439716312,0.517889845420228,1.0,26/116,14.53%,PTPN7;CYP1A1;TGFB1;HCLS1;FLT3;CSF1R;TGFBR1;PTPN18;NR1H4;TNF;LDLRAP1;CXCR4;IL18;CASP1;CTNNB1;TGFBR2;RAMP1;SMAD3;STAT5B;IL18BP;HDAC6;CCL2;TWF2;TIPARP;PID1;LRRK2
prerank,Golgi to lysosome transport (GO:0090160),0.667125118052477,1.2893597962082868,0.1752136752136752,0.519585380236601,1.0,6/11,19.71%,LAPTM5;RBSN;CLN3;GAK;CCDC91;SORT1
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),0.5925636650408512,1.289085939849302,0.18929016189290163,0.5198296137104783,1.0,9/20,13.76%,SLC8A1;KCNMA1;SLC9A1;TFAP2B;NEDD4L;ATP6AP1;ATP1B3;LACC1;ATP1B2
prerank,cell-matrix adhesion (GO:0007160),0.5156946065275045,1.2885380864305978,0.088659793814433,0.5208505977113435,1.0,10/95,3.09%,ITGAL;FERMT3;HPSE;ITGB2;ITGA4;ITGB3;ITGB5;THY1;ITGA2;ANGPTL3
prerank,porphyrin-containing compound catabolic process (GO:0006787),0.6276429095588112,1.288528250139365,0.20108695652173914,0.519791107008169,1.0,4/14,14.98%,BLVRB;SLCO2B1;ABCC1;SLCO1B1
prerank,heme catabolic process (GO:0042167),0.6276429095588112,1.288528250139365,0.20108695652173914,0.519791107008169,1.0,4/14,14.98%,BLVRB;SLCO2B1;ABCC1;SLCO1B1
prerank,Rap protein signal transduction (GO:0032486),0.6719573645983904,1.288200559585933,0.18882175226586104,0.5202393054324791,1.0,6/10,14.55%,RAP2A;RAP1B;PLK2;RAP2B;RAPGEF1;RAP1A
prerank,response to alcohol (GO:0097305),0.5664709753136643,1.2881899342168586,0.16951219512195123,0.5197246439399151,1.0,4/27,6.68%,TGFB1;TGFBR1;SDF4;TGFBR2
prerank,glycolipid metabolic process (GO:0006664),0.536123439172713,1.2876360176140789,0.12913553895410887,0.5207958891058628,1.0,13/47,12.73%,HEXB;CTSA;GM2A;PSAP;HEXA;SMPD3;FUCA1;CERK;ST6GALNAC4;PGAP1;B3GALNT1;ARSA;SUMF2
prerank,regulation of apoptotic signaling pathway (GO:2001233),0.5375312991140502,1.287278776080916,0.15175537938844846,0.5212150127758124,1.0,9/36,9.42%,CX3CR1;TGFBR1;TNF;PYCARD;CRADD;CSNK2A2;CSNK2A1;RB1;QARS1
prerank,plasma membrane repair (GO:0001778),0.6244718067897689,1.2870367762764787,0.2016348773841962,0.521359741996357,1.0,6/13,19.88%,MYH9;SYTL4;DYSF;AHNAK2;ARL8B;SMPD1
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.588977195900982,1.2868743705386132,0.17422434367541767,0.521272394463487,1.0,11/24,17.05%,IRAK2;MAP2K6;UBE2V1;TNFAIP3;NOD2;TAB2;IKBKG;CASP8;ITCH;TAB3;UBE2N
prerank,heterochromatin organization (GO:0070828),-0.47850952354134874,-1.2868685357961833,0.16260162601626016,0.8652886311338084,1.0,5/14,10.17%,SMCHD1;EZH1;MECOM;SETDB2;SETD7
prerank,protein localization to synapse (GO:0035418),-0.5027332234123043,-1.286636616755663,0.156794425087108,0.8574136067518999,1.0,3/12,11.11%,NLGN1;BSN;SHANK1
prerank,regulation of protein localization (GO:0032880),0.5196644342823477,1.2866019654372707,0.14528101802757157,0.5215229742059625,1.0,11/58,10.10%,PLEKHM2;CTSD;ITGB3;MMD;TRIM25;TRIM5;RAB14;ZDHHC7;TRIM27;ATCAY;TPR
prerank,microvillus assembly (GO:0030033),0.6253610384063473,1.2860508953580663,0.2079343365253078,0.5226377485313464,1.0,9/14,22.14%,RAP2A;RAP1B;TNIK;RAP2B;RAP1A;FXYD5;MINK1;MAP4K4;RAPGEF6
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.5443725136300911,1.285699038406934,0.1592920353982301,0.5230644634730928,1.0,6/38,5.09%,TREM2;NLRC3;NR1H4;TANK;PYCARD;TNFAIP3
prerank,glutathione derivative metabolic process (GO:1901685),0.5936029451282183,1.2856368549994155,0.19235511713933415,0.5221573300224147,1.0,3/20,3.21%,ESD;AKR1A1;HPGDS
prerank,glutathione derivative biosynthetic process (GO:1901687),0.5936029451282183,1.2856368549994155,0.19235511713933415,0.5221573300224147,1.0,3/20,3.21%,ESD;AKR1A1;HPGDS
prerank,response to glucocorticoid (GO:0051384),0.5812991949456827,1.2855303291973463,0.16647264260768335,0.5219344526115318,1.0,3/26,6.34%,CALCR;TNF;ANXA1
prerank,interleukin-12-mediated signaling pathway (GO:0035722),0.53278427156546,1.2854633170148637,0.12121212121212122,0.5215959244455837,1.0,8/46,7.75%,LCP1;TYK2;IL12RB2;AIP;RAP1B;STAT4;P4HB;CAPZA1
prerank,rRNA 3'-end processing (GO:0031125),-0.5277978100730056,-1.2844535284576373,0.18309859154929578,0.8570413337492961,1.0,5/10,19.27%,RPS21;ERI1;EXOSC7;EXOSC8;EXOSC9
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.5056753015182789,1.2842654055226517,0.08154943934760449,0.5245247928481592,1.0,15/113,6.87%,LGALS3;TGFB1;PLEK;SYK;LCP1;FNIP2;ABCA1;GTF2H1;TNF;FNIP1;SNCA;ASAP1;RAP1B;TP53;TAL1
prerank,cellular response to fatty acid (GO:0071398),0.648098525752864,1.2842084492708015,0.21408839779005526,0.5241189912536902,1.0,3/12,3.77%,LPL;FFAR2;NR1H4
prerank,dendritic spine organization (GO:0097061),0.5646063977942536,1.2841765987357212,0.2146341463414634,0.5236835056123885,1.0,3/26,6.43%,TREM2;LGMN;DOCK10
prerank,calcium import into the mitochondrion (GO:0036444),-0.5245450888737312,-1.2836520954395323,0.2222222222222222,0.851637994778857,1.0,4/10,17.88%,AFG3L2;MICU1;MCUR1;SLC25A23
prerank,regulation of kinase activity (GO:0043549),0.5039308990871662,1.2833782360817005,0.11597151576805696,0.5254354365827769,1.0,9/89,4.28%,TREM2;FGR;FLT3;CD74;NLRC5;SLAMF8;CSF1R;DSTYK;TTN
prerank,negative regulation of interleukin-1 production (GO:0032692),0.5913588341900129,1.2811571603567444,0.19497607655502391,0.531270916776044,1.0,4/23,15.67%,CX3CR1;TNFAIP3;GAS6;CD33
prerank,icosanoid metabolic process (GO:0006690),0.5403210503200278,1.281062326199852,0.15860517435320584,0.5310015006440225,1.0,6/40,10.31%,TBXAS1;ALOX12;DAGLB;HPGD;PON3;ABCC1
prerank,cellular glucose homeostasis (GO:0001678),0.5422383671757228,1.27960605452549,0.15271493212669685,0.5346667979254887,1.0,12/41,16.81%,HK3;LRRC8D;ERN1;PPARGC1A;TRA2B;GAS6;FOXK1;ADCY8;HK2;SOX4;HIF1A;GCK
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),0.5625897935343372,1.279575102068752,0.17044100119189512,0.5342070672381537,1.0,7/29,11.55%,CCR2;STAT5A;PKD2;IFNAR1;STAT4;STAT5B;CCL2
prerank,positive regulation of translational initiation (GO:0045948),0.595050484691915,1.278762631896619,0.17357512953367876,0.5359811757429436,1.0,3/18,8.61%,MTOR;YTHDF3;LARP1
prerank,protein localization to endoplasmic reticulum (GO:0070972),-0.4392633741006767,-1.2786413329692476,0.15444015444015444,0.8623007213983033,1.0,4/16,3.14%,ANK2;RYR2;UBAC2;BCAP31
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),0.6160037342164835,1.2785734869803889,0.21081081081081082,0.5359891091229031,1.0,4/15,9.24%,BMP2K;PIK3CB;DGKD;SCYL2
prerank,blood vessel morphogenesis (GO:0048514),0.5234518484231437,1.2784450058416084,0.14044350580781415,0.5358091553548211,1.0,14/54,16.11%,SHH;TGFB1;SYK;TGFBR1;ANGPTL3;CCM2;TGFBR2;LOX;LRP5;NRP1;CCBE1;RASA1;NF1;RBPJ
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.5788822976806791,1.277428914852285,0.18696186961869618,0.5381277977587868,1.0,3/23,3.02%,ITGAX;PIK3CD;MDK
prerank,regulation of cell-matrix adhesion (GO:0001952),0.5146174567525764,1.2770714308637046,0.125531914893617,0.5386501655160466,1.0,25/64,20.53%,PTK2B;CD3E;THY1;DUSP3;PIK3CB;MACF1;SLC9A1;CASK;ACTG1;VCL;NF2;THBS1;CDK6;PTPRA;RASA1;NF1;CD36;CCL25;CORO1C;RHOA;MINK1;PLEKHA2;ROCK2;GSK3B;MAP4K4
prerank,cellular response to mechanical stimulus (GO:0071260),0.5329455190732432,1.2767766772005367,0.1631753031973539,0.5389592010604111,1.0,14/46,13.89%,AQP1;TLR8;TLR7;CASP1;MAP3K14;CRADD;SLC9A1;MAP3K1;BAK1;F11R;SOX9;CASP8;NFKB1;IRF1
prerank,regulation of coagulation (GO:0050818),0.6457972711068065,1.2764213359567653,0.2145922746781116,0.5394006661261869,1.0,1/11,0.82%,GP1BA
prerank,negative regulation of TORC1 signaling (GO:1904262),-0.47357507632172957,-1.275355007991866,0.18545454545454546,0.8661445522545272,1.0,4/13,11.64%,SESN3;CASTOR2;KPTN;ATM
prerank,vasculogenesis (GO:0001570),0.5512477179973109,1.2751789158921223,0.16399082568807338,0.5424280060074742,1.0,4/32,6.68%,SHH;TGFB1;CCM2;TGFBR2
prerank,regulation of myoblast fusion (GO:1901739),0.6436250323615853,1.2746847694839318,0.1994261119081779,0.543210523737038,1.0,4/11,11.10%,MAPK14;RIPOR2;CFLAR;CD53
prerank,negative regulation of multicellular organismal process (GO:0051241),0.49514839919381776,1.27465607882881,0.03003003003003003,0.5427374796366461,1.0,43/199,13.92%,SLC6A4;GPNMB;SHH;SLC11A1;TGFB1;PLCL2;FCGR2B;SRGN;SLAMF8;MAD2L2;MDK;TLE3;MAP2K6;NR1H4;TNF;RGCC;DDIT3;SPI1;TIMP1;WWC2;PPP1R11;NKX2-1;MYOCD;MEF2C;FLCN;RB1;ATP2B1;DUSP10;ARHGDIB;PFN2;SOX9;RPS6KA4;PTPRO;ADIPOR1;GRN;HDAC9;CHSY1;PPP2CA;RAB11FIP5;NPTN;VASN;GAS6;TRPV3
prerank,digestive tract development (GO:0048565),-0.35785309627139367,-1.2740897107699438,0.08633093525179857,0.8625901967349109,1.0,13/32,14.14%,COBL;PCSK5;NIPBL;GLI2;SALL1;GLI3;SMO;GLI1;PKDCC;CCDC39;CHD8;RARB;STRA6
prerank,protein-containing complex assembly (GO:0065003),0.49309436816448454,1.2738015148496913,0.011,0.5446745383489515,1.0,62/259,15.86%,NCKAP1L;PTK2B;FERMT3;CD3E;BIN2;AIM2;CD74;SH3PXD2B;VAMP3;CTSC;P2RX7;SKAP2;DHX9;TLE3;SNX9;WIPF1;TNF;PPP6R1;MITF;TRAF2;TEAD1;CTNNB1;TRAPPC9;TP53;LEO1;SLC9A1;CAPZA1;HFE;MCFD2;CTSZ;PDCD6;HSF1;PPARGC1A;EPRS1;AMER1;TUBGCP4;RAB1B;RBBP5;SOX9;PYGO2;DET1;SEC24D;SEC16A;MDN1;CSNK1A1;F5;SEC16B;RANBP9;IKBKG;CASP8;STX5;TRAPPC6A;ADCY8;DARS1;TRADD;TSPAN4;PDZD11;LRRK2;CAPN3;AP2M1;GRIA1;BCL9
prerank,positive regulation of catabolic process (GO:0009896),0.5164585344680643,1.2735505134798186,0.1226215644820296,0.5448370411297278,1.0,25/65,20.78%,VSIR;ANGPTL3;ATG7;TNF;TNFAIP3;RAB7A;PLK2;CSNK2A1;NEDD4L;FZR1;SORL1;ITCH;STX5;TIPARP;HUWE1;AREL1;GSK3A;SMURF1;IDE;VPS28;DACT1;SEC22B;WWP1;GSK3B;PRKN
prerank,endochondral bone morphogenesis (GO:0060350),-0.4964249785713222,-1.273225808521261,0.15309446254071662,0.8576022592953106,1.0,8/11,25.38%,FOXC1;BMP4;INPPL1;TMEM119;COL13A1;TRPV4;BMPR2;FGFR3
prerank,glycosphingolipid metabolic process (GO:0006687),0.5329312697512493,1.2726247741690333,0.15064102564102563,0.5469778270958492,1.0,19/42,21.48%,HEXB;CTSA;GM2A;PSAP;HEXA;SMPD3;CERK;B3GALNT1;ST8SIA1;ARSA;SUMF2;LARGE1;ASAH1;B4GALNT1;GBA2;SMPD1;ABCA2;SUMF1;B4GALT6
prerank,cellular response to tumor necrosis factor (GO:0071356),0.49009844506725514,1.271934580087292,0.04,0.5484351328451527,1.0,42/175,18.28%,PTK2B;AIM2;NFE2L2;TNFRSF11A;DHX9;CCL8;TNF;OCSTAMP;TNFSF8;TANK;TRAF2;FOXO3;PYCARD;TRAF3;MAP3K14;TP53;ACTN4;PSMB10;TMSB4X;ERBIN;ST18;CCL14;TRAF5;TNFRSF21;PSMA2;CCL13;LIMS1;GBP3;CCL2;TNFRSF1B;PSME3;TRADD;PSMB5;PID1;PSMD8;PSMD7;PSMB9;ASAH1;CCL25;ARHGEF2;PSMD2;BIRC2
prerank,positive regulation of glucose metabolic process (GO:0010907),-0.4790278340667621,-1.2719133538852156,0.20080321285140562,0.8544718951561336,1.0,7/14,19.56%,IRS1;DDB1;GPLD1;ARPP19;AKT1;NNMT;IRS2
prerank,regulation of cell division (GO:0051302),0.5130075788516485,1.2717254866177794,0.12551867219917012,0.5484933455818857,1.0,14/72,11.28%,SHH;SMYD5;ZFYVE26;KLHL21;BCL2L1;TAL1;PLK4;PLK2;FLCN;MYO19;UVRAG;RAB11A;SETD2;BECN1
prerank,nitrogen compound transport (GO:0071705),0.49231030485075705,1.2711950837941894,0.0763819095477387,0.5495022282137423,1.0,18/141,9.15%,SLC6A3;SLC6A4;SLC11A1;SLC16A10;SLC15A3;AQP1;SLC52A1;LRRC8D;SLC7A7;SLC7A8;MYH9;RAB7A;SLC36A1;SLC38A4;RAMP1;SLC43A2;SLC44A2;SLC6A15
prerank,glucose homeostasis (GO:0042593),0.5088288883923108,1.2708461086217337,0.12564366632337795,0.5499503010984698,1.0,20/83,16.81%,HK3;LRRC8D;MLXIPL;FFAR2;CEBPA;USF1;TFAP2B;PPARGC1A;SLC8B1;ADIPOR1;FOXK1;ADCY8;MBD5;WFS1;HK2;SOX4;HIF1A;ADIPOR2;APPL2;GCK
prerank,positive regulation of cell population proliferation (GO:0008284),0.4879103524902515,1.270553263426579,0.004,0.5501980361798524,1.0,74/423,13.41%,PTPRC;CD86;PTK2B;SLAMF1;LYN;SHH;HCK;ITGAX;HPSE;TGFB1;CXCL5;HCLS1;FLT3;LGMN;CD74;RPL23;AQP1;CSF1R;TGFBR1;TCIRG1;MLXIPL;S100B;TNFRSF11A;DHX9;MDK;OSM;IL12RB2;TNF;IL6R;CNOT8;IL18;TIMP1;CCND2;FZD9;AIF1;GAB2;CCAR1;TGFBR2;RPS15A;PIM1;CCKBR;EPO;FLT3LG;MEF2C;AQP11;KIF14;DOT1L;CSNK2A1;TFAP2B;KIF20B;GID8;NTF3;HSF1;CCL14;PRKCH;ACER3;LRP5;HDAC4;NAP1L1;SOX9;THBS1;GRN;PHIP;PRDX3;CIAO1;NOD2;SDCBP;CDK6;TBC1D8;NRG1;STX3;BAMBI;PRLR;GAS6
prerank,positive regulation of microtubule polymerization (GO:0031116),-0.37816452726641375,-1.2705089669102232,0.16447368421052633,0.8513509450472433,1.0,9/28,15.10%,SLAIN2;CLIP1;PAK1;DRG1;MET;CDK5RAP2;MAPT;NAV3;OCLN
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.5753204175870765,1.2701177428140789,0.2107904642409034,0.5508324586134874,1.0,4/20,5.61%,CCND3;RGCC;PKD2;CCND2
prerank,regulation of lipid catabolic process (GO:0050994),0.5769739139756728,1.2699612496795076,0.20408163265306123,0.5507422931698429,1.0,3/19,7.24%,ANGPTL3;TNF;ABCD1
prerank,embryonic eye morphogenesis (GO:0048048),-0.5022313576970947,-1.2697684892105956,0.20327868852459016,0.8463147414238092,1.0,3/11,8.21%,EFEMP1;MFAP5;FBN1
prerank,negative regulation of calcium ion transport (GO:0051926),0.6143226260667747,1.269349823005415,0.19733333333333333,0.5519160829202808,1.0,3/15,8.56%,LILRB1;EPO;TRIM27
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.6168039161738297,1.2681660034550868,0.2151394422310757,0.5547544985129622,1.0,2/15,2.77%,PTK2B;TEC
prerank,positive regulation of hemostasis (GO:1900048),0.6535830504340375,1.2680926774647718,0.2303120356612184,0.5538640082102062,1.0,2/10,11.25%,HPSE;THBS1
prerank,positive regulation of coagulation (GO:0050820),0.6535830504340375,1.2680926774647718,0.2303120356612184,0.5538640082102062,1.0,2/10,11.25%,HPSE;THBS1
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),0.656503577794579,1.267593680420449,0.21796759941089838,0.5547819461260922,1.0,4/10,10.93%,ALOX12;PRKCD;CD9;SH2B3
prerank,protein autophosphorylation (GO:0046777),0.48829946493020354,1.2675180853356356,0.07344064386317907,0.5544303666079302,1.0,40/157,18.95%,PTK2B;FGR;LYN;HCK;FLT3;MAPKAPK3;MAP4K1;TAOK3;CSF1R;MTOR;TEC;ERN1;NEK6;PRKD2;TAF1;MKNK1;STK10;PIM1;PIM2;TNIK;CHEK2;SMG1;STK17B;MAP2K2;TXK;MAP3K12;CAMKK2;STK24;BMX;LRRK2;SRC;MAP3K11;EPHA4;STK4;EPHA8;SIK2;PDPK1;VRK1;MINK1;TAOK1
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.576188893708419,1.2671193077291234,0.21193666260657734,0.5550249804584557,1.0,6/23,19.98%,GUCY2F;SAG;CNGB1;GRK4;METAP2;NMT1
prerank,energy derivation by oxidation of organic compounds (GO:0015980),-0.396467509740542,-1.2666175049132915,0.1511627906976744,0.8498797080646139,1.0,16/24,31.28%,LEPR;NDUFS1;SLC25A13;NDUFS4;COQ10B;GFPT1;COX15;SDHAF4;GFPT2;MRAP2;ACADVL;LYRM7;CYCS;COX10;MTLN;NR4A3
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.5391057070246258,1.266484589771836,0.16928251121076232,0.5563247966659621,1.0,11/36,17.82%,CD74;NLRC5;LAPTM5;CXCR4;CD300LF;CASP1;TXK;GAS6;IRGM;HIF1A;UBE2K
prerank,basement membrane organization (GO:0071711),0.6093205340945219,1.2661083365440629,0.20712401055408972,0.5568888998745414,1.0,1/14,0.14%,CTSS
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.6000467771029767,1.2653458586067055,0.21045751633986928,0.5586485292886647,1.0,4/17,10.79%,MYO1G;IL18;BTN3A3;IL18BP
prerank,negative regulation of hydrolase activity (GO:0051346),0.5190988160105695,1.264769650505946,0.17046688382193267,0.5597693995334184,1.0,8/49,9.97%,KLRK1;FZD10;RASA4;CST7;ARFGEF1;WNK1;ATP5IF1;F11R
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.4976129386471037,1.2641935465353744,0.13389121338912133,0.5608769026147689,1.0,21/70,16.55%,CYBB;NCF4;VAMP3;ITGB5;NCF2;FCGR1A;FCER1G;PSMB10;TAP1;PSMA2;PSME3;IKBKG;SNAP23;B2M;PSMB5;PSMD8;PSMD7;PSMB9;CD36;PDIA3;TAP2
prerank,phosphorylation (GO:0016310),0.48812273257734656,1.263651072366518,0.008,0.561853591253433,1.0,104/384,17.41%,PTK2B;BTK;FGR;LYN;GMFG;PIK3CG;HCK;TGFB1;SYK;DGKZ;RSKR;FNIP2;PIK3CD;MAP4K1;TAOK3;TGFBR1;TYK2;PRKCD;MTOR;BMP2K;PIK3CB;TEC;GRK3;ERN1;NEK6;CDK14;PRKD2;MYLK3;CDK8;DGKK;MORC3;TLK1;DGKE;TAF1;PRKCB;MKNK1;CDK11B;STK10;TGFBR2;NADK;MAP3K5;PIM1;PLK4;WNK1;CDK17;PIM2;CERK;TNIK;PLK2;CSNK1G2;CHEK2;DGKG;DGKD;CSNK2A1;MAP3K1;STRADB;PRKCH;AGK;CDK7;STK17B;FAM20C;RNASEL;PKN1;TXK;RPS6KA4;POMK;NLK;PRKACB;CCL2;CSNK1A1;FYN;GRK4;MAP3K12;CDK6;CREB1;DGKI;LIPE;MERTK;CAMKK2;SHPK;BRAF;GAS6;STK24;STK3;BMX;LRRK2;NIM1K;WNK4;TESK2;STRADA;SGK3;GSK3A;CDK15;XYLB;MAP3K11;GNPTAB;COQ8B;STK4;GK;PPP3CB;PIK3R4;RPS6KA5;CDK18;SIK2
prerank,rRNA catabolic process (GO:0016075),0.609002320868607,1.263133016798244,0.21739130434782608,0.5628222825706611,1.0,1/16,0.36%,SLFN14
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.506980122203679,1.2626414200948706,0.14973821989528796,0.5636758530600411,1.0,13/70,12.01%,FERMT3;ITGA4;ITGB3;VAMP3;MICALL2;SPI1;MEF2C;KIF14;RB1;ACTN1;PARVB;NRP1;METTL3
prerank,positive regulation of gene expression (GO:0010628),0.4845073542634985,1.261847707969561,0.008,0.5654507253604932,1.0,83/442,14.37%,CLEC9A;LILRB1;TREM2;FGR;PF4;CALCR;PIK3CG;ITGAX;SLC11A1;TGFB1;CD3E;STAP1;CD74;NFE2L2;IL1A;VSIR;PIK3CD;RPL23;PLCG2;NIBAN1;TGFBR1;CRTAM;TLR2;TAF1A;P2RX7;MTOR;PIK3CB;MAPK14;POLR1E;ERN1;TNF;SF3B1;RGCC;MITF;TTN;PDCL3;PLXNB2;TENT4B;CCDC88B;NFAM1;CIRBP;ACTB;TYROBP;TP53;NKX2-1;TNRC6A;YTHDF3;TICAM1;HFE;MEF2C;LARP4B;MOV10;SMAD3;LURAP1;PPARGC1A;AGO4;NOS1AP;ACTG1;CPEB3;RPL26;INHBA;MAP2K2;POLR1B;POLR2L;TXK;LIMS1;DTNBP1;SOX9;THBS1;AGO3;ZCCHC4;METTL3;VSTM2A;SEC16B;BRAF;GAS6;PCIF1;POLDIP3;HCFC1;UPF3B;PID1;CADM1;HNRNPD
prerank,neural tube development (GO:0021915),0.5964313815345,1.2614808254053955,0.22580645161290322,0.5660175591459919,1.0,2/15,4.10%,TGFB1;PKD2
prerank,negative regulation of protein binding (GO:0032091),0.506620358119952,1.2609549396826638,0.14613778705636743,0.5670247146589203,1.0,15/71,15.37%,ARRB2;BAG2;ITGA4;PRKCD;ACTB;TFIP11;HFE;DISC1;CTSZ;PSME3IP1;SORL1;B2M;ATP2A3;LRRK2;TLE5
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",0.6005300811580955,1.25957342994562,0.20293724966622162,0.5705309192844387,1.0,3/15,10.88%,NPAS4;CLN3;ZDHHC3
prerank,positive regulation of cell motility (GO:2000147),0.48456209796659844,1.2595729844278363,0.04804804804804805,0.5699735869801267,1.0,36/205,12.62%,PTK2B;FERMT3;GPNMB;FGR;ITGAX;TGFB1;CASS4;F10;VSIR;PIK3CD;CSF1R;TGFBR1;MGAT5;MDK;ANGPTL3;SEMA4D;ITGA6;LGR6;AIF1;MAPRE1;CCAR1;ACTN4;RIPOR1;NEDD9;SNAI1;FAM89B;PTP4A1;NTF3;PODXL;ACTG1;BCAR1;SEMA4A;THBS1;GRN;SDCBP;NUMB
prerank,chemical homeostasis (GO:0048878),0.5087454058609971,1.2595017116493845,0.15602094240837697,0.5696434448465441,1.0,13/61,11.14%,TREM2;ANGPTL3;CLN8;CEBPA;TENT4B;ABCB4;USF1;WNK1;AQP11;ABHD4;NEDD4L;VGF;SLC66A1
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.4915557706573104,1.259498222391013,0.09191919191919191,0.5690961027717739,1.0,39/122,17.21%,CIITA;SMOC2;PPP1R3E;NLRC5;NIBAN1;TLR2;MTOR;DHX9;RGCC;PRKD2;PLXNB2;SLC25A37;CIRBP;YTHDF3;LARP4B;CPEB3;RPL26;BRPF3;THBS1;CCL2;STN1;ZCCHC4;METTL3;NOD2;KAT7;DNA2;PCIF1;NFKB1;POLDIP3;UPF3B;HNRNPD;TMEM106A;SOX4;BCAR3;FAF1;NOX1;GCK;RPS4X;IL33
prerank,amino acid transport (GO:0006865),0.5141009261694041,1.2593634400811924,0.162891046386192,0.5689389626990439,1.0,13/49,16.73%,SLC16A10;SLC7A7;SLC7A8;SLC38A6;SLC36A1;SLC38A4;SLC43A2;SLC6A15;SLC36A4;SLC38A10;SLC25A45;SLC1A4;SLC43A1
prerank,regulation of cellular component movement (GO:0051270),0.5121859180608933,1.2583181706665842,0.1581798483206934,0.5714112146760597,1.0,13/49,14.01%,LYN;TGFBR1;CD9;ARAP1;ACTN4;ACTN1;PKN1;DIAPH1;HDAC6;CDK6;NRG1;ZSWIM6;ARHGAP18
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),-0.4319691637638234,-1.2579219264887112,0.16810344827586207,0.8743249975281998,1.0,6/17,8.42%,PIK3R3;EPHB4;EFNB2;ROBO1;SLIT2;GPLD1
prerank,interleukin-35-mediated signaling pathway (GO:0070757),0.6322827931438373,1.2578504463317433,0.21594202898550724,0.5722030349830586,1.0,2/11,7.45%,IL12RB2;STAT4
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.4983607845575304,1.2578119098887335,0.12487100103199174,0.571745330703654,1.0,25/80,17.08%,GSAP;NIBAN1;PRKCD;MTOR;TNF;ABCG1;PLXNB2;SMPD3;CIRBP;YTHDF3;LARP4B;CPEB3;RPL26;THBS1;ZCCHC4;METTL3;PCIF1;POLDIP3;NSMAF;UPF3B;HNRNPD;SOX4;GSK3A;EPHA4;RPS4X
prerank,negative regulation of cell adhesion (GO:0007162),0.505162866674894,1.2575646848400897,0.11709844559585492,0.5719388740202002,1.0,14/72,11.30%,PTPRC;TGFB1;PLXNC1;MDK;SEMA4D;TGFBI;PLXNB2;RIPOR2;SIPA1;SPINT2;PODXL;ARHGDIB;NF2;PTPRO
prerank,positive regulation of activated T cell proliferation (GO:0042104),0.5761890599971917,1.2574461367374006,0.2249357326478149,0.5717647623156298,1.0,3/18,5.85%,PYCARD;IL18;HMGB1
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.49715960407487747,1.2571225465897047,0.14361140443505807,0.5721812541229613,1.0,20/67,16.55%,CYBB;NCF4;VAMP3;ITGB5;NCF2;FCGR1A;PSMB10;TAP1;PSMA2;PSME3;IKBKG;SNAP23;B2M;PSMB5;PSMD8;PSMD7;PSMB9;CD36;PDIA3;TAP2
prerank,negative regulation of apoptotic process (GO:0043066),0.48329824355506085,1.2568113248329909,0.004,0.572478401141605,1.0,97/444,16.31%,NCKAP1L;PTK2B;TREM2;ASCL1;SHH;HCK;CX3CR1;CLEC5A;HCLS1;GATA1;PCID2;LGMN;CD74;CBL;AQP1;ALOX12;ADAM8;PRKCD;ANGPT4;TNFAIP8;DSTYK;NUP62;MDK;SEMA4D;NR1H4;TNF;FNIP1;SNCA;APOE;DNAJC3;CLN3;CCND2;CD44;FZD9;FZD3;CFLAR;CTNNB1;ANXA1;BCL2L1;TP53;PIM1;TAX1BP1;PIM2;PLK2;MALT1;MEF2C;KIF14;TPT1;CSNK2A2;CSNK2A1;TFAP2B;RB1;TRIM27;ARHGAP10;NTF3;PPARGC1A;PRKCH;QARS1;BABAM2;MGMT;ANXA4;SON;BNIP1;MAEA;SOX9;THBS1;CCL2;GRN;PHIP;PRDX3;ANGPTL4;PRDX2;ITCH;MERTK;PRLR;BRAF;GAS6;NFKB1;RETREG1;ARHGDIA;RNF144B;ATAD3A;WFS1;BAG1;MIEN1;AREL1;CAPN3;VDAC1;CPEB4;ERCC5;SRC;AHI1;MTDH;FANK1;RASA1;TXNDC5;NAA38
prerank,hexose metabolic process (GO:0019318),0.5402735732599724,1.2560614212103478,0.18025258323765786,0.5741830881146651,1.0,11/39,17.27%,KCNJ11;AKR1A1;ALDOB;BRAT1;SORD;FUCA1;TFAP2B;CHST15;PMM1;GALM;PPARD
prerank,positive regulation of protein processing (GO:0010954),0.5825986050944905,1.2558280706289031,0.21364221364221364,0.5743723373823385,1.0,5/19,15.24%,BAG2;ADAM8;MYH9;CCBE1;PLGRKT
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.5450781820082301,1.2557075303575465,0.19549763033175355,0.574174862112823,1.0,3/29,8.12%,RUNX1;VPS18;VPS11
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.5326508768064867,1.255601294851598,0.19750283768444948,0.5739370866386366,1.0,11/38,16.72%,CX3CR1;SIRPA;TNF;PKD2;P2RX4;SMAD3;NOS1AP;DDAH1;CD36;CD47;HSP90AA1
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.5731863859572938,1.2553401253671839,0.23145780051150894,0.5741389118014151,1.0,5/18,11.55%,ITGA4;MDK;HMGB1;MEF2C;CCL2
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.5219053825333726,1.2551869173157095,0.17070484581497797,0.5740085859615132,1.0,11/45,11.60%,TGFB1;NABP1;NME6;AURKAIP1;RGCC;FZD3;CTNNB1;PLK2;SMAD3;ANGEL2;TRIM35
prerank,intestinal lipid absorption (GO:0098856),0.6310341124950011,1.255109554793609,0.23032904148783978,0.5736667846933069,1.0,3/11,16.04%,CEL;SOAT2;CD36
prerank,glycerophospholipid metabolic process (GO:0006650),0.5074309953464782,1.2548308105501078,0.13130252100840337,0.5739107891985823,1.0,18/75,15.84%,PLCB2;PLEK;PIGM;CSF1R;ABHD12;CLN3;PIGL;PIGX;PIGV;PLA2G7;AGK;PIGH;PRDX6;ABHD3;SYNJ1;GDE1;ABCA3;GDPD3
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.4870788367107995,1.2547563424401027,0.05305305305305305,0.5735944268239062,1.0,66/208,20.84%,TREM2;CARD11;CD74;PLCG2;GPRC5B;TRIM25;S100B;NUP62;TSPAN6;NLRC3;TRIM5;NEK6;NR1H4;TNF;UBE2V1;TANK;TRAF2;PYCARD;TNFAIP3;CASP1;TRAF3;MAP3K14;PRKCB;CFLAR;PIM2;TICAM1;PLK2;MALT1;ATP2C1;TRIM27;ZDHHC13;SLC44A2;LURAP1;TRAF5;LITAF;TRIM8;LGALS1;MID2;NOD2;ALPK1;TAB2;NLRX1;IKBKG;CASP8;TRADD;DDX1;TMEM106A;TAB3;CAPN3;MTDH;UBE2N;TRIM62;REL;RHOA;PDPK1;BIRC2;TNFSF10;PER1;RIOK3;EDA2R;OPTN;HSPB1;ZMYND11;PRKN;CARD19;BIRC3
prerank,phosphatidic acid biosynthetic process (GO:0006654),0.5203197594111116,1.2546741532248995,0.1827027027027027,0.5732865650264362,1.0,8/46,9.00%,DGKZ;DDHD1;LPCAT1;PLD2;DGKE;DGKG;DGKD;ABHD4
prerank,defense response to tumor cell (GO:0002357),0.6320918802428837,1.2546359802833325,0.22804532577903683,0.5728413140854076,1.0,3/10,12.90%,LAPTM5;SPI1;PRDX2
prerank,modulation by host of viral genome replication (GO:0044827),-0.47827650992507165,-1.2543271660538988,0.18450184501845018,0.8794880922203365,1.0,10/13,19.11%,NUCKS1;PPIB;IFI27;CCNK;FMR1;FBXL2;TBC1D20;EIF2AK4;ZC3H12A;VAPA
prerank,prostanoid metabolic process (GO:0006692),0.6153970380184758,1.254319493223599,0.22375690607734808,0.5732604382485194,1.0,2/13,4.51%,HPGDS;HPGD
prerank,calcium ion transport into cytosol (GO:0060402),-0.40339760431444693,-1.254069905677862,0.178743961352657,0.8726099520559455,1.0,13/21,27.72%,CACNA1C;RYR2;JPH1;ITPR3;GRIN2B;CACNA2D1;GRIN1;TRPV4;JPH2;JPH4;TRPM2;CACNB3;GRIN2D
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.5199076922022847,1.2539703831654467,0.18831168831168832,0.5737426983085416,1.0,8/46,11.23%,FERMT3;ITGA4;ITGB3;VAMP3;MICALL2;KIF14;PARVB;NRP1
prerank,entry into host (GO:0044409),0.6187340134107624,1.2539125224039134,0.2296718972895863,0.5733769094125247,1.0,4/13,6.29%,CBL;GRB2;CXCR4;CTNNB1
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),0.6133823296914067,1.253601392529763,0.20917678812415655,0.573737373225858,1.0,2/14,3.38%,PRKAR2B;PKIB
prerank,cardiac atrium morphogenesis (GO:0003209),-0.4392056229323067,-1.2531398667872464,0.18220338983050846,0.8683671539213745,1.0,12/16,49.50%,HEY2;BMPR2;TGFB2;PROX1;DLL4;TBX20;NOG;MYH6;GATA4;NOTCH2;ZFPM1;ISL1
prerank,inhibitory synapse assembly (GO:1904862),0.6367500829287143,1.252594045507366,0.21378340365682139,0.5760951691453534,1.0,2/11,2.79%,NPAS4;FGF13
prerank,regulation of adenylate cyclase activity (GO:0045761),0.5750690621614232,1.2523896610436502,0.2195416164053076,0.576155430023032,1.0,9/22,18.16%,CCR2;EDNRB;AKAP5;CAP1;LTB4R2;GNAI3;NF1;CACNA1D;GNAI2
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.5461157824667576,1.2523156132736055,0.20253164556962025,0.5758210418049666,1.0,4/32,2.52%,TGFB1;CD300A;PRKCD;MTOR
prerank,positive regulation of cholesterol efflux (GO:0010875),0.5657692098200707,1.2517818851843923,0.2231920199501247,0.5768477719251672,1.0,6/21,15.27%,TREM2;APOE;EEPD1;GPS2;LRP1;ABCA3
prerank,mRNA stabilization (GO:0048255),0.5265536857406373,1.2512481764645436,0.18604651162790697,0.5778823176493592,1.0,7/40,9.54%,SLC11A1;DHX9;MAPK14;CIRBP;LARP1;TENT5C;ANGEL2
prerank,endomembrane system organization (GO:0010256),0.48320754783738323,1.2511786052398672,0.06519558676028084,0.5775120976873116,1.0,63/178,20.79%,HOOK3;PLEKHM2;SPTBN5;ATP8B4;SRGN;LMAN1L;TMED3;REEP6;PI4K2A;SNX33;VPS18;ARFGEF1;AP3D1;SYNE1;USP6NL;VMP1;VPS11;DNAJC13;ARHGAP21;ARFGEF2;VAPB;WASHC4;SYNGR1;SYNGR2;DYSF;TMCC1;BNIP1;ATL1;EXOC8;SEC16A;CSNK1A1;PI4K2B;SEC16B;TOR1AIP2;TOR1A;HUWE1;TRAPPC11;HOOK2;LRRK2;GAK;USP8;ALS2;LAMTOR1;LMAN2;CDC42;SNX10;VPS33B;LYSMD3;GOLGB1;GOLPH3;UBXN2A;TMEM170A;ATL2;LAPTM4B;RAB29;DNM1L;OPTN;ATL3;TRAPPC12;SEC31A;NSFL1C;COG7;SPTSSB
prerank,regulation of integrin activation (GO:0033623),0.6060252881502464,1.25094940684122,0.22192513368983957,0.577608760808671,1.0,7/15,22.43%,PLEK;RAP1B;KIF14;SRC;FBLIM1;PIEZO1;SELP
prerank,positive regulation of ATP metabolic process (GO:1903580),0.5416316497637468,1.2499654003315754,0.18657565415244595,0.5799384372419295,1.0,10/32,16.72%,TREM2;P2RX7;MLXIPL;PFKFB4;TMSB4X;PPARGC1A;PID1;PFKFB3;HIF1A;GAPDHS
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.5512656386197851,1.2494809176553545,0.21595092024539878,0.5808103773123116,1.0,11/26,20.84%,TREM2;TLR2;GPS2;IRF1;LGR4;CD36;APPL2;BIRC2;FLOT1;NFKBIL1;BIRC3
prerank,placenta development (GO:0001890),-0.47258575587957063,-1.2490812144738108,0.21660649819494585,0.875750172234413,1.0,8/12,43.89%,SOD1;PPARG;PTK2;ADAM19;ANG;E2F7;PLAC1;E2F8
prerank,positive regulation of programmed cell death (GO:0043068),0.4838857388769829,1.2490741763440059,0.024,0.581436567643008,1.0,63/272,17.55%,FGD2;VAV1;LILRB1;IRF5;PREX1;SYK;ABR;PLEKHN1;CTSD;LAPTM5;TNFAIP8;VAV2;ARHGEF18;MTCH1;ATG7;TNF;SNCA;ITGA6;FOXO3;PYCARD;VAV3;HMGB1;FZD9;APAF1;CTNNB1;DNM2;GNA13;CCAR1;TP53;CRADD;MAP3K5;KCNMA1;FLCN;GADD45B;ITSN1;BAK1;STK17B;ARHGEF17;HDAC6;TRIM35;IAPP;UTP11;CTNNBL1;CASP8;ARHGEF3;STK3;TRADD;ARHGEF11;BMF;LRRK2;SOX4;PTPA;RPS6KA2;TOP2A;FANK1;NF1;MAP3K11;FAF1;ARHGEF26;STK4;BIN1;ARHGEF2;UBE2Z
prerank,phosphate ion homeostasis (GO:0055062),0.6442428995763754,1.2490567635568235,0.24536376604850213,0.5809335720654235,1.0,2/10,9.60%,TFAP2B;XPR1
prerank,response to nutrient levels (GO:0031667),0.5843496287061838,1.2489636450857333,0.23915900131406045,0.5806470140824764,1.0,2/17,4.87%,MTOR;CD68
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.48223300264477226,1.2488599609874769,0.021,0.5803794228484761,1.0,56/348,11.72%,ARRB2;LILRB1;TREM2;PF4;CALCR;ITGAX;SLC11A1;TGFB1;CD3E;PCSK9;STAP1;CD74;NFE2L2;IL1A;VSIR;PIK3CD;RPL23;LAPTM5;VAMP3;PLCG2;TGFBR1;TLR2;P2RX7;MTOR;PTPN1;PIK3CB;MAPK14;TNF;SNCA;RGCC;MITF;TTN;PDCL3;TYROBP;TP53;NKX2-1;TNRC6A;TICAM1;RESF1;HFE;MEF2C;MOV10;SMAD3;NTF3;PPARGC1A;SCYL2;AGO4;NOS1AP;ACTG1;ATF7IP;INHBA;LIMS1;DTNBP1;SOX9;CD63;AGO3
prerank,double-strand break repair via break-induced replication (GO:0000727),0.6254686871810455,1.2487301577683683,0.2302357836338419,0.5802014687733393,1.0,3/12,10.17%,MCM5;MCM6;MCM2
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.5607210759590175,1.248648697115724,0.23086269744835966,0.5798980221798463,1.0,5/26,8.46%,ANAPC15;ESPL1;NEK6;CDC23;RB1
prerank,regulation of protein export from nucleus (GO:0046825),-0.3939549975340229,-1.2485033133041779,0.18404907975460122,0.8702650551807044,1.0,7/23,7.63%,RAPGEF3;PTPN14;TCF7L2;SP100;ANP32B;BAG3;IFI27
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.4851580142244321,1.2482063401000878,0.09716599190283401,0.580633702999282,1.0,25/114,15.62%,PTK2B;AIM2;TNFRSF11A;TNF;TNFSF8;TRAF2;FOXO3;PYCARD;TRAF3;MAP3K14;TP53;ACTN4;PSMB10;TMSB4X;ST18;TRAF5;PSMA2;LIMS1;TNFRSF1B;PSME3;TRADD;PSMB5;PSMD8;PSMD7;PSMB9
prerank,actin cytoskeleton reorganization (GO:0031532),0.5033402916821388,1.2480596201503085,0.176033934252386,0.5805284687125728,1.0,16/63,11.23%,PLEK;CASS4;GRB2;PTPN1;RAP2A;MICALL2;MYH9;ANXA1;NEDD9;TNIK;THSD7B;ATP2C1;BCAR1;PARVB;DTNBP1;NRP1
prerank,regulation of immune effector process (GO:0002697),0.5208985462185993,1.248049898731623,0.18853362734288864,0.580014196857362,1.0,5/41,8.94%,IRF4;FCGR2B;C1QC;C1QA;C1QB
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),0.6427914940046372,1.2472663674457134,0.24629080118694363,0.5812341558399791,1.0,6/10,17.86%,PCSK9;MYLIP;AP2S1;CLTC;AP2M1;VLDLR
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),0.6427914940046372,1.2472663674457134,0.24629080118694363,0.5812341558399791,1.0,6/10,17.86%,PCSK9;MYLIP;AP2S1;CLTC;AP2M1;VLDLR
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.6222472388015307,1.2469119801148942,0.23450134770889489,0.5816735066181126,1.0,5/13,14.40%,ZMIZ2;SPI1;ARID1A;ARID1B;ELOF1
prerank,negative regulation of actin filament polymerization (GO:0030837),0.5603839824484612,1.246766524099591,0.21798029556650247,0.581537021033966,1.0,9/22,13.45%,CYRIB;PRKCD;ARFGEF1;TMSB4X;PFN2;PFN1;TWF2;TMSB10;SSH2
prerank,embryonic hemopoiesis (GO:0035162),0.6177283487763159,1.2466638458841497,0.23756906077348067,0.5813037644221146,1.0,4/12,10.93%,TGFBR2;TAL1;FLT3LG;SH2B3
prerank,synaptic vesicle membrane organization (GO:0048499),0.5861437712546541,1.2466030330507039,0.21887287024901703,0.5809183422225782,1.0,9/17,17.73%,STX11;AP3D1;SNAP29;SYNGR1;SYNGR2;STX3;SNAP23;TOR1A;STX2
prerank,cellular response to heat (GO:0034605),0.5379181811254771,1.244920582400332,0.2,0.5852915234354251,1.0,12/35,18.36%,IL1A;ATXN3;HSBP1;PDCD6;HSF1;TPR;THBS1;RBBP7;STUB1;IER5;HSP90AA1;SLU7
prerank,protein localization to membrane (GO:0072657),0.48050616938788426,1.2447149291471362,0.0531062124248497,0.5853696283219709,1.0,42/187,14.81%,MRAP;ITGAL;FYB1;RFTN1;ITGB2;RAB8B;ITGA4;SH3PXD2B;RAB34;MYO5A;THY1;RAB32;RABEP1;FGF13;RAP2A;PKP2;TNF;TTC7A;NPC1;AP3D1;TSPAN32;AGRN;RAMP1;TNIK;PACS1;TSPAN14;ARL5B;RAB11A;RAB40C;F11R;CACNB2;DENND4C;TM9SF2;ZDHHC3;SEC16A;ATP1B3;BRAF;GAS6;PDZD11;RAP1A;GAK;CAPN3
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.5609631815492891,1.2446034195761715,0.21645569620253163,0.585153765453091,1.0,6/21,13.50%,ADCY7;GUCY2F;ADCY6;NPR2;ADCY8;ADCY3
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",0.5129604372256683,1.2445313748038487,0.19078947368421054,0.5848331247994882,1.0,9/46,14.53%,PTK2B;CCR2;DGKZ;TNF;CLN3;MEF2C;CCL2;DGKI;LRRK2
prerank,protein dephosphorylation (GO:0006470),0.4856999679395382,1.2440759565556259,0.08779011099899092,0.5856040255940894,1.0,32/135,18.69%,PTPRC;PTPN7;PPM1H;UBASH3B;DAPP1;PPP2CB;PTPRJ;DUSP3;PTPN1;DUSP29;PTPN18;PTPRE;MTMR3;DUSP10;RPAP2;PTPRU;PTPRO;TIMM50;PPP2CA;ILKAP;SSH2;CTTNBP2NL;PTPRT;PPP1CC;PTPRA;PTEN;PTPN12;PPP3CB;PPM1M;PPP2R5C;PTPN3;PPP4R2
prerank,negative regulation of biosynthetic process (GO:0009890),0.5919597451199079,1.2440693325783323,0.2526178010471204,0.5850745481294347,1.0,3/16,7.84%,CIITA;ABCD1;TRAP1
prerank,positive regulation of innate immune response (GO:0045089),0.5438005563348963,1.2430413760992847,0.1891891891891892,0.5874113738307271,1.0,5/30,4.97%,NLRC5;ADAM8;DHX9;TLR8;SPI1
prerank,positive regulation of myoblast differentiation (GO:0045663),0.5941350991143591,1.2428384969849178,0.23730964467005075,0.5873899068575564,1.0,4/16,8.78%,MAPK14;RIPOR2;MEF2C;AKIRIN1
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.4962073984900261,1.2426752645905983,0.15126050420168066,0.5873037608415405,1.0,22/73,18.20%,CALCR;TGFB1;HCLS1;FNIP2;MAD2L2;OSM;TNF;FNIP1;SNCA;PRKD2;CD44;NTF3;PFN2;HDAC6;BRAF;GAS6;BCAR3;IRGM;HSP90AA1;STK4;AKAP9;CREBL2
prerank,regulation of blood coagulation (GO:0030193),0.5423537201458876,1.242607147378414,0.20833333333333334,0.5869800579962825,1.0,3/27,4.14%,HPSE;GP1BA;APOE
prerank,dephosphorylation (GO:0016311),0.48278536889165097,1.2422875185611995,0.08844221105527639,0.587351394071047,1.0,35/147,18.69%,PTPRC;PTPN7;PPM1H;DAPP1;PPP2CB;PTPRJ;DUSP3;PTPN1;DUSP29;PTPN18;PTPRE;MTMR3;PLPPR1;DUSP10;FRA10AC1;PTPRU;PTPRO;TIMM50;PPP2CA;ILKAP;SSH2;CTTNBP2NL;THNSL2;PXYLP1;PTPRT;PPP1CC;PTPRA;PTEN;PTPN12;PPP3CB;PPM1M;DUSP23;PPP2R5C;PTPN3;PPP4R2
prerank,mesenchyme morphogenesis (GO:0072132),-0.41891278015062083,-1.2421735161365837,0.18442622950819673,0.8857974621132475,1.0,4/17,12.61%,BMPR1A;ACVR1;ACVRL1;NOS3
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.4888255889209103,1.2414432623080685,0.13963039014373715,0.5893231862821893,1.0,31/93,19.11%,CALCR;TGFB1;HCLS1;FNIP2;MAD2L2;NSD1;MLXIPL;OSM;NCK2;TNF;FNIP1;SNCA;PRKD2;CD44;NTF3;PFN2;HDAC6;DDIT4;BRAF;GAS6;BCAR3;IRGM;PTEN;HSP90AA1;STK4;AKAP9;SPTBN4;CREBL2;PAQR3;CNKSR3;RPTOR
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.4848983340238359,1.2411303212143363,0.0914572864321608,0.589712531467225,1.0,46/158,18.52%,CARD11;CD74;GPRC5B;TRIM25;S100B;NUP62;TSPAN6;TRIM5;NEK6;TNF;UBE2V1;TRAF2;CASP1;MAP3K14;PRKCB;CFLAR;PIM2;TICAM1;PLK2;MALT1;ATP2C1;TRIM27;ZDHHC13;SLC44A2;LURAP1;TRAF5;LITAF;TRIM8;LGALS1;MID2;NOD2;ALPK1;TAB2;IKBKG;CASP8;TRADD;DDX1;TMEM106A;TAB3;MTDH;UBE2N;TRIM62;REL;RHOA;BIRC2;TNFSF10
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),0.5488964305549857,1.2408270067998377,0.21749408983451538,0.5900092642964396,1.0,9/26,16.72%,TNF;PKD2;P2RX4;SMAD3;NOS1AP;DDAH1;TMEM106A;CD36;HSP90AA1
prerank,striated muscle tissue development (GO:0014706),-0.370100223948925,-1.2407685884334094,0.15217391304347827,0.883312513026146,1.0,6/29,10.33%,SGCD;CAV1;SGCZ;PGM5;BMP5;SIX1
prerank,response to muramyl dipeptide (GO:0032495),0.6258023332706015,1.2406702872311823,0.24305555555555555,0.5899041420799448,1.0,3/12,12.25%,IRF5;ERBIN;NOD2
prerank,metal ion export (GO:0070839),0.5388277646608822,1.2405150618536378,0.2107728337236534,0.5898048872838111,1.0,7/31,14.28%,SLC11A1;ATP7A;KCNIP2;SLC9A1;ATP1B3;ATP1B2;KCNA5
prerank,regulation of ruffle assembly (GO:1900027),0.56298369450673,1.2404009003509622,0.21497584541062803,0.5895782757747572,1.0,7/23,11.10%,STAP1;ARHGAP24;PLEKHM1;P2RX4;P2RY12;PFN2;PFN1
prerank,actin filament polymerization (GO:0030041),0.5391496415665785,1.240392497197883,0.22143698468786807,0.5890623137587802,1.0,6/29,10.92%,PREX1;PSTPIP1;MICALL2;AIF1;WASHC3;DIAPH1
prerank,collagen fibril organization (GO:0030199),-0.2976882173165076,-1.2401950026283972,0.11538461538461539,0.8779608836002742,1.0,33/88,17.78%,COL5A2;COL8A1;COL12A1;COL25A1;SERPINH1;PLOD2;COL4A1;COL4A5;COL3A1;TLL1;COL6A3;PLOD1;COL4A2;COL4A3;PPIB;PLEC;COL4A6;ITGB4;COL5A3;COL1A2;COL20A1;LOXL1;ADAMTS2;COL6A2;COL1A1;COL16A1;COL6A1;COL26A1;COL9A2;COL14A1;DPT;PLOD3;CD151
prerank,embryonic heart tube development (GO:0035050),-0.4465447376452463,-1.239812838841844,0.21923076923076923,0.8721667633460286,1.0,6/14,25.28%,RYR2;ACVR1;HES1;SOX17;SOX18;IFT122
prerank,phosphatidic acid metabolic process (GO:0046473),0.5106814004532448,1.2393429509895895,0.19548872180451127,0.5915347254927052,1.0,8/48,9.00%,DGKZ;DDHD1;LPCAT1;PLD2;DGKE;DGKG;DGKD;ABHD4
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.6173803477503953,1.2391780208659249,0.24689655172413794,0.5914691969226211,1.0,3/12,9.69%,APOBEC1;RESF1;ATF7IP
prerank,regulation of intracellular signal transduction (GO:1902531),0.4751765542422888,1.2391194903994545,0.005,0.5911119948477362,1.0,101/420,18.95%,ARHGAP45;ARHGAP30;FGD2;VAV1;TREM2;LYN;ARHGAP25;PREX1;ARHGAP9;ABR;ARHGAP15;ARHGAP39;PRKAR2B;TAOK3;ARHGAP22;PLCG2;MTOR;ARHGAP24;RFFL;VAV2;MAPK14;ARHGEF18;MAP2K6;ARAP1;TNF;PIP5K1C;PRKD2;TRAF2;PIP4K2A;PYCARD;AKAP5;RMI1;EXO1;VAV3;TRAF3;FAM13B;WWC2;TAGAP;TAF1;BRIP1;MYO9B;GNA13;TP53;GNA12;TMSB4X;TNIK;CHEK2;CSNK2A2;CSNK2A1;FLCN;ITSN1;ARHGAP21;ARHGAP10;ARHGAP1;ATP6AP2;ARHGDIB;TRAF5;ARHGEF17;CMKLR1;USP7;NF2;RBBP7;DDIT4;PIP4P1;IKBKG;RRS1;ARHGEF3;DNA2;ARHGDIA;STK3;ARHGAP18;BRD7;ARHGEF11;LBH;LRRK2;NOC2L;TMEM127;CAPN3;PHLPP1;A2M;TAF3;TTI1;RPL11;ARHGEF26;PTEN;STK4;ARHGAP23;SGMS1;ARHGEF2;MEAF6;RHOA;PDPK1;CDC42;PTPMT1;BIRC2;PPP2R5C;CHN2;MINK1;CHD4;TAF11;TAOK1
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.6367804705952802,1.2387917224708453,0.25487465181058494,0.591540687744593,1.0,3/10,6.13%,ITGB3;PRKD2;PRKCB
prerank,cellular response to chemical stress (GO:0062197),0.4905012141232476,1.2387569318017861,0.12976313079299692,0.5911060920841288,1.0,29/96,18.38%,CYBB;NCF4;NFE2L2;LRRC8D;NCF2;ATG7;SNCA;PKD2;FOXO3;TXNRD1;AIF1;LONP1;PPARGC1A;PRDX1;PYCR2;MSRA;PRDX3;PRDX6;PRDX2;LRRK2;CPEB2;NOX1;ERO1A;PRDX5;GPX8;PYROXD1;STX2;KEAP1;GSR
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.6034314550479012,1.2387457893311347,0.23342541436464087,0.5905943806711856,1.0,3/13,8.05%,CD74;CD44;SNAI1
prerank,regulation of RNA metabolic process (GO:0051252),0.5002545761820514,1.2380834101174496,0.19275825346112885,0.5919386296342508,1.0,20/59,15.97%,RBM38;ZNF326;MITF;RC3H2;GRSF1;METTL4;RC3H1;PCBP3;HNRNPL;SON;PTBP2;TNFRSF1B;TRA2B;PRX;BRDT;FAM50A;PCBP1;IGF2BP3;RASA1;AHNAK2
prerank,regulation of Ras protein signal transduction (GO:0046578),0.49455822135320454,1.2380810538482252,0.14776274713839752,0.5913999203550288,1.0,20/85,13.97%,VAV1;LYN;RASAL3;GRB2;NUP62;ARHGEF18;MYO9B;EPO;ERBIN;DENND1A;KIF14;FLCN;DENND4B;ARHGDIB;DENND4C;RAPGEF1;DENND4A;SYNGAP1;ARHGDIA;ARF6
prerank,positive regulation of autophagy (GO:0010508),0.4895383120164643,1.2370029719272166,0.15946502057613168,0.594011292357992,1.0,24/81,16.30%,PIK3CB;TRIM5;FOXO3;HMGB1;TFEB;SCOC;PIM2;SVIP;TICAM1;PLK2;FLCN;TRIM27;LARP1;PAFAH1B2;TRIM8;MID2;IKBKG;CAMKK2;GNAI3;LRRK2;RNF152;MTDH;GSK3A;IRGM
prerank,cellular response to organonitrogen compound (GO:0071417),0.4871976010207955,1.236766641734655,0.12972420837589377,0.5941572242388931,1.0,36/99,21.78%,P2RY6;AQP1;HCN4;P2RX7;MTOR;P2RY2;NR1H4;PKD2;RAP1B;P2RX4;TAF1;CTNNB1;ACTB;P2RY12;MEF2C;LARP1;IMPACT;CPEB3;DIAPH1;RAPGEF1;SOX9;GLRA2;LAMTOR3;CAPN2;RAP1A;CPEB4;LAMTOR1;AKAP9;GOLPH3;RPTOR;INPP5K;P2RY1;HCN1;ZFP36L1;RRAGA;RRAGB
prerank,positive regulation of calcium ion transport (GO:0051928),0.5227211974274851,1.2365238845903561,0.22171428571428572,0.5942972838334365,1.0,8/36,16.61%,LGALS3;P2RX7;P2RX4;ATP2B1;CACNB2;CCL2;WFS1;CACNA1D
prerank,ureteric bud morphogenesis (GO:0060675),0.5824105565605473,1.2363919131714538,0.2453083109919571,0.5941112754663384,1.0,2/16,4.10%,SHH;PKD2
prerank,positive regulation of cellular process (GO:0048522),0.47469793727706455,1.236244574365881,0.002,0.5939731736659075,1.0,109/565,16.67%,CD86;DOCK2;PTK2B;SLAMF1;TREM2;LYN;CALCR;SHH;HCK;ITGAX;SLC11A1;TGFB1;CXCL5;FCGR2B;HCLS1;FLT3;LGMN;SIRPA;RPL23;CSF1R;TGFBR1;ADAM8;PRKCD;PTPRJ;TLR2;CAMK1D;TCIRG1;P2RX7;MLXIPL;S100B;TNFRSF11A;MDK;OSM;IL12RB2;CST7;TNF;FCER1G;PRKD2;IL6R;CNOT8;BRAT1;PYCARD;TIMP1;P2RX4;CCND2;AIF1;GAB2;CCAR1;TGFBR2;ACTN4;TAL1;RPS15A;CCKBR;P4HB;EPO;FLT3LG;AQP11;KIF14;DOT1L;CSNK2A1;FLCN;TFAP2B;KIF20B;GID8;NTF3;HSF1;CCL14;ACER3;LRP5;HDAC4;RNF10;NAP1L1;SOX9;THBS1;GRN;TNFRSF1B;PHIP;PRDX3;CIAO1;DYNC1H1;SDCBP;ADGRG1;TBC1D8;NRG1;STX3;BAMBI;MERTK;PRLR;GAS6;HCFC1;CDC6;ZFHX3;INO80;IL2RG;SOX4;MEIS1;LRP1;FASN;IER5;ACACA;IL13RA1;CD36;CXCL16;COPS9;EPHA4;FAF1;PTEN;CD47;NOX1
prerank,piRNA metabolic process (GO:0034587),-0.4049233860838985,-1.236186434740414,0.17,0.8776932018473446,1.0,19/19,59.56%,TDRKH;MYBL1;EXD1;TEX15;PIWIL2;TDRD9;DDX4;TDRD12;PIWIL4;FKBP6;MAEL;MOV10L1;HENMT1;ASZ1;GPAT2;BTBD18;TDRD1;PIWIL1;PLD6
prerank,positive regulation of type I interferon production (GO:0032481),0.5018883724677886,1.235876105851793,0.16579770594369134,0.5944354444222267,1.0,21/73,19.17%,IRF5;TLR2;DHX9;TLR8;TLR7;LRRFIP1;CD14;XRCC5;CTNNB1;SETD2;TRIM56;POLR2L;RNF135;NFKB1;IRF1;HSP90AA1;DDX41;FLOT1;POLR2E;RIOK3;CRCP
prerank,axonal fasciculation (GO:0007413),-0.46781995967253176,-1.23567325546688,0.22818791946308725,0.8723759507501486,1.0,4/12,4.78%,SEMA5A;ARHGAP35;EPHA3;EPHB2
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.4954488234125225,1.2352538817363838,0.15592515592515593,0.5957552769889458,1.0,15/76,12.25%,CD86;LAPTM5;TLR2;TLR7;TSPAN6;NLRC3;TNF;SPI1;CD14;ADGRG3;ACTN4;TMSB4X;LIMS1;ADIPOR1;NOD2
prerank,glycerophospholipid catabolic process (GO:0046475),0.5413015731018512,1.2350874949591995,0.21997621878715815,0.5957062874232051,1.0,12/27,23.52%,ABHD12;PLA2G7;LIPC;PRDX6;GDE1;ABHD16A;GDPD3;PLA2G5;GPCPD1;PLA2G6;INPP5F;PLA2G4E
prerank,detection of visible light (GO:0009584),0.5889760043370251,1.2350503798460064,0.2395287958115183,0.5952726424405008,1.0,4/16,12.70%,GNAQ;REEP6;CNGB1;ABCA4
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.5227026059711983,1.2346452565013917,0.18568232662192394,0.595887122111032,1.0,6/39,5.28%,PIK3CG;PIK3CD;PIK3CB;PIP4K2A;PI4K2A;TTC7A
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.600984820799013,1.234569672380185,0.23647798742138365,0.5955644885243595,1.0,5/16,9.73%,PIGM;PIGL;PIGX;PIGV;PIGH
prerank,neutral amino acid transport (GO:0015804),0.5407622447848288,1.234333928986265,0.22860492379835873,0.5957447716814576,1.0,9/28,16.73%,SLC7A8;SLC38A6;SLC36A1;SLC43A2;SLC6A15;SLC36A4;CTNS;SLC1A4;SLC43A1
prerank,RNA catabolic process (GO:0006401),0.5155137016844509,1.2343120957986873,0.17735042735042736,0.5952496909167491,1.0,24/46,26.90%,SLFN14;ERN1;SND1;ZC3H12D;AGO4;AGO3;RNASEH1;METTL3;DNA2;HNRNPD;PABPC4;RNASEH2A;DIS3L2;RNASE6;NUDT12;ZPR1;DCP2;SIDT2;XRN2;NCBP1;DXO;RNASE3;SUPV3L1;LSM6
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.6141238610180366,1.234182282835781,0.25274725274725274,0.595084854176645,1.0,2/12,3.81%,TGFB1;TNF
prerank,positive regulation of protein catabolic process (GO:0045732),0.49268584156392004,1.2333147250465617,0.14963880288957687,0.597037909357901,1.0,33/84,20.78%,ADAM8;SNX9;ATG7;TNF;APOE;SNX33;TNFAIP3;RAB7A;PLK2;VPS11;CSNK2A1;AMER1;NEDD4L;FZR1;TNFRSF1B;SORL1;ITCH;STX5;TIPARP;HUWE1;AREL1;GSK3A;SMURF1;IDE;FAF1;HSP90AA1;VPS28;FURIN;DACT1;SEC22B;WWP1;GSK3B;PRKN
prerank,regulation of ion transmembrane transport (GO:0034765),0.5258983565293015,1.2324962465586584,0.228310502283105,0.5988516973712867,1.0,4/33,10.05%,KCNJ11;P2RX7;WNK1;NEDD4L
prerank,regulation of cholesterol esterification (GO:0010872),0.6476776771563928,1.2317964175320677,0.24238026124818576,0.6002830148971218,1.0,5/10,21.24%,ABCG1;APOE;STARD4;LAMTOR1;ABCA2
prerank,response to tumor necrosis factor (GO:0034612),0.48569593420694773,1.2307559055581625,0.15061475409836064,0.6027644776152405,1.0,26/91,21.77%,NFE2L2;TNFRSF11A;DHX9;CCL8;OCSTAMP;GCH1;TANK;PYCARD;ERBIN;CCL14;TNFRSF21;CCL13;GBP3;CCL2;CASP8;TRADD;PID1;CXCL16;ASAH1;CCL25;ARHGEF2;SMPD1;INPP5K;BAG4;ZFP36L1;CX3CL1
prerank,positive regulation of monooxygenase activity (GO:0032770),0.5429137940035771,1.2306450098849087,0.22694174757281554,0.6025162716684745,1.0,11/26,22.05%,PIK3CB;TNF;GCH1;ATP7A;APOE;NOS1AP;POR;HIF1A;GDNF;TERF2;CDH3
prerank,zinc ion transmembrane transport (GO:0071577),-0.39493908856962695,-1.230542542491251,0.22395833333333334,0.8842699169442539,1.0,9/22,26.16%,SLC39A13;SLC39A8;SLC30A1;SLC39A1;SLC39A14;SLC39A3;SLC39A10;TRPM2;SLC39A12
prerank,eye development (GO:0001654),-0.3212119824595154,-1.2302972295319083,0.12903225806451613,0.8780479521274368,1.0,13/54,11.18%,COL5A2;CACNA1C;FOXC1;PBX1;NIPBL;EFEMP1;SHROOM2;MEIS2;FBN1;PBX4;SMG9;PBX3;PBX2
prerank,mitotic spindle checkpoint signaling (GO:0071174),0.5615978978149977,1.2302938411775948,0.23333333333333334,0.6019222016945206,1.0,4/20,10.10%,IK;MAD2L2;TRIP13;TPR
prerank,spindle assembly checkpoint signaling (GO:0071173),0.5615978978149977,1.2302938411775948,0.23333333333333334,0.6019222016945206,1.0,4/20,10.10%,IK;MAD2L2;TRIP13;TPR
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),0.5615978978149977,1.2302938411775948,0.23333333333333334,0.6019222016945206,1.0,4/20,10.10%,IK;MAD2L2;TRIP13;TPR
prerank,positive regulation of protein secretion (GO:0050714),0.4941056945116825,1.2301556829630613,0.18162839248434237,0.6017609829149456,1.0,7/69,4.28%,TREM2;TGFB1;IL1A;ADAM8;TLR2;ABCG1;TTN
prerank,positive regulation of ERAD pathway (GO:1904294),0.6043927138542251,1.229458654718817,0.23756906077348067,0.6032375931371613,1.0,3/13,6.40%,NFE2L2;HERPUD1;ATXN3
prerank,chondrocyte differentiation (GO:0002062),0.5260254533156129,1.2289447799357374,0.22415795586527293,0.6041582678021451,1.0,8/32,13.62%,RUNX1;TGFB1;MEF2C;SULF2;CREB3L2;SOX9;SNX19;SOX6
prerank,bicellular tight junction assembly (GO:0070830),-0.32887929981181424,-1.228464837125611,0.1595744680851064,0.8773583362233464,1.0,10/46,10.37%,CDH5;AFDN;PRKCI;PARD3;CLDN5;CLDN11;MPP7;PARD6G;CLDN14;DLG1
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.41613474752781343,-1.2281968822415705,0.1826086956521739,0.8713038596183573,1.0,9/18,26.44%,ACSL1;HACD1;ELOVL5;ACSL6;ELOVL1;ACSBG1;HACD2;ACSL4;ACSL3
prerank,negative regulation of potassium ion transport (GO:0043267),0.6076884842793652,1.2281855954525778,0.24722222222222223,0.6057747130258632,1.0,1/13,0.31%,PTK2B
prerank,protein localization to microtubule organizing center (GO:1905508),0.600954466171587,1.2276653737991032,0.2640750670241287,0.606732634420546,1.0,2/15,6.40%,HOOK3;CEP192
prerank,pentose-phosphate shunt (GO:0006098),0.6276108794342217,1.2271767852432063,0.266304347826087,0.6075910935016001,1.0,5/11,19.36%,RPE;SHPK;PGLS;PGD;RBKS
prerank,sensory perception (GO:0007600),0.504997548062372,1.2265801979230209,0.20814977973568283,0.6087118235665554,1.0,10/45,13.51%,CCR2;P2RX7;PRDM12;WHRN;P2RX4;MYO7A;CCL2;SCN9A;CDH23;RETREG1
prerank,regulation of intracellular protein transport (GO:0033157),0.5283828108187931,1.2265579755560547,0.23174971031286212,0.6082400573390994,1.0,7/32,12.39%,TGFB1;LCP1;PTPN1;RIPOR1;KIF20B;TPR;PCM1
prerank,actin filament network formation (GO:0051639),0.613883707691722,1.2262990143550423,0.24492753623188407,0.6084388435966889,1.0,4/11,10.21%,LCP1;PLS1;FHOD1;ACTN1
prerank,mesonephros development (GO:0001823),-0.49765484742443983,-1.2262237532946256,0.20655737704918034,0.8718618948732892,1.0,7/11,35.32%,BMP4;PAX2;ZBTB16;FGF10;BMP7;FGF1;OSR1
prerank,bile acid and bile salt transport (GO:0015721),0.5531344781373985,1.2261837727290692,0.22939068100358423,0.6082558330005162,1.0,3/24,3.77%,SLCO2B1;ABCC3;NR1H4
prerank,positive regulation of fat cell differentiation (GO:0045600),0.5007237353579931,1.2260619671588864,0.20352035203520352,0.6080758755732458,1.0,15/47,18.20%,LPL;METRNL;RREB1;PIM1;CEBPB;ASXL2;LRP5;CMKLR1;VSTM2A;CREB1;SYAP1;WDFY2;ZBTB7B;PPARD;CREBL2
prerank,heart morphogenesis (GO:0003007),-0.31195269094944844,-1.2258527961383894,0.15714285714285714,0.866539008761794,1.0,14/50,13.76%,BMPR1A;RYR2;NIPBL;EPHB4;ACVR1;TGFBR3;ACVRL1;TBX3;FKBP1A;HES1;OLFM1;TBX1;NOS3;SOX17
prerank,positive regulation of cellular respiration (GO:1901857),0.6316869137751355,1.2258383539995452,0.23919308357348704,0.6082061224063516,1.0,2/11,4.57%,IL10RB;IFNAR1
prerank,negative regulation of myoblast differentiation (GO:0045662),0.6037006541349534,1.2256469943150168,0.25274725274725274,0.6081781552688623,1.0,3/13,11.20%,TGFB1;SOX9;SRA1
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.5146738333591767,1.2256063829249784,0.21639344262295082,0.6077565353338074,1.0,13/44,18.46%,PCID2;AQP1;CST7;TNF;FNIP1;SNCA;CD44;CSNK2A1;THBS1;GAS6;SRC;DNAJB6;MAP2K5
prerank,positive regulation of organelle organization (GO:0010638),0.5292145267762803,1.2254859450199678,0.21205098493626884,0.6075414010069348,1.0,7/32,12.53%,TREM2;P2RX7;RAB3GAP2;ANXA1;PPARGC1A;UVRAG;SYNJ1
prerank,skeletal muscle contraction (GO:0003009),0.5672434086295798,1.225356106596277,0.22526041666666666,0.6073873180713631,1.0,4/19,15.12%,STAC;TNNT3;STAC3;RCSD1
prerank,carboxylic acid metabolic process (GO:0019752),0.5259010149638985,1.2247955032714848,0.22336769759450173,0.608424155500025,1.0,5/33,11.56%,TBXAS1;SLC2A3;PON3;ST3GAL1;CYB5A
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.6337929137224279,1.2247031166245208,0.2624633431085044,0.6076374801378669,1.0,2/10,6.71%,REEP6;CNGB1
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.6337929137224279,1.2247031166245208,0.2624633431085044,0.6076374801378669,1.0,2/10,6.71%,REEP6;CNGB1
prerank,regulation of transport (GO:0051049),0.5223752496883803,1.224659124856095,0.24573378839590443,0.6072284866088066,1.0,11/36,14.59%,SNCA;REEP6;ACTB;GAPVD1;ACTG1;RAB11A;EPB41;NRP1;ICA1L;LRRK2;YRDC
prerank,inner ear morphogenesis (GO:0042472),-0.4006331643480502,-1.2243115062435255,0.21025641025641026,0.8655738059074074,1.0,8/22,15.27%,MYO6;TTC39C;ZIC1;EPHB2;TBX18;SIX1;TBX1;PAX2
prerank,regulation of translational initiation (GO:0006446),0.4995434617609594,1.224310314547462,0.18629550321199143,0.6076902250434424,1.0,15/63,10.95%,NCK2;DNAJC3;ATF3;EIF5B;YTHDF3;CEBPB;EIF4EBP2;EIF1;LARP1;EIF4H;IMPACT;TPR;EIF2B2;CTIF;EIF4G3
prerank,organic hydroxy compound transport (GO:0015850),0.5236269168880705,1.2239123797674085,0.2153325817361894,0.608317796353505,1.0,9/36,18.31%,SLCO2B1;ABCC3;NPC2;NR1H4;SLC16A1;OSBP;SLCO1B1;STARD5;RXRA
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.5142282304845125,1.2238657896927982,0.21986607142857142,0.6079173822317779,1.0,8/39,10.94%,TGFB1;MAD2L2;RGCC;AKNA;WNK1;SPINT2;PODXL;NF2
prerank,cAMP biosynthetic process (GO:0006171),0.6209323691997046,1.2234085405952249,0.25801749271137026,0.6087055099835202,1.0,4/10,13.50%,ADCY7;ADCY6;ADCY8;ADCY3
prerank,primary alcohol metabolic process (GO:0034308),0.5456317963054821,1.2233949752322504,0.2334963325183374,0.608214718178655,1.0,5/25,15.84%,CYP1A1;DHRS3;RETSAT;GDE1;GDPD3
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.6252024786225795,1.2231025077504347,0.25968436154949787,0.6085775281275877,1.0,3/11,10.81%,TGFB1;TP53;MAP2K2
prerank,dopamine metabolic process (GO:0042417),0.583219651573902,1.2229096932510848,0.24427480916030533,0.6086114605187525,1.0,5/18,14.71%,SNCA;GCH1;ATP7A;COMT;MAOA
prerank,regulation of myoblast differentiation (GO:0045661),0.5350564634595767,1.2226254251373356,0.2149425287356322,0.60890608601749,1.0,7/32,11.20%,TGFB1;MAPK14;RIPOR2;MEF2C;AKIRIN1;SOX9;SRA1
prerank,regulation of receptor-mediated endocytosis (GO:0048259),0.5143021697891453,1.2222301448751203,0.23690205011389523,0.6095001142539709,1.0,9/35,18.33%,CBL;BMP2K;PIK3CB;LDLRAP1;HFE;B2M;ARF6;PICALM;FLOT1
prerank,negative regulation of heart contraction (GO:0045822),0.6280077870346787,1.2217641021282724,0.2574679943100996,0.6102567990698948,1.0,1/11,0.66%,PIK3CG
prerank,actin filament depolymerization (GO:0030042),-0.47653401821862024,-1.2213476634504914,0.24422442244224424,0.8694170180639477,1.0,5/11,8.52%,GSN;CFL2;WDR1;MICAL3;MICAL2
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.48551178979157633,1.2211753646394288,0.177732379979571,0.6114348926593139,1.0,21/80,15.16%,TBC1D10C;VAMP3;SNX5;TMEM87B;HEATR5A;RBSN;RAB7A;RAB7B;TMEM87A;TBC1D10A;TRIM27;VPS54;TBC1D17;CLTC;YKT6;STX5;VPS29;VTI1A;SNX2;TBC1D14;HEATR5B
prerank,protein localization to centrosome (GO:0071539),0.5862200825638667,1.2209716758859814,0.247074122236671,0.6115036939104651,1.0,6/17,18.33%,HOOK3;CEP192;PCM1;NUDCD3;SNX10;GOLGB1
prerank,glycoprotein metabolic process (GO:0009100),0.504924883852947,1.2209433270083407,0.19073275862068967,0.6110415400779905,1.0,18/53,19.22%,HPSE;MAN1C1;GCNT1;ST8SIA4;OGA;MAN2B1;ST8SIA1;MAN2A2;STT3B;B4GALT7;LARGE1;HIF1A;MGAT4B;ERP44;FBXO44;GOLPH3;MAN1A2;GANC
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.5422677735258831,1.220907509598798,0.22695035460992907,0.6106051480805055,1.0,3/25,2.08%,PCSK9;ITGB3;RIN3
prerank,cellular iron ion homeostasis (GO:0006879),0.5100557657173846,1.2207424063107615,0.17841880341880342,0.6105453517592349,1.0,9/55,11.46%,SLC11A1;FRRS1;ATP6V0A2;IREB2;ATP6V0D1;HFE;FTL;ATP6AP1;ACO1
prerank,cellular response to increased oxygen levels (GO:0036295),0.6286866624350756,1.2206852855817794,0.2770745428973277,0.6101742154878727,1.0,4/11,11.03%,ATG7;ATP6V0A2;ATP6V0D1;ATP6AP1
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.5281188916760902,1.2193371643515074,0.2409778812572759,0.6135066905494504,1.0,9/28,16.71%,ERN1;TRAF2;DDIT3;MAP3K5;CEBPB;BAK1;ATP2A3;SELENOK;ERO1A
prerank,negative regulation of viral entry into host cell (GO:0046597),0.608905512910422,1.2191161740115495,0.2680851063829787,0.6136381863970968,1.0,3/12,11.21%,CIITA;TRIM5;MID2
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.5787653280467937,1.2183851983066678,0.2536912751677852,0.6152161283092931,1.0,2/15,5.65%,CD74;CD44
prerank,presynaptic endocytosis (GO:0140238),0.5522931101378631,1.2177170268515305,0.24387254901960784,0.6166042356481733,1.0,7/24,12.53%,SNCA;PIP5K1C;CEL;SYT2;STON2;STON1;SYNJ1
prerank,high-density lipoprotein particle remodeling (GO:0034375),0.5907358592288735,1.2173075232954933,0.24935064935064935,0.617235076182018,1.0,3/15,8.57%,ABCG1;APOE;LIPC
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.6271137465779774,1.2167108151910617,0.2619047619047619,0.6184605895796799,1.0,2/10,4.05%,MAD2L2;RGCC
prerank,negative regulation of response to wounding (GO:1903035),0.5626983144563729,1.2166852754985023,0.25949367088607594,0.618000844854853,1.0,7/19,23.29%,MDK;RTN4RL1;CASK;EPHA4;CRK;FGF2;INPP5F
prerank,ventricular septum development (GO:0003281),-0.3295502127977332,-1.2165569254731494,0.12931034482758622,0.8793128986287478,1.0,9/37,7.15%,ZFPM2;BMPR1A;ROBO2;ACVR1;SALL1;TGFBR3;ROBO1;SLIT2;SMAD4
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.4823956491028979,-1.2163096207969875,0.2268041237113402,0.8734724696150409,1.0,8/11,31.11%,UQCRC2;UQCRH;UQCRC1;UQCRQ;CYC1;UQCRFS1;CYCS;UQCC3
prerank,alcohol catabolic process (GO:0046164),0.6220419122842245,1.2162538652548156,0.2651851851851852,0.6187083860511214,1.0,2/10,4.47%,APOE;CEL
prerank,epithelial tube morphogenesis (GO:0060562),0.5322970781358177,1.2162232629269727,0.2337962962962963,0.6182606976866553,1.0,9/32,9.61%,SHH;CSF1R;CCM2;PRKD2;PKD2;CTNNB1;MTSS1;MEF2C;PODXL
prerank,inner ear receptor cell stereocilium organization (GO:0060122),0.6176647992228013,1.2161385198596604,0.2772133526850508,0.6179549292599628,1.0,2/10,5.56%,PLS1;WHRN
prerank,regulation of cell migration (GO:0030334),0.46617250451014347,1.2158127333619748,0.031,0.6183662887448894,1.0,62/382,9.76%,PTK2B;FERMT3;GPNMB;FGR;SHH;ITGAX;TGFB1;CASS4;F10;TMIGD3;CD74;VSIR;PIK3CD;CYRIB;CSF1R;TGFBR1;MGAT5;PTPRJ;THY1;DUSP3;SLURP1;ARSB;RFFL;PLXNC1;MDK;ANGPTL3;RAP2A;SEMA4D;ITGA6;MITF;CLN3;PLXNB2;FOXO3;MCTP1;LGR6;ADGRG3;MACF1;ANXA1;DOCK10;AIF1;MAPRE1;CCAR1;ACTN4;NKX2-1;GNA12;RIPOR1;NEDD9;YTHDF3;TMSB4X;RAP2B;SNAI1;KIF14;FLCN;FAM89B;PTP4A1;DUSP10;PODN;NTF3;PODXL;ACTG1;BCAR1;VCL
prerank,camera-type eye development (GO:0043010),-0.3669795998619388,-1.2151105466540992,0.21176470588235294,0.8712093038282631,1.0,7/25,15.27%,CACNA1C;EFEMP1;SHROOM2;FBN1;TENM3;STRA6;PAX2
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.5003935891468669,1.2145223048169687,0.20310765815760268,0.6215131941060907,1.0,10/47,13.46%,PLEK;WDTC1;SIRPA;ERLIN1;ERLIN2;ACADL;SNAI1;PRMT3;FYN;NFKB1
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),0.5761660955672355,1.214013254248169,0.2637795275590551,0.622460186078005,1.0,5/16,9.57%,PIK3CB;TNF;GCH1;APOE;NOS1AP
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.5097900319409825,1.212627294621063,0.22371364653243847,0.6259155684537028,1.0,7/41,11.19%,PTPRC;PLCG2;SLC8A1;PKD2;ITPR2;IBTK;CHERP
prerank,transcription by RNA polymerase I (GO:0006360),0.5196047898612163,1.2122735952171677,0.21764032073310424,0.6264434379675612,1.0,8/34,10.96%,GTF2H1;TAF1A;POLR1E;TAF1;TTF1;CDK7;POLR1B;POLR2L
prerank,retinoic acid metabolic process (GO:0042573),-0.4387593161582797,-1.2119644215036671,0.2379182156133829,0.8751631558529884,1.0,5/14,37.01%,SCPEP1;ALDH1A2;ADH1A;CYP2S1;BCO2
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.551988750738375,1.2117994856920087,0.25475285171102663,0.6272951385378209,1.0,3/21,4.32%,P2RY6;ERN1;LDLRAP1
prerank,regulation of brown fat cell differentiation (GO:0090335),0.5827648559696988,1.211125633130217,0.26412614980289095,0.6286364526867275,1.0,6/16,16.21%,METRNL;RREB1;PIM1;FLCN;VSTM2A;ZBTB7B
prerank,positive regulation of protein metabolic process (GO:0051247),0.47600029716312997,1.2107410823025786,0.14939024390243902,0.6292614047951087,1.0,36/110,21.24%,CD86;TGFB1;ATG7;TNF;APOE;SLC25A37;IL18;TNFAIP3;RAB7A;CD80;PLK2;CSNK2A1;NEDD4L;RAB1B;INHBA;FZR1;RANBP9;SORL1;ITCH;STX5;TIPARP;HUWE1;WFS1;AREL1;GSK3A;SMURF1;IDE;VPS28;MAP2K5;DACT1;ROCK2;SEC22B;WWP1;GSK3B;PRKN;ABCA2
prerank,negative regulation of blood coagulation (GO:0030195),0.5181040457775976,1.2107354884446677,0.24184476940382452,0.6287358727071954,1.0,3/38,4.14%,GP1BA;F10;APOE
prerank,protein localization to mitochondrion (GO:0070585),-0.46656058554405755,-1.2104195336277046,0.22847682119205298,0.8742481833236538,1.0,6/11,16.31%,HK1;PINK1;COX18;DNAJA1;AKT1;MTCH2
prerank,regulation of cardiac muscle contraction (GO:0055117),0.517727573911456,1.2104171851146663,0.23809523809523808,0.6291077703877327,1.0,5/34,7.37%,PIK3CG;HCN4;SLC8A1;P2RX4;SLC9A1
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.5967541364764791,1.2103324891482543,0.2538569424964937,0.6288279626121378,1.0,3/12,9.57%,MDK;WNK1;FUT9
prerank,negative regulation of hippo signaling (GO:0035331),0.6048530793812914,1.2103046403216762,0.2695035460992908,0.6283853467724445,1.0,3/12,6.25%,MAPK14;WWC2;MAP2K3
prerank,tRNA aminoacylation (GO:0043039),0.5025503528641296,1.2100515801409244,0.2348993288590604,0.6285515713992026,1.0,17/37,22.57%,VARS1;FARSB;GATB;GARS1;PPA2;RARS1;QARS1;EPRS1;LARS2;DARS1;DARS2;FARS2;AIMP1;TARS1;YARS1;SARS1;SARS2
prerank,monocarboxylic acid catabolic process (GO:0072329),0.559362587008126,1.2098767620396031,0.25154894671623296,0.6285231256945474,1.0,3/21,6.19%,LPIN2;CEL;NUDT19
prerank,myelin maintenance (GO:0043217),0.6177147020352158,1.2097441410850904,0.28717201166180756,0.6283893427859786,1.0,6/10,17.99%,CXCR4;ABCD1;PRX;DEGS1;PTEN;ABCD2
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),0.5219585697188563,1.2096920868556862,0.2542565266742338,0.6280008135873143,1.0,8/29,12.01%,NLRC5;PTPN1;SAMHD1;YTHDF3;RNASEL;TTLL12;USP18;METTL3
prerank,regulation of stem cell population maintenance (GO:2000036),-0.40503348125853234,-1.2096511521184659,0.2,0.8704868797674353,1.0,3/18,6.04%,PTN;CNOT3;REST
prerank,fatty acid biosynthetic process (GO:0006633),0.48992054407413754,1.2096032577516327,0.21035940803382663,0.6277285835321541,1.0,12/63,16.13%,CYP1A1;LPL;ALOX12;HPGD;ABCD1;LIPC;HACD4;ABHD3;NDUFAB1;DEGS1;ACACA;FADS1
prerank,regulation of keratinocyte migration (GO:0051547),0.6061439208327757,1.2095392587511984,0.26874115983026875,0.6273855776393759,1.0,6/12,20.53%,MTOR;ARF6;PTEN;MAPRE2;IQSEC1;MAP4K4
prerank,regulation of JNK cascade (GO:0046328),0.4720608399758723,1.2094480273718864,0.16056910569105692,0.6271143287145525,1.0,20/101,13.36%,PTK2B;SLAMF1;FCGR2B;SIRPA;TAOK3;DUSP3;RAP2A;TRAF2;PYCARD;TRAF3;HMGB1;MAP3K5;GADD45B;DUSP10;TRAF5;DUSP19;NOD2;SDCBP;ITCH;GPS2
prerank,presynapse assembly (GO:0099054),-0.4277533218311093,-1.209370555104216,0.21705426356589147,0.8650324814163861,1.0,5/16,8.58%,NLGN1;IL1RAPL1;WNT5A;BSN;LRRTM3
prerank,fatty acid metabolic process (GO:0006631),0.4749494009851348,1.2087821624939312,0.1484848484848485,0.628517376047638,1.0,24/115,17.99%,CYP1A1;LPL;LPIN2;SGPL1;ALOX12;ANGPTL3;CEL;HPGD;NUDT19;PON3;ACSF2;LIPC;PPARGC1A;ADIPOR1;NDUFAB1;FASN;ACACA;CD36;ADIPOR2;CPT2;PNPLA3;PPARD;ACOT2;ABCD2
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.5495248054513452,1.2085802309292923,0.25609756097560976,0.6285289882818921,1.0,4/21,10.10%,IK;MAD2L2;TRIP13;TPR
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.472031299830142,1.2085690348735245,0.16395112016293278,0.6280288874103545,1.0,24/108,13.66%,SYK;CTSD;LAPTM5;MTCH1;TNF;SNCA;TRAF2;PYCARD;CASP1;XDH;HMGB1;APAF1;CFLAR;CRADD;MAP3K5;MALT1;ST18;SMAD3;GRAMD4;PDCD6;DAP;CASP8;ATP2A3;TRADD
prerank,negative regulation of programmed cell death (GO:0043069),0.4657967177011648,1.2084804554447075,0.038,0.6277606061408919,1.0,73/355,16.53%,NCKAP1L;PTK2B;TREM2;ASCL1;SHH;HCK;CLEC5A;GATA1;PCID2;CD74;CBL;LAPTM5;AQP1;ANGPT4;TNFAIP8;DSTYK;NUP62;SEMA4D;NR1H4;SNCA;DNAJC3;CLN3;RAB7A;CCND2;CD44;CFLAR;CTNNB1;ANXA1;BCL2L1;TP53;PIM1;TAX1BP1;PIM2;PLK2;MALT1;KIF14;TPT1;TFAP2B;ARHGAP10;BABAM2;MGMT;ANXA4;SON;BNIP1;SOX9;THBS1;PHIP;PRDX3;ANGPTL4;PRDX2;ITCH;PRLR;BRAF;GAS6;NFKB1;ARHGDIA;RNF144B;ATAD3A;WFS1;BAG1;MIEN1;AREL1;CAPN3;VDAC1;ERCC5;SRC;AHI1;MTDH;FANK1;RASA1;TXNDC5;NAA38;YME1L1
prerank,regulation of apoptotic process (GO:0042981),0.4637030639316122,1.2084175072437076,0.006,0.6274011557152088,1.0,143/676,16.75%,NCKAP1L;FGD2;VAV1;PTK2B;LILRB1;IRF5;ASCL1;SHH;HCK;PREX1;CD3E;CLEC5A;ABR;CTSB;PCSK9;FLT3;GATA1;PCID2;CD74;PLEKHN1;CTSD;CBL;AQP1;ANGPT4;TNFAIP8;DSTYK;NUP62;VAV2;ARHGEF18;MTCH1;SEMA4D;NR1H4;ATG7;TNF;TMEM219;SNCA;ITGA6;TRAF2;DNAJC3;CLN3;FOXO3;PYCARD;VAV3;CASP1;CCND2;CD44;HMGB1;ANP32A;FZD9;APAF1;CFLAR;CTNNB1;ANXA1;BCL2L1;DNM2;GNA13;CCAR1;TP53;ACTN4;CRADD;MAP3K5;PIM1;KCNMA1;TAX1BP1;PIM2;PLK2;MALT1;MEF2C;KIF14;TPT1;FLCN;GADD45B;TFAP2B;ITSN1;ARHGAP10;NTF3;BAK1;BABAM2;BCAR1;MGMT;ANXA4;STK17B;ACTN1;SON;ARHGEF17;LGALS1;BNIP1;NF2;TRIM24;SOX9;SRA1;THBS1;TRIM35;IAPP;PHIP;PRDX3;ANGPTL4;UTP11;CTNNBL1;PRDX2;CASP8;ITCH;LRP8;ARHGEF3;PRLR;BRAF;GAS6;NFKB1;ARHGDIA;STK3;TRADD;RNF144B;ATAD3A;WFS1;BAG1;ARHGEF11;MIEN1;BMF;AREL1;SOX4;CAPN3;VDAC1;PHLPP1;ERCC5;SRC;AHI1;PTPA;STEAP3;MTDH;RPS6KA2;TOP2A;FANK1;RASA1;NF1;MAP3K11;RTN4;TXNDC5;NAA38;FAF1;ARHGEF26;YME1L1;HSP90AA1;STK4
prerank,regulation of dendrite extension (GO:1903859),0.5787666447613793,1.2081648308792203,0.27547169811320754,0.6275984838099231,1.0,9/18,21.68%,SYT17;SYT2;NEDD4L;SMURF1;RASAL1;PLAA;UNC13A;RIMS1;ITSN2
prerank,negative regulation of extracellular matrix organization (GO:1903054),0.63141596864724,1.2081276797060874,0.28355957767722473,0.6271992182070786,1.0,2/10,11.69%,TGFB1;TNFRSF1B
prerank,pulmonary valve morphogenesis (GO:0003184),-0.4158220697549521,-1.2076089252395417,0.1963470319634703,0.8649581454655779,1.0,8/17,14.14%,ROBO2;BMP4;ROBO1;SLIT2;NOS3;JAG1;SMAD6;STRA6
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.33048116364274344,-1.2075065315398614,0.1553398058252427,0.859074965405153,1.0,7/35,9.28%,RBFOX2;UBR5;NR3C2;AR;KDM3A;TADA3;CALCOCO1
prerank,regulation of mitotic sister chromatid separation (GO:0010965),0.584600634504629,1.207399780374746,0.2727272727272727,0.6287361993320074,1.0,5/15,13.80%,PTTG1;NEK6;CDC23;TPR;CDC6
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.5770665373948727,1.207216628976885,0.27882037533512066,0.6287630656477495,1.0,4/14,7.23%,CREB3;HERPUD1;BCL2L1;CREB3L1
prerank,tRNA modification (GO:0006400),-0.29779542308468865,-1.2067509085727992,0.08771929824561403,0.8555357506654436,1.0,23/62,22.88%,NSUN6;DTWD2;METTL6;SSB;THADA;TYW5;THUMPD3;TPRKB;NSUN2;TRMT6;QTRT2;PUS10;TARBP1;DUS2;TYW1;URM1;MTO1;ANKRD16;TRMT5;WDR4;LCMT2;WDR6;DTWD1
prerank,positive regulation of hydrolase activity (GO:0051345),0.4729240510970945,1.206638129754246,0.14170854271356784,0.6298821471696248,1.0,38/137,18.53%,DOCK8;RGS10;FZD10;THY1;SNX9;CCL8;PSAP;ARAP1;SEMA4D;ITGA6;RASGRP2;USP6NL;DOCK11;DOCK10;AGRN;FLCN;CCL14;F11R;TBC1D2;CCL13;RAPGEF1;LIMS1;CCL2;ARHGAP27;MMUT;RAP1A;BCAR3;NF1;GNB5;ALS2;RGS1;SNX13;CCL25;SNX18;RHOA;PICALM;MAPRE2;ITGB1
prerank,positive regulation of cell division (GO:0051781),0.5092970803846003,1.2059202814849805,0.2318181818181818,0.631342494097844,1.0,9/38,17.93%,SHH;TAL1;KIF14;KIF20B;KIF23;CDC6;RHOA;GIPC1;CDC42
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.537010510476835,1.2050780651284234,0.2392857142857143,0.6332901864521372,1.0,5/25,10.39%,STAP1;PRKCD;ARHGAP24;CAPZB;PFN2
prerank,positive regulation of vasculature development (GO:1904018),0.4780039283293976,1.2048550205587516,0.17784552845528456,0.6334007255384375,1.0,24/94,18.59%,RUNX1;ITGAX;IL1A;SMOC2;PIK3CD;AQP1;ANGPT4;ANGPTL3;PRKD2;PDCL3;PRKCB;VEGFB;PDCD6;THBS1;GRN;ANGPTL4;NINJ1;HK2;MTDH;HIF1A;PDPK1;AGO2;ITGB1;VEGFD
prerank,cellular response to starvation (GO:0009267),0.4703058796812371,1.2046209252761182,0.12637913741223672,0.6335565456425586,1.0,44/147,19.42%,ATP6V0D2;PCSK9;ATP6V0E1;GAS2L1;TCIRG1;MTOR;ATP6V1C1;ATG7;FNIP1;SREBF2;MAP1LC3B;ATP6V1E1;FOXO3;TFEB;TP53;MAP3K5;RIPOR1;SEH1L;ATP6V0D1;MTMR3;CEBPB;FLCN;XPR1;IMPACT;BECN1;DAP;TBL2;STK24;LAMTOR3;LRRK2;NIM1K;ATP6V0B;SREBF1;RNF152;CPEB4;FADS1;GCN1;PIK3R4;LAMTOR1;SIK2;ATP6V1F;ATG14;RPTOR;SEC13
prerank,aromatic amino acid family metabolic process (GO:0009072),0.6288541743038297,1.2043158215769778,0.25985401459854013,0.6338801028483061,1.0,3/10,9.08%,ATP7A;KYNU;QDPR
prerank,protein depolymerization (GO:0051261),-0.36397156241001105,-1.204154284026899,0.1895424836601307,0.8581833485193443,1.0,11/27,18.47%,NCKAP5;GSN;CFL2;STMN2;WDR1;MICAL3;MICAL2;KIF24;STMN4;STMN3;KIF18A
prerank,negative regulation of BMP signaling pathway (GO:0030514),-0.309001054531315,-1.2031937793715843,0.17105263157894737,0.8552295861233284,1.0,10/51,9.52%,FSTL1;CRIM1;BMPR1A;BMPER;NBL1;SMAD9;SMAD4;SMAD5;FBN1;SMAD1
prerank,regulation of melanin biosynthetic process (GO:0048021),0.6207307698847989,1.2026304417492981,0.25773195876288657,0.6381563287311102,1.0,5/10,22.05%,ZEB2;ATP7A;CTNS;GIPC1;CDH3
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.522810775362763,1.2018511414592592,0.25825471698113206,0.639841207266089,1.0,2/27,1.05%,TREM2;FCGR2B
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.5427099840778038,1.201543414140395,0.2509090909090909,0.6401681232181979,1.0,4/22,7.31%,THY1;TNF;CD44;WNK1
prerank,positive regulation of glial cell differentiation (GO:0045687),0.5668182697217397,1.201505810722266,0.2796934865900383,0.63972564713806,1.0,3/17,4.58%,TGFB1;MDK;CXCR4
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.5473371007546916,1.2013049471602526,0.2690863579474343,0.6397781210951412,1.0,10/21,22.61%,PCID2;AIM2;PYCARD;FYN;SOX2;PSMB9;BIRC2;BIRC3;MT3;DELE1
prerank,chromosome condensation (GO:0030261),0.5137758285907422,1.2009757835520103,0.25934314835787087,0.6402168510828352,1.0,11/36,19.91%,ACIN1;TTN;NCAPG2;CSNK2A2;CSNK2A1;RB1;AKAP8L;TOP2A;INCENP;SMC4;MCPH1
prerank,microtubule-based transport (GO:0099111),-0.4588946120056064,-1.2006425479808769,0.2152777777777778,0.8579889813259278,1.0,11/12,46.05%,DYNC1I1;SPEF2;CABYR;ROPN1L;ADCY10;SPAG17;DYNC1I2;SPA17;DNAAF2;CCDC40;DNAAF4
prerank,negative regulation of transposition (GO:0010529),0.5668023138383471,1.2005967618496138,0.27411167512690354,0.6407869349980302,1.0,2/16,8.46%,SMYD5;MOV10
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.4772146109811637,1.2001874679607187,0.18503118503118504,0.6414522853648799,1.0,19/77,15.27%,LGALS3;CX3CR1;TGFBR1;TNF;ITGA6;HERPUD1;FZD9;CFLAR;BCL2L1;CSNK2A2;CSNK2A1;RB1;QARS1;THBS1;PHIP;PSME3;NOC2L;PIH1D1;SRC
prerank,proteolysis (GO:0006508),0.4601537828502323,1.1997776259622117,0.0811623246492986,0.6420552795288778,1.0,49/252,17.05%,CTSS;KLK3;MMP12;CTSB;NAPSA;LGMN;FAM111A;SRGN;CTSD;CTSC;CTSA;CTSK;CTSL;ECE2;EEF1AKMT4-ECE2;CLN3;CAPN15;CASP1;DDI2;LONP1;MALT1;ZMPSTE24;CTSZ;SPPL3;SPCS1;NLN;TINAGL1;CTSE;TBL1X;MMP19;CASP7;PARL;CASP8;LRP8;PCSK7;ERAP1;PSMB5;CAPN2;ECEL1;CAPN3;SPPL2A;METAP2;PRCP;SVBP;IDE;YME1L1;FURIN;ATG4A;PITRM1
prerank,positive regulation of dendrite extension (GO:1903861),0.5819498009381842,1.1988783722799004,0.2886334610472541,0.6441448244693159,1.0,9/17,21.68%,SYT17;SYT2;NEDD4L;SMURF1;RASAL1;PLAA;UNC13A;RIMS1;ITSN2
prerank,cartilage development (GO:0051216),0.4902401492309691,1.198382510365041,0.24065934065934066,0.6450868692981747,1.0,10/49,13.62%,RUNX1;TGFB1;ATP7A;CD44;MEF2C;SULF2;CREB3L2;SOX9;SNX19;SOX6
prerank,positive regulation of cholesterol transport (GO:0032376),0.5253732191089382,1.1982115300526897,0.24733727810650888,0.6450336189470729,1.0,7/27,15.27%,TREM2;APOE;ABCB4;EEPD1;GPS2;LRP1;ABCA3
prerank,protein-containing complex disassembly (GO:0032984),0.4913468489688932,1.1980969730999904,0.22399150743099788,0.6448227433019864,1.0,18/54,21.74%,RPL23;LIX1;FRAT2;MAP1LC3B;CLN3;CTNNB1;TECPR1;SNAP29;UVRAG;AMER1;CSNK1A1;SNX14;VPS33B;PYM1;FZD2;GSK3B;EPG5;VAMP8
prerank,iron ion homeostasis (GO:0055072),0.49449778574791725,1.1979143798096015,0.2073684210526316,0.6448384238894417,1.0,11/58,14.06%,SLC11A1;FRRS1;ATP6V0A2;IREB2;ATP6V0D1;HFE;FTL;ATP6AP1;ACO1;B2M;FTH1
prerank,regulation of ERAD pathway (GO:1904292),0.6016556141569502,1.1978775990267607,0.26606875934230195,0.6444105011688284,1.0,3/11,8.14%,HERPUD1;ATXN3;AQP11
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.5342432743159407,1.197813641291435,0.25478468899521534,0.6440551790443468,1.0,8/25,16.72%,TNF;PKD2;P2RX4;SMAD3;NOS1AP;DDAH1;CD36;HSP90AA1
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.580548239663956,1.197417524379799,0.2887700534759358,0.6447086790655923,1.0,3/15,11.89%,SLFN14;ZC3H12D;RNASEH1
prerank,negative regulation of lymphocyte migration (GO:2000402),0.6129517749340431,1.1973327497172173,0.2920353982300885,0.6444195620875445,1.0,2/10,5.96%,CD200R1;RIPOR2
prerank,Ras protein signal transduction (GO:0007265),0.4662310712271864,1.1972174971319578,0.15492957746478872,0.6442220442491471,1.0,33/137,14.79%,GRAP2;LAT;RREB1;GRB2;ELMO1;MAPK14;RAP2A;RASGRP2;RAP1B;RGL2;SHC2;MYO9B;AIF1;GNA13;TP53;GNA12;RIPOR1;PLK2;RAP2B;RASGRP3;RB1;ARHGAP1;ARHGDIB;RAPGEF1;CYFIP1;RASSF1;ADGRG1;ARHGEF3;RRAS2;ARHGDIA;ARHGEF11;RAP1A;USP8
prerank,positive regulation of organelle assembly (GO:1902117),0.5009101332666149,1.1968988424054363,0.21868131868131868,0.6446360578462075,1.0,10/44,12.29%,LCP1;NUP62;KCTD17;TNF;ASAP1;PIP4K2A;RAB3GAP2;PLK4;DYNC1H1;SDCBP
prerank,regulation of ion transmembrane transporter activity (GO:0032412),-0.31887686115828706,-1.1965506191684359,0.1896551724137931,0.8653774659501162,1.0,6/39,3.84%,UTRN;ANK2;FHL1;TCAF1;AHCYL1;FGF12
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.5259675859332441,1.196480551553757,0.2545662100456621,0.6453071512564089,1.0,10/30,20.45%,RFFL;TRAF2;TNFAIP3;CFLAR;BCL2L1;CASP8;TRADD;ARHGEF2;TNFSF10;GSK3B
prerank,regulation of postsynapse organization (GO:0099175),0.5273217746923559,1.196138986182607,0.2615933412604043,0.6457658867650123,1.0,8/28,16.35%,FCGR2B;ARHGAP22;ABHD17B;ABHD17C;LZTS3;TANC2;LRRK2;EPHA4
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),0.5775277395763837,1.196136824391039,0.296043656207367,0.6452416162895156,1.0,4/14,11.55%,ITGA4;RGCC;THBS1;CCL2
prerank,cellular response to sterol (GO:0036315),-0.45287437153169613,-1.1954834977609667,0.26071428571428573,0.8631102926062516,1.0,6/13,20.76%,RORA;GPLD1;SMO;INSIG2;INSIG1;PTCH1
prerank,lipid transport (GO:0006869),0.4717526696200239,1.1953558437833967,0.17342799188640973,0.6470197372396584,1.0,25/97,18.31%,ABCA1;SLCO2B1;ABCC3;ATP8A1;GM2A;MFSD2B;NPC2;CLN8;NR1H4;ABCG1;APOE;CLN3;PRELID3B;ABCD1;FABP5;ABCA4;OSBP;SLCO1B1;OSBPL8;ABCA3;CD36;PPARD;ABCD2;STARD5;RXRA
prerank,nuclear membrane reassembly (GO:0031468),-0.3038036219433987,-1.1947096998396929,0.14545454545454545,0.8598445300419019,1.0,20/54,22.38%,SPAST;NUP93;IST1;NUP188;NUP98;PPP2R2A;AHCTF1;NDC1;NUP37;VPS4A;RCC1;EMD;CHMP4B;CHMP4A;NUP133;LMNA;CHMP2A;RAN;NUP43;LBR
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.5096384709222646,1.194678957064797,0.2620192307692308,0.6484473558973631,1.0,5/33,8.24%,CBL;NUP62;ARAP1;DOK1;DGKD
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.5390852741722345,1.1943447839762715,0.26334519572953735,0.6488751783652014,1.0,5/26,9.15%,LGMN;SMOC2;DUSP3;TAL1;HSF1
prerank,regulation of cellular ketone metabolic process (GO:0010565),-0.2956715800694206,-1.1942592613813703,0.06896551724137931,0.8556124488148714,1.0,25/61,22.04%,CAV1;PANK2;PSME4;PSMD11;PSMA5;PSMA4;PPARA;PSMD14;AZIN1;PSMC6;PSMC3;PSMB3;PSMC1;PSMD5;PSMA3;PSMD3;PSMD6;PSMC5;ODC1;PSME2;FGFR4;PSMB4;PSMC4;PDK2;PSMB6
prerank,positive regulation of establishment of protein localization (GO:1904951),0.5547566980814445,1.1942103196152098,0.2797385620915033,0.6487214135258254,1.0,3/18,8.87%,TREM2;TNF;CCT8
prerank,protein transport (GO:0015031),0.46120985262258407,1.1941429903408092,0.058,0.6483878289920854,1.0,100/332,19.53%,ATP6V0D2;IL10RA;TBC1D9;RAB8B;CD74;ABCA1;LAPTM5;TBC1D10C;ATP6V0E1;RAB34;UNC93B1;CTSA;TCIRG1;RAB32;ATP6V1C1;TMED3;SNX9;ABCG1;APOE;ATP6V1E1;SEL1L;RAB14;ATP6V0A2;SNX33;RAB3GAP2;MYH9;TBC1D16;RAB7A;TBC1D22A;STX11;TLK1;AP3D1;USP6NL;PRKCB;MACF1;DNM2;STXBP3;ATP6V0D1;RAMP1;VMP1;TBC1D10A;HFE;RAB28;PPY;SNX27;RAB31;ARHGAP1;PDCD6;SYNRG;ARL5B;ARL4A;RAB1B;TBC1D2;ATP6V0A1;TBC1D17;COPA;ATP6AP1;CLTC;HDAC6;TBC1D2B;WDR11;ARRDC4;TBC1D8;STX3;STX5;SAR1A;RPGR;STX8;GGA2;ARF6;VPS29;SCAMP2;NEURL1B;ATP6V0B;LRP1;TBC1D14;STEAP3;TBC1D22B;YWHAH;SVBP;CD36;SNX13;ARFIP2;IFT27;ARHGEF2;MON1A;STX2;VLDLR;VPS33B;LRP1B;SLU7;GOLPH3;ATP6V1F;TBC1D12;LTBP2;TBC1D5;MCOLN1;RAB29;SEC13;OPTN
prerank,regulation of macrophage activation (GO:0043030),0.5243635644048669,1.1932250983568409,0.25504151838671413,0.650449868149478,1.0,4/30,4.57%,FCGR2B;CD74;GPR137B;CEBPA
prerank,regulation of exit from mitosis (GO:0007096),0.5036579670001687,1.192712635329429,0.2435754189944134,0.6513939274038405,1.0,4/38,6.58%,ANAPC15;RGCC;CDC23;UBE2S
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.5677808433271806,1.1922531291871425,0.2858990944372574,0.6521259050635944,1.0,7/17,19.71%,LPL;ANGPTL3;LIPC;HDAC9;ANGPTL4;FURIN;SORT1
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.5544328861668671,1.1921546256418882,0.2844387755102041,0.6518807958483704,1.0,1/18,0.63%,KCNJ11
prerank,negative regulation of cellular component organization (GO:0051129),0.47419191458948723,1.1918086700678792,0.23419689119170983,0.6523567766959932,1.0,15/74,12.79%,LILRB1;LGALS3;NR1H4;TNF;MCTP1;SNX33;XRCC5;DNM2;TFIP11;SVIP;HSF1;IMPACT;HDAC6;IAPP;SORL1
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.47707186799065016,1.1917695882304236,0.20889348500517063,0.6519368523822631,1.0,15/80,9.02%,SYK;CTSD;AQP1;TNF;FNIP1;SNCA;PYCARD;CASP1;CD44;HMGB1;MAP3K5;MALT1;CSNK2A1;GRAMD4;PDCD6
prerank,mitotic chromosome condensation (GO:0007076),0.5335946515776134,1.1916838179236566,0.2684964200477327,0.6516450250396593,1.0,8/26,19.91%,TTN;NCAPG2;CSNK2A2;CSNK2A1;RB1;AKAP8L;SMC4;MCPH1
prerank,cardiac muscle tissue development (GO:0048738),-0.3043075408347257,-1.1914935606513335,0.171875,0.858978779282845,1.0,12/50,10.26%,SGCD;BMPR1A;BMP4;SGCZ;AKAP13;BMP5;CACNA1G;SMAD4;SIK1;SMAD5;SMAD1;TBX18
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.47125671197275265,1.1905026422231748,0.2361111111111111,0.6544898716799203,1.0,20/65,18.68%,CBL;PTPRJ;DUSP3;GRB2;NUP62;ARAP1;DOK1;ZFYVE28;RHBDF2;SH3KBP1;DGKD;MVB12B;EPS15;BCAR3;RHBDF1;EPN1;PTPN12;PDE6H;CDC42;PTPN3
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.48647348646001826,1.1904543663654032,0.23125659978880675,0.6540966768350565,1.0,14/59,13.46%,CSF1R;MED17;MITF;CDK8;CTNNB1;TP53;TNRC6A;CEBPB;MOV10;AGO4;MED27;SOX9;AGO3;NFKB1
prerank,positive regulation of brown fat cell differentiation (GO:0090336),0.5916214614633555,1.1903962265403878,0.3025210084033613,0.6537348567384401,1.0,5/13,16.21%,METRNL;RREB1;PIM1;VSTM2A;ZBTB7B
prerank,regulation of inclusion body assembly (GO:0090083),-0.4712502089653102,-1.1901399161094968,0.2268370607028754,0.8578067317538636,1.0,9/11,39.13%,SNCAIP;SACS;DNAJB2;BAG5;DNAJA4;DNAJB1;HSPA1A;HSPA1B;HSPA2
prerank,mRNA catabolic process (GO:0006402),0.49972710300909595,1.1899711299968552,0.2281081081081081,0.6543937959628673,1.0,9/44,16.57%,SLFN14;ERN1;ZC3H12D;RC3H1;AGO4;AGO3;METTL3;THRAP3;TUT7
prerank,phosphate ion transport (GO:0006817),0.5640676603538843,1.1895945039574138,0.2884864165588616,0.6549289166132984,1.0,4/16,13.02%,SLC37A2;XPR1;SLC20A2;SLC25A30
prerank,stabilization of membrane potential (GO:0030322),0.5778154968291402,1.189177593212918,0.3038821954484605,0.6555791968604487,1.0,3/16,7.51%,KCNN4;KCNK6;KCNK13
prerank,positive regulation of apoptotic process (GO:0043065),0.4603930301654146,1.1886286345166612,0.064,0.6565629695648497,1.0,65/293,17.55%,FGD2;VAV1;LILRB1;IRF5;PREX1;ABR;PCSK9;PLEKHN1;CTSD;TGFBR1;TNFAIP8;VAV2;ARHGEF18;MTCH1;ATG7;TNF;SNCA;ITGA6;FOXO3;PYCARD;DDIT3;VAV3;HMGB1;FZD9;APAF1;CTNNB1;DNM2;GNA13;CCAR1;TP53;CRADD;MAP3K5;KCNMA1;FLCN;GADD45B;TFAP2B;ITSN1;BAK1;STK17B;ARHGEF17;TRIM35;GRN;IAPP;UTP11;CTNNBL1;CASP8;ARHGEF3;STK3;TRADD;ARHGEF11;BMF;SOX4;TLE5;PTPA;RPS6KA2;TOP2A;FANK1;NF1;MAP3K11;FAF1;ARHGEF26;STK4;BIN1;ARHGEF2;UBE2Z
prerank,modulation by symbiont of entry into host (GO:0052372),0.5676289321037454,1.188345186196316,0.2985658409387223,0.6568476515991102,1.0,6/16,17.06%,TRIM25;TRIM5;TRIM27;EXOC7;EXOC2;TRIM62
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.5187845294515956,1.1882775759555029,0.27630057803468205,0.6564969384549673,1.0,18/29,25.87%,ADAR;SMAD3;PUM2;AGO4;SNIP1;AGO3;METTL3;PRKRA;TUT7;TARBP2;AGO2;ZC3H7A;DICER1;LIN28B;DROSHA;ZC3H7B;AGO1;PUM1
prerank,regulation of dopamine secretion (GO:0014059),0.5321378192098717,1.188262370095779,0.2704326923076923,0.6560179224550746,1.0,5/25,11.09%,SYT17;SNCA;SYT2;SYT10;DTNBP1
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.5941222460194029,1.188110869641545,0.28751753155680226,0.6558731427762017,1.0,5/11,18.96%,VAPB;BNIP1;ATL1;RTN4;ATL2
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),0.5716249618986611,1.1880862059048574,0.28218465539661897,0.6554003468199887,1.0,4/16,11.23%,PTPRJ;PTPN1;BCAR1;NRP1
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.5394993024714111,1.1880220659957055,0.2858926342072409,0.655059339713873,1.0,5/21,7.23%,CREB3;HERPUD1;DDIT3;BCL2L1;CREB3L1
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.5312426071189725,1.1874414480734872,0.2773207990599295,0.6561812783422882,1.0,7/25,17.78%,CALCR;THY1;SNCA;CACNB2;CAPN3;CEMIP;PDPK1
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.5967305592745759,1.187401638651441,0.2897727272727273,0.6557554474070201,1.0,3/12,12.25%,MUC13;SOX9;NOD2
prerank,positive regulation of protein import into nucleus (GO:0042307),0.5278430288529451,1.1871078931475405,0.27837514934289126,0.6560784125495774,1.0,5/28,10.10%,TGFB1;HCLS1;PRKCD;SMAD3;TPR
prerank,regulation of oxidoreductase activity (GO:0051341),0.5906860370509445,1.187060329804853,0.27530364372469635,0.6556804535232656,1.0,4/13,12.25%,SLAMF8;ATP7A;HDAC6;NOD2
prerank,smooth muscle tissue development (GO:0048745),0.6100737542810649,1.1867456818930804,0.2995720399429387,0.6560546715326361,1.0,1/10,0.68%,SHH
prerank,cellular response to cAMP (GO:0071320),0.513372450951517,1.186438763181223,0.2597701149425287,0.6564110685113712,1.0,10/30,21.24%,AQP1;HCN4;PKD2;RAP1B;RAPGEF1;RAP1A;AKAP9;INPP5K;HCN1;ZFP36L1
prerank,regulation of anoikis (GO:2000209),-0.38679300587985366,-1.186337845130526,0.2311111111111111,0.8644930243118789,1.0,4/19,7.55%,ANKRD13C;CAV1;TLE1;SIK1
prerank,regulation of microtubule-based process (GO:0032886),-0.3198194524870847,-1.1855205955691963,0.15748031496062992,0.861436216199888,1.0,11/36,14.99%,EFNA5;PHLDB2;CYLD;EPHA3;PHLDB1;ROCK1;MAP6;MAPT;TPPP;MARK4;TRIM36
prerank,regulation of aerobic respiration (GO:1903715),0.5765233210539902,1.1839226339583622,0.2760898282694848,0.6630285152792917,1.0,3/15,7.24%,CBFA2T3;ATP7A;ABCD1
prerank,regulation of catecholamine secretion (GO:0050433),0.5168656805828483,1.1838118264089565,0.2850521436848204,0.6628137902281231,1.0,5/29,11.09%,SYT17;SNCA;SYT2;SYT10;DTNBP1
prerank,regulation of intracellular transport (GO:0032386),0.5000260498928147,1.183583531129326,0.2688053097345133,0.6629405842861179,1.0,4/38,4.64%,LCP1;NEFH;PTPN1;REEP6
prerank,sterol metabolic process (GO:0016125),0.4780660566491045,1.1834395900916823,0.24973656480505796,0.6628137458616515,1.0,8/60,5.56%,ABCA1;ANGPTL3;CLN8;ABCG1;APOE;LDLRAP1;LIPA;SOAT2
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.5452802517830451,1.1832133471108526,0.2956852791878173,0.6629084802564044,1.0,13/20,25.87%,PUM2;AGO4;SNIP1;AGO3;PRKRA;TARBP2;AGO2;ZC3H7A;DICER1;DROSHA;ZC3H7B;AGO1;PUM1
prerank,regulation of actin filament-based movement (GO:1903115),-0.47307302221147896,-1.1831589935935392,0.2524271844660194,0.8635543919836697,1.0,2/10,5.88%,ANK2;SRI
prerank,negative regulation of viral life cycle (GO:1903901),0.5718959440655111,1.1830839633322559,0.2978142076502732,0.6627435069966565,1.0,2/15,3.63%,CIITA;TRIM5
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.5576308844131257,1.1816395707628262,0.3082010582010582,0.6664217520537495,1.0,3/18,4.11%,GSAP;TNF;ABCG1
prerank,genitalia development (GO:0048806),0.5839556045823722,1.1810414715896798,0.28337874659400547,0.6675613822265001,1.0,2/12,6.22%,SHH;CHD7
prerank,positive regulation of cell-cell adhesion (GO:0022409),0.49407967903146616,1.1807820892949075,0.2682926829268293,0.6677847744706876,1.0,15/41,24.03%,CD3E;THY1;MDK;TNF;CD44;PODXL;PTPRU;DENND6A;CD47;FLOT1;PIEZO1;MEGF10;CX3CL1;PTPN23;MAGI1
prerank,negative regulation of protein phosphorylation (GO:0001933),0.4617644850341219,1.1804917126611774,0.17971887550200802,0.6681038204657092,1.0,42/150,20.08%,PTPRC;LYN;UBASH3B;TGFB1;SIRPA;NIBAN1;PRKCD;THY1;GNAQ;MLXIPL;NCK2;SEMA4D;SNCA;DNAJC3;XDH;SAMSN1;RB1;TRIM27;NTF3;QARS1;IBTK;IMPACT;DUSP19;DTNBP1;SNX25;DDIT4;PID1;RTRAF;LRRK2;NF1;PTEN;TARBP2;CORO1C;LDLRAD4;PDPK1;PAQR3;GREM1;ATG14;CNKSR3;INPP5K;HSPB1;PTPN6
prerank,regulation of phosphorylation (GO:0042325),0.4647887652953096,1.1803913884222141,0.19635627530364372,0.6678735973711046,1.0,21/120,12.34%,NCKAP1L;LYN;STAP1;FNIP2;NLRC5;SLAMF8;PTGES3;NUP62;FNIP1;ITGA6;PLXNB2;SEH1L;FLCN;TPR;INHBA;NRP1;THBS1;NUP205;PHIP;SDCBP;PPP2CA
prerank,termination of RNA polymerase I transcription (GO:0006363),0.5159060048611437,1.1803192344998135,0.2549707602339181,0.6675332607071592,1.0,7/30,10.96%,GTF2H1;TAF1A;POLR1E;TTF1;CDK7;POLR1B;POLR2L
prerank,negative regulation of protein ubiquitination (GO:0031397),0.4893730433167706,1.1800731530631103,0.23917748917748918,0.6677235003997779,1.0,5/50,5.94%,ARRB2;BAG2;IVNS1ABP;TNFAIP3;TAF1
prerank,transcription by RNA polymerase III (GO:0006383),0.5152107798202985,1.180040969215477,0.26435406698564595,0.6672832496641725,1.0,10/27,19.17%,IVNS1ABP;GTF3C4;GTF3A;POLR2L;SNAPC3;ELL;RO60;SNAPC4;ICE2;CRCP
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.5232740592985311,1.1799768412126932,0.2816568047337278,0.6669409441376096,1.0,10/27,21.91%,SLFN14;ERN1;ZC3H12D;RNASEH1;ZC3H12C;PCF11;TRIR;DICER1;TOE1;RNASE6
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.465922010799875,1.179781112828942,0.19433198380566802,0.6669538602346832,1.0,43/119,23.29%,INPP5D;PIK3CG;PIK3R5;PIK3CD;PIGM;PLCG2;PIK3CB;PIP5K1C;INPP4B;PIP4K2A;PI4K2A;RAB14;TTC7A;PIGL;MTMR3;PIGV;SMG1;PIGH;PI4K2B;SYNJ1;BMX;PLEKHA1;EFR3A;PTEN;PIK3R4;PGAP2;PLEKHA2;INPP5K;PIGU;PIGC;SOCS3;PIGN;PIK3CA;ITPKB;SOCS4;SOCS7;FGF2;MTMR9;MTMR14;DPM2;PIGP;OCRL;INPP5F
prerank,organelle fission (GO:0048285),0.5308661161064332,1.1796450630706654,0.2876543209876543,0.6667976465361654,1.0,13/24,25.18%,PEX11A;MTFR2;DNM2;TMCC1;SEC16B;CORO1C;DNM1L;FIS1;PRKN;ACOT8;MTFR1;MFF;WASHC5
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.4638880431654977,1.1794501721669337,0.2016376663254862,0.6668025702147804,1.0,31/104,20.69%,CSF1R;GTF2H1;THY1;SLC8A1;CCND3;SNCA;BCCIP;PYCARD;CCND2;ACTB;RB1;UVRAG;CDK7;LRP5;DUSP19;MAP2K2;PARP16;PPP2CA;CDC6;CCNE2;PIH1D1;SRC;SYAP1;INCENP;IRGM;KSR1;RHOA;RPTOR;CNPPD1;CDK5R1;TELO2
prerank,positive regulation of ATPase activity (GO:0032781),0.4949191641231257,1.178207450403563,0.27450980392156865,0.6699088674602062,1.0,12/41,13.76%,MYL3;DHX9;ALDOB;VMP1;TNNT3;AHSA1;PFN2;PFN1;ATP1B3;TOR1AIP2;DNAJC9;ATP1B2
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.45134145844080165,1.1779181799130694,0.032,0.6702188887033799,1.0,98/476,14.81%,CD86;RUNX1;NFE2;CIITA;SHH;IRF4;TGFB1;GATA1;PCID2;CD74;SNX5;TGFBR1;NFATC1;MED17;RREB1;GTF2H1;MAD2L2;NSD1;MLXIPL;SS18L1;ELF4;NUP62;YAF2;RXRB;NR1H4;TNF;APOE;UBE2V1;MITF;FOXO3;DDIT3;CXXC1;SPP1;NDP;HIVEP3;RNF111;FLI1;TEAD1;MAP2K3;CTNNB1;TFEB;DNM2;TP53;KLF6;CD80;TBL1XR1;NKX2-1;TAL1;MAP3K5;MYOCD;PIM2;ZFP90;EPO;CEBPB;CHEK2;SNAI1;MEF2C;TFAP2B;BICRA;SMAD3;MMS19;ARID1A;MDFIC;PPARGC1A;RNF4;ATF7IP;LRP5;HDAC4;ARID1B;RNF10;ATAD2;SEC14L2;TBL1X;INHBA;TRIM56;MAP2K2;CREB3L2;ELF2;SOX9;PHIP;MAP3K12;CREB1;BAMBI;SMARCD3;CAMKK2;NFKB1;FOXK1;GPATCH3;HCFC1;ZFHX3;IRF1;SOX2;BRD7;HNRNPD;ARHGEF11;LBH;SOX4;CAPN3
prerank,miRNA metabolic process (GO:0010586),0.5452643530970525,1.1778155050510293,0.28607594936708863,0.6699589688621657,1.0,10/20,21.57%,TENT4B;SND1;BCDIN3D;PRKRA;TUT7;TARBP2;AGO2;DIS3L2;DICER1;LIN28B
prerank,regulation of sprouting angiogenesis (GO:1903670),-0.33282333681173104,-1.177511410086613,0.24166666666666667,0.8767898349439394,1.0,11/33,13.59%,TJP1;SEMA6A;BMPER;EPN2;SYNJ2BP;KLF2;SMAD1;RHOJ;KLF4;ADAMTS9;GLUL
prerank,cytoskeleton organization (GO:0007010),0.4593819790885816,1.1771777062513589,0.1927346115035318,0.6713057315306579,1.0,30/114,17.75%,FGD2;THY1;NCKIPSD;MDK;APOE;TNFAIP3;PLD2;FMNL3;FGD6;CAPZB;NEDD9;RANBP10;MICAL1;TNIK;SH3KBP1;SIPA1;ARHGAP10;DIAPH1;CCL13;CCL2;PHIP;RANBP9;DES;SIPA1L3;DST;PDZD8;WDPCP;BIN1;ANK1;RHOA
prerank,positive regulation of blood coagulation (GO:0030194),0.5548825973851096,1.1771461432183286,0.3087248322147651,0.6708520885579694,1.0,3/17,11.25%,HPSE;USF1;THBS1
prerank,response to chemokine (GO:1990868),0.581777832864704,1.1767346347608656,0.3170391061452514,0.6715418222089683,1.0,4/13,10.93%,DOCK8;RIPOR2;WNK1;SH2B3
prerank,RNA interference (GO:0016246),0.5570779554471532,1.176226356488932,0.28874172185430463,0.6724427474161478,1.0,10/17,25.05%,DHX9;AGO4;AGO3;PRKRA;NRDE2;TARBP2;AGO2;DICER1;DROSHA;AGO1
prerank,action potential (GO:0001508),0.4912183567447701,1.1762183034512939,0.27827050997782704,0.6719434840830629,1.0,3/44,4.53%,GNA15;GNAQ;CLN3
prerank,regulation of mRNA metabolic process (GO:1903311),0.6136555524541216,1.1761257741961917,0.30196629213483145,0.6716818294646821,1.0,4/11,13.53%,DHX9;CDK11B;SRPK3;SAFB2
prerank,nucleoside salvage (GO:0043174),0.6101393560997782,1.1759144515462487,0.3101361573373676,0.6717783549642656,1.0,4/10,16.33%,UCK1;CDA;UCK2;DCK
prerank,histone lysine demethylation (GO:0070076),-0.3731315970130257,-1.1752248534276615,0.20481927710843373,0.8786956730470064,1.0,11/25,18.26%,PHF2;KDM5C;JMJD1C;KDM3A;KDM4B;KDM4A;KDM1B;KDM2A;KDM4D;KDM6A;KDM8
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.48297577921026336,1.1750506999316594,0.2679528403001072,0.6737303186942126,1.0,12/54,16.98%,ARRB2;BAG2;IVNS1ABP;TNFAIP3;CTNNB1;PRMT3;SOX4;CAPN3;SVBP;COPS9;RPL11;VPS28
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.5071635542671318,1.1748499421138225,0.30327868852459017,0.6738002656942131,1.0,4/31,3.69%,TGFB1;TGFBR1;MYL3;PKP2
prerank,synaptic vesicle recycling (GO:0036465),0.513350763259468,1.1740422338191994,0.2900232018561485,0.6756651761980814,1.0,8/31,12.53%,SNCA;PIP5K1C;CEL;PLD2;SYT2;STON2;STON1;SYNJ1
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),-0.41071290930820525,-1.1740254270620951,0.25877192982456143,0.8773177374129667,1.0,8/17,20.79%,SPRED2;PARD3;CALM3;SPRY2;DGKQ;DMTN;PPEF2;SMAD7
prerank,regulation of cell-cell adhesion (GO:0022407),0.49502238993966213,1.173730153840416,0.26773455377574373,0.6760677707005976,1.0,7/39,10.94%,FERMT3;TGFB1;ADAM8;SPINT2;FUT9;PODXL;NF2
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),0.5830323626542393,1.1734589513653575,0.29901269393511987,0.6763243104074315,1.0,2/13,2.09%,TGFB1;TGFBR1
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.5687077684441506,1.1728651220080306,0.3150684931506849,0.6774994454563963,1.0,6/15,23.23%,TGFB1;LRP1;DPP4;CLASP1;DDR1;PDPN
prerank,regulation of protein secretion (GO:0050708),0.46234825058064366,1.1723060105554755,0.22154471544715448,0.6785642506808162,1.0,26/119,16.82%,TREM2;KCNJ11;TGFB1;IL1A;ADAM8;TNF;ABCG1;APOE;TTN;RHBDF2;CACNA1A;TFAP2B;ITPR2;SYTL4;ENSA;SLC8B1;EXOC1;ARF6;MYH10;KCNA5;RAP1A;CD33;RHBDF1;CACNA1D;GCK;PPP3CB
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.4572168205381677,1.1715239366699925,0.20854526958290945,0.6802691397174174,1.0,31/101,17.08%,TGFB1;NIBAN1;MTOR;ATG7;AURKAIP1;PLXNB2;ASPH;CIRBP;YTHDF3;TBC1D10A;VPS11;LARP4B;BAK1;CPEB3;AMER1;RPL26;INHBA;THBS1;ZCCHC4;METTL3;CASP8;PCIF1;STUB1;POLDIP3;UPF3B;HNRNPD;SOX4;CAPN3;FAF1;HSP90AA1;RPS4X
prerank,protein localization to organelle (GO:0033365),-0.26151786131401983,-1.1715213193329983,0.0,0.8804899532218632,1.0,41/133,16.77%,APP;ANK2;RAB6A;UBAC2;LMBRD1;BMP4;SSB;ZNF423;CEP250;ATP6V1D;ARL3;YBX1;TOLLIP;PAF1;CALR;GCC2;BBS4;ARL6;EHD1;ALDH3A2;TRAM1;SCG3;ARL1;SIX1;TOPORS;SEC61G;BBS2;XPA;WDR35;GBP2;COL1A1;CTDNEP1;EMD;DNAJA1;SERP1;IFT20;SEC61B;AUP1;MTCH2;LAMP2;LMNA
prerank,ncRNA catabolic process (GO:0034661),0.5186994362928034,1.1713733877698123,0.2757009345794392,0.6801775017788476,1.0,3/28,6.86%,SLFN14;TENT4B;SND1
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.5336459847790462,1.1712153101286196,0.2827669902912621,0.6800828222096376,1.0,5/21,10.29%,HPSE;SULF2;HS3ST4;XYLT1;EXTL3
prerank,regulation of MAPK cascade (GO:0043408),0.4517393511859613,1.1709908157015068,0.1716867469879518,0.68017837492031,1.0,32/157,17.35%,PTPRC;LYN;SYK;FLT3;CD74;LAPTM5;TAOK3;PLCG2;PTPRJ;DUSP3;P2RX7;OSM;TRIM5;HMGB1;TNIK;ATP6AP2;DUSP19;MAP2K2;GPR37;IAPP;STK3;SOX2;LBH;TMEM106A;PHLPP1;BCAR3;NF1;STK4;EPHA8;IQGAP1;KSR1;LAMTOR1
prerank,organic cation transport (GO:0015695),-0.38572627028570683,-1.1709769310462137,0.24568965517241378,0.876974888648029,1.0,9/19,28.73%,SLC47A1;RALBP1;SEC14L1;SLC25A42;SLC5A7;SLC25A19;SLC22A2;SLC25A29;SLC25A26
prerank,glycosaminoglycan metabolic process (GO:0030203),0.4790855356899488,1.1704580628536965,0.2523461939520334,0.6810915472177893,1.0,9/54,9.39%,HPSE;GUSB;GNS;IDS;HEXA;FUCA1;AGRN;NDST1;XYLT1
prerank,L-glutamate transmembrane transport (GO:0015813),-0.47786891243431007,-1.1700163596615365,0.2829581993569132,0.874693625309928,1.0,3/10,6.22%,SLC25A12;ARL6IP5;SLC25A13
prerank,cellular response to ketone (GO:1901655),0.4972414225728247,1.1695941034563657,0.2926829268292683,0.6830316726958174,1.0,12/35,19.65%,MAP4K1;AQP1;ADCY6;SPP1;LARP1;ADCY8;ADCY3;GNG2;SRC;NCOA4;GOLPH3;ROCK2
prerank,transition metal ion homeostasis (GO:0055076),0.5148712563200524,1.1695328857457574,0.29694835680751175,0.6826748134282394,1.0,10/28,22.07%,SLC11A1;IREB2;HFE;FTL;B2M;PICALM;ATP13A2;HMOX2;PRKN;MT3
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.5168114912113349,1.1690391843776788,0.2927120669056153,0.683550638506235,1.0,3/27,2.82%,CD74;AQP1;DHX9
prerank,positive regulation of phosphorylation (GO:0042327),0.4515481595414116,1.169023916738234,0.116,0.6830679593361598,1.0,23/240,5.61%,NCKAP1L;TREM2;GPNMB;LYN;TGFB1;FLT3;CD74;ITGB3;CSF1R;NIBAN1;P2RX7;MLXIPL;DSTYK;PTGES3;RAP2A;SEMA4D;CCND3;TNF;FNIP1;ITGA6;BRAT1;PFKFB4;CCND2
prerank,autophagosome maturation (GO:0097352),0.514425841438687,1.1689430805948273,0.27726218097447797,0.6827902719443792,1.0,12/32,21.74%,LIX1;MAP1LC3B;CLN3;VMP1;TECPR1;SNAP29;UVRAG;SNX14;VPS33B;ATG14;EPG5;VAMP8
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.5014864603458675,1.1686114408058033,0.27011494252873564,0.683251848118269,1.0,7/32,10.96%,GTF2H1;TAF1A;POLR1E;TAF1;CDK7;POLR1B;POLR2L
prerank,regulation of angiogenesis (GO:0045765),0.45371509138737703,1.1684587102799306,0.14914914914914915,0.6831388573753129,1.0,20/192,7.43%,RUNX1;KLK3;GPNMB;PF4;ITGAX;CCR2;IL1A;SMOC2;PIK3CD;AQP1;ANGPT4;ANGPTL3;RGCC;PRKD2;PDCL3;TNFAIP3;PRKCB;CTNNB1;STAB1;VEGFB
prerank,copper ion transport (GO:0006825),0.5822654674408317,1.1682155716892504,0.307909604519774,0.6833553981906896,1.0,4/11,15.44%,ATP7A;ATOX1;SLC31A2;STEAP3
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),-0.327278010536686,-1.1679231807759438,0.21238938053097345,0.8760964749801843,1.0,13/37,16.40%,EFNA5;PHLDB2;CYLD;EPHA3;STMN2;PHLDB1;ROCK1;MAP6;MAPT;TPPP;STMN4;TRIM36;STMN3
prerank,cellular response to oxygen levels (GO:0071453),0.6111375155429822,1.1675590211513378,0.31710709318497915,0.6847443850067374,1.0,4/10,15.08%,ATP6V0A2;ATP6V0D1;ATP6AP1;CPEB4
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.46877720843396053,1.1671148977191546,0.2630480167014614,0.6854916720864157,1.0,11/75,9.02%,STAT5A;ITGA4;PIK3CD;ITGB3;TGFBR1;MDK;PRKD2;PDCL3;HMGB1;VEGFB;PDCD6
prerank,carboxylic acid transmembrane transport (GO:1905039),0.48560764478287277,1.1669905781564722,0.26539753639417696,0.6853442119059724,1.0,10/40,13.28%,SLC7A7;SLC7A8;SLC38A6;SLC36A1;SLC38A4;SLC36A4;SLC16A1;ABCC1;SLC25A30;SLC38A10
prerank,positive regulation of keratinocyte migration (GO:0051549),0.5979110190341264,1.1668067140705236,0.3178519593613933,0.6853583954179346,1.0,5/10,20.53%,MTOR;ARF6;MAPRE2;IQSEC1;MAP4K4
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.5645012455237962,1.1666649193065999,0.28454172366621067,0.68523329395025,1.0,1/13,1.91%,CYRIB
prerank,apical protein localization (GO:0045176),-0.46480307623150285,-1.1666145154319072,0.2668918918918919,0.8749253326884586,1.0,6/10,21.36%,SHROOM3;SHROOM2;ATP8B1;JAM3;GOPC;VANGL2
prerank,generation of neurons (GO:0048699),0.45124329947373765,1.16640479041011,0.14859437751004015,0.6854527376082589,1.0,28/190,13.01%,RUNX1;ASCL1;SHH;CX3CR1;PCSK9;FZD10;HES7;FGF13;IER2;PLXNB2;MYT1L;BHLHE41;THOC2;FZD3;CTNNB1;LRP12;DISC1;MEF2C;PEX13;FUT9;MAP1B;OLIG1;ARTN;NRP1;CDK6;DDIT4;TAFA1;NAV1
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.45417584177984194,1.1663896472366588,0.22233502538071065,0.6849671683008688,1.0,25/102,16.81%,PCSK9;ADCY7;RAB8B;LPIN2;PRKAR2B;MYO5A;CYSLTR2;PRKCD;ADCY6;HDAC5;USF1;RAB31;EPRS1;DENND4C;PRKACB;HDAC9;NR4A1;NFKB1;ADCY8;ADCY3;SRC;GSK3A;SYAP1;CPEB2;GCK
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.45747969812961115,1.1660583592378941,0.1769464105156724,0.6853772328142838,1.0,26/142,13.99%,CALCR;CX3CR1;CCR2;CD52;SLC8A1;CLN3;CXCR4;S1PR4;HMGB1;FZD9;CCKBR;TMEM178A;CACNA1A;ATP2B1;SMAD3;SPPL3;CYSLTR1;SLC8B1;CMKLR1;ATP2B3;TACR1;IAPP;NPTN;CDH23;ADCY8;C3AR1
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.45678241544125114,1.1658594899862509,0.22008113590263692,0.6854407535444796,1.0,31/112,18.77%,ARRB2;TGFB1;NRROS;CBL;TGFBR1;ITGB5;ARHGEF18;SKI;HPGD;ZMIZ2;TGFBR2;TGFBRAP1;MEF2C;ZFYVE9;SMAD3;F11R;LIMS1;SOX9;NLK;BAMBI;SOX6;ZYX;USP9X;SRC;SMURF1;LPXN;APPL2;FURIN;RHOA;ITGB1;LTBP2
prerank,organic substance transport (GO:0071702),0.4566352440498559,1.1658170370215424,0.2062374245472837,0.6850150906734696,1.0,25/120,18.21%,SLC6A3;SLC6A4;ABCA1;SLCO2B1;ATP8A1;GM2A;MFSD2B;CLN8;ABCG1;MYH9;RAB7A;ABCD1;RAMP1;TAP1;ARRDC4;ABCA4;CUBN;SCAMP2;SLCO1B1;ABCA3;SLC18A1;TAP2;ABCD2;VPS33B;LRP1B
prerank,ceramide metabolic process (GO:0006672),0.4837419861722356,1.165348809208194,0.26419213973799127,0.685843188439683,1.0,16/49,21.24%,CERS6;SGPL1;CLN8;CERK;AGK;ACER3;ORMDL2;PPP2CA;NSMAF;DEGS1;ASAH1;SGMS1;SPTSSA;SMPD1;SPTSSB;ABCA2
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.4711810432571414,1.1648183507480314,0.28324324324324324,0.6868288900551905,1.0,10/51,14.54%,NCKAP1L;TAOK3;ATP7A;DNM2;TNIK;KIF20B;NTF3;DTNBP1;LRRK2;SNX2
prerank,tight junction assembly (GO:0120192),-0.3019003280840693,-1.164619473938876,0.23333333333333334,0.8761518875165527,1.0,11/49,11.60%,CDH5;AFDN;PRKCI;PARD3;CLDN5;CLDN11;MPP7;PARD6G;CLDN14;DLG1;CLDN12
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.4940340738558429,1.164531092861927,0.2939110070257611,0.6871022507697504,1.0,7/33,8.66%,PLCG2;CCND3;RGCC;CCND2;ANXA1;AIF1;LSM11
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.5760231703914798,1.163826441745548,0.31213872832369943,0.6886230984867949,1.0,3/12,8.96%,PTPN1;ERN1;BAK1
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.5435891246839812,1.1638186186241757,0.3272490221642764,0.6881193332638381,1.0,2/16,4.10%,SHH;PKD2
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.4983740210020376,1.163797073537699,0.28018223234624146,0.6876530043901385,1.0,12/36,17.90%,PLCB2;NFATC1;FZD3;CTNNB1;TNRC6A;MOV10;AGO4;NLK;AGO3;GNG2;PPP3CB;AGO2
prerank,cAMP metabolic process (GO:0046058),0.5625989102035869,1.1635459319301256,0.3024523160762943,0.6878469456506657,1.0,4/13,13.50%,ADCY7;ADCY6;ADCY8;ADCY3
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.5499220669432191,1.1634945649534734,0.30719794344473006,0.6874828058604656,1.0,4/18,10.81%,TGFB1;TNF;TP53;MAP2K2
prerank,response to exogenous dsRNA (GO:0043330),0.5511517792008448,1.1632882112951142,0.3248407643312102,0.6875816122302081,1.0,3/18,7.53%,RFTN1;DHX9;TICAM1
prerank,amino acid transmembrane transport (GO:0003333),0.4762798777985232,1.1630616385178636,0.27783783783783783,0.6877541645509425,1.0,10/45,13.28%,LRRC8D;SLC7A7;SLC7A8;SLC38A6;SLC36A1;SLC38A4;SLC16A2;SLC36A4;SLC25A18;SLC38A10
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.45259851345057656,1.162942974062975,0.20951417004048584,0.687569692656494,1.0,32/128,18.77%,ARRB2;TGFB1;NRROS;CBL;TGFBR1;ITGB5;ARHGEF18;SKI;HPGD;ZMIZ2;RNF111;TGFBR2;HFE;TGFBRAP1;ZFYVE9;SMAD3;F11R;INHBA;NLK;BAMBI;MEGF8;STUB1;ZYX;USP9X;SRC;SMURF1;LPXN;APPL2;FURIN;RHOA;ITGB1;LTBP2
prerank,mitochondrial outer membrane permeabilization (GO:0097345),-0.4411290136050574,-1.1626616885361991,0.2872727272727273,0.8770072247351559,1.0,6/13,16.04%,RHOT1;BNIP3;BCL2L11;BLOC1S2;BAD;BAX
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.4499285058093781,1.1616036169986783,0.16566265060240964,0.6909387769854711,1.0,47/166,17.08%,SMOC2;PPP1R3E;NIBAN1;MTOR;MLXIPL;DHX9;ZEB2;TNF;SNCA;RGCC;ATP7A;PRKD2;PKD2;PLXNB2;SLC25A37;P2RX4;CIRBP;YTHDF3;LARP4B;SMAD3;PPARGC1A;NOS1AP;CPEB3;RPL26;BRPF3;THBS1;STN1;ZCCHC4;METTL3;KAT7;DNA2;PCIF1;DDAH1;POLDIP3;UPF3B;HNRNPD;STARD4;SOX4;SREBF1;BCAR3;PAOX;CD36;HIF1A;FAF1;HSP90AA1;GCK;RPS4X
prerank,regulation of oligodendrocyte differentiation (GO:0048713),0.5462544661169413,1.1616010075854801,0.3160621761658031,0.6904200108320901,1.0,6/18,16.03%,MDK;CXCR4;TMEM98;TNFRSF21;TNFRSF1B;NF1
prerank,homeostasis of number of cells (GO:0048872),0.5929543547110074,1.1615742587375175,0.3179916317991632,0.6899687217719945,1.0,2/12,7.72%,CX3CR1;OCIAD1
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.45908662554384494,1.1611673054031109,0.2579324462640737,0.6905828444966359,1.0,8/87,3.02%,PTK2B;IQGAP2;CORO1A;FZD10;CSF1R;PRKCD;MTOR;MDK
prerank,cellular biogenic amine metabolic process (GO:0006576),0.5774300709938285,1.1611296970756764,0.3256445047489824,0.6901561178985727,1.0,4/12,14.71%,ATP7A;DDC;AMD1;MAOA
prerank,cellular response to insulin stimulus (GO:0032869),0.4531670785020366,1.160444412077809,0.20241691842900303,0.6915328582731397,1.0,32/124,16.81%,ATP6V0D2;PCSK9;RAB8B;LPIN2;ATP6V0E1;MYO5A;TCIRG1;GRB2;ATP6V1C1;ATP6V1E1;ATP6V0A2;HDAC5;USF1;ATP6V0D1;ZDHHC7;RAB31;AP3S1;EPRS1;BCAR1;DENND4C;ATP6V0A1;ATP6AP1;ZNF106;PHIP;HDAC9;ATP6V0B;BCAR3;GSK3A;SYAP1;IDE;CPEB2;GCK
prerank,quinone biosynthetic process (GO:1901663),0.5573184272420723,1.1600777199198515,0.32421340629274964,0.6921042095616708,1.0,8/14,21.44%,COQ9;PDSS1;COQ7;COQ8B;FDXR;COQ3;COQ6;UBIAD1
prerank,membrane lipid catabolic process (GO:0046466),0.5911687937244335,1.1600671145311434,0.33081570996978854,0.6916069966913212,1.0,2/10,6.72%,SGPL1;FUCA1
prerank,regulation of macroautophagy (GO:0016241),0.46039384608826783,1.1599075368814402,0.23045685279187816,0.6915467105599584,1.0,24/105,14.61%,ATP6V0D2;ATP6V0E1;SNX5;MTOR;ATP6V1C1;ERN1;ATP6V1E1;CLN3;ATP6V0A2;SCOC;ATP6V0D1;LARP1;PAFAH1B2;SMG1;ATP6V0A1;HDAC6;EXOC8;EXOC7;EXOC1;IKBKG;LAMTOR3;GNAI3;LRRK2;ATP6V0B
prerank,cellular response to nitrogen compound (GO:1901699),0.5282268349282225,1.159720207646183,0.30973451327433627,0.691544371350023,1.0,10/20,24.44%,NR1H4;DDI2;HSF1;ATRX;RIOK3;ROCK2;SPIDR;EPG5;ATP2B4;DDX11
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.4863841637444881,1.1595019895526806,0.2657952069716776,0.6916437861783399,1.0,4/48,3.87%,PTK2B;UBASH3B;THY1;SNCA
prerank,regulation of cholesterol transport (GO:0032374),0.5442989469550539,1.1585350573607653,0.3166458072590738,0.6938543305329214,1.0,9/20,21.24%,TSPO;ABCB4;TTC39B;NFKB1;ARV1;LRP1;LAMTOR1;NAXE;ABCA2
prerank,cGMP-mediated signaling (GO:0019934),0.5664211928577577,1.1579347184855875,0.3196159122085048,0.6950586642212483,1.0,2/13,4.14%,AQP1;APOE
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",0.5230329888443396,1.157624753286924,0.2909090909090909,0.695420561879795,1.0,12/24,22.84%,SMYD5;DNMT3A;SPI1;TRIM27;RBBP7;MTF2;TASOR;PHF1;RBBP4;EED;AEBP2;H3-3A
prerank,ubiquinone biosynthetic process (GO:0006744),0.549688928288081,1.1573843432481932,0.3235294117647059,0.6956120727538843,1.0,8/15,21.44%,COQ9;PDSS1;COQ7;COQ8B;FDXR;COQ3;COQ6;UBIAD1
prerank,pyruvate metabolic process (GO:0006090),0.47522750150406773,1.1568686298322495,0.2899786780383795,0.6965812327441042,1.0,15/52,16.87%,HK3;PFKL;ALDOB;ENO3;SLC16A1;GPI;PDHA1;HK2;VDAC1;ME3;GAPDHS;GCK;LDHA;PGAM4;PGAM1
prerank,positive regulation of cell cycle (GO:0045787),0.4704806482744902,1.1568311343520645,0.2923728813559322,0.6961607561018506,1.0,10/62,9.15%,LGMN;SMOC2;DUSP3;CCND3;RGCC;PKD2;CCND2;TAL1;RPS15A;HSF1
prerank,positive regulation of cation transmembrane transport (GO:1904064),0.487681169277295,1.1566596327438081,0.29287305122494434,0.6961250770375467,1.0,5/41,9.57%,CTSS;KCNN4;STAC;KCNMA1;NOS1AP
prerank,neuron differentiation (GO:0030182),0.44861107502832537,1.1563875211056547,0.20240480961923848,0.6964166322640184,1.0,18/165,11.08%,RUNX1;ASCL1;SHH;PCSK9;FZD10;TGFBR1;IER2;ATP8A2;MYT1L;THOC2;FZD3;CTNNB1;WNK1;MEF2C;MYO7A;FUT9;INHBA;OLIG1
prerank,phosphate ion transmembrane transport (GO:0035435),0.5783877558791636,1.1563473206991994,0.3087621696801113,0.6959995168036577,1.0,4/12,13.02%,SLC37A2;XPR1;SLC20A2;SLC25A30
prerank,regulation of cytoplasmic transport (GO:1903649),0.57886275123953,1.1556563757268543,0.3333333333333333,0.6974513709488626,1.0,5/11,15.27%,DNAJC13;MAP2K2;USP7;LRRK2;SRC
prerank,positive regulation of vascular permeability (GO:0043117),0.5818243095926963,1.1555393841659267,0.3241758241758242,0.6972810457026369,1.0,2/12,5.38%,TGFB1;FGFBP3
prerank,cardiac muscle cell development (GO:0055013),0.5358745289165113,1.1550823632917027,0.3124215809284818,0.6980353532387565,1.0,3/20,4.39%,SLC8A1;TTN;MYLK3
prerank,apical junction assembly (GO:0043297),-0.30159895558847305,-1.154874022043967,0.21518987341772153,0.8970318569239197,1.0,11/53,10.37%,CDH5;AFDN;PRKCI;PARD3;CLDN5;CLDN11;MPP7;WDR1;PARD6G;CLDN14;DLG1
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.46031326735055,1.1547449234345422,0.26068821689259647,0.6984953998810982,1.0,10/67,12.44%,PTK2B;CD3E;CASS4;RREB1;MDK;NEDD9;P4HB;LIMS1;NRP1;CDK6
prerank,regulation of oxidative phosphorylation (GO:0002082),0.5506305431195873,1.1546389677803202,0.3244613434727503,0.6982758582352039,1.0,3/16,7.24%,MLXIPL;ATP7A;ABCD1
prerank,lung epithelium development (GO:0060428),0.5883760176111491,1.1541591192931429,0.31797235023041476,0.699124550830118,1.0,1/10,0.60%,ASCL1
prerank,protein export from nucleus (GO:0006611),0.5059794519508589,1.1538502059148004,0.31919905771495877,0.6995126895984531,1.0,11/27,22.39%,TGFB1;XPO1;CSE1L;STRADB;TPR;XPO6;STRADA;SMURF1;DESI1;CHP1;XPO7
prerank,regulation of neuron migration (GO:2001222),-0.3482679863435046,-1.1537004693051323,0.23952095808383234,0.8955271359238749,1.0,8/26,4.32%,SEMA6A;NIPBL;COL3A1;NTNG1;SEMA3A;ULK4;DAB2IP;NEXMIF
prerank,neuron projection organization (GO:0106027),0.5640298163066306,1.1536264813022734,0.33026315789473687,0.6996429952664045,1.0,3/15,7.24%,LGMN;PLS1;ABCD1
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.47713662774960575,1.1535104564663698,0.271412680756396,0.6994354227252458,1.0,18/42,22.57%,VARS1;FARSB;GARS1;PPA2;RARS1;QARS1;EPRS1;LARS2;CARS2;DARS1;DARS2;TARS2;FARS2;AIMP1;TARS1;YARS1;SARS1;SARS2
prerank,extracellular matrix organization (GO:0030198),0.44194194187298536,1.1528916754658858,0.13413413413413414,0.7006402162881115,1.0,34/276,7.70%,CTSS;ITGAL;MMP12;ITGA2B;ITGAX;TGFB1;ITGB2;LCP1;SMOC2;ITGA4;SH3PXD2B;ITGB3;TGFBR1;ITGB5;ADAM8;ITGA2;CTSK;CTSL;ADAMTS8;ITGA6;ATP7A;COLGALT1;TTR;TGFBI;CRTAP;SPP1;TIMP1;CD44;ITGAE;TNR;AGRN;CREB3L1;P4HB;LOX
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),0.5812032145528853,1.1528334366658535,0.34054834054834054,0.7002977945075932,1.0,2/10,10.05%,PCSK9;NEDD4L
prerank,positive regulation of sodium ion transport (GO:0010765),0.5780520108386733,1.152819929952918,0.341991341991342,0.6998200425704474,1.0,3/12,8.16%,SCN4B;PKP2;PRSS8
prerank,negative regulation of macroautophagy (GO:0016242),-0.3412551866257066,-1.1525867461713666,0.21518987341772153,0.8938605565498394,1.0,16/26,23.76%,MTM1;FEZ1;NRBP2;TMEM39A;LZTS1;PINK1;CHMP4B;CHMP4A;AKT1;NUPR1;CLEC16A;PHF23;USP36;SMCR8;FEZ2;UBQLN4
prerank,peptidyl-amino acid modification (GO:0018193),0.6037405262585706,1.1524684179888443,0.3177842565597668,0.7002749516713584,1.0,5/10,28.72%,ATP7A;METAP2;TTLL4;METAP1D;FKBP10
prerank,regulation of amyloid fibril formation (GO:1905906),0.5556484140185179,1.1524357055235557,0.30213903743315507,0.6998403559199777,1.0,2/15,4.14%,TREM2;APOE
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),0.5986874169505064,1.1523315740131532,0.3400576368876081,0.699614627263332,1.0,3/10,8.33%,DIP2B;MYOCD;FLCN
prerank,protein phosphorylation (GO:0006468),0.4431675006556804,1.1522927968068166,0.074,0.699193265484666,1.0,107/478,17.41%,PTK2B;BTK;FGR;LYN;GMFG;HCK;TGFB1;SYK;FLT3;MAPKAPK3;RSKR;FNIP2;PIK3CD;MAP4K1;TAOK3;CSF1R;TGFBR1;TYK2;PRKCD;GTF2H1;TLR2;CAMK1D;MTOR;BMP2K;TEC;TLR7;MAPK14;GRK3;MAP2K6;ERN1;NEK6;CDK14;PRKD2;MYLK3;CDK8;MORC3;TLK1;TAF1;PRKCB;MKNK1;CDK11B;STK10;TGFBR2;MAP3K5;PIM1;PLK4;WNK1;CDK17;PIM2;TNIK;PLK2;CSNK1G2;CHEK2;PRKCQ;CSNK2A2;CSNK2A1;MAP3K1;STRADB;ABI1;SMG1;PRKCH;CDK7;STK17B;STK32C;FAM20C;RNASEL;PKN1;TXK;RPS6KA4;NLK;PRKACB;CCL2;CSNK1A1;FYN;GRK4;MAP3K12;CDK6;CREB1;LIPE;MERTK;CAMKK2;BRAF;GAS6;STK24;STK3;BMX;LRRK2;NIM1K;WNK4;TESK2;SRC;STRADA;SGK3;GSK3A;RPS6KA2;CDK15;MAP3K11;INCENP;EPHA4;COQ8B;STK4;EPHA8;PPP3CB;PIK3R4;RPS6KA5;CDK18;SIK2
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.5346330545028263,1.1521670258765968,0.31145431145431146,0.6990023694350136,1.0,5/20,9.68%,WDTC1;ERLIN1;ERLIN2;ACADL;PRMT3
prerank,regulation of macromolecule metabolic process (GO:0060255),0.4513550125344621,1.1521154940657414,0.188,0.698635720378622,1.0,43/170,19.71%,PTPRC;TREM2;ASCL1;SHH;CAVIN4;SIRPA;SLC8A1;PRDM12;TRIM5;APOE;ZUP1;TBC1D16;TFEB;AIF1;NFKBID;MTMR3;TRIM27;PCBP3;TXK;NELL1;AFF1;CDK6;ZFP64;COQ7;ZNF445;MEGF8;PCBP1;SOX2;HNRNPD;RO60;IGF2BP3;C1D;RASA1;HIF1A;MARF1;LAMTOR1;FLOT1;PRDM10;FUBP3;GDNF;ROCK2;ATRAID;SORT1
prerank,positive regulation of metabolic process (GO:0009893),0.45184680282042883,1.1518628823939703,0.2535641547861507,0.6988192184691892,1.0,24/103,16.92%,IRF4;SYK;CCR2;FABP4;CAMK1D;TNF;CXCR4;IL18;ACADL;CEBPB;FABP5;HSF1;PPARGC1A;CMKLR1;ADIPOR1;DYNC1H1;PRLR;FASN;ACACA;CD36;ZBTB7B;ADIPOR2;APPL2;CPT2
prerank,regulation of organelle assembly (GO:1902115),0.45444924505812234,1.151741982221628,0.2732012513034411,0.6986282641480082,1.0,27/72,19.80%,HCK;TBC1D10C;TBC1D16;TBC1D22A;USP6NL;PLK2;MTMR3;TBC1D10A;CEP76;VPS11;RNF4;RAB1B;TBC1D2;TBC1D17;TBC1D2B;TBC1D8;ATXN2L;TBC1D14;TBC1D22B;PDCD6IP;ATG3;RABEP2;DYNC2LI1;TBC1D12;TBC1D5;TRAPPC12;SENP6
prerank,regulation of microtubule nucleation (GO:0010968),-0.464230425381707,-1.1512955422933673,0.28753993610223644,0.8928879858278468,1.0,2/10,4.47%,EML2;PAK1
prerank,regulation of sister chromatid cohesion (GO:0007063),0.5729420756345319,1.1511025142447726,0.30374479889042993,0.6999000517286127,1.0,3/12,8.46%,ESPL1;CTNNB1;RB1
prerank,regulation of gluconeogenesis (GO:0006111),-0.3453274010464482,-1.1510568460346893,0.27044025157232704,0.8884729223551407,1.0,11/27,23.11%,OGT;DDB1;SIK1;SELENOS;ZNF692;DGKQ;ARPP19;C1QTNF3;NNMT;PDK2;CRY1
prerank,organelle organization (GO:0006996),0.44135800779467016,1.1510522036276016,0.097,0.6995451197651572,1.0,113/388,20.79%,FGD2;PLEKHM2;SPTBN5;ATP8B4;LMAN1L;PEX11A;RAB34;THY1;RAB32;NCKIPSD;MTFR2;MDK;TMED3;ATXN7;ATP7A;PKD2;APOE;PYROXD2;REEP6;PI4K2A;RAB14;VPS18;ARFGEF1;TNFAIP3;NDP;PLD2;RAB7A;FMNL3;SYNE1;TTC29;FGD6;USP6NL;CAPZB;LONP1;NEDD9;ABCD1;YTHDF3;IRAG2;RANBP10;VMP1;MICAL1;TNIK;SH3KBP1;VPS11;MSTO1;RAB31;SIPA1;ARHGAP21;ARHGAP10;PPARGC1A;VAPB;TMCC1;BNIP1;DIAPH1;CCL13;ATL1;CCL2;PEX7;PHIP;PRDX3;SEC16A;CSNK1A1;PI4K2B;WDR81;SEC16B;RANBP9;SAR1A;FNBP1L;TOR1AIP2;TOR1A;HCFC1;ATAD3A;DES;HUWE1;TRAPPC11;LRRK2;GAK;EPS15;ABCA3;SIPA1L3;AGTPBP1;TWNK;DST;PDCD6IP;PDZD8;YME1L1;PLAAT3;WDPCP;PNPLA3;BIN1;LMAN2;ANK1;CDC42;ABCD2;LYSMD3;GOLGB1;GOLPH3;UBXN2A;ATL2;MCOLN1;RAB29;DNM1L;PALLD;OPTN;SORT1;ATL3;TRAPPC12;SEC31A;KIF3A;NSFL1C;COG7;PRKN;SPTSSB
prerank,negative regulation of peptidase activity (GO:0010466),-0.29583367957812773,-1.1506559425548897,0.21428571428571427,0.8844069556116945,1.0,12/47,18.09%,SERPINH1;SERPINE2;SERPING1;TIMP2;SPOCK2;TIMP3;SERPINB9;SERPINF1;ECM1;AKT1;GAPDH;PARK7
prerank,regulation of hippo signaling (GO:0035330),0.5399896998073899,1.1500019344798518,0.3350717079530639,0.701952511195539,1.0,4/17,10.94%,MAPK14;WWC2;MAP2K3;NF2
prerank,cellular component assembly (GO:0022607),0.44125291304157954,1.1498823215068352,0.156,0.7017538022182095,1.0,44/253,14.81%,NCKAP1L;PTK2B;TGFB1;CD3E;LCP1;NEFH;CD74;VAMP3;SKAP2;SNX9;PLS1;WIPF1;PKP2;MITF;TRAF2;TEAD1;AIF1;ACTB;TP53;NEDD9;YTHDF3;VMP1;MICAL1;CAPZA1;HFE;TRIP13;PPARGC1A;EPRS1;ACTG1;TUBGCP4;PARVB;LIMS1;SOX9;CYFIP1;DET1;MDN1;RANBP9;IKBKG;GAS6;DARS1;TSPAN4;NOC2L;JHY;CAPN3
prerank,macrophage differentiation (GO:0030225),0.5620927227237247,1.1497796849379918,0.3305785123966942,0.7015298287331054,1.0,6/13,24.09%,CSF1R;CASP8;CDC42;PARP1;VEGFA;IL15
prerank,brain morphogenesis (GO:0048854),0.5820243959875961,1.1494471009722962,0.3328785811732606,0.7019175677543592,1.0,1/12,0.40%,SLC6A4
prerank,negative regulation of chemokine production (GO:0032682),0.5568967177989074,1.1492934514738489,0.3355614973262032,0.7018281483268674,1.0,1/14,1.41%,SIRPA
prerank,mRNA 3'-end processing (GO:0031124),-0.2739580909056659,-1.148927508354909,0.12903225806451613,0.8848160053724383,1.0,24/78,15.25%,WDR33;APP;SARNP;SRRM1;RPRD2;CPSF6;SCAF8;AHCYL1;FIP1L1;CPSF7;THOC7;CSTF2;THOC1;PAPOLA;THOC5;U2AF2;PAF1;SRSF11;PAPOLG;RPRD1B;EIF4A3;SRSF1;TUT1;CSTF3
prerank,mitochondrial fusion (GO:0008053),-0.391721937775414,-1.148708637526026,0.27755102040816326,0.8803823837242756,1.0,9/18,25.71%,AFG3L2;SPG7;GDAP1;BAX;MFN2;MIGA2;MIEF1;STOML2;MIEF2
prerank,response to amino acid starvation (GO:1990928),0.4644992444992634,1.1486865201237508,0.28631138975966564,0.7030205901948271,1.0,23/72,19.42%,ATP6V0D2;ATP6V0E1;TCIRG1;MTOR;ATP6V1C1;ATP6V1E1;TFEB;MAP3K5;SEH1L;ATP6V0D1;CEBPB;FLCN;LARP1;IMPACT;DAP;LAMTOR3;ATP6V0B;RNF152;GCN1;LAMTOR1;ATP6V1F;RPTOR;SEC13
prerank,regulation of actin filament bundle assembly (GO:0032231),0.5128693600390447,1.148591594780065,0.31566548881036516,0.7027626209507916,1.0,11/26,21.77%,PLEK;FHOD1;SLC9A1;ACTG1;PFN2;PFN1;SYNPO;CDC42;ROCK2;PRKN;CX3CL1
prerank,cardiac myofibril assembly (GO:0055003),0.550410182125132,1.1480883961227926,0.3288409703504043,0.7036725536668582,1.0,3/15,6.76%,TTN;MYLK3;MEF2A
prerank,anion transport (GO:0006820),0.48868616117497277,1.1480022748008567,0.3201357466063348,0.7034092467743283,1.0,8/33,17.03%,TSPO;SLCO2B1;LRRC8D;VDAC2;VDAC1;SLCO1B1;LRRC8C;SLC13A3
prerank,regulation of endothelial cell migration (GO:0010594),0.4582960124752818,1.147992207455442,0.2716049382716049,0.7029219830894101,1.0,16/85,11.65%,PTK2B;PIK3CG;RIN2;SMOC2;PIK3CD;ITGB3;ANGPT4;PIK3CB;PRKD2;APOE;PDCD6;BCAR1;NRP1;THBS1;GPI;GRN
prerank,plasma membrane organization (GO:0007009),0.4618767303627177,1.1478010635957578,0.29652996845425866,0.7029517840640537,1.0,20/61,17.99%,BIN2;P2RX7;SNX9;CLN3;CXCR4;SNX33;MYH9;MICALL1;ABCD1;SYTL4;DYSF;BIN3;FNBP1L;ARV1;DEGS1;AHNAK2;ARL8B;BIN1;STX2;ABCD2
prerank,negative regulation of JNK cascade (GO:0046329),0.5025034277932849,1.1475367873771045,0.31517960602549244,0.7031674733388371,1.0,11/31,20.78%,SIRPA;TAOK3;DUSP3;DUSP10;DUSP19;ITCH;GPS2;DACT1;PER1;ZMYND11;PRKN
prerank,epithelium development (GO:0060429),0.44617475257055916,1.1472339883081253,0.24845995893223818,0.7034873127543404,1.0,7/107,5.04%,LGALS3;MEOX1;SHH;TGFB1;CTSB;PKD2;DMBT1
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.4671156465039795,-1.1472258831985798,0.3212996389891697,0.8801968499307392,1.0,3/11,15.94%,MLLT3;RSPO3;WNT5B
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.4667197835795155,1.1470943243142713,0.29778247096092925,0.7033481259261221,1.0,14/60,13.46%,CSF1R;MED17;CDK8;CTNNB1;TP53;TNRC6A;CEBPB;MOV10;AGO4;ATF7IP;MED27;SOX9;AGO3;NFKB1
prerank,negative regulation of ATP metabolic process (GO:1903579),0.551719597154577,1.1462164590924355,0.31450577663671375,0.7053654222875173,1.0,7/17,19.61%,CBFA2T3;MLXIPL;FLCN;HDAC4;PID1;TIGAR;FIS1
prerank,response to UV-B (GO:0010224),-0.43575767721566794,-1.1456878038362681,0.28052805280528054,0.8800083920989423,1.0,5/12,22.36%,MSH2;MME;RELA;HYAL1;CDKN1A
prerank,protein kinase B signaling (GO:0043491),0.5150389645089763,1.1455990445225392,0.3223844282238443,0.7065890828932264,1.0,9/23,24.66%,TGFB1;TNF;CCL2;GAS6;PTEN;ZFP36L1;MT3;IGF1;KDR
prerank,cellular response to metal ion (GO:0071248),0.4461581153182683,1.1454556254461576,0.2535496957403651,0.706462085691379,1.0,42/123,22.29%,SLFN14;SYT17;ADCY7;LGMN;AQP1;PLCG2;RASA4;SNCA;PKD2;RASGRP2;P2RX4;MEF2A;SYT2;HFE;MEF2C;SYT10;HSF1;GLRA2;B2M;BRAF;ADCY8;LRRK2;CAPN3;IQGAP1;SCN5A;ADD1;TIGAR;MCOLN1;HVCN1;SMPD1;ATP13A2;PRKN;ITPKB;MT3;MT1G;MT1B;MT1E;MT1F;MT1A;MT1X;MT1M;MT1H
prerank,response to ethanol (GO:0045471),0.5513441675135319,1.1453752652772518,0.3292847503373819,0.7061583274003553,1.0,2/14,2.97%,ADCY7;SDF4
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.45402421051456815,1.1453428716491962,0.2939936775553214,0.7057405980103733,1.0,17/66,16.66%,GPNMB;CCND3;RGCC;PKD2;CCND2;ANXA1;AIF1;KIF14;RB1;LSM11;CCL2;CDK6;PSME3;INO80;BRD7;PTEN;APPL2
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.46072020631530125,1.1453025574950757,0.27789256198347106,0.7053412905345848,1.0,21/82,18.10%,TUBB;PRKAR2B;HAUS2;TUBA4A;CNTRL;CEP192;MAPRE1;TP53;CEP70;PLK4;CEP76;KIF14;HAUS1;DYNC1H1;PCM1;CEP152;HAUS8;NINL;HSP90AA1;AKAP9;CEP63
prerank,negative regulation of cellular catabolic process (GO:0031330),0.4653856920285836,1.1451634601150522,0.27789473684210525,0.7052281744004882,1.0,15/63,16.01%,TREM2;IL10RA;MTOR;TIMP1;EIF4G3;NELL1;DAP;TAB2;SORL1;FOXK1;BMF;TAB3;TBC1D14;GSK3A;NRDE2
prerank,negative regulation of endothelial cell migration (GO:0010596),0.4902110853079246,1.1450250381195792,0.3195402298850575,0.7050766731805714,1.0,8/36,11.25%,TGFB1;ANGPT4;TNF;RGCC;APOE;HMGB1;MEF2C;THBS1
prerank,respiratory chain complex IV assembly (GO:0008535),-0.356554499843985,-1.1448640781128618,0.21348314606741572,0.877462812320642,1.0,13/21,30.04%,COX16;OXA1L;COX18;COX15;COA8;COX14;COX17;TIMM21;COA5;SCO1;COA3;COX10;SURF1
prerank,transition metal ion transport (GO:0000041),0.4895533057975955,1.144642671112193,0.3135011441647597,0.7056098742190657,1.0,7/35,14.34%,SLC11A1;ATP7A;ATOX1;IREB2;ATP2C1;FTH1;SLC31A2
prerank,protein localization to cell periphery (GO:1990778),0.44556869089260454,1.1443154457095235,0.2408906882591093,0.7060038793752053,1.0,40/133,19.96%,MRAP;FYB1;RAB8B;RAB34;MYO5A;RABEP1;FGF13;RAP2A;PKP2;TNF;TTC7A;TSPAN32;RAMP1;TNIK;PACS1;TSPAN14;RAB11A;RAB40C;F11R;CACNB2;DENND4C;ZDHHC3;SEC16A;ATP1B3;GAS6;PDZD11;RAP1A;GAK;EFR3A;SMURF1;ANK1;SPTBN4;FLOT1;TESC;PACS2;RAB29;ROCK2;FCHO2;INPP5K;P2RY1
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.5091946516004724,1.1440367308312538,0.33410672853828305,0.706304852039849,1.0,6/27,8.09%,PRKCD;PTPN1;PTPRE;PIP4K2A;PRKCB;PRKCQ
prerank,negative regulation of viral release from host cell (GO:1902187),0.56810971044786,1.1437479829788937,0.36114911080711354,0.7066334799375692,1.0,4/13,11.60%,TRIM5;TRIM8;MID2;TRIM35
prerank,vesicle transport along microtubule (GO:0047496),-0.3676548122696748,-1.1437370714477315,0.27450980392156865,0.8760666212952039,1.0,8/23,11.16%,KIF5B;DYNC1I1;PAFAH1B1;NDEL1;KIF3B;NDE1;KIF5A;KIFAP3
prerank,response to endoplasmic reticulum stress (GO:0034976),0.4489805451939695,1.1437263755068272,0.24745417515274948,0.7061838365074132,1.0,33/107,20.87%,NIBAN1;ERN1;HERPUD1;TRAF2;ATF3;SEL1L;DDIT3;TP53;MAP3K5;CREB3L1;P4HB;CEBPB;TMX1;BAK1;DERL1;CREB3L2;THBS1;SEC16A;ATF6B;ATP2A3;WFS1;CCDC47;SELENOK;PDIA3;ERO1A;ERP44;FLOT1;ERLEC1;OS9;QRICH1;GSK3B;PRKN;TMEM259
prerank,membrane protein proteolysis (GO:0033619),0.48423888652861935,1.1432465212897716,0.2924634420697413,0.7070730485321276,1.0,9/37,14.82%,TGFB1;NAPSA;MYH9;PRKCQ;SPPL3;PARL;NFKB1;ERAP1;SPPL2A
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.4949125335096898,1.1424538458118554,0.32954545454545453,0.7088180589025479,1.0,4/32,4.10%,P2RY6;THY1;SNCA;PKD2
prerank,metanephros development (GO:0001656),0.508078409029898,1.1417300612419914,0.3361244019138756,0.7103645047021236,1.0,3/26,4.10%,SHH;BASP1;PKD2
prerank,striated muscle contraction (GO:0006941),0.4688622871147498,1.1412578593566443,0.30960086299892126,0.711198716549952,1.0,10/53,15.12%,SCN4B;MYL3;SLC8A1;TTN;STAC;TNNT3;DTNA;STAC3;ARHGEF11;RCSD1
prerank,proteoglycan metabolic process (GO:0006029),0.5001140011781653,1.1411978913855292,0.32391048292108365,0.7108563390294969,1.0,5/26,12.61%,HPSE;SULF2;HS3ST4;XYLT1;B4GALT7
prerank,regulation of cardiac muscle cell action potential (GO:0098901),-0.3482769557003601,-1.1411898137358365,0.21818181818181817,0.8794509471282009,1.0,10/25,10.73%,CACNA1C;ANK2;CAV1;RYR2;CXADR;JUP;CALM3;TBX18;DLG1;CTNNA3
prerank,positive regulation of dephosphorylation (GO:0035306),0.5088549560756549,1.1404493765309127,0.3142857142857143,0.712486990205484,1.0,13/27,24.55%,TGFB1;PRKCD;SPPL3;SRC;PTPA;SMPD1;ANKLE2;PTBP1;PIN1;MTMR9;PPP1R16B;CAMTA1;PPIA
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.5658375468637267,1.1401565754851477,0.34324324324324323,0.7127556553340807,1.0,2/13,2.82%,CD74;DHX9
prerank,positive regulation of signaling (GO:0023056),0.48396699551368066,1.1400237511048623,0.32086167800453513,0.71263616218334,1.0,5/37,6.74%,CLSTN1;VAMP3;TNF;SNCA;CD80
prerank,glucose metabolic process (GO:0006006),0.4644636099499015,1.1398567039598921,0.3226837060702875,0.7125880277431043,1.0,14/58,17.27%,KCNJ11;AKR1A1;ALDOB;BRAT1;SORD;ENO3;TFAP2B;PPARGC1A;LRP5;GPI;GAPDHS;PGAM1;GALM;PPARD
prerank,negative regulation of angiogenesis (GO:0016525),0.4553776798378373,1.1396016281783587,0.2860103626943005,0.7127783073220968,1.0,10/84,7.23%,KLK3;PF4;CCR2;ANGPT4;PIK3CB;TNF;RGCC;CTNNB1;STAB1;CREB3L1
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.5293856893456763,1.1395153196733345,0.34668335419274093,0.7125066220737074,1.0,10/19,20.78%,SREBF2;CSNK2A2;HDAC6;CAMKK2;SREBF1;VDAC1;GSK3A;DNM1L;ATP13A2;PRKN
prerank,endocardial cushion morphogenesis (GO:0003203),-0.39061607282598165,-1.1394676908842412,0.2785388127853881,0.8799811372744678,1.0,4/18,5.20%,BMPR1A;BMP4;ACVR1;ACVRL1
prerank,regulation of ceramide biosynthetic process (GO:2000303),0.562713865275636,1.1394473405459336,0.3514246947082768,0.7122045671064634,1.0,5/15,13.76%,PRKCD;TNF;SMPD3;ORMDL2;NSMAF
prerank,positive regulation of protein import (GO:1904591),0.49762434660090193,1.1393310013849385,0.3391812865497076,0.7120185675257745,1.0,5/30,10.10%,TGFB1;HCLS1;PRKCD;SMAD3;TPR
prerank,negative regulation of cell motility (GO:2000146),0.44786005765879344,1.1391988401511115,0.265989847715736,0.7118913354109534,1.0,26/108,16.50%,SHH;TMIGD3;CD74;PTPRJ;THY1;DUSP3;SLURP1;RAP2A;MITF;FOXO3;MCTP1;NKX2-1;RAP2B;FLCN;SPINT2;DUSP10;PODN;VCL;NF2;PTPRU;ADARB1;STK24;PTPRT;NF1;EPHA4;PTEN
prerank,neuropeptide signaling pathway (GO:0007218),0.4632386580922131,1.1388594196909148,0.30325288562434416,0.712343775751715,1.0,9/58,12.79%,CYSLTR2;GALR1;SORCS3;PPY;CYSLTR1;GPR37;GLRA2;LTB4R2;SORL1
prerank,regulation of cellular protein metabolic process (GO:0032268),0.47104198485072174,1.1385751431076794,0.30691964285714285,0.7126276173005882,1.0,10/47,14.71%,TGFB1;EDNRB;WDR91;APOE;FOXO3;INHBA;CYFIP1;PCIF1;NFKB1;PUM3
prerank,cytosolic calcium ion transport (GO:0060401),-0.3379736737699368,-1.1385048175168972,0.2222222222222222,0.878085782547498,1.0,9/28,12.43%,CACNA1C;RYR2;AFG3L2;MICU1;JPH1;ITPR3;SLC35G1;MCUR1;CACNA2D1
prerank,cellular response to reactive oxygen species (GO:0034614),0.4640052708095931,1.1380284720927818,0.31322751322751324,0.7136218010717365,1.0,12/59,13.08%,NFE2L2;SIRPA;AQP1;PRKCD;PKD2;TNFAIP3;ANXA1;MAP3K5;IMPACT;HDAC6;PRDX3;CAMKK2
prerank,regulation of cellular amine metabolic process (GO:0033238),-0.28998969295422705,-1.137448042754605,0.2,0.8766143541532342,1.0,20/50,22.04%,PSME4;PSMD11;PSMA5;PSMA4;PSMD14;AZIN1;PSMC6;PSMC3;PSMB3;PSMC1;PSMD5;PSMA3;PSMD3;PSMD6;PSMC5;ODC1;PSME2;PSMB4;PSMC4;PSMB6
prerank,nuclear migration (GO:0007097),0.5665150583468815,1.136685361523077,0.33197278911564626,0.716823318539205,1.0,1/13,0.14%,HOOK3
prerank,positive regulation of chromatin organization (GO:1905269),0.5656174345654946,1.1356798540037232,0.35318559556786705,0.7191079783662306,1.0,7/12,22.86%,TAL1;ATRX;UBE2N;TINF2;TERF2;H3-3A;TERF2IP
prerank,negative regulation of insulin secretion (GO:0046676),0.5255897380003735,1.1352296996269826,0.32734274711168165,0.7198209278950495,1.0,1/17,0.63%,KCNJ11
prerank,alanine transport (GO:0032328),0.5845847670482305,1.1352227140099571,0.36053412462908013,0.7193213313267884,1.0,3/10,15.11%,SLC36A1;SLC36A4;SLC1A4
prerank,positive regulation of response to stimulus (GO:0048584),0.47832476786417566,1.1351852548065855,0.3230429988974642,0.7189336942290707,1.0,7/40,15.19%,FCGR2B;PRKCD;DHX9;CD80;YPEL3;B2M;IER5
prerank,carbohydrate homeostasis (GO:0033500),0.4588253957787128,1.1346813253364443,0.2946708463949843,0.7198298133641982,1.0,19/67,20.10%,MLXIPL;FFAR2;CEBPA;TENT4B;USF1;TFAP2B;VGF;SLC8B1;ADIPOR1;ADCY8;MBD5;WFS1;SOX4;ADIPOR2;APPL2;GCK;KLF7;INPP5K;PYGL
prerank,lipoprotein biosynthetic process (GO:0042158),0.5811321928318516,1.1340751700057423,0.34643377001455605,0.7209533867536202,1.0,2/11,4.14%,ATG7;APOE
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.5347935166570011,1.1340507133178022,0.35301668806161746,0.7205095474308281,1.0,8/18,20.80%,CAMK1D;PRKD2;RPS6KA4;LRP8;ADCY8;RPS6KA5;RELN;CRTC3
prerank,regulation of centrosome cycle (GO:0046605),-0.36188607461615896,-1.1339879631889986,0.24120603015075376,0.8829277319372676,1.0,12/21,37.49%,NAT10;CHMP5;CHMP4B;MARK4;CHMP2A;NPM1;ATF5;CHMP4C;CHMP1B;GEN1;CEP131;XRCC3
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),-0.4579419153865322,-1.1334409035117081,0.31666666666666665,0.8797900044771443,1.0,4/10,13.25%,OGT;SELENOS;ZNF692;DGKQ
prerank,epithelial cell differentiation (GO:0030855),0.446110594331201,1.1334126738249821,0.30832476875642345,0.72181014645743,1.0,9/88,9.80%,LGALS3;ASCL1;CTSB;BASP1;DMBT1;ANXA1;ZDHHC7;TDRD7;ANXA4
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.4569752155711171,1.1333718920035882,0.3061440677966102,0.7214242941928249,1.0,9/60,8.87%,SMOC2;PTGES3;PKIB;RGCC;PRKD2;XRCC5;CTNNB1;PRKCQ;CCT8
prerank,endodermal cell differentiation (GO:0035987),0.489606195112108,1.1333674629532426,0.32744405182567726,0.7209238619550866,1.0,6/31,10.54%,ITGB2;ITGA4;ITGB5;LEO1;SETD2;INHBA
prerank,protein deneddylation (GO:0000338),0.5759217001447379,1.1331146381570942,0.3540462427745665,0.7211664910030571,1.0,3/10,13.52%,COPS6;COPS4;TOR1A
prerank,regulation of nitric-oxide synthase activity (GO:0050999),0.48710544438018316,1.1328692577007433,0.31314285714285717,0.7213249062007812,1.0,11/36,16.72%,IL1A;PIK3CB;TNF;GCH1;APOE;DNM2;NOS1AP;SPR;DDAH1;HIF1A;HSP90AA1
prerank,sensory perception of light stimulus (GO:0050953),0.4499092665918706,1.1326770542148565,0.2950310559006211,0.721354488960988,1.0,14/87,14.22%,CABP4;DRAM2;DHRS3;ATXN7;GUCY2F;WHRN;RP2;CNGB1;MYO7A;CRYBB1;RPGR;CDH23;OAT;WFS1
prerank,positive regulation of signaling receptor activity (GO:2000273),0.48422474450638153,1.1323664286004627,0.319634703196347,0.72167861252857,1.0,11/36,19.92%,CCR2;TAF1;HFE;NRP1;HDAC6;CCL2;BUD31;HIF1A;GREM1;ITGB1;RELN
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.5662262377956017,1.1321733436329082,0.3439306358381503,0.7216992468463256,1.0,3/11,13.59%,PRKCD;MAP3K5;STK24
prerank,termination of RNA polymerase II transcription (GO:0006369),-0.3288071621178348,-1.1321724199476002,0.2537313432835821,0.8789806001367564,1.0,13/33,22.05%,WDR33;SCAF8;FIP1L1;CPSF7;CSTF2;PAPOLA;SNRPD3;MAZ;CSTF3;SNRPG;SNRPF;CSTF2T;NCBP2
prerank,negative regulation of myotube differentiation (GO:0010832),0.5683864399425731,1.1320503622031748,0.3610719322990127,0.7215626739418468,1.0,3/12,9.95%,BHLHE41;HDAC5;HDAC4
prerank,sphingolipid metabolic process (GO:0006665),0.44490093789768637,1.1317284331220683,0.26713709677419356,0.7219313596331887,1.0,33/108,21.46%,HEXB;CERS6;SGPL1;CTSA;GM2A;PSAP;CLN8;PRKD2;HEXA;SMPD3;CERK;CSNK1G2;HACD4;AGK;B3GALNT1;ACER3;VAPB;ORMDL2;PPP2CA;ARSA;SUMF2;NSMAF;ARV1;DEGS1;ASAH1;SGMS1;B4GALNT1;GBA2;SPTSSA;SMPD1;SPTSSB;ABCA2;SUMF1
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.5906797288160879,1.1316993608291137,0.34520123839009287,0.7215096998469832,1.0,4/10,17.21%,TLR2;CCL2;NOD2;IL33
prerank,neuron projection fasciculation (GO:0106030),-0.4618737530725643,-1.131674230375684,0.3161094224924012,0.8756973479275619,1.0,3/10,4.78%,SEMA5A;ARHGAP35;EPHB2
prerank,respiratory system development (GO:0060541),0.48666254381608615,1.1313717522418019,0.3150684931506849,0.7219455371094101,1.0,5/32,6.82%,SHH;BASP1;CEBPA;CHD7;NKX2-1
prerank,activin receptor signaling pathway (GO:0032924),0.545585098216113,1.1312403370888493,0.3531799729364005,0.7217911999374305,1.0,3/15,10.54%,TGFBR1;SMAD3;INHBA
prerank,purine ribonucleotide transport (GO:0015868),0.5372311663453125,1.1311626785003075,0.3577981651376147,0.7215106270598148,1.0,2/16,2.47%,ABCC6;LRRC8D
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.5028869289585749,1.1310942646441793,0.34256055363321797,0.721200291970263,1.0,9/28,16.66%,PRKCD;PTPN1;PTPRE;PIP4K2A;PRKCB;PRKCQ;PID1;GSK3A;APPL2
prerank,regulation of cellular pH (GO:0030641),0.496407330277453,1.1309818448677005,0.31014823261117447,0.7210066213212479,1.0,10/29,22.07%,SLC9A4;CLN3;SLC9A9;SLC9A1;ATP6AP1;LACC1;SLC9A8;SLC9B1;SLC9A7;CHP1
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),-0.36935193937980065,-1.1301887991120576,0.28640776699029125,0.8756307730311481,1.0,6/20,8.55%,SEMA6A;SEMA5A;SEMA3A;SEMA6D;SEMA3C;SEMA3D
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.5870578640143471,1.1298246436853563,0.34417344173441733,0.7237406109256436,1.0,5/10,22.07%,SNCA;HDAC6;ETFBKMT;PRKN;MT3
prerank,cellular response to amino acid starvation (GO:0034198),0.45659793087684447,1.1292902543946732,0.3158995815899582,0.7246473670195678,1.0,22/71,19.42%,ATP6V0D2;ATP6V0E1;TCIRG1;MTOR;ATP6V1C1;ATP6V1E1;TFEB;MAP3K5;SEH1L;ATP6V0D1;CEBPB;FLCN;IMPACT;DAP;LAMTOR3;ATP6V0B;RNF152;GCN1;LAMTOR1;ATP6V1F;RPTOR;SEC13
prerank,regulation of regulated secretory pathway (GO:1903305),0.48878448090107207,1.1292418928594834,0.325,0.724267692138181,1.0,6/34,11.09%,SYT17;UNC13D;VPS18;SYT2;SYT10;DTNBP1
prerank,regulation of microtubule-based movement (GO:0060632),0.5844215293440944,1.128984979704295,0.3869565217391304,0.7244659313400404,1.0,2/11,11.27%,NEFH;HDAC6
prerank,response to muscle stretch (GO:0035994),0.5345647556609877,1.1288064767831159,0.351278600269179,0.7244465428421665,1.0,4/15,7.37%,SLC8A1;TTN;CTNNB1;SLC9A1
prerank,central nervous system neuron differentiation (GO:0021953),0.4876698386104955,1.1284980561907887,0.34059633027522934,0.7247837037970234,1.0,3/33,6.29%,DRAXIN;ATP7A;CTNNB1
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.4604912841213371,1.1276613817869112,0.3200859291084855,0.7265419230012734,1.0,13/52,15.03%,TREM2;LGALS3;PLS1;TNF;CLN3;AKAP5;STAC;ATP2C1;PRKCH;STX3;STAC3;ARF6;LRP1
prerank,regulation of protein localization to cell surface (GO:2000008),0.4859432083684275,1.1275530869408215,0.3276255707762557,0.7263306320885972,1.0,15/33,25.15%,TNF;SNX33;CTNNB1;TYROBP;HFE;NEDD4L;RAB11FIP5;STX3;TOR1A;PICALM;LEPROTL1;ABCA2;GPM6B;GPD1L;HSP90AB1
prerank,regulation of protein import into nucleus (GO:0042306),0.48028228469729084,1.1274182408473192,0.339041095890411,0.7262002020681377,1.0,6/36,10.10%,TGFB1;HCLS1;PRKCD;SMAD3;MDFIC;TPR
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.45137340001310544,1.1270688610183068,0.29906542056074764,0.7266335321550138,1.0,17/78,15.64%,BAG2;NFE2L2;CBFA2T3;RNF180;RNF19B;HERPUD1;CEBPA;TAF1;HECTD1;FZR1;DET1;CSNK1A1;STUB1;RNF144B;LRRK2;PIAS1;GSK3A
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.4409532178928941,1.1269501563921178,0.2649746192893401,0.7264617772645144,1.0,46/110,25.70%,RPL23;RPL17;RPL10A;PNRC2;RPS2;RPL18A;RPS15A;GSPT1;CASC3;SMG1;RPL6;RPLP2;RPL26;CTIF;RPS20;RPS16;PPP2CA;RPS14;RPL19;UPF3B;RPL9;RPS11;RPL11;SMG7;RPS23;RPS4X;UPF2;RPS27;RPL4;PYM1;RPL7A;RPL15;RPL29;RPL22;RPS7;RPS13;EIF3E;RPLP1;RPS15;RPS5;RPL41;RPL10;NCBP1;RPS8;RPL5;RPL18
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),-0.36900110655064977,-1.1269339540605339,0.2857142857142857,0.8815831867027798,1.0,6/19,9.80%,APP;MAPK8;MTPN;KLF2;CHRNA7;KLF4
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.5275768548204509,1.12655386416393,0.3440721649484536,0.7270657966824766,1.0,3/17,11.20%,GMFG;WASF2;CYFIP1
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.4315496719906692,1.1260567073135617,0.047,0.7278858363473697,1.0,145/834,13.98%,RUNX1;LILRB1;IRF5;NPAS4;MMP12;PF4;ASCL1;CIITA;SHH;IRF4;IRF8;SLC11A1;TGFB1;HCLS1;GATA1;NFE2L2;POU2F2;BRD8;LPIN2;NLRC5;NFATC1;MED17;RREB1;TLR2;MLXIPL;SS18L1;ELF4;DHX9;ZEB2;IER2;OSM;SP7;MAML3;CREB3L4;CREB3;BARX2;NCK2;RXRB;FOXD2;NR1H4;TNF;SREBF2;TET3;ITGA6;RGCC;PRKD2;PKD2;MLXIP;BPTF;MITF;SKI;ATF3;CEBPA;CDK8;FOXO3;FHOD1;ZMIZ2;DDIT3;SPI1;IL18;FIZ1;HDAC5;GALR1;HMGB1;RNF111;TEAD1;MRTFA;CTNNB1;TFEB;TP53;KLF6;MEF2A;AKNA;TBL1XR1;NKX2-1;NRL;TAL1;USF1;MYOCD;AGRN;LEO1;YY1;TCF20;SLC9A1;CEBPB;ASXL2;ST18;LMO2;MEF2C;DOT1L;NKRF;CDC5L;FLCN;TFAP2B;SMAD3;AKIRIN1;IRF2;HSF1;PPARGC1A;ATRX;CDK7;CREBRF;RNF4;STAT5B;MCRS1;LRP5;HDAC4;ACTR2;LITAF;RNF10;NFIC;ATAD2;TBL1X;INHBA;ACTR3;RNASEL;TXK;SOX9;RPS6KA4;PTOV1;NR2C2;NRIP1;PHIP;ATF6B;NOD2;MTF2;ELL;CREB1;LAGE3;IKBKG;ZFP64;KAT7;SMARCD3;NR4A1;MAX;SMARCB1;GPS2;NFKB1;HCFC1;PCBP1;ZFHX3;IRF1;INO80;PID1;RTRAF
prerank,regulation of synapse organization (GO:0050807),0.49639969196471284,1.1253658144690537,0.32667450058754405,0.7293449147269009,1.0,6/26,11.67%,ARHGAP22;TNF;CLN3;ABHD17B;MEF2C;ABHD17C
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.35714188547316306,-1.1251246136890785,0.2937853107344633,0.8826382541846626,1.0,7/22,7.97%,SCAF8;CDK12;THOC1;BRD4;THOC5;CCNK;CCNT1
prerank,positive regulation of angiogenesis (GO:0045766),0.44611147056022793,1.1251179993308655,0.2797979797979798,0.729501209953084,1.0,13/108,7.43%,RUNX1;ITGAX;IL1A;SMOC2;PIK3CD;AQP1;ANGPT4;MDK;ANGPTL3;PRKD2;PDCL3;PRKCB;VEGFB
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.4979937928107081,1.1249542397166867,0.3498789346246973,0.7294650056118102,1.0,7/24,14.53%,CREB3;HERPUD1;BCL2L1;CREB3L1;AQP11;WFS1;LRRK2
prerank,protein localization to plasma membrane (GO:0072659),0.43963694363825506,1.1249411394636541,0.27603640040444893,0.72899988062132,1.0,37/129,19.96%,MRAP;FYB1;RAB8B;RAB34;MYO5A;FGF13;RAP2A;PKP2;TNF;TTC7A;TSPAN32;RAMP1;TNIK;PACS1;TSPAN14;RAB11A;RAB40C;F11R;CACNB2;DENND4C;ZDHHC3;SEC16A;ATP1B3;GAS6;RAP1A;GAK;EFR3A;SMURF1;ANK1;SPTBN4;FLOT1;TESC;PACS2;ROCK2;FCHO2;INPP5K;P2RY1
prerank,regulation of cellular catabolic process (GO:0031329),0.45172942807224997,1.12481158631799,0.32123799359658484,0.7288358244525642,1.0,21/62,21.78%,DRAM2;WDR91;PSAP;GPR137B;PIP4K2A;DDIT3;DCAF12;ABCD1;MTMR3;RAB39B;HDAC6;VPS29;LRRK2;KEAP1;RPTOR;HSPB1;OSBPL7;PRKN;RRAGA;SCARB2;RRAGB
prerank,chloride transport (GO:0006821),-0.2681655332484287,-1.1245887129941687,0.15217391304347827,0.8797207734810493,1.0,17/74,17.41%,SLC12A2;CLIC4;SLC12A7;SLC4A10;GABRB2;CLCN6;GABRB1;SLC26A7;GABRA2;CLIC5;CLCN2;GABRB3;TTYH3;ANO4;TTYH1;SLC12A8;GLRB
prerank,regulation of protein localization to membrane (GO:1905475),-0.33929944029588954,-1.1242316496670175,0.2945205479452055,0.87618483641417,1.0,6/28,4.10%,SPTBN1;GPC6;GPC5;GSN;MMP14;AR
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.4437501308486168,1.1241224836546906,0.30390143737166325,0.7302389399090689,1.0,20/90,16.92%,IRF4;SYK;CCR2;FABP4;CXCR4;IL18;ACADL;CEBPB;FABP5;HSF1;PPARGC1A;CMKLR1;ADIPOR1;DYNC1H1;PRLR;CD36;ZBTB7B;ADIPOR2;APPL2;CPT2
prerank,cardiac muscle contraction (GO:0060048),0.47774289462817343,1.124110059716383,0.3538283062645012,0.7297650450171398,1.0,4/34,4.28%,SCN4B;MYL3;SLC8A1;TTN
prerank,peptidyl-serine phosphorylation (GO:0018105),0.43681915040898434,1.1240877894132943,0.2613065326633166,0.7293207939239372,1.0,48/153,21.33%,MAPKAPK3;MAP4K1;TGFBR1;PRKCD;CAMK1D;MTOR;MAPK14;ERN1;NEK6;PRKD2;MORC3;TLK1;TAF1;PRKCB;MKNK1;TGFBR2;WNK1;PLK2;CSNK1G2;PRKCQ;CSNK2A2;CSNK2A1;SMG1;PRKCH;STK32C;MAP2K2;PKN1;RPS6KA4;NLK;CSNK1A1;MAP3K12;GAS6;LRRK2;SGK3;RPS6KA2;STK4;RPS6KA5;PDPK1;VRK1;TOP1;ROCK2;TLK2;DCLK3;CDK5R1;GSK3B;CSNK1G3;MARK1;BRSK1
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.43939823695137387,1.1240232117786844,0.282103134479272,0.7289902108838261,1.0,33/124,17.93%,ARRB2;PLCB2;FZD10;NFATC1;FZD9;FZD3;CTNNB1;PSMB10;TNRC6A;AP2S1;MOV10;DAAM1;AGO4;PSMA2;PFN1;CLTC;NLK;AGO3;PSME3;PSMB5;PSMD8;GNG2;AP2M1;PSMD7;PSMB9;VANGL1;SMURF1;FZD8;PPP3CB;RHOA;PSMD2;AGO2;CDC42
prerank,positive regulation of peptidase activity (GO:0010952),0.5148260549426489,1.123772644780597,0.3383270911360799,0.7291917871360503,1.0,4/20,12.48%,VSIR;TANK;GRN;PSME3
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.5345225233776851,1.1236386460394667,0.3687002652519894,0.729039566030285,1.0,3/15,15.57%,DDC;SMOX;PAOX
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.4885064459126979,1.1235988172306763,0.3570595099183197,0.7286435743574309,1.0,5/30,13.13%,LPAR6;GPR17;F11R;ADGRG1;ARHGEF3
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.43042345114752417,1.1235260697411098,0.034,0.728339732383034,1.0,199/1082,14.68%,CD86;RUNX1;NFE2;LILRB1;IRF5;NPAS4;MMP12;PF4;ASCL1;CIITA;SHH;IRF4;IRF8;SLC11A1;TGFB1;HCLS1;GATA1;PCID2;CD74;NFE2L2;POU2F2;BRD8;LPIN2;NLRC5;SNX5;TGFBR1;NFATC1;MED17;RREB1;GTF2H1;MAD2L2;TLR2;MTOR;NSD1;MLXIPL;SS18L1;ELF4;DHX9;NUP62;ZEB2;IER2;OSM;SP7;MAML3;CREB3L4;CREB3;BARX2;NCK2;YAF2;RXRB;FOXD2;NR1H4;TNF;SREBF2;TET3;ITGA6;RGCC;PRKD2;PKD2;MLXIP;APOE;UBE2V1;BPTF;MITF;SKI;ATF3;CEBPA;CDK8;FOXO3;FHOD1;ZMIZ2;DDIT3;CXXC1;SPP1;SPI1;IL18;FIZ1;NDP;HIVEP3;HDAC5;GALR1;HMGB1;RNF111;FLI1;TEAD1;MRTFA;MAP2K3;CTNNB1;TFEB;DNM2;TP53;KLF6;CD80;MEF2A;AKNA;TBL1XR1;NKX2-1;NRL;TAL1;USF1;MAP3K5;MYOCD;AGRN;YY1;TCF20;SLC9A1;PIM2;ZFP90;EPO;CEBPB;ASXL2;ST18;LMO2;CHEK2;SNAI1;MEF2C;DOT1L;NKRF;CDC5L;FLCN;TFAP2B;BICRA;SMAD3;MMS19;AKIRIN1;ARID1A;IRF2;HSF1;MDFIC;PPARGC1A;ATRX;CDK7;CREBRF;RNF4;ATF7IP;STAT5B;MCRS1;LRP5;HDAC4;ACTR2;LITAF;ARID1B;RNF10;DDX39B;NFIC;ATAD2;SEC14L2;TBL1X;INHBA;ACTR3;TRIM56;RNASEL;MAP2K2;CREB3L2;TXK;ELF2;SOX9;RPS6KA4;PTOV1;NR2C2;NRIP1;PHIP;ATF6B;NOD2;MTF2;MAP3K12;ELL;HEATR1;CREB1;LAGE3;IKBKG;ZFP64;KAT7;BAMBI;SMARCD3;NR4A1;MAX;CAMKK2;SMARCB1;GPS2;NFKB1;FOXK1;GPATCH3;HCFC1;PCBP1;ZFHX3;IRF1;INO80;PID1;RTRAF;SOX2;BRD7;HNRNPD;ELOF1;ARHGEF11;LBH;SOX4;SREBF1;MEIS1
prerank,organophosphate biosynthetic process (GO:0090407),-0.30657020266150664,-1.123355837568641,0.22549019607843138,0.8739882210555111,1.0,12/37,20.85%,PPIP5K2;IP6K1;AGPAT4;GK5;AGPAT3;AGPAT5;IP6K2;GPHN;MBOAT1;ITPKC;IPMK;NFS1
prerank,N-glycan processing (GO:0006491),0.5286368173225344,1.1231634690466321,0.3533246414602347,0.728795409223772,1.0,8/18,19.22%,MAN1C1;ST8SIA4;ST8SIA1;MAN2A2;GNPTAB;MGAT4B;MAN1A2;GANC
prerank,regulation of peptide hormone secretion (GO:0090276),0.45858754717670314,1.1230879416606394,0.29245283018867924,0.7284982131403701,1.0,16/67,16.82%,KCNJ11;FFAR2;TNF;RASL10B;CHD7;CACNA1A;HFE;TFAP2B;ITPR2;ENSA;SLC8B1;KCNA5;RAP1A;CACNA1D;GCK;PPP3CB
prerank,regulation of cellular amino acid metabolic process (GO:0006521),-0.2874532403352118,-1.1229619620305946,0.23943661971830985,0.8705385296776842,1.0,21/53,22.04%,PSME4;PSMD11;PSMA5;PSMA4;PSMD14;AZIN1;PSMC6;PSMC3;PSMB3;PSMC1;PSMD5;PSMA3;PSMD3;PSMD6;PSMC5;BCKDK;ODC1;PSME2;PSMB4;PSMC4;PSMB6
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.5119888959194417,1.1229319385181686,0.34903381642512077,0.7284412193100709,1.0,2/21,2.09%,SHH;RAB34
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.44755690934596776,1.1227195196082003,0.30929989550679204,0.7285206329932163,1.0,15/72,13.45%,TREM2;CORO1A;CYRIB;PRKCD;FGF13;SNCA;ATXN7;APOE;ARFGEF1;MAPRE1;PFN2;PFN1;IAPP;TWF2;SSH2
prerank,pyrimidine nucleoside catabolic process (GO:0046135),-0.456101459180413,-1.1226089926996552,0.3333333333333333,0.8670561506695268,1.0,2/10,5.30%,UPP2;NT5E
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.31886731675876245,-1.122360700771564,0.23841059602649006,0.8631984028807695,1.0,10/30,10.62%,FSTL1;LTBP4;LATS1;TGFBR3;XIAP;PCSK6;SMAD4;FKBP1A;LATS2;TWSG1
prerank,glycerolipid metabolic process (GO:0046486),0.5714209501886188,1.1217066672870233,0.3561046511627907,0.7308267666228537,1.0,2/11,8.19%,DGKZ;DGKG
prerank,regulation of amyloid-beta formation (GO:1902003),0.4778463683173111,1.1207983579831962,0.3421354764638347,0.7327999146467906,1.0,18/34,25.48%,GSAP;TNF;ABCG1;APOE;SORL1;RTN1;GSK3A;RTN4;EPHA4;BIN1;PICALM;ROCK2;ABCA2;PIN1;EFNA1;IGF1;IFNGR1;GGA3
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.5120465602163781,1.1204548055957337,0.35828220858895704,0.733247167587649,1.0,7/23,20.70%,PLEK;CBFA2T3;HDAC4;GSK3A;GCK;TIGAR;CLK2
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.5532558159868844,1.1201737267894867,0.3539325842696629,0.7335557501451877,1.0,1/13,2.15%,TYK2
prerank,cation transmembrane transport (GO:0098655),0.4660884402267016,1.1199325200663695,0.32968236582694416,0.7337168419872493,1.0,6/44,10.22%,KCNJ11;SLC25A20;SLC7A8;PKD2;SLC25A38;SLC36A4
prerank,regulation of vasculogenesis (GO:2001212),0.545999167012696,1.1197468981662428,0.363754889178618,0.7337174477302915,1.0,2/14,5.36%,RIN2;XDH
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.506986993702469,1.1196191676385674,0.3598531211750306,0.733080561511305,1.0,5/23,12.29%,ZEB2;RNF111;FLCN;THBS1;SDCBP
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.506986993702469,1.1196191676385674,0.3598531211750306,0.733080561511305,1.0,5/23,12.29%,ZEB2;RNF111;FLCN;THBS1;SDCBP
prerank,mRNA destabilization (GO:0061157),0.4779675631392172,1.1193965435799345,0.34662236987818384,0.7331982359168732,1.0,15/38,22.44%,PLEKHN1;YTHDF3;RC3H2;ZC3H12D;MOV10;RC3H1;CPEB3;METTL3;MEX3D;TUT7;ROCK2;FTO;DIS3L2;ZFP36L1;CNOT1
prerank,positive regulation of protein autophosphorylation (GO:0031954),0.5118902381722489,1.1193789441176198,0.3552795031055901,0.732741338522772,1.0,2/22,3.44%,GPNMB;RAP2A
prerank,phosphatidylglycerol metabolic process (GO:0046471),0.507809635687215,1.1193072123184962,0.3609112709832134,0.7324364142210906,1.0,3/24,5.78%,LPCAT1;PGS1;CDS2
prerank,ion transport (GO:0006811),0.44427033416026174,1.1189738909820883,0.29006085192697767,0.7328519055297112,1.0,21/111,14.91%,P2RX1;TSPO;SLC15A3;HCN4;SLC9A4;KCNN4;SLC8A1;SLC36A1;SLC9A9;CNGB1;WNK1;SLC9A1;AQP11;SLC8B1;SLC20A2;SLC25A18;CTNS;WNK4;SLC9A8;VDAC2;VDAC1
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.45439569557765475,1.1182105947063996,0.3365591397849462,0.73441819201952,1.0,10/56,9.82%,ESPL1;CCND3;RGCC;CDC23;CCND2;ANXA1;AIF1;RB1;LSM11;RAB11A
prerank,regulation of protein dephosphorylation (GO:0035304),0.4808862820347533,1.1178047535433382,0.3445566778900112,0.7350531204329591,1.0,18/37,26.62%,TGFB1;PRKCD;PPP6R1;YWHAB;ENSA;SPPL3;PTPA;SMPD1;ANKLE2;PTBP1;PIN1;PPP1R16B;CAMTA1;PPIA;HTT;MFHAS1;TIPRL;TSC1
prerank,negative regulation of protein modification process (GO:0031400),0.44923931833101793,1.1175414528067875,0.3164426059979317,0.735258013417081,1.0,24/79,20.78%,LYN;TGFB1;SIRPA;DBI;NIBAN1;CRTAP;XDH;YWHAB;ENSA;IBTK;IMPACT;CDYL;PID1;LRRK2;PTPA;PTEN;CORO1C;PAQR3;ATG14;TINF2;INPP5K;FXYD1;GSK3B;PRKN
prerank,smooth muscle cell differentiation (GO:0051145),0.5572560600066949,1.1175313289500428,0.3769338959212377,0.7347828098081421,1.0,4/12,8.10%,EDNRB;MRTFA;MYOCD;MEF2C
prerank,Golgi organization (GO:0007030),0.43614428713281506,1.116958094947663,0.29107505070993916,0.7358725807240273,1.0,36/112,20.57%,PLEKHM2;SPTBN5;ATP8B4;LMAN1L;TMED3;PI4K2A;ARFGEF1;SYNE1;USP6NL;VMP1;ARHGAP21;SEC16A;CSNK1A1;PI4K2B;SEC16B;STX5;HUWE1;TRAPPC11;VTI1A;LRRK2;GAK;LMAN2;CDC42;VRK1;LYSMD3;GOLGB1;GOLPH3;UBXN2A;ATL2;RAB29;OPTN;ATL3;TRAPPC12;SEC22B;NSFL1C;COG7
prerank,regulation of monooxygenase activity (GO:0032768),0.5047676523841647,1.116435800404237,0.3695121951219512,0.7368067710660231,1.0,10/23,20.68%,IL1A;SNCA;DNM2;NOS1AP;SPR;DDAH1;POR;HSP90AA1;GDNF;ZDHHC21
prerank,regulation of p38MAPK cascade (GO:1900744),0.4716930503229761,1.1163681962015173,0.3348314606741573,0.73650074734708,1.0,6/35,10.78%,TREM2;SPI1;XDH;GADD45B;DUSP10;RELL1
prerank,regulation of protein phosphorylation (GO:0001932),0.43197247074509465,1.1161169573488254,0.211,0.7366720812932159,1.0,56/256,18.59%,TREM2;GPNMB;FGR;LYN;TGFB1;ITGB2;CD74;SIRPA;FNIP2;ITGB3;CSF1R;NIBAN1;NSD1;RAP2A;SEMA4D;CCND3;TNF;FNIP1;TTN;PDCL3;ATF3;PLXNB2;BRAT1;XDH;CCND2;VEGFB;TNIK;CEBPB;FLCN;IBTK;IMPACT;SOX9;PHIP;FYN;PPP2CA;PPIL4;CAMKK2;NPTN;GAS6;MOB1B;PID1;LRRK2;AKAP8L;WDFY2;IRGM;PTEN;HSP90AA1;STK4;PECAM1;CORO1C;SPTBN4;FLOT1;PAQR3;ANGPT1;PPP2R5C;VEGFD
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.4468912033273531,1.1159681540722273,0.32254697286012524,0.7366305051165054,1.0,16/73,13.66%,LAPTM5;MTCH1;TNF;SNCA;TRAF2;PYCARD;CASP1;XDH;APAF1;CFLAR;CRADD;SMAD3;DAP;CASP8;ATP2A3;TRADD
prerank,melanosome organization (GO:0032438),0.49483252553128587,1.115535230401561,0.34441805225653205,0.7372708977851689,1.0,5/26,13.35%,LYST;RAB32;AP3D1;DTNBP1;TRAPPC6A
prerank,regulation of neurotransmitter receptor activity (GO:0099601),-0.27226219776715754,-1.1153251392260233,0.16666666666666666,0.8816496868677286,1.0,28/57,26.66%,DLG2;APP;DLGAP1;NLGN1;GRIA3;GRIA2;DLGAP2;ACTN2;NEFL;GRIN2B;DLG1;SHANK1;PRRT1;GRIN1;CACNG8;CAMK2A;OPRM1;DLG3;SHISA9;GSG1L;DLGAP3;SHISA7;GRIA4;CAMK2B;CACNG2;LRRC7;NPTX1;NPTXR
prerank,ceramide transport (GO:0035627),0.5534313461919425,1.1152856017017365,0.37276478679504815,0.7374745736739846,1.0,2/12,6.00%,PSAP;ABCB4
prerank,long-chain fatty acid metabolic process (GO:0001676),0.452890602468179,1.1152597407928535,0.3231578947368421,0.7370495250273621,1.0,6/64,7.24%,CYP1A1;ALOX12;DAGLB;HPGD;ACADL;ABCD1
prerank,intracellular lipid transport (GO:0032365),0.5089722613599147,1.1149959161560545,0.3565217391304348,0.7372682754473087,1.0,7/21,17.99%,SLC25A20;NPC2;ABCD1;ARV1;ACACA;CPT2;ABCD2
prerank,rRNA metabolic process (GO:0016072),0.4305644487160754,1.1147518655177358,0.26907630522088355,0.7374142359161316,1.0,45/160,21.04%,SLFN14;RPL23;RPL17;EMG1;RPL10A;UTP20;NOB1;TEX10;FBL;RPS2;EXOSC1;LAS1L;RPL18A;KRR1;RPL6;DDX27;RPLP2;RPL26;RPS16;MDN1;UTP11;HEATR1;RPS14;RPL19;IMP3;RPL9;PES1;C1D;PIH1D1;RPL11;WDR12;RPS27;RPL4;FCF1;WDR75;RPL7A;RPL15;EXOSC3;RPL29;RRP7A;UTP3;TRIR;RPL22;IMP4;RPS7
prerank,regulation of lymphocyte migration (GO:2000401),0.5845616472687869,1.1145809386439858,0.3768545994065282,0.737339899842723,1.0,2/10,10.61%,STK10;SLC8B1
prerank,glutamate receptor signaling pathway (GO:0007215),0.4680064442969195,1.114545423874788,0.3337129840546697,0.7369374589824951,1.0,4/37,4.53%,PTK2B;DAGLB;GNAQ;CLN3
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),0.48354069625409557,1.113958924154459,0.3541147132169576,0.7380548976245103,1.0,6/25,16.71%,PTGES3;SDF2L1;DNAJC7;BAG1;GAK;ERO1A
prerank,regulation of vasculature development (GO:1901342),0.4908479184494419,1.113914723102627,0.34275184275184273,0.7376876346773955,1.0,2/26,6.29%,GPNMB;CTNNB1
prerank,retinoid metabolic process (GO:0001523),0.44874332853331333,1.113649832095405,0.33298647242455776,0.7379257203898466,1.0,10/71,15.03%,CYP1A1;LPL;DHRS3;APOE;TTR;AGRN;ABCA4;LRP8;RETSAT;LRP1
prerank,regulation of sensory perception of pain (GO:0051930),-0.4545221076546039,-1.113458909994542,0.3401360544217687,0.8829912575529097,1.0,7/11,39.42%,ATPSCKMT;CCN3;ZFHX2;ACP3;SPX;F2R;TMEM100
prerank,positive regulation of cell cycle process (GO:0090068),0.44023541374806974,1.113302874693132,0.31991744066047473,0.7383704717497238,1.0,16/91,13.89%,PCID2;IL1A;NUP62;RGCC;PLK4;KIF14;KIF20B;KIF23;ATRX;LRP5;TPR;DBF4;PHIP;DYNC1H1;CDC6;INO80
prerank,negative regulation of signal transduction (GO:0009968),0.43410639169777443,1.1132153454582239,0.223,0.7381205588160382,1.0,30/249,9.42%,PTPRC;SLAMF1;LYN;UBASH3B;PLEK;CX3CR1;LGMN;NFATC1;PRKCD;PTPRJ;PTPN1;PIK3CB;PTPN18;TNF;SNCA;PTPRE;PIP4K2A;MGRN1;TNFAIP3;XDH;PRKCB;YWHAB;CREB3L1;PRKCQ;CSNK2A2;CSNK2A1;RB1;SULF2;PDCD6;QARS1
prerank,regulation of gene expression (GO:0010468),0.4265002948840278,1.1125625676526907,0.078,0.7393900417418499,1.0,175/903,16.43%,PTPRC;RUNX1;LILRB1;TREM2;PF4;LYN;CALCR;ASCL1;SHH;ITGAX;SLC11A1;TGFB1;CD3E;HCLS1;STAP1;LGMN;CD74;CAVIN4;NFE2L2;IL1A;SIRPA;VSIR;PIK3CD;RPL23;RBM38;HAVCR2;PLCG2;TGFBR1;RREB1;TLR2;P2RX7;MTOR;NSD1;MLXIPL;PIK3CB;MAPK14;MSR1;SLC8A1;PRDM12;YAF2;TRIM5;TNF;RGCC;APOE;UBE2V1;ZNF326;MITF;TTN;PDCL3;PPIE;NFXL1;CEBPA;DDIT3;CXXC1;SPI1;TRAF3;WWC2;XDH;ZUP1;HDAC5;TAF1;BACH1;BTN3A3;CHD7;SBNO1;TFEB;CDK11B;AIF1;TYROBP;DNM2;CCAR1;TP53;NKX2-1;TNRC6A;YY1;CREB3L1;NFKBID;GCFC2;TICAM1;CEBPB;HINT1;FOXN2;HFE;TGFBRAP1;CHEK2;GRSF1;PRKCQ;MEF2C;FLCN;MOV10;RB1;METTL4;TRIM27;LARP1;SMAD3;RC3H1;GTF2IRD1;IRF2;PPARGC1A;TDRD7;PCBP3;PUM2;ATRX;AGO4;RPL6;NOS1AP;ACTG1;HNRNPL;HDAC4;NFX1;SON;INHBA;MAP2K2;TXK;HCFC2;ZSCAN26;LIMS1;DTNBP1;SOX9;NELL1;RPS6KA4;HDAC6;NLK;AFF1;DENND4A;NR2C2;PTBP2;AGO3;ZNF628;GZF1;VSTM2A;TRA2B;PRX;MTF2;PPP2CA;CDK6;BRDT;SEC16B;ZFP64;KAT7;CASP8;COQ7;TIPARP;BRAF;FOXN3;FAM50A;GAS6;NFKB1;MEGF8;SOX6;HCFC1;PCBP1;ZFHX3;PID1;SOX2;HNRNPD;RO60;SOX4;IGF2BP3;ZBTB11;C1D;ICOSLG;SPTY2D1;TLE5;REXO4;GSK3A;AHNAK2;OGG1;CD36;RBPJ;FADS1;ZBTB7B;HIF1A;RPL11;SBNO2
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.47895040419268714,1.1118513657403886,0.34584755403868034,0.7409055724389799,1.0,7/34,11.23%,CASS4;RREB1;MDK;NEDD9;P4HB;LIMS1;NRP1
prerank,V(D)J recombination (GO:0033151),0.5610405306797036,1.111786533414153,0.3627311522048364,0.7405845125968128,1.0,2/11,6.22%,HMGB1;LIG3
prerank,glycogen metabolic process (GO:0005977),-0.33275546804348366,-1.1116409036997479,0.294478527607362,0.8844316267578183,1.0,11/27,21.94%,PGM1;PHKA2;PYGB;PHKG2;UGP2;PHKB;PYGM;PER2;AGL;PPP1R3C;PHKA1
prerank,DNA replication initiation (GO:0006270),0.47452501221802684,1.1116143511478194,0.36435868331441545,0.7405702377685182,1.0,10/37,16.90%,MCM5;ORC3;MCM6;MCM2;DBF4;ORC4;CDC34;CDC6;NOC3L;LRWD1
prerank,cellular response to light stimulus (GO:0071482),0.44476606448316647,1.1115674283250323,0.3539915966386555,0.7401950382059932,1.0,14/66,16.15%,AQP1;PRKCD;SAG;TAF1;TP53;CNGB1;YY1;BAK1;RPL26;METTL3;INO80;BMF;NOC2L;COPS9
prerank,regulation of biomineral tissue development (GO:0070167),0.4970077624786369,1.1113496098658768,0.36416861826697894,0.7402693357707687,1.0,5/26,13.41%,TGFB1;BMP2K;CEBPB;SOX9;GAS6
prerank,AMP metabolic process (GO:0046033),-0.4123008448501333,-1.1108228832227558,0.3146067415730337,0.882724261328004,1.0,10/13,29.57%,ADSS2;NT5E;AK3;AMPD3;AMPD2;ADSL;AK4;NUDT2;NT5C1A;ADSS1
prerank,regulation of dephosphorylation (GO:0035303),0.5396476650487767,1.1107163579610457,0.3740053050397878,0.7415302562780208,1.0,7/15,26.03%,MTMR3;SRC;SMG7;INPP5K;MTMR9;PPP1R16B;CDK5RAP3
prerank,anterior/posterior pattern specification (GO:0009952),0.4541439231983861,1.1102369487667072,0.34717784877529284,0.7423513514228042,1.0,9/53,10.28%,BASP1;TGFBR1;HES7;SKI;DDIT3;BHLHE41;ATP6AP2;LRP5;HOXA6
prerank,protein stabilization (GO:0050821),0.42821292923619275,1.110169865248105,0.2722722722722723,0.7420490546698741,1.0,63/168,22.44%,BAG2;RPL23;PRKCD;GNAQ;PTGES3;PDCL3;SEL1L;CRTAP;MORC3;TAF1;OTUD3;TYROBP;PIM2;CHEK2;CCT8;PPARGC1A;CDK7;ATF7IP;PFN2;TBL1X;USP7;PFN1;NLK;GRN;SEC16A;WDR81;CREB1;ATP1B3;STK3;HCFC1;ATP1B2;CCT5;USP9X;WFS1;BAG1;SOX4;PRKRA;RTN4;IRGM;EPHA4;RPL11;PTEN;STXBP4;HSP90AA1;STK4;VHL;CREBL2;FLOT1;TESC;COG7;TELO2;NAA15;PRKN;BAG4;RPS7;CRYAB;PIN1;FLNA;WIZ;CHP1;MT3;MTMR9;MDM4
prerank,synaptic vesicle endocytosis (GO:0048488),0.47792055936719513,1.1098643394364223,0.35870818915801617,0.7423901923407243,1.0,10/33,14.66%,SNCA;PIP5K1C;CEL;DNM2;SYT2;STON2;ITSN1;STON1;SYNJ1;GAK
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.3440579181481489,-1.109473501033685,0.3181818181818182,0.8823542396357286,1.0,10/23,26.44%,FAR1;ACSL1;HACD1;ELOVL5;ACSL6;ELOVL1;ACSBG1;HACD2;ACSL4;ACSL3
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.50136497143683,1.1094684931496965,0.37544696066746125,0.7429825972882874,1.0,9/24,20.53%,PTPRJ;THY1;DUSP3;LIMS1;NRP1;ARF6;MAPRE2;IQSEC1;MAP4K4
prerank,transcription preinitiation complex assembly (GO:0070897),0.557940645751111,1.1094574122961636,0.3810848400556328,0.7425236887230462,1.0,5/12,18.84%,POLR1E;TAF1;BDP1;GTF2B;TAF11
prerank,regulation of endothelial cell apoptotic process (GO:2000351),0.4720004779235957,1.109047467965462,0.34486607142857145,0.743119305888658,1.0,8/39,13.41%,NFE2L2;ITGA4;TNF;RGCC;TNFAIP3;THBS1;CCL2;GAS6
prerank,limb morphogenesis (GO:0035108),0.5137217712664817,1.1090414906242518,0.3688212927756654,0.7426391296434895,1.0,4/20,13.52%,SHH;SKI;TFAP2B;MEGF8
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.5662229453285301,1.108797023409373,0.3770949720670391,0.7428304262188941,1.0,4/11,14.40%,ZMIZ2;ARID1A;ARID1B;ELOF1
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),-0.399818788310189,-1.108503354912212,0.3135593220338983,0.880883271261107,1.0,4/15,7.60%,ATF2;RAD17;TIPIN;MRE11
prerank,regulation of cell population proliferation (GO:0042127),0.4250953485020189,1.1078609379281161,0.116,0.7449306570044915,1.0,110/691,14.77%,CD86;RUNX1;PTK2B;SLAMF1;GPNMB;PF4;LYN;SHH;HCK;ITGAX;TGFB1;CXCL5;HCLS1;FLT3;TMIGD3;LGMN;STAT5A;IL1A;TSPO;CBFA2T3;RPL23;CSF1R;TGFBR1;PTPRJ;TCIRG1;SLURP1;MLXIPL;S100B;TNFRSF11A;ADAMTS8;NUP62;OSM;UTP20;NCK2;IL12RB2;RGCC;PKD2;SKI;IL6R;CNOT8;CEBPA;ATP8A2;TIMP1;CCND2;XRCC5;SPEG;CTNNB1;AIF1;GAB2;CCAR1;TGFBR2;TP53;RPS15A;MYOCD;CCKBR;PIM2;STAT4;EPO;ST18;FLT3LG;AQP11;KIF14;DOT1L;CSNK2A1;TFAP2B;KIF20B;GID8;PODN;NTF3;HSF1;CCL14;ABI1;STRN;P3H2;ACER3;STAT5B;LRP5;HDAC4;NAP1L1;INHBA;SH2B3;NF2;LIMS1;SOX9;CHERP;THBS1;PTPRU;AGO3;PHIP;PRDX3;CIAO1;SDCBP;CDK6;ADGRG1;TBC1D8;NRG1;STX3;BAMBI;ADARB1;PRLR;DDAH1;CDC6;RAB33B;IRF1;FTH1;BRD7;SOX4;MEIS1;TMEM127;PRKRA
prerank,positive regulation of biomineral tissue development (GO:0070169),0.4599033843993854,1.1075803448986692,0.3650615901455767,0.7451969616074213,1.0,8/40,11.24%,TGFB1;P2RX7;SLC8A1;FZD9;CEBPB;MEF2C;ATP2B1;NELL1
prerank,morphogenesis of a polarized epithelium (GO:0001738),0.5562568904396422,1.107147086952566,0.39777468706536856,0.7458648877729797,1.0,6/12,19.32%,ACTB;ZDHHC7;ACTG1;AHI1;LAMA3;SCRIB
prerank,fatty acid oxidation (GO:0019395),0.44380043094735966,1.1068708370135196,0.3669527896995708,0.7460874728918536,1.0,16/57,18.65%,ALOX12;EHHADH;ACAD10;ACADL;ABCD1;PEX13;PPARGC1A;ECHS1;ILVBL;ECI1;ADIPOR1;ADIPOR2;CPT2;PPARD;ABCD2;ECHDC1
prerank,positive regulation of synaptic transmission (GO:0050806),0.4402418339211943,1.1064720840256121,0.33194154488517746,0.7467023910063254,1.0,12/72,13.49%,PTK2B;CCR2;LGMN;CLSTN1;TNF;AKAP5;PLK2;ZDHHC3;DTNBP1;CCL2;NPTN;ADCY8
prerank,negative regulation of nuclear division (GO:0051784),0.5604800044950664,1.1063909562112115,0.38156028368794326,0.7464124920247766,1.0,2/11,4.03%,NME6;AURKAIP1
prerank,oligodendrocyte differentiation (GO:0048709),0.5072962264975658,1.1062093177334762,0.35805626598465473,0.7464243375152803,1.0,4/19,13.62%,SHH;EIF2B2;SOX9;SOX6
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),-0.3269647560230575,-1.1062065814298705,0.2805755395683453,0.8836382625073161,1.0,10/29,17.36%,RAB6A;GOSR1;COG2;COPZ2;TRAPPC3;COG1;RAB6B;COPB1;VTI1B;COPG2
prerank,positive regulation of bone mineralization (GO:0030501),0.4622449495898415,1.106192083619077,0.373015873015873,0.7459861148358183,1.0,7/35,11.24%,TGFB1;P2RX7;SLC8A1;FZD9;MEF2C;ATP2B1;NELL1
prerank,positive regulation of potassium ion transport (GO:0043268),-0.3035694652447109,-1.1056192002370597,0.2336448598130841,0.8809634414469539,1.0,8/38,10.54%,ANK2;KCNN2;FHL1;KIF5B;ACTN2;GABBR2;DLG1;KCNJ3
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.4435124083635851,1.1053254288529597,0.33263816475495306,0.7478182153182089,1.0,16/74,13.31%,TGFB1;TGFBR1;MAD2L2;MTOR;MDK;RGCC;CTNNB1;TGFBR2;NKX2-1;SNAI1;SMAD3;ADIPOR1;SDCBP;PPP2CA;BAMBI;VASN
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.3313670641435973,-1.1053152919386362,0.2822085889570552,0.8773714462558648,1.0,4/26,4.70%,ANK2;FHL1;ATP1B1;ACTN2
prerank,glial cell development (GO:0021782),0.4882024636241518,1.1051336170675654,0.35180722891566263,0.7478493877346212,1.0,7/25,16.03%,NRROS;TLR2;MDK;EIF2B2;CDK6;SOX4;NF1
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.4403843809239772,1.104960603507881,0.3302564102564103,0.7478075722216774,1.0,26/88,16.83%,MYO5A;RABEP1;AP1S3;EXOC6;CCDC93;RAB14;RP2;DNM2;VPS35L;CLINT1;AP1B1;FTL;ARFGEF2;DTNBP1;CLTC;EXOC8;EXOC1;SORL1;EXOC2;SNAP23;EXOC5;FTH1;SCAMP2;EPS15;TXNDC5;MON2
prerank,positive regulation of vacuole organization (GO:0044090),0.5702203283239984,1.1045680662332416,0.38226744186046513,0.7483699275690194,1.0,3/10,11.65%,PIP4K2A;RAB3GAP2;GRN
prerank,renal filtration (GO:0097205),0.5720404333734351,1.1044435038245168,0.3816568047337278,0.748221921085411,1.0,2/10,8.85%,MYO1E;SULF2
prerank,positive regulation of mRNA metabolic process (GO:1903313),0.5407523710578941,1.1043215957361001,0.3795423956931359,0.748059952932723,1.0,4/13,8.99%,CNOT8;GTPBP1;MOV10;RC3H1
prerank,positive regulation of telomere capping (GO:1904355),0.519481722848611,1.1039426869582551,0.3774069319640565,0.7485563634650328,1.0,4/17,14.37%,PKIB;PRKCQ;TNKS2;HNRNPD
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.4417954299040046,1.1035196062841763,0.3378099173553719,0.7492083091480928,1.0,17/76,16.50%,BAG2;CBFA2T3;LAPTM5;RNF180;RNF19B;CEBPA;TAF1;HECTD1;DET1;CSNK1A1;STUB1;RNF144B;LRRK2;PIAS1;GSK3A;SMURF1;PTEN
prerank,cellular response to purine-containing compound (GO:0071415),0.5719033598763438,1.1034255250365281,0.35522388059701493,0.7489720073741918,1.0,2/10,3.19%,P2RY6;SLC8A1
prerank,organic acid transport (GO:0015849),0.43278704973180687,1.1032328263067104,0.3421859039836568,0.7490083113034487,1.0,21/94,18.31%,SLC16A10;SLCO2B1;LRRC8D;ABCC3;SLC7A7;SLC7A8;NR1H4;SLC36A1;SLC38A4;SLC43A2;SLC6A15;SLC16A1;SLC25A30;SLC25A45;SLCO1B1;SLC1A4;SLC43A1;SLC13A3;PPARD;STARD5;RXRA
prerank,glutamate metabolic process (GO:0006536),0.5170977686609457,1.103001869171379,0.36107554417413573,0.7491628212930422,1.0,2/19,2.77%,DGLUCY;MTHFS
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.4412735710963903,1.1029084848652826,0.34273772204806685,0.7489068695583315,1.0,26/73,22.84%,SMYD5;TAF1A;POLR1E;DNMT3A;SF3B1;SPI1;HDAC5;ACTB;TRIM27;HDAC4;POLR1B;POLR2L;HDAC6;RBBP7;MTF2;ERCC6;TASOR;MYO1C;PHF1;POLR2E;RBBP4;EED;TAF1C;SMARCA5;AEBP2;H3-3A
prerank,regulation of glycogen metabolic process (GO:0070873),0.5576255419718532,1.1027958925168084,0.3875181422351234,0.7486928556515764,1.0,1/12,1.62%,PPP1R3E
prerank,visual perception (GO:0007601),0.43885791893946335,1.102545873150992,0.3485005170630817,0.7489263970725248,1.0,13/84,14.22%,CABP4;DRAM2;DHRS3;ATXN7;GUCY2F;REEP6;RP2;CNGB1;MYO7A;CRYBB1;RPGR;OAT;WFS1
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.43989819705552013,1.1024781255974994,0.3475991649269311,0.7486148095352023,1.0,13/70,13.66%,TGFB1;P2RX7;TNF;TRAF2;IL6R;BCL2L1;CRADD;SMAD3;BAK1;INHBA;TNFRSF1B;CASP8;TRADD
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.5120870579904158,1.1024080565982777,0.36770186335403726,0.7483063075806781,1.0,5/19,11.84%,SULT4A1;SLC35B3;BPNT1;PAPSS1;TPST1
prerank,positive regulation of lipid metabolic process (GO:0045834),0.4982750256955828,1.1018502331628022,0.3661616161616162,0.749315323165622,1.0,4/22,4.14%,MTOR;MLXIPL;ANGPTL3;APOE
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),-0.34316575951376255,-1.1014056819927687,0.31386861313868614,0.8855076889745348,1.0,11/31,13.30%,DLG2;PRKCI;LIN7A;SYNJ2BP;PARD3;MYO9A;WDR1;DLG1;LIN7C;MTCL1;EZR
prerank,I-kappaB phosphorylation (GO:0007252),0.5713733110117949,1.1011872283440396,0.39255014326647564,0.7506092822385015,1.0,2/10,2.91%,TLR2;TLR7
prerank,positive regulation of vasculogenesis (GO:2001214),0.5695104801878275,1.1011471854981276,0.36984352773826457,0.7502232186046285,1.0,1/10,1.10%,RIN2
prerank,response to interferon-beta (GO:0035456),0.49263548102737653,1.1010756816005183,0.382953181272509,0.7499311718648355,1.0,7/22,20.52%,AIM2;CDC34;UBE2G2;IRF1;IRGM;UBE2K;IFITM2
prerank,nucleosome organization (GO:0034728),0.4488959120440478,1.100855729114587,0.3464818763326226,0.7500266690876318,1.0,13/55,15.29%,NFE2;BPTF;SRCAP;ARID1A;ATRX;SETD2;NAP1L1;SOX9;BRDT;SMARCD3;SMARCB1;INO80;SPTY2D1
prerank,positive regulation of nervous system process (GO:0031646),0.5194417093001276,1.1007882989967748,0.38563829787234044,0.7497171184876514,1.0,4/18,11.69%,ITGAX;CST7;RNF10;TNFRSF1B
prerank,intermediate filament organization (GO:0045109),0.516586903342638,1.0999803234037362,0.3679369250985545,0.7513912734234316,1.0,5/17,17.63%,BFSP2;PKP2;GFAP;DES;DNAJB6
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.40083484692811344,-1.0996884383950838,0.3076923076923077,0.8864891493667117,1.0,5/15,19.88%,RSPO3;NPHP3;GPC3;WNT5B;SPEF1
prerank,regulation of lipid kinase activity (GO:0043550),0.5535638806741447,1.099600167929905,0.367911479944675,0.7519320063499133,1.0,3/11,12.33%,WDR91;RB1;WDR81
prerank,negative regulation of hormone secretion (GO:0046888),0.5644363262272816,1.0994846114175096,0.3654970760233918,0.7517676302519348,1.0,2/10,12.59%,OSM;RAB11FIP5
prerank,muscle tissue development (GO:0060537),0.5475428930666242,1.0993233542589629,0.37972972972972974,0.7516912948145856,1.0,5/13,16.03%,SHH;SRPK3;POGLUT1;CSRP1;NF1
prerank,secretion (GO:0046903),0.5408863410133917,1.0992710444048337,0.37092391304347827,0.7513351234863183,1.0,1/14,1.60%,TPD52
prerank,glutamine family amino acid catabolic process (GO:0009065),-0.41585442249324023,-1.099265217345307,0.3333333333333333,0.8834655017165525,1.0,7/13,23.42%,NOS3;GLUL;NOS1;GAD1;GLS;GLS2;ALDH4A1
prerank,regulation of stem cell differentiation (GO:2000736),0.4304045104408905,1.0992575873922723,0.33298969072164947,0.750881067860818,1.0,18/89,16.29%,RUNX1;SMYD5;GATA1;OSM;SP7;PSMB10;TAL1;OCIAD1;LMO2;PSMA2;METTL3;PSME3;ITCH;PSMB5;PSMD8;PSMD7;PSMB9;PUS7
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.4418902555552502,1.0991429762667921,0.3482794577685089,0.7506932270498847,1.0,7/75,6.60%,KLK3;PF4;CCR2;ANGPT4;RGCC;CTNNB1;STAB1
prerank,regulation of receptor binding (GO:1900120),0.5659162297284802,1.0989511053277345,0.37700145560407566,0.7507106934023094,1.0,3/10,13.42%,HFE;B2M;ATP2A3
prerank,regulation of transferase activity (GO:0051338),0.5136423547268595,1.098851239871781,0.3712021136063408,0.7505212159415708,1.0,2/17,1.96%,NLRC5;SLAMF8
prerank,fat cell differentiation (GO:0045444),0.44904428823624715,1.0988160258282582,0.35337552742616035,0.7501344746506424,1.0,13/57,15.24%,METRNL;SDF4;FFAR2;CEBPA;OSBPL11;BBS9;TFAP2B;PPARGC1A;NR4A1;TMEM120A;ERAP1;PID1;OSBPL8
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.47409386835096784,1.0980822818587734,0.3873563218390805,0.7515670534135803,1.0,6/30,10.33%,CD74;CD44;BCL2L1;SNAI1;TPT1;DDX39B
prerank,negative regulation of gene expression (GO:0010629),0.4227966360951662,1.097877752948652,0.224,0.7515997971433355,1.0,48/302,13.46%,RUNX1;SLFN14;GPNMB;SLC11A1;SMYD5;TGFB1;CD3E;FCGR2B;LGMN;SRGN;HAVCR2;MSR1;ERN1;DNMT3A;TNF;RGCC;APOE;CNOT8;SPI1;XDH;PPP1R11;TAF1;TNRC6A;YY1;CREB3L1;ZC3H12D;MEF2C;FLCN;MOV10;RB1;ATP2B1;TRIM27;LARP1;EPRS1;AGO4;CPEB3;MAP2K2;RPS6KA4;PTBP2;AGO3;RBBP7;METTL3;HDAC9;MTF2;NPTN;TIPARP;PCIF1;NFKB1
prerank,sulfate transport (GO:0008272),-0.3892823418129353,-1.0978576212133453,0.32014388489208634,0.8835947701237382,1.0,7/14,30.78%,SLC26A2;SLC26A7;SLC25A14;SLC25A11;SLC26A6;RACGAP1;SLC26A8
prerank,response to estradiol (GO:0032355),0.47934390339186095,1.0976625581403847,0.37714285714285717,0.7517006330137636,1.0,5/31,11.82%,TGFB1;CTNNB1;ANXA1;STAT5B;NRIP1
prerank,regulation of protein acetylation (GO:1901983),-0.4070317859828696,-1.0976356716827251,0.3238434163701068,0.8800178608688839,1.0,2/12,1.83%,CEP295;RAPGEF3
prerank,adenine nucleotide transport (GO:0051503),0.5181324243671165,1.0973373865660923,0.383916990920882,0.752057835051844,1.0,2/17,2.47%,ABCC6;LRRC8D
prerank,positive regulation of telomerase activity (GO:0051973),0.4674788390169951,1.0972192433398444,0.38100686498855835,0.7518992725891365,1.0,5/33,8.09%,PTGES3;PKIB;XRCC5;CTNNB1;PRKCQ
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),0.5643832404696753,1.0971151893185551,0.4,0.7516814942480783,1.0,5/11,15.94%,PCBP3;ZNF445;PCBP1;IGF2BP3;RASA1
prerank,DNA strand elongation (GO:0022616),-0.3697425500463377,-1.0966337350368986,0.296137339055794,0.8788091798220581,1.0,13/18,37.94%,MRE11;POLA1;GINS3;TERT;MCM4;DCLRE1B;MCMDC2;POLD2;RFC3;GINS1;RFC4;MCM3;MCM7
prerank,regulation of lamellipodium morphogenesis (GO:2000392),0.5518117851042621,1.0966225895738932,0.3919308357348703,0.7524978980157527,1.0,7/11,23.23%,RREB1;CD44;SRC;CORO1C;ARPIN;ARHGEF7;PDPN
prerank,tube closure (GO:0060606),0.47416782052542994,1.096599786747106,0.3791469194312796,0.752076927979816,1.0,3/31,4.59%,TGFB1;SKI;PLXNB2
prerank,cardiac ventricle morphogenesis (GO:0003208),0.45970232897973484,1.0965868605678635,0.376536312849162,0.7516268459593772,1.0,8/41,16.11%,TGFB1;MYL3;PKP2;TGFBR2;MEF2C;SOX4;GSK3A;RBPJ
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.2734719026622575,-1.0963572301497928,0.2777777777777778,0.8754208380841905,1.0,25/55,22.47%,FBXL7;FHL1;PSME4;PSMD11;PSMA5;PSMA4;RBX1;PSMD14;PSMC6;PINX1;PSMC3;PSMB3;PSMC1;PSMD5;PSMA3;PSMD3;PSMD6;PSMC5;USP47;PSME2;PSMB4;PSMC4;SKP1;PSMB6;CUL1
prerank,negative regulation of defense response (GO:0031348),0.4415188197168018,1.0962139846001702,0.3485952133194589,0.7521012545280039,1.0,9/77,5.09%,SIRPA;METRNL;PRKCD;NLRC3;NR1H4;APOE;OTULIN;TRAFD1;TNFAIP3
prerank,glucan catabolic process (GO:0009251),0.5296667889266291,1.0954436654459268,0.3724966622162884,0.7536951478336951,1.0,1/15,0.75%,MGAM
prerank,cholesterol metabolic process (GO:0008203),0.4368758482732418,1.0953761097036427,0.36401673640167365,0.7533895841489602,1.0,8/68,5.56%,ABCA1;ANGPTL3;CLN8;ABCG1;APOE;LDLRAP1;CEL;SOAT2
prerank,primary neural tube formation (GO:0014020),0.47686072927758993,1.0951655922568921,0.3706793802145411,0.7534564216956062,1.0,3/30,4.59%,TGFB1;SKI;PLXNB2
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.42212451080160485,1.095028274850064,0.2845691382765531,0.753354365723059,1.0,21/182,8.46%,RUNX1;APOBEC1;TGFB1;CD3E;PCSK9;LGMN;HAVCR2;RIN3;MSR1;TNF;APOE;SPI1;XDH;TAF1;TNRC6A;YY1;CREB3L1;MEF2C;FLCN;MOV10;RB1
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.5311058186168938,1.0950152448368986,0.3821917808219178,0.7529065070060533,1.0,6/15,23.66%,TNF;TICAM1;NOD2;HIF1A;GBP5;STAT3
prerank,calcium-ion regulated exocytosis (GO:0017156),0.4884969291467369,1.094755416069021,0.38128654970760234,0.7531270292868409,1.0,4/27,9.11%,SYT17;SDF4;SYT2;SYT10
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.4270277063457796,1.0946730841998995,0.29518072289156627,0.7528831183214281,1.0,23/151,10.54%,CERS6;LPIN2;SGPL1;LPCAT1;ESD;AKR1A1;HPGDS;GCNT1;GCH1;PRKD2;APOE;PCYT1A;CHKB;LPCAT2;CSNK1G2;CSNK2A2;CSNK2A1;SLC44A2;HACD4;ACER3;VAPB;STARD10;INHBA
prerank,O-glycan processing (GO:0016266),0.4514494206131672,1.0943380000015464,0.35714285714285715,0.7533326807677465,1.0,8/54,8.51%,GCNT1;GALNT10;MUC13;GALNT15;GALNT7;ST6GALNAC4;GALNT6;ST3GAL1
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.47617015265311907,1.094243162808547,0.3884297520661157,0.7531066279710733,1.0,4/29,8.98%,SLC11A1;CIRBP;LARP1;TENT5C
prerank,protein localization to cell junction (GO:1902414),-0.35321358661673674,-1.0942175498695228,0.335,0.8779645911886561,1.0,6/22,12.45%,NLGN1;TJP1;BSN;SHANK1;JAM3;HEG1
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),0.4328755107487539,1.0934286395774977,0.34674922600619196,0.7548386093322204,1.0,38/87,25.70%,RPL23;RPL17;RPL10A;RPS2;RPL18A;RPS15A;RPL6;RPLP2;RPL26;RPS20;RPS16;RPS14;RPL19;SRP19;RPL9;RPS11;RPL11;RPS23;RPS4X;RPS27;SEC63;RPL4;RPL7A;RPL15;RPL29;RPL22;RPS7;SRP14;RPS13;RPLP1;RPS15;SRP9;RPS5;RPL41;RPL10;RPS8;RPL5;RPL18
prerank,cell-substrate junction assembly (GO:0007044),-0.3057307221058233,-1.0934109537379417,0.3115942028985507,0.8763398100606029,1.0,9/33,8.60%,SORBS1;PEAK1;TAOK2;ACTN2;PTPRK;BCR;WHAMM;PLEC;ITGB4
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.44844216090409117,1.0933040935821765,0.3703308431163287,0.754679891499929,1.0,13/50,18.46%,AQP1;RFFL;TNF;FNIP1;SNCA;CD44;CSNK2A1;THBS1;GAS6;PIH1D1;SRC;DNAJB6;MAP2K5
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),-0.26374705769065004,-1.0931022611528427,0.23529411764705882,0.8689611222193143,1.0,29/56,24.08%,NDUFAF7;TIMMDC1;NDUFS5;NDUFA7;NDUFS1;NDUFS4;NDUFS3;NDUFAF2;OXA1L;NDUFAF6;NUBPL;NDUFAF4;NDUFAF5;NDUFB5;NDUFB2;TMEM126B;NDUFA8;NDUFS2;NDUFB7;ACAD9;NDUFA10;NDUFB6;NDUFB3;NDUFB10;NDUFS7;NDUFC1;NDUFA3;FOXRED1;TIMM21
prerank,NADH dehydrogenase complex assembly (GO:0010257),-0.26374705769065004,-1.0931022611528427,0.23529411764705882,0.8689611222193143,1.0,29/56,24.08%,NDUFAF7;TIMMDC1;NDUFS5;NDUFA7;NDUFS1;NDUFS4;NDUFS3;NDUFAF2;OXA1L;NDUFAF6;NUBPL;NDUFAF4;NDUFAF5;NDUFB5;NDUFB2;TMEM126B;NDUFA8;NDUFS2;NDUFB7;ACAD9;NDUFA10;NDUFB6;NDUFB3;NDUFB10;NDUFS7;NDUFC1;NDUFA3;FOXRED1;TIMM21
prerank,regulation of cell differentiation (GO:0045595),0.4266201571396235,1.093008841144476,0.3015075376884422,0.7550088818397684,1.0,31/148,19.30%,RUNX1;LGALS3;SHH;SMYD5;TGFB1;TGFBR1;MDK;TNF;PRKCB;TRPS1;CEBPB;OCIAD1;TFAP2B;NTF3;TAF8;PPP2CA;CDK6;GPS2;ZFHX3;YWHAH;NF1;FADS1;MCRIP1;TRIP4;BIN1;VHL;CASZ1;BIRC2;GREM1;MAFB;GDNF
prerank,proteasome assembly (GO:0043248),-0.4282811859793595,-1.09296274908799,0.37293729372937295,0.8653074953887185,1.0,8/11,40.65%,PSMD11;PSMD5;OTUD6B;PSMG1;ADRM1;PSMD10;PSMD9;POMP
prerank,regulation of protein catabolic process (GO:0042176),0.43266747783473963,1.092959652649255,0.3384146341463415,0.7546706614239597,1.0,38/99,22.74%,CTSA;MAD2L2;WDR91;ATG7;TNF;TNFAIP3;RAB7A;PLK2;CHEK2;CSNK2A1;NEDD4L;GFAP;FZR1;SORL1;ITCH;STX5;TIPARP;HUWE1;AREL1;GSK3A;SMURF1;IDE;FAF1;VPS28;FURIN;DACT1;SEC22B;WWP1;SF3B3;ATP13A2;GSK3B;PRKN;AZIN2;ZDHHC2;PIN1;FLNA;MDM4;NKD1
prerank,cellular response to calcium ion (GO:0071277),0.44354571712252994,1.0921475640348555,0.36935991605456453,0.7563881035095971,1.0,18/67,19.88%,SYT17;LGMN;PLCG2;RASA4;PKD2;RASGRP2;MEF2A;SYT2;MEF2C;SYT10;BRAF;ADCY8;CAPN3;IQGAP1;SCN5A;ADD1;MCOLN1;SMPD1
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.4799332021119499,1.0920344856940176,0.39975550122249387,0.756213150299376,1.0,6/26,8.66%,CCND3;RGCC;CCND2;ANXA1;AIF1;LSM11
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.4505532662877585,1.0919921453110764,0.3708467309753483,0.7558487361193118,1.0,20/52,25.40%,EDEM1;ERN1;DNAJC3;CXXC1;ATP6V0D1;VAPB;EXTL3;PARP16;TLN1;TATDN2;WFS1;GSK3A;ADD1;SEC31A;HYOU1;DDX11;PPP2R5B;PDIA6;EXTL2;XBP1
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.4830626787835433,1.0919120337107668,0.3763440860215054,0.7555955258654024,1.0,5/27,10.81%,TGFB1;DHX9;TP53;PUM2;MAP2K2
prerank,response to cAMP (GO:0051591),0.46428996913023,1.0919039557657688,0.3624161073825503,0.7551395232728183,1.0,11/37,21.24%,AQP1;HCN4;PKD2;RAP1B;VGF;RAPGEF1;RAP1A;AKAP9;INPP5K;HCN1;ZFP36L1
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.5182786904653028,1.0918809057172851,0.39169909208819714,0.7547224839569181,1.0,5/18,15.64%,BHLHE41;HDAC5;HDAC4;SOX6;GSK3A
prerank,organonitrogen compound catabolic process (GO:1901565),0.45205629923556306,1.0918762678825107,0.36585365853658536,0.7542552591480312,1.0,15/57,17.56%,SGPL1;NPL;MTOR;CLN8;RENBP;NAGK;PLA2G7;LIPC;TXN2;NAALADL1;TRIM24;ERAP1;CAPN3;IDE;USE1
prerank,negative regulation of cell population proliferation (GO:0008285),0.4204998103567192,1.0916854222364858,0.227,0.7542876483365779,1.0,62/351,14.77%,PTK2B;TREM2;GPNMB;LYN;TGFB1;TMIGD3;IL1A;CD300A;CBFA2T3;PTPRJ;SLURP1;ADAMTS8;NUP62;OSM;UTP20;NCK2;NLRC3;RGCC;PKD2;SKI;CEBPA;ATP8A2;TNFAIP3;MORC3;SPEG;CTNNB1;MTSS1;AIF1;TP53;MYOCD;PIM2;SLC16A2;ST18;AQP11;FLCN;TFAP2B;DUSP10;PODN;ABI1;STRN;P3H2;INHBA;SH2B3;NF2;SOX9;CHERP;NELL1;PTPRU;CDK6;ADGRG1;B4GALT7;ADARB1;B2M;DDAH1;CDC6;IRF1;FTH1;SOX2;BRD7;SOX4;TMEM127;PRKRA
prerank,regulation of histone acetylation (GO:0035065),0.4720545921593661,1.091606474923782,0.3781609195402299,0.7540122011932104,1.0,13/33,21.80%,SNCA;SPI1;HDAC5;MYOCD;FLCN;PPARGC1A;RPS6KA4;BRD7;NOC2L;RPS6KA5;SETD5;IWS1;CTBP1
prerank,carboxylic acid transport (GO:0046942),0.444885817783083,1.0911030880107735,0.3801478352692714,0.7548967699221861,1.0,14/55,17.42%,PSAP;SLC7A8;SLC38A6;CLN3;SLC36A1;SLC16A2;SLC6A15;SLC36A4;SLC16A1;SLC66A1;SLC1A4;SLC16A6;SLC13A3;SLC16A13
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.5516635634583636,1.090935372115352,0.37410071942446044,0.7548768092790066,1.0,2/11,4.62%,FBL;TENT4B
prerank,cellular respiration (GO:0045333),-0.28144271557339867,-1.0908766014043554,0.23404255319148937,0.8677118142676834,1.0,27/41,32.99%,UQCRC2;UQCRH;NDUFS1;SLC25A13;NDUFS4;OXA1L;SLC25A14;COQ10B;MTFR1L;COX15;ATP5F1D;UQCRC1;ETFA;NDUFS7;ETFRF1;ETFB;SDHAF4;UQCRFS1;LYRM7;MDH2;CYCS;COX10;MTLN;SURF1;NR4A3;NDUFS8;SIRT3
prerank,regulation of cellular protein localization (GO:1903827),0.45664577578270427,1.090715289295076,0.366120218579235,0.7550007579647362,1.0,14/45,21.61%,SHH;LCP1;PTPN1;CTNNB1;HFE;SETD2;RAB11FIP5;TOR1A;HSP90AA1;CCDC66;ATP13A2;SPIDR;ABCA2;PIN1
prerank,pulmonary valve development (GO:0003177),-0.3662352521166519,-1.0905073754987387,0.3422222222222222,0.8648741546030391,1.0,8/18,14.14%,ROBO2;BMP4;ROBO1;SLIT2;NOS3;JAG1;SMAD6;STRA6
prerank,limb development (GO:0060173),-0.33939424437198495,-1.0902905597167225,0.28378378378378377,0.8615588161035569,1.0,13/28,26.27%,PCSK5;KREMEN1;SALL1;GLI3;MAP3K20;RSPO2;PTCH1;FGF10;KAT2B;LRP4;IFT122;SMOC1;KAT2A
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.5550812560473279,1.0901994388828211,0.39971550497866287,0.7559316060941392,1.0,3/11,8.99%,ANXA1;RC3H2;RC3H1
prerank,regulation of signal transduction (GO:0009966),0.42218886287226226,1.0901126717863854,0.3066132264529058,0.7556922399645098,1.0,26/190,12.36%,RUNX1;TREM2;UBASH3B;TGFB1;CD3E;IRAK2;LFNG;PTPN1;NUP62;DHRS3;GRK3;NCK2;MTCH1;TRIM5;SREBF2;TIMP1;CD80;ZDHHC7;MDFIC;ZDHHC3;DTNBP1;CD63;WDR11;FYN;PPP2CA;GRK4
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.45223933103327724,1.0898163544567077,0.39775280898876403,0.7560192137592217,1.0,7/43,6.51%,P2RY6;ERN1;TNF;LDLRAP1;IL6R;IL18;AIF1
prerank,regulation of muscle contraction (GO:0006937),-0.3227344108346466,-1.0892937320966982,0.34523809523809523,0.8604915510531831,1.0,7/26,13.05%,CHRM2;CAV1;SRI;KCNA1;ATP1A2;PLCE1;KCNB2
prerank,nucleoside catabolic process (GO:0009164),-0.4259035830226192,-1.089126922737307,0.36774193548387096,0.857033637330151,1.0,2/11,5.30%,UPP2;NT5E
prerank,establishment of spindle orientation (GO:0051294),-0.3237612895132026,-1.0889920648263576,0.2916666666666667,0.8535433006381266,1.0,6/28,11.09%,PAFAH1B1;MAP4;GPSM2;NDEL1;NDE1;CDK5RAP2
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.42917407496799354,1.0888733217338997,0.37163561076604557,0.758018252964651,1.0,16/73,16.29%,RUNX1;GATA1;OSM;SPI1;PSMB10;TAL1;LMO2;PSMA2;METTL3;PSME3;ITCH;PSMB5;PSMD8;PSMD7;PSMB9;PUS7
prerank,actin-myosin filament sliding (GO:0033275),0.4547150980886926,1.0883844036457262,0.3737259343148358,0.7583206627949954,1.0,6/38,13.93%,MYL3;TTN;TNNT3;TPM4;TPM3;DES
prerank,muscle filament sliding (GO:0030049),0.4547150980886926,1.0883844036457262,0.3737259343148358,0.7583206627949954,1.0,6/38,13.93%,MYL3;TTN;TNNT3;TPM4;TPM3;DES
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.44742151255436025,1.0882390997548756,0.3926645091693635,0.7582431556927989,1.0,10/55,13.92%,GRB2;MAPK14;SNCA;XDH;TGFBR2;TP53;THBS1;PARL;COQ7;PID1
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.36469218761123035,-1.088185595563013,0.32710280373831774,0.8520922505389654,1.0,8/17,23.33%,SOD2;PRKG1;TGFB3;PPARG;TAFA5;PDCD4;CDKN1A;GPER1
prerank,cardiac cell development (GO:0055006),0.5598088354623008,1.0878446811550324,0.3948497854077253,0.7588215764302476,1.0,2/11,4.28%,SLC8A1;TTN
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.4326182218271269,1.087733111101038,0.3543788187372709,0.7586452492782828,1.0,23/94,18.10%,TUBB;MKS1;PRKAR2B;HAUS2;TUBA4A;CNTRL;CEP192;MAPRE1;CEP70;PLK4;CEP76;HAUS1;RAB11A;DYNC1H1;PCM1;CEP152;HAUS8;CEP162;AHI1;NINL;HSP90AA1;AKAP9;CEP63
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.5330476705540494,1.0876169883912017,0.39859154929577467,0.7584852449545557,1.0,3/13,14.22%,PTPN1;ATF6B;WFS1
prerank,insulin receptor signaling pathway (GO:0008286),0.4384460077833467,1.0875677635160916,0.375,0.7581542294305604,1.0,18/69,16.09%,ATP6V0D2;ATP6V0E1;TCIRG1;GRB2;ATP6V1C1;ATP6V1E1;ATP6V0A2;ATP6V0D1;AP3S1;BCAR1;ATP6V0A1;ATP6AP1;ZNF106;PHIP;ATP6V0B;BCAR3;GSK3A;IDE
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.4301344526212881,1.0872721628756912,0.3481404958677686,0.7584379331380665,1.0,16/85,15.64%,TREM2;BAG2;CBFA2T3;RNF180;RNF19B;CEBPA;TAF1;HECTD1;ATXN3;DET1;CSNK1A1;STUB1;RNF144B;LRRK2;PIAS1;GSK3A
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.5334598397512192,1.0872557580270727,0.41456953642384103,0.7580064350234019,1.0,3/14,13.41%,RFFL;GPS2;GAS6
prerank,positive regulation of protein modification process (GO:0031401),0.4217497184686505,1.0867873592604969,0.3026052104208417,0.7587588607287058,1.0,25/203,9.57%,TREM2;GPNMB;LYN;TGFB1;CD74;ITGB3;CSF1R;NIBAN1;PRKCD;RAP2A;SEMA4D;CCND3;ATG7;TNF;FNIP1;BRAT1;RAB3GAP2;CCND2;SVIP;VEGFB;RAMP1;TNIK;FLCN;SPPL3;NOS1AP
prerank,cell cycle checkpoint signaling (GO:0000075),0.5333894996714119,1.086700231498374,0.38950276243093923,0.7585183885516199,1.0,7/12,27.37%,NABP1;PLK2;PRCC;ZWINT;BUB1B;ZWILCH;WEE1
prerank,regulation of execution phase of apoptosis (GO:1900117),0.5470794406317854,1.085538812686875,0.38865248226950355,0.7611431455696344,1.0,3/11,6.70%,FZD3;BCL2L1;TP53
prerank,anterograde axonal transport (GO:0008089),-0.2945046078719733,-1.08491431636002,0.26956521739130435,0.8579960100146906,1.0,8/37,10.38%,DLG2;KIF5B;SPAST;SOD1;NEFL;MAPK8IP3;KIF3B;KIF5A
prerank,negative regulation of cell division (GO:0051782),-0.4169582123246191,-1.0847178308344119,0.36942675159235666,0.8547385273563797,1.0,7/11,43.89%,ZFYVE19;VPS4A;ORC6;CHMP4C;E2F7;MYC;E2F8
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.5505739647843797,1.0844526706136457,0.39779005524861877,0.7635465999472094,1.0,2/11,6.70%,MAD2L2;TP53
prerank,regulation of sodium ion transport (GO:0002028),0.45724560513381,1.0838899160309219,0.37703016241299303,0.7645320777106659,1.0,12/34,18.96%,SCN4B;P2RX7;PKP2;P2RX4;WNK1;PRSS8;WNK4;YWHAH;SCN5A;SPTBN4;PER1;CNKSR3
prerank,neural tube closure (GO:0001843),0.4606961594148854,1.0836473361626002,0.4037122969837587,0.7647106519878585,1.0,3/34,4.59%,TGFB1;SKI;PLXNB2
prerank,telomere maintenance via telomere trimming (GO:0090737),0.5573867977829674,1.0835589570856239,0.40830945558739257,0.7634967110541352,1.0,4/10,18.75%,EXO1;DNA2;SLX4;ERCC1
prerank,t-circle formation (GO:0090656),0.5573867977829674,1.0835589570856239,0.40830945558739257,0.7634967110541352,1.0,4/10,18.75%,EXO1;DNA2;SLX4;ERCC1
prerank,formation of extrachromosomal circular DNA (GO:0001325),0.5573867977829674,1.0835589570856239,0.40830945558739257,0.7634967110541352,1.0,4/10,18.75%,EXO1;DNA2;SLX4;ERCC1
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.5437770414570973,1.0832918346721732,0.4055232558139535,0.7637483135356028,1.0,2/10,10.05%,PCSK9;NEDD4L
prerank,ncRNA export from nucleus (GO:0097064),-0.2953876488622624,-1.0830737049165424,0.2818181818181818,0.8559748889490313,1.0,17/36,22.05%,NUP93;NUP188;RANBP2;SSB;NUP98;NUP42;PHAX;NDC1;RAE1;NUP153;NUP37;NUP133;NUP50;RAN;NUP43;NPM1;NCBP2
prerank,peptidyl-serine modification (GO:0018209),0.4197360641766482,1.0827840361934573,0.3340020060180542,0.7645946355541218,1.0,51/166,21.33%,MAPKAPK3;MAP4K1;TGFBR1;PRKCD;CAMK1D;MTOR;MAPK14;NEK6;PRKD2;MORC3;TLK1;TAF1;PRKCB;MKNK1;TGFBR2;WNK1;PLK2;CSNK1G2;POGLUT2;PRKCQ;CSNK2A2;CSNK2A1;POGLUT1;SMG1;PRKCH;HPF1;STK32C;PKN1;RPS6KA4;CSNK1A1;MAP3K12;GAS6;GALNT2;LRRK2;MGAT5B;SGK3;RPS6KA2;STK4;RPS6KA5;GALNT1;PDPK1;VRK1;TOP1;ROCK2;TLK2;DCLK3;CDK5R1;GSK3B;CSNK1G3;MARK1;BRSK1
prerank,pyrimidine nucleobase metabolic process (GO:0006206),0.5496578387014538,1.082768521240448,0.4092827004219409,0.7641625287796066,1.0,3/12,15.71%,CTPS1;CDA;DPYSL5
prerank,positive regulation of neuron differentiation (GO:0045666),0.4556680248184129,1.0825588808576927,0.3789237668161435,0.764220039333516,1.0,5/40,9.84%,ASCL1;GPRC5B;MMD;MEF2C;IMPACT
prerank,SNARE complex assembly (GO:0035493),0.5459203715652552,1.0825200631295868,0.38589211618257263,0.7638441434014372,1.0,3/10,9.41%,VAMP3;SNCA;UVRAG
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.44578362546537526,1.0823922711686715,0.37318435754189944,0.7636916157790805,1.0,7/43,7.56%,CBL;PTPRJ;DUSP3;GRB2;ZFYVE28;RAB7A;SH3KBP1
prerank,negative regulation of blood pressure (GO:0045776),-0.41604121868801186,-1.0822188491804803,0.33969465648854963,0.8547741202048462,1.0,6/13,26.63%,SCPEP1;NOS3;NOS1;DRD2;BMPR2;GPR37L1
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.44042985707601046,1.0821318064346084,0.38353196099674974,0.7639014269925737,1.0,13/52,15.03%,TREM2;LGALS3;PLS1;TNF;AKAP5;STAC;PRKCH;EPB41;STX3;EPB41L2;STAC3;ARF6;LRP1
prerank,'de novo' posttranslational protein folding (GO:0051084),0.4582712257117143,1.081998733114324,0.3912009512485137,0.7637611383510435,1.0,7/30,16.71%,PTGES3;SDF2L1;DNAJC7;CHCHD4;BAG1;GAK;ERO1A
prerank,long-chain fatty acid transport (GO:0015909),0.4738841116693621,1.0818171454072496,0.388631090487239,0.7637640511202872,1.0,9/30,17.99%,FABP4;SLC25A20;APOE;ABCD1;FABP5;ACACA;CD36;CPT2;ABCD2
prerank,long-chain fatty acid import into cell (GO:0044539),-0.43201946640857347,-1.0816557972796879,0.3790849673202614,0.8526203291482389,1.0,6/10,28.88%,ACSL1;SLC27A1;SLC27A4;ACSL3;SLC2A1;SLC27A2
prerank,embryonic axis specification (GO:0000578),-0.3895036858274734,-1.081508335851124,0.3374485596707819,0.8493514223097953,1.0,10/15,44.05%,COBL;TBX3;SMAD6;PTCH1;STIL;FZD5;CXXC4;RIPPLY2;WNT7A;HOXD8
prerank,regulation of cellular localization (GO:0060341),0.4415502624916938,1.0808602607598874,0.380327868852459,0.7657808120995674,1.0,9/46,16.72%,LYN;UNC13D;NR1H4;REEP6;LRP5;DYNC1H1;LRRK2;STXBP4;HSP90AA1
prerank,protein targeting to ER (GO:0045047),0.42303951060872214,1.0801656088584874,0.37448979591836734,0.7671620903982989,1.0,41/99,25.70%,RPL23;RPL17;EDEM1;RPL10A;RPS2;RPL18A;RPS15A;SPCS2;SPCS1;RPL6;RPLP2;RPL26;RPS20;RPS16;RPS14;RPL19;SRP19;RPL9;RPS11;RPL11;RPS23;RPS4X;RPS27;SEC63;RPL4;RPL7A;RPL15;RPL29;RPL22;RPS7;SRP14;RPS13;RPLP1;RPS15;SRP9;RPS5;RPL41;RPL10;RPS8;RPL5;RPL18
prerank,positive regulation of heart contraction (GO:0045823),-0.3654261292612133,-1.080022919574168,0.32407407407407407,0.850094728066982,1.0,8/19,29.71%,RYR2;ATP1A2;EDN1;EDN3;TGFB2;CHGA;ATP2A2;SCN3B
prerank,sodium ion homeostasis (GO:0055078),0.5025299612253389,1.0799376434045074,0.4010416666666667,0.7672815457776302,1.0,6/21,13.76%,SLC8A1;SLC9A1;TFAP2B;NEDD4L;ATP1B3;ATP1B2
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.31765659275264324,-1.0799037390688566,0.3333333333333333,0.8466501352961852,1.0,12/27,26.75%,ANK2;DMD;JPH1;FKBP1A;SELENON;AHNAK;NOS1;JPH2;JPH4;PDE4D;CALM2;CACNB3
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.498495072878915,1.0798614766786645,0.39648682559598497,0.7669905865429513,1.0,6/23,11.48%,TSPAN6;NLRC3;SPI1;ADGRG3;TMSB4X;ADIPOR1
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.49309222822647164,1.0797814599473954,0.3943139678615575,0.7667126610373222,1.0,4/22,13.13%,CYRIB;TRAF2;MALT1;B2M
prerank,regulation of histone H3-K9 methylation (GO:0051570),0.5559084183601986,1.0797631119334796,0.3884057971014493,0.7662710478034453,1.0,2/10,9.48%,PRDM12;ATRX
prerank,cellular response to alcohol (GO:0097306),0.442408790798819,1.079610066743169,0.3870967741935484,0.7662173344496848,1.0,13/42,20.42%,ADCY7;MAP4K1;ADCY6;CTNNB1;LARP1;GLRA2;ADCY8;ADCY3;GNG2;GOLPH3;GRAMD1C;SPIDR;OSBPL7
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.48372450293244224,1.0786124193599722,0.39155920281359907,0.7683193932345936,1.0,5/24,9.02%,ITGB3;PTPN1;PRKD2;PRKCB;PDCD6
prerank,negative regulation of response to external stimulus (GO:0032102),0.4250017563430748,1.0784704004318109,0.3586626139817629,0.7682328763436299,1.0,16/105,13.40%,SIRPA;METRNL;PRKCD;DUSP3;NLRC3;RTN4RL1;NR1H4;APOE;OTULIN;TRAFD1;TNFAIP3;RB1;CASK;ITCH;GPS2;FNDC4
prerank,regulation of SMAD protein signal transduction (GO:0060390),0.4918787968041483,1.078038453075283,0.3944020356234097,0.7689001602374234,1.0,3/21,8.40%,TGFB1;TGFBR1;FAM89B
prerank,cellular protein-containing complex assembly (GO:0034622),0.41785426429717215,1.0779592532914843,0.3460381143430291,0.7686252426712128,1.0,47/159,21.82%,TGFB1;CD3E;VAMP3;TBCEL;DHX9;PTGES3;NCK2;SNX9;SNCA;TRAF2;DNAI4;FMOD;LONP1;AP2S1;TBCC;PSMG3;CHCHD4;SMAD3;HSF1;UVRAG;EIF4H;TPR;IMMP2L;CLTC;NUP205;NRG1;PRLR;BBS12;SRP19;EPS15;SRC;AP2M1;RTN4;HSP90AA1;GTF2B;BIN1;MIS12;PICALM;ANGPT1;TMEM170A;FCHO2;GPX4;CYBA;PDE4DIP;DNAJB14;VAMP8;PSMG2
prerank,ubiquinone metabolic process (GO:0006743),0.5147898684859367,1.0779538880669408,0.4163265306122449,0.7681638911812407,1.0,8/15,21.44%,COQ9;PDSS1;COQ7;COQ8B;FDXR;COQ3;COQ6;UBIAD1
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.5375931186203374,1.0777918679795317,0.3988995873452545,0.7681691194125094,1.0,3/13,11.84%,SULT4A1;BPNT1;TPST1
prerank,carnitine metabolic process (GO:0009437),0.5410640965730973,1.0773619787846844,0.39385474860335196,0.7688864802999721,1.0,5/12,23.85%,ALDH9A1;ACADL;CPT2;CROT;CPT1A
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.5137001555602173,1.0772989023626764,0.4017971758664955,0.7685763461818543,1.0,1/17,2.53%,LPCAT1
prerank,cellular polysaccharide catabolic process (GO:0044247),0.516930198685981,1.0771609914762044,0.3949801849405548,0.7684629773487032,1.0,1/16,0.75%,MGAM
prerank,nuclear body organization (GO:0030575),-0.4162327908958201,-1.0766882250282555,0.3795620437956204,0.8525239479567914,1.0,4/12,22.96%,AFF2;PML;WRAP53;USP50
prerank,actin filament bundle assembly (GO:0051017),0.4623645868226544,1.0765464015394626,0.3875,0.7695808030544163,1.0,5/33,7.51%,LCP1;PLS1;AIF1;NEDD9;MICAL1
prerank,negative regulation of cell differentiation (GO:0045596),0.4159402932317876,1.0764278406902377,0.34804413239719156,0.7694053483176906,1.0,31/181,14.68%,PTK2B;ASCL1;SHH;TGFB1;ABCA1;ITGB3;TGFBR1;MAD2L2;SEMA4D;PKP2;TNF;ABCG1;SKI;XDH;NKX2-1;MYOCD;LEO1;RB1;SMAD3;LRP5;SOX9;SRA1;ADIPOR1;PPP2CA;CDK6;BAMBI;VASN;GPS2;SOX2;BBS12;MEIS1
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.551927096889393,1.076398767424821,0.39939024390243905,0.7690196340102496,1.0,3/10,14.53%,NFE2L2;GPR37;LRRK2
prerank,positive regulation of smooth muscle cell migration (GO:0014911),0.4993000650812819,1.0763055502384309,0.4165588615782665,0.7687907382798935,1.0,4/17,11.23%,MDK;AIF1;DOCK4;NRP1
prerank,actin polymerization or depolymerization (GO:0008154),0.44187675309676383,1.0760598389440201,0.3971861471861472,0.7689511808652597,1.0,10/50,12.19%,PREX1;PSTPIP1;MICALL2;FLII;AIF1;MICAL1;WASHC3;ABI1;DIAPH1;TWF2
prerank,negative regulation of cellular process (GO:0048523),0.41490960990332654,1.0756666713830205,0.25,0.7695704863645664,1.0,88/521,14.77%,PTK2B;LILRB1;TREM2;GPNMB;LYN;SHH;SMYD5;TGFB1;FCGR2B;TMIGD3;IL1A;SIRPA;CBFA2T3;VAMP3;PTPRJ;TLR2;SLURP1;ADAMTS8;PLXNC1;NUP62;MDK;OSM;CD9;UTP20;NCK2;SEMA4D;NME6;RGCC;PKD2;SKI;TGFBI;HPGD;CEBPA;PLXNB2;ATP8A2;MYH9;RIPOR2;SPEG;CTNNB1;CDA;TP53;MYOCD;PIM2;EPO;ST18;AQP11;FLCN;TFAP2B;RB1;SMAD3;SIPA1;PODN;TMEM98;CASK;ABI1;STRN;PODXL;P3H2;IMPACT;ARHGDIB;ACTN1;INHBA;TNFRSF21;DYSF;SH2B3;NF2;CHERP;BECN1;PTPRU;PARP16;TNFRSF1B;RBBP7;PPP2CA;CDK6;ADGRG1;NR4A1;ADARB1;ARHGDIA;DDAH1;CTTNBP2NL;CDC6;IRF1;FTH1;WFS1;BRD7;SOX4;TMEM127;PRKRA
prerank,peptide cross-linking (GO:0018149),0.47710795254637395,1.075646405798598,0.40613496932515336,0.7691505158508745,1.0,3/25,11.25%,F13A1;ANXA1;THBS1
prerank,negative regulation of transmembrane transport (GO:0034763),0.5617846979648586,1.0754393181393995,0.4067055393586006,0.7692202485063634,1.0,4/10,19.95%,PRKCB;THBS1;CTTNBP2NL;INPP5K
prerank,glutamine family amino acid metabolic process (GO:0009064),0.4569803952452542,1.0753692797230157,0.4016110471806674,0.7689211926918591,1.0,6/33,14.00%,DGLUCY;MTHFS;ART4;PYCR2;DDAH1;OAT
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.43289366361741505,1.0750788089167036,0.38636363636363635,0.7691786602197805,1.0,5/53,6.99%,TREM2;BAG2;APOE;XPO1;GNA12
prerank,regulation of cell communication (GO:0010646),0.45410099091621686,1.075077023682159,0.39120631341600903,0.7687105598689112,1.0,6/35,6.34%,PTPN1;NUP62;SLC8A1;GRK3;MTCH1;ANXA1
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.4248818282975369,1.074499257946168,0.3856691253951528,0.7697251460587392,1.0,15/70,16.29%,RUNX1;GATA1;OSM;PSMB10;TAL1;LMO2;PSMA2;METTL3;PSME3;ITCH;PSMB5;PSMD8;PSMD7;PSMB9;PUS7
prerank,negative regulation of neuron differentiation (GO:0045665),0.48287781809303293,1.0744487704434325,0.4215080346106304,0.7693771788350429,1.0,6/22,20.45%,ASCL1;SOX9;B2M;SOX2;CNTN4;GSK3B
prerank,diol biosynthetic process (GO:0034312),0.5107567142531845,1.0743294854520997,0.4010840108401084,0.7692118657426384,1.0,6/15,21.24%,GCH1;QDPR;ACER3;SPR;ASAH1;ABCA2
prerank,protein K11-linked ubiquitination (GO:0070979),0.4770856939817255,1.0736261245340035,0.3910482921083628,0.7705592231066438,1.0,7/27,11.26%,CDC23;UBE2D3;UBE2S;UBE2E3;RNF4;UBE2H;FZR1
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),0.4636838355676269,1.0736033891133079,0.3965317919075145,0.7701515446545647,1.0,6/35,11.85%,CD300A;MTOR;PPP6R1;PPP1R11;BOD1L1;PPP4R4
prerank,inner dynein arm assembly (GO:0036159),-0.4436951938705599,-1.073505676766196,0.35587188612099646,0.8583998933904518,1.0,9/10,52.94%,DNAAF5;CCDC39;CFAP100;CCDC40;DNAAF4;DNAH1;DNAAF1;DNAI3;CFAP73
prerank,negative regulation of intracellular protein transport (GO:0090317),-0.338621648980433,-1.0733764210647154,0.35784313725490197,0.8550895209871748,1.0,8/22,18.42%,SP100;GDI1;LMAN1;RAB23;INSIG1;DMTN;PARK7;CABP1
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.5309548266038558,1.0733735447675181,0.41562064156206413,0.7702888120192475,1.0,5/13,13.27%,EDEM1;SEC16A;SEC16B;SORL1;SAR1A
prerank,positive regulation of mitochondrion organization (GO:0010822),0.4382595108133767,1.0732584175297146,0.4002145922746781,0.7700965767715823,1.0,14/57,20.78%,TREM2;DDHD1;PYCARD;TP53;BAK1;PPARGC1A;CAMKK2;BMF;GSK3A;TNFSF10;DNM1L;FIS1;GSK3B;PRKN
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.4588375094044025,1.0729184486134384,0.41723356009070295,0.770494406849927,1.0,7/32,14.05%,PKIB;XRCC5;CTNNB1;PRKCQ;CCT8;TNKS2;CCT5
prerank,regulation of mitochondrial depolarization (GO:0051900),0.5448828096734907,1.072898879573455,0.39880952380952384,0.7700809160955391,1.0,6/10,24.66%,FZD9;ABCD1;LRRK2;SRC;RACK1;KDR
prerank,negative regulation of protein polymerization (GO:0032272),0.4711086325747344,1.0724065005593466,0.3898916967509025,0.7709194905440516,1.0,9/27,13.45%,CYRIB;PRKCD;SNCA;ARFGEF1;MAPRE1;PFN2;PFN1;TWF2;SSH2
prerank,neurotrophin signaling pathway (GO:0038179),0.4862735993539351,1.0719008898762497,0.42803504380475593,0.7717284811951785,1.0,8/21,19.71%,GRB2;NTF3;BCAR1;RAPGEF1;DDIT4;RAP1A;KIDINS220;SORT1
prerank,histone lysine methylation (GO:0034968),0.46275390412882217,1.071448385944751,0.4020618556701031,0.7723968399763668,1.0,10/33,18.42%,WDR5B;CXXC1;SETD6;DPY30;DOT1L;RBBP5;SMYD3;SUV39H1;SETD1B;WDR82
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.48652596880065896,1.0705892515589512,0.4095354523227384,0.7742113344998768,1.0,5/22,7.50%,P2RY6;PKD2;STAC;SLC9A1;VMP1
prerank,cellular biogenic amine catabolic process (GO:0042402),0.5458337184098829,1.0705577509479391,0.4186991869918699,0.7738073858975464,1.0,4/10,20.02%,SMOX;ALDH7A1;COMT;SLC44A1
prerank,positive regulation of transforming growth factor beta production (GO:0071636),-0.4289749441129524,-1.0705517032564378,0.3584905660377358,0.8599348949105333,1.0,4/11,11.23%,BMPR1A;CD200;CD46;PTGS2
prerank,autophagosome organization (GO:1905037),0.4401497156309042,1.0702839219826192,0.42548596112311016,0.7740587956609175,1.0,18/50,22.34%,ATG7;MAP1LC3B;RAB7A;VMP1;EMC6;RAB1B;BECN1;ATG2B;IRGM;ATG3;UBXN2A;ATG14;PACS2;TMEM41B;ATP13A2;NSFL1C;TP53INP2;RB1CC1
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),-0.4129452560779005,-1.0702361319263323,0.38380281690140844,0.8534424860005372,1.0,3/12,7.04%,EFNA5;KANK1;AP1AR
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),-0.4129452560779005,-1.0702361319263323,0.38380281690140844,0.8534424860005372,1.0,3/12,7.04%,EFNA5;KANK1;AP1AR
prerank,regulation of wound healing (GO:0061041),0.4436272226221278,1.070159964547095,0.39620535714285715,0.773921055726149,1.0,6/42,9.65%,GP1BA;ARFGEF1;TNFAIP3;ANXA1;CASK;ACTG1
prerank,protein oxidation (GO:0018158),0.5485259408878508,1.0699665827067937,0.41553133514986373,0.7739635552080407,1.0,5/11,21.46%,LOX;CHCHD4;PRDX3;LOXL3;SUMF1
prerank,macroautophagy (GO:0016236),0.42306714000452483,1.0692434098481245,0.38244197780020184,0.775356048083788,1.0,40/118,22.54%,LIX1;TCIRG1;VTA1;ATG7;MAP1LC3B;CLN3;PIP4K2A;PLEKHM1;MTMR3;FUNDC1;CSNK2A2;CSNK2A1;TECPR1;SNAP29;UVRAG;VPS37C;BECN1;TOMM40;VDAC1;VPS39;SRC;SNX14;ATG3;ARL8B;VPS28;PIK3R4;VPS33B;ATG14;PLAA;TBC1D5;TOMM20;MFN1;ATP13A2;EPG5;STAM2;PRKN;VAMP8;RB1CC1;ATG10;MTMR14
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.4960206513340825,1.0688527824307759,0.3935897435897436,0.7758871377389592,1.0,10/20,22.31%,KCTD17;HERPUD1;BAK1;WFS1;CCDC47;SELENOK;PACS2;FIS1;RAP1GDS1;TGM2
prerank,cellular response to oxidative stress (GO:0034599),0.4181265965740282,1.0688064281472263,0.3772819472616633,0.775547879245275,1.0,30/118,18.38%,CYBB;NCF4;NFE2L2;PRKCD;NCF2;SNCA;PKD2;FOXO3;TXNRD1;AIF1;TP53;LONP1;PPARGC1A;PRDX1;PYCR2;MSRA;PRDX3;PRDX6;PRDX2;CAMKK2;LRRK2;HIF1A;CPEB2;ERO1A;PRDX5;GPX8;PYROXD1;STX2;KEAP1;GSR
prerank,striated muscle cell differentiation (GO:0051146),0.5029825049101512,1.0686372695168493,0.39846743295019155,0.7755213924996146,1.0,5/16,12.63%,SKI;PLD3;MYOCD;MEF2C;NRG1
prerank,regulation of vasoconstriction (GO:0019229),-0.32642265357218603,-1.0680385679718236,0.34806629834254144,0.8561859698606824,1.0,11/27,27.30%,CAV1;ECE1;ACE;CHRM3;PER2;TBXA2R;BMPR2;KCNMB2;AGTR1;ACE2;AGT
prerank,pteridine-containing compound metabolic process (GO:0042558),0.5330156682377294,1.0680294468231224,0.4171195652173913,0.7766140811919237,1.0,5/13,17.44%,GCH1;QDPR;SPR;HSP90AA1;FPGS
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),0.5115769122402097,1.0676797700049954,0.4116059379217274,0.7770284548025321,1.0,4/15,9.46%,EDEM1;RAB3GAP2;SPCS2;SPCS1
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),0.5044835067889625,1.0668278994624738,0.4112271540469974,0.778744991996067,1.0,1/18,0.31%,PTK2B
prerank,eye photoreceptor cell development (GO:0042462),0.5112596518499921,1.066720222414339,0.4098798397863818,0.7785312828715631,1.0,3/15,8.12%,THY1;NRL;MYO7A
prerank,endoderm formation (GO:0001706),0.4535566675695371,1.0661042294181904,0.4,0.7796595494544921,1.0,5/35,10.54%,ITGB2;ITGA4;ITGB5;SETD2;INHBA
prerank,positive regulation of exocytosis (GO:0045921),0.4553328941678615,1.0659065120044644,0.40558659217877097,0.7797155765598014,1.0,11/35,20.00%,UNC13D;SNCA;SMPD3;RAB7A;SYTL4;ATP6AP1;SDCBP;PDCD6IP;RAB27B;STXBP5;ATP13A2
prerank,neuron development (GO:0048666),0.4151108854064522,1.0656616613141707,0.3678391959798995,0.7798287064206536,1.0,19/141,9.82%,RUNX1;LYN;ASCL1;PRDM12;MICALL2;ATP7A;APOE;ATP8A2;MYT1L;THOC2;HMGB1;GPRIN3;MICALL1;LRP12;WNK1;MEF2C;RB1;ATCAY;RAB11A
prerank,C21-steroid hormone metabolic process (GO:0008207),0.49042053829926047,1.0650583592207417,0.41594022415940224,0.7809517118292888,1.0,4/20,20.62%,TSPO;FDXR;FDX1;STARD3
prerank,positive regulation of lamellipodium organization (GO:1902745),0.4605409582259456,1.0649784664840787,0.41629464285714285,0.7806796061088151,1.0,11/32,17.93%,RREB1;ARPC2;WASF2;AKIRIN1;ACTR2;ACTR3;CYFIP1;TWF2;SRC;CORO1C;CDC42
prerank,fatty acid catabolic process (GO:0009062),0.425055674967418,1.064501804747967,0.39979123173277664,0.7814847413627124,1.0,25/67,24.26%,LPIN2;EHHADH;CEL;ACAD10;NUDT19;ACADL;ABCD1;PEX13;ECHS1;ILVBL;ECI1;ABHD3;MMUT;CPT2;PPARD;PCCA;ABCD2;ECHDC1;LPIN1;ACOT8;CROT;MMAA;ABHD2;HADHA;HADH
prerank,regulation of protein metabolic process (GO:0051246),0.44384381872672185,1.064334808873506,0.4063526834611172,0.7814659188203164,1.0,13/44,19.65%,GSAP;SHH;APOE;TRAF3;CHEK2;NEDD4L;SPOP;PARL;WFS1;FAF1;FURIN;MAP2K5;ROCK2
prerank,regulation of centriole replication (GO:0046599),0.4960222188093869,1.0639169198976126,0.4165554072096128,0.7820459161381534,1.0,5/17,7.73%,NUP62;MDM1;PLK4;PLK2;CEP76
prerank,regulation of viral release from host cell (GO:1902186),0.49147256924670507,1.0633545077660997,0.42714819427148193,0.7829780370647142,1.0,5/21,11.60%,TRIM25;TRIM5;TRIM8;MID2;TRIM35
prerank,cellular response to nerve growth factor stimulus (GO:1990090),-0.33569301352065406,-1.0632456694621124,0.37745098039215685,0.8666791454790737,1.0,11/22,22.13%,NTRK3;STMN2;NGF;EHD1;MAPT;RAPGEF2;AKT1;MAGI2;WASF1;BDNF;NTRK2
prerank,vasodilation (GO:0042311),-0.3985417183388339,-1.0626594976875465,0.373015873015873,0.864780704347482,1.0,7/13,26.87%,SOD2;SOD1;KLF2;NOS3;NOS1;GPER1;ADRB2
prerank,negative regulation of phosphorylation (GO:0042326),0.4250364979078976,1.0623868846909323,0.4131551901336074,0.7849625774332721,1.0,22/85,20.78%,LYN;TGFB1;STAP1;SIRPA;CBFA2T3;NIBAN1;XDH;IBTK;IMPACT;HDAC4;INHBA;PRDX3;PID1;LRRK2;PTEN;CORO1C;PAQR3;TIGAR;ATG14;INPP5K;ANKLE2;PRKN
prerank,regulation of membrane depolarization (GO:0003254),0.4995296853494619,1.0621958360329413,0.4095112285336856,0.7849949523271622,1.0,6/18,18.68%,HCN4;ABCD1;NEDD4L;LRRK2;SCN5A;PTPN3
prerank,positive regulation of T cell cytokine production (GO:0002726),0.48587496207326464,1.0618373582461522,0.41511771995043373,0.7854620174411259,1.0,5/20,13.13%,TRAF2;IL18;MALT1;DENND1B;B2M
prerank,epiboly involved in wound healing (GO:0090505),0.4981590397397508,1.0615595070797856,0.4131578947368421,0.7857097635789897,1.0,8/16,23.23%,LCP1;CD44;MRTFA;TOR1A;RHOA;FLNA;DDR1;PDPN
prerank,potassium ion transport (GO:0006813),0.4174824400426771,1.0606663880705218,0.40365111561866124,0.7875413836175825,1.0,13/120,7.51%,KCNJ11;AQP1;HCN4;SLC9A4;KCNN4;KCNK6;PKD2;KCNIP2;SLC9A9;CCDC51;KCNMA1;SLC9A1;KCNK13
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.3258521522388141,-1.0603587566572321,0.34146341463414637,0.8674895610272699,1.0,13/24,30.40%,DMD;JPH1;SRI;FKBP1A;CALM3;SELENON;NOS1;JPH2;JPH4;PDE4D;CALM2;GSTO1;CASQ2
prerank,regulation of response to interferon-gamma (GO:0060330),0.5123346847103889,1.0601340954806033,0.4161073825503356,0.7884131982835632,1.0,9/14,30.33%,IFNGR2;PIAS1;SOCS3;IFNGR1;PARP9;HSP90AB1;CDC37;SUMO1;JAK2
prerank,negative regulation of chemotaxis (GO:0050922),-0.30325989694920674,-1.059339273220025,0.2992125984251969,0.8667016792020509,1.0,9/31,8.55%,SEMA6A;ROBO2;SEMA5A;SEMA3A;SEMA6D;ROBO1;SLIT2;SEMA3C;SEMA3D
prerank,extracellular structure organization (GO:0043062),0.4067346046882765,1.0590880797524846,0.34634634634634637,0.7905771314930162,1.0,26/204,10.54%,ITGAL;MMP12;ITGA2B;ITGAX;ITGB2;SMOC2;ITGA4;ITGB3;TGFBR1;ITGB5;ITGA2;ADAMTS8;ITGA6;ATP7A;TTR;TGFBI;SPP1;CD44;ITGAE;TNR;AGRN;LOX;BCAN;ITGAM;F11R;MMP19
prerank,cotranslational protein targeting to membrane (GO:0006613),0.4168049280549614,1.058620179454763,0.41513292433537835,0.7913168676805938,1.0,38/91,25.70%,RPL23;RPL17;RPL10A;RPS2;RPL18A;RPS15A;RPL6;RPLP2;RPL26;RPS20;RPS16;RPS14;RPL19;SRP19;RPL9;RPS11;RPL11;RPS23;RPS4X;RPS27;SEC63;RPL4;RPL7A;RPL15;RPL29;RPL22;RPS7;SRP14;RPS13;RPLP1;RPS15;SRP9;RPS5;RPL41;RPL10;RPS8;RPL5;RPL18
prerank,mitochondrial calcium ion homeostasis (GO:0051560),-0.3377103175410902,-1.0584882063969125,0.3247422680412371,0.8653316275635211,1.0,4/21,3.95%,AFG3L2;BCAP31;MICU1;SLC8A3
prerank,artery morphogenesis (GO:0048844),0.4633584002967197,1.0582569567248277,0.40229885057471265,0.7917937459210663,1.0,8/30,16.03%,TGFBR1;ANGPTL3;PKD2;HPGD;TFAP2B;NRP1;LRP1;NF1
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.43522313666044316,1.0581123024403667,0.41594827586206895,0.7916855210031454,1.0,8/50,14.42%,GTF2H1;CCND3;BCCIP;CCND2;ACTB;CDK7;CDC6;CCNE2
prerank,BMP signaling pathway (GO:0030509),-0.2660488172683934,-1.0577353636430495,0.3333333333333333,0.8638236843182964,1.0,15/62,14.77%,BMPR1A;SLC33A1;RGMA;BMP4;ACVR1;TGFBR3;ACVRL1;SMAD9;BMP5;SMAD4;SMAD5;SMAD1;RGMB;SMAD6;TGFB3
prerank,DNA geometric change (GO:0032392),0.47092280050484286,1.05746305829902,0.4170731707317073,0.7928669031343614,1.0,6/24,14.16%,DHX9;HMGB1;ANXA1;MCM9;DNA2;DDX1
prerank,cytoplasmic translation (GO:0002181),0.4187441821486537,1.056851725468886,0.40392561983471076,0.7939593080728837,1.0,40/91,25.70%,RPL23;RPL17;RPL10A;RPS2;RPL18A;RPS15A;GSPT1;EIF4A1;RPL6;RPL26;RPS20;RPS16;RPS14;RPL19;RWDD1;RPL9;TMA7;RPS11;RPL11;RPS23;RPS4X;RPS27;RPL4;RPL7A;RPL15;RPL29;RPL22;RPS7;RPS13;RPL22L1;RPLP1;EIF3M;RPS15;RPS5;RPL41;DRG2;RPL10;RPS8;RPL5;RPL18
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.5361788795227849,1.0568170502530332,0.42896174863387976,0.7935868105534954,1.0,3/13,11.23%,PLXNC1;PLXNB2;NRP1
prerank,"transcription, DNA-templated (GO:0006351)",0.4083964824728339,1.0564937408137918,0.374,0.793928508839747,1.0,70/207,25.40%,ARRB2;IVNS1ABP;RREB1;GTF2H1;TAF1A;FOXO3;EAF1;TAF1;GTF3C4;BTF3;TP53;MEF2A;TTF1;LEO1;GTF3A;TRIP13;GMEB2;MMS19;HSF1;CDK7;NFX1;NFIC;KLF13;POLR2L;TRIM24;MBD1;PMF1;SNAPC3;ELL;MLLT1;NFKB1;RO60;TWNK;MAF;ERCC6;TAF3;ZBTB7B;GTF2B;RSF1;NFYA;TCEA1;CREBL2;GTF2H5;POLR2E;TAF11;FUBP3;ELOB;MED4;CRCP;GLIS3;IWS1;TAF1C;IRF9;SMARCA5;ELOC;POLR3A;NELFE;GTF2A1;CTR9;PARP1;MNT;TFAM;MRPL12;PAX8;PWP1;THRA;NCBP1;XAB2;NFIX;XBP1
prerank,positive regulation of vasoconstriction (GO:0045907),-0.3922509140721051,-1.0563286381984733,0.3609271523178808,0.8641959361060936,1.0,1/13,1.12%,CAV1
prerank,sphingoid metabolic process (GO:0046519),-0.40286333132786845,-1.0560340800041734,0.39100346020761245,0.8614663764739211,1.0,7/12,40.93%,SGPP1;SPHK1;PLPP3;PLPP1;PLPP2;ASAH2;SPTLC3
prerank,GPI anchor biosynthetic process (GO:0006506),0.46792961609947864,1.055949572420819,0.4300341296928328,0.7948720374047088,1.0,13/30,24.47%,PIGM;PIGL;PIGX;PIGV;PGAP1;PIGH;PGAP2;PIGU;PIGC;PIGN;DPM2;PIGP;PIGK
prerank,regulation of TOR signaling (GO:0032006),0.4298026204699901,1.0559284262574233,0.4162330905306972,0.7944553695120959,1.0,23/67,21.95%,TREM2;RFFL;FNIP1;GNA12;SEH1L;FLCN;PDCD6;DDIT4;GAS6;LAMTOR3;TMEM127;PIH1D1;GSK3A;TTI1;LAMTOR1;GOLPH3;RPTOR;SEC13;TELO2;RRAGA;PIK3CA;RRAGB;NPRL3
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.4462167483493847,1.0558772817298716,0.42696629213483145,0.7941101398674926,1.0,7/39,11.23%,SHH;PKD2;CTNNB1;TGFBR2;NKX2-1;LRP5;NRP1
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),-0.3062576867245701,-1.055842265817554,0.3984375,0.8584895285976004,1.0,14/29,23.26%,ARRDC3;ABL1;DCUN1D4;TOPORS;PINK1;FBXW7;DTX3L;UBE2L3;FEM1A;DCUN1D3;PARK7;BMI1;SMAD7;BAG5
prerank,fatty acid transport (GO:0015908),0.500786328601565,1.0557948929557204,0.43483870967741933,0.7938586444600615,1.0,5/17,17.27%,FABP4;APOE;FABP5;CD36;PPARD
prerank,regulation of histone modification (GO:0031056),0.5164468989240519,1.0556681217355646,0.42896174863387976,0.7937098021587137,1.0,6/13,21.22%,MYOCD;FLCN;HPF1;AKAP8L;UBE2N;SETD5
prerank,regulation of intracellular pH (GO:0051453),0.44960912663030983,1.0553692491376205,0.43288590604026844,0.793982424669771,1.0,11/34,22.07%,SLC9A4;CLN3;SLC9A9;SLC9A1;LRRK2;SLC9A8;NOX1;TMEM165;SLC9B1;SLC9A7;CHP1
prerank,modulation of chemical synaptic transmission (GO:0050804),0.4153078099544453,1.0552613142323348,0.4075975359342916,0.79378528941379,1.0,14/107,8.95%,NPAS4;CX3CR1;ABR;DGKZ;CLSTN1;TNF;CEL;CLN3;MCTP1;BTBD9;CACNA1A;MEF2C;EIF4EBP2;NTF3
prerank,cardiac muscle cell action potential (GO:0086001),0.4600824274790564,1.0552502317161327,0.4363207547169811,0.7933435286840557,1.0,5/30,4.32%,SCN4B;HCN4;SLC8A1;PKP2;KCNIP2
prerank,regulation of cell cycle (GO:0051726),0.410395514613659,1.0545476052597675,0.36236236236236236,0.794669060082234,1.0,47/271,14.24%,PTPRC;LILRB1;TGFB1;RPL23;GAS2L1;TGFBR1;MLXIPL;MAP2K6;ERN1;NEK6;RGCC;PKD2;HPGD;FBXL22;FZD9;CDK11B;TP53;SND1;RPS15A;PIM2;CSNK2A2;CSNK2A1;GADD45B;KIF20B;RB1;SMAD3;SIPA1;CDK7;SON;INHBA;NF2;MAEA;TTLL12;SOX9;SRA1;THBS1;RASSF1;RNF40;METTL3;SDCBP;CDK6;FBXL3;NR4A1;ADARB1;HCFC1;IRF1;SOX2
prerank,autophagosome assembly (GO:0000045),0.434033857609126,1.0544926159358048,0.4160346695557963,0.7943529053059805,1.0,18/52,22.34%,ATG7;MAP1LC3B;RAB7A;VMP1;EMC6;RAB1B;BECN1;ATG2B;SMURF1;IRGM;ATG3;UBXN2A;ATG14;PACS2;TMEM41B;NSFL1C;TP53INP2;RB1CC1
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),0.4939135967146691,1.0534622983228425,0.43505674653215637,0.7965169872276133,1.0,3/18,5.80%,PCID2;NXF1;THOC2
prerank,determination of left/right symmetry (GO:0007368),0.45264183266352,1.0532029252858814,0.4342403628117914,0.7967182369305268,1.0,3/36,5.50%,SHH;PKD2;ODAD2
prerank,ephrin receptor signaling pathway (GO:0048013),0.41756094944343614,1.0530691107083072,0.41284403669724773,0.7965991574685094,1.0,25/82,17.93%,LYN;VAV2;NCK2;VAV3;ARPC2;EFNA2;ACTB;AP2S1;ARPC3;ITSN1;ACTG1;ACTR2;ACTR3;YES1;ARPC4;SDCBP;FYN;EFNB3;SRC;AP2M1;RASA1;EPHA4;EPHA8;RHOA;CDC42
prerank,regulation of protein-containing complex disassembly (GO:0043244),0.5092936975869462,1.052560986739932,0.4182058047493404,0.797427882873186,1.0,4/16,11.27%,TNF;CLN3;GSPT1;HDAC6
prerank,ceramide biosynthetic process (GO:0046513),0.4432957425867941,1.052235842406849,0.4194961664841183,0.7978281420774889,1.0,14/40,22.59%,CERS6;CLN8;ST8SIA4;ST6GALNAC4;AGK;DEGS1;ASAH1;SGMS1;B4GALNT1;SPTSSA;SMPD1;SPTSSB;B4GALT6;CERS4
prerank,aspartate family amino acid metabolic process (GO:0009066),-0.3518429038685124,-1.0521265268137239,0.3617886178861789,0.8661648041963118,1.0,6/18,12.66%,SLC25A12;FOLH1;MTHFD1;SLC25A13;SMS;GOT1
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.53177607338584,1.0516946979874404,0.4332425068119891,0.7987598791289032,1.0,4/11,17.24%,NOS1AP;CACNB2;CACNB1;BIN1
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.4426784296019808,1.0500417359598484,0.4306487695749441,0.80248461749844,1.0,12/38,15.64%,SREBF2;MICALL2;UBE2D3;VPS11;CSNK2A2;ATP5IF1;PARL;HUWE1;LRRK2;SREBF1;UBE2J2;GSK3A
prerank,cell junction maintenance (GO:0034331),0.5139192697869055,1.049974664796238,0.448,0.8021785888724753,1.0,1/14,2.01%,CSF1R
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.47654249498282786,1.0497325841463507,0.4405940594059406,0.8023342511771792,1.0,2/21,4.27%,MED17;MITF
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.4140576447319591,1.0491014208641014,0.42464358452138495,0.8034100555689054,1.0,17/94,13.59%,FNIP2;PRKCD;ERN1;TRAF2;PYCARD;DDIT3;APAF1;BCL2L1;TP53;MAP3K5;CEBPB;HINT1;CHEK2;BAK1;TNFRSF1B;ATP2A3;STK24
prerank,regulation of DNA biosynthetic process (GO:2000278),0.4628176561656772,1.0488171182687258,0.4340071343638526,0.8036836138551504,1.0,3/27,4.09%,SMOC2;RGCC;PRKD2
prerank,peroxisome organization (GO:0007031),0.46221871485793964,1.0484227532757036,0.4254545454545455,0.8042122991175524,1.0,11/25,25.04%,PEX11A;ABCD1;PEX7;SEC16B;PLAAT3;ABCD2;DNM1L;FIS1;ACOT8;TMEM135;MFF
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),0.47793957939392373,1.0481200254570597,0.445679012345679,0.8045210266248647,1.0,4/20,11.55%,ITGA4;RGCC;THBS1;CCL2
prerank,regulation of transforming growth factor beta production (GO:0071634),0.49136686609448466,1.0479352408639104,0.443717277486911,0.8045083617699257,1.0,1/18,0.34%,LILRB1
prerank,actin filament bundle organization (GO:0061572),0.4476512931595348,1.047441698516801,0.43757159221076747,0.805290041539114,1.0,5/33,7.51%,LCP1;PLS1;AIF1;NEDD9;MICAL1
prerank,cellular sodium ion homeostasis (GO:0006883),0.5037884220440006,1.0468305157449342,0.44,0.8063352325411468,1.0,5/15,13.76%,SLC8A1;SLC9A1;NEDD4L;ATP1B3;ATP1B2
prerank,long-term synaptic potentiation (GO:0060291),0.47074283292784724,1.0465837674909217,0.4455569461827284,0.8064919321121652,1.0,2/21,7.63%,PTK2B;PLK2
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.47981821498643146,1.0463568119502682,0.43765903307888043,0.8066084136535783,1.0,3/20,10.05%,PCSK9;EPO;NEDD4L
prerank,negative regulation of cell migration (GO:0030336),0.40917171439278877,1.0461645652388316,0.42078708375378404,0.8066393604229007,1.0,34/137,17.39%,SHH;TMIGD3;CD74;PTPRJ;THY1;DUSP3;SLURP1;RAP2A;MITF;FOXO3;MCTP1;TIMP1;NKX2-1;RAP2B;FLCN;DUSP10;PODN;VCL;ARHGDIB;PFN2;NF2;PTPRU;ADIPOR1;ADGRG1;ADARB1;STK24;ATP1B2;PTPRT;LRP1;NF1;EPHA4;PTEN;CORO1C;LDLRAD4
prerank,protein insertion into ER membrane (GO:0045048),-0.28487732890561457,-1.0461558843358167,0.3853211009174312,0.8799596520634758,1.0,13/37,19.11%,APP;EMC7;ALDH3A2;TRAM1;SEC61G;EMC10;EMC4;EMD;SERP1;SEC61B;EMC1;GET4;VAPA
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.5237137234100773,1.045789237095061,0.4373219373219373,0.8070898564475971,1.0,4/12,16.33%,UCK1;CDA;UCK2;DCK
prerank,negative regulation of axonogenesis (GO:0050771),0.46350626118005567,1.0456847342050484,0.4339853300733496,0.8068741317568331,1.0,8/27,17.75%,THY1;FGF13;DIP2B;ARHGDIA;EFNB3;RTN4;PTEN;RHOA
prerank,response to histamine (GO:0034776),-0.4245208270595478,-1.044540132609183,0.3867924528301887,0.881221567919632,1.0,3/10,10.55%,GABRB2;GABRB1;GABRB3
prerank,cellular transition metal ion homeostasis (GO:0046916),0.41454519763627823,1.0442938948738398,0.4205128205128205,0.809799207470388,1.0,25/91,22.29%,SLC11A1;FRRS1;ATP7A;ATOX1;ATP6V0A2;IREB2;ATP6V0D1;HFE;FTL;ATP6AP1;ACO1;FTH1;SLC31A2;ATP13A2;SLC39A6;HMOX2;MT3;MT1G;MT1B;MT1E;MT1F;MT1A;MT1X;MT1M;MT1H
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",0.4722337544492564,1.0439328879343643,0.4246575342465753,0.8102417213841031,1.0,3/22,4.59%,EDEM1;MAN1C1;SEL1L
prerank,regulation of Wnt signaling pathway (GO:0030111),0.40833323748956174,1.0432044388829187,0.4314516129032258,0.811631700303998,1.0,19/108,12.34%,RUNX1;NFATC1;TLR2;GNAQ;CDK14;OTULIN;SKI;TNFAIP3;LGR6;MACF1;CTNNB1;DISC1;CSNK2A1;SULF2;MDFIC;ATP6AP2;AMER1;NLK;PPP2CA
prerank,protein polymerization (GO:0051258),0.42589227065664526,1.0431788952934615,0.4340836012861736,0.8112287597739597,1.0,9/55,12.85%,PREX1;FGF13;PSTPIP1;MICALL2;AIF1;UBE2S;WASHC3;DIAPH1;RNF135
prerank,positive regulation of cell differentiation (GO:0045597),0.3994023183620029,1.0431405683970485,0.3973973973973974,0.8108476982705953,1.0,38/237,13.62%,PF4;ASCL1;TGFB1;RIN2;LPL;TGFBR1;GPRC5B;MMD;MTOR;MDK;MAPK14;SP7;MSR1;RGCC;IL6R;IL18;RIPOR2;CTNNB1;TGFBR2;MEF2A;CEBPB;ASXL2;SNAI1;MEF2C;SMAD3;AKIRIN1;PRKCH;IMPACT;LRP5;CMKLR1;ATP6AP1;SOX9;NELL1;SDCBP;CREB1;BAMBI;NFKB1;SOX6
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.4076307784368614,1.0429787871869896,0.4256825075834176,0.8107821256883608,1.0,16/113,12.99%,MMP12;STAT5A;PIK3CD;ITGB3;TGFBR1;RREB1;MDK;PRKD2;PDCL3;VEGFB;PDCD6;SOX9;NRP1;GRN;NOD2;NR4A1
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),-0.38601244115371114,-1.0426632008856462,0.4230769230769231,0.8831384982529245,1.0,8/14,25.55%,ECE1;ACE;NOS3;ENPEP;EDN1;EDN3;AGTR1;ACE2
prerank,apoptotic process (GO:0006915),0.40183050176805435,1.0424219164199497,0.421,0.8117289495370886,1.0,38/203,15.00%,PTK2B;ITGB2;IL1A;PRKCD;TLR2;MTOR;ELMO1;ESPL1;CXCR4;BRAT1;PYCARD;CD14;CASP1;APAF1;CFLAR;BCL2L1;CDK11B;TGFBR2;BAK1;ATCAY;MCM2;TNFRSF21;BNIP1;CASP7;IAPP;DAP;PPP2CA;DDIT4;IKBKG;CASP8;STK3;TRADD;IRF1;HK2;BMF;CAPN3;VDAC1;RNF152
prerank,polarized epithelial cell differentiation (GO:0030859),0.5049619545825611,1.0424218738167645,0.44878706199460916,0.8112591989875879,1.0,5/13,19.32%,RAP2A;ZDHHC7;RHOA;CDC42;SCRIB
prerank,hydrogen peroxide metabolic process (GO:0042743),0.4747471812171078,1.042108544778913,0.43532338308457713,0.8115809908115992,1.0,7/19,20.99%,PRDX1;PRDX3;PRDX2;PXDN;NOX1;PRDX5;CYBA
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.43777889610457665,1.0418173533024648,0.44162995594713655,0.8118176038153695,1.0,7/46,10.10%,TGFB1;HCLS1;PRKCD;DHX9;TP53;SMAD3;TPR
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.5282276455187578,1.0413188468263053,0.43045387994143486,0.8126270959239965,1.0,3/10,9.69%,HMGB1;TP53;ATF7IP
prerank,positive regulation of neurogenesis (GO:0050769),0.42299541173022237,1.0412736969446277,0.4384133611691023,0.8122763856426477,1.0,14/68,13.64%,CX3CR1;SS18L1;PLXNC1;SLITRK1;PLXNB2;FZD3;CTNNB1;DISC1;NAP1L1;NUMB;SMARCD3;NPTN;ARHGDIA;CUX1
prerank,gland development (GO:0048732),0.424815893927048,1.041037969134506,0.4450373532550694,0.8124186473620221,1.0,14/59,16.03%,SHH;PCSK9;TGFBR1;MDK;PKD2;CEBPA;ANXA1;NKX2-1;SOX9;NRG1;SOX2;TG;IGSF3;NF1
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.4294855626579298,1.0408682076859506,0.4465065502183406,0.8123998062601897,1.0,17/48,21.97%,TAF1A;POLR1E;SF3B1;ZMIZ2;ACTB;ARID1A;ARID1B;ATAD2;POLR1B;POLR2L;ELOF1;ERCC6;MYO1C;POLR2E;PADI2;TAF1C;SMARCA5
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.5198382082830331,1.0407884198276447,0.44521497919556174,0.8121219775480458,1.0,2/12,7.57%,SOAT2;P4HB
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.46773916562839324,1.0400160609382607,0.4490035169988277,0.8135849782382438,1.0,7/24,12.19%,ARPC2;WASF2;AKIRIN1;ACTR2;ACTR3;CYFIP1;TWF2
prerank,positive regulation of stem cell differentiation (GO:2000738),-0.3684998698448123,-1.039966409722274,0.3601694915254237,0.8877782746498887,1.0,3/16,1.09%,SOX5;FOXC1;PTN
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.3166486566316432,-1.039813043572689,0.37714285714285717,0.8846727164544864,1.0,18/24,35.85%,RFC1;XRCC1;RFC2;LIG1;UBC;POLK;RPA3;UBA52;POLD2;RPA2;RFC3;RPS27A;LIG4;POLE;RFC4;PCNA;POLD4;POLD1
prerank,positive regulation of cell projection organization (GO:0031346),0.4089892084109704,1.039146180050277,0.4353535353535353,0.8152801976032276,1.0,20/115,14.55%,PTK2B;LYN;CAMK1D;ARSB;SS18L1;PLXNC1;MDK;SLITRK1;ITGA6;APOE;PLXNB2;CBFA2T2;FUT9;RAPGEF1;TWF2;NPTN;ARHGDIA;CUX1;ATP1B2;RAP1A
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.472496203943493,1.0390712719770245,0.43638676844783714,0.8149976492064659,1.0,6/21,17.71%,SCN4B;NOS1AP;KCNA5;CACNA1D;SCN5A;AKAP9
prerank,mitotic sister chromatid segregation (GO:0000070),0.40990250093178654,1.0386934800659735,0.44455747711088506,0.8155107259541227,1.0,26/98,20.57%,NUP62;ESPL1;CDC23;TTN;NCAPG2;SEH1L;KIF14;CSNK2A2;CSNK2A1;RB1;KIF23;RAB11A;BECN1;PDS5A;RRS1;INO80;AKAP8L;PDCD6IP;NAA50;EML4;CENPK;MIS12;SMC4;MCPH1;DIS3L2;CUL3
prerank,regulation of small molecule metabolic process (GO:0062012),0.4608097877972079,1.0385003440281029,0.4630484988452656,0.8155503166805773,1.0,8/28,14.80%,NR1H4;APOE;FMO5;ACADL;ADIPOR1;TTC39B;FOXK1;ARV1
prerank,polyol biosynthetic process (GO:0046173),-0.36199692069381384,-1.0384445137940688,0.41379310344827586,0.8853257399859102,1.0,7/16,23.13%,PPIP5K2;IP6K1;IP6K2;ITPKC;IPMK;ISYNA1;CYP2R1
prerank,regulation of lysosomal lumen pH (GO:0035751),0.5182706710516137,1.0384030529575499,0.4444444444444444,0.8153394062181825,1.0,5/12,17.27%,CLN3;ATP6AP2;GRN;LRRK2;TMEM165
prerank,outer dynein arm assembly (GO:0036158),0.5088725349112359,1.038326337271575,0.45105820105820105,0.8150751417010227,1.0,3/14,13.03%,ODAD2;ODAD1;CCDC63
prerank,positive regulation of translation (GO:0045727),0.40862695366481694,1.0381547007772849,0.4298780487804878,0.815033094432341,1.0,24/94,17.95%,NIBAN1;MTOR;DHX9;PLXNB2;CIRBP;FASTKD3;YTHDF3;LARP4B;LARP1;CPEB3;RPL26;THBS1;ZCCHC4;METTL3;PCIF1;POLDIP3;UPF3B;RCC1L;HNRNPD;SOX4;USP16;RPS4X;AGO2;CNBP
prerank,positive regulation of chondrocyte differentiation (GO:0032332),-0.4341152346916868,-1.0380140245175284,0.4084967320261438,0.8830729872108704,1.0,4/10,17.07%,SOX5;ACVRL1;PKDCC;ZBTB16
prerank,cellular senescence (GO:0090398),0.45185911863974704,1.0376192186657711,0.4419431279620853,0.8159129518178649,1.0,3/27,4.97%,PRKCD;MAPK14;SPI1
prerank,chromosome organization (GO:0051276),-0.22877486936295446,-1.0374957303038344,0.4666666666666667,0.8809907169792336,1.0,19/99,10.95%,SMARCA4;COPS5;LATS1;DDB2;TCF7L2;HMG20A;DDB1;EZH1;NUCKS1;ABL1;MSH2;HMGN3;HDAC2;RBX1;EZH2;PWWP3A;TOP2B;SETD7;RAE1
prerank,intracellular protein transport (GO:0006886),0.398586890794408,1.0371452329116482,0.399,0.8166271728945925,1.0,79/304,19.42%,MMP12;TBC1D9;TGFB1;SYK;CD74;LAPTM5;TBC1D10C;UNC93B1;CTSA;RAB32;NUP62;AP1S3;TMED3;SNX9;XPO1;RAB14;RAB3GAP2;TBC1D16;RAB7A;TBC1D22A;STX11;TLK1;AP3D1;USP6NL;STXBP3;TBC1D10A;RAB28;SNX27;CSE1L;RAB31;STRADB;PDCD6;SYNRG;ARL5B;ARL4A;TPR;RAB1B;TBC1D2;TBC1D17;COPA;CLTC;HDAC6;TBC1D2B;WDR11;XPO6;SEC16A;TBC1D8;STX3;SORL1;STX5;SAR1A;RPGR;STX8;GGA2;ARF6;VPS29;TBC1D14;STRADA;TBC1D22B;YWHAH;SMURF1;RPL11;SNX13;APPL2;ARFIP2;VPS28;IFT27;ARHGEF2;MYO1C;STX2;GIPC1;VPS33B;SLU7;TBC1D12;LTBP2;TBC1D5;DESI1;RAB29;SEC13
prerank,amino acid import (GO:0043090),0.4714806102027702,1.0367175571118084,0.4425,0.8172436185559299,1.0,4/21,9.26%,SLC7A8;SLC36A1;SLC16A2;SLC25A38
prerank,regulation of viral life cycle (GO:1903900),0.46554339556508084,1.0362919616592534,0.4479804161566707,0.8178681677520837,1.0,3/21,8.56%,TRIM25;TRIM5;TRIM27
prerank,positive regulation of cilium assembly (GO:0045724),-0.35185223968026846,-1.0360935093190753,0.38738738738738737,0.8814847319131154,1.0,10/18,22.65%,ARHGAP35;CEP135;CCP110;BBS4;MARK4;CEP120;FUZ;CCDC88A;WRAP73;CROCC
prerank,regulation of filopodium assembly (GO:0051489),0.4443880342576126,1.0360066552595741,0.46357615894039733,0.8181257470449709,1.0,10/38,14.41%,PRKCD;ARAP1;RIPOR2;DOCK11;CAPZB;AGRN;NRP1;FNBP1L;ARF6;MIEN1
prerank,chordate embryonic development (GO:0043009),0.4193659070962143,1.0359230451010601,0.43576017130620986,0.8178521479046813,1.0,7/55,9.39%,TGFB1;TGFBR1;PKD2;CHD7;FLCN;SULF2;XYLT1
prerank,protein import into peroxisome membrane (GO:0045046),0.462148022540821,1.0351262714917138,0.4486094316807739,0.8194256334467722,1.0,4/22,9.09%,RAB8B;ABCD1;PEX13;PXMP2
prerank,thyroid hormone generation (GO:0006590),0.5396794661836786,1.0349630157898915,0.45664739884393063,0.8193801218248736,1.0,2/10,14.26%,CTSK;TG
prerank,pyrimidine nucleoside metabolic process (GO:0006213),-0.38263027502827396,-1.0347945836877852,0.4074074074074074,0.8819335655246248,1.0,7/14,29.97%,UPP2;NT5E;DHODH;NT5C1A;UMPS;UPB1;CAD
prerank,histone H2A acetylation (GO:0043968),0.5035667553548724,1.0342416513107657,0.4779220779220779,0.8206616488852779,1.0,7/16,25.08%,BRD8;EP400;NAA40;MEAF6;MORF4L2;MORF4L1;SPHK2
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.4496084764285559,1.0341858359004124,0.45210280373831774,0.8203333822754805,1.0,8/31,18.54%,GPNMB;PKD2;RB1;CCL2;CDK6;BRD7;PTEN;DACT1
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),0.45945017206963495,1.0337987761080882,0.4514218009478673,0.8208419539136342,1.0,6/25,14.62%,CTSS;STAC;WNK1;ATP1B3;ATP1B2;WNK4
prerank,cardiac muscle cell differentiation (GO:0055007),0.4700571033239195,1.0337929772765069,0.44254278728606355,0.8203870990440248,1.0,5/21,12.63%,SLC8A1;TTN;MYOCD;MEF2C;NRG1
prerank,external encapsulating structure organization (GO:0045229),0.39717812818968345,1.0337071375077516,0.4094094094094094,0.8201308309830503,1.0,25/205,10.54%,ITGAL;MMP12;ITGA2B;ITGAX;ITGB2;SMOC2;ITGA4;ITGB3;ITGB5;ITGA2;ADAMTS8;ITGA6;ATP7A;TTR;TGFBI;SPP1;CD44;ITGAE;TNR;AGRN;LOX;BCAN;ITGAM;F11R;MMP19
prerank,peptide hormone secretion (GO:0030072),-0.31161902496522254,-1.0334253045676072,0.39226519337016574,0.8824542829811177,1.0,9/26,24.67%,LTBP4;CDK16;RIMS2;CAMK2G;PARK7;PTPRN;EDN1;EDN3;ADCYAP1
prerank,extracellular transport (GO:0006858),-0.40680183795058045,-1.033028770644917,0.427536231884058,0.8802533318416719,1.0,9/12,46.05%,SPEF2;CABYR;ROPN1L;ADCY10;SPAG17;SPA17;DNAAF2;CCDC40;DNAAF4
prerank,mitotic cell cycle phase transition (GO:0044772),0.40340351510163636,1.0328819165411678,0.4144144144144144,0.8216517872798396,1.0,37/203,14.42%,TUBB;GPR132;PRKAR2B;HAUS2;CDK14;CCND3;CDC23;TUBA4A;FBXL22;CCND2;CNTRL;CEP192;MAPRE1;UBE2S;DNM2;CEP70;GSPT1;PLK4;PIM2;PLK2;CEP76;CHEK2;RB1;ENSA;HAUS1;CDK7;DBF4;INHBA;CDC34;DYNC1H1;PCM1;CDK6;FBXL3;MAX;CEP152;HAUS8;CCNE2
prerank,organic anion transport (GO:0015711),0.40880996407466175,1.0328145753497562,0.4511819116135663,0.8213606584485245,1.0,12/76,15.17%,AQP1;ABCC6;SLC52A1;SLCO2B1;LRRC8D;CYB5R1;SLC16A2;CYB5RL;MGST1;SLC35A3;SLCO1B1;LRRC8C
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.45225476906291107,1.0323139744680867,0.45017182130584193,0.8221127601129417,1.0,4/31,9.11%,SYT17;SYT2;STXBP3;SYT10
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),0.4586592366659802,1.0321552213737282,0.4518430439952438,0.8220274800277954,1.0,7/23,16.72%,P2RX7;MLXIPL;PFKFB4;NFKB1;PFKFB3;HIF1A;GAPDHS
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.43040013357111956,1.0320221444560786,0.45132743362831856,0.8218921919347334,1.0,8/43,11.18%,TGFB1;TNF;FOXO3;SPI1;TEAD1;TP53;SMAD3;SOX9
prerank,regulation of protein sumoylation (GO:0033233),0.491197526994314,1.0319701814484332,0.4507978723404255,0.8215619922569578,1.0,6/17,20.01%,CTNNB1;HDAC4;UBA2;CAPN3;PIAS1;RWDD3
prerank,endothelial cell migration (GO:0043542),-0.2786953132358761,-1.0319620432574919,0.40707964601769914,0.8799059335152383,1.0,10/37,16.08%,FSTL1;CDH5;STARD13;ID1;ABL1;FAP;CCN3;NOS3;SCG2;STAT1
prerank,odontogenesis (GO:0042476),-0.28519422698988806,-1.031917036317858,0.3798449612403101,0.8766309496129154,1.0,9/35,14.77%,FOXC1;EDA;BMP4;GLI2;WNT6;HDAC2;COL1A2;TBX1;TGFB3
prerank,regulation of axon guidance (GO:1902667),0.5362973077467811,1.0317844655522324,0.44903988183161003,0.8215475860945178,1.0,5/10,28.44%,NRP1;ZSWIM6;MYCBP2;VEGFA;ZSWIM5
prerank,establishment of protein localization to organelle (GO:0072594),0.406037040475223,1.0306607064683255,0.46321243523316064,0.8238567834823393,1.0,8/72,10.10%,MMP12;IL10RA;SYK;NUP62;CD68;CSE1L;RAB11A;TPR
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),-0.38547520058053897,-1.0305971522908277,0.3874538745387454,0.8772045928304142,1.0,7/14,21.50%,AUTS2;SMAD4;DNMT1;SNW1;PAXIP1;KMT2E;PRDM9
prerank,sodium-independent organic anion transport (GO:0043252),0.5326567925786692,1.0305597297759708,0.46599131693198265,0.8236254332930976,1.0,3/10,14.98%,SLCO2B1;SLC16A2;SLCO1B1
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.42877134909252057,1.030463729673933,0.47216035634743875,0.8234111930977573,1.0,11/39,20.22%,PCSK9;SCN4B;FGF13;WNK1;NEDD4L;WNK4;FXYD5;YWHAH;FXYD6;PTPN3;FXYD1
prerank,positive regulation of cell killing (GO:0031343),0.5124213391944699,1.0301710022587423,0.453781512605042,0.8237000264780525,1.0,1/13,0.95%,SYK
prerank,regulation of RNA export from nucleus (GO:0046831),0.5156960864017303,1.0301125300137655,0.4583333333333333,0.8233913962504578,1.0,5/11,16.01%,DHX9;TPR;SETD2;AKAP8L;NRDE2
prerank,regulation of heart contraction (GO:0008016),0.41124663484231655,1.0299631272661685,0.46130346232179226,0.8232913277388276,1.0,15/90,13.93%,KCNJ11;TMIGD3;HCN4;SLC8A1;KCNIP2;P2RX4;ASPH;ATP2B1;ITPR2;NPR2;ATP2B3;ATP1B3;ATP2A3;ATP1B2;DES
prerank,neuron projection development (GO:0031175),0.39770736247822847,1.0296617495623592,0.454,0.8235484380712633,1.0,42/168,20.53%,NCKAP1L;LYN;NEFH;TAOK3;PRDM12;MICALL2;ATP7A;APOE;WHRN;HMGB1;DOCK10;DNM2;GPRIN3;MICALL1;LRP12;TNIK;KIF20B;RB1;NTF3;ATCAY;RAB11A;DTNBP1;STX3;TOR1A;LRRK2;ERCC6;SVBP;CAMSAP2;ALS2;EPHA4;PTEN;EPHA8;TBC1D23;MANF;CDC42;MINK1;TAOK1;GDNF;CNTN4;CDK5R1;GSK3B;MAP4K4
prerank,negative regulation of locomotion (GO:0040013),0.5056146547175859,1.0293797828969813,0.471004243281471,0.8237658639526555,1.0,2/12,8.84%,DUSP3;SPINT2
prerank,pseudouridine synthesis (GO:0001522),-0.3924014114957937,-1.0293766069966195,0.4037735849056604,0.8773300992302296,1.0,10/13,40.34%,PUS10;TRUB2;GAR1;NOP10;PUS1;PUS7L;NHP2;TRUB1;PUSL1;RPUSD2
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.4054843213592925,1.0291646384335678,0.46334012219959264,0.8238243989823643,1.0,29/100,20.78%,BAG2;CBFA2T3;RNF180;RNF19B;HERPUD1;CEBPA;XPO1;TAF1;HECTD1;GNA12;HFE;USP7;DET1;CSNK1A1;SDCBP;STUB1;RNF144B;LRRK2;PIAS1;GSK3A;RPL11;GIPC1;KEAP1;ELOB;DESI1;TLK2;RAD23B;GSK3B;PRKN
prerank,positive regulation of dendritic spine development (GO:0060999),-0.33882716155226855,-1.0291404824944772,0.43,0.8746149740163378,1.0,10/20,19.34%,NLGN1;CAPRIN1;DLG5;FMR1;SHANK3;SHANK1;DBN1;DHX36;CAPRIN2;CAMK1
prerank,regulation of histone methylation (GO:0031060),0.5048174479149194,1.028820854619904,0.4588068181818182,0.824233542868521,1.0,3/13,15.10%,NSD1;TTLL12;PIH1D1
prerank,regulation of chromosome segregation (GO:0051983),0.4970565474406145,1.0288035999050094,0.45794392523364486,0.8238036248999303,1.0,4/16,13.80%,CSNK2A2;CSNK2A1;PUM2;CDC6
prerank,muscle cell development (GO:0055001),-0.2949258581926215,-1.028637200288363,0.40298507462686567,0.8729213407902221,1.0,5/30,3.14%,ANK2;NEBL;CXADR;DMD;SGCZ
prerank,negative regulation of proteolysis (GO:0045861),0.44000094893862157,1.02856153999027,0.464804469273743,0.8239383382848265,1.0,9/34,19.16%,CST7;CLN8;CLN3;TIMP1;HDAC6;LRRK2;EPHA4;PTPN3;TMEM59
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.39344980263043566,1.0285573488096265,0.316,0.8234859629191611,1.0,270/1668,14.34%,RUNX1;BATF3;SPIC;NFE2;LILRB1;IRF5;NPAS4;MMP12;AHRR;PF4;ASCL1;CIITA;MEOX1;SHH;IRF4;IRF8;SLC11A1;TGFB1;IKZF1;HCLS1;TOX4;UXT;GATA1;STAT5A;NFE2L2;POU2F2;BRD8;FNIP2;LPIN2;NLRC5;RPL23;CSF1R;NFATC1;HES7;MED17;RREB1;GTF2H1;MAD2L2;EDNRB;TLR2;BCL11A;NSD1;MLXIPL;SS18L1;ELF4;DHX9;ZEB2;MAPK14;IER2;OSM;MED13L;SP7;MAML3;CREB3L4;CREB3;BARX2;NCK2;PRDM12;SEMA4D;RXRB;FOXD2;NR1H4;DNMT3A;TNF;FNIP1;SNCA;SREBF2;TET3;ITGA6;RGCC;RFX1;PRKD2;PKD2;MLXIP;APOE;CIR1;BPTF;UBE2D3;MITF;ZFP30;CRYM;SKI;ATF3;CEBPA;CDK8;FOXO3;SRCAP;FHOD1;ZMIZ2;LRRFIP1;DDIT3;SPI1;IL18;FIZ1;MYT1L;ZBTB12;PGBD1;WWC2;ZBTB39;HIVEP3;MAFG;MAFK;HOXC8;BHLHE41;HDAC5;GALR1;HMGB1;TAF1;RNF111;BRIP1;BACH1;FLI1;PRKCB;TEAD1;PCGF6;MRTFA;CTNNB1;TRPS1;TFEB;MTA3;ZFP69;ZNF177;TP53;KLF6;MEF2A;AKNA;TBL1XR1;NKX2-1;PHF21A;NRL;TAL1;USF1;MYOCD;RCOR1;TNRC6A;AGRN;KDM7A;HSBP1;YY1;TCF20;CREB3L1;SLC9A1;STAT4;ZFP90;EPO;CEBPB;ASXL2;DBX2;ST18;LMO2;SNAI1;MEF2C;DOT1L;NKRF;CDC5L;FLCN;TFAP2B;MOV10;RB1;TRIM27;GMEB2;SMAD3;AKIRIN1;ARID1A;ZFP14;TADA1;GTF2IRD1;IRF2;HSF1;PPARGC1A;ZNF32;ARID3B;ATRX;AGO4;CDK7;CREBRF;RNF4;ARID4A;ANXA4;IMPACT;GMEB1;CPEB3;STAT5B;MCRS1;LRP5;MIDEAS;HDAC4;NFX1;NFE2L1;NEDD4L;TPR;ACTR2;LITAF;CCNL1;ZNF83;TGIF1;ARID1B;HOXA6;RNF10;RPAP2;NFIC;ATAD2;TBL1X;INHBA;MED27;ACTR3;KLF13;CHD1;RNASEL;CREB3L2;PKN1;BAZ1A;TXK;HCFC2;ZSCAN26;ELF2;OLIG1;SOX9;SRA1;RPS6KA4;PTOV1;JDP2;NR2C2;AGO3;ETV6;ZNF740;NRIP1;E2F6;PHIP;GZF1;CIAO1;HDAC9;HSF5;ATF6B;NOD2;SDCBP;MTF2;CREB1;RPS14;LAGE3;IKBKG;ZFP64;KAT7;ZSCAN18;SMARCD3;NR4A1;PPIL4;MAX;SMARCB1;ZFX;ZNF445;GPS2;NFKB1;FOXK1;SAFB2;RFX7;SOX6;CUX1;HCFC1;PCBP1;ZFHX3;IRF1;INO80;PID1;RTRAF;USP9X;WFS1;SOX2;KDM3B;BRD7
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.46491187104934145,1.0282107092237698,0.46568627450980393,0.8238949536511039,1.0,4/24,11.77%,PRKAR2B;MGRN1;PDE11A;CDC34
prerank,negative regulation of cytoskeleton organization (GO:0051494),0.45164650499563475,1.0280876897318245,0.4561611374407583,0.823733364736655,1.0,8/29,13.45%,CORO1A;CYRIB;PRKCD;ARFGEF1;PFN2;PFN1;TWF2;SSH2
prerank,regulation of cellular component organization (GO:0051128),0.4019158498010769,1.0278052646956641,0.4438877755511022,0.8239548994017862,1.0,36/135,19.65%,CD22;MAD2L2;MTOR;PTPN1;SEMA4D;TNF;APOE;TRAF2;RASGRP2;RAP1B;CDK11B;AP2S1;PRKCQ;STON2;KIF14;METTL4;BCAR1;GFAP;RAPGEF1;STON1;ITCH;HCFC1;RAB33B;ATAD3A;ARHGEF11;RAP1A;SGK3;CAMSAP2;CD36;IRGM;HSP90AA1;LAMTOR1;PICALM;DCUN1D5;RPTOR;ROCK2
prerank,renal absorption (GO:0070293),-0.42605488330505176,-1.027608819820796,0.422360248447205,0.8726895030456882,1.0,2/10,5.49%,GSN;KLHL3
prerank,mesenchymal to epithelial transition (GO:0060231),0.532763671573115,1.0274468920196151,0.46074074074074073,0.8243929099552822,1.0,1/10,1.62%,BASP1
prerank,positive regulation of muscle cell differentiation (GO:0051149),0.45706118646846977,1.0273450024862592,0.44765342960288806,0.8241621849809024,1.0,6/24,12.63%,MAPK14;CTNNB1;MEF2A;MYOCD;MEF2C;NRG1
prerank,sensory perception of mechanical stimulus (GO:0050954),-0.23590370906004765,-1.0270471311716816,0.45454545454545453,0.8709133647825196,1.0,12/85,7.32%,PIEZO2;ROR1;GRM7;NIPBL;DCDC2;GSDME;EML2;COL4A3;EYA1;SOD1;USP53;WDR1
prerank,positive regulation of neuron projection development (GO:0010976),0.40690457512071726,1.0263993911752083,0.46557040082219936,0.8260481717141117,1.0,16/85,14.55%,PTK2B;LYN;CAMK1D;ARSB;MDK;ITGA6;APOE;PLXNB2;CBFA2T2;FUT9;RAPGEF1;TWF2;LRP8;NPTN;ATP1B2;RAP1A
prerank,positive regulation of natural killer cell activation (GO:0032816),0.5037176931544398,1.0263151244526145,0.46900269541778977,0.8258006652612023,1.0,4/13,13.41%,IL18;TYROBP;TICAM1;GAS6
prerank,regulation of cellular protein catabolic process (GO:1903362),0.47859328710679333,1.0260148402756668,0.47341772151898737,0.8261043853270331,1.0,8/18,19.66%,WDR91;VPS11;AMER1;NELL1;FAF1;HSP90AA1;DACT1;ATRAID
prerank,negative regulation of DNA binding (GO:0043392),0.46032288226575085,1.0259611554494494,0.45838218053927315,0.82577780489437,1.0,2/28,2.40%,GATA1;MAD2L2
prerank,carbohydrate biosynthetic process (GO:0016051),-0.321870697268968,-1.0258640267400183,0.4306930693069307,0.8711987647185636,1.0,7/21,16.06%,B3GALT5;ST3GAL4;ST6GALNAC6;MPDU1;ST8SIA6;ST3GAL3;B3GALT1
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.41255876715014955,1.025862906021193,0.4528710725893825,0.8255498227263443,1.0,15/64,18.91%,PCID2;GTF2H1;POLR1E;EAF1;LEO1;CDK7;SETD2;POLR2L;ELL;MLLT1;ELOF1;TCEA1;GTF2H5;POLR2E;ELOB
prerank,microtubule polymerization or depolymerization (GO:0031109),-0.3161619287170111,-1.0256975150134786,0.4293785310734463,0.8684427255373961,1.0,12/24,21.11%,NCKAP5;STMN2;MAPT;KIF24;TPPP;STMN4;STMN3;HDGFL3;MAP7D3;KIF18A;TRPV4;STMN1
prerank,tetrahydrobiopterin metabolic process (GO:0046146),0.5216431121179526,1.0256684757590282,0.4599447513812155,0.8255856250148023,1.0,4/11,16.72%,GCH1;QDPR;SPR;HSP90AA1
prerank,microtubule depolymerization (GO:0007019),-0.3545421468453574,-1.0253375283417352,0.4186991869918699,0.8661492420529648,1.0,7/17,21.11%,NCKAP5;STMN2;KIF24;STMN4;STMN3;KIF18A;STMN1
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.24607367483456133,-1.0251571585542603,0.40425531914893614,0.863471746256285,1.0,28/65,22.47%,FBXL7;FHL1;PSME4;PSMD11;PSMA5;PSMA4;RBX1;PSMD14;PSMC6;NABP2;PINX1;PSMC3;ZFYVE19;PSMB3;VPS4A;PSMC1;PSMD5;PSMA3;PSMD3;PSMD6;PSMC5;USP47;PSME2;PSMB4;PSMC4;SKP1;PSMB6;CUL1
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.3716052239426181,-1.0245758814982315,0.43478260869565216,0.861987074899028,1.0,4/15,10.54%,KCNN2;ATP1B1;KCND3;KCNJ3
prerank,error-free translesion synthesis (GO:0070987),-0.3267207450609776,-1.0244102081101567,0.3979591836734694,0.8592121089907314,1.0,15/22,39.93%,REV1;RFC1;RCHY1;RFC2;UBC;RPA3;UBA52;RPA2;RFC3;RPS27A;RFC4;PCNA;POLD1;UFD1;RFC5
prerank,mitochondrial genome maintenance (GO:0000002),0.5182727729267109,1.0239795299733039,0.46480938416422285,0.8292926671593117,1.0,7/11,27.01%,MEF2A;LONP1;MGME1;MPV17;PARP1;AKT3;TOP3A
prerank,mRNA metabolic process (GO:0016071),0.40808623301420455,1.023424115795435,0.45965270684371806,0.8302003452679669,1.0,16/90,12.06%,SLFN14;ERN1;SF3B2;AURKAIP1;SCAF11;TP53;ZC3H12D;LSM11;HSF1;PPARGC1A;PCBP3;AGO4;SON;AGO3;METTL3;PRPF8
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.47472478246447647,1.0231261908157887,0.45359477124183006,0.8304816745589229,1.0,3/17,3.19%,SCN4B;HCN4;SLC8A1
prerank,positive regulation of filopodium assembly (GO:0051491),0.4673414834325632,1.023124033830794,0.4800483675937122,0.8300208416430417,1.0,8/24,17.93%,ARAP1;RIPOR2;DOCK11;AGRN;NRP1;FNBP1L;MIEN1;CDC42
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.5118528748838104,1.0228883091529457,0.46944444444444444,0.8301118751806057,1.0,4/12,20.62%,TSPO;FDXR;FDX1;STARD3
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",-0.2552295679438021,-1.0227456165030044,0.47368421052631576,0.8607921572723696,1.0,21/84,15.79%,RBFOX2;FXR2;YTHDC1;DAZAP1;MBNL2;RBFOX3;REST;NUP98;U2AF2;SRRM4;KHDRBS3;FMR1;HNRNPA1;NOVA2;METTL16;QKI;HNRNPU;SNW1;KHDRBS2;PUF60;LARP7
prerank,acute-phase response (GO:0006953),0.5138897179679766,1.0223337260927357,0.43072702331961593,0.8309993327436983,1.0,2/12,7.68%,IL6R;CEBPB
prerank,protein import (GO:0017038),0.4010840849060779,1.0222490190388045,0.4690721649484536,0.8307648814864584,1.0,11/84,10.10%,MMP12;SYK;RAB8B;NUP62;APOE;SNX33;ABCD1;CSE1L;PEX13;PXMP2;TPR
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.3935905636820421,1.0220740910562014,0.416,0.8307318872913348,1.0,98/572,14.24%,RUNX1;BATF3;ASCL1;CIITA;SHH;IRF8;UXT;GATA1;FNIP2;RPL23;RREB1;MAD2L2;EDNRB;BCL11A;NSD1;ZEB2;PRDM12;SEMA4D;NR1H4;DNMT3A;TNF;FNIP1;SNCA;SREBF2;CIR1;BPTF;UBE2D3;MITF;CRYM;SKI;ATF3;FOXO3;LRRFIP1;DDIT3;SPI1;MYT1L;WWC2;MAFK;BHLHE41;HDAC5;HMGB1;TAF1;BACH1;TRPS1;MTA3;ZFP69;ZNF177;TP53;MEF2A;TBL1XR1;NKX2-1;PHF21A;HSBP1;YY1;ZFP90;EPO;CEBPB;SNAI1;MEF2C;FLCN;TFAP2B;RB1;TRIM27;SMAD3;GTF2IRD1;IRF2;HSF1;ATRX;IMPACT;CPEB3;HDAC4;NFX1;NEDD4L;TPR;TGIF1;NFIC;TBL1X;HCFC2;SOX9;JDP2;NR2C2;ETV6;NRIP1;E2F6;GZF1;HDAC9;SDCBP;MTF2;RPS14;MAX;GPS2;NFKB1;CUX1;HCFC1;ZFHX3;USP9X;WFS1;SOX2
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.4875290529294362,1.0218578279405721,0.46403385049365303,0.8308366036970947,1.0,8/13,23.95%,ATG7;UBA2;DESI1;DESI2;SENP6;ATG10;UBA7;UBA5
prerank,cellular protein modification process (GO:0006464),0.39135339096541444,1.0214423798545051,0.406,0.8314167990167793,1.0,210/982,18.95%,PTPRC;PTK2B;BTK;PTPN7;FGR;LYN;GMFG;PPM1H;HCK;DAPP1;TGFB1;SYK;PCSK9;WDTC1;RSKR;FNIP2;PIK3CD;MAP4K1;TAOK3;COPS6;F13A1;TGFBR1;TYK2;PPP2CB;PRKCD;PTPRJ;MTOR;PTPN1;DUSP29;BMP2K;TEC;GRK3;PTPN18;ERN1;NEK6;CDK14;ATG7;ART4;PTPRE;PRKD2;ST8SIA4;APOE;UBE2D3;MYLK3;DNAJC3;CEL;CDK8;FBXL22;SPP1;RNF7;TIMP1;OARD1;NPC1;MORC3;FBXL18;TLK1;PARP8;TAF1;PTP4A2;KLHL21;PRKCB;ANXA1;MKNK1;CDK11B;UBE2S;STK10;TGFBR2;PSMB10;MAP3K5;OGA;PIM1;PLK4;WNK1;CDK17;PIM2;TNIK;P4HB;PLK2;MTMR3;CSNK1G2;LOX;CHEK2;CSNK2A1;ST3GAL1;MAP3K1;STRADB;DUSP10;MAN2B1;CHML;PRKCH;PGAP1;FUT9;CDK7;B3GALNT1;PIGH;RAB11A;MCRS1;STK17B;RAB1B;VGF;ST8SIA1;FAM20C;MSRA;RNASEL;LGALS1;CHGB;PKN1;PSMA2;TXK;YES1;RBBP5;THBS1;RPS6KA4;PTPRU;PTPRO;TIMM50;NLK;FBXO40;PRKACB;PARP16;CCL2;CDC34;KLHL11;RBBP7;FBXO32;MAN2A2;CSNK1A1;F5;FYN;PPP2CA;TNKS2;GRK4;MAP3K12;CDK6;PSME3;CREB1;STT3B;B4GALT7;SUMF2;FBXL3;LIPE;ILKAP;MERTK;CAMKK2;COPS4;TIPARP;BRAF;GAS6;SSH2;STK24;STK3;PSMB5;CTTNBP2NL;PTPRT;BMX;WFS1;PSMD8;LRRK2;NIM1K;WNK4;PPP1CC;CCDC8;DCAF17;TESK2;LARGE1;METAP2;PTPRA;PSMD7;STRADA;GAN;PSMB9;SGK3;GSK3A;CDK15;MAP3K11;HIF1A;ATG3;APLP2;COQ8B;PTEN;WSB2;ERO1A;STK4;PTPN12;PPP3CB;MACROD1;DCAF5;FEM1B;PIK3R4;RPS6KA5;CDK18;SIK2;VHL;PPM1M;PDPK1;PSMD2;KEAP1;DDOST;VRK1;FBXO44;PPP2R5C;CSK;MINK1;PTPN3;PPP4R2;MXRA8;SPSB2;IGFBP4;ELOB;TAOK1
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.3999428095390935,1.0214163760502335,0.4492462311557789,0.8310365570594905,1.0,27/124,17.60%,LYN;PLEK;CSF1R;PRDM12;MICALL2;PKD2;APOE;HMGB1;TTC29;GPRIN3;MICALL1;LRP12;RB1;ATCAY;RAB11A;DTNBP1;CYFIP1;STX3;TOR1A;ATP1B2;PLEKHA1;ERCC6;EPHA8;ARFIP2;WDPCP;TBC1D23;MANF
prerank,epithelial to mesenchymal transition (GO:0001837),0.4216309808035635,1.0213989822003129,0.46936542669584247,0.8306225193364023,1.0,13/47,20.45%,TGFB1;TGFBR1;CTNNB1;AKNA;SNAI1;LIMS1;SOX9;RBPJ;HIF1A;TASOR;LOXL3;ROCK2;GSK3B
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),0.5017347021690235,1.0213717495277792,0.47802197802197804,0.8302209114737318,1.0,2/14,5.17%,LPIN2;CHKB
prerank,manganese ion transport (GO:0006828),0.49355814114673763,1.0213448886176717,0.4454664914586071,0.8298282947173202,1.0,2/14,8.01%,SLC11A1;ATP2C1
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.4091926382300771,1.0212905778803476,0.4766355140186916,0.829489064080068,1.0,15/65,17.78%,TGFB1;NRROS;TGFBR1;SKI;TGFBR2;NKX2-1;FAM89B;SMAD3;SNX25;BAMBI;VASN;STUB1;SMURF1;LDLRAD4;PDPK1
prerank,regulation of osteoblast proliferation (GO:0033688),0.47863690492584393,1.0205083425908623,0.4557291666666667,0.8309233475781967,1.0,5/17,19.66%,HPSE;NELL1;RHOA;GREM1;ATRAID
prerank,regulation of endothelial cell proliferation (GO:0001936),0.4093687943647561,1.020370111260974,0.4731958762886598,0.8308210453895042,1.0,16/88,13.08%,STAT5A;PIK3CD;ITGB3;TGFBR1;RGCC;PRKD2;APOE;PDCL3;XDH;VEGFB;ATP5IF1;PDCD6;NRP1;THBS1;NR4A1;ATP5F1A
prerank,regulation of urine volume (GO:0035809),0.5223532834153736,1.0201547506469153,0.4732142857142857,0.8309075694830829,1.0,4/10,19.95%,ADCY6;TFAP2B;ADM;INPP5K
prerank,cellular response to catecholamine stimulus (GO:0071870),0.4619802256412574,1.0198217759221726,0.48009650180940894,0.8312536184062997,1.0,13/23,28.04%,SNCA;ADCY6;SLC9A1;GNG2;LRRK2;PRKN;TGM2;GABPA;ATP2B4;MAPK1;MAPK3;PRKACA;APLP1
prerank,cGMP biosynthetic process (GO:0006182),0.527466519449225,1.0197952145637676,0.463855421686747,0.8308600304491559,1.0,2/10,10.24%,GUCY2F;NPR2
prerank,T-helper cell differentiation (GO:0042093),0.4946094830657818,1.0194618047058843,0.4786795048143054,0.8312380686170887,1.0,4/14,9.45%,ATP7A;HMGB1;TMEM98;GPR183
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.4011741304066514,1.0192261695456697,0.45774647887323944,0.831349125710057,1.0,23/128,14.27%,TUBB;PRKAR2B;HAUS2;CDK14;TUBA4A;FBXL22;BACH1;CNTRL;CEP192;MAPRE1;DNM2;CEP70;PLK4;CEP76;CHEK2;ENSA;HAUS1;CDK7;DYNC1H1;PCM1;FBXL3;CEP152;HAUS8
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),-0.3293645056428864,-1.0190706420453388,0.441747572815534,0.8680094692106345,1.0,12/20,25.78%,ADSS2;NT5C2;GMPS;PFAS;AK3;AMPD3;AMPD2;PAICS;ADSL;IMPDH1;AK4;PPAT
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.43440438256315334,1.0190184908836768,0.47845804988662133,0.8313846700709132,1.0,9/36,13.06%,UXT;YAF2;APAF1;PCGF6;RING1;PHC1;E2F6;RBBP7;MAX
prerank,bone morphogenesis (GO:0060349),0.4946540878564051,1.0186832236495549,0.469050894085282,0.831743096841414,1.0,2/14,9.91%,SKI;LRP5
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.4781977529143614,1.0186222005242473,0.4828897338403042,0.8314386545986632,1.0,5/19,12.47%,SMOC2;PIK3CB;XDH;CD63;CCBE1
prerank,cytoplasmic microtubule organization (GO:0031122),0.4135876034883122,1.0182089885358534,0.4518201284796574,0.8319986840211947,1.0,13/54,16.12%,HOOK3;CCDC88B;CLIP2;RAB11A;TUBGCP6;TUBGCP4;DYNC1H1;PCM1;KATNA1;HOOK2;DST;CAMSAP2;FIGN
prerank,negative regulation of fat cell differentiation (GO:0045599),0.4357349853790104,1.0178919608907753,0.4810267857142857,0.8322871772766325,1.0,6/34,14.33%,TGFB1;TNF;FLCN;SMAD3;GPS2;BBS12
prerank,protein maturation (GO:0051604),0.39911851067938214,1.017667478266042,0.46961894953656025,0.8323893752878262,1.0,22/95,17.05%,CTSS;SRGN;ECE2;EEF1AKMT4-ECE2;CLN3;DDI2;TSPAN32;TSPAN14;MMS19;CIAO2A;CIAO1;NAA40;SORL1;NDUFAB1;STUB1;PCSK7;GALNT2;ECEL1;METAP2;NAA50;FURIN;PITRM1
prerank,rRNA transcription (GO:0009303),0.4833474994794837,1.0174222443524612,0.46329113924050636,0.8325168843694596,1.0,3/17,7.93%,POLR1E;GTF3C4;GTF3A
prerank,heart looping (GO:0001947),0.429224039185028,1.0171167018962581,0.4821826280623608,0.8328441421988682,1.0,4/39,8.10%,SHH;PKD2;TGFBR2;MEF2C
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.4245652498817693,1.016726915605254,0.48366013071895425,0.8333482452425159,1.0,9/48,13.64%,CASS4;RREB1;SS18L1;MDK;NEDD9;P4HB;LIMS1;NRP1;CUX1
prerank,regulation of programmed cell death (GO:0043067),0.39404399743756735,1.0165161975162469,0.48148148148148145,0.8333977437326652,1.0,34/161,16.74%,CD3E;CTSB;FLT3;NUP62;TNF;TMEM219;TRAF2;CASP1;ANP32A;APAF1;TP53;ACTN4;CRADD;MALT1;TPT1;NTF3;BCAR1;ACER3;ACTN1;LGALS1;NF2;TRIM24;SOX9;SRA1;PRDX2;LRP8;WFS1;LRRK2;PHLPP1;STEAP3;FANK1;RTN4;HSP90AA1;ASAH1
prerank,liver development (GO:0001889),0.4425417587170545,1.0164758652425725,0.4731182795698925,0.833024955769578,1.0,5/32,7.68%,PCSK9;PKD2;CEBPA;ANXA1;CEBPB
prerank,protein catabolic process (GO:0030163),0.41953278316519915,1.0164549759947754,0.48264984227129337,0.8326182087317486,1.0,15/59,18.32%,CTSD;MTOR;CLN8;APOE;DDI2;OGA;CHEK2;TRIM24;STT3B;UBE2G2;CAPN3;IDE;HSP90AA1;USE1;FBXO44
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.40934399647785097,1.0161709033766422,0.48863636363636365,0.8328915806384547,1.0,19/80,14.41%,P2RX7;KCTD17;ARAP1;ARPC2;PLEKHM1;RIPOR2;DOCK11;AGRN;WASF2;P2RY12;AKIRIN1;ACTR2;ACTR3;PFN1;CYFIP1;NRP1;TWF2;FNBP1L;MIEN1
prerank,response to estrogen (GO:0043627),0.4446843810799558,1.0157975308982052,0.46503496503496505,0.83331885983732,1.0,6/31,15.49%,TRIM25;OCSTAMP;TRIM24;RBBP5;SRA1;NCOA4
prerank,COPII-coated vesicle budding (GO:0090114),0.40821306332394725,1.0157370536838366,0.49375,0.8329936194315397,1.0,27/68,24.69%,CTSC;PPP6R1;TRAPPC9;MCFD2;CTSZ;PDCD6;VAPB;RAB1B;SEC24D;SEC16A;F5;SEC16B;STX5;SAR1A;TRAPPC6A;GRIA1;TRAPPC2L;SEC13;SEC22B;SEC31A;USO1;CUL3;NAPA;TRAPPC10;NSF;SEC24C;TRAPPC4
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.41064448359348127,1.0153732670096751,0.4963273871983211,0.8324799585008985,1.0,25/61,24.69%,CTSC;PPP6R1;TRAPPC9;MCFD2;CTSZ;PDCD6;RAB1B;SEC24D;SEC16A;F5;SEC16B;STX5;TRAPPC6A;GRIA1;TRAPPC2L;SEC13;SEC22B;SEC31A;USO1;CUL3;NAPA;TRAPPC10;NSF;SEC24C;TRAPPC4
prerank,COPII vesicle coating (GO:0048208),0.41064448359348127,1.0153732670096751,0.4963273871983211,0.8324799585008985,1.0,25/61,24.69%,CTSC;PPP6R1;TRAPPC9;MCFD2;CTSZ;PDCD6;RAB1B;SEC24D;SEC16A;F5;SEC16B;STX5;TRAPPC6A;GRIA1;TRAPPC2L;SEC13;SEC22B;SEC31A;USO1;CUL3;NAPA;TRAPPC10;NSF;SEC24C;TRAPPC4
prerank,vesicle coating (GO:0006901),0.41064448359348127,1.0153732670096751,0.4963273871983211,0.8324799585008985,1.0,25/61,24.69%,CTSC;PPP6R1;TRAPPC9;MCFD2;CTSZ;PDCD6;RAB1B;SEC24D;SEC16A;F5;SEC16B;STX5;TRAPPC6A;GRIA1;TRAPPC2L;SEC13;SEC22B;SEC31A;USO1;CUL3;NAPA;TRAPPC10;NSF;SEC24C;TRAPPC4
prerank,regulation of biosynthetic process (GO:0009889),0.5159901931697208,1.015352763620216,0.46584699453551914,0.8320705770817719,1.0,1/11,3.87%,SNCA
prerank,negative regulation of protein dephosphorylation (GO:0035308),0.46318814703315414,1.0149679797765483,0.45465686274509803,0.8325384140592897,1.0,11/21,27.84%,PPP1R11;YWHAB;ENSA;BOD1L1;PPP4R4;PTPA;GSK3B;PPP1R16B;MFHAS1;TIPRL;CRY2
prerank,nuclear membrane disassembly (GO:0051081),0.5043094657514214,1.0148418264739407,0.48601864181091875,0.8323806180706579,1.0,5/14,20.90%,NEK6;PRKCB;AKAP8L;VRK1;LPIN1
prerank,regulation of interleukin-1 production (GO:0032652),0.5019759488919433,1.0142186216351565,0.4691689008042895,0.8334316500644545,1.0,3/15,6.34%,SIRPA;HMGB1;ANXA1
prerank,cellular protein localization (GO:0034613),0.39398440867433077,1.0141573092485217,0.468,0.8331262495165578,1.0,97/285,23.15%,TBC1D9;CD74;SH3PXD2B;LAPTM5;TBC1D10C;UNC93B1;CTSA;RAB32;TMED3;SNX9;RAP2A;RAB14;RAB3GAP2;TBC1D16;TBC1D22A;STX11;TLK1;AP3D1;USP6NL;CTNNB1;STXBP3;TBC1D10A;MYO7A;RAB28;SNX27;RAB31;ITSN1;PDCD6;SYNRG;ARL5B;ARL4A;VCL;RAB1B;TBC1D2;TM9SF2;TBC1D17;COPA;CLTC;HDAC6;PTPRU;CD63;TBC1D2B;BICD2;WDR11;TBC1D8;STX3;STX5;SAR1A;RPGR;STX8;GGA2;ARF6;LAMTOR3;VPS29;LRRK2;CAPN3;TBC1D14;AHI1;TBC1D22B;YWHAH;SMURF1;SNX13;MESD;ARFIP2;IFT27;ARHGEF2;LAMTOR1;STX2;VPS33B;SLU7;ANGPT1;TBC1D12;PACS2;TBC1D5;RAB29;SEC13;HHEX;SEC31A;USO1;ARCN1;COG7;AMOT;PIGU;HERC2;RRAGA;RRAGB;ERP29;UNC50;FLNA;NAPA;ABHD17A;NPHP1;ADPRH;ARL5A;CEP68;TBC1D9B;STX7
prerank,triglyceride biosynthetic process (GO:0019432),0.4780086197652148,1.0140481200611486,0.47104247104247104,0.8329247321781955,1.0,7/18,20.90%,LPIN2;AGMO;GK;PNPLA3;DGAT2;MOGAT1;LPIN1
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.3881552402748228,-1.0140178711915524,0.43636363636363634,0.8793774413048494,1.0,6/12,18.48%,ANKRD13C;RER1;KDELR3;INSIG2;INSIG1;KDELR1
prerank,regulation of protein modification process (GO:0031399),0.41779726961751046,1.013943555983984,0.47783783783783784,0.8327228751725668,1.0,21/50,24.71%,LYN;FNIP2;ATG7;FNIP1;PLXNB2;FLCN;HPF1;PHIP;PPP2CA;PUM3;CORO1C;ATG14;HSPB1;ABCA2;PIN1;MT3;ATG10;FKTN;PPP1R16B;SPRED3;SPRED1
prerank,regulation of Rho protein signal transduction (GO:0035023),0.4098988795269429,1.013389119603962,0.49270833333333336,0.833604252815641,1.0,14/72,13.58%,LPAR6;ABCA1;ARHGEF18;APOE;GPR17;RIPOR2;MYO9B;FLCN;ARHGDIB;F11R;NRP1;ADGRG1;ARHGEF3;ARHGDIA
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.40947153830270355,1.0132152822619906,0.5010504201680672,0.833585536926964,1.0,16/66,14.24%,TGFB1;NLRC3;RGCC;APOE;XDH;MTSS1;AQP11;ATP5IF1;DUSP10;CASK;SOX9;THBS1;CDK6;ATP5F1A;B2M;SOX2
prerank,regulation of secretion (GO:0051046),-0.379467801270825,-1.013154498157471,0.3879003558718861,0.878515719240136,1.0,7/13,27.26%,MYO6;GPLD1;FGF10;EGF;ERBB3;ACSL3;POFUT2
prerank,positive regulation of ossification (GO:0045778),0.4212986982627021,1.0129401905276862,0.4751693002257336,0.8337774000077155,1.0,7/39,11.24%,TGFB1;P2RX7;SLC8A1;FZD9;MEF2C;ATP2B1;NELL1
prerank,regulation of multicellular organismal development (GO:2000026),0.4515251936040331,1.0128702672408052,0.4885954381752701,0.8335035096870859,1.0,2/25,4.84%,HPSE;RAB14
prerank,regulation of cytoplasmic translation (GO:2000765),0.4967130131589112,1.012842715897742,0.4540612516644474,0.8331183365453652,1.0,6/14,20.50%,DHX9;CPEB3;CPEB4;CPEB2;CNBP;PKM
prerank,Golgi to plasma membrane transport (GO:0006893),0.41626048977518204,1.0126759683384992,0.4854054054054054,0.8330753910177353,1.0,13/47,13.79%,RAB34;RABEP1;EXOC6;CCDC93;MACF1;VPS35L;RAB31;ARFGEF2;EXOC8;EXOC1;EXOC2;EXOC5;GGA2
prerank,myofibril assembly (GO:0030239),0.42573540716173564,1.0124669426544495,0.4786418400876232,0.8331255608040976,1.0,7/42,14.81%,TTN;MYLK3;FLII;CFLAR;TNNT3;CSRP1;CAPN3
prerank,purine nucleotide catabolic process (GO:0006195),0.49670416658015526,1.011893080176289,0.47419804741980476,0.8340635258471314,1.0,3/13,8.29%,XDH;HINT1;PNP
prerank,maintenance of blood-brain barrier (GO:0035633),-0.2941681233358271,-1.0118497230393955,0.4318181818181818,0.879128587887054,1.0,9/30,15.10%,SLC12A2;TJP1;CDH5;DMD;CLDN5;CLDN12;JAM3;LAMC1;OCLN
prerank,sensory perception of chemical stimulus (GO:0007606),-0.3480049681254832,-1.0117122891133272,0.4230769230769231,0.8763771737896447,1.0,7/15,23.15%,GNAS;GNAL;UBR3;BBS4;SLC24A4;DRD2;MKKS
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),0.5164321127339195,1.0106405275758283,0.48660084626234135,0.8365792532073946,1.0,2/10,7.24%,MLXIPL;ABCD1
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.4339528023593182,1.0097991318937884,0.4872093023255814,0.838116899123221,1.0,8/32,17.23%,MMP12;CASK;NF2;THBS1;SRC;RASA1;PTEN;CORO1C
prerank,response to metal ion (GO:0010038),0.40473240419070267,1.0096401035218783,0.48520084566596194,0.8380435562746714,1.0,12/67,12.34%,IL1A;PPP2CB;SNCA;TTN;HAAO;KCNMA1;HFE;PDCD6;ALG2;NEDD4L;THBS1;PPP2CA
prerank,neuron apoptotic process (GO:0051402),-0.3356185318221588,-1.0095864728443018,0.42857142857142855,0.8793534591504426,1.0,5/19,18.04%,APP;BNIP3;ATN1;NAE1;GAPDH
prerank,myoblast differentiation (GO:0045445),-0.36998574639337817,-1.0094495857557106,0.4358974358974359,0.8765801599046477,1.0,6/14,13.26%,TCF7L2;REST;HINFP;EPAS1;JAG1;MAPK12
prerank,regulation of epithelial cell migration (GO:0010632),0.4144631264997384,1.0091634151100128,0.4913232104121475,0.8387634022051335,1.0,15/51,17.23%,PLCG2;RREB1;ARSB;MACF1;DUSP10;RAB11A;PFN2;PFN1;SOX9;HDAC6;ADIPOR1;SRC;RTN4;HIF1A;CORO1C
prerank,acute inflammatory response (GO:0002526),0.45605414790042764,1.0091395455711503,0.4892086330935252,0.8383626069178222,1.0,3/23,7.68%,MYLK3;IL6R;CEBPB
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.48797099994338444,1.0090263502222407,0.4889196675900277,0.8381865406919841,1.0,2/13,4.53%,CBL;ZFYVE28
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.45123520283382285,1.007434837751993,0.48578199052132703,0.8414947948830824,1.0,4/26,7.84%,PLCG2;SNCA;ABCD1;TRAP1
prerank,regulation of fat cell differentiation (GO:0045598),0.4028342247854696,1.0073263902913672,0.4827586206896552,0.8413127892350504,1.0,16/74,18.20%,TGFB1;LPL;TNF;CEBPB;ASXL2;SMAD3;LRP5;CMKLR1;TAF8;CREB1;GPS2;BBS12;SYAP1;WDFY2;PPARD;CREBL2
prerank,positive regulation of positive chemotaxis (GO:0050927),-0.3513384519379297,-1.0073064486422563,0.43162393162393164,0.8793620880035424,1.0,7/15,17.54%,NTRK3;F3;VEGFC;CXCL12;IL16;SCG2;PGF
prerank,cell cycle G1/S phase transition (GO:0044843),0.4073146704370223,1.0070215357594081,0.48900523560209425,0.8415899295244655,1.0,14/61,16.10%,GPR132;GSPT1;PIM2;PLK2;RB1;CDK7;DBF4;INHBA;CDC34;CDK6;MAX;CCNE2;USP29;MAP3K11
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.44816614776247515,1.0064348656116582,0.4809976247030879,0.842534325199087,1.0,2/25,3.66%,LYST;VTA1
prerank,cellular response to inorganic substance (GO:0071241),0.453539191591961,1.0057912290710946,0.4993757802746567,0.8435740433247375,1.0,7/21,24.44%,AQP1;DDI2;ATRX;MTR;SPIDR;MT3;DDX11
prerank,protein deacetylation (GO:0006476),0.42633824585049673,1.0057394533811659,0.47898230088495575,0.8432380199223374,1.0,10/41,13.99%,HDAC5;MTA3;TBL1XR1;RCOR1;MIDEAS;HDAC4;TBL1X;HDAC6;HDAC9;HDAC11
prerank,skin development (GO:0043588),-0.24521150248976847,-1.005452265786615,0.4444444444444444,0.881225171529035,1.0,14/65,15.14%,COL5A2;ERRFI1;CLIC4;COL3A1;WNT5A;BCR;ITGB4;COL5A3;COL1A2;MET;JAG1;CASP3;COL1A1;UGCG
prerank,regulation of nucleocytoplasmic transport (GO:0046822),0.5030423630404575,1.0051606036374194,0.48575498575498577,0.8441191597661412,1.0,2/12,10.10%,TGFB1;TPR
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.44434935995980046,1.004882200857193,0.48009650180940894,0.8443359980951534,1.0,12/27,27.02%,CHSY3;BCAN;XYLT1;CHSY1;CHST15;PXYLP1;CHPF;CSPG4;B3GAT2;CHST3;CHST11;CHST9
prerank,extracellular matrix assembly (GO:0085029),0.4524046174198872,1.0043698618154504,0.48,0.8451045460536953,1.0,6/23,18.76%,TGFB1;ATP7A;GAS6;PXDN;MFAP4;LTBP3
prerank,establishment of mitotic spindle orientation (GO:0000132),-0.3171593314909973,-1.003775775848414,0.4585635359116022,0.8827857341695968,1.0,5/23,11.09%,PAFAH1B1;GPSM2;NDEL1;NDE1;CDK5RAP2
prerank,establishment of skin barrier (GO:0061436),0.48361070583945115,1.0034978773357883,0.46476964769647694,0.846230202616225,1.0,1/15,1.99%,ALOX12
prerank,regulation of water loss via skin (GO:0033561),0.48361070583945115,1.0034978773357883,0.46476964769647694,0.846230202616225,1.0,1/15,1.99%,ALOX12
prerank,muscle cell migration (GO:0014812),0.5253509457210475,1.0033794383134136,0.4910979228486647,0.8460471811795856,1.0,1/10,1.74%,ITGB3
prerank,regulation of G0 to G1 transition (GO:0070316),0.4267654035011362,1.0031077567555329,0.4988662131519274,0.846234284194434,1.0,9/38,13.06%,UXT;YAF2;APAF1;PCGF6;RING1;PHC1;E2F6;RBBP7;MAX
prerank,tRNA transport (GO:0051031),-0.28419858206064397,-1.0031011819954978,0.49572649572649574,0.8816946266955106,1.0,11/35,11.87%,NUP93;NUP188;RANBP2;SSB;NUP98;NUP42;YBX1;NDC1;RAE1;NUP153;NUP37
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.39122331058572085,1.002996631418399,0.5040650406504065,0.8460371308382316,1.0,23/118,16.35%,GPNMB;TGFB1;CYRIB;LFNG;RAP2A;SEMA4D;TNFAIP3;CTNNB1;CAPZB;TNIK;MEF2C;MYO19;RC3H1;POGLUT1;NEDD4L;PHIP;LZTS3;PID1;TANC2;LRRK2;PDZD8;NF1;EPHA4
prerank,artery development (GO:0060840),0.45532076597852317,1.0023471738986538,0.46989374262101535,0.8470512142491644,1.0,5/23,11.23%,TGFBR1;ANGPTL3;PKD2;HECTD1;NRP1
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.4638680007068279,1.002241036388733,0.4821648216482165,0.8468494307969924,1.0,8/20,25.15%,PTGES3;LONP1;PSMG3;BBS12;HSP90AA1;PSMG2;HSPA4;HSP90AB1
prerank,regulation of smooth muscle contraction (GO:0006940),-0.33184253580040785,-1.002017581857108,0.4386792452830189,0.8817662719625632,1.0,6/20,14.95%,CHRM2;CAV1;SETD3;PLCE1;KCNB2;CHRM3
prerank,MAPK cascade (GO:0000165),0.3840252639634205,1.0015890841394632,0.496,0.847925805751423,1.0,69/295,18.95%,PTPN7;TGFB1;RASAL3;FLT3;SPTBN5;LAT;CSF2RB;TAOK3;GRB2;PIK3CB;FGF13;CCM2;RASA4;TNF;RASA3;IL18;RGL2;SHC2;BCL2L1;YWHAB;MEF2A;PSMB10;MAP3K5;ABHD17B;TNIK;FLT3LG;PRKCQ;MEF2C;RASGRP3;HSF1;MAP2K2;PSMA2;ARTN;SOX9;CCL2;ABHD17C;SYNGAP1;FYN;PSME3;NRG1;RANBP9;IKBKG;CAMKK2;BRAF;NFKB1;PSMB5;LAMTOR3;IL2RG;PSMD8;WDR83;LRRK2;PPP1CC;IL3RA;PTPRA;PSMD7;PSMB9;RASA1;NF1;RASGRP4;RASAL1;KSR1;SPTBN4;PSMD2;PAQR3;ANGPT1;CSF2RA;MINK1;PTPN3;TAOK1
prerank,negative regulation of neuron projection development (GO:0010977),0.4074582042867108,1.0006955738248728,0.4920297555791711,0.8495953942284276,1.0,18/56,19.41%,MYLIP;THY1;BCL11A;RTN4RL1;APOE;ADCY6;CBFA2T2;PTPRO;ARHGDIA;EFNB3;GAK;RTN4;EPHA4;PTEN;RHOA;DENND5A;PAQR3;RAB29
prerank,regulation of humoral immune response (GO:0002920),0.4137984957877259,1.0006289038363971,0.495114006514658,0.849297502507222,1.0,6/44,14.90%,FCGR2B;C1QC;C1QA;C1QB;C3AR1;C4B
prerank,membrane organization (GO:0061024),0.38625791248717195,1.0004400062178904,0.4974974974974975,0.8492866341600851,1.0,63/227,21.09%,ARRB2;CBL;VAMP3;GRB2;RABEP1;SNX9;MTCH1;PIP5K1C;LDLRAP1;CLN3;ARPC2;NPC1;STX11;AP3D1;LPCAT2;ACTB;DNM2;GAPVD1;AP2S1;SYT2;ARPC3;SH3KBP1;ATP2C1;STON2;ITSN1;SNAP29;ACTG1;VAPB;SYNGR1;ACTR2;SYNGR2;ACTR3;DYSF;TMCC1;CLTC;TIMM50;ARPC4;SYNJ1;SNAP23;SAR1A;FNBP1L;TOR1AIP2;TOR1A;HUWE1;GAK;EPS15;AP2M1;PDCD6IP;EPN1;CORO1C;BIN1;VPS33B;PICALM;UBXN2A;TMEM170A;DNM1L;FCHO2;FNBP1;USO1;NSFL1C;STAM2;AZIN2;RIMS1
prerank,positive regulation of protein depolymerization (GO:1901881),0.5048816056297942,0.9999991102608854,0.4978843441466855,0.849826372625769,1.0,1/11,0.91%,PLEK
prerank,establishment of protein localization to extracellular region (GO:0035592),0.4270013102585061,0.9998625611726306,0.4847457627118644,0.8496901397938941,1.0,9/39,18.77%,RAB8B;ABCA1;SEL1L;PPY;STEAP3;SVBP;MON1A;GOLPH3;LTBP2
prerank,positive regulation of cellular protein localization (GO:1903829),0.3983604750122299,0.9997048509590012,0.5010593220338984,0.84961217891105,1.0,16/69,20.78%,TGFB1;NUP62;TNF;GPR137B;SNX33;TYROBP;FYN;STX3;KAT7;CENPQ;RTN4;VPS28;ENTR1;TRAPPC12;GSK3B;PRKN
prerank,regulation of telomere capping (GO:1904353),0.45113356309831365,0.9994085156712765,0.4920245398773006,0.8499009592217024,1.0,5/23,14.37%,PKIB;PRKCQ;USP7;TNKS2;HNRNPD
prerank,regulation of cytokinesis (GO:0032465),0.39669360551353583,0.999370783718038,0.5217391304347826,0.8495375777341936,1.0,20/78,18.01%,ZFYVE26;KLHL21;BCL2L1;PLK4;PLK2;KIF14;FLCN;KIF20B;MYO19;KIF23;UVRAG;RAB11A;SETD2;BECN1;CDC6;PIK3R4;RHOA;GIPC1;CDC42;ENTR1
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),-0.3283981887494618,-0.9992521861631,0.4460093896713615,0.886647502081346,1.0,11/18,30.04%,COX16;OXA1L;COX18;COA8;COX14;COX17;TIMM21;COA5;SCO1;COA3;SURF1
prerank,cardiac conduction system development (GO:0003161),-0.31428145571211796,-0.9992003980910121,0.45121951219512196,0.8836713918824205,1.0,7/24,10.26%,BMPR1A;BMP4;CACNA1G;SMAD4;SMAD5;SMAD1;TBX18
prerank,positive regulation of transferase activity (GO:0051347),0.39041713042424464,0.9990603745998479,0.5075528700906344,0.8497669614176828,1.0,12/142,6.29%,TREM2;TGFB1;FLT3;CD74;DBI;CSF1R;DSTYK;PTGES3;PKIB;RPS2;XRCC5;CTNNB1
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),-0.40875138200411054,-0.9988689079172788,0.4646153846153846,0.8814556339388421,1.0,2/10,13.44%,CAV1;ANK3
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.47743711228330343,0.9984775813914982,0.4884353741496599,0.8506450697850094,1.0,4/14,18.40%,TGFBR1;SOX9;RFLNA;GREM1
prerank,phasic smooth muscle contraction (GO:0014821),0.5126930982664927,0.9982060481168648,0.5095447870778267,0.8508369762738781,1.0,1/10,2.42%,EDNRB
prerank,negative regulation of cell cycle (GO:0045786),0.40756988076439915,0.9981431276315393,0.5093555093555093,0.8505318110143238,1.0,21/73,20.96%,LILRB1;TGFB1;HPGD;CEBPA;MYOCD;RB1;SMAD3;SIPA1;ANGEL2;INHBA;TRIM35;CDK6;NR4A1;RPS6KA2;PTEN;PTPN3;SCRIB;HHEX;NPPC;HEXIM1;TFAP4
prerank,negative regulation of histone acetylation (GO:0035067),0.5021442640925556,0.9977066207593819,0.4895977808599168,0.8510906988618624,1.0,3/11,14.68%,SNCA;SPI1;NOC2L
prerank,regulation of myotube differentiation (GO:0010830),0.43863796012810746,0.9976820620872402,0.48736462093862815,0.8506945369050898,1.0,5/24,12.15%,MAPK14;BHLHE41;HDAC5;HDAC4;HDAC9
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),0.40094534955490024,0.9975236853811196,0.502092050209205,0.8506251467679504,1.0,18/69,19.86%,TRIM25;EDEM1;HERPUD1;SEL1L;ERLIN1;ERLIN2;DERL1;UBE4B;STT3B;UBE2G2;STUB1;WFS1;UBE2J2;FAM8A1;FBXO44;EDEM2;OS9;TMEM67
prerank,mesenchymal cell differentiation (GO:0048762),0.40698655670024575,0.9973062164005196,0.5118279569892473,0.8507047372439163,1.0,8/51,11.18%,TGFB1;TGFBR1;CTNNB1;AKNA;SNAI1;MEF2C;LIMS1;SOX9
prerank,positive regulation of osteoblast differentiation (GO:0045669),-0.27714983973047475,-0.9970911832715442,0.43,0.8834608812557346,1.0,6/43,4.03%,SUCO;BMPR1A;WNT4;PRKD1;BMP4;ACVR1
prerank,beta-catenin destruction complex disassembly (GO:1904886),0.45660161094012247,0.9970056962818,0.47984886649874053,0.8509619641425765,1.0,6/21,20.45%,FRAT2;CTNNB1;AMER1;CSNK1A1;FZD2;GSK3B
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),-0.3590743842935538,-0.9968113719557432,0.4493927125506073,0.8812005468647808,1.0,3/15,7.10%,PIEZO2;SCN1A;KCNA1
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.3997019583992188,0.9962866093961295,0.48891235480464623,0.8521882361132205,1.0,12/63,13.66%,LGALS3;TGFBR1;TNF;ITGA6;TRAF2;PYCARD;CFLAR;THBS1;PHIP;PSME3;CASP8;TRADD
prerank,ncRNA processing (GO:0034470),0.3825029322465114,0.9961098190630975,0.5115115115115115,0.8521454293537335,1.0,74/200,25.70%,RPL23;RPL17;EMG1;RPL10A;UTP20;NOB1;TEX10;FBL;RPS2;EXOSC1;LAS1L;RPL18A;ADAR;SMAD3;INTS8;KRR1;AGO4;RPL6;DDX27;RPLP2;RPL26;RPS16;AGO3;METTL3;MDN1;UTP11;HEATR1;RPS14;INTS6;RPL19;PRKRA;IMP3;RPL9;PES1;C1D;PIH1D1;RPL11;TUT7;FARS2;TARBP2;WDR12;RPS27;AGO2;INTS1;RPL4;FCF1;WDR75;RPL7A;RPL15;EXOSC3;RPL29;RRP7A;UTP3;RPL22;IMP4;RPS7;DICER1;LIN28B;SARS1;EXOSC2;RPLP1;ZCCHC8;ADAT1;RPS15;INTS3;RPL41;XRN2;DROSHA;DDX10;RPL10;AGO1;UTP6;RPL5;RPL18
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.39481883628023723,0.9958074315749866,0.48803329864724243,0.8523976725580131,1.0,21/67,19.20%,TBC1D10C;TBC1D16;P2RX4;TBC1D22A;USP6NL;CAPZB;TBC1D10A;PODXL;TBC1D2;TBC1D17;TBC1D2B;TWF2;TBC1D8;ARF6;TBC1D14;TBC1D22B;ATG3;RABEP2;CDC42;DYNC2LI1;TBC1D5
prerank,adipose tissue development (GO:0060612),0.4972665810178163,0.9956711224612604,0.48797736916548795,0.8522780961116712,1.0,2/11,9.91%,SH3PXD2B;LRP5
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.4240704291039799,0.995576558202891,0.4983534577387486,0.8520346800786083,1.0,12/43,17.41%,SNX5;PRKCD;PTPN1;PTPRE;PIP4K2A;PRKCB;PRKCQ;SORL1;PID1;GSK3A;ZBTB7B;SIK2
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),-0.25421891683682335,-0.9955468275857597,0.4492753623188406,0.881798630143746,1.0,12/53,11.86%,SMCHD1;EYA2;EGFR;FXR2;SPRED2;NACC2;EYA1;FMR1;CEBPG;EYA4;ATM;CCAR2
prerank,mRNA methylation (GO:0080009),-0.34916010646085893,-0.9951933150676464,0.4248927038626609,0.8797042785940095,1.0,6/15,14.68%,CBLL1;METTL14;NSUN2;METTL16;TRMT6;CMTR1
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.44988195974318074,0.994916389610164,0.4945717732207479,0.853102803925502,1.0,10/23,25.59%,NLRC5;IFNGR2;TXK;PIAS1;IRGM;SOCS3;IFNGR1;PARP9;HSP90AB1;CDC37
prerank,positive regulation of glycolytic process (GO:0045821),0.4526499015534748,0.9948750038419925,0.4817961165048544,0.8523010195332125,1.0,6/20,16.72%,P2RX7;MLXIPL;PFKFB4;PFKFB3;HIF1A;GAPDHS
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),0.4526499015534748,0.9948750038419925,0.4817961165048544,0.8523010195332125,1.0,6/20,16.72%,P2RX7;MLXIPL;PFKFB4;PFKFB3;HIF1A;GAPDHS
prerank,DNA synthesis involved in DNA repair (GO:0000731),-0.27795847290113984,-0.9947097641968027,0.4421052631578947,0.8780207758046237,1.0,30/42,35.85%,REV1;RFC1;WRNIP1;PRIMPOL;ZBTB1;WRN;USP10;RFC2;POLN;POLA1;UBC;POLK;POLI;UBE2L6;ISG15;FAAP20;RPA3;UBA52;USP43;POLD2;RPA2;RFC3;RPS27A;PCLAF;POLE;RFC4;PCNA;CDKN2D;POLD4;POLD1
prerank,carbohydrate derivative catabolic process (GO:1901136),0.4636287159183561,0.9943691355905259,0.49809885931558934,0.8530390580818017,1.0,5/18,18.32%,SAMHD1;FUCA1;OGA;STT3B;FBXO44
prerank,RNA 3'-end processing (GO:0031123),-0.23150117661275288,-0.9942340574423355,0.5365853658536586,0.8763547901724799,1.0,18/69,15.25%,WDR33;SARNP;SRRM1;RPRD2;FIP1L1;CPSF7;THOC7;CSTF2;THOC1;PAPOLA;THOC5;U2AF2;SRSF11;RPRD1B;EIF4A3;SRSF1;TUT1;CSTF3
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.3797070249042551,0.9941220219063126,0.548,0.8531472773750329,1.0,336/1646,18.80%,CD86;RUNX1;BATF3;SPIC;NFE2;IRF5;NPAS4;AHRR;ASCL1;CIITA;MEOX1;SHH;IRF4;IRF8;TGFB1;IKZF1;HCLS1;TOX4;UXT;GATA1;PCID2;CD74;STAT5A;NFE2L2;POU2F2;BASP1;CBFA2T3;SNX5;TGFBR1;NFATC1;HES7;MED17;RREB1;GTF2H1;MAD2L2;BCL11A;NSD1;MLXIPL;SS18L1;ELF4;DHX9;NUP62;ZEB2;MAPK14;MED13L;SP7;CREB3L4;CREB3;BARX2;YAF2;RXRB;FOXD2;CDK14;NR1H4;TNF;SREBF2;RFX1;MLXIP;APOE;UBE2V1;CIR1;BPTF;ZNF326;MITF;ZFP30;PPIE;NFXL1;ATF3;CEBPA;FOXO3;SRCAP;ZMIZ2;LRRFIP1;DDIT3;CXXC1;SPP1;SPI1;MYT1L;ZBTB12;NDP;PGBD1;WWC2;ZBTB39;HIVEP3;MAFG;MAFK;HOXC8;TSC22D4;BHLHE41;HDAC5;HMGB1;XRCC5;RNF111;BRIP1;BACH1;FLI1;PRKCB;TEAD1;PCGF6;CHD7;SBNO1;MAP2K3;CTNNB1;TRPS1;TFEB;MTA3;ZFP69;CDK11B;DNM2;CCAR1;ZNF177;TP53;KLF6;CD80;MEF2A;TBL1XR1;NKX2-1;NRL;TAL1;USF1;MAP3K5;MYOCD;RCOR1;KDM7A;YY1;TCF20;CREB3L1;GCFC2;CDK17;PIM2;STAT4;ZFP90;EPO;CBFA2T2;CEBPB;HINT1;DBX2;FOXN2;TGFBRAP1;ST18;CHEK2;SNAI1;PRKCQ;MEF2C;NKRF;CDC5L;TFAP2B;RB1;METTL4;RBM15B;GMEB2;CIART;BICRA;SMAD3;MMS19;ARID1A;ZFP14;TADA1;GTF2IRD1;IRF2;HSF1;MDFIC;PPARGC1A;ZNF32;ARID3B;QARS1;ATRX;RPL6;CREBRF;RNF4;RING1;ATF7IP;ARID4A;ANXA4;GMEB1;STAT5B;LRP5;MIDEAS;HDAC4;NFX1;NFE2L1;LITAF;CCNL1;ZNF83;TGIF1;ARID1B;HOXA6;RNF10;NFIC;ATAD2;SEC14L2;TBL1X;INHBA;PHC1;MED27;TRIM56;KLF13;CHD1;MAP2K2;CREB3L2;PKN1;BAZ1A;ZMYND15;POLR2L;HCFC2;ZSCAN26;LIMS1;ELF2;OLIG1;SOX9;SRA1;RPS6KA4;HDAC6;NLK;JDP2;DENND4A;NR2C2;DAP;ETV6;ZNF740;E2F6;ZNF628;PHIP;GZF1;CIAO1;HDAC9;HSF5;ATF6B;MTF2;PPP2CA;MBD1;MAP3K12;CREB1;NRG1;BRDT;KAT7;ZSCAN18;BAMBI;SMARCD3;NR4A1;MAX;CAMKK2;SMARCB1;ZFX;ZNF445;FOXN3;GAS6;NFKB1;FOXK1;SAFB2;RFX7;GPATCH3;SOX6;CUX1;HCFC1;CDC6;ZFHX3;IRF1;SOX2;KDM3B;BRD7;HNRNPD;ARHGEF11;LBH;SOX4;SREBF1;MEIS1;CAPN3;ZBTB11;POU6F1;IFRD1;PIAS1;SPTY2D1;TLE5;EID1;NR2C1;MTDH;REXO4;MAF;FOSL2;ERCC6;YWHAH;THRAP3;FANK1;CDK15;USP21;USP16;OGG1;MED29;RBPJ;FADS1;ZBTB7B;HIF1A;SIX5;SBNO2;SUV39H1;PPP3CB;PBXIP1;REL;TRIP4;ZNF568;ZKSCAN2;PPARD;RSF1;ZSCAN2;RPS6KA5;ZGPAT;CDK18;BACH2;VHL;NFYA;PCGF1;CASZ1;KDM4C;NPAS2;CNBP;PROX2;ZNF35;HSF2;CREBL2;PICALM;LOXL3;SFMBT1;RXRA;TESC;JUNB;PHF1;KLF5;CUX2;CIPC;POU2F3;KLF7;CHD4;CTBP2;PER1;MAFB
prerank,cell junction organization (GO:0034330),0.3964713440438422,0.9938786752924277,0.5198744769874477,0.8532694740359003,1.0,12/71,11.06%,TGFB1;RAB8B;SNCA;ACTB;AGRN;VMP1;C1QA;CAPZA1;RAB39B;SMAD3;ACTG1;LIMS1
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.4885641297455761,0.9930082395100084,0.4765957446808511,0.8548357203969177,1.0,5/12,17.73%,STX11;SNAP29;STX3;SNAP23;STX2
prerank,proteasomal protein catabolic process (GO:0010498),0.3851701635746837,0.9924203024562063,0.5395395395395396,0.8557614421481068,1.0,58/201,20.78%,ARRB2;NFE2L2;RFFL;KCTD17;UBE2D3;SEL1L;FBXL22;DDIT3;DDI2;CTNNB1;ATXN3;PSMB10;TBL1XR1;KIF14;GID8;DERL1;RNF4;UBE4B;NEDD4L;APPBP2;TBL1X;PSMA2;MAEA;CDC34;SPOP;PSME3;RNF216;RMND5B;ITCH;STUB1;PSMB5;HUWE1;PSMD8;AREL1;ZNRF1;CCDC47;PSMD7;PSMB9;GSK3A;SMURF1;FAF1;FEM1B;UBE2K;PSMD2;BIRC2;FBXO44;PPP2R5C;UBXN2A;KCTD5;SPSB2;PLAA;ERLEC1;WWP1;RAD23B;FBXW11;NSFL1C;CUL3;PRKN
prerank,regulation of protein ubiquitination (GO:0031396),0.3925218298091461,0.9924031219186622,0.5258358662613982,0.8553522993972716,1.0,22/108,18.48%,ARRB2;BAG2;IVNS1ABP;LAPTM5;TGFBR1;TNFAIP3;MALT1;DERL1;PRMT3;AMER1;STUB1;HUWE1;WFS1;LRRK2;SOX4;GSK3A;SVBP;HSP90AA1;VPS28;UBE2N;BIRC2;ANGPT1
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.4871253190968633,0.9923102952527233,0.509915014164306,0.8551053008920875,1.0,4/13,17.21%,TLR2;CCL2;NOD2;IL33
prerank,negative regulation of establishment of protein localization (GO:1904950),-0.40138677433538006,-0.9914752002372428,0.4603174603174603,0.8814386436821352,1.0,5/10,30.15%,MAPT;PPM1F;DNAJA1;TERF1;NDFIP2
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",0.5098909676485578,0.9911623020855924,0.5093525179856115,0.8568358609954566,1.0,4/11,17.90%,TNRC6A;AGO4;AGO3;AGO2
prerank,miRNA mediated inhibition of translation (GO:0035278),0.5098909676485578,0.9911623020855924,0.5093525179856115,0.8568358609954566,1.0,4/11,17.90%,TNRC6A;AGO4;AGO3;AGO2
prerank,cation transport (GO:0006812),0.38707519994326706,0.9903752262720843,0.5407035175879397,0.8582181669551715,1.0,19/166,12.02%,SLC6A3;SCN4B;AQP1;HCN4;KCNN4;FGF13;KCNK6;SLC8A1;SLC7A8;KCNIP2;CLN3;SLC36A1;CNGB1;KCNMA1;NEDD4L;SLC36A4;SLC8B1;SLC66A1;SCN9A
prerank,negative regulation of RNA metabolic process (GO:0051253),0.46036265176074065,0.9902589423351039,0.5156445556946183,0.8580376440848403,1.0,2/18,3.81%,TGFB1;TNF
prerank,cellular protein metabolic process (GO:0044267),0.38033795147460414,0.9901566588625651,0.535,0.8578287215669032,1.0,89/396,18.79%,KLK3;PCSK9;NAPSA;LGMN;CSF2RB;RPL23;RPL17;RPL10A;SFTPA1;SFTPA2;ST8SIA4;APOE;UBE2D3;DNAJC3;RPS2;SPP1;DMBT1;RRBP1;TIMP1;RPL18A;FARSB;MRPL41;UBE2S;TTF1;RPS15A;SPCS2;GSPT1;P4HB;ATP23;LOX;SEC11C;CHEK2;EIF4EBP2;ST3GAL1;MRPL51;MAN2B1;SPPL3;SPCS1;RPL6;PIGH;MCRS1;VGF;RPLP2;RPL26;FAM20C;RPS20;MSRA;LGALS1;CHGB;YES1;RPS16;CDC34;LMCD1;PARL;F5;RPS14;B4GALT7;UBE2G2;GAS6;DARS1;RPL19;WFS1;IGF2BP3;RPL9;ABCA3;IDE;RPS11;ATG3;RPL11;APLP2;YME1L1;RPS23;ERO1A;FURIN;RPS4X;MRPS21;FDXR;RPS27;FDX1;AGO2;RPL4;MRPS14;PABPC4;CSF2RA;MRPL3;MSRB2;PPP4R2;MXRA8;IGFBP4
prerank,negative regulation of receptor internalization (GO:0002091),0.49135763951629335,0.990137523401615,0.5021216407355021,0.857412449513721,1.0,3/12,15.23%,RIN3;SDCBP;ANKRD13A
prerank,cellular response to interleukin-1 (GO:0071347),0.38464483634624624,0.989962869977434,0.5161290322580645,0.8573431000136079,1.0,34/143,17.85%,IL1A;SIRPA;IRAK2;CCL8;UBE2V1;MYLK3;TANK;PYCARD;PSMB10;ST18;RC3H1;CCL14;PSMA2;CCL13;SOX9;RPS6KA4;GBP3;CCL2;NOD2;PSME3;TAB2;IKBKG;NFKB1;PSMB5;PSMD8;TAB3;PSMD7;PSMB9;HIF1A;CD47;CCL25;UBE2N;RPS6KA5;PSMD2
prerank,regulation of lamellipodium assembly (GO:0010591),0.424647999334177,0.9898966800255893,0.5066964285714286,0.8570363119620914,1.0,8/34,12.19%,ARPC2;CAPZB;WASF2;AKIRIN1;ACTR2;ACTR3;CYFIP1;TWF2
prerank,monocarboxylic acid metabolic process (GO:0032787),0.3888069310445484,0.9898110500580997,0.5369807497467072,0.8567971323216429,1.0,22/117,17.81%,CYP1A1;LPL;SGPL1;ALOX12;MTHFS;ANGPTL3;CKB;NPC1;KYNU;ACSF2;SLC16A1;MCCC2;PDHA1;PDZD11;VDAC1;FASN;ME3;CD36;LDHA;PPARD;ACOT2;PCCA
prerank,nuclear export (GO:0051168),0.39210015587949587,0.9897152794774351,0.5201238390092879,0.8565732677958711,1.0,23/80,19.39%,TGFB1;NUP62;DHX38;XPO1;NXF1;THOC2;CASC3;MALT1;CSE1L;STRADB;WASHC4;TPR;DDX39B;XPO6;POLDIP3;UPF3B;THOC3;STRADA;SMURF1;SLU7;SRSF6;DESI1;SRSF2
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.43714834997558644,0.9892272457364366,0.5125448028673835,0.8572842086638234,1.0,10/28,22.65%,TNF;SPI1;CRADD;ZDHHC3;CASP8;TRADD;SORT1;DEDD;DELE1;BID
prerank,muscle cell differentiation (GO:0042692),0.4280705248609411,0.9891118248847547,0.5081206496519721,0.8570909579494546,1.0,8/32,13.14%,DUSP29;SYNE1;SPEG;MRTFA;MYOCD;MEF2C;FBXO40;NINJ1
prerank,substantia nigra development (GO:0021762),0.4171648589632227,0.9889536937921405,0.5028121484814398,0.8570037310239479,1.0,12/37,23.03%,BASP1;CKB;ACTB;SEC16A;YWHAH;COX6B1;RHOA;CDC42;GNB4;PADI2;RAD1;NDRG2
prerank,regulation of axon regeneration (GO:0048679),0.4788720421085421,0.9886033771276275,0.49506346967559944,0.8573278481786585,1.0,4/12,16.35%,RTN4RL1;GRN;STK24;EPHA4
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.5056594917457815,0.9884844159135304,0.48450704225352115,0.8571493661319637,1.0,4/10,16.89%,ATP5MC2;ATP5F1A;ATP5PD;ATP5MG
prerank,ion homeostasis (GO:0050801),0.42729734532953284,0.9884514403270135,0.505720823798627,0.8567737041004383,1.0,5/30,10.05%,HCN4;P2RY2;AP3D1;WNK1;NEDD4L
prerank,spindle assembly (GO:0051225),0.39739192981893434,0.9879991810827639,0.5225603357817419,0.8573831438171402,1.0,18/67,18.47%,HAUS2;NEK6;BCCIP;CEP192;MAPRE1;STARD9;CHEK2;HAUS1;RAB11A;TUBGCP6;TUBGCP4;STAG2;INO80;HAUS8;KIF2A;RHOA;CEP63;MAPRE2
prerank,regulation of AMPA receptor activity (GO:2000311),-0.3080595769437861,-0.9877120788785769,0.5084745762711864,0.8889523614440652,1.0,10/25,26.87%,NLGN1;SHANK3;SHANK1;PRRT1;CACNG8;SHISA9;GSG1L;SHISA7;CACNG2;ADRB2
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.4375197508535923,0.9864210988525476,0.4945321992709599,0.8606166456265316,1.0,12/24,20.11%,FCER1G;HFE;TAPBPL;TAP1;SEC24D;B2M;ERAP1;IDE;PDIA3;TAP2;SEC13;SEC31A
prerank,ameboidal-type cell migration (GO:0001667),0.4007029552350942,0.9863988104644502,0.5233949945593036,0.8602178073655861,1.0,4/51,3.56%,SHH;ITGA4;SGPL1;SEMA4D
prerank,response to progesterone (GO:0032570),0.4609897144853223,0.9863000474677098,0.5025252525252525,0.8599938614390094,1.0,3/18,15.27%,TGFB1;THBS1;SRC
prerank,inorganic cation transmembrane transport (GO:0098662),0.3817723663528681,0.9862400797244019,0.557,0.8596781420857555,1.0,22/268,8.01%,SLC6A3;SLC6A4;KCNJ11;SLC11A1;SCN4B;ATP6V0E1;HCN4;SLC9A4;KCNN4;P2RX7;KCNK6;SLC8A1;PKD2;SLC36A1;P2RX4;SLC9A9;CCDC51;SLC9A1;ATP6V0D1;KCNK13;CACNA1A;ATP2C1
prerank,ribosome biogenesis (GO:0042254),0.3793216831177894,0.9860957235727148,0.5470941883767535,0.8595627091423194,1.0,50/187,21.04%,RPL23;RPL17;EMG1;RPL10A;UTP20;NOB1;TEX10;FBL;RPS2;EXOSC1;XPO1;LAS1L;URB2;RPL18A;GTF3A;KRR1;SURF6;RPL6;DDX27;RPLP2;RPL26;RPS16;MDN1;UTP11;HEATR1;RPS14;RRS1;RPL19;NOC2L;IMP3;RPL9;PES1;C1D;PIH1D1;RPL11;WDR12;RPS27;RPL4;DDX31;FCF1;WDR75;RPL7A;RPL15;EXOSC3;RPL29;RRP7A;UTP3;RPL22;IMP4;RPS7
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.4474869102660563,0.9860482021848993,0.5049627791563276,0.8592213592439039,1.0,7/22,16.04%,STAC;CACNB4;NOS1AP;CACNB2;CACNB1;STAC3;GNB5
prerank,positive regulation of DNA binding (GO:0043388),0.4240985458367337,0.9855266387161198,0.49480968858131485,0.8600104964779595,1.0,4/31,8.46%,TGFB1;SKI;HMGB1;RB1
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.48475641729411056,0.9852887654635992,0.49303621169916434,0.8601107303708739,1.0,4/13,14.19%,UTP20;NOP9;RRS1;TSR1
prerank,regulation of trophoblast cell migration (GO:1901163),0.4762972926776122,0.985168914722287,0.5,0.8599670353203147,1.0,7/14,25.37%,TIMP1;YTHDF3;ARHGDIB;AGO2;VEGFA;GJA1;C1QBP
prerank,positive regulation of DNA replication (GO:0045740),0.47288991509857337,0.9851146952236945,0.515032679738562,0.8596411161068386,1.0,7/16,16.38%,DHX9;BRPF3;STN1;KAT7;DNA2;BCAR3;FAF1
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.4648787062251878,0.9848246009831665,0.5142857142857142,0.859865036789104,1.0,4/19,11.23%,PTPRJ;THY1;LIMS1;NRP1
prerank,signal transduction in response to DNA damage (GO:0042770),0.4079638349479577,0.9847289711164301,0.5234972677595628,0.8596337972658636,1.0,9/49,9.48%,MAD2L2;GRB2;MAPK14;BRIP1;TP53;CHEK2;DOT1L;CDC5L;ATRX
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.4815243517701262,0.98439902762175,0.5198412698412699,0.8594727023726563,1.0,3/15,11.09%,AP3D1;AP3S1;DTNBP1
prerank,anterograde synaptic vesicle transport (GO:0048490),0.4815243517701262,0.98439902762175,0.5198412698412699,0.8594727023726563,1.0,3/15,11.09%,AP3D1;AP3S1;DTNBP1
prerank,cardiocyte differentiation (GO:0035051),0.5019528335434758,0.9839411180424069,0.4964131994261119,0.8600946194670087,1.0,3/10,12.63%,EEF1AKMT4-ECE2;MYOCD;NRG1
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),0.4752586304575803,0.9837968050824342,0.5,0.8599796286401509,1.0,3/15,9.59%,HERPUD1;SEL1L;DERL1
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),0.5028711197166835,0.9837136784684108,0.49575070821529743,0.8597058913778481,1.0,2/11,9.43%,DHX9;PUM2
prerank,establishment of protein localization to membrane (GO:0090150),0.3990271312407389,0.9833443474167579,0.5232067510548524,0.8600973093936685,1.0,18/66,17.93%,RFTN1;RAB3GAP2;NPC1;MICALL1;ZDHHC14;AQP11;ZDHHC7;RAB11A;ZDHHC3;VPS37C;SDCBP;BRAF;ZDHHC1;ZDHHC24;RABGEF1;ATG3;MYO1C;SEC63
prerank,response to reactive oxygen species (GO:0000302),-0.25294829458861284,-0.9830453310960884,0.49206349206349204,0.8995141430436157,1.0,16/54,17.20%,MAPK8;EGFR;SOD2;AGAP3;MAPK9;PTPRK;SOD1;PDGFRA;STK25;CHUK;MAPT;AKT1;GLRX2;HYAL1;COA8;ERCC6L2
prerank,negative regulation of cell cycle process (GO:0010948),0.3980324032185011,0.9830079386772077,0.5286016949152542,0.8604124218681536,1.0,12/61,13.06%,UXT;YAF2;ESPL1;NME6;AURKAIP1;APAF1;PCGF6;RING1;PHC1;E2F6;RBBP7;MAX
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),-0.3667118700021426,-0.9830072610964444,0.4782608695652174,0.8965815414726722,1.0,3/13,4.82%,ZFPM2;BMPR1A;TGFBR3
prerank,response to calcium ion (GO:0051592),0.3878684428554793,0.9829414598677375,0.5498981670061099,0.8601213789863761,1.0,15/102,9.11%,SYT17;LGMN;PLCG2;RASA4;PKD2;TTN;KCNIP2;RASGRP2;MEF2A;KCNMA1;SYT2;MEF2C;PDCD6;ALG2;SYT10
prerank,cristae formation (GO:0042407),-0.29391538224559405,-0.9827852191862593,0.4230769230769231,0.8941483592839151,1.0,10/27,16.24%,AFG3L2;APOOL;IMMT;ATP5PO;ATP5PF;ATP5MC3;SPG7;DMAC2L;SAMM50;ATP5F1D
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.38931793906525985,0.9822669247055322,0.5270684371807968,0.8611588493427503,1.0,23/83,20.74%,GPR132;CDK14;BACH1;GSPT1;CDK17;PIM2;PLK2;RB1;CDK7;DBF4;INHBA;CDC34;CDK6;MAX;CDC6;CCNE2;USP29;CDK15;CDK18;CRLF3;CDC45;CUL3;NPAT
prerank,embryonic digit morphogenesis (GO:0042733),0.4542849803102719,0.9821666800477229,0.5050632911392405,0.8609334354533477,1.0,1/18,0.68%,SHH
prerank,endocrine system development (GO:0035270),0.44877453255307775,0.9819219525433226,0.5152253349573691,0.8610615489007296,1.0,6/21,16.03%,TGFBR1;MDK;NKX2-1;SOX2;TG;NF1
prerank,cellular response to glucose stimulus (GO:0071333),0.42183775646357397,0.9816832769150299,0.5195852534562212,0.8611773538501308,1.0,7/30,14.61%,MLXIPL;ERN1;TRA2B;RAB11FIP5;GAS6;ADCY8;SOX4
prerank,histone modification (GO:0016570),0.38444329123635385,0.9815862241164932,0.5385395537525355,0.8609633909202261,1.0,24/109,17.33%,BRD8;PRKCD;NSD1;ATXN7;HDAC5;MTA3;TBL1XR1;RCOR1;MIDEAS;HDAC4;TBL1X;PHC1;RPS6KA4;HDAC6;HDAC9;MAP3K12;HUWE1;HDAC11;USP21;USP16;INCENP;NAA50;UBE2N;RPS6KA5
prerank,isotype switching (GO:0045190),-0.39604282865515894,-0.9814359154031608,0.4808259587020649,0.8947641187259793,1.0,6/10,36.40%,MSH2;MSH6;BATF;HSPD1;LIG4;RNF8
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),-0.3955927455225066,-0.9811097681235639,0.5076452599388379,0.8926397525893234,1.0,2/10,3.69%,DLGAP1;DLGAP2
prerank,regulation of pH (GO:0006885),0.5002367543493456,0.9810339230826167,0.5139664804469274,0.861727506939405,1.0,4/11,20.59%,SLC9A1;ATP6AP1;LACC1;SLC9A7
prerank,cell cycle G2/M phase transition (GO:0044839),0.385871337835754,0.9808097960175979,0.53420523138833,0.8618110746711476,1.0,27/129,18.10%,TUBB;PRKAR2B;HAUS2;CDK14;TUBA4A;FBXL22;CNTRL;CEP192;MAPRE1;DNM2;CEP70;PLK4;CEP76;CHEK2;ENSA;HAUS1;CDK7;DYNC1H1;PCM1;FBXL3;CEP152;HAUS8;AKAP8L;NINL;HSP90AA1;AKAP9;CEP63
prerank,linoleic acid metabolic process (GO:0043651),0.4578588831061184,0.9804497104477167,0.5185643564356436,0.8621386370873735,1.0,4/17,17.83%,ALOX12;ABCD1;FADS1;GSTM2
prerank,aortic valve development (GO:0003176),0.42220456201494777,0.9800472080432798,0.5183066361556065,0.8625841436057248,1.0,6/34,11.69%,TGFB1;NFATC1;SNAI1;RB1;SOX9;TNFRSF1B
prerank,heart contraction (GO:0060047),0.4071993676092021,0.9794128853855371,0.5265486725663717,0.863589683285381,1.0,4/41,4.28%,SCN4B;MYL3;SLC8A1;TTN
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",-0.3450654938303992,-0.9788074943797381,0.49130434782608695,0.8961202494275701,1.0,8/16,26.86%,PSIP1;DCPS;SRSF1;SNRPC;NCBP2;DDX23;SRSF12;CACTIN
prerank,intracellular protein transmembrane transport (GO:0065002),-0.2700887773601122,-0.9785155957396898,0.5227272727272727,0.8939474200291658,1.0,24/42,33.29%,DNAJC19;TIMM17A;PEX5;GRPEL2;PEX6;SEC61G;C2CD5;PEX14;TOMM70;SEC61B;TIMM23;SEC61A1;PAM16;PEX26;TIMM21;PEX10;ROMO1;GRPEL1;ZFAND2B;HSPD1;PEX16;DNLZ;AIFM1;TOMM40L
prerank,cellular potassium ion homeostasis (GO:0030007),-0.36905248605126056,-0.9780645780875588,0.5019011406844106,0.8922491336886844,1.0,3/13,7.58%,SLC12A2;ATP1B1;ATP1A2
prerank,positive regulation of cell development (GO:0010720),0.4284546808295411,0.9776170886115041,0.5395348837209303,0.8672132186878242,1.0,5/31,12.62%,CX3CR1;TYROBP;NAP1L1;ATP6AP1;NUMB
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.44617860387722325,0.9775460880246022,0.4968632371392723,0.8669352381298745,1.0,11/21,23.68%,DUSP3;MACF1;SLC9A1;ACTG1;VCL;PTPRA;CORO1C;RHOA;ROCK2;CLASP1;GPM6B
prerank,nuclear membrane organization (GO:0071763),-0.3165567792838324,-0.9769518562817385,0.49019607843137253,0.8924917847178571,1.0,8/19,23.33%,SPAST;VPS4A;EMD;CHMP4B;TMEM43;TARDBP;CHMP2A;GPER1
prerank,response to ketone (GO:1901654),0.44071261340507534,0.9769077867717515,0.5223700120918985,0.8678858788857774,1.0,3/24,11.25%,TGFB1;ABCB4;THBS1
prerank,cellular response to estrogen stimulus (GO:0071391),0.47715473570910966,0.9767969250507555,0.5149456521739131,0.8676894747598629,1.0,5/14,20.45%,OCSTAMP;TRIM24;SRA1;NCOA4;SFR1
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.43923171358888574,0.9767201746394556,0.5197604790419161,0.8674264173676441,1.0,4/22,10.78%,SPI1;XDH;GADD45B;RELL1
prerank,nucleotide catabolic process (GO:0009166),0.45809746016355934,0.9765598025062496,0.5246753246753246,0.8673346271850688,1.0,3/16,8.29%,XDH;SAMHD1;PNP
prerank,detection of mechanical stimulus (GO:0050982),0.45046217968806357,0.9761212555137677,0.5245901639344263,0.8678681978857616,1.0,3/19,6.29%,PKD2;TTN;CTNNB1
prerank,axon extension (GO:0048675),-0.3003709976673342,-0.9759500225328838,0.44385026737967914,0.8924165885742428,1.0,5/23,6.36%,SEMA5A;AUTS2;SEMA3A;ULK2;SLIT2
prerank,glycerolipid catabolic process (GO:0046503),0.4459468181494289,0.975873208082563,0.5093399750933998,0.8679644426573311,1.0,7/19,23.90%,ABHD12;PRDX6;GDE1;GDPD3;GPCPD1;PLA2G4E;ABHD2
prerank,cellular response to radiation (GO:0071478),0.4107697470608104,0.9757814053566436,0.5509518477043673,0.8677259487807579,1.0,4/40,6.70%,GRB2;MAPK14;TANK;TP53
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),0.5123700548338541,0.9748559341596829,0.5104790419161677,0.8693159885882994,1.0,3/10,11.77%,MGRN1;PDE11A;CDC34
prerank,negative regulation of catalytic activity (GO:0043086),0.43927603315148955,0.9746489091774645,0.5204200700116686,0.8693268522752843,1.0,5/24,11.27%,CLN3;TIMP1;TP53;ATP5IF1;HDAC6
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.40400709338809826,0.9745755723813992,0.5666666666666667,0.8690523594876061,1.0,2/53,6.34%,CNR2;ANXA1
prerank,negative regulation of viral process (GO:0048525),0.39882621388344563,0.9743481048026161,0.5573248407643312,0.8691084334780335,1.0,17/57,24.55%,FAM111A;TRIM5;TNF;TRIM27;TRIM8;RNASEL;MID2;TRIM35;TRIM62;PARP10;IFITM2;HEXIM1;ILF3;IFIT1;IFITM1;UBP1;PPIA
prerank,keratinocyte differentiation (GO:0030216),-0.2815594436223947,-0.9742823905710911,0.509090909090909,0.8940067880104199,1.0,6/29,15.14%,CLIC4;WNT5A;BCR;JAG1;CASP3;UGCG
prerank,clathrin-dependent endocytosis (GO:0072583),0.4284239179753703,0.9735301510805205,0.5170316301703163,0.8705022123384046,1.0,13/26,23.29%,PIP5K1C;AP2S1;GPR107;ITSN1;CLTC;FNBP1L;SIGLEC1;GAK;AP2M1;PICALM;FCHO2;ITSN2;INPP5F
prerank,protein lipidation (GO:0006497),0.3981473162024776,0.9733763655599035,0.5356004250797024,0.8704150347875531,1.0,21/59,23.19%,PIGM;ATG7;PIGL;PIGV;ZDHHC14;ZDHHC7;ZDHHC13;ZDHHC16;PIGH;ZDHHC3;ZDHHC1;SELENOK;PGAP2;ZDHHC21;PIGU;PIGC;ZDHHC2;PIGN;ATG10;DPM2;PIGP
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.4805363344808975,0.9731525117344041,0.5020408163265306,0.870476609245351,1.0,4/13,17.60%,FCGR2B;AQP11;WFS1;MANF
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.3776463592265158,0.9731147906959602,0.567,0.8701143333472807,1.0,38/184,18.10%,TUBB;ANAPC15;PRKAR2B;HAUS2;NEK6;RGCC;CDC23;TUBA4A;CNTRL;CEP192;MAPRE1;UBE2S;PSMB10;CEP70;PLK4;CEP76;KIF14;HAUS1;PSMA2;FZR1;DYNC1H1;PCM1;PSME3;CEP152;PSMB5;CDC6;INO80;HAUS8;PSMD8;PSMD7;PSMB9;NINL;APPL2;HSP90AA1;ANAPC11;AKAP9;PSMD2;CEP63
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.40087049493869487,0.9729490908552272,0.5387168141592921,0.8700316702139564,1.0,11/47,18.95%,SCIMP;TAOK3;RAP2A;QARS1;MAP2K2;NOD2;KLHDC10;PHLPP1;GREM1;PER1;TAOK1
prerank,ERAD pathway (GO:0036503),0.3882223379254754,0.9728048015753087,0.5432989690721649,0.8699281848435163,1.0,23/83,21.29%,TRIM25;EDEM1;HERPUD1;SEL1L;ATXN3;ERLIN1;ERLIN2;DERL1;UBE4B;STT3B;UBE2G2;TOR1A;STUB1;WFS1;UBE2J2;CCDC47;FAM8A1;FBXO44;ERLEC1;OS9;TMEM67;PRKN;DNAJB14
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.44063001471992885,0.9727001236823323,0.5476190476190477,0.8697114450670576,1.0,9/25,20.35%,BCAS2;SF3B1;SCAF11;PRPF8;TRA2B;WDR83;SLU7;SF3B3;SRSF10
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.41095736960649254,0.9721120892610527,0.5279642058165548,0.8705783445776547,1.0,8/37,12.29%,RPL23;PDCL3;TAF1;HFE;CSNK2A2;CSNK2A1;USP7;SDCBP
prerank,regulation of actin filament depolymerization (GO:0030834),0.4787020930865077,0.9719787101531301,0.5040983606557377,0.8704288150316049,1.0,1/12,0.91%,PLEK
prerank,neuromuscular process controlling balance (GO:0050885),0.4905400873859893,0.9719453102549815,0.5298196948682385,0.8700588013165892,1.0,3/12,13.32%,CLN3;MYO7A;CDH23
prerank,supramolecular fiber organization (GO:0097435),0.3748870424319927,0.9716390964477881,0.595,0.8703324892429674,1.0,75/333,18.77%,MYO1F;HOOK3;ARHGAP25;MYO1G;MYO1E;CORO1A;BFSP2;TGFBR1;MYO5A;MAD2L2;FGF13;ELMO1;SNCA;ITGA6;ATP7A;COLGALT1;TTR;TGFBI;CRTAP;CCDC88B;FLII;CLIP2;P4HB;LOX;MYO7A;KIF14;TSPAN14;MYO19;TPM4;BCAR1;P3H2;TUBGCP6;TUBGCP4;ACTN1;GFAP;BIN3;IAPP;DYNC1H1;ITM2B;PCM1;B4GALT7;TPM3;SORL1;KATNA1;B2M;PXDN;GGA2;DES;USP9X;HOOK2;KIF2A;CAPN3;LAMA3;DST;CAMSAP2;COL22A1;NF1;CD36;FIGN;COL23A1;MFAP4;FURIN;CORO1C;ARHGEF2;MARCKS;MYO1C;DNAJB6;RHOA;CDC42;MYO15A;ELMO2;LOXL3;GREM1;LTBP3;LTBP2
prerank,regulation of secretion by cell (GO:1903530),0.39835037711326726,0.971523913221444,0.5587606837606838,0.8701645539092181,1.0,6/54,8.10%,RAB8B;VAMP3;MCTP1;RHBDF2;ANXA1;MEF2C
prerank,positive regulation of actin filament depolymerization (GO:0030836),0.49917269999003877,0.9706052241005809,0.5395894428152492,0.8717149224072352,1.0,1/10,0.91%,PLEK
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.38822026328317605,0.9703318329345417,0.5537190082644629,0.871890012527557,1.0,19/78,20.96%,GTF2H1;CCND3;RGCC;PKD2;BCCIP;CEBPA;CCND2;ACTB;MYOCD;CDK7;CDC6;CCNE2;PTEN;CCNYL1;CNPPD1;HHEX;CDK5R1;HEXIM1;TFAP4
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.42225132614001887,0.9700525491988508,0.5275229357798165,0.8720701278325598,1.0,8/30,15.64%,SREBF2;MICALL2;UBE2D3;VPS11;CSNK2A2;HUWE1;UBE2J2;GSK3A
prerank,central nervous system myelination (GO:0022010),0.48766580819154576,0.969243146964056,0.5349500713266762,0.8733914877508816,1.0,6/11,27.99%,PTEN;ABCA2;B4GALT6;TENM4;CNTNAP1;B4GALT5
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.5030942365083593,0.9691346172225539,0.5400593471810089,0.8731891642073044,1.0,3/10,13.89%,ATRX;DBF4;INO80
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.41201260973174025,0.9691056578579073,0.5230596175478065,0.8728156152363103,1.0,7/35,14.05%,PKIB;XRCC5;CTNNB1;PRKCQ;CCT8;TNKS2;CCT5
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.39269356731396227,0.9689318951469738,0.54,0.8727539780891145,1.0,14/59,20.03%,CD84;PCDHB6;PLXNB2;EMB;TRO;NPTN;PTPRT;CADM1;KIRREL3;PECAM1;ITGB1;VSTM2L;PALLD;CNTN4
prerank,positive regulation of epithelial cell differentiation (GO:0030858),-0.32501710509139103,-0.9689075753899125,0.4976303317535545,0.905534795132605,1.0,4/17,15.59%,VEZF1;BMP4;ATOH8;BAD
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.4614380695299581,0.9688066217709185,0.5323834196891192,0.8725886112432168,1.0,4/16,15.83%,RMI1;HFM1;SLX4;TOP2A
prerank,positive regulation of protein binding (GO:0032092),0.3947262715588746,0.9686586380126193,0.5369198312236287,0.8724597204563239,1.0,23/56,22.55%,PPP2CB;APOE;TAF1;HFE;SPPL3;DERL1;EPB41;PPP2CA;BAMBI;B2M;STK3;LRRK2;LRP1;IDE;RPL11;STK4;ADD1;FLOT1;DACT1;GSK3B;PRKN;PIN1;VTN
prerank,response to hexose (GO:0009746),0.4400531542693633,0.9684018872393663,0.5576923076923077,0.8725689219589583,1.0,4/25,11.25%,LPL;PFKL;EIF2B2;THBS1
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.3895948881312112,0.9679191793958184,0.5269978401727862,0.8731640603326319,1.0,18/62,23.31%,PCID2;GTF2H1;EAF1;LEO1;CDK7;SETD2;POLR2L;ELL;MLLT1;ELOF1;TCEA1;GTF2H5;POLR2E;ELOB;IWS1;ELOC;NELFE;CTR9
prerank,positive regulation of response to wounding (GO:1903036),0.42648575815697365,0.9678697790670886,0.503731343283582,0.8728222122600962,1.0,5/24,11.65%,MDK;ARFGEF1;ANXA1;ACTG1;GRN
prerank,protein import into nucleus (GO:0006606),0.3850945446135119,0.9677657071047883,0.5391120507399577,0.8726008041910686,1.0,4/66,2.92%,MMP12;SYK;RPL23;NUP62
prerank,histone H3-K4 methylation (GO:0051568),0.4302322688070239,0.9672757732832648,0.5288574793875147,0.8732136521676672,1.0,8/26,19.49%,WDR5B;TET3;CXXC1;DPY30;RBBP5;SETD1B;WDR82;TET2
prerank,positive regulation of neuron migration (GO:2001224),-0.38591948099203144,-0.9670282990984524,0.49056603773584906,0.9078690401765375,1.0,6/11,11.99%,SEMA6A;NIPBL;SEMA3A;DAB2IP;RAPGEF2;NSMF
prerank,sarcomere organization (GO:0045214),0.423687869145923,0.9670101267516331,0.5274853801169591,0.8733878738744616,1.0,5/27,14.81%,TTN;MYLK3;TNNT3;CSRP1;CAPN3
prerank,regulation of tau-protein kinase activity (GO:1902947),0.4935993817700538,0.9667859255370498,0.5249643366619116,0.873458029426856,1.0,3/10,16.72%,RB1;SORL1;HSP90AA1
prerank,peptide catabolic process (GO:0043171),-0.29434583445402024,-0.9663407856573558,0.5290322580645161,0.906865216945479,1.0,9/23,23.98%,LTA4H;ECE1;CPQ;ACE;NPEPPS;CHAC2;ENPEP;GGT7;TPP1
prerank,GPI anchor metabolic process (GO:0006505),0.43397712457179993,0.9661120829363525,0.5256410256410257,0.8745189693955817,1.0,11/26,23.19%,PIGM;PIGL;PIGV;PGAP1;PIGH;PGAP2;PIGU;PIGC;PIGN;DPM2;PIGP
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.37165309427898857,0.9660391768967937,0.675,0.8742502768267473,1.0,136/807,14.43%,RUNX1;BATF3;ASCL1;CIITA;SHH;IRF8;TGFB1;IKZF1;UXT;GATA1;FNIP2;BASP1;CBFA2T3;RPL23;RREB1;MAD2L2;EDNRB;BCL11A;NSD1;MLXIPL;ZEB2;PRDM12;YAF2;SEMA4D;NR1H4;DNMT3A;TNF;FNIP1;SNCA;SREBF2;CIR1;BPTF;UBE2D3;MITF;CRYM;SKI;ATF3;CEBPA;FOXO3;LRRFIP1;DDIT3;SPI1;MYT1L;WWC2;MAFK;TSC22D4;BHLHE41;HDAC5;HMGB1;XRCC5;TAF1;BACH1;PCGF6;CTNNB1;TRPS1;MTA3;ZFP69;ZNF177;TP53;MEF2A;TBL1XR1;NKX2-1;PHF21A;RCOR1;HSBP1;YY1;CREB3L1;GCFC2;ZFP90;EPO;CBFA2T2;CEBPB;SNAI1;MEF2C;NKRF;FLCN;TFAP2B;RB1;RBM15B;TRIM27;CIART;SMAD3;GTF2IRD1;IRF2;HSF1;MDFIC;QARS1;RING1;ATF7IP;ARID4A;IMPACT;CPEB3;MIDEAS;HDAC4;NFX1;NEDD4L;TPR;TGIF1;NFIC;TBL1X;PHC1;ZMYND15;HCFC2;LIMS1;SOX9;HDAC6;JDP2;NR2C2;DAP;ETV6;NRIP1;E2F6;GZF1;HDAC9;SDCBP;MTF2;MBD1;CREB1;RPS14;NRG1;KAT7;MAX;GPS2;FOXN3;GAS6;NFKB1;FOXK1;CUX1;HCFC1;ZFHX3;IRF1;USP9X;WFS1;SOX2;BRD7;LBH
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),0.3742439357164835,0.9654549714618516,0.5871743486973948,0.8750837040623582,1.0,63/168,25.70%,RPL23;RPL17;RPL10A;PNRC2;RPS2;CNOT8;TENT4B;RPL18A;RPS15A;GSPT1;RC3H2;CASC3;RC3H1;SMG1;RPL6;RPLP2;RPL26;CTIF;RPS20;RPS16;PPP2CA;RPS14;RPL19;UPF3B;RPL9;THRAP3;RPS11;RPL11;SMG7;TUT7;RPS23;RPS4X;UPF2;RPS27;RPL4;PYM1;RPL7A;RPL15;RPL29;DIS3L2;RPL22;RPS7;ZFP36L1;DCP1B;RPS13;PNLDC1;CNOT7;CNOT1;EIF3E;RPLP1;RPS15;DCP2;RPS5;CNOT2;RPL41;XRN2;RPL10;AGO1;NCBP1;RPS8;RPL5;DXO;RPL18
prerank,microtubule anchoring (GO:0034453),0.490529670955806,0.9649808988701363,0.5339943342776204,0.8757078982313536,1.0,3/12,12.39%,BCCIP;BICD2;PCM1
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.37325747583891566,0.9646371153464216,0.621,0.8759958289527,1.0,77/327,19.06%,HCLS1;TGFBR1;RREB1;NSD1;MLXIPL;YAF2;UBE2V1;MITF;PPIE;NFXL1;CEBPA;DDIT3;CXXC1;SPI1;WWC2;BACH1;CHD7;SBNO1;TFEB;CDK11B;DNM2;CCAR1;TP53;ACTN4;GCFC2;CEBPB;HINT1;FOXN2;TGFBRAP1;CHEK2;PRKCQ;MEF2C;RB1;GTF2IRD1;IRF2;PPARGC1A;ATRX;RPL6;NFX1;HCFC2;ZSCAN26;RPS6KA4;NLK;DENND4A;NR2C2;ZNF628;GZF1;MTF2;PPP2CA;BRDT;KAT7;FOXN3;SOX6;HCFC1;ZFHX3;SOX2;HNRNPD;SOX4;ZBTB11;SPTY2D1;REXO4;OGG1;FADS1;HIF1A;SBNO2;TRIP4;RPS6KA5;VHL;NFYA;PCGF1;CASZ1;CNBP;ZNF35;CREBL2;PHF1;MAFB;TULP3
prerank,atrioventricular valve morphogenesis (GO:0003181),-0.31680867458734513,-0.9645232311300824,0.4657534246575342,0.909024481306126,1.0,5/19,13.22%,BMPR1A;ACVR1;SMAD4;OLFM1;SMAD6
prerank,ATP transport (GO:0015867),0.4911713024417305,0.9640467111631476,0.5181422351233672,0.8768534045422878,1.0,1/10,1.90%,ABCC6
prerank,negative regulation of epithelial cell migration (GO:0010633),-0.2749559884658091,-0.9637617512925801,0.5263157894736842,0.908240497985586,1.0,8/33,8.30%,NR2F2;MCC;DAB2IP;SYNJ2BP;ACVRL1;SP100;SLIT2;KRIT1
prerank,energy reserve metabolic process (GO:0006112),-0.32030779156486605,-0.9631802864770991,0.5113122171945701,0.9068601529374279,1.0,10/19,25.51%,LEPR;PHKG2;UGP2;PHKB;PYGM;GFPT1;PPP1R3C;PHKA1;GFPT2;MRAP2
prerank,connective tissue development (GO:0061448),0.40493697628297254,0.9623194149995535,0.544,0.8802076083515525,1.0,8/35,13.62%,SH3PXD2B;ATP7A;CD44;SULF2;LRP5;CREB3L2;SOX9;SOX6
prerank,regulation of fatty acid oxidation (GO:0046320),0.45217945121545705,0.9622493861412696,0.5309139784946236,0.8799281188840348,1.0,5/16,16.66%,ACADL;ABCD1;PPARGC1A;SOX9;APPL2
prerank,modification-dependent protein catabolic process (GO:0019941),0.3720577621922409,0.9620332540416023,0.6268806419257773,0.879953000421948,1.0,33/193,13.69%,ANAPC15;CBL;MYLIP;TRIM25;PTTG1;RFFL;RNF149;WDR91;RNF19B;HERPUD1;CDC23;RNF7;PPP1R11;TAF1;RNF111;ATXN3;UBE2S;LONP1;RNF150;RC3H2;RNF114;RC3H1;UBE4B;NEDD4L;UBE2H;FZR1;RNF40;CDC34;WDR81;ITCH;UBE2G2;STUB1;RNF144B
prerank,neuron projection morphogenesis (GO:0048812),0.3689933072027324,0.9618789435908074,0.5841683366733467,0.8798662587081134,1.0,19/137,11.42%,NCKAP1L;NEFH;TAOK3;S100B;SLITRK1;ATP7A;CTNNB1;DOCK10;ACTB;DNM2;MEF2A;TNIK;KIF20B;NTF3;IMPACT;FLRT1;MAP1B;DTNBP1;ATL1
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),-0.3453590101884352,-0.961468282144204,0.4823529411764706,0.9086120934896009,1.0,4/14,6.34%,CPSF6;FIP1L1;CPSF7;CSTF2
prerank,regulation of mitotic cell cycle (GO:0007346),0.3741692128983764,0.9612918836506495,0.5995995995995996,0.8807243731515513,1.0,36/171,17.85%,ANAPC15;TGFB1;LGMN;SMOC2;DUSP3;NEK6;CDC23;CDK11B;UBE2S;PSMB10;TAL1;PIM2;KIF20B;RB1;SMAD3;HSF1;ANGEL2;PSMA2;MAEA;TTLL12;SRA1;FZR1;RNF40;TRIM35;SDCBP;PSME3;PSMB5;PSMD8;CCDC8;INTS13;PSMD7;PSMB9;DYNLT3;IQGAP1;ANAPC11;PSMD2
prerank,regulation of fatty acid beta-oxidation (GO:0031998),-0.358811046142645,-0.9612153697536417,0.5056179775280899,0.9063933025555612,1.0,9/14,29.63%,IRS1;PPARA;LONP2;AKT1;IRS2;MFSD2A;TWIST1;TYSND1;MTLN
prerank,negative regulation of protein secretion (GO:0050709),0.40253662769188636,0.9612017308826288,0.5449374288964732,0.8804801206070196,1.0,3/38,4.68%,KCNJ11;APOE;RHBDF2
prerank,membrane depolarization (GO:0051899),0.41585816166180317,0.9611984037534943,0.5355064027939465,0.8800456019347026,1.0,9/32,17.43%,P2RX7;P2RX4;CACNA1A;CACNB4;ATP5IF1;SCN9A;CACNA1B;YWHAH;SCN5A
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),0.4517181607800671,0.9606121234116394,0.5522388059701493,0.8808771896526423,1.0,6/20,17.33%,DIP2B;PPARGC1A;RPS6KA4;BRD7;SOX4;RPS6KA5
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.4888993020563931,0.960402981508848,0.5378266850068776,0.8808779243683652,1.0,2/12,6.13%,NEK6;PRKCB
prerank,ether lipid metabolic process (GO:0046485),0.4660718645753601,0.9602082483193358,0.5400788436268068,0.880864301745838,1.0,7/14,16.78%,DHRS7B;PLA2G7;PEX7;LIPE;AGMO;NCEH1;PLAAT3
prerank,glucose import (GO:0046323),0.4728925022594247,0.9601745825168134,0.532345013477089,0.8804996441091723,1.0,2/13,8.19%,SLC2A3;ZDHHC7
prerank,synapse assembly (GO:0007416),0.3875619978924533,0.9601148781032662,0.565582371458552,0.8801840118531213,1.0,5/67,4.59%,NPAS4;PCDHB6;FGF13;SLITRK1;PLXNB2
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.43010983101512934,0.9596778755555411,0.5364647713226205,0.8806770925213357,1.0,5/22,15.62%,NFE2L2;PSMB10;PSMA2;PSMB5;PSMB9
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.3946369927081059,0.9595279885092795,0.5559174809989142,0.8805633015055324,1.0,8/48,12.48%,FNIP2;PYCARD;BCL2L1;TP53;CHEK2;BAK1;TNFRSF1B;DDIT4
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.36889876192085613,0.9591903005718121,0.629,0.8808352631578036,1.0,79/341,18.90%,ARRB2;ANAPC15;NFE2L2;CBL;MYLIP;TRIM25;PTTG1;RFFL;RNF149;WDR91;KCTD17;RNF19B;HERPUD1;CDC23;UBE2D3;FBXL22;DDIT3;RNF7;TNFAIP3;PPP1R11;TAF1;RNF111;CTNNB1;ATXN3;UBE2S;PSMB10;TBL1XR1;RNF150;RC3H2;KIF14;RNF114;GID8;RC3H1;RNF4;UBE4B;NEDD4L;UBE2H;APPBP2;TBL1X;PSMA2;MAEA;VPS37C;FZR1;RNF40;CDC34;SPOP;WDR81;PSME3;RNF216;RMND5B;ITCH;UBE2G2;STUB1;RNF144B;PSMB5;HUWE1;USP9X;PSMD8;AREL1;ZNRF1;MVB12B;PSMD7;PSMB9;GSK3A;SMURF1;FAF1;VPS28;FEM1B;ZNRF3;ANAPC11;UBE2K;PSMD2;KEAP1;BIRC2;PPP2R5C;UBXN2A;KCTD5;SPSB2;PLAA
prerank,phosphatidylinositol dephosphorylation (GO:0046856),-0.3001787944103119,-0.9591077107618616,0.5082872928176796,0.9093408033242234,1.0,3/23,1.33%,MTM1;SACM1L;MTMR7
prerank,keratan sulfate biosynthetic process (GO:0018146),0.43399141370343564,0.9591036075276861,0.5660146699266504,0.8806110868762692,1.0,4/26,8.51%,PRELP;B4GALT1;FMOD;ST3GAL1
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.4116545239978687,0.9590009796653827,0.5695216907675195,0.8803794696514656,1.0,2/37,2.20%,ITGAL;CRTAM
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.4222163103316577,0.9588421692987612,0.558303886925795,0.8802834169422825,1.0,5/30,14.29%,KLK3;PKN1;HDAC6;SAFB2;KLK2
prerank,cellular response to UV-A (GO:0071492),0.47645614067554287,0.9587219679539292,0.5225718194254446,0.8801011954443073,1.0,1/11,5.21%,TIMP1
prerank,regulation of viral genome replication (GO:0045069),0.3924951432685676,0.9584642110998496,0.5671641791044776,0.8801941455315372,1.0,17/56,24.55%,FAM111A;TNF;PPIE;ADAR;LARP1;VAPB;RNASEL;ADARB1;TARBP2;PPIH;PARP10;IFITM2;CNOT7;ILF3;IFIT1;IFITM1;PPIA
prerank,regulation of feeding behavior (GO:0060259),-0.3754652029974343,-0.9579675739598068,0.49828178694158076,0.9095643449968905,1.0,5/11,36.27%,LEPR;EIF2AK4;NR4A3;AGRP;CFAP20
prerank,aortic valve morphogenesis (GO:0003180),0.4186935991218157,0.9578696178338578,0.55,0.881022836002104,1.0,5/30,11.18%,TGFB1;NFATC1;SNAI1;RB1;SOX9
prerank,protein targeting to lysosome (GO:0006622),0.4465436039496653,0.9578344003543235,0.549685534591195,0.8806611116335125,1.0,5/20,16.46%,LAPTM5;RAB7A;SORL1;NCOA4;GNPTAB
prerank,protein O-linked glycosylation via serine (GO:0018242),0.49896172971123104,0.9577532293394211,0.5299270072992701,0.8803965374600222,1.0,5/10,17.74%,POGLUT2;POGLUT1;GALNT2;MGAT5B;GALNT1
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.34880597882401676,-0.9574742674374457,0.4583333333333333,0.9079665559422709,1.0,3/14,4.70%,ANK2;ATP1B1;ACTN2
prerank,positive regulation of intracellular protein transport (GO:0090316),0.3752687378321331,0.9573204995108854,0.6038306451612904,0.8808562704957076,1.0,29/144,15.73%,TGFB1;ITGB2;HCLS1;PRKCD;SREBF2;MICALL2;UBE2D3;AKAP5;YWHAB;TP53;RIPOR1;VPS11;CSNK2A2;KIF20B;SMAD3;ITGAM;TPR;SEC16A;FYN;PCM1;SEC16B;SORL1;CASP8;SAR1A;GAS6;HUWE1;UBE2J2;GSK3A;YWHAH
prerank,cellular response to BMP stimulus (GO:0071773),-0.24009899682649913,-0.9570927695812841,0.5789473684210527,0.9061169226357862,1.0,12/66,9.52%,BMPR1A;SLC33A1;RGMA;BMP4;ACVR1;TGFBR3;ACVRL1;SMAD9;BMP5;SMAD4;SMAD5;SMAD1
prerank,positive regulation of cell communication (GO:0010647),0.4136188422211307,0.9570622600373081,0.5294811320754716,0.8809740615535073,1.0,3/28,6.74%,CLSTN1;TNF;CD80
prerank,regulation of catabolic process (GO:0009894),0.4521122552365316,0.956612979242388,0.554002541296061,0.8814717112116588,1.0,8/18,21.36%,HPGD;CHEK2;ZDHHC7;NEDD4L;FAF1;FURIN;ITGB1;ZDHHC2
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.3884485027484727,0.9563839492856352,0.567741935483871,0.8815082423342304,1.0,8/55,6.86%,TGFBR1;TNF;TRAF2;PYCARD;DDIT3;BCL2L1;TP53;CRADD
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.4121567258765706,0.9563514856417358,0.5442890442890443,0.8811437953548305,1.0,8/33,18.54%,GPNMB;PKD2;RB1;CCL2;CDK6;BRD7;PTEN;DACT1
prerank,spliceosomal snRNP assembly (GO:0000387),-0.2589156866649328,-0.9563123604075534,0.49557522123893805,0.9054607490739855,1.0,16/38,24.79%,PRPF3;SNRPD3;SNRPD1;TGS1;SNRPC;WDR77;SNRPG;COIL;SNRPF;PRPF19;LSM2;PRPF6;CD2BP2;SRSF12;PRMT7;PRPF31
prerank,determination of heart left/right asymmetry (GO:0061371),0.40169100352421894,0.95604658361884,0.5622932745314223,0.881370920051555,1.0,4/42,8.10%,SHH;PKD2;TGFBR2;MEF2C
prerank,DNA double-strand break processing (GO:0000729),0.44084024297752966,0.955070709861153,0.5448548812664907,0.8829756140354063,1.0,5/18,17.05%,UBE2V2;DNA2;SLX4;SMARCAD1;UBE2N
prerank,neurotransmitter transport (GO:0006836),0.3852829964798817,0.9548215368548499,0.58098223615465,0.8830534442091483,1.0,10/73,15.93%,SLC6A3;SLC6A4;APBA1;STXBP3;SLC6A15;CASK;SYNJ1;PPFIA1;PDZD11;DNAJC5
prerank,positive regulation of epidermal cell differentiation (GO:0045606),-0.3336630906329864,-0.9548133724745358,0.5207547169811321,0.9068827322150774,1.0,2/15,2.48%,FOXC1;BMP4
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.2744843499645593,-0.9548109727619706,0.5289855072463768,0.9012432635055493,1.0,10/32,11.87%,NUP93;NUP188;RANBP2;SSB;NUP98;NUP42;NDC1;RAE1;NUP153;NUP37
prerank,tRNA export from nucleus (GO:0006409),-0.2744843499645593,-0.9548109727619706,0.5289855072463768,0.9012432635055493,1.0,10/32,11.87%,NUP93;NUP188;RANBP2;SSB;NUP98;NUP42;NDC1;RAE1;NUP153;NUP37
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.4582876469985903,0.9545890256017835,0.5377604166666666,0.8831078680829737,1.0,6/15,22.44%,TENT4B;TNRC6A;CPEB3;AGO2;CNOT7;CNOT1
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),0.4579341236028354,0.954032739650586,0.5225102319236017,0.8838126028228059,1.0,5/14,20.83%,PKD2;TMSB4X;FAF1;KEAP1;NFKBIE
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.39280678210570324,0.9538094106108479,0.5661605206073753,0.8838432917382384,1.0,7/46,6.51%,TNF;IL6R;IL18;TNFAIP3;XRCC5;CTNNB1;AIF1
prerank,signal peptide processing (GO:0006465),0.4777280305658291,0.9537113003596357,0.5515239477503628,0.8836085920919552,1.0,6/11,17.02%,SPCS2;SEC11C;SPPL3;SPCS1;PARL;FURIN
prerank,potassium ion homeostasis (GO:0055075),-0.29819633830984177,-0.9537086064837631,0.4918918918918919,0.9015522362345502,1.0,3/23,1.49%,SLC12A2;SLC12A7;ATP1B1
prerank,peptide biosynthetic process (GO:0043043),0.36696775907956375,0.9536883254942492,0.6024096385542169,0.8832197455014865,1.0,59/153,26.27%,RPL23;RPL17;RPL10A;RPS2;RRBP1;RPL18A;FARSB;MRPL41;RPS15A;GSPT1;EIF4EBP2;MRPL51;RPL6;RPLP2;RPL26;RPS20;GGTA1;RPS16;RPS14;DARS1;RPL19;IGF2BP3;RPL9;RPS11;RPL11;RPS23;FURIN;RPS4X;MRPS21;RPS27;AGO2;RPL4;MRPS14;PABPC4;MRPL3;RPL7A;RPL15;MRPL10;RPL29;RPL22;RPS7;RPS13;SARS1;RPLP1;RPS15;MRPL18;MRPL52;RPS5;RPL41;RPL10;MRPL37;MRPS12;ABCF1;RPS8;RPL5;RPL18;EEF1A1;RPL28;MRPS15
prerank,zinc ion transport (GO:0006829),-0.31060994831492583,-0.9536094171277474,0.47393364928909953,0.899009994634588,1.0,7/21,25.80%,SLC39A13;SLC39A8;SLC30A1;SLC39A1;SLC39A14;SLC39A3;TRPM2
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.44146500659274013,0.9535329313793702,0.5371577574967406,0.8830913198661233,1.0,2/17,8.05%,TGFB1;SNAI1
prerank,hepaticobiliary system development (GO:0061008),0.4404918434425883,0.9530899975534115,0.53515625,0.8835677903595249,1.0,3/20,4.57%,PCSK9;PKD2;CEBPA
prerank,regulation of dendritic spine development (GO:0060998),-0.31561123228976945,-0.9529786438990615,0.526829268292683,0.8979670915393914,1.0,7/19,11.45%,NLGN1;GRIN3A;DLG5;FMR1;SHANK3;SHANK1;PPFIA2
prerank,fatty acid transmembrane transport (GO:1902001),0.44185354136477456,0.952827061376531,0.5515527950310559,0.8836940469733017,1.0,6/19,17.99%,SLC25A20;ABCD1;ACACA;CD36;CPT2;ABCD2
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.3948421849841761,0.9523536377729704,0.5813953488372093,0.8842672478110811,1.0,15/51,21.77%,PLEK;TGFBR1;RGCC;FHOD1;PFN2;NF2;PFN1;NRP1;SYNPO;CD47;RHOA;CDC42;ROCK2;EVL;CX3CL1
prerank,axonal transport of mitochondrion (GO:0019896),-0.3846967444562101,-0.9522173861666641,0.5303514376996805,0.8971484345420109,1.0,4/11,11.33%,SPAST;NEFL;SYBU;MAPT
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.4499067568209076,0.9518748179053149,0.5389784946236559,0.8847954520776639,1.0,4/17,17.71%,SCN4B;NOS1AP;SCN5A;AKAP9
prerank,positive regulation of protein sumoylation (GO:0033235),0.4957559250286952,0.9513121303565528,0.5442477876106194,0.8855557873918383,1.0,4/10,20.01%,HDAC4;UBA2;PIAS1;RWDD3
prerank,negative regulation of glycolytic process (GO:0045820),0.4986195382215949,0.9510023415126893,0.548480463096961,0.8853343281306763,1.0,2/10,9.95%,CBFA2T3;HDAC4
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.4986195382215949,0.9510023415126893,0.548480463096961,0.8853343281306763,1.0,2/10,9.95%,CBFA2T3;HDAC4
prerank,respiratory tube development (GO:0030323),0.41514927219950815,0.9503006335674381,0.5490654205607477,0.8863926078835678,1.0,3/28,6.82%,SHH;CEBPA;NKX2-1
prerank,stress-activated MAPK cascade (GO:0051403),0.3883056234259119,0.9502066743181492,0.5933831376734259,0.8861599388301844,1.0,15/61,17.05%,IRAK2;MAPK14;CCM2;UBE2V1;MAP2K3;MAP3K5;NOD2;MAP3K12;TAB2;IKBKG;GPS2;NFKB1;TAB3;MAP3K11;UBE2N
prerank,positive regulation of viral life cycle (GO:1903902),0.4298868964141993,0.9494086748104347,0.5365239294710328,0.8873970018315737,1.0,3/22,10.78%,CD74;P4HB;LGALS1
prerank,response to nitric oxide (GO:0071731),0.4599323659266116,0.9493643735254097,0.5478502080443828,0.8870422987953158,1.0,1/13,1.86%,AQP1
prerank,in utero embryonic development (GO:0001701),0.4227205928848913,0.949222430318415,0.5493827160493827,0.8869021931996707,1.0,3/25,8.33%,TGFBR1;CHD7;FLCN
prerank,snRNA metabolic process (GO:0016073),-0.3222437958704969,-0.9489423606250577,0.5301724137931034,0.9030721234401025,1.0,7/17,19.34%,INTS9;INTS10;MTREX;TUT1;INTS4;INTS2;MEPCE
prerank,histone H2A monoubiquitination (GO:0035518),-0.32707169861482815,-0.9487817744442585,0.5344827586206896,0.9007300629413869,1.0,6/17,10.90%,DDB2;RYBP;DDB1;TRIM37;PCGF2;PCGF3
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),-0.3239394089084291,-0.948042711464733,0.515625,0.9000863362570289,1.0,3/16,8.91%,RBFOX2;AR;TADA3
prerank,positive regulation of viral genome replication (GO:0045070),0.4169087284494031,0.9479165246218614,0.5398126463700235,0.8892796820687126,1.0,13/29,26.38%,PPIE;ADAR;LARP1;VAPB;ADARB1;TOP2A;TARBP2;PPIH;CNOT7;IFIT1;PPIA;PKN2;HACD3
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.3667018606190566,0.9479062808179244,0.664,0.8888642852497391,1.0,78/314,20.78%,ARRB2;ANAPC15;NFE2L2;TRIM25;EDEM1;PTTG1;RFFL;KCTD17;HERPUD1;CDC23;UBE2D3;SEL1L;FBXL22;DDIT3;DCAF12;FBXL18;TAF1;CTNNB1;ATXN3;ERLIN1;ERLIN2;UBE2S;PSMB10;TBL1XR1;KIF14;RB1;GID8;DERL1;RNF4;UBE4B;NEDD4L;APPBP2;TBL1X;PSMA2;MAEA;FZR1;CDC34;SPOP;PSME3;RNF216;STT3B;FBXL3;RMND5B;ITCH;UBE2G2;STUB1;PSMB5;HUWE1;WFS1;PSMD8;AREL1;UBE2J2;ZNRF1;FAM8A1;PSMD7;PSMB9;GSK3A;SMURF1;FAF1;FEM1B;ANAPC11;UBE2K;PSMD2;BIRC2;FBXO44;PPP2R5C;UBXN2A;KCTD5;SPSB2;PLAA;OS9;TMEM67;WWP1;RAD23B;FBXW11;NSFL1C;CUL3;PRKN
prerank,steroid biosynthetic process (GO:0006694),-0.2474295601852081,-0.9478607026465948,0.532258064516129,0.8978499413369924,1.0,25/56,33.95%,OSBPL9;OSBPL1A;HMGCR;CYP7B1;CYP51A1;INSIG2;INSIG1;SQLE;AMACR;LSS;CYP39A1;PMVK;LBR;SCP2;HSD17B4;DHCR7;EBP;SLC27A2;SC5D;STAR;TM7SF2;HSD11B1;SRD5A1;OSBPL2;CH25H
prerank,RNA stabilization (GO:0043489),0.4083310565981659,0.947647851566723,0.5648679678530425,0.8889585208433848,1.0,4/33,8.98%,SLC11A1;CIRBP;LARP1;TENT5C
prerank,protein localization to vacuole (GO:0072665),-0.3553354605879502,-0.9474881051279131,0.49491525423728816,0.89609058632369,1.0,5/13,20.92%,LMBRD1;KPTN;CD81;LAMTOR5;GLMP
prerank,membrane depolarization during action potential (GO:0086010),0.4216309538377379,0.9474596632712015,0.5657418576598311,0.8889081028211736,1.0,7/26,17.43%,SCN4B;HCN4;SLC8A1;SCN9A;YWHAH;CACNA1D;SCN5A
prerank,protein localization to Golgi apparatus (GO:0034067),0.4259486260953942,0.9471317849479856,0.5592814371257485,0.8891602615496992,1.0,14/27,23.03%,RIPOR1;ARL5B;BICD2;SORL1;RAB33B;GAK;PAQR3;GOLPH3;OPTN;COG7;VPS13C;GBP5;VPS13A;ARL5A
prerank,histone methylation (GO:0016571),0.42234912155241605,0.9470814117404982,0.5593419506462984,0.8888269715184012,1.0,5/26,16.48%,NSD1;FBL;SETD6;SMYD3;SUV39H1
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.43870438531784783,0.9468620702795482,0.5444015444015444,0.8888568858431826,1.0,2/20,3.31%,NFE2L2;CREB3
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),-0.3318730517988214,-0.9466760027305212,0.5813008130081301,0.8956172184920238,1.0,3/16,4.82%,ZFPM2;BMPR1A;TGFBR3
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.4173745003103446,0.9463708188580017,0.5676328502415459,0.8894313242212069,1.0,3/26,4.53%,CBL;NCK2;ZFYVE28
prerank,ERBB2 signaling pathway (GO:0038128),0.41100555459698673,0.9454956672605727,0.5670945157526255,0.8908424132152246,1.0,8/31,16.80%,GRB2;PTPN18;ERBIN;NRG1;STUB1;SRC;HSP90AA1;PTPN12
prerank,nonribosomal peptide biosynthetic process (GO:0019184),-0.36401598386274064,-0.9450735781370954,0.5360824742268041,0.8970947793950212,1.0,7/12,35.78%,BDH2;GSS;OPLAH;CHAC2;GGCT;HAGH;GGT1
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.46381589480584,0.9447766898647333,0.5533980582524272,0.8919097970691963,1.0,3/13,14.53%,NFE2L2;GPR37;LRRK2
prerank,response to interleukin-6 (GO:0070741),0.48775977192331055,0.9446492968045282,0.5660377358490566,0.8917500611582538,1.0,5/10,16.43%,NFKB1;PID1;PTPRT;SELPLG;SBNO2
prerank,positive regulation of exosomal secretion (GO:1903543),0.45817153059117605,0.9443752619153171,0.5443708609271524,0.8918739766367269,1.0,5/15,20.00%,SMPD3;RAB7A;SDCBP;PDCD6IP;ATP13A2
prerank,regulation of cell motility (GO:2000145),0.367721263344293,0.9442894631464078,0.6198179979777553,0.89162695773246,1.0,29/121,22.04%,TGFB1;CYRIB;CSF1R;PLXNC1;PLXNB2;ADGRG3;MACF1;DOCK10;TMSB4X;KIF14;SPINT2;PKN1;DIAPH1;CDK6;NRG1;TMSB10;ARHGAP18;KIF2A;SGK3;RHOA;MINK1;ROCK2;CRK;SPATA13;AMOT;MEMO1;PIN1;FLNA;FGF2
prerank,protein localization to kinetochore (GO:0034501),0.45995749960532534,0.9439973750983384,0.5642076502732241,0.8917812823265614,1.0,5/14,23.99%,IK;MIS12;KNL1;BUB3;CENPT
prerank,dicarboxylic acid transport (GO:0006835),-0.27678675846088885,-0.9436962826646763,0.5533333333333333,0.8981146541343051,1.0,4/28,6.22%,SLC25A12;ARL6IP5;SLC26A7;SLC25A13
prerank,regulation of protein localization to nucleus (GO:1900180),0.39010258382521207,0.943256398595292,0.562019758507135,0.8928735709690656,1.0,2/43,0.90%,SHH;TGFB1
prerank,rRNA processing (GO:0006364),0.3645561740782504,0.9431905672592185,0.634,0.8925715341531428,1.0,46/172,21.04%,RPL23;RPL17;EMG1;RPL10A;UTP20;NOB1;TEX10;FBL;RPS2;EXOSC1;LAS1L;RPL18A;KRR1;RPL6;DDX27;RPLP2;RPL26;RPS16;MDN1;UTP11;HEATR1;RPS14;RPL19;IMP3;RPL9;PES1;C1D;PIH1D1;RPL11;WDR12;RPS27;RPL4;FCF1;RIOK3;WDR75;RPL7A;RPL15;EXOSC3;SART1;RPL29;RRP7A;UTP3;SRFBP1;RPL22;IMP4;RPS7
prerank,regulation of cell cycle process (GO:0010564),0.3736086292319165,0.9431741359554293,0.6180344478216818,0.8921680404812314,1.0,19/104,12.21%,ZFYVE26;KLHL21;CTNNB1;BCL2L1;SND1;PLK4;PLK2;CSNK2A2;CSNK2A1;FLCN;KIF20B;MYO19;UVRAG;RAB11A;SETD2;DBF4;SOX9;BECN1;DYNC1H1
prerank,regulation of muscle cell differentiation (GO:0051147),0.40895348080899313,0.9431365956056453,0.5560693641618497,0.8918093085210709,1.0,10/31,22.05%,MAPK14;CTNNB1;MEF2A;MYOCD;MEF2C;HDAC9;CDC42;MEGF10;PTBP1;CDH15
prerank,positive regulation of protein localization to membrane (GO:1905477),0.3712847197311867,0.9430935906469541,0.6044852191641182,0.8914549113542396,1.0,21/98,17.78%,TREM2;LGALS3;ITGB2;PLS1;TNF;AKAP5;STAC;YWHAB;TP53;PRKCH;ITGAM;FYN;STX3;CASP8;STAC3;ARF6;LRP1;YWHAH;CEMIP;MYO1C;PDPK1
prerank,sulfation (GO:0051923),0.48356870201267166,0.9430273273567952,0.5547945205479452,0.8911636126505973,1.0,1/11,4.99%,SULT4A1
prerank,cell differentiation in hindbrain (GO:0021533),0.481417641837514,0.9430259327250685,0.5421348314606742,0.8907337079002652,1.0,2/11,15.48%,ATP7A;AGTPBP1
prerank,regulation of telomerase activity (GO:0051972),0.3903385829485723,0.9429641185941421,0.5674778761061947,0.8904266217641483,1.0,6/45,8.09%,PTGES3;PKIB;XRCC5;CTNNB1;TP53;PRKCQ
prerank,regulation of neuron projection arborization (GO:0150011),-0.33716400421152776,-0.9421903471757215,0.5311355311355311,0.8993848655890845,1.0,5/15,12.28%,NTNG1;WNT5A;MYO9A;FZD4;GRIP1
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.3964909653270315,0.9420695159227412,0.5643015521064302,0.8918395881615476,1.0,16/38,23.99%,CENPO;ASF1B;ATRX;RBBP7;CENPI;CENPQ;CENPK;RSF1;UBN1;RBBP4;IPO4;ITGB3BP;SMARCA5;H3-3A;KNL1;CENPT
prerank,oogenesis (GO:0048477),0.45545946297461526,0.9419984433831474,0.5624161073825503,0.8915630830949492,1.0,4/15,17.07%,MDK;TRIP13;METTL3;MARF1
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.39236882550346125,0.9415484668484638,0.587527352297593,0.8920629173553797,1.0,8/47,11.23%,CASS4;RREB1;MDK;ACTN4;NEDD9;P4HB;LIMS1;NRP1
prerank,regulation of axon extension involved in axon guidance (GO:0048841),-0.2911660528607632,-0.9415449541552039,0.5116279069767442,0.8983359536299304,1.0,6/24,8.55%,SEMA6A;SEMA5A;SEMA3A;SEMA6D;SEMA3C;SEMA3D
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.38561855276301454,0.9413308508573319,0.5675082327113062,0.8920890038700061,1.0,13/48,20.17%,ADCY7;SLC25A16;GUCY2F;ADCY6;SLC35B3;NPR2;PAPSS1;ADCY8;ADCY3;IMPDH2;PPCDC;ADCY9;NPPC
prerank,mRNA modification (GO:0016556),-0.2976300791437434,-0.9412005297626788,0.5404040404040404,0.8964999201312203,1.0,7/22,14.68%,CBLL1;METTL14;NSUN2;METTL16;TRMT6;TRUB2;CMTR1
prerank,sphingolipid biosynthetic process (GO:0030148),0.37784711736902354,0.9411763218012154,0.5974842767295597,0.8919889886809137,1.0,20/71,22.59%,CERS6;SGPL1;CLN8;PRKD2;CSNK1G2;HACD4;AGK;ACER3;VAPB;ST8SIA1;LARGE1;DEGS1;ASAH1;SGMS1;SPTSSA;SMPD1;SPTSSB;B4GALT6;PRKD3;CERS4
prerank,positive regulation of developmental growth (GO:0048639),0.39479713250845316,0.9411176577788228,0.5702036441586281,0.8916836748800799,1.0,13/49,21.68%,SYT17;SEMA4D;MACF1;AGRN;SYT2;NEDD4L;TWF2;SMURF1;RASAL1;PLAA;UNC13A;RIMS1;ITSN2
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.38034810870145686,0.9407491430393069,0.5929861849096706,0.8920009909022237,1.0,17/58,21.92%,UBE2V2;HMGB1;XRCC5;LIG3;ATP23;UVRAG;BABAM2;ERCC6;BABAM1;MDC1;UBE2N;ERCC1;POLM;HERC2;DCLRE1C;NSMCE2;ERCC4
prerank,negative regulation of cellular senescence (GO:2000773),-0.3375540716907085,-0.9406611518572655,0.5543071161048689,0.8952271938395127,1.0,6/13,24.19%,ZKSCAN3;YBX1;MAP3K3;HMGA2;TERT;TWIST1
prerank,regulation of chondrocyte differentiation (GO:0032330),0.42129166918166044,0.9404120203208467,0.5513447432762836,0.8922481144419873,1.0,5/24,13.62%,TGFBR1;MDK;TRPS1;SOX9;SOX6
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.4872520456665751,0.9402247400352235,0.5292397660818714,0.8921908204563206,1.0,5/10,25.37%,TSPAN6;GPATCH3;RIOK3;RNF125;C1QBP
prerank,positive regulation of RNA metabolic process (GO:0051254),0.3957014926705781,0.9396518791893184,0.5925110132158591,0.8929337704127784,1.0,8/45,13.46%,TGFB1;ERN1;TP53;GRSF1;ZC3H18;MAP2K2;HEATR1;NFKB1
prerank,nuclear pore complex assembly (GO:0051292),-0.39143579139602863,-0.9394574718686454,0.5297619047619048,0.8959142814216124,1.0,5/10,11.37%,NUP93;NUP98;AHCTF1;NDC1;NUP153
prerank,regulation of dendrite morphogenesis (GO:0048814),0.40905625083423214,0.9394219668502166,0.5679723502304147,0.8929529146908293,1.0,9/32,20.45%,SS18L1;RAP2A;SEMA4D;TNIK;NEDD4L;CUX1;YWHAH;CUX2;GSK3B
prerank,positive regulation of hormone secretion (GO:0046887),0.44154950807088283,0.9392692025680457,0.5606860158311345,0.8928463895681509,1.0,4/17,14.06%,SPP1;RASL10B;HFE;NMB
prerank,heterocycle biosynthetic process (GO:0018130),0.45684834152645387,0.9391630876837643,0.5568942436412316,0.8926336602984701,1.0,2/14,10.15%,GCH1;PYCR2
prerank,modulation by symbiont of host process (GO:0044003),0.4811726015237452,0.9390050290101762,0.5790251107828656,0.8925110825833128,1.0,3/10,20.10%,TLR2;B2M;ENO1
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.36503274424534166,0.9385223894559003,0.6270161290322581,0.8930861144922004,1.0,57/148,28.29%,RPL23;MTOR;RFFL;MAPK14;MAP2K6;PIP4K2A;RMI1;EXO1;TAF1;BRIP1;TP53;CHEK2;CSNK2A2;CSNK2A1;RPS20;USP7;RBBP7;PIP4P1;RRS1;DNA2;BRD7;NOC2L;TAF3;RPL11;MEAF6;PDPK1;PPP2R5C;CHD4;TAF11;RBBP4;CDK5R1;HEXIM1;TTC5;PHF20;PIN1;RAD1;MDM4;SGK1;NUAK1;RPS15;CHD5;ATR;RPA1;PRKAG1;RPL5;CDK5RAP3;ING5;MTA2;TAF6;TOP3A;PAK1IP1;TAF15;PRKAA1;KAT5;RHNO1;HDAC1;RAD9B
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.41729213997721243,0.9381243246115881,0.5745992601726264,0.8934601359353845,1.0,11/24,23.85%,TENT4B;STN1;TNKS2;SLX4;SRC;TINF2;TERF2;ERCC4;TEN1;PARP1;DCP2
prerank,negative regulation of viral genome replication (GO:0045071),0.39686825386385466,0.9378330127822094,0.58157602663707,0.8936339304702678,1.0,12/40,23.80%,FAM111A;TNF;RESF1;RNASEL;TASOR;PARP10;INPP5K;IFITM2;SETDB1;ILF3;IFIT1;IFITM1
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.4590296130674062,0.9376494127066393,0.5661375661375662,0.893551061784237,1.0,2/14,9.43%,TLR2;PUM2
prerank,regulation of NMDA receptor activity (GO:2000310),0.40284436527340367,0.9371180147890282,0.5885111371629543,0.894196963278086,1.0,2/32,1.16%,PTK2B;CCR2
prerank,sensory organ development (GO:0007423),0.3838104541670699,0.9369694317028078,0.5854978354978355,0.8940636394005874,1.0,9/51,15.38%,ASCL1;SH3PXD2B;CHD7;MYO7A;ZDHHC16;SOX2;MEIS1;SIPA1L3;AHI1
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.4526308190141942,0.9367232216722484,0.5848275862068966,0.8941614501133849,1.0,3/15,12.48%,GRB2;BCAR1;DDIT4
prerank,protein localization to condensed chromosome (GO:1903083),0.46619874499878705,0.9366174452415761,0.5605633802816902,0.8939632856477986,1.0,1/12,2.30%,IK
prerank,response to interferon-alpha (GO:0035455),0.4486577367424621,0.9362175010186348,0.5617685305591678,0.8943444880975623,1.0,5/16,14.39%,IFNAR1;ADAR;TPR;GAS6;RO60
prerank,negative regulation of microtubule polymerization (GO:0031115),-0.3632227487185066,-0.936119318773161,0.5102040816326531,0.901707263167756,1.0,4/12,4.64%,CDH5;STMN2;EML2;DYRK1A
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.38313372098289955,0.9359270638917381,0.6094929881337648,0.8944872730615263,1.0,10/51,15.27%,PKIB;TENT4B;XRCC5;CTNNB1;PRKCQ;CCT8;STN1;TNKS2;CCT5;SRC
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.4578256886881917,0.9351964811932961,0.5674603174603174,0.8955674163211954,1.0,1/13,1.72%,NEIL2
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.3835226776214438,-0.9345625021572063,0.5524691358024691,0.903109010684251,1.0,6/10,24.58%,APP;SHANK3;RAB5A;SYP;DRD2;CAMK2B
prerank,regulation of acrosome reaction (GO:0060046),-0.39264419757735514,-0.9339715006474079,0.5750798722044729,0.9019933047772691,1.0,8/10,60.75%,CACNA1H;PLCB1;SPINK13;SERPINA10;FAM170B;PRSS37;PLA2G10;GLRA1
prerank,regulation of DNA metabolic process (GO:0051052),0.39357008795986986,0.933896896144718,0.5969498910675382,0.897810093524749,1.0,14/44,22.86%,UBE2V2;UBE2V1;XRCC5;POLH;SMG1;KAT7;HNRNPD;SMARCAD1;KPNA1;UBE2N;MPV17;TERF2;WDR70;TERF2IP
prerank,potassium ion import across plasma membrane (GO:1990573),0.39788233313573573,0.9337635857122557,0.590443686006826,0.8976528945168106,1.0,2/41,2.24%,KCNJ11;HCN4
prerank,atrioventricular valve development (GO:0003171),-0.3338903578225292,-0.9337417573884818,0.5703125,0.8999538989366579,1.0,2/14,4.03%,BMPR1A;ACVR1
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.4505148379363508,0.9331253930928514,0.5918635170603674,0.8984913944795423,1.0,4/15,14.16%,TSEN15;ERN1;RTRAF;DDX1
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.41076582539664996,0.9329338770506591,0.5785123966942148,0.8984493267203837,1.0,3/27,8.05%,CD74;CD44;SNAI1
prerank,regulation of focal adhesion assembly (GO:0051893),0.38282608255135175,0.9325075580181879,0.5878594249201278,0.8988658534114415,1.0,15/54,17.75%,PTPRJ;THY1;DUSP3;MACF1;SLC9A1;ACTG1;VCL;LIMS1;NRP1;THBS1;SRC;PTPRA;PTEN;CORO1C;RHOA
prerank,epidermal cell differentiation (GO:0009913),-0.2564534397689197,-0.9321219920869309,0.5757575757575758,0.9014708074611438,1.0,8/41,15.14%,CLIC4;WNT5A;BCR;HDAC2;GLI1;JAG1;CASP3;UGCG
prerank,nucleotide-excision repair (GO:0006289),0.3637774093809151,0.9318092645751735,0.6185147507629705,0.8998810040566954,1.0,23/101,18.79%,COPS6;GTF2H1;PPIE;RNF111;BRIP1;LIG3;UVSSA;ATXN3;TP53;MMS19;CDK7;USP7;POLR2L;COPS4;SLX4;POLD3;ERCC5;ERCC6;OGG1;TCEA1;GTF2H5;ERCC1;POLR2E
prerank,regulation of synapse maturation (GO:0090128),-0.3779380316712857,-0.9317950240184698,0.5483870967741935,0.899599760461344,1.0,5/10,28.16%,DAB2IP;ARHGEF15;ANAPC2;CAMK2B;YWHAZ
prerank,positive regulation of histone acetylation (GO:0035066),0.4255254613774014,0.931704404454257,0.5997552019583844,0.899664885724867,1.0,11/23,27.11%,PPARGC1A;RPS6KA4;KAT7;SMARCB1;BRD7;PIH1D1;RPS6KA5;ARRB1;SPHK2;GLYR1;MAPK3
prerank,cellular response to glucose starvation (GO:0042149),0.3911419077117499,0.9316530418502135,0.5827814569536424,0.8993373152611189,1.0,22/41,28.84%,FOXO3;TP53;MTMR3;IMPACT;BECN1;TBL2;NIM1K;CPEB4;PIK3R4;SIK2;ATG14;BRSK1;NUAK1;PRKAG1;NUAK2;XBP1;SH3GLB1;PRKAA1;ITFG2;SESN1;SESN2;PMAIP1
prerank,cellular response to cadmium ion (GO:0071276),-0.275930451729153,-0.9315969688393573,0.5163043478260869,0.8975014261868115,1.0,4/24,9.25%,MAPK8;EGFR;MAPK9;CHUK
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.3867524443946988,0.9312042496743909,0.5772626931567328,0.8998280058400289,1.0,5/45,12.29%,TGFB1;TGFBR1;HFE;INHBA;SDCBP
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.4630538588261757,0.9311602713544457,0.5859269282814614,0.8994806102254196,1.0,1/12,2.02%,PLCG2
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.35973175523247775,0.9309290391271579,0.73,0.8995467759290564,1.0,79/366,18.20%,HCLS1;GATA1;ORC3;TGFBR1;RREB1;NSD1;MLXIPL;YAF2;UBE2V1;MITF;PPIE;NFXL1;CEBPA;FOXO3;DDIT3;CXXC1;SPI1;WWC2;BACH1;CHD7;SBNO1;TFEB;CDK11B;DNM2;CCAR1;TP53;GCFC2;CEBPB;HINT1;FOXN2;TGFBRAP1;CHEK2;PRKCQ;MEF2C;RB1;GTF2IRD1;IRF2;PPARGC1A;ATRX;RPL6;NFX1;HCFC2;ZSCAN26;CYFIP1;RPS6KA4;NLK;DENND4A;NR2C2;ZNF628;GZF1;MTF2;PPP2CA;BRDT;KAT7;FOXN3;PCIF1;SOX6;HCFC1;ZFHX3;SOX2;HNRNPD;SOX4;PUM3;ZBTB11;SPTY2D1;REXO4;OGG1;FADS1;HIF1A;SBNO2;TRIP4;RPS6KA5;VHL;NFYA;PCGF1;CASZ1;CNBP;ZNF35;CREBL2
prerank,regulation of vacuole organization (GO:0044088),0.42641374289582207,0.9309175329493236,0.5549872122762148,0.8991407008973532,1.0,11/20,24.20%,ENO3;MTMR3;RAB1B;TBC1D14;TBC1D12;LAPTM4B;ENO1;SCARB2;NPRL3;ADPRH;IFT88
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.36029728461714705,-0.9305310843552015,0.5164835164835165,0.8976305386457939,1.0,4/11,18.09%,REST;PINK1;ATF4;PARK7
prerank,transcription by RNA polymerase II (GO:0006366),0.3556269411364617,0.9297476077470527,0.692,0.9010156294516655,1.0,68/305,19.13%,ARRB2;PCID2;POU2F2;MED17;RREB1;GTF2H1;TAF1A;MAML3;NABP1;RXRB;NR1H4;EAF1;HDAC5;ELL2;TAF1;BTF3;TEAD1;TBL1XR1;LEO1;CSTF1;TRIP13;GMEB2;LSM11;INTS8;PPARGC1A;CDK7;NFX1;SETD2;RPAP2;NFIC;TBL1X;MED27;KLF13;POLR2L;TRIM24;TAF8;NR2C2;HDAC9;MBD1;PMF1;SNAPC3;ELL;NR4A1;MLLT1;NFKB1;INTS6;ELOF1;INTS13;NR2C1;MAF;ERCC6;TAF3;RBPJ;ZBTB7B;SNAPC4;GTF2B;ICE2;PPARD;NFYA;PCF11;INTS1;TCEA1;GTF2H5;RXRA;POLR2E;TAF11;ELOB;MED4
prerank,peptidyl-lysine trimethylation (GO:0018023),0.4125141438186969,0.9297329075167922,0.5834319526627219,0.90061461349917,1.0,9/26,21.22%,SMYD5;TET3;SETD2;ETFBKMT;SUV39H1;SETD1B;WDR82;TET2;SETD5
prerank,regulation of cell-substrate adhesion (GO:0010810),0.3881504907276135,0.9294566891418182,0.5886917960088692,0.9007572334729914,1.0,10/42,18.64%,THY1;PIK3CB;ATXN3;LIMS1;PTPRO;NF1;CORO1C;RHOA;CORO2B;MINK1
prerank,DNA methylation (GO:0006306),0.41890391173292035,0.9288985765911011,0.5905118601747815,0.901468570812838,1.0,4/23,9.69%,DNMT3A;METTL4;ATRX;ATF7IP
prerank,pre-replicative complex assembly (GO:0036388),0.37038760856471753,0.9288038054323305,0.6253968253968254,0.9012337073399829,1.0,13/64,15.62%,MCM5;ORC3;PSMB10;MCM6;MCM2;PSMA2;ORC4;PSME3;PSMB5;CDC6;PSMD8;PSMD7;PSMB9
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.43917154216438786,0.9286732383243729,0.5784190715181933,0.9010668161068154,1.0,2/18,6.34%,AQP1;ANXA1
prerank,positive regulation of pseudopodium assembly (GO:0031274),-0.37357452334994634,-0.9286348772655945,0.5516129032258065,0.8974043293942459,1.0,4/10,22.81%,CDC42EP5;CDC42EP4;APC;WASHC1
prerank,regulation of pseudopodium assembly (GO:0031272),-0.37357452334994634,-0.9286348772655945,0.5516129032258065,0.8974043293942459,1.0,4/10,22.81%,CDC42EP5;CDC42EP4;APC;WASHC1
prerank,cellular calcium ion homeostasis (GO:0006874),0.36204684337027043,0.9286111500288731,0.641566265060241,0.9007597777999735,1.0,33/133,20.00%,CCR2;KCTD17;SLC8A1;CCL8;HERPUD1;CLN3;FZD9;TMEM178A;ATP2C1;TPT1;ATP2B1;BAK1;CCL14;VAPB;ATP13A1;SLC8B1;CCL13;CHERP;ATP2B3;NPTN;CDH23;ATP2A3;ADCY8;WFS1;CCDC47;SELENOK;PDZD8;TMEM165;MICU2;PACS2;CALCA;ATP13A5;ATP13A2
prerank,regulation of exosomal secretion (GO:1903541),0.43371745471386314,0.9282529426088177,0.5669975186104218,0.9010461249361104,1.0,6/19,20.78%,SMPD3;RAB7A;SDCBP;PDCD6IP;ATP13A2;PRKN
prerank,lamellipodium organization (GO:0097581),0.4020618092636173,0.9280930586508085,0.5885780885780886,0.9009569470722798,1.0,12/29,20.63%,ABLIM2;P2RY12;VCL;PARVB;CYFIP1;PTPRO;SNX2;ARFIP2;GOLPH3;ITGB1;RHOD;SPATA13
prerank,translation (GO:0006412),0.3550535567933695,0.9276010166129307,0.6896896896896897,0.9015518434060685,1.0,77/208,25.75%,RPL23;RPL17;VARS1;RPL10A;RPS2;RRBP1;RPL18A;FARSB;MRPL41;GTPBP1;RPS15A;GSPT1;GATB;EIF4EBP2;GARS1;PPA2;MRPL51;RARS1;QARS1;EPRS1;RPL6;LARS2;RPLP2;RPL26;RPS20;RPS16;RPS14;DARS1;RPL19;RWDD1;DARS2;IGF2BP3;RPL9;TMA7;RPS11;RPL11;RPS23;FARS2;RPS4X;MRPS21;RPS27;AGO2;RPL4;MRPS14;PABPC4;MRPL3;RPL7A;RPL15;MRPL10;RPL29;AIMP1;RPL22;RPS7;TARS1;YARS1;RPS13;EEF1G;SARS1;SARS2;RPL22L1;RPLP1;RPS15;MRPL18;MRPL52;RPS5;RPL41;DRG2;GATC;RPL10;MRPL37;MRPS34;MRPS12;ABCF1;RPS8;RPL5;RPL18;EEF1A1
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.4191086208049287,0.9275380159541358,0.585820895522388,0.9012349460720337,1.0,7/24,22.07%,ITGB2;ITGAM;FYN;CEMIP;MYO1C;FIS1;CHP1
prerank,heme biosynthetic process (GO:0006783),0.4232665935491666,0.9273939143048165,0.5768292682926829,0.9011108121838305,1.0,4/22,10.00%,TSPO;ATP5IF1;SLC25A38;NFE2L1
prerank,potassium ion export across plasma membrane (GO:0097623),-0.35373078572041966,-0.9269598965476025,0.547945205479452,0.8991604079522246,1.0,3/13,5.64%,KCNK5;KCND3;KCNT2
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.438925776699283,0.9268891607244886,0.5751014884979703,0.9016911885751379,1.0,2/14,7.24%,EHHADH;ABCD1
prerank,regulation of cellular response to stress (GO:0080135),0.3634481601758161,0.9267718745731951,0.641051567239636,0.901486839160269,1.0,33/115,21.26%,BAG2;MTOR;PTGES3;NUP62;NEK6;DNAJC7;ATF3;CLN3;HSBP1;ABCD1;SEH1L;CEBPB;HSF1;SMG1;TPR;NUP205;ADCY8;CHORDC1;BAG1;HSP90AA1;MANF;DNAJB6;NPAS2;CORO2B;RPTOR;SEC13;ROCK2;GSK3B;PRKN;NUP54;BAG4;CRYAB;NEK4
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.4646154738633177,0.9265779199317342,0.5648648648648649,0.901448665421078,1.0,3/13,6.91%,RENBP;NAGK;OGA
prerank,protein transmembrane import into intracellular organelle (GO:0044743),-0.2579305441428661,-0.9263954616147274,0.5735294117647058,0.8980197474724697,1.0,19/31,33.29%,DNAJC19;TIMM17A;PEX5;GRPEL2;PEX6;PEX14;TOMM70;TIMM23;PAM16;PEX26;TIMM21;PEX10;ROMO1;GRPEL1;HSPD1;PEX16;DNLZ;AIFM1;TOMM40L
prerank,protein localization to cell-cell junction (GO:0150105),0.44283601741576356,0.9263026155231181,0.5677852348993289,0.901582737934744,1.0,4/15,9.97%,ARHGEF18;ACTB;ACTG1;F11R
prerank,carnitine shuttle (GO:0006853),0.47052156321479677,0.9258506087360698,0.5619047619047619,0.9020565774378297,1.0,3/11,16.92%,SLC25A20;ACACA;CPT2
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.2854067492531073,-0.925751545386601,0.5157232704402516,0.8969403672452881,1.0,6/26,10.09%,SRI;THADA;ATP1A2;FKBP1A;FMR1;CALM3
prerank,regulation of protein binding (GO:0043393),0.36498355348194456,0.9257489571129197,0.6535750251762337,0.9018505029738461,1.0,29/114,18.54%,BAG2;PRKCD;LDLRAP1;HDAC5;TAF1;ACTB;TFIP11;HFE;DISC1;CTSZ;SPPL3;DERL1;EPB41;HDAC4;PPP2CA;PSME3IP1;SORL1;BAMBI;B2M;STK3;LRRK2;LRP1;TLE5;IDE;RPL11;STK4;ADD1;FLOT1;DACT1
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.36231336013157756,0.9256719185795542,0.6673387096774194,0.9015738989632289,1.0,31/145,18.10%,TUBB;GPR132;PRKAR2B;HAUS2;TUBA4A;CNTRL;CEP192;MAPRE1;PSMB10;CEP70;PLK4;CEP76;KIF14;HAUS1;RAB11A;PSMA2;DYNC1H1;PCM1;PSME3;CEP152;PSMB5;HAUS8;PSMD8;PSMD7;PSMB9;NINL;RAD51B;HSP90AA1;AKAP9;PSMD2;CEP63
prerank,nuclear transport (GO:0051169),0.4427443721476544,0.9253775458269518,0.577023498694517,0.9017405837555811,1.0,4/16,11.72%,XPO1;ANP32A;RBM15B;NUP205
prerank,negative regulation of developmental process (GO:0051093),0.3737919418279054,0.9253217600905647,0.6266944734098019,0.9014241242819728,1.0,18/69,21.55%,SHH;TGFB1;THY1;BCL11A;SPI1;RC3H1;SOX9;CDK6;GAS6;HUWE1;VAT1;SFMBT1;GREM1;KLF7;ROCK2;PRKN;ARPIN;PARP3
prerank,sensory perception of sound (GO:0007605),-0.21465756449815623,-0.9252119641207086,0.7916666666666666,0.8957429718250938,1.0,14/88,12.21%,ROR1;GRM7;NIPBL;DCDC2;GSDME;EML2;COL4A3;EYA1;SOD1;USP53;WDR1;CLIC5;ATP6V0A4;TBX1
prerank,positive regulation of TORC1 signaling (GO:1904263),0.4429989038785423,0.9251994477951597,0.6010430247718384,0.901256467327455,1.0,8/16,21.78%,GPR137B;SEH1L;FLCN;PIP4P1;PIH1D1;TELO2;RRAGA;RRAGB
prerank,endothelial tube morphogenesis (GO:0061154),0.48071677012078307,0.9248211521655255,0.5947521865889213,0.9015569952244294,1.0,3/10,6.29%,CCM2;PRKD2;CTNNB1
prerank,DNA replication (GO:0006260),0.361436981758504,0.9247218880740088,0.6281661600810537,0.9013343407270235,1.0,18/105,13.80%,MCM5;FAM111A;ORC3;RMI1;EXO1;BRIP1;MCM6;MCM2;NAP1L1;DBF4;BAZ1A;ORC4;WDHD1;MCM9;KAT7;DNA2;MCMBP;CDC6
prerank,protein deacylation (GO:0035601),0.4143128851659337,0.9245000854200448,0.5789473684210527,0.901344722863604,1.0,5/23,11.67%,HDAC5;ABHD17B;HDAC4;HDAC6;ABHD17C
prerank,regulation of mitochondrial fission (GO:0090140),0.4164139837544016,0.9244431059599223,0.5698529411764706,0.9010374021635456,1.0,8/24,20.78%,CYRIB;DDHD1;MYO19;LRRK2;DNM1L;FIS1;INF2;PRKN
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.34327237921957343,-0.9243613581110615,0.5364963503649635,0.8952406681712342,1.0,3/12,7.48%,UNC13B;RIMS2;SYT7
prerank,lysine metabolic process (GO:0006553),0.4694812484450232,0.924332370172176,0.6013513513513513,0.9004130157076935,1.0,3/12,12.95%,CRYM;OGDH;ALDH7A1
prerank,lysine catabolic process (GO:0006554),0.4694812484450232,0.924332370172176,0.6013513513513513,0.9004130157076935,1.0,3/12,12.95%,CRYM;OGDH;ALDH7A1
prerank,rRNA pseudouridine synthesis (GO:0031118),-0.37520715066324933,-0.9240887946892352,0.5230263157894737,0.8934301991392773,1.0,8/10,41.35%,GAR1;NOP10;TSR3;RPUSD1;NHP2;NAF1;RPUSD2;RPUSD3
prerank,cellular response to UV (GO:0034644),0.3685639565089264,0.923992638363723,0.6294363256784968,0.9006518613960023,1.0,15/76,16.45%,AQP1;PRKCD;TIMP1;TAF1;TP53;YY1;BAK1;IMPACT;RPL26;METTL3;INO80;BMF;NOC2L;COPS9;MFAP4
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.3646771773094993,0.9237410686939584,0.6431492842535788,0.9007126582581509,1.0,21/95,17.78%,TGFB1;TGFBR1;ZEB2;SKI;RNF111;TGFBR2;NKX2-1;FLCN;FAM89B;SMAD3;THBS1;SNX25;SDCBP;BAMBI;VASN;STUB1;BCL9;SMURF1;LDLRAD4;GIPC1;PDPK1
prerank,intraciliary transport involved in cilium assembly (GO:0035735),-0.25174643870171454,-0.923355196634546,0.6173913043478261,0.8927550538504009,1.0,17/37,26.84%,KIF3C;IFT46;IFT57;IFT172;KIF3B;IFT81;KIFAP3;IFT74;WDR35;IFT20;IFT43;DYNC2I2;DYNLL2;IFT22;IFT122;WDR19;TRAF3IP1
prerank,calcium ion homeostasis (GO:0055074),0.3642399772430821,0.9233221901408387,0.6456211812627292,0.9011096126543775,1.0,18/95,14.22%,CCR2;SLC8A1;CCL8;SNCA;ATP2C1;TPT1;TFAP2B;ATP2B1;CCL14;VAPB;ATP13A1;SLC8B1;CCL13;CHERP;ATP2B3;NPTN;ATP2A3;WFS1
prerank,negative regulation of DNA replication (GO:0008156),-0.3340194926141587,-0.9233029468320194,0.5310077519379846,0.8903774332353679,1.0,5/13,18.90%,RAD17;WAPL;TSPYL2;S100A11;CDAN1
prerank,regulation of monocyte differentiation (GO:0045655),0.4559372044282226,0.9226014141481209,0.5743243243243243,0.9021051267589436,1.0,2/14,3.61%,CD74;ACIN1
prerank,cellular response to decreased oxygen levels (GO:0036294),0.37925408056890353,0.922466688260574,0.6274921301154249,0.9019442714093898,1.0,13/65,16.48%,AQP1;ADAM8;ANGPT4;MTOR;RGCC;TP53;P4HB;TBL2;STUB1;CPEB4;HIF1A;CPEB2;SUV39H1
prerank,regulation of cilium assembly (GO:1902017),0.3694302823187232,0.9220141883231181,0.6097560975609756,0.902387709623493,1.0,18/62,19.20%,TBC1D10C;KCTD17;TBC1D16;TBC1D22A;USP6NL;TBC1D10A;TBC1D2;TBC1D17;TBC1D2B;TBC1D8;TBC1D14;TBC1D22B;ATG3;RABEP2;ENTR1;DYNC2LI1;TAPT1;TBC1D5
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),0.4233004756346635,0.9218940423667671,0.5862944162436549,0.9022162954501743,1.0,2/20,8.46%,TGFB1;RB1
prerank,JNK cascade (GO:0007254),0.3906921266939021,0.9218275800456343,0.6109865470852018,0.9019268253777148,1.0,12/40,18.64%,IRAK2;UBE2V1;MAP3K5;NOD2;MAP3K12;TAB2;IKBKG;GPS2;TAB3;MAP3K11;UBE2N;MINK1
prerank,mitochondrion disassembly (GO:0061726),0.39642441998216554,0.9214971668138358,0.6046242774566474,0.9021669497792644,1.0,10/34,22.34%,CTSK;ATG7;MAP1LC3B;FUNDC1;BECN1;ATG2B;ATG3;FIS1;PRKN;RB1CC1
prerank,cellular copper ion homeostasis (GO:0006878),0.4412004478136579,0.9214892092597486,0.5796897038081805,0.9017572673486337,1.0,2/14,4.49%,ATP7A;ATOX1
prerank,protein complex oligomerization (GO:0051259),0.3629617169422732,0.9212683603104549,0.6444672131147541,0.9017563464362311,1.0,18/85,16.53%,CARD11;LRRC8D;SNCA;PKD2;PYCARD;SLC9A1;AQP11;ATL1;RNF135;NINJ1;TMEM120A;ADCY8;LRRC8C;TWNK;PDCD6IP;ALS2;ZNHIT6;YME1L1
prerank,proton transmembrane transport (GO:1902600),0.3994020383450947,0.9210454154986144,0.6090395480225989,0.901765499163441,1.0,4/36,7.43%,ATP6V0E1;SLC36A1;SLC9A1;ATP6V0D1
prerank,modulation by host of symbiont process (GO:0051851),0.40495212596011065,0.9210169284116213,0.5820045558086561,0.9013992480941875,1.0,2/31,1.86%,CX3CR1;AQP1
prerank,cellular response to topologically incorrect protein (GO:0035967),0.39527781951450214,0.9209684269928,0.6016355140186916,0.9010788639208877,1.0,7/31,13.60%,PTPN1;ERN1;ATXN3;BAK1;HSF1;HDAC6;STUB1
prerank,histone exchange (GO:0043486),0.3914558805508584,0.9205214911337732,0.6060948081264108,0.9015318596073314,1.0,14/37,23.99%,CENPO;SRCAP;RBBP7;CENPI;SPTY2D1;CENPQ;CENPK;RSF1;RBBP4;ITGB3BP;VPS72;SMARCA5;KNL1;CENPT
prerank,chondroitin sulfate biosynthetic process (GO:0030206),0.42375210696410137,0.920300520161455,0.5914249684741488,0.9015659955669084,1.0,9/21,27.02%,CHSY3;BCAN;CHSY1;CHST15;CHPF;CSPG4;CHST3;CHST11;CHST9
prerank,regulation of dendrite development (GO:0050773),0.3919521806279119,0.9194555103567409,0.5886363636363636,0.902777301982736,1.0,8/37,12.93%,CAMK1D;BCL11A;RAP2A;SEMA4D;TNIK;NEDD4L;CSMD3;LRP8
prerank,purine-containing compound biosynthetic process (GO:0072522),-0.2793053982382494,-0.9192444678139285,0.5714285714285714,0.8979796951602378,1.0,13/25,27.03%,ADK;DGUOK;GMPS;MTHFD1;PRPS2;AMPD3;GMPR;AMPD2;PAICS;ADSL;PPAT;PRPS1;PRPS1L1
prerank,inorganic cation import across plasma membrane (GO:0098659),0.3719103257008981,0.9189540416190742,0.6550264550264551,0.9033135339495129,1.0,6/75,7.37%,KCNJ11;HCN4;SLC9A4;SLC8A1;SLC9A9;SLC9A1
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.4578701288813123,0.9186647385749009,0.5834482758620689,0.9034553187377812,1.0,2/12,5.36%,PIK3CB;XDH
prerank,RNA transport (GO:0050658),0.3672971681466095,0.9182503740463078,0.6356020942408377,0.9038693566993202,1.0,20/71,21.24%,RFTN1;NUP62;DHX38;NXF1;THOC2;TGFBR2;CASC3;TPR;DDX39B;POLDIP3;UPF3B;RTRAF;THOC3;FLOT1;SLU7;SRSF6;SRSF2;SLBP;SRSF3;ZFP36L1
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.3716246854549337,0.918229573774038,0.6317460317460317,0.9034905937916373,1.0,8/62,8.26%,NFE2L2;CREB3;HERPUD1;BCL2L1;CREB3L1;EPO;SNAI1;TPT1
prerank,amyloid precursor protein catabolic process (GO:0042987),0.44739175563578304,0.9175533443202031,0.5795006570302234,0.9044083898829934,1.0,2/14,4.53%,ABCG1;CLN3
prerank,peroxisomal membrane transport (GO:0015919),0.40255199069196007,0.9174501227674904,0.6163742690058479,0.9041819560590278,1.0,5/27,11.58%,RAB8B;ABCD1;PEX13;PXMP2;PEX7
prerank,autophagy of mitochondrion (GO:0000422),0.3887406309017142,0.9172927125242855,0.5938914027149321,0.9040807015896648,1.0,11/38,22.34%,CTSK;ATG7;MAP1LC3B;FUNDC1;BECN1;ATG2B;ATG3;ATG14;FIS1;PRKN;RB1CC1
prerank,epithelial cell-cell adhesion (GO:0090136),0.4710685028681665,0.9172511952254517,0.5885714285714285,0.9037311500078781,1.0,2/11,9.76%,ITGB5;VCL
prerank,skeletal muscle organ development (GO:0060538),0.41860009659857084,0.917208424737295,0.5913461538461539,0.9033995550111166,1.0,3/26,8.10%,BASP1;CFLAR;MEF2C
prerank,monocyte differentiation (GO:0030224),0.4851445331965165,0.9170335662559855,0.6118518518518519,0.9032816574240672,1.0,2/10,5.26%,CSF1R;MYH9
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.48214625327099336,0.9170042762927623,0.5743740795287187,0.9029158238278756,1.0,2/10,5.36%,PIK3CB;XDH
prerank,UV protection (GO:0009650),0.4765546340262091,0.9170000828847857,0.5864106351550961,0.9025070250567615,1.0,3/10,16.45%,SDF4;ERCC5;MFAP4
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),-0.3700201461990427,-0.9169325394149329,0.5608974358974359,0.9013013082378402,1.0,3/10,11.92%,NEXMIF;ACER2;JAM3
prerank,stress granule assembly (GO:0034063),0.42470293291888284,0.9163865631315202,0.6195928753180662,0.9032268552595305,1.0,5/20,16.68%,CIRBP;YTHDF3;DYNC1H1;ATXN2L;RPS23
prerank,apoptotic nuclear changes (GO:0030262),0.4017873208062629,0.9162042608966823,0.5858343337334934,0.9031810466164167,1.0,11/24,27.67%,ACIN1;HMGB1;TOP2A;KPNA1;DICER1;DNASE2;DFFB;CECR2;CDK5RAP3;KPNB1;HMGB2
prerank,tRNA wobble base modification (GO:0002097),-0.3365422200546769,-0.9159073499204476,0.5517241379310345,0.9015271498213505,1.0,5/14,20.80%,ELP3;ELP4;URM1;MTO1;DPH3
prerank,regulation of translation (GO:0006417),0.3552597327164826,0.9155622705322364,0.7007007007007007,0.9040058702646949,1.0,34/173,14.83%,NIBAN1;MTOR;DHX9;CNOT8;PLXNB2;FOXO3;EIF5B;CIRBP;GSPT1;YTHDF3;TRAP1;LARP4B;EIF1;LARP1;EPRS1;EIF4H;IMPACT;CPEB3;EIF2B2;RPL26;CTIF;EIF4G3;CYFIP1;THBS1;ZCCHC4;METTL3;PCIF1;POLDIP3;UPF3B;DDX1;HNRNPD;SOX4;PUM3;IGF2BP3
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.38549204870358933,0.9149552386040588,0.6181619256017505,0.9047686561164634,1.0,15/44,22.44%,CNOT8;GTPBP1;TNRC6A;YTHDF3;MOV10;RC3H1;CPEB3;METTL3;MEX3D;AGO2;ROCK2;FTO;ZFP36L1;CNOT7;CNOT1
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.42058462266205116,0.9145616969147892,0.60450563204005,0.9051186330518286,1.0,10/22,26.03%,RPL23;RPS20;HEXIM1;RPS7;RPS15;CHD5;SPRED3;ATR;SPRED1;CDK5RAP3
prerank,bicarbonate transport (GO:0015701),0.4012352647634059,0.914538452132805,0.5995316159250585,0.9047426940910657,1.0,3/25,12.10%,AQP1;CYB5R1;CYB5RL
prerank,phosphatidylcholine catabolic process (GO:0034638),0.4604897472889238,0.9139051254444889,0.5869872701555869,0.9055652704244721,1.0,4/10,23.25%,PLA2G7;LIPC;PLA2G5;PLA2G6
prerank,regulation of mRNA stability (GO:0043488),0.35333945527809546,0.9137268384300148,0.6813627254509018,0.9054962247979322,1.0,35/145,20.12%,SLC11A1;PCID2;PRKCD;EXOSC1;XPO1;ANP32A;CIRBP;YWHAB;FASTKD3;PSMB10;YTHDF3;RC3H2;LARP1;TENT5C;RC3H1;PUM2;FASTKD1;PSMA2;METTL3;PSME3;PSMB5;HNRNPD;PSMD8;IGF2BP3;PSMD7;PSMB9;THRAP3;MEX3D;PSMD2;GDNF;SERBP1;ROCK2;FTO;HSPB1;EXOSC3
prerank,RNA splicing (GO:0008380),0.36389983379023016,0.9136456486865006,0.6471794871794871,0.9052139898373701,1.0,24/95,21.66%,IVNS1ABP;BCAS2;SF3B2;SF3B1;SNRNP25;SCAF11;ZMAT5;SNRPD2;PPARGC1A;DDX39B;LUC7L3;PRPF8;TRA2B;PPP2CA;WDR83;PPIG;NRDE2;SLU7;SNRNP35;SRSF2;SF3B3;SRSF10;PTBP1;PDCD7
prerank,rRNA methylation (GO:0031167),0.41561335753547657,0.9136384434873682,0.5972568578553616,0.9048112278393752,1.0,3/22,11.99%,EMG1;FBL;ZCCHC4
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.3784064323588454,0.9133326204467498,0.619625137816979,0.9049788815282905,1.0,11/41,24.89%,ALOX12;DAGLB;ABCD1;DEGS1;FADS1;GSTM2;GPX4;ACOT8;SCD;FADS2;PTGS1
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.4447395638672059,0.9132833022928464,0.5896774193548387,0.9046480587753226,1.0,3/15,6.91%,RENBP;NAGK;OGA
prerank,cellular metal ion homeostasis (GO:0006875),0.3584994002362837,0.9128591000346921,0.6690427698574338,0.9050370073379468,1.0,20/102,13.76%,CCR2;SLC8A1;CCL8;KCNMA1;SLC9A1;ATP2C1;TPT1;ATP2B1;CCL14;VAPB;NEDD4L;ATP13A1;SLC8B1;CCL13;CHERP;ATP2B3;NPTN;ATP1B3;ATP2A3;ATP1B2
prerank,response to ionizing radiation (GO:0010212),0.3633985485876871,0.9127127583103757,0.6403326403326404,0.9049121323971734,1.0,18/70,21.96%,GRB2;MAPK14;NABP1;TANK;BRAT1;ANXA1;TP53;BABAM2;INO80;IKBIP;BABAM1;SWI5;SMPD1;SPIDR;CLK2;BRSK1;RAD1;RFWD3
prerank,epithelial cell migration (GO:0010631),-0.26366551202101546,-0.9125009370161444,0.5825242718446602,0.9076439680113133,1.0,10/37,16.08%,FSTL1;STARD13;KANK1;KANK2;ABL1;FAP;ROCK1;NOS3;SCG2;STAT1
prerank,negative regulation of cartilage development (GO:0061037),0.4387376896523837,0.912496738672998,0.5833333333333334,0.9048719654090498,1.0,3/13,18.40%,TGFBR1;SOX9;GREM1
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.399754063650432,0.9123555745399111,0.6161026837806302,0.9047638143390498,1.0,3/29,4.61%,NT5C3B;CNOT8;EXOSC1
prerank,RNA processing (GO:0006396),0.3560706398647026,0.9120216664746442,0.7077077077077077,0.9049777698923174,1.0,45/176,21.66%,APOBEC1;IVNS1ABP;BCAS2;SF3B2;SF3B1;AURKAIP1;RBM39;TENT4B;SNRNP25;SCAF11;TFIP11;ZMAT5;SNRPD2;ADAR;PPARGC1A;HNRNPL;DDX39B;SON;RNASEL;LUC7L3;METTL3;PRPF8;PPP2CA;ADARB1;HNRNPD;ALKBH5;PPIG;AKAP8L;NUFIP1;NRDE2;TUT7;PABPC4;SLU7;RBMS2;HNRNPF;SNRNP35;SRSF2;PABPN1;SF3B3;TSEN2;DICER1;PTBP1;HNRNPA0;LIN28B;PDCD7
prerank,protein palmitoylation (GO:0018345),0.3954128678068664,0.9117044924927581,0.6157517899761337,0.905160380972561,1.0,8/30,15.37%,ZDHHC14;ZDHHC7;ZDHHC13;ZDHHC16;ZDHHC3;ZDHHC1;ZDHHC24;SELENOK
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),-0.35233675173495116,-0.9109506348498468,0.5694444444444444,0.9090155179045709,1.0,3/12,5.16%,SORBS1;IRS1;EPM2AIP1
prerank,primary miRNA processing (GO:0031053),-0.3691797956299802,-0.9109180329688867,0.5909090909090909,0.9065840995444494,1.0,4/10,11.19%,DGCR8;HNRNPA2B1;SMAD1;PUS10
prerank,nucleic acid metabolic process (GO:0090304),-0.21094172433021185,-0.9103701489384965,0.6739130434782609,0.9054493919066704,1.0,27/69,28.29%,RBFOX2;NT5E;TOPBP1;DUSP11;HNRNPR;HNRNPA2B1;DDX24;METTL14;ATXN2;HNRNPA1;WRN;HNRNPU;EXD2;RBMX;HNRNPH2;POLG;RAN;POLR2C;DDX54;NCBP2;GTF2F1;PCBP2;SETMAR;POLR2J;PDE12;POLR2D;KPNA2
prerank,regulation of gene silencing by miRNA (GO:0060964),0.3675014089951255,0.9102424427600554,0.6242105263157894,0.907575932343221,1.0,9/62,11.72%,TGFB1;DHX9;NUP62;TNRC6A;SEH1L;PUM2;TPR;POLR2L;NUP205
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.4269717400476029,0.9101877842959415,0.5903919089759798,0.9072616348598849,1.0,3/17,9.59%,HERPUD1;SEL1L;DERL1
prerank,cellular response to virus (GO:0098586),0.392670356198964,0.9100423676717012,0.6058823529411764,0.9071097476858764,1.0,6/30,18.99%,POU2F2;MAPK14;IRGM;HIF1A;HSP90AA1;RIOK3
prerank,mitochondrion transport along microtubule (GO:0047497),0.44077524044293326,0.9099689603994737,0.5941422594142259,0.9068364646385983,1.0,1/13,1.14%,UXT
prerank,negative regulation of cellular component movement (GO:0051271),0.4272880902000964,0.909441090913279,0.5851755526657998,0.9073732962348685,1.0,3/15,10.21%,CD9;SPINT2;ACTN1
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.3704561221878277,0.9093333472505805,0.6450584484590861,0.9071556779499004,1.0,15/57,23.07%,ADCY7;PSAP;ADCY6;AKAP5;P2RY12;GPR37;ADCY8;ADCY3;GNAI3;RGS1;GNAI2;ADCY9;FLNA;MTNR1A;HTR1F
prerank,RNA destabilization (GO:0050779),0.4239684802818916,0.9089119629140334,0.5954198473282443,0.9075352212857081,1.0,9/18,25.87%,YTHDF3;ZC3H18;METTL3;MEX3D;ROCK2;FTO;LIN28B;DXO;PUM1
prerank,response to UV (GO:0009411),0.3566835313750524,0.9087926159141316,0.6403688524590164,0.907327132331804,1.0,21/95,16.45%,AQP1;PRKCD;SDF4;TAF1;CIRBP;UVSSA;TP53;USF1;POLH;YY1;BAK1;UBE4B;RPL26;METTL3;INO80;BMF;NOC2L;ERCC5;ERCC6;COPS9;MFAP4
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",0.4255223297129607,0.9082244136981525,0.5942028985507246,0.9079553431956967,1.0,5/17,23.62%,IK;RB1;MIS12;KNL1;BUB3
prerank,aorta morphogenesis (GO:0035909),-0.31480999275786775,-0.908221686858029,0.5833333333333334,0.9082539286817854,1.0,5/17,13.17%,BMPR1A;ACVRL1;TBX1;ADAMTS9;JAG1
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),0.4435568126992099,0.9081472815107006,0.604,0.9076814842023962,1.0,8/14,24.66%,PIK3CD;VEGFB;NRP1;MYO1C;VEGFD;PIK3CA;VEGFA;KDR
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.3610092166488319,0.9081112009042914,0.6227608008429927,0.9073426073053845,1.0,16/72,18.79%,COPS6;GTF2H1;PPIE;LIG3;UVSSA;CDK7;USP7;POLR2L;COPS4;POLD3;ERCC5;ERCC6;TCEA1;GTF2H5;ERCC1;POLR2E
prerank,mitochondrion localization (GO:0051646),0.4111022168404096,0.9073074665640852,0.5938303341902313,0.9084416389642399,1.0,9/19,25.47%,BRAT1;MEF2A;MSTO1;ATCAY;LRRK2;MFN1;MARK1;MARK2;TRAK1
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.38403140979674283,0.9069175396040424,0.6196531791907515,0.90874918372323,1.0,8/33,16.66%,PLCG2;TAF1;KIF14;PSME3;INO80;PTEN;STXBP4;APPL2
prerank,protein neddylation (GO:0045116),-0.34105620472583187,-0.9068353058448878,0.5802919708029197,0.9091538167335519,1.0,6/13,18.16%,DCUN1D4;RBX1;NAE1;UBA3;DCUN1D3;UBE2M
prerank,protein targeting to peroxisome (GO:0006625),0.3949134328016156,0.9067599868143486,0.6207701283547258,0.908620357082935,1.0,5/29,11.58%,RAB8B;ABCD1;PEX13;PXMP2;PEX7
prerank,regulation of spindle organization (GO:0090224),0.4266028095637715,0.9066889206267675,0.5992167101827677,0.9083374458247722,1.0,4/18,12.21%,NUP62;RNF4;CLTC;DYNC1H1
prerank,peptidyl-threonine modification (GO:0018210),0.36082113777794383,0.9064036591199071,0.6334033613445378,0.9084506636428505,1.0,19/66,20.45%,TGFBR1;PRKCD;PRKD2;TAF1;TGFBR2;WNK1;CSNK2A2;CSNK2A1;NLK;MAP3K12;GALNT2;LRRK2;GSK3A;GALNTL6;GALNT1;PDPK1;ROCK2;CDK5R1;GSK3B
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.3501667822261002,0.9062475257334353,0.6977911646586346,0.9083254275507541,1.0,34/152,15.72%,TGFB1;GPRC5B;TLR2;ZEB2;DKK2;SKI;TNFAIP3;LGR6;FZD9;MACF1;PSMB10;TBL1XR1;WNK1;CSNK1G2;DISC1;CSNK2A1;GID8;SULF2;ATP6AP2;AMER1;TBL1X;PSMA2;TNKS2;PSME3;BAMBI;NFKB1;PSMB5;PSMD8;LRRK2;SOX4;USP8;PSMD7;PSMB9;LGR4
prerank,negative regulation of endothelial cell proliferation (GO:0001937),0.38982212567126656,0.9061120654903076,0.6194285714285714,0.9081661374476334,1.0,9/35,16.03%,RGCC;APOE;XDH;MEF2C;ATP5IF1;THBS1;CCL2;ATP5F1A;NF1
prerank,histone H4 deacetylation (GO:0070933),0.4762434425630005,0.9060849076391316,0.5945165945165946,0.9078048835053749,1.0,4/10,16.17%,RCOR1;HDAC4;HDAC9;SMARCAD1
prerank,chloride transmembrane transport (GO:1902476),-0.24241679139924016,-0.9057937556573026,0.6575342465753424,0.9091747851963717,1.0,9/48,17.41%,SLC12A2;SLC12A7;GABRB2;GABRB1;GABRA2;GABRB3;ANO4;SLC12A8;GLRB
prerank,positive regulation of protein acetylation (GO:1901985),-0.35971058079262985,-0.9042176206597032,0.5845588235294118,0.9106626294044232,1.0,3/12,6.31%,CEP295;RAPGEF3;DIP2A
prerank,myelin assembly (GO:0032288),0.46610312698713496,0.9041672021121453,0.5870870870870871,0.9110526744380392,1.0,7/10,28.63%,CD9;DICER1;ABCA2;TENM4;CNTNAP1;PMP22;GPC1
prerank,regulation of striated muscle contraction (GO:0006942),0.4033778892465975,0.9041091062081683,0.6095238095238096,0.9107334371425517,1.0,4/27,8.17%,HCN4;MYL3;P2RX4;TNNT3
prerank,muscle contraction (GO:0006936),0.3527206440450161,0.9037989196722572,0.6898288016112789,0.9108985160390873,1.0,18/126,14.40%,ITGB5;HCN4;MYL3;SLC8A1;TTN;KCNIP2;ASPH;MYL12A;TNNT3;TPM4;VCL;DTNA;DYSF;TLN1;TPM3;SMTN;DES;ARHGEF11
prerank,regulation of cation channel activity (GO:2001257),0.3537737465151236,0.9036339846010375,0.634320735444331,0.9108065983031607,1.0,7/89,8.10%,CTSS;PTK2B;FGF13;STAC;EPO;CACNB4;MEF2C
prerank,regulation of centrosome duplication (GO:0010824),-0.2605274598015079,-0.9032466953570575,0.6176470588235294,0.9105915086558062,1.0,15/29,32.21%,CEP295;SPICE1;NAT10;CHMP5;CHMP4B;CENATAC;ALMS1;CEP120;CHMP2A;NPM1;STIL;CHMP4C;CEP295NL;CCNF;CHMP1B
prerank,Rho protein signal transduction (GO:0007266),0.3719673648232023,0.9030728755544591,0.6334405144694534,0.9114196033809786,1.0,19/53,23.94%,MYO9B;GNA13;GNA12;RIPOR1;ARHGAP1;ARHGDIB;ADGRG1;ARHGEF3;ARHGDIA;ARHGEF11;RHOA;CDC42;CDC42EP3;RHOD;ROCK2;CFL1;RHOG;PDPN;EPS8L1
prerank,"base-excision repair, AP site formation (GO:0006285)",0.42400126149504136,0.9023786002696237,0.6040353089533418,0.9123035938775098,1.0,6/17,22.86%,NEIL2;ERCC5;OGG1;TINF2;TERF2;TERF2IP
prerank,cellular macromolecule biosynthetic process (GO:0034645),0.3455836802677355,0.9023230037377526,0.774,0.911991975226626,1.0,100/306,26.27%,MCM5;FAM111A;ORC3;RPL23;RPL17;RPL10A;GCNT1;APOE;RPS2;RMI1;EXO1;RRBP1;RPL18A;BRIP1;FARSB;MRPL41;MEF2A;GTPBP1;RPS15A;GSPT1;EIF4EBP2;MMS19;MRPL51;RPL6;FUT9;MCM6;MCM2;NAP1L1;DBF4;RPLP2;RPL26;INHBA;RPS20;POLR2L;RPS16;ORC4;MCM9;RPS14;KAT7;DNA2;DARS1;RPL19;CDC6;POLD3;IGF2BP3;RPL9;LARGE1;RPS11;RPL11;RPS23;RPS4X;MRPS21;RPS27;AGO2;RPL4;MRPS14;PABPC4;CREBL2;GOLPH3;RNASEH2A;MRPL3;POLR2E;TOP1;FUBP3;RPL7A;RPL15;MRPL10;RPL29;CDC45;RPL22;RPS7;RAD1;RPS13;EEF1G;SARS1;RPLP1;POLR3A;RPS15;MRPL18;MRPL52;RPS5;ATR;RPL41;PAX8;PWP1;RPA1;RPL10;MRPL37;XAB2;MRPS12;ABCF1;RPS8;RPL5;EXT2;RPL18;EEF1A1;ING5;RPL28;PTMA;MRPS15
prerank,regulation of blood circulation (GO:1903522),0.3848195823125411,0.9020550311918981,0.6299659477866061,0.9120516909028846,1.0,2/34,4.32%,TMIGD3;KCNIP2
prerank,cell-cell junction maintenance (GO:0045217),0.45602678907839056,0.9019005587273015,0.6138888888888889,0.9119408208672715,1.0,1/11,2.01%,CSF1R
prerank,regulation of osteoblast differentiation (GO:0045667),-0.21494423215558567,-0.901481160619685,0.6842105263157895,0.9125293203729758,1.0,30/82,26.38%,SUCO;CRIM1;BMPR1A;TMEM64;WNT4;PRKD1;BMP4;ACVR1;RORB;REST;CTNNBIP1;CCN1;ATF4;SMAD6;PPARG;TWIST2;HDAC7;FERMT2;RANBP3L;TMEM119;PTK2;PTCH1;CHRD;BMPR2;MEN1;TWIST1;ACVR2B;FGFR2;SMOC1;HGF
prerank,regulation of fibrinolysis (GO:0051917),0.4377482639865711,0.9014164186781947,0.5852981969486823,0.9124322293723068,1.0,2/13,11.25%,USF1;THBS1
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.3616173118970788,0.9009147915420235,0.643312101910828,0.912977191134327,1.0,16/59,20.45%,TGFBR1;PRKCD;PRKD2;TAF1;TGFBR2;WNK1;CSNK2A2;CSNK2A1;NLK;MAP3K12;LRRK2;GSK3A;PDPK1;ROCK2;CDK5R1;GSK3B
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.4402777168529033,0.9008397977147348,0.5895316804407713,0.9127031975407894,1.0,6/13,19.44%,EDEM1;SVIP;UBE2G2;EDEM2;ERLEC1;OS9
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.36214612998776685,0.9006774110243195,0.6557894736842105,0.9125796758250042,1.0,9/66,14.05%,TGFB1;HCLS1;PRKCD;SMAD3;CCT8;MCRS1;TPR;KAT7;CCT5
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.3765120769628247,0.900643155789555,0.6024498886414253,0.9122280112373795,1.0,4/37,8.10%,P2RY6;ERN1;LDLRAP1;MEF2C
prerank,regulation of actin filament-based process (GO:0032970),0.3604388958488563,0.900153907631724,0.6431535269709544,0.9127167828827116,1.0,17/70,20.49%,IQGAP2;CORO1A;FZD10;PRKCD;MTOR;F11R;TWF2;ARHGAP18;LRP1;IQGAP1;RHOA;CORO2B;TAOK1;RHOD;ROCK2;ARHGEF19;CRK
prerank,regulation of long-term synaptic potentiation (GO:1900271),0.4007984749424185,0.9000942784407189,0.6283704572098476,0.912415071467352,1.0,4/28,6.55%,LGMN;APOE;AKAP5;TYROBP
prerank,negative regulation of cell death (GO:0060548),0.3543848131699152,0.8996450157738947,0.661139896373057,0.9128030389302234,1.0,25/88,22.07%,GPNMB;CD200R1;NUP62;SNCA;TRAF2;PPARGC1A;IMPACT;BECN1;PARP16;TNFRSF1B;FYN;SORL1;IKBKG;WFS1;LRRK2;SOX4;NPAS2;TIGAR;SRSF6;NENF;ATP13A2;GSK3B;PRKN;FGF2;MT3
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.347808649558014,0.8989782732117994,0.782,0.9135836942666417,1.0,68/259,20.63%,FGD2;MKS1;RAB8B;P2RX7;RAP2A;EXOC6;ASAP1;IFT52;RAP1B;FGD6;RP2;MTSS1;AIF1;CNGB1;ABLIM2;BBS9;PLK4;ATP6V0D1;TNIK;P2RY12;DISC1;RAP2B;SNAP29;VCL;RAB11A;ACTR2;ACTR3;PARVB;CYFIP1;NRP1;HDAC6;PTPRO;EXOC8;WDR11;DYNC2I1;EXOC7;EXOC1;SDCBP;PCM1;EXOC2;IFT80;TXNDC15;EXOC5;RPGR;FNBP1L;ARF6;EXOC3;RAP1A;CEP162;FXYD5;AHI1;WDR90;ARFIP2;WDPCP;NUDCD3;SNX10;GOLPH3;ITGB1;MINK1;CCDC66;CLUAP1;RHOD;TMEM67;INPP5K;KIF3A;AIF1L;MAP4K4;SPATA13
prerank,synaptic vesicle localization (GO:0097479),-0.33219178935071,-0.8989557596681382,0.5871886120996441,0.9162400942883324,1.0,5/13,15.76%,NLGN1;KIF5B;SYNDIG1;KIF5A;RAB27A
prerank,regulation of cardiac conduction (GO:1903779),0.3688948228410476,0.898906325714243,0.6511134676564156,0.9133010170217298,1.0,10/54,13.76%,KCNJ11;SLC8A1;ASPH;ATP2B1;ITPR2;NPR2;ATP2B3;ATP1B3;ATP2A3;ATP1B2
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.41505881448611837,0.8985589567552276,0.6192259675405742,0.9135304284255817,1.0,1/20,0.90%,TGFB1
prerank,cellular response to pH (GO:0071467),0.42019782161390423,0.898075783385884,0.6089238845144357,0.9140260919667403,1.0,6/17,22.07%,SLC9A1;IMPACT;RAB11FIP5;MCOLN1;HVCN1;CHP1
prerank,endoplasmic reticulum organization (GO:0007029),0.3553305195936302,0.8976477672959575,0.6777546777546778,0.9144027291672553,1.0,23/72,20.79%,LMAN1L;REEP6;VAPB;TMCC1;BNIP1;ATL1;CYB5A;SEC16A;SEC16B;STX5;TOR1AIP2;LRRK2;GAK;UBE2J2;CCDC47;RTN4;LMAN2;TMEM170A;ATL2;DNM1L;ATL3;SEC31A;SPTSSB
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.3914866931274551,0.8972578886686186,0.628735632183908,0.9147063371114644,1.0,5/31,17.15%,GCH1;DHRS11;PYCR2;PRLR;FDXR
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),-0.3717359755238828,-0.8971245882857297,0.5961538461538461,0.918196994501791,1.0,3/10,25.44%,FBXW7;HBEGF;EGF
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.38915212467633,0.8970888444751891,0.6402714932126696,0.914614919369663,1.0,9/35,16.36%,PCDHB6;ATP2C1;CDH8;CDH9;CDH12;CDH23;DCHS1;CDH19;PCDHGB4
prerank,regulation of organelle organization (GO:0033043),0.35468845121446985,0.8966098036247467,0.6735751295336787,0.9150708066015838,1.0,24/80,21.45%,MYO5A;ZEB2;ARMH3;RBSN;CLN3;USP6NL;VPS11;F11R;DIAPH1;PARL;STX5;SAR1A;RAB33B;CAPN2;CAMSAP2;AKAP9;GOLPH3;TAOK1;DNM1L;FIS1;ATP13A2;PRKN;PDE4DIP;SCARB2
prerank,positive regulation of protein export from nucleus (GO:0046827),-0.3167891399773657,-0.8955307540864526,0.6192660550458715,0.9195090173341758,1.0,4/15,6.77%,RAPGEF3;TCF7L2;ANP32B;BAG3
prerank,mRNA splice site selection (GO:0006376),-0.25093963825435633,-0.8954397667740945,0.6746031746031746,0.9172969079958347,1.0,16/30,34.39%,PSIP1;YTHDC1;SF3A1;SRSF1;PUF60;SNRPC;SRSF12;CELF4;CELF6;LUC7L;SF3A2;CELF5;LUC7L2;SF3A3;CELF2;SRSF9
prerank,histone deacetylation (GO:0016575),0.38089605375074576,0.8947801424579811,0.6459489456159823,0.9180045509045981,1.0,11/43,16.17%,HDAC5;MTA3;TBL1XR1;RCOR1;MIDEAS;HDAC4;TBL1X;HDAC6;HDAC9;HDAC11;SMARCAD1
prerank,regulation of protein polymerization (GO:0032271),0.382603259613274,0.8946772962479447,0.6334478808705613,0.9177685029204811,1.0,9/35,18.72%,HCLS1;PFN2;PFN1;COTL1;ARHGAP18;RASA1;CAMSAP2;HSP90AA1;GBA2
prerank,positive regulation of ion transport (GO:0043270),0.36585788135844377,0.894430368911867,0.6483516483516484,0.9178093737915679,1.0,12/48,19.30%,SCN4B;P2RX7;PKP2;P2RX4;PRSS8;ATP2B1;CACNB2;WFS1;CACNA1D;SCN5A;CNKSR3;GDNF
prerank,regulation of exocytosis (GO:0017157),0.37362898487517693,0.8939893174962659,0.6338028169014085,0.918178966166603,1.0,6/46,11.03%,RAB8B;UNC13D;SNCA;ANXA1;SYTL4;ATP6AP1
prerank,circulatory system development (GO:0072359),0.35058859119441366,0.8938159721193728,0.6777442094662638,0.9180894637502615,1.0,24/118,16.50%,SHH;TGFB1;SH3PXD2B;TGFBR1;EEF1AKMT4-ECE2;PKP2;PKD2;ADAP2;TGFBR2;MEF2A;LDB3;MEF2C;ZDHHC16;SMYD4;SOX9;WDR11;HDAC9;TAB2;CASP8;SOX4;PDLIM1;POU6F1;NF1;PTEN
prerank,phospholipid biosynthetic process (GO:0008654),-0.24408118120975167,-0.8937673516509379,0.63,0.9189758890783186,1.0,12/36,16.30%,FAR1;SAMD8;AGPAT4;AGPAT3;SGMS2;AGPAT5;NUS1;CPNE3;HDHD5;SRD5A3;CRLS1;MBOAT1
prerank,monocarboxylic acid transport (GO:0015718),0.3704470068116109,0.8933205009553652,0.6461704422869471,0.9185956110285803,1.0,12/51,18.31%,SLCO2B1;ABCC3;NR1H4;ABCB4;SLC16A2;SLC16A1;SLCO1B1;CD36;SLC16A6;SLC16A13;STARD5;RXRA
prerank,heterochromatin assembly (GO:0031507),-0.2903160748690784,-0.8926341547719496,0.6137566137566137,0.9193220936447186,1.0,2/20,4.79%,SMCHD1;EZH1
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.38597394009386327,0.8920537115252416,0.6131639722863741,0.9205132423834526,1.0,5/29,11.25%,TNF;TRAF2;PYCARD;INHBA;THBS1
prerank,pharyngeal system development (GO:0060037),-0.3200753019322719,-0.891903233457457,0.60546875,0.9185971987261023,1.0,5/15,12.21%,BMPR1A;BMP4;BMP5;HES1;TBX1
prerank,membrane lipid metabolic process (GO:0006643),0.40363200196149684,0.8919021995946815,0.6091127098321343,0.9203610500819592,1.0,5/22,14.80%,CERK;ST6GALNAC4;AGK;AGMO;ARV1
prerank,release of cytochrome c from mitochondria (GO:0001836),0.4179067145183692,0.8918736053010028,0.609254498714653,0.9199929249923077,1.0,8/17,25.04%,FZD9;BCL2L1;BAK1;TIMM50;DNM1L;FIS1;BID;MFF
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.44078592108091835,0.8916426022144747,0.605121293800539,0.9200018158472996,1.0,2/14,9.54%,MAPK14;ANGEL2
prerank,histone monoubiquitination (GO:0010390),-0.28270645196686583,-0.891552264671728,0.631578947368421,0.9169882373871465,1.0,7/24,12.26%,DDB2;RYBP;DDB1;TRIM37;PAF1;WAC;DTX3L
prerank,modulation of excitatory postsynaptic potential (GO:0098815),0.3992928859574995,0.8913559820830572,0.6206060606060606,0.9201377385213119,1.0,1/26,0.31%,PTK2B
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.3553995765529339,0.8912398429622866,0.6694915254237288,0.9199362986652037,1.0,18/69,18.84%,POU2F2;NABP1;ELL2;INTS8;CDK7;RPAP2;POLR2L;TAF8;SNAPC3;ELL;INTS6;INTS13;SNAPC4;GTF2B;ICE2;INTS1;POLR2E;TAF11
prerank,negative regulation of cell projection organization (GO:0031345),0.3649576237459855,0.8912100121784261,0.6474428726877041,0.9195759221270635,1.0,14/48,19.41%,MYLIP;RTN4RL1;APOE;ADCY6;CBFA2T2;PTPRO;FYN;GAK;YWHAH;EPHA4;PTEN;DENND5A;PAQR3;RAB29
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),-0.26093446207794846,-0.8911512392808669,0.6848484848484848,0.9155496413244628,1.0,12/29,26.44%,ACSL1;HACD1;ELOVL5;ACSL6;ACLY;PPT1;CBR4;ELOVL1;ACSBG1;HACD2;ACSL4;ACSL3
prerank,oligosaccharide metabolic process (GO:0009311),0.3708533360790152,0.8903532164712107,0.6515151515151515,0.9206955476836984,1.0,7/46,10.45%,ST8SIA4;B4GALT1;ST6GALNAC4;MAN2B1;MAN2B2;FUT9;ST8SIA1
prerank,snRNA transcription (GO:0009301),0.35483471302013614,0.8903078548978026,0.6687830687830688,0.9203604244587827,1.0,18/70,18.84%,POU2F2;NABP1;ELL2;INTS8;CDK7;RPAP2;POLR2L;TAF8;SNAPC3;ELL;INTS6;INTS13;SNAPC4;GTF2B;ICE2;INTS1;POLR2E;TAF11
prerank,regulation of peptidase activity (GO:0052547),-0.2969627357305249,-0.8902650421440023,0.6261682242990654,0.9153500804854816,1.0,6/19,13.60%,CAV1;NRDC;PINK1;ECM1;MAPK12;PSMA3
prerank,protein import into mitochondrial matrix (GO:0030150),-0.292595730836134,-0.8900963340702287,0.6305418719211823,0.9133253654369384,1.0,11/18,33.29%,DNAJC19;TIMM17A;GRPEL2;TOMM70;TIMM23;PAM16;TIMM21;ROMO1;GRPEL1;DNLZ;TOMM40L
prerank,cellular glucan metabolic process (GO:0006073),-0.3612463231190033,-0.8897231077255806,0.5729166666666666,0.9118320097642748,1.0,6/11,21.94%,PHKG2;UGP2;PHKB;PYGM;PPP1R3C;PHKA1
prerank,regulation of neuron projection development (GO:0010975),0.34348143321616487,0.8895844232028917,0.7341389728096677,0.9212463114828872,1.0,42/163,22.07%,PTK2B;LYN;MYLIP;CAMK1D;ARSB;MDK;RTN4RL1;ITGA6;APOE;PLXNB2;ADCY6;CBFA2T2;DISC1;FUT9;RAPGEF1;PTPRO;CSMD3;TWF2;NPTN;LZTS3;ATP1B2;TANC2;LRRK2;RAP1A;GAK;GSK3A;CAMSAP2;EPHA4;PTEN;DENND5A;PAQR3;KIDINS220;RAB29;RELN;CDK5R1;GSK3B;MARK1;BRSK1;SCARB2;CX3CL1;CFL1;MT3
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),0.4429355853900665,0.8890627412981857,0.6204986149584487,0.9217614086925767,1.0,3/12,16.30%,TNF;UVRAG;IRGM
prerank,regulation of cellular metabolic process (GO:0031323),0.36927430944846873,0.8888357213550643,0.6655701754385965,0.9217667237348678,1.0,14/45,21.24%,NPC2;ABCG1;TBC1D16;PARL;COQ7;STUB1;PID1;FASN;ACACA;LAMTOR1;FLOT1;MPV17;PRKN;ABCA2
prerank,organelle assembly (GO:0070925),0.34098302570699546,0.8885695481214069,0.823,0.9218348681194145,1.0,84/384,19.47%,BIN2;MKS1;RAB8B;SH3PXD2B;CORO1A;RAB32;NUP62;HAUS2;VTA1;NEK6;ATG7;EXOC6;ASAP1;MAP1LC3B;IFT52;RAB7A;CDS2;FLII;CIRBP;RP2;MAPRE1;CNGB1;BBS9;PLK4;YTHDF3;ATP6V0D1;VMP1;STARD9;DISC1;RC3H1;HAUS1;SNAP29;EMC6;RAB11A;TUBGCP6;TUBGCP4;ACTR2;RAB1B;ACTR3;VPS37C;HDAC6;BECN1;EXOC8;WDR11;DYNC2I1;DYNC1H1;EXOC7;EXOC1;PCM1;EXOC2;IFT80;TXNDC15;EXOC5;RPGR;FNBP1L;TRAPPC6A;INO80;SYNPO;EXOC3;HAUS8;CAPN3;CEP162;ATXN2L;ABCA3;AHI1;WDR90;PDCD6IP;ATG2B;IRGM;ATG3;RPS23;VPS28;WDPCP;NUDCD3;MIS12;CEP63;SNX10;MAPRE2;UBXN2A;ATG14;PACS2;TMEM41B;CCDC66;CLUAP1
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.3469148295944697,0.888406087522989,0.6866734486266531,0.9217365385800877,1.0,30/107,22.29%,SLC11A1;CCR2;SLC8A1;CCL8;ATP2C1;TPT1;ATP2B1;CCL14;VAPB;ATP13A1;SLC8B1;CCL13;CHERP;ATP2B3;NPTN;ATP2A3;TMEM165;ATP13A5;ATP13A2;SLC39A6;SLC10A7;MT3;MT1G;MT1B;MT1E;MT1F;MT1A;MT1X;MT1M;MT1H
prerank,response to insulin (GO:0032868),0.3517810361736995,0.8882773825343324,0.679959100204499,0.9215439008066353,1.0,21/80,21.24%,PCSK9;RAB8B;LPIN2;MYO5A;HDAC5;USF1;RAB31;EPRS1;DENND4C;HDAC9;GSK3A;SYAP1;ZBTB7B;CPEB2;GCK;PDPK1;SORT1;INPP5K;PKM;LPIN1;ZFP36L1
prerank,regulation of cellular response to heat (GO:1900034),0.35371957459537734,0.8879853486875886,0.6790890269151139,0.9216784675724451,1.0,21/77,21.16%,BAG2;MTOR;PTGES3;NUP62;DNAJC7;HSBP1;SEH1L;HSF1;TPR;NUP205;CHORDC1;BAG1;IER5;HSP90AA1;DNAJB6;RPTOR;SEC13;GSK3B;NUP54;BAG4;CRYAB
prerank,diterpenoid metabolic process (GO:0016101),0.3663242006255997,0.8879149652692654,0.6741935483870968,0.9214049927173857,1.0,8/55,15.03%,LPL;DHRS3;APOE;TTR;AGRN;ABCA4;LRP8;LRP1
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),0.4012754861441089,0.887190444168602,0.6399521531100478,0.9223014389980853,1.0,4/24,10.00%,TSPO;ATP5IF1;SLC25A38;NFE2L1
prerank,Rac protein signal transduction (GO:0016601),0.40975446386553216,0.8871204454240912,0.6142857142857143,0.9220142077654024,1.0,3/18,11.20%,ELMO1;AIF1;CYFIP1
prerank,spliceosomal complex assembly (GO:0000245),0.37387848994026496,0.8867076813362172,0.652452025586354,0.922330752792705,1.0,12/46,20.35%,SF3B1;SCAF11;GCFC2;SRPK3;SNRPD2;DDX39B;LUC7L3;DDX1;CRNKL1;SNRNP200;SRSF6;SRSF10
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.35132936182690505,0.8864080563651915,0.6794208893485005,0.9224422759400164,1.0,19/85,17.93%,ARRB2;FZD3;PSMB10;AP2S1;DAAM1;PSMA2;PFN1;CLTC;PSME3;PSMB5;PSMD8;AP2M1;PSMD7;PSMB9;VANGL1;SMURF1;RHOA;PSMD2;CDC42
prerank,tRNA methylation (GO:0030488),-0.24662907739233791,-0.8858351579983402,0.6119402985074627,0.9185282312218486,1.0,17/34,32.91%,NSUN6;METTL6;THADA;THUMPD3;NSUN2;TARBP1;DALRD3;MTO1;TRMT5;LCMT2;WDR6;TRMT44;TRMT13;TRMT10C;TYW3;TRMT12;TRMT112
prerank,regulation of carbohydrate catabolic process (GO:0043470),-0.2313100203753684,-0.885797250759468,0.6902654867256637,0.9162075728471404,1.0,10/41,11.87%,OGT;NUP93;NUP188;RANBP2;NUP98;NUP42;NDC1;RAE1;NUP153;NUP37
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.39321021680202356,0.8850427559631319,0.6383720930232558,0.9244910105641995,1.0,15/27,31.19%,BRD8;KAT7;NAA50;PHF20;MORF4L2;MORF4L1;TAF6;KAT5;CREBBP;EP300;SGF29;MRGBP;KAT6A;BAG6;KAT8
prerank,purine-containing compound salvage (GO:0043101),-0.3361000636307323,-0.8850263858892137,0.5912162162162162,0.9156196930028505,1.0,5/12,18.07%,ADK;DGUOK;AMPD3;GMPR;AMPD2
prerank,dorsal/ventral pattern formation (GO:0009953),0.4092339251285504,0.8848784085096634,0.6331210191082802,0.9243800211351921,1.0,1/20,0.68%,SHH
prerank,regulation of viral transcription (GO:0046782),0.3698853982340038,0.8847176119914713,0.6418918918918919,0.9242435721199048,1.0,12/39,24.49%,DHX9;TRIM27;MDFIC;POLR2L;MID2;TARBP2;TRIM62;RSF1;POLR2E;HEXIM1;NELFE;UBP1
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.38380334871276645,0.8847017618274756,0.6400462962962963,0.9238613548890457,1.0,3/31,4.61%,NT5C3B;CNOT8;EXOSC1
prerank,epidermis development (GO:0008544),-0.2225185305488971,-0.8846038081151866,0.7205882352941176,0.91426756128048,1.0,19/56,32.28%,PLOD1;EMP1;YBX1;HDAC2;ALDH3A2;GLI1;FLOT2;UGCG;GATA6;PTHLH;FGF7;LAMC2;FGFR2;ATP2A2;SCEL;KRTDAP;CCN2;EDAR;DSP
prerank,regulation of potassium ion transport (GO:0043266),0.3805533211502724,0.8845915505939245,0.6247058823529412,0.9236367950214508,1.0,2/31,4.32%,PTK2B;KCNIP2
prerank,positive regulation of ruffle assembly (GO:1900029),0.4360603962321993,0.8842067139357339,0.6130718954248366,0.9239056000082362,1.0,3/13,11.10%,PLEKHM1;P2RY12;PFN1
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.45338358918758254,0.8841420116690017,0.6175595238095238,0.9236042255330593,1.0,3/10,9.89%,LEO1;HSF1;CPEB3
prerank,gliogenesis (GO:0042063),0.42777444214256494,0.883744721188286,0.6114058355437666,0.9239055941414255,1.0,4/15,12.44%,CD9;ANXA1;METTL3;CDK6
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),-0.3453451219664685,-0.8836357749108218,0.5869565217391305,0.9140681481083722,1.0,7/12,25.95%,RAD17;TOPBP1;STK33;NAE1;CLSPN;SETMAR;ORC1
prerank,ribosomal small subunit assembly (GO:0000028),0.4157459808075172,0.8835962513135113,0.6368421052631579,0.9237683532750981,1.0,7/16,23.92%,XRCC5;ERAL1;RPS14;RPS27;RRP7A;RPS15;RPS5
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.4515455673358306,0.8834736513395732,0.6058495821727019,0.9235720864682495,1.0,3/12,16.50%,UBE2S;FZR1;PTEN
prerank,oligosaccharide biosynthetic process (GO:0009312),-0.28749295902052385,-0.8834160593469523,0.601010101010101,0.9121849964584656,1.0,6/20,16.06%,B3GALT5;ST3GAL4;ST6GALNAC6;MPDU1;ST3GAL3;B3GALT1
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.2572662368711841,-0.8832042293336341,0.6754966887417219,0.9103138043587335,1.0,11/30,19.98%,OGT;RYBP;N4BP1;USP14;TRIM39;WAC;CCAR2;NOP53;PARK7;UCHL5;DDRGK1
prerank,response to glucose (GO:0009749),0.3704632540626757,0.88319770412446,0.6517954298150164,0.9236434044957003,1.0,10/46,16.81%,LPL;PFKL;ERN1;EIF2B2;THBS1;TRA2B;GAS6;ADCY8;SOX4;GCK
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.4511415445682855,0.8830589416777183,0.6197771587743732,0.923472368803945,1.0,2/11,5.93%,RENBP;NAGK
prerank,negative regulation of cell aging (GO:0090344),-0.305954781241796,-0.8829961277052438,0.6129032258064516,0.9084612199527573,1.0,7/16,27.97%,ZKSCAN3;YBX1;MAP3K3;HMGA2;TERT;TWIST1;MIF
prerank,regulation of lipid biosynthetic process (GO:0046890),0.3799721045977561,0.8829828465404651,0.6391402714932126,0.9231978865304131,1.0,8/32,18.20%,MTOR;MLXIPL;APOE;ADIPOR1;CREB1;ADIPOR2;ASAH1;CREBL2
prerank,cellular response to gamma radiation (GO:0071480),0.416622179088161,0.8827408772456848,0.621859296482412,0.9232224953273247,1.0,4/17,10.47%,XRCC5;TP53;HSF1;RPL26
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.20533936865766614,-0.882582541257315,0.7222222222222222,0.9070484139699824,1.0,29/88,22.47%,FBXL7;PSME4;PSMD11;PSMA5;PSMA4;RBX1;PSMD14;FBXL2;PSMC6;SKP2;PSMC3;FBXW7;PSMB3;PSMC1;PSMD5;CUL2;PSMA3;PSMD3;PSMD6;PSMC5;FBXO31;PSME2;FBXO17;PSMB4;FBXO38;PSMC4;SKP1;PSMB6;CUL1
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.4137247463825074,0.8825532364612082,0.6264591439688716,0.923135858369297,1.0,5/18,20.78%,NFE2L2;TRAP1;HIF1A;HSPB1;PRKN
prerank,lamellipodium assembly (GO:0030032),0.39002293410400957,0.8825225947466199,0.6189349112426036,0.9227779408172488,1.0,13/26,24.54%,ABLIM2;P2RY12;VCL;PARVB;CYFIP1;PTPRO;ARFIP2;GOLPH3;ITGB1;RHOD;SPATA13;ARHGEF7;SRGAP2
prerank,protein acetylation (GO:0006473),-0.2601043033795386,-0.8819472563153569,0.6805555555555556,0.9061614241378928,1.0,10/30,22.07%,ESCO1;CLOCK;NAT10;HAT1;MAPT;NAA60;ING4;NAA35;SPHK1;KAT2B
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.4071744029538479,0.8817536497957579,0.6361355081555834,0.9237143864178873,1.0,8/19,22.92%,MTOR;CEBPA;ELL;PRDX5;ICE2;RPTOR;ZC3H8;TENM1
prerank,ncRNA transcription (GO:0098781),0.4301367863905102,0.8817363598775506,0.6141732283464567,0.9233406614648428,1.0,3/13,12.43%,GTF3A;RPAP2;SNAPC3
prerank,CENP-A containing nucleosome assembly (GO:0034080),0.38570846364308065,0.8813624212271651,0.6410256410256411,0.9231604181387278,1.0,11/29,23.99%,CENPO;RBBP7;CENPI;CENPQ;CENPK;RSF1;RBBP4;ITGB3BP;SMARCA5;KNL1;CENPT
prerank,CENP-A containing chromatin organization (GO:0061641),0.38570846364308065,0.8813624212271651,0.6410256410256411,0.9231604181387278,1.0,11/29,23.99%,CENPO;RBBP7;CENPI;CENPQ;CENPK;RSF1;RBBP4;ITGB3BP;SMARCA5;KNL1;CENPT
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),0.43548026735169143,0.8811439587413891,0.6178082191780822,0.9231283707800443,1.0,2/13,4.79%,LGMN;AKAP5
prerank,cellular modified amino acid catabolic process (GO:0042219),0.42495133093053833,0.8804206445774511,0.6209150326797386,0.9239671033787117,1.0,1/15,2.36%,ABHD12
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.34547235283379585,0.8802731101430363,0.7462387161484454,0.9238134923422134,1.0,24/159,16.36%,CD84;ITGAL;ITGB2;PCDHB6;CRTAM;SLITRK1;PLXNB2;EMB;TGFBR2;TRO;ATP2C1;ITGAM;CDH8;CDH9;CDH12;NPTN;CDH23;PTPRT;CADM1;KIRREL3;MPZ;DCHS1;CDH19;PCDHGB4
prerank,steroid hormone biosynthetic process (GO:0120178),0.38699286021734197,0.8800891632304454,0.6508670520231213,0.9237418603300785,1.0,8/29,26.31%,TSPO;HSD17B11;FDXR;FDX1;STARD3;HSD17B8;MED1;STARD3NL
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.3611365947810651,0.8800084265002918,0.6706521739130434,0.9234727781251565,1.0,14/49,19.61%,HERPUD1;PYCARD;DDIT3;BCL2L1;TP53;P4HB;BECN1;BMF;NOC2L;SRC;SGMS1;PTPMT1;DNM1L;FIS1
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.4061952513198323,0.879981267743996,0.6160830090791181,0.9231189989097105,1.0,5/18,19.30%,TNF;ATP7A;NOD2;POR;GDNF
prerank,regulation of cell aging (GO:0090342),0.45050166609571957,0.8798673745865413,0.6316526610644257,0.9229068749271574,1.0,1/11,3.66%,NEK6
prerank,positive regulation of glycogen metabolic process (GO:0070875),-0.33140931973389454,-0.8797036591604955,0.6119402985074627,0.909127244819725,1.0,3/13,5.16%,SORBS1;IRS1;EPM2AIP1
prerank,synaptic vesicle exocytosis (GO:0016079),0.37604306327291753,0.8793699097529656,0.6540178571428571,0.9233503398840686,1.0,12/40,21.09%,SNCA;PIP5K1C;STX11;SYT2;SYT10;SNAP29;STX3;SNAP23;DNAJC5;STX2;UNC13A;RIMS1
prerank,cellular response to growth factor stimulus (GO:0071363),0.3420423856138788,0.878884208068066,0.7525150905432596,0.9237559668292407,1.0,27/151,13.62%,TGFB1;LGMN;TGFBR1;DUSP3;DSTYK;MAPK14;ERN1;PRKD2;CD44;MAP2K3;CTNNB1;ANXA1;TGFBR2;MEF2C;SMAD3;ACAP2;BCAR1;STAT5B;RAPGEF1;LIMS1;SOX9;NRP1;CCL2;VSTM2A;TWF2;NR4A1;SOX6
prerank,response to prostaglandin E (GO:0034695),0.44606187581757994,0.8788427774589676,0.6168639053254438,0.9234211754337182,1.0,2/10,14.48%,ADCY6;GNG2
prerank,positive regulation of DNA metabolic process (GO:0051054),0.3481268626136839,0.8777124191741524,0.6815286624203821,0.9250245987586886,1.0,14/61,18.58%,SMOC2;DHX9;RGCC;PRKD2;HMGB1;ATRX;BABAM2;USP7;USP9X;ERCC6;BABAM1;UBE2N;NPAS2;TIGAR
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),-0.3441952378337939,-0.8775798442334374,0.5876623376623377,0.9116198439037176,1.0,2/11,4.70%,CAV1;ACTN2
prerank,cellular response to unfolded protein (GO:0034620),0.38526764560986093,0.8768263206484712,0.6248506571087217,0.9261679171167004,1.0,4/26,9.15%,PTPN1;ERN1;BAK1;HSF1
prerank,negative regulation of protein processing (GO:0010955),0.4310810495884466,0.8766178537305019,0.616551724137931,0.9261266113512342,1.0,4/12,19.16%,CTSZ;THBS1;LRRK2;TMEM59
prerank,positive regulation of axonogenesis (GO:0050772),0.37267178581749255,0.8760718411991117,0.6641137855579868,0.926694449755622,1.0,5/43,6.18%,PLXNC1;SLITRK1;SEMA4D;PLXNB2;MACF1
prerank,spinal cord development (GO:0021510),0.43284706788617916,0.8755206179918307,0.6163101604278075,0.9272550401584938,1.0,6/12,22.81%,PKD2;SOX4;NF1;LOXL3;RELN;ZPR1
prerank,glutathione metabolic process (GO:0006749),0.372593375958958,0.8755013192732322,0.6685456595264938,0.9268795635633243,1.0,2/38,3.21%,GSTT4;HPGDS
prerank,positive regulation of viral process (GO:0048524),0.35283924038607206,0.8739820186463264,0.6867724867724868,0.9290905082959899,1.0,13/60,18.79%,DHX9;PPIE;RAB7A;ADAR;LARP1;MDFIC;VAPB;POLR2L;ADARB1;TARBP2;RSF1;PPIH;POLR2E
prerank,protein glycosylation (GO:0006486),0.34152751685575716,0.8739631560594334,0.7449799196787149,0.9287136578577045,1.0,35/125,20.62%,MGAT5;MAN1C1;GALNT10;TET3;ST8SIA4;NPC1;B4GALT1;GALNT7;OGA;GALNT6;AQP11;ST3GAL1;ALG2;POGLUT1;FUT9;B3GALNT1;ST8SIA1;POMK;DPAGT1;STT3B;B4GALT7;GALNT2;LARGE1;PMM1;MGAT5B;TMEM165;ALG11;MGAT4B;GALNT1;DDOST;TET2;MGAT1;STT3A;COG7;TUSC3
prerank,protein modification by small protein conjugation (GO:0032446),0.3382300870955387,0.8734783087236282,0.861,0.929093149590469,1.0,98/361,23.54%,ARRB2;NFE2L2;CBL;MYLIP;BCL11A;UBE2V2;NUP62;TRIM5;ATG7;MKRN1;CDC23;UBE2D3;OTULIN;MSL2;VPS18;MGRN1;RNF7;HLTF;RNF111;KLHL21;UVSSA;UBE2S;LEO1;KLHL7;SEH1L;VPS11;TRIM27;UBE2E3;PEX13;DERL1;NFX1;NEDD4L;UBE2H;TPR;USP7;TRIM24;RNF40;TRIM35;NUP205;CDC34;DET1;FBXO32;ARRDC4;FBXL3;RNF135;ITCH;UBE2G2;STUB1;HUWE1;UBA2;USP9X;AREL1;UBE2J2;DTX4;RNF152;PIAS1;GAN;SMURF1;HIF1A;ATG3;UBE2N;TRIM62;ZNRF3;ANAPC11;VHL;UBE2Z;UBE2K;KEAP1;DCUN1D5;SPSB2;ELOB;OS9;WWP1;FBXW11;CUL3;LZTR1;PRKN;UBE2R2;NUP54;HERC2;NSMCE2;RRAGA;CDC16;RFWD3;ELOC;UBE2E1;ATG10;TNFAIP1;SPSB1;UBA7;EIPR1;FBXO4;CTR9;RACK1;MYCBP2;NUP85;RNF181;UBE2I
prerank,amino sugar biosynthetic process (GO:0046349),0.4383551528468287,0.8733728201253217,0.6148555708390646,0.9288531264302123,1.0,2/12,5.93%,RENBP;NAGK
prerank,dicarboxylic acid catabolic process (GO:0043649),0.42806312547548336,0.873343386222821,0.624484181568088,0.9285024566771587,1.0,1/13,2.77%,MTHFS
prerank,regulation of necroptotic process (GO:0060544),0.40371809310229545,0.8731875239837366,0.6618181818181819,0.928347241481285,1.0,11/23,20.84%,FZD9;CFLAR;SDCBP;CASP8;STUB1;PDCD6IP;HSP90AA1;ARHGEF2;BIRC2;FLOT1;BIRC3
prerank,regulation of mRNA processing (GO:0050684),0.38394514488674447,0.8723662628135747,0.6754285714285714,0.9292966198666354,1.0,15/32,25.80%,DHX9;RBM39;CDK11B;SRPK3;SON;SAFB2;PABPN1;SRSF10;SRSF3;ZFP36L1;IWS1;NCBP1;HNRNPK;CPSF4;JMJD6
prerank,morphogenesis of an epithelium (GO:0002009),0.3842006569533013,0.8720624793506032,0.6404761904761904,0.9293921987098005,1.0,6/25,15.67%,ACTB;ACTG1;VCL;SOX9;AHI1;LAMA3
prerank,mitotic metaphase plate congression (GO:0007080),0.3603060604846532,0.8719317023909351,0.6855277475516867,0.929213500855635,1.0,10/51,17.53%,NUP62;CDC23;SEH1L;KIF14;RAB11A;BECN1;RRS1;PDCD6IP;EML4;MIS12
prerank,regulation of establishment of planar polarity (GO:0090175),0.3436322793294803,0.8717228276143554,0.7051546391752578,0.9291782654272717,1.0,22/88,20.28%,ARRB2;FZD3;PSMB10;AP2S1;DAAM1;PSMA2;PFN1;CLTC;PSME3;PSMB5;PSMD8;AP2M1;PSMD7;PSMB9;VANGL1;SMURF1;RHOA;PSMD2;CDC42;DACT1;ARHGEF19;FZD2
prerank,membrane lipid biosynthetic process (GO:0046467),0.35263778373044763,0.8702971980281473,0.7018104366347178,0.9312147256680617,1.0,7/58,9.81%,CERS6;SGPL1;PRKD2;CSNK1G2;HACD4;ACER3;VAPB
prerank,gene expression (GO:0010467),0.33468866607254427,0.8702183692781322,0.846,0.9309361346696432,1.0,125/348,26.37%,APOBEC1;RPL23;RPL17;NUP62;RPL10A;RBM39;RPS2;DHX38;RRBP1;NXF1;THOC2;RPL18A;FARSB;MRPL41;MEF2A;TSPAN32;RPS15A;GSPT1;TFIP11;SEH1L;CASC3;EIF4EBP2;TSPAN14;RBM15B;ADAR;MMS19;MRPL51;SMG1;RPL6;HNRNPL;TPR;DDX39B;RPLP2;RPL26;RPS20;RNASEL;POLR2L;RPS16;NUP205;RPS14;SORL1;ADARB1;DARS1;STUB1;RPL19;POLDIP3;GALNT2;UPF3B;THOC3;HNRNPD;ALKBH5;IGF2BP3;RPL9;NUFIP1;RPS11;RPL11;SMG7;RPS23;RPS4X;MRPS21;UPF2;RPS27;AGO2;RPL4;MRPS14;PABPC4;CREBL2;TESC;SLU7;FYTTD1;GOLPH3;MRPL3;POLR2E;RBMS2;FUBP3;HNRNPF;SRSF6;SRSF2;SEC13;PABPN1;RPL7A;RPL15;HHEX;MRPL10;RPL29;SLBP;SRSF3;RPL22;NUP54;RPS7;RPS13;SARS1;TASP1;RPLP1;POLR3A;NUP85;RPS15;MRPL18;ATXN1;MRPL52;RPS5;NUP155;RPL41;PAX8;PWP1;DDX20;XRN2;DROSHA;RPL10;MRPL37;NCBP1;XAB2;MRPS12;ABCF1;HNRNPK;RPS8;RPL5;RPL18;CPSF4;EEF1A1;MCM3AP;RPL28;PTMA;MRPS15;NOVA1
prerank,mucosal immune response (GO:0002385),0.4181552143254348,0.8697977205661868,0.6293800539083558,0.9312490469911137,1.0,2/15,12.31%,FFAR2;DEFA6
prerank,nuclear envelope organization (GO:0006998),-0.28512165032151804,-0.869698346123689,0.6551724137931034,0.9275203818649153,1.0,5/20,16.33%,NUP93;VPS4A;CTDNEP1;EMD;TMEM43
prerank,regulation of protein targeting to membrane (GO:0090313),0.38141050311937896,0.8696324805622916,0.6384976525821596,0.9311155286812574,1.0,8/28,22.07%,ITGB2;ITGAM;FYN;CEMIP;MYO1C;FIS1;INPP5K;CHP1
prerank,regulation of cellular component biogenesis (GO:0044087),0.368756600608753,0.8695366782038062,0.6674082313681868,0.9308775620599574,1.0,14/39,19.65%,APOE;TRAF2;RAP1B;VPS11;GFAP;RAPGEF1;HCFC1;RAP1A;SPTY2D1;CD36;IRGM;HSP90AA1;PARP10;ROCK2
prerank,regulation of RNA splicing (GO:0043484),0.35041568036094156,0.869283253296955,0.680672268907563,0.9308988670582757,1.0,13/69,13.39%,RBM38;ERN1;ZNF326;RBM39;GRSF1;METTL4;HNRNPL;SON;PTBP2;TRA2B;PRX;BRDT;FAM50A
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.38532728348620165,0.8691411883565666,0.6459554513481829,0.9307228144700561,1.0,7/26,18.43%,GCNT1;ALG2;LARGE1;RRM2B;GK;ALG11;GOLPH3
prerank,negative regulation of axon extension (GO:0030517),-0.2513696285309639,-0.8691234545697306,0.6842105263157895,0.9265750577955045,1.0,6/30,8.55%,SEMA6A;SEMA5A;SEMA3A;SEMA6D;SEMA3C;SEMA3D
prerank,ether lipid biosynthetic process (GO:0008611),0.44354698235678003,0.8689409960114098,0.6295264623955432,0.9306915078865141,1.0,3/10,11.58%,LPCAT2;DHRS7B;PEX7
prerank,cellular response to leucine starvation (GO:1990253),0.4484538578796036,0.8685944863703555,0.6273653566229985,0.9308721166176055,1.0,4/10,21.78%,MTOR;IMPACT;GCN1;RRAGB
prerank,cellular amide metabolic process (GO:0043603),0.34540770028006873,0.8684977025252102,0.7376387487386479,0.9306285304669558,1.0,21/102,17.81%,DBI;SGPL1;MTHFS;CLN8;SMPD3;CERK;ST3GAL1;ACSF2;ABHD4;NLN;MCCC2;DNPEP;ORMDL2;PPP2CA;NSMAF;PDZD11;ACOT9;PLAAT3;FPGS;ACOT2;PCCA
prerank,purine ribonucleotide catabolic process (GO:0009154),0.39950077503558956,0.8684842800974587,0.6388206388206388,0.9302487740003641,1.0,4/21,8.29%,XDH;NUDT4;HINT1;PNP
prerank,regulation of protein autophosphorylation (GO:0031952),0.3697647530874296,0.8681703298504532,0.6611111111111111,0.9303678608272176,1.0,2/36,3.44%,GPNMB;RAP2A
prerank,aspartate family amino acid catabolic process (GO:0009068),0.40232836420183976,0.8674375330952283,0.6472049689440994,0.9312171457066287,1.0,3/19,12.95%,CRYM;OGDH;ALDH7A1
prerank,cell-cell junction assembly (GO:0007043),0.35025818167756406,0.8674021681893807,0.6946808510638298,0.9308727920275286,1.0,13/63,12.04%,CD9;PKP2;PIP5K1C;CTNNB1;ACTB;GJB6;FLCN;ACTG1;CDH8;VCL;CDH9;CDH12;TLN1
prerank,protein modification by small protein removal (GO:0070646),0.3326606028372886,0.8673214804498176,0.809,0.9306137166381062,1.0,61/252,20.84%,ARRB2;COPS6;OTULINL;TGFBR1;ATXN7;TRAF2;USP35;TNFAIP3;TRAF3;ATXN3;OTUD3;ACTB;TP53;PSMB10;STAMBPL1;YY1;ASXL2;SMAD3;BABAM2;MCRS1;USP7;PSMA2;USP48;USP31;BECN1;USP18;PSME3;IKBKG;COPS4;FOXK1;TOR1A;HCFC1;PSMB5;INO80;USP9X;MBD5;PSMD8;USP8;JOSD2;USP29;PSMD7;PSMB9;USP21;USP16;HIF1A;BABAM1;PTEN;IL33;RHOA;PSMD2;KEAP1;BIRC2;DESI1;DESI2;TOMM20;SENP6;RAD23B;STAM2;SENP7;PRKN;BIRC3
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.44563695262240877,0.8671881685041887,0.6448736998514116,0.9304473689968209,1.0,3/10,17.93%,RAP2A;RHOA;CDC42
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.3940983356223151,0.8670656303431078,0.6489226869455006,0.9298662747526606,1.0,7/22,21.36%,ZDHHC14;ZDHHC7;ZDHHC3;ZDHHC1;ZDHHC24;ZDHHC21;ZDHHC2
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.3940983356223151,0.8670656303431078,0.6489226869455006,0.9298662747526606,1.0,7/22,21.36%,ZDHHC14;ZDHHC7;ZDHHC3;ZDHHC1;ZDHHC24;ZDHHC21;ZDHHC2
prerank,ganglioside biosynthetic process (GO:0001574),0.42203012506843385,0.8663540836537365,0.6455368693402329,0.9306385096346292,1.0,3/15,8.51%,ST8SIA4;ST6GALNAC4;ST3GAL1
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.43603081730720705,0.8662687701067981,0.6418732782369146,0.9303703290966094,1.0,6/11,21.25%,SH2B3;NF2;ADIPOR1;PTPRT;VHL;SOCS3
prerank,positive regulation of actin nucleation (GO:0051127),-0.3458815266231809,-0.865380785972986,0.6288659793814433,0.932606661747636,1.0,3/11,5.31%,GSN;BRK1;WHAMM
prerank,positive regulation of viral transcription (GO:0050434),0.3859901787085381,0.8653528046319162,0.6547911547911548,0.9315095590388088,1.0,5/25,18.79%,DHX9;MDFIC;POLR2L;RSF1;POLR2E
prerank,chromatin remodeling at centromere (GO:0031055),0.37514181181581974,0.8652291281757948,0.6655132641291811,0.9313099876232959,1.0,11/31,23.99%,CENPO;RBBP7;CENPI;CENPQ;CENPK;RSF1;RBBP4;ITGB3BP;SMARCA5;KNL1;CENPT
prerank,cellular response to ionizing radiation (GO:0071479),0.3605304647440857,0.8651657423153903,0.6803900325027086,0.9310272330044642,1.0,7/47,10.47%,GRB2;MAPK14;TANK;XRCC5;TP53;HSF1;RPL26
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.3564364535253787,0.8645168836443607,0.6716899892357373,0.931747218048534,1.0,13/44,21.97%,KCNN4;KCNIP2;KCNMA1;WNK1;NOS1AP;ATP1B3;ATP1B2;GNG2;WNK4;AKAP9;KCNJ2;KCNJ10;FLNA
prerank,negative regulation of smoothened signaling pathway (GO:0045879),-0.26904773707825064,-0.8643555826814998,0.6184971098265896,0.9325493055638444,1.0,12/23,27.12%,GLIS2;GLI3;HHIP;GPC3;KCTD21;GPR161;PTCH1;KIF7;RFX4;IFT122;ULK3;PTCH2
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),-0.21279286044089427,-0.8641646796882514,0.7627118644067796,0.9306849416619298,1.0,18/57,18.75%,RINT1;ATF2;RAD17;TAOK2;TIPIN;TOPBP1;TRIM39;MRE11;WAC;ATM;STK33;NOP53;MRNIP;SDE2;PRKDC;FBXO31;CDK2;HMGA2
prerank,cardiac muscle cell membrane repolarization (GO:0099622),-0.34552745521146,-0.8634714224991947,0.6041666666666666,0.9298923065300272,1.0,3/11,10.54%,ATP1B1;KCND3;KCNJ3
prerank,regulation of response to oxidative stress (GO:1902882),0.44007724529498304,0.8634503030797834,0.6312925170068027,0.933091652176878,1.0,2/11,7.24%,MCTP1;ABCD1
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),-0.3361058456854048,-0.8632474131455753,0.6475409836065574,0.9280439069452069,1.0,7/13,24.79%,PRPF3;PRPF19;LSM2;PRPF6;CD2BP2;SRSF12;PRPF31
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.4147182048097581,0.8631449202546934,0.6444444444444445,0.9331870949245487,1.0,3/16,8.26%,BCL2L1;SNAI1;TPT1
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.401899507922909,0.8629971080514242,0.6379084967320261,0.9330137872656278,1.0,5/18,17.24%,SLC43A2;EPO;NEDD4L;SLC43A1;BIN1
prerank,maintenance of protein localization in organelle (GO:0072595),-0.290596985879559,-0.8628781737560822,0.6591928251121076,0.9265294802336698,1.0,10/19,21.39%,PML;HK1;BBS4;TOPORS;PINK1;HNRNPU;AKT1;SUPT7L;BCL3;SKP1
prerank,regulation of actomyosin structure organization (GO:0110020),0.4304286775721897,0.8626388156405396,0.6605113636363636,0.9331746602319275,1.0,5/13,19.65%,FHOD1;SLC9A1;ACTG1;CDC42;ROCK2
prerank,smoothened signaling pathway (GO:0007224),0.36844650602957507,0.8624427655688335,0.6693548387096774,0.9330864163933051,1.0,2/32,7.36%,SHH;PTCHD1
prerank,histone H4-K16 acetylation (GO:0043984),0.40242133812718406,0.8624176409613012,0.6695979899497487,0.932721971008244,1.0,8/19,21.53%,MSL2;MCRS1;KAT7;HCFC1;JADE2;MEAF6;MSL1;PHF20
prerank,magnesium ion transport (GO:0015693),-0.3252580291614133,-0.8621352921284078,0.6485507246376812,0.9258726746690764,1.0,5/12,19.16%,SLC41A1;NIPA2;NIPAL2;MRS2;CNNM4
prerank,axonemal dynein complex assembly (GO:0070286),0.38734517517221667,0.8612973245033635,0.6682577565632458,0.9341818118729867,1.0,4/27,13.03%,DNAI4;ODAD2;ODAD1;CCDC63
prerank,positive regulation of cytokinesis (GO:0032467),0.3723249435527886,0.8611592705994116,0.6705882352941176,0.9340031490733117,1.0,8/32,20.57%,KIF14;KIF20B;KIF23;CDC6;RHOA;GIPC1;CDC42;CUL3
prerank,motile cilium assembly (GO:0044458),-0.32979091745420264,-0.8609769080231118,0.6690909090909091,0.9261365056507617,1.0,4/12,17.61%,BBOF1;BBS5;CCDC39;E2F4
prerank,embryonic heart tube morphogenesis (GO:0003143),0.36061941594703356,0.8609267359821836,0.6875,0.9339893096483741,1.0,4/43,8.10%,SHH;PKD2;TGFBR2;MEF2C
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.33293402950630974,0.8608732944330456,0.825,0.9336767331098217,1.0,48/248,15.72%,DRAXIN;TGFB1;TMEM131L;GPRC5B;MAD2L2;GNAQ;ZEB2;MDK;TLE3;CDK14;DKK2;APOE;OTULIN;TPBGL;DDIT3;LGR6;FZD9;CTNNB1;PSMB10;TBL1XR1;WNK1;CSNK1G2;GID8;SCYL2;ATP6AP2;AMER1;TBL1X;PSMA2;SOX9;PTPRU;PTPRO;CSNK1A1;TNKS2;PSME3;BAMBI;NFKB1;STK3;PSMB5;SOX2;PSMD8;LRRK2;SOX4;USP8;TLE5;PSMD7;PSMB9;GSK3A;LGR4
prerank,regulation of heart rate by cardiac conduction (GO:0086091),0.35750526071540245,0.8601206651735602,0.6617812852311161,0.9345390584307505,1.0,9/38,17.71%,SCN4B;HCN4;PKP2;CACNB2;KCNA5;CACNA1D;BIN1;SCN5A;AKAP9
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.38848061514132415,0.8598482827558751,0.6630565583634176,0.9345995193838995,1.0,3/26,5.09%,NLRC3;TRAFD1;TNFAIP3
prerank,positive regulation of synapse assembly (GO:0051965),0.38271046547957005,0.8594148871747798,0.6466431095406361,0.9349212723700705,1.0,4/27,10.79%,CLSTN1;SEMA4D;AGRN;SEMA4A
prerank,protein auto-ADP-ribosylation (GO:0070213),0.4229581110575167,0.8591904309509403,0.63268156424581,0.934890768990402,1.0,7/12,23.59%,PARP8;PARP16;TNKS2;TIPARP;PARP10;PARP3;PARP1
prerank,oxoacid metabolic process (GO:0043436),0.38055242489106045,0.8583695758568356,0.6607565011820331,0.9358215467464116,1.0,4/27,11.84%,SULT4A1;BPNT1;PPA2;TPST1
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.33157046733347467,0.8582745766181924,0.7740628166160081,0.9355868949047996,1.0,27/138,18.84%,MED17;GTF2H1;MAML3;RXRB;NR1H4;HDAC5;TAF1;TEAD1;TBL1XR1;PPARGC1A;CDK7;TBL1X;MED27;POLR2L;TAF8;NR2C2;HDAC9;NR4A1;NR2C1;TAF3;RBPJ;GTF2B;PPARD;GTF2H5;RXRA;POLR2E;TAF11
prerank,protein secretion (GO:0009306),0.3489090735032678,0.8582232392872873,0.6856223175965666,0.9352785311923628,1.0,11/56,18.77%,RAB8B;ABCA1;SEL1L;ANXA1;PPY;SNX19;STEAP3;SVBP;MON1A;GOLPH3;LTBP2
prerank,response to unfolded protein (GO:0006986),0.35087218515140206,0.8579347518008796,0.6876355748373102,0.9353481946398405,1.0,13/48,20.78%,PTPN1;ERN1;HERPUD1;DDIT3;BAK1;HSF1;DERL1;STT3B;HSP90AA1;ERP44;OPTN;HSPB1;PRKN
prerank,cellular response to acid chemical (GO:0071229),0.38044327162426533,0.8579062492691782,0.6585081585081585,0.9349887663377904,1.0,12/27,25.40%,MTOR;CPEB3;GLRA2;LAMTOR3;CAPN2;CPEB4;LAMTOR1;RPTOR;RRAGA;RRAGB;VEGFA;XBP1
prerank,tetrahydrofolate metabolic process (GO:0046653),0.4457270608593773,0.8576528384415552,0.6426426426426426,0.9349978578729796,1.0,1/10,2.77%,MTHFS
prerank,DNA alkylation (GO:0006305),0.4027885411439271,0.8575055596244443,0.677461139896373,0.9344409043709482,1.0,3/19,9.69%,DNMT3A;ATRX;ATF7IP
prerank,DNA methylation or demethylation (GO:0044728),0.4027885411439271,0.8575055596244443,0.677461139896373,0.9344409043709482,1.0,3/19,9.69%,DNMT3A;ATRX;ATF7IP
prerank,glucan biosynthetic process (GO:0009250),0.4309641423131675,0.8574621596815708,0.6462196861626248,0.9337081304684992,1.0,2/12,9.01%,GYG1;GBE1
prerank,glycogen biosynthetic process (GO:0005978),0.4309641423131675,0.8574621596815708,0.6462196861626248,0.9337081304684992,1.0,2/12,9.01%,GYG1;GBE1
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.37275443873687497,0.8571557459095824,0.6768361581920904,0.9338304327644064,1.0,8/34,12.99%,MAPK14;ERN1;PRKD2;MAP2K3;ANXA1;VEGFB;NRP1;NR4A1
prerank,histone mRNA catabolic process (GO:0071044),-0.29116464308863266,-0.8564664749938108,0.6708860759493671,0.9336398356274799,1.0,5/15,14.46%,SSB;ERI1;ATM;UPF1;TUT1
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.35950176633548864,0.8563523910184285,0.6722037652270211,0.9347134631204143,1.0,5/40,9.29%,PRKCD;UBE2V2;UBE2V1;POLH;SMG1
prerank,negative regulation of epithelial cell differentiation (GO:0030857),-0.3093113347605851,-0.856193999538527,0.6551724137931034,0.9319884351861115,1.0,4/14,16.40%,CAV1;SPRED2;SPRY2;NOTCH4
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.329725675629367,0.8561862209515266,0.7857142857142857,0.9345785165602485,1.0,32/166,19.17%,MED17;GTF2H1;TAF1A;MAML3;POLR1E;RXRB;NR1H4;HDAC5;TAF1;TEAD1;TBL1XR1;PPARGC1A;CDK7;TBL1X;MED27;POLR1B;POLR2L;TAF8;NR2C2;HDAC9;NR4A1;NR2C1;TAF3;RBPJ;GTF2B;PPARD;RSF1;GTF2H5;RXRA;POLR2E;TAF11;CRCP
prerank,lung development (GO:0030324),0.36551810125682993,0.8559353904262348,0.6674364896073903,0.9346043921015561,1.0,3/33,6.82%,SHH;CEBPA;NKX2-1
prerank,heart trabecula morphogenesis (GO:0061384),-0.284808301556196,-0.8558336960770854,0.6636771300448431,0.9304485000278512,1.0,8/18,20.15%,BMPR1A;ADGRG6;TGFBR3;BMP5;FKBP1A;S1PR1;TEK;RBP4
prerank,clathrin coat assembly (GO:0048268),0.4147503938911344,0.8555815453810711,0.6747638326585695,0.9347825674872021,1.0,5/15,19.79%,AP2S1;CLTC;EPS15;PICALM;FCHO2
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.35416449506482806,0.8550706314288825,0.703862660944206,0.9352318533223042,1.0,12/52,15.73%,SREBF2;MICALL2;UBE2D3;YWHAB;TP53;VPS11;CSNK2A2;CASP8;HUWE1;UBE2J2;GSK3A;YWHAH
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.33575040769709336,0.8547405624506501,0.8106212424849699,0.9353724360013609,1.0,51/173,20.57%,F10;SPTBN5;LMAN1L;CTSC;TMED3;KDELR2;CAPZB;CAPZA1;ACTR10;MCFD2;CTSZ;PDCD6;PGAP1;VAPB;RAB1B;COG6;COPA;YKT6;DCTN5;SEC24D;SEC16A;DYNC1H1;F5;SEC16B;STX5;SAR1A;TRAPPC6A;GAS6;TRAPPC11;VTI1A;GRIA1;LMAN2;ANK1;USE1;SPTBN4;DCTN6;ERGIC1;GOLGB1;TRAPPC2L;ATL2;COG5;RAB29;SEC13;ATL3;TRAPPC12;SEC22B;SEC31A;USO1;ARCN1;CUL3;COG7
prerank,retinoic acid receptor signaling pathway (GO:0048384),0.44464425953219067,0.8547021981802194,0.6366322008862629,0.9350534571912414,1.0,2/10,6.77%,RXRB;ACTN4
prerank,glycerol metabolic process (GO:0006071),0.4450011025908218,0.8543907030201973,0.6661764705882353,0.9351638457920172,1.0,3/10,19.85%,ANGPTL3;GK;COQ3
prerank,mammary gland epithelium development (GO:0061180),0.41442487337913625,0.8543248173261435,0.6759776536312849,0.934870560317586,1.0,1/14,2.01%,CSF1R
prerank,acylglycerol biosynthetic process (GO:0046463),0.39026499822501687,0.8542724845282396,0.6506765067650676,0.9345661731305706,1.0,7/23,20.90%,LPIN2;AGMO;GK;PNPLA3;DGAT2;MOGAT1;LPIN1
prerank,protein targeting to mitochondrion (GO:0006626),0.35429118236637336,0.8535361102510423,0.7211538461538461,0.9353460709844439,1.0,18/52,23.68%,TSPO;AIP;CHCHD4;TIMM22;AGK;IMMP2L;TIMM50;TOMM40;PMPCB;HSP90AA1;PITRM1;TOMM20;FIS1;PMPCA;DNAJC15;TIMM29;TIMM8B;HSPA4
prerank,calcineurin-NFAT signaling cascade (GO:0033173),0.42575700371993735,0.8528534506114797,0.6389301634472511,0.9356550809581186,1.0,1/10,2.16%,NFATC1
prerank,calcineurin-mediated signaling (GO:0097720),0.42575700371993735,0.8528534506114797,0.6389301634472511,0.9356550809581186,1.0,1/10,2.16%,NFATC1
prerank,regulation of mRNA catabolic process (GO:0061013),0.3308443469122271,0.8525479311411952,0.7555555555555555,0.935744447798402,1.0,22/121,15.62%,PCID2;PRKCD;CNOT8;EXOSC1;XPO1;ANP32A;YWHAB;PSMB10;GTPBP1;YTHDF3;RC3H2;MOV10;RC3H1;PUM2;PSMA2;PSME3;PSMB5;HNRNPD;PSMD8;IGF2BP3;PSMD7;PSMB9
prerank,apoptotic DNA fragmentation (GO:0006309),0.40038340890826596,0.852464404196179,0.6332046332046332,0.935481288036486,1.0,9/16,29.29%,HMGB1;KPNA1;DICER1;DNASE2;DFFB;CECR2;KPNB1;HMGB2;DFFA
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.3920437226532423,0.8523881770200734,0.6625310173697271,0.9352187871472218,1.0,9/21,23.21%,ABCD1;TRAP1;HDAC6;ABCD2;PRKN;SIRT5;MT3;AATF;SLC30A10
prerank,regulation of lamellipodium organization (GO:1902743),0.4139101244290021,0.8519938657203366,0.6518817204301075,0.9354779894249738,1.0,4/14,17.93%,CD44;CAPZB;TWF2;CDC42
prerank,regulation of gastrulation (GO:0010470),-0.3082074610786274,-0.8519409840938397,0.6470588235294118,0.9367692670767697,1.0,2/14,6.23%,PHLDB2;PHLDB1
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.4487573188536966,0.851707561906302,0.6769662921348315,0.9355442190509593,1.0,5/10,19.95%,PRKCB;PID1;GSK3A;APPL2;INPP5K
prerank,female gamete generation (GO:0007292),0.3729710741742067,0.8514698665465743,0.6604651162790698,0.9355338459973163,1.0,6/29,17.07%,MDK;TRIP13;METTL3;MCM9;USP9X;MARF1
prerank,response to hydroxyurea (GO:0072710),0.4305061215308855,0.8510541552123716,0.6460431654676259,0.9358195391097256,1.0,3/11,12.86%,DDI2;ATRX;KAT7
prerank,homologous chromosome segregation (GO:0045143),0.39004359277949785,0.850520166699301,0.6687657430730478,0.9363092310794201,1.0,1/20,2.80%,PTTG1
prerank,protein methylation (GO:0006479),-0.21991480220364962,-0.850191848665869,0.8314606741573034,0.9382948812935695,1.0,21/40,32.91%,RAB6A;SETD3;FAM98B;SNRPD3;ATPSCKMT;EZH2;PCMT1;PRMT8;PRMT1;EEF2KMT;LCMT1;METTL22;PRMT7;EEF1AKMT2;N6AMT1;CAMKMT;ICMT;NTMT1;VCPKMT;EHMT1;TRMT112
prerank,sodium ion export across plasma membrane (GO:0036376),0.42122428559121866,0.8499810610537726,0.673972602739726,0.9368141457654625,1.0,3/13,13.76%,SLC9A1;ATP1B3;ATP1B2
prerank,cGMP metabolic process (GO:0046068),0.4179850620993433,0.8494441456500662,0.6471408647140865,0.9372734776282045,1.0,2/12,10.24%,GUCY2F;NPR2
prerank,sequestering of extracellular ligand from receptor (GO:0035581),0.4202877357898537,0.8493240952611133,0.6718528995756718,0.9370501672708375,1.0,1/13,1.25%,NRROS
prerank,sulfur compound biosynthetic process (GO:0044272),0.3351884174602934,0.8492719619016248,0.7530487804878049,0.936730737706002,1.0,25/104,21.76%,PRELP;ESD;AKR1A1;HPGDS;SLC35B3;B4GALT1;CHSY3;FMOD;ST3GAL1;BCAN;GGTA1;PAPSS1;CHSY1;CHST15;MGST1;CBS;GSTM2;ANGPT1;CHPF;CSPG4;CNDP2;SLC10A7;B4GALT6;B4GALT2;GCLM
prerank,protein K63-linked deubiquitination (GO:0070536),0.36477437539544383,0.8488958989049785,0.6785714285714286,0.9369145967350678,1.0,8/31,16.40%,TNFAIP3;ATXN3;STAMBPL1;BABAM2;USP7;USP8;USP16;BABAM1
prerank,protein O-linked glycosylation (GO:0006493),0.33653832312541626,0.8483192700957078,0.7703252032520326,0.9374693366113107,1.0,19/96,16.63%,SDF2L1;GCNT1;GALNT10;TET3;MUC13;GALNT15;GALNT7;OGA;ST6GALNAC4;GALNT6;POGLUT2;ST3GAL1;POGLUT1;TMTC4;POMK;GALNT2;LARGE1;MGAT5B;GALNTL6
prerank,regulation of embryonic development (GO:0045995),-0.22733541989685552,-0.8479051923152894,0.7318840579710145,0.9409434684159556,1.0,10/34,20.42%,PHLDB2;NIPBL;PHLDB1;TDG;NPHP3;ZBED3;SOX17;DHX36;RBM19;RPS6KA6
prerank,DNA replication checkpoint signaling (GO:0000076),-0.30002321005543764,-0.8475356222450909,0.6708860759493671,0.939441481435571,1.0,4/16,12.86%,RAD17;TIPIN;TOPBP1;NAE1
prerank,necroptotic process (GO:0070266),0.40229131007637864,0.8474510318398212,0.6726804123711341,0.9384703097988384,1.0,3/16,8.92%,CD14;TICAM1;LY96
prerank,centromere complex assembly (GO:0034508),0.3589562452518251,0.8469867760561431,0.6985376827896513,0.9388238381911023,1.0,12/36,23.99%,CENPO;RBBP7;CENPI;CENPQ;CENPK;RSF1;MIS12;RBBP4;ITGB3BP;SMARCA5;KNL1;CENPT
prerank,regulation of actin nucleation (GO:0051125),0.41934516461340365,0.8468938181295314,0.6566523605150214,0.9385783608695921,1.0,1/12,1.76%,CORO1A
prerank,regulation of telomere maintenance (GO:0032204),0.37065155059115046,0.8468796772380883,0.6533018867924528,0.9382032739410391,1.0,10/26,22.86%,XRCC5;SMG1;ATRX;USP7;HNRNPD;ERCC1;TINF2;TERF2;ERCC4;TERF2IP
prerank,regulation of DNA damage checkpoint (GO:2000001),-0.34395641230089713,-0.8464686207612585,0.6375,0.9394077267260068,1.0,4/10,11.86%,THOC1;THOC5;WDR76;CCAR2
prerank,telomere organization (GO:0032200),0.35121649671005467,0.8462920161854623,0.6817679558011049,0.9387281860915689,1.0,16/43,24.86%,PTGES3;XRCC5;DOT1L;STN1;DNA2;POLD3;TINF2;RAD51D;TERF2;PARP3;ERCC4;H3-3A;TERF2IP;PARP1;ATR;RPA1
prerank,nervous system development (GO:0007399),0.32534112358290396,0.8459093405305875,0.901,0.9389391966215441,1.0,63/429,16.24%,PCDHA6;ASCL1;SHH;TGFB1;PCSK9;PCDHB6;TGFBR1;DAGLB;MYLIP;EDNRB;S100B;FGF13;ZEB2;MDK;NAV2;SLITRK1;PRDM12;CLN8;SREBF2;PKD2;ST8SIA4;CXCR4;NRGN;MYT1L;NDP;FZD9;APAF1;TEAD1;CHD7;ATXN3;APBA1;MEF2C;BPNT1;NTF3;BCAN;HDAC4;EIF2B2;INHBA;ARTN;CHERP;NELL1;SNTG2;NR2C2;PRX;UTP11;ITM2B;NRG1;NAV1;MERTK;NINJ1;SH3GL3;SOX6;MBD5;EFNB3;KIRREL3;IGF2BP3;MPZ;AHI1;ERCC6;DPYSL5;MTR;NF1;DCHS1
prerank,positive regulation by host of viral transcription (GO:0043923),-0.30486859744376094,-0.8455743958484756,0.6680497925311203,0.9388480374819286,1.0,4/15,12.89%,SMARCA4;NUCKS1;CCNT1;SNW1
prerank,endothelial cell proliferation (GO:0001935),0.39599786877393517,0.845460416140628,0.6658031088082902,0.9392511584314834,1.0,2/17,3.63%,ANGPT4;ERN1
prerank,nerve growth factor signaling pathway (GO:0038180),0.43149537808102967,0.8442784236598675,0.6720351390922401,0.9407106641327058,1.0,4/10,19.06%,NTF3;RAPGEF1;RAP1A;KIDINS220
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.3647547845610229,0.8442186464569656,0.6790697674418604,0.9404131951886412,1.0,10/32,22.81%,CDK14;BACH1;CDK17;RB1;CDC6;CDK15;CDK18;CDC45;NPAT;ZPR1
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.4115403148136597,0.8439066626249818,0.657030223390276,0.9405316361968822,1.0,6/14,22.07%,ACTN4;WNK1;SLC9A1;WNK4;TESC;CHP1
prerank,protein deubiquitination (GO:0016579),0.3241379854037966,0.8437825968671028,0.855,0.9403341573168165,1.0,51/242,18.28%,ARRB2;OTULINL;TGFBR1;ATXN7;OTULIN;TRAF2;USP35;TNFAIP3;TRAF3;ATXN3;OTUD3;ACTB;TP53;PSMB10;STAMBPL1;YY1;ASXL2;SMAD3;BABAM2;MCRS1;USP7;PSMA2;USP48;USP31;BECN1;USP18;PSME3;IKBKG;FOXK1;MINDY1;HCFC1;PSMB5;INO80;USP9X;MBD5;PSMD8;USP8;JOSD2;USP29;PSMD7;PSMB9;USP21;USP16;HIF1A;BABAM1;PTEN;IL33;RHOA;PSMD2;KEAP1;BIRC2
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.33421488433813484,0.8437165990474325,0.7711340206185567,0.9400467096301697,1.0,16/87,16.50%,GPNMB;GPR132;RGCC;PKD2;PSMB10;RB1;PSMA2;CCL2;CDK6;PSME3;PSMB5;BRD7;PSMD8;PSMD7;PSMB9;PTEN
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.386448094475769,0.8431790078518354,0.6645962732919255,0.9405147659938388,1.0,6/20,20.78%,TGFBR1;ITCH;HIF1A;HSP90AA1;DCUN1D5;PRKN
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.3339008812525381,0.8429662170179669,0.770854271356784,0.9404674979046403,1.0,26/125,19.42%,ERCC6L;CENPO;ESPL1;NEK6;BCCIP;XPO1;MAPRE1;SEH1L;PLK2;SETD2;DYNC1H1;PMF1;CENPI;KIF2A;PPP1CC;INTS13;CENPQ;PTPA;INCENP;EML4;CENPK;MIS12;RPS27;DCTN6;TAOK1;SEC13
prerank,negative regulation of metabolic process (GO:0009892),0.34789888457648205,0.8428987631390725,0.706951871657754,0.9401794948164766,1.0,7/54,8.46%,PLCL2;TLE3;MAP2K6;DDIT3;ZDHHC7;FLCN;RB1
prerank,antibacterial humoral response (GO:0019731),0.40543174123599535,0.8428920688195557,0.6731266149870802,0.9397909863344737,1.0,5/16,26.04%,DMBT1;DEFA6;RNASE6;PLA2G6;RNASE3
prerank,negative regulation of small molecule metabolic process (GO:0062014),-0.2847709883577046,-0.8427139073778336,0.677570093457944,0.9425489093523786,1.0,5/20,16.58%,WNT4;NCOR1;SIK1;C1QTNF3;BCKDK
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.3676664414657955,0.8417956729352252,0.6781065088757396,0.9411289881789769,1.0,9/29,20.34%,UTP20;RPS16;NOP9;HEATR1;RPS14;RRS1;TSR1;NGDN;UTP3
prerank,establishment of apical/basal cell polarity (GO:0035089),0.40850799430434787,0.8417717704954053,0.651595744680851,0.9407666484913697,1.0,4/14,19.32%,RAP2A;RHOA;CDC42;SCRIB
prerank,epithelial structure maintenance (GO:0010669),0.4293897717514141,0.8415598789787846,0.6398243045387995,0.9407021738138321,1.0,3/11,20.89%,MUC13;NOD2;STRAP
prerank,neuromuscular process (GO:0050905),0.40915034530357786,0.8413272384842253,0.6767015706806283,0.9406794458645475,1.0,2/16,4.53%,GCH1;CLN3
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.3746955618280292,0.8413251187729611,0.6637824474660075,0.9402876747072406,1.0,2/23,8.71%,TGFB1;SMAD3
prerank,regulation of DNA recombination at telomere (GO:0072695),0.3854916051433125,0.841084958510683,0.6700379266750948,0.9398614201393836,1.0,6/19,22.86%,ATRX;POLR2L;POLR2E;TINF2;TERF2;TERF2IP
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.3854916051433125,0.841084958510683,0.6700379266750948,0.9398614201393836,1.0,6/19,22.86%,ATRX;POLR2L;POLR2E;TINF2;TERF2;TERF2IP
prerank,neuron projection extension (GO:1990138),0.36280783299218833,0.8406763853341214,0.7068366164542295,0.940117140364346,1.0,10/32,17.31%,CTNNB1;IMPACT;FLRT1;MAP1B;CYFIP1;NRP1;USP9X;HSP90AA1;PPP3CB;IQGAP1
prerank,contractile actin filament bundle assembly (GO:0030038),0.40768670179588157,0.8406109911346658,0.6766712141882674,0.9394381749843262,1.0,10/15,24.83%,ITGB5;ZYX;PDLIM1;SRC;RHOA;ITGB1;CUL3;TNFAIP1;KCTD13;ARRB1
prerank,stress fiber assembly (GO:0043149),0.40768670179588157,0.8406109911346658,0.6766712141882674,0.9394381749843262,1.0,10/15,24.83%,ITGB5;ZYX;PDLIM1;SRC;RHOA;ITGB1;CUL3;TNFAIP1;KCTD13;ARRB1
prerank,NAD biosynthetic process (GO:0009435),0.38596087934295903,0.8402895793384222,0.6796482412060302,0.9395553250795253,1.0,7/20,19.31%,HAAO;KYNU;NMNAT3;PARP16;NAXD;NAXE;PARP10
prerank,positive regulation of cytoplasmic transport (GO:1903651),0.42738164040763116,0.8397698491239529,0.6582984658298466,0.9399726759239728,1.0,6/11,26.07%,VPS11;SORL1;PRKN;EIPR1;PTPN23;RAB21
prerank,ovarian follicle development (GO:0001541),0.419325857350322,0.8397083651043331,0.6639344262295082,0.9396818518993899,1.0,3/13,10.54%,CEBPB;EIF2B2;INHBA
prerank,potassium ion transmembrane transport (GO:0071805),0.3291399359383444,0.8391853239885795,0.7904858299595142,0.9401017979305679,1.0,11/135,7.51%,KCNJ11;HCN4;SLC9A4;KCNN4;KCNK6;PKD2;KCNIP2;SLC9A9;CCDC51;SLC9A1;KCNK13
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),-0.28804687365862136,-0.838392188424568,0.6708860759493671,0.9492064655485009,1.0,10/16,25.78%,ADSS2;GMPS;PFAS;AMPD3;AMPD2;PAICS;ADSL;IMPDH1;NUDT2;PPAT
prerank,metal ion transport (GO:0030001),0.33086683644001724,0.8383328197063196,0.7438524590163934,0.9410621961902964,1.0,14/86,13.81%,SLC11A1;KCNN4;SLC8A1;CCL8;PKD2;RAMP1;CACNA1A;ATP2C1;TPT1;NIPAL3;FYN;CDH23;ATP2A3;CACNA1B
prerank,establishment of vesicle localization (GO:0051650),0.39922002615935126,0.8382395117121125,0.6901041666666666,0.9408127658475777,1.0,5/18,13.52%,DNM2;RAB11A;SYNJ1;IKBKG;TOR1A
prerank,microtubule bundle formation (GO:0001578),-0.2272557249053751,-0.8380335591163088,0.7659574468085106,0.9477089820482922,1.0,19/42,32.13%,NCKAP5;SPAST;CLIP1;MAP1S;CDK5RAP2;MTCL1;TPPP;MARK4;CFAP74;RP1;SPEF1;NUMA1;SPAG16;GAS8;CFAP46;TTLL3;AAAS;LRGUK;CAPN6
prerank,peripheral nervous system development (GO:0007422),-0.2610390373429781,-0.8380077374512412,0.7417840375586855,0.9454833596255741,1.0,5/23,11.59%,ADGRG6;NFASC;NGF;ALDH3A2;SCN8A
prerank,myoblast fusion (GO:0007520),-0.33046488407021296,-0.8371360795703565,0.65,0.9450206078436437,1.0,7/12,23.87%,ADAMTS5;ADAM12;ADAMTS15;CD81;KCNH1;NOS1;CACNA1H
prerank,chromatin remodeling (GO:0006338),0.33137690239381024,0.8371342456601748,0.7824310520939735,0.942152964263306,1.0,28/100,19.98%,NPM3;BPTF;SRCAP;HDAC5;ACTB;RB1;ARID1A;ATRX;HDAC4;ARID1B;BAZ1A;HCFC2;SOX9;BRDT;SMARCD3;SMARCB1;HCFC1;INO80;PIH1D1;ERCC6;SMARCAD1;RSF1;KDM4C;CHD4;TOP1;KDM5A;RBBP4;KDM5B
prerank,RNA methylation (GO:0001510),-0.20516232406666754,-0.8370216311064342,0.7692307692307693,0.9430169754484473,1.0,21/60,23.10%,NSUN6;METTL6;THADA;CBLL1;THUMPD3;METTL14;NSUN2;METTL5;METTL16;TRMT6;TARBP1;TGS1;CMTR1;MTO1;MTERF4;MEPCE;NOP2;TRMT5;LCMT2;WDR6;NSUN5
prerank,amino acid import across plasma membrane (GO:0089718),0.37574247386580045,0.836668702380473,0.6918392204628502,0.942477599386722,1.0,3/24,7.46%,SLC7A8;SLC36A1;SLC16A2
prerank,negative regulation of catabolic process (GO:0009895),0.3488197895016657,0.8366670139921571,0.7144396551724138,0.9420860816388035,1.0,5/47,9.95%,CBFA2T3;MAD2L2;TNF;ZDHHC7;HDAC4
prerank,positive regulation of macroautophagy (GO:0016239),0.347521376765605,0.8364632402125536,0.7080610021786492,0.942004435616549,1.0,10/48,16.30%,PIP4K2A;RAB3GAP2;SCOC;LARP1;PAFAH1B2;UVRAG;IKBKG;GNAI3;VDAC1;IRGM
prerank,negative regulation of phosphatase activity (GO:0010923),0.37482526918545284,0.8361876792714392,0.6779252110977081,0.9420423565394372,1.0,5/25,15.43%,SEMA4D;PPP1R11;BOD1L1;PPP4R4;PTPA
prerank,protein K48-linked ubiquitination (GO:0070936),0.34570628527838493,0.8360759309993289,0.7214514407684098,0.9418221500486273,1.0,19/54,22.15%,RFFL;UBE2D3;TNFAIP3;UBE2E3;RNF4;NEDD4L;UBE2H;CDC34;RNF216;ITCH;UBE2G2;ZNRF1;RNF152;UBE2K;CUL3;PRKN;UBE2R2;RNF146;UBE2E1
prerank,heart development (GO:0007507),0.32599926253931466,0.8355875683497188,0.8112449799196787,0.9422114914307292,1.0,25/150,14.97%,SHH;TGFB1;SH3PXD2B;TGFBR1;EEF1AKMT4-ECE2;PKP2;PKD2;ADAP2;CHD7;TGFBR2;MEF2A;MYOCD;LDB3;MEF2C;ZDHHC16;SMYD4;SOX9;WDR11;HDAC9;TAB2;CASP8;MEGF8;SOX4;PDLIM1;POU6F1
prerank,glycine metabolic process (GO:0006544),-0.32073859701993335,-0.8353154306440277,0.6632653061224489,0.9444041897810649,1.0,6/12,40.87%,DLD;RIDA;GCSH;SHMT2;GLDC;SHMT1
prerank,protein localization to lysosome (GO:0061462),0.3688916032911405,0.8346207011363453,0.7012987012987013,0.9433259872953641,1.0,13/28,27.24%,LAPTM5;RAB7A;SORL1;NCOA4;RTN4;ATP13A2;SCARB2;RNF128;MFSD1;GGA3;HGS;SNX16;NAGPA
prerank,nitric oxide mediated signal transduction (GO:0007263),0.3988096510793085,0.8345819198375672,0.6692913385826772,0.9429998559070535,1.0,3/16,16.04%,APOE;DDAH1;CD36
prerank,regulation of epithelial cell differentiation (GO:0030856),0.39039073379812195,0.8345483196962352,0.6728971962616822,0.9426578112161015,1.0,3/17,11.18%,MAFG;CEBPB;SOX9
prerank,myotube differentiation (GO:0014902),0.39111960958188696,0.834371305009448,0.6884615384615385,0.9425395532147883,1.0,3/17,8.10%,SKI;PLD3;MEF2C
prerank,embryonic limb morphogenesis (GO:0030326),0.35634712981062094,0.8341146453512611,0.7047511312217195,0.9425541627631483,1.0,3/34,6.29%,SHH;SKI;CTNNB1
prerank,ribosomal large subunit biogenesis (GO:0042273),0.3404981580783784,0.8331941354192394,0.7261904761904762,0.9435768792398417,1.0,12/54,17.61%,RPL10A;LAS1L;GTF3A;SURF6;RPL6;RPL26;MDN1;RRS1;NOC2L;PES1;RPL11;WDR12
prerank,regulation of protein localization to centrosome (GO:1904779),0.428628644806849,0.8331747729041105,0.6770833333333334,0.943217304424074,1.0,1/10,2.92%,NUP62
prerank,sister chromatid segregation (GO:0000819),0.36534177665415724,0.8329199353540135,0.7167630057803468,0.943221414715396,1.0,8/31,19.64%,ESPL1;NCAPG2;RB1;INO80;TOP2A;CENPK;MIS12;SMC4
prerank,positive regulation of cellular senescence (GO:2000774),0.42840166592922513,0.8328659108685563,0.6489971346704871,0.9429102915999307,1.0,2/10,13.13%,YPEL3;B2M
prerank,ribosomal small subunit biogenesis (GO:0042274),0.3533803237948076,0.8328306430859526,0.7130242825607064,0.9425769189276544,1.0,16/39,26.93%,EMG1;NOB1;ERAL1;SURF6;RPS16;RPS14;RPS27;RIOK3;RRP7A;SRFBP1;RPS7;RPS15;RPS5;NOP14;LSM6;RPS6
prerank,regulation of astrocyte differentiation (GO:0048710),-0.3242330817376961,-0.8326614378705292,0.6773049645390071,0.9476326886289888,1.0,2/12,10.90%,SERPINE2;HES1
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.3657851330521943,0.832611526669437,0.6990407673860911,0.9425307751461128,1.0,3/27,9.00%,LPIN2;CHKB;ABHD4
prerank,mitotic cytokinesis (GO:0000281),0.3432685530964128,0.8326041701757568,0.7279651795429815,0.9421503123184052,1.0,12/47,17.17%,SNX9;ESPL1;SNX33;CNTROB;KIF23;SON;MYH10;USP8;PDCD6IP;RASA1;INCENP;SNX18
prerank,regulation of isotype switching (GO:0045191),0.41167278012309416,0.8325278807950657,0.683377308707124,0.9418732290464389,1.0,4/14,21.55%,MAD2L2;SHLD1;SHLD2;PARP3
prerank,regulation of transcription by RNA polymerase I (GO:0006356),-0.2802171898125797,-0.832242234445006,0.7116279069767442,0.9462350216512628,1.0,5/18,14.41%,UBTF;EIF2AK3;ATF4;DHX33;UTP15
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),-0.3051635483688923,-0.8317991275494275,0.6926229508196722,0.9449226803046639,1.0,9/14,25.78%,ADK;ADSS2;GMPS;PFAS;RFK;PAICS;ADSL;IMPDH1;PPAT
prerank,protein targeting to membrane (GO:0006612),0.3303469520016667,0.8315772504314277,0.7683557394002068,0.942973822477902,1.0,23/83,21.73%,RAB8B;MICALL1;ABCD1;ZDHHC14;AQP11;ZDHHC7;PEX13;PXMP2;ZDHHC3;VPS37C;SDCBP;ZDHHC1;ZDHHC24;SRP19;RABGEF1;ATG3;MYO1C;SEC63;ABCD2;FIS1;ZDHHC21;ZDHHC2;SRP14
prerank,negative regulation of defense response to virus (GO:0050687),0.4337618746106324,0.8315550963509275,0.6726190476190477,0.9426186514400731,1.0,5/10,25.37%,TSPAN6;ITCH;TARBP2;ILRUN;C1QBP
prerank,DNA modification (GO:0006304),0.37594014264419223,0.8309540341552251,0.6877323420074349,0.9431016751052179,1.0,8/22,23.59%,NEIL2;OGG1;TINF2;EXOSC3;TERF2;PARP3;TERF2IP;PARP1
prerank,development of primary male sexual characteristics (GO:0046546),0.35269153523434366,0.8302306010226168,0.6990632318501171,0.9438049100157383,1.0,4/34,11.18%,GATA1;LHFPL2;INHBA;SOX9
prerank,error-prone translesion synthesis (GO:0042276),-0.27033751520267624,-0.8300718955527308,0.6752577319587629,0.9461786306150093,1.0,16/21,35.26%,REV3L;REV1;RFC1;PRIMPOL;RFC2;POLE2;UBC;POLK;POLI;RPA3;UBA52;RPA2;RFC3;RPS27A;RFC4;PCNA
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.40187061106099786,0.8293253476142647,0.6829931972789116,0.9447894564647527,1.0,5/14,22.04%,CREB3L1;SULF2;THBS1;SPRY4;FGF2
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.36096461474387553,0.8290979827203943,0.7086705202312139,0.9447467833871891,1.0,10/30,22.98%,MGAT5;OSTC;MCFD2;STT3B;DDOST;MGAT1;STT3A;TUSC3;MAGT1;DPM2
prerank,gonad development (GO:0008406),0.3456793724433934,0.8290736988528379,0.7256235827664399,0.9443983801339315,1.0,2/41,1.62%,GATA1;BASP1
prerank,lipid biosynthetic process (GO:0008610),0.33296436214343683,0.8287208027227538,0.7766393442622951,0.944563467577203,1.0,12/77,17.15%,LPL;LPCAT1;CLN8;DHRS11;LIPC;PDSS1;PRLR;NDUFAB1;SREBF1;ACACA;FADS1;FDXR
prerank,mRNA processing (GO:0006397),0.31966298111143887,0.8280552693679318,0.91,0.9452050707852906,1.0,75/287,21.69%,IK;SNRNP27;GTF2H1;DHX9;ERN1;BCAS2;SF3B2;SF3B1;AURKAIP1;PPIE;DHX38;SNRNP25;CWF19L1;SCAF11;THOC2;CCAR1;DNAJC8;TFIP11;GCFC2;ZMAT5;CSTF1;CASC3;SNRPD2;CDC5L;RBM15B;CWC27;PPARGC1A;CDK7;HNRNPL;RBMX2;DDX39B;SON;SNIP1;POLR2L;CHERP;METTL3;PRPF8;TRA2B;CTNNBL1;RBM41;POLDIP3;PCBP1;UPF3B;THOC3;HNRNPD;WDR83;ALKBH5;BUD31;AKAP8L;CWF19L2;LSM8;CRNKL1;PCF11;PPIH;DDX41;GTF2H5;SLU7;POLR2E;SNRNP200;HNRNPF;SRSF6;SNRPB2;SNRNP35;PNN;SRSF2;PABPN1;SF3B3;SART1;SRSF10;SRSF3;PTBP1;HNRNPA0;UBL5;PDCD7;PRCC
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),0.38918988775895574,0.82754410589305,0.6766623207301173,0.945555541633026,1.0,6/16,21.02%,ATP5MC2;ATP5F1E;ATP5F1A;ATP5PD;ATP5MG;ATP5MF
prerank,nitric oxide biosynthetic process (GO:0006809),0.41064960185791183,0.8275117185364355,0.6793478260869565,0.945215823377147,1.0,2/13,11.59%,GCH1;SPR
prerank,purine-containing compound catabolic process (GO:0072523),0.402146221262463,0.8273672898081261,0.6918844566712518,0.9450350724545187,1.0,2/13,8.29%,XDH;PNP
prerank,methylguanosine-cap decapping (GO:0110156),0.42999482950733137,0.8271075726325305,0.6874074074074074,0.9450443110472095,1.0,1/10,4.01%,PNRC2
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",0.40882722965277396,0.826574182948456,0.6779891304347826,0.9454638514837099,1.0,7/14,24.51%,XRCC5;ATRX;TNKS2;TINF2;TERF2;TERF2IP;ATR
prerank,dendritic spine morphogenesis (GO:0060997),-0.2912414089389008,-0.8264207938341512,0.7307692307692307,0.9512524161159943,1.0,4/15,11.11%,EPHB2;DIP2A;SHANK3;SHANK1
prerank,fatty acid elongation (GO:0030497),0.4014647985663058,0.8260402539262233,0.6639344262295082,0.9458438456449083,1.0,2/13,8.77%,ABCD1;HACD4
prerank,protein N-linked glycosylation (GO:0006487),0.33292625568165807,0.8255434505609927,0.7650727650727651,0.9462214209516763,1.0,20/66,21.39%,MGAT5;MAN1C1;B4GALT1;OSTC;ST3GAL1;MCFD2;ALG2;DPAGT1;STT3B;B4GALT7;PMM1;MGAT5B;TMEM165;ALG11;MGAT4B;DDOST;MGAT1;STT3A;TUSC3;MAGT1
prerank,mitochondrial RNA metabolic process (GO:0000959),0.3946097185703543,0.8255019710660058,0.6801040312093628,0.9458965860707084,1.0,5/14,24.33%,FOXO3;FASTKD1;TWNK;TFAM;MRPL12
prerank,actin filament capping (GO:0051693),0.38173369354920367,0.8254069350978452,0.676056338028169,0.9452578156672307,1.0,4/18,12.19%,FLII;CAPZB;CAPZA1;TWF2
prerank,barbed-end actin filament capping (GO:0051016),0.38173369354920367,0.8254069350978452,0.676056338028169,0.9452578156672307,1.0,4/18,12.19%,FLII;CAPZB;CAPZA1;TWF2
prerank,protein ubiquitination (GO:0016567),0.318624531999752,0.8253394529041005,0.957,0.9449682693611972,1.0,93/471,18.32%,ARRB2;NFE2L2;CBL;MYLIP;TRIM25;UBE2V2;ZNRF2;RNF19B;TRIM5;MKRN1;CDC23;UBE2V1;UBE2D3;OTULIN;TRAF2;FBXL22;MSL2;VPS18;MGRN1;RNF7;FBXL18;HLTF;TAF1;RNF111;KLHL21;CTNNB1;UVSSA;UBE2S;PSMB10;LEO1;KLHL7;LONRF1;RC3H2;VPS11;TRIM27;RNF114;UBE2E3;PEX13;RC3H1;DERL1;RNF4;UBE4B;NFX1;NEDD4L;UBE2H;RNF10;PHC1;USP7;PSMA2;TRIM24;RNF40;FBXO40;TRIM35;CDC34;SPOP;DET1;FBXO32;TNKS2;ARRDC4;PSME3;FBXL3;RNF135;ITCH;UBE2G2;STUB1;RNF144B;PSMB5;HUWE1;USP9X;PSMD8;AREL1;UBE2J2;DTX4;ZNRF1;RNF152;PSMD7;GAN;PSMB9;SMURF1;HIF1A;ATG3;FANCL;UBE2N;TRIM62;ZNRF3;ANAPC11;VHL;UBE2Z;UBE2K;PSMD2;KEAP1;BIRC2;FBXO44
prerank,polyamine metabolic process (GO:0006595),0.4077401054346071,0.8252256154349485,0.7066290550070522,0.9447504429108788,1.0,4/13,15.57%,SMOX;AMD1;HDAC6;PAOX
prerank,nitric oxide metabolic process (GO:0046209),0.40581553491317934,0.825098037758204,0.6837837837837838,0.944540360570711,1.0,2/14,11.59%,GCH1;SPR
prerank,leukotriene metabolic process (GO:0006691),0.38119295470563114,0.82508641236279,0.6812903225806451,0.9441724772534998,1.0,5/19,23.78%,ALOX12;ABCC1;ABCC10;PLA2G5;DPEP2
prerank,ribonucleoprotein complex biogenesis (GO:0022613),0.33412417551299506,0.8250410607208494,0.7435622317596566,0.9438410124498967,1.0,13/57,18.07%,EMG1;XPO1;URB2;GTF3A;SURF6;RPL26;RPS16;RRS1;NOC2L;PES1;RPL11;WDR12;DDX31
prerank,positive regulation of lyase activity (GO:0051349),-0.29261066797150015,-0.8249824774301311,0.7106382978723405,0.951804812647106,1.0,6/14,21.09%,CACNA1C;NOS3;PARK7;NOS1;FXN;ISCU
prerank,nucleoside triphosphate metabolic process (GO:0009141),-0.3028304765377218,-0.8245546943336186,0.7177700348432056,0.9503993949550494,1.0,8/14,32.76%,ENPP3;AK3;AK4;SMPDL3A;CMPK2;NME2;CMPK1;AK7
prerank,negative regulation of translational initiation (GO:0045947),0.4106158355544902,0.824302862513156,0.7144827586206897,0.9445803018441699,1.0,5/13,22.56%,EIF4EBP2;LARP1;TPR;AGO2;EIF3E
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.32038790681709595,0.8241563071293048,0.8006072874493927,0.9444096579594781,1.0,27/129,15.72%,TGFB1;GPRC5B;ZEB2;DKK2;LGR6;FZD9;PSMB10;TBL1XR1;WNK1;CSNK1G2;GID8;ATP6AP2;AMER1;TBL1X;PSMA2;TNKS2;PSME3;BAMBI;NFKB1;PSMB5;PSMD8;LRRK2;SOX4;USP8;PSMD7;PSMB9;LGR4
prerank,monovalent inorganic cation homeostasis (GO:0055067),-0.26177109961169853,-0.8240911047483528,0.7696629213483146,0.9490681058506387,1.0,2/23,1.03%,SLC12A2;SLC12A7
prerank,negative regulation of programmed necrotic cell death (GO:0062099),0.424692492246256,0.8232353433406022,0.6977715877437326,0.9454207554746592,1.0,5/11,20.84%,FZD9;CASP8;ARHGEF2;BIRC2;BIRC3
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),-0.26238969786355226,-0.8232194625620801,0.7515151515151515,0.948582324851871,1.0,4/22,12.20%,VPS37A;UBAP1;SNF8;VPS4A
prerank,cellular response to interleukin-7 (GO:0098761),0.3870958875221274,0.8229939548908726,0.6657894736842105,0.9450075312740138,1.0,3/17,14.02%,STAT5A;STAT5B;IL2RG
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.3870958875221274,0.8229939548908726,0.6657894736842105,0.9450075312740138,1.0,3/17,14.02%,STAT5A;STAT5B;IL2RG
prerank,double-strand break repair (GO:0006302),0.31877560373271463,0.8228810804466603,0.8478478478478478,0.9447942597588235,1.0,41/158,21.97%,ZFYVE26;MAD2L2;UBE2V2;NABP1;RMI1;HMGB1;XRCC5;SAMHD1;BRIP1;LIG3;YY1;ATP23;CHEK2;TRIP13;BABAM2;HPF1;APTX;MCM9;DNA2;INO80;SLX4;DDX1;ERCC5;SMARCAD1;RAD51B;BABAM1;MDC1;UBE2N;ERCC1;SWI5;RAD51D;POLM;SPIDR;SFR1;HERC2;DCLRE1C;NSMCE2;PARP3;ERCC4;RFWD3;SMARCA5
prerank,negative regulation by host of viral transcription (GO:0043922),-0.31555527898172175,-0.8225852959934301,0.6431095406360424,0.9476709753373429,1.0,4/12,18.75%,REST;PSMC3;TARDBP;HMGA2
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.420587896743274,0.8224835727206504,0.6947674418604651,0.9450137508855891,1.0,4/11,17.99%,ABCD1;TRAP1;FYN;ABCD2
prerank,ketone body metabolic process (GO:1902224),0.4271656737582576,0.8215749433949402,0.6947218259629101,0.9459877956511651,1.0,1/10,3.39%,OXCT1
prerank,microtubule nucleation (GO:0007020),-0.2754138946215257,-0.8214281930397257,0.700507614213198,0.947883806970585,1.0,6/19,13.94%,SLAIN2;TUBGCP2;NDEL1;NDE1;GOLGA2;TPPP
prerank,ATP synthesis coupled proton transport (GO:0015986),0.3821144581555907,0.821137902656243,0.6852085967130215,0.94625097431171,1.0,6/17,21.02%,ATP5MC2;ATP5F1E;ATP5F1A;ATP5PD;ATP5MG;ATP5MF
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.3436519498042261,0.8208712996538484,0.7405405405405405,0.9462449991384762,1.0,6/46,8.46%,PLCL2;TLE3;MAP2K6;DDIT3;FLCN;RB1
prerank,regulation of epithelial cell proliferation (GO:0050678),0.327293262871555,0.8207280680481168,0.7723076923076924,0.9460793197651884,1.0,14/85,14.24%,TGFB1;NLRC3;MTSS1;AQP11;DUSP10;LIMS1;SOX9;GRN;NOD2;CDK6;NR4A1;B2M;RAB33B;SOX2
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.42229647811381343,0.8204233308891447,0.6787709497206704,0.9461269126626737,1.0,7/10,26.03%,NELL1;EPHA4;FURIN;ATRAID;EFNA1;RIC1;CDK5RAP3
prerank,negative regulation of protein catabolic process (GO:0042177),0.3502715208153591,0.8201933026771546,0.7374301675977654,0.9460796384370368,1.0,4/40,5.21%,CTSA;MAD2L2;SNCA;TIMP1
prerank,negative regulation of interleukin-8 production (GO:0032717),0.38344358316935173,0.8200675481737846,0.6861219195849546,0.9458724710517458,1.0,5/17,18.46%,ANXA1;TMSB4X;ANXA4;CD33;MAP2K5
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),-0.3002649549708018,-0.8198685126141959,0.6857142857142857,0.9487810633590086,1.0,2/13,3.80%,SORBS1;IRS1
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.3714544185309133,0.8197879710411768,0.6920245398773006,0.9459154985469307,1.0,5/21,14.82%,MYH9;PRKCQ;SPPL3;ERAP1;SPPL2A
prerank,neuron remodeling (GO:0016322),-0.32595055955131436,-0.8196472076003173,0.7006172839506173,0.9469894415308159,1.0,1/10,0.14%,APP
prerank,double-strand break repair via homologous recombination (GO:0000724),0.32343716114007215,0.8193631296480323,0.8210633946830266,0.9461508370519962,1.0,28/95,24.14%,MCM5;ZFYVE26;NABP1;RMI1;SAMHD1;LIG3;YY1;RAD54L;MCM6;MCM2;MCM9;INO80;SLX4;ERCC5;RAD51B;UBE2N;SWI5;RAD51D;SPIDR;CDC45;SFR1;NSMCE2;ERCC4;RFWD3;SEM1;MORF4L1;PARP1;GINS4
prerank,maturation of LSU-rRNA (GO:0000470),0.3677246061060225,0.8192211506296607,0.6902761104441777,0.9459776757819227,1.0,7/26,19.83%,RPL10A;LAS1L;DDX18;PES1;ZNHIT6;WDR12;RPL7A
prerank,regulation of cellular amide metabolic process (GO:0034248),0.3551169324658497,0.8190761957631653,0.736046511627907,0.9457979848781433,1.0,9/32,18.58%,PRKCD;NR1H4;FOXO3;CYFIP1;PCIF1;PUM3;PGAM1;PICALM;TIGAR
prerank,regulation of stress fiber assembly (GO:0051492),0.3273037348563965,0.8189957573631561,0.7644584647739222,0.9455296768725844,1.0,13/74,11.23%,TGFBR1;ARHGEF18;ARAP1;RGCC;FHOD1;SLC9A1;WASF2;ACTG1;F11R;PFN2;NF2;PFN1;NRP1
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.4227548805463837,0.8184395694706351,0.7134587554269175,0.9459489088374637,1.0,6/11,24.91%,MTOR;SMARCB1;PIH1D1;DDX11;PWP1;SIRT7
prerank,sphingolipid catabolic process (GO:0030149),0.38770745282327523,0.8184127904932139,0.6932599724896836,0.9456003941332548,1.0,4/15,19.88%,SGPL1;ACER3;ASAH1;SMPD1
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.39562000969303857,0.8183517149195036,0.6859838274932615,0.9453087682378392,1.0,4/14,17.61%,DDX18;PES1;ZNHIT6;WDR12
prerank,Notch signaling pathway (GO:0007219),0.33393701647390023,0.8183376587206516,0.7563559322033898,0.9449458179010491,1.0,3/59,3.24%,ASCL1;MDK;MAML3
prerank,regulation of synapse assembly (GO:0051963),0.34263011933531545,0.8182300888961508,0.7278688524590164,0.9447149968586037,1.0,5/46,8.10%,CLSTN1;TLR2;SLITRK1;SNCA;MEF2C
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.35617495374393493,0.8181747692080269,0.7158962795941376,0.9444170170488557,1.0,3/33,5.09%,NFE2L2;MDK;TNFAIP3
prerank,negative regulation of amyloid-beta formation (GO:1902430),0.3865780853561293,0.8181003832921949,0.7116883116883117,0.9441296672798923,1.0,8/17,25.48%,APOE;SORL1;RTN1;RTN4;BIN1;PIN1;IGF1;GGA3
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.36135421991153244,0.8178614519114553,0.7137809187279152,0.9441216844118713,1.0,7/29,17.39%,MAD2L2;NKX2-1;ADIPOR1;PPP2CA;VASN;PTEN;LDLRAD4
prerank,L-amino acid transport (GO:0015807),0.3590168806466718,0.8173572559078262,0.7131428571428572,0.9445243509084794,1.0,6/28,15.11%,SLC7A8;SLC36A1;SLC36A4;SLC25A18;CTNS;SLC1A4
prerank,regulation of cardiac muscle cell contraction (GO:0086004),0.3655525468530318,0.816818806280756,0.7226890756302521,0.9449387278483958,1.0,3/27,3.69%,HCN4;FGF13;PKP2
prerank,regulation of mitochondrial fusion (GO:0010635),0.4186145861667217,0.8167164398756047,0.6780626780626781,0.944701416826482,1.0,4/11,20.78%,PID1;HUWE1;VAT1;PRKN
prerank,mitochondrial transcription (GO:0006390),0.4175840113782891,0.8166896983113586,0.692090395480226,0.9443606209667584,1.0,4/10,24.33%,FOXO3;TWNK;TFAM;MRPL12
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),0.4035412400560692,0.8163575991166832,0.6824324324324325,0.9444636574083995,1.0,5/13,23.91%,RENBP;NAGK;SLC35A3;GNPNAT1;GNPDA2
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.3239707104722061,0.8163493541209766,0.7848360655737705,0.9440958843184218,1.0,20/86,18.91%,NFE2L2;ATF3;DDIT3;BACH1;TP53;PSMB10;EPO;IMPACT;PSMA2;PSME3;PSMB5;INO80;PSMD8;PSMD7;PSMB9;HIF1A;GCN1;VHL;PSMD2;ELOB
prerank,negative regulation of cellular protein localization (GO:1903828),0.3525508590926114,0.8161747940704189,0.711340206185567,0.943957463244284,1.0,11/34,20.55%,SNX33;SPI1;RIPOR2;FLCN;NEDD4L;ANKRD13A;PICALM;ROCK2;LEPROTL1;GSK3B;NSFL1C
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.36811196512725464,0.8160970244598414,0.7018181818181818,0.9436808654300897,1.0,1/23,0.90%,TGFB1
prerank,protein targeting (GO:0006605),0.3184350697441772,0.8157932476402925,0.8123107971745711,0.9437566943834382,1.0,28/118,19.61%,TSPO;EDEM1;AP1S3;AIP;MICALL1;SPCS2;ZDHHC14;AQP11;ZDHHC7;TIMM22;SPCS1;ZDHHC3;VPS37C;SDCBP;SORL1;TOMM40;ZDHHC1;ZDHHC24;RABGEF1;ATG3;RPL11;PITRM1;MYO1C;GIPC1;SEC63;LTBP2;TOMM20;FIS1
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.36853055880889507,0.8150247514514211,0.707196029776675,0.9444774257920068,1.0,10/22,28.08%,UTP20;NOP9;RRS1;PES1;WDR12;EXOSC3;EXOSC2;URB1;NOP14;EXOSC10
prerank,regulation of mitotic spindle assembly (GO:1901673),-0.27057804957533793,-0.814892578595025,0.7073170731707317,0.954036948405193,1.0,10/19,33.39%,DRG1;CEP97;HNRNPU;CHMP5;CHMP4B;CHMP2A;CHMP4C;CHMP1B;HSPA1A;EML3
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),-0.31613393641999726,-0.8146452692924262,0.6678082191780822,0.9522736938426607,1.0,3/12,9.85%,SORBS1;IRS1;PRKCZ
prerank,canonical Wnt signaling pathway (GO:0060070),0.3276872939922171,0.8145878608068639,0.7702845100105374,0.9447430994150752,1.0,13/68,16.50%,FZD10;FRAT2;FZD9;FZD3;CTNNB1;SCYL2;LRP5;AMER1;CSNK1A1;LRRK2;BCL9;FZD8;PTEN
prerank,aorta development (GO:0035904),0.4003684417702528,0.8142744309197162,0.684,0.944828742989791,1.0,4/14,15.03%,PKD2;HECTD1;TFAP2B;LRP1
prerank,regulation of neuron differentiation (GO:0045664),0.32694299359218315,0.8142193477658614,0.7878787878787878,0.9445341703040009,1.0,17/76,20.23%,ASCL1;GPRC5B;MMD;MEF2C;NTF3;IMPACT;ZFHX3;SOX2;LRRK2;YWHAH;BIN1;ARHGEF2;CASZ1;RHOA;BEND6;CNTN4;CDK5R1
prerank,protein localization to chromatin (GO:0071168),-0.2717992054713178,-0.8137985076772665,0.7047619047619048,0.9517240664292413,1.0,3/18,6.33%,NIPBL;WAPL;MSH2
prerank,cellular response to DNA damage stimulus (GO:0006974),0.31172528973118374,0.8133531515546543,0.931,0.9454248385653663,1.0,58/336,16.97%,LYN;EID3;FAM111A;FNIP2;TAOK3;GTF2H1;GRB2;MAPK14;MAP2K6;NABP1;TANK;BRAT1;DDIT3;EXO1;VAV3;OARD1;XRCC5;TAF1;SAMHD1;BACH1;BCL2L1;TP53;POLH;YY1;CHEK2;DOT1L;ENDOV;MMS19;BAK1;UVRAG;RAD54L;ZDHHC16;BABAM2;MGMT;HPF1;RBBP5;APTX;BOD1L1;WDHD1;TNFRSF1B;METTL3;PDS5A;MCM9;IKBKG;RNF169;INO80;SLX4;SLF2;REXO4;TOP2A;USP16;OGG1;NRDE2;RAD51B;SUV39H1;STXBP4;FANCL;MACROD1
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.3665304226302984,0.8133486087012384,0.7089820359281437,0.9450514047210877,1.0,8/25,21.22%,ZNF326;EAF1;DDX39B;ELL;KAT7;ERCC6;ZMYND11;SETD5
prerank,protein acylation (GO:0043543),0.342941978658622,0.8132268336056965,0.7310734463276836,0.9448437659811484,1.0,12/38,21.36%,ZDHHC14;ZDHHC7;ZDHHC13;NAT9;ZDHHC16;ZDHHC3;ZDHHC1;SELENOK;GTF2B;ZDHHC21;NAA80;ZDHHC2
prerank,skeletal muscle tissue development (GO:0007519),0.3584178333470972,0.8127595087019147,0.719441210710128,0.9451247403727551,1.0,3/32,8.10%,SKI;CFLAR;MEF2C
prerank,regulation of early endosome to late endosome transport (GO:2000641),0.38272035355791434,0.8125784910085552,0.6977660972404731,0.9449976518370923,1.0,8/18,27.11%,VPS11;DNAJC13;MAP2K2;SRC;PTPN23;RAB21;MAPK1;MAPK3
prerank,skeletal system morphogenesis (GO:0048705),0.3383969605818858,0.8122984791041191,0.7308120133481646,0.9450071061008469,1.0,8/42,13.96%,TGFBR1;SKI;LRP5;DYNC2I1;MEGF8;RFLNA;RAB33B;ANKRD11
prerank,programmed necrotic cell death (GO:0097300),0.37801205862386567,0.8121378774349266,0.7002551020408163,0.9448636852092072,1.0,3/18,8.92%,CD14;TICAM1;LY96
prerank,visual system development (GO:0150063),0.34101905940879923,0.8119551767167471,0.7317620650953984,0.9447512702087834,1.0,7/37,15.34%,SH3PXD2B;C1QA;ITGAM;ZDHHC16;SOX2;MEIS1;SIPA1L3
prerank,monoacylglycerol metabolic process (GO:0046462),0.3897265449773572,0.8119523153951007,0.6759628154050464,0.9443750385157229,1.0,3/13,18.87%,ABHD12;ABHD16A;DGAT2
prerank,RNA metabolic process (GO:0016070),0.31810983169488904,0.8116071618707479,0.8132530120481928,0.944499137172361,1.0,33/127,21.19%,APOBEC1;DHX9;RBM39;SND1;TFIP11;ADAR;PCBP3;AGO4;FASTKD1;HNRNPL;DDX39B;RNASEL;POLR2L;AGO3;RNASEH1;METTL3;LAGE3;ADARB1;PCBP1;HNRNPD;NUFIP1;LSM8;AGO2;PABPC4;RNASEH2A;POLR2E;RBMS2;HNRNPF;FTO;PABPN1;DICER1;PTBP1;HNRNPA0
prerank,mitochondrial fission (GO:0000266),0.38813765235135544,0.8114080335582727,0.6885906040268457,0.9443894718510459,1.0,7/16,25.04%,MTFR2;DNM2;DNM1L;FIS1;PRKN;MTFR1;MFF
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.3466887037796527,0.8112309784395241,0.7360801781737194,0.9442609784921588,1.0,17/37,26.64%,SND1;ADPRM;ENTPD1;RNASEH1;HNRNPD;ENTPD2;PABPC4;RNASEH2A;ENTPD3;RNASE6;DNASE1L1;SIDT2;XRN2;NCBP1;DFFB;RNASE3;SUPV3L1
prerank,regulation of programmed necrotic cell death (GO:0062098),0.3837431589985496,0.8111786774523342,0.7116104868913857,0.9439624127884236,1.0,10/20,20.84%,CFLAR;SDCBP;CASP8;STUB1;PDCD6IP;HSP90AA1;ASAH1;BIRC2;FLOT1;BIRC3
prerank,midbody abscission (GO:0061952),-0.2740982918332492,-0.8109840434243059,0.7272727272727273,0.9549255475222379,1.0,5/17,20.05%,VPS4A;CHMP5;CHMP4B;CHMP4A;CHMP2A
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.36839064015675055,0.8109671356756263,0.7379807692307693,0.9438904848738658,1.0,6/24,21.35%,NFE2L2;TNFAIP3;GAS6;PDPK1;ANGPT1;RAMP2
prerank,oligodendrocyte development (GO:0014003),-0.2888300943782699,-0.8109347576546393,0.6982758620689655,0.9528323634311648,1.0,7/15,30.94%,EIF2B3;TPPP;EIF2B5;EIF2B4;NSUN5;SOX10;EIF2B1
prerank,negative regulation of double-strand break repair (GO:2000780),0.346592889323894,0.8109164002848692,0.7168949771689498,0.9435738240240474,1.0,8/30,19.14%,MAD2L2;TFIP11;HSF1;RNF169;ERCC6;OGG1;SHLD1;SHLD2
prerank,glutathione biosynthetic process (GO:0006750),-0.32073811865865404,-0.8102964768627196,0.7266666666666667,0.9518601966362142,1.0,6/11,35.78%,GSS;OPLAH;CHAC2;GGCT;HAGH;GGT1
prerank,positive regulation of nervous system development (GO:0051962),0.34078462036202517,0.8096770963502617,0.7222832052689352,0.944937009384144,1.0,2/42,1.58%,CX3CR1;CLSTN1
prerank,2-oxoglutarate metabolic process (GO:0006103),-0.2997109776783734,-0.8096172644378737,0.7164750957854407,0.9509820490466064,1.0,4/13,14.29%,ADHFE1;D2HGDH;GOT1;DLST
prerank,synaptic membrane adhesion (GO:0099560),-0.2938813582085009,-0.809431650756684,0.7188755020080321,0.949138545178009,1.0,2/14,2.95%,GPC6;NTNG1
prerank,snRNA processing (GO:0016180),-0.2785753313298077,-0.8094072168749952,0.7142857142857143,0.9470338683227971,1.0,6/16,18.93%,INTS9;INTS14;INTS10;TUT1;INTS4;INTS2
prerank,axon guidance (GO:0007411),0.3167813933072005,0.8092246269748262,0.8898898898898899,0.9452025320231264,1.0,46/201,20.56%,SHH;DRAXIN;SPTBN5;PIK3CD;GRB2;PIK3CB;PLXNC1;SEMA4D;TUBB3;DOK1;CXCR4;PLXNB2;EMB;LGR6;EFNA2;TNR;GAB2;SH3KBP1;PRKCQ;SEMA4A;ARTN;CYFIP1;NRP1;PTPRO;FYN;RANBP9;NPTN;EFNB3;SRC;PTPRA;LAMA3;EPHA4;EPHA8;SEMA4B;RPS6KA5;SPTBN4;VLDLR;TMEFF1;KLF7;VSTM2L;GDNF;PALLD;RELN;CNTN4;CDK5R1;DOK5
prerank,positive regulation of heterochromatin assembly (GO:0031453),0.4097940356328551,0.80879781392027,0.7085137085137085,0.945437485332213,1.0,4/11,16.60%,RESF1;ATF7IP;TPR;TASOR
prerank,regulation of glycolytic process (GO:0006110),0.3255908556368858,0.8082658156887773,0.7549120992761117,0.9458067523865956,1.0,14/68,16.87%,CBFA2T3;P2RX7;MLXIPL;NUP62;PFKFB4;SEH1L;HDAC4;TPR;NUP205;PFKFB3;HIF1A;GAPDHS;GCK;PGAM1
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.3737508289620303,0.808162904641473,0.7097591888466414,0.9455641507540941,1.0,9/19,25.48%,APOE;SORL1;RTN1;RTN4;BIN1;PICALM;PIN1;IGF1;GGA3
prerank,establishment of epithelial cell polarity (GO:0090162),0.37153934317687254,0.8079897000777846,0.6771356783919598,0.9454282748238614,1.0,6/19,18.43%,RAP2A;CYTH1;SIPA1L3;RHOA;CDC42;GOLPH3
prerank,histone H3-K9 demethylation (GO:0033169),-0.31629309278805295,-0.8074426618078546,0.7107142857142857,0.9486364163718406,1.0,5/11,16.80%,JMJD1C;KDM3A;KDM4B;KDM4A;KDM4D
prerank,pyrimidine-containing compound catabolic process (GO:0072529),-0.2850082191075588,-0.8068709710696235,0.7238493723849372,0.947586047934992,1.0,7/16,29.98%,UPP2;NT5E;CRMP1;DPYSL2;NT5C1A;UPB1;DPYSL3
prerank,regulation of protein localization to cell periphery (GO:1904375),0.3811427178274786,0.8063671713352915,0.7095541401273885,0.9473563539278934,1.0,9/18,23.15%,LDLRAP1;CLN3;ACTB;ZDHHC7;STX8;ABCA2;ZDHHC2;VAMP8;STX7
prerank,relaxation of muscle (GO:0090075),0.39346478229383475,0.8062484248356139,0.6975748930099858,0.9471383984463846,1.0,2/13,5.57%,SLC8A1;P2RX4
prerank,negative regulation of vascular permeability (GO:0043116),0.40433954190771104,0.805622827708145,0.6966292134831461,0.9476539890490668,1.0,6/12,24.84%,PTPRJ;DDAH1;ANGPT1;RAMP2;VEGFA;SH3GL2
prerank,copper ion homeostasis (GO:0055070),0.3717792019606686,0.8054974648895137,0.7175675675675676,0.947471269986199,1.0,2/17,4.49%,ATP7A;ATOX1
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),0.3962432482278432,0.8054274717499238,0.709043250327654,0.9471946445926036,1.0,5/14,21.97%,TIMP1;LIMS1;CD63;LOXL3;FLNA
prerank,protein localization to cell surface (GO:0034394),0.36111483358744356,0.8052789712758748,0.7456445993031359,0.9470298307542925,1.0,13/26,25.48%,CTNNB1;VCL;PTPRU;GGA2;ARF6;SMURF1;MESD;ANGPT1;PIGU;UNC50;FLNA;PIGK;GGA3
prerank,organic hydroxy compound biosynthetic process (GO:1901617),-0.21528469063906258,-0.8047660296075955,0.7924528301886793,0.9494478460271073,1.0,22/44,33.95%,OSBPL9;OSBPL1A;HMGCR;CYP7B1;INSIG2;INSIG1;SQLE;PER2;PARK7;AMACR;CYP39A1;PMVK;LBR;SCP2;HSD17B4;DHCR7;EBP;SLC27A2;SC5D;TM7SF2;OSBPL2;CH25H
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.382399609107601,0.8041047307453398,0.6980891719745222,0.9482927824564038,1.0,2/17,9.11%,UNC13D;SYT10
prerank,protein polyubiquitination (GO:0000209),0.31147937719753693,0.8037800886378118,0.924,0.9483531178626888,1.0,64/297,18.32%,MYLIP;UBE2V2;RFFL;ZNRF2;RNF19B;TRIM5;MKRN1;CDC23;UBE2V1;UBE2D3;TRAF2;FBXL22;TNFAIP3;TRAF3;FBXL18;TAF1;HECTD1;CTNNB1;UBE2S;PSMB10;LONRF1;RC3H2;TRIM27;RNF114;UBE2E3;RC3H1;RNF4;UBE4B;TRAF5;NEDD4L;UBE2H;TRIM56;PSMA2;FZR1;FBXO40;CDC34;SPOP;FBXO32;TNKS2;PSME3;RNF216;FBXL3;RNF135;ITCH;UBE2G2;STUB1;RNF144B;PSMB5;HUWE1;PSMD8;AREL1;UBE2J2;ZNRF1;RNF152;PSMD7;PSMB9;SMURF1;UBE2N;TRIM62;ANAPC11;UBE2K;PSMD2;BIRC2;FBXO44
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.40000886495455734,0.8035065322902022,0.6995768688293371,0.9483493067395724,1.0,6/11,22.84%,ASF1B;ATRX;UBN1;RBBP4;IPO4;H3-3A
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.35851332226541677,0.8032683792337894,0.7164556962025317,0.9482924445602263,1.0,4/22,12.07%,P2RX4;MEF2A;SLC9A1;LMCD1
prerank,positive regulation of telomere maintenance (GO:0032206),0.34099870852560776,0.8031523522807307,0.7178899082568807,0.9480814239732668,1.0,6/31,14.37%,PKIB;PRKCQ;ATRX;TNKS2;SLX4;HNRNPD
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),-0.2039720509663446,-0.8030900308826322,0.8589743589743589,0.950476375564837,1.0,10/48,11.87%,OGT;NUP93;NUP188;RANBP2;NUP98;NUP42;NDC1;RAE1;NUP153;NUP37
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.32633940194329497,0.8029279461219977,0.7647690655209453,0.9480177811387503,1.0,7/54,10.47%,RGCC;CNOT8;TP53;CRADD;PLK2;CHEK2;RPL26
prerank,response to amino acid (GO:0043200),0.3460310477545508,0.8028929208404995,0.7185761957730812,0.9476957565595855,1.0,10/31,21.78%,MTOR;CPEB3;GLRA2;LAMTOR3;CAPN2;CPEB4;LAMTOR1;RPTOR;RRAGA;RRAGB
prerank,atrial septum morphogenesis (GO:0060413),-0.3227869615459156,-0.8027026793782049,0.7037037037037037,0.9490213405252856,1.0,4/10,26.25%,ACVR1;HEY2;BMPR2;TGFB2
prerank,regulation of glycogen biosynthetic process (GO:0005979),-0.2531574642593071,-0.8022359041561704,0.7840909090909091,0.9477429235141155,1.0,4/24,8.48%,SORBS1;IRS1;EPM2AIP1;SELENOS
prerank,protein localization to chromosome (GO:0034502),0.3491589692532844,0.802217635156556,0.7457044673539519,0.9482871057636734,1.0,12/34,24.86%,XRCC5;RB1;ATRX;TNKS2;MCM9;SLF2;TINF2;TERF2;PARP3;TERF2IP;ATR;RPA1
prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.35157719766403484,0.8008737251001417,0.7383292383292384,0.9498049964104662,1.0,8/27,20.22%,SCN4B;NEDD4L;FXYD5;YWHAH;SCN5A;FXYD6;PTPN3;FXYD1
prerank,phosphatidylserine metabolic process (GO:0006658),0.34675388909749866,0.8004502140507932,0.7230046948356808,0.9500229163608688,1.0,6/32,20.32%,ABHD12;OSBPL10;OSBPL8;ABHD16A;PLAAT3;PLA2G5
prerank,regulation of histone H3-K4 methylation (GO:0051569),-0.2783580404639016,-0.8003996146252444,0.7574468085106383,0.9489517555913144,1.0,5/16,17.04%,AUTS2;SMAD4;DNMT1;SNW1;PAXIP1
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.3441676006378045,0.8001958776676792,0.7286374133949192,0.9499940364650028,1.0,6/31,12.94%,SEMA4D;SKI;LRP5;SOX9;CDK6;BAMBI
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.35961677244197177,0.8001856428724162,0.7330827067669173,0.9496295580735791,1.0,2/22,6.70%,MED17;TP53
prerank,acyl-CoA metabolic process (GO:0006637),0.3438176339167931,0.7999588873256857,0.7442371020856202,0.9495805243512851,1.0,6/35,17.50%,DBI;OGDH;ACSF2;ACOT9;ACACA;ACOT2
prerank,calcium ion transport (GO:0006816),0.3114628486084536,0.7999363071594079,0.8348439073514602,0.9492351972091801,1.0,22/113,17.27%,KCNN4;P2RX7;SLC8A1;CCL8;PKD2;ORAI2;P2RX4;RAMP1;CACNA1A;ATP2C1;TPT1;CACNB2;FYN;CDH23;GAS6;ATP2A3;CACNA1B;TRPV3;SELENOK;CACNA1D;CRACR2B;TMEM165
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.22044286308353275,-0.7998933464456319,0.8,0.9477804088066186,1.0,23/37,35.85%,RFC1;DDB2;DDB1;RBX1;CHD1L;XPA;RFC2;GTF2H3;UBC;POLK;RPA3;GTF2H4;UBA52;POLD2;RPA2;RFC3;RPS27A;CUL4B;RFC4;PCNA;NTHL1;POLD4;POLD1
prerank,striated muscle cell development (GO:0055002),0.39329775595454486,0.7998672152000136,0.7166212534059946,0.9489612514262173,1.0,2/14,14.81%,FLII;CAPN3
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.3732528167053766,0.7997186795402321,0.7169811320754716,0.9487988130181497,1.0,5/19,18.33%,MAD2L2;RGCC;PTPRU;DENND6A;FLOT1
prerank,acyl-CoA biosynthetic process (GO:0071616),-0.2778640166406247,-0.7994922028781469,0.7385892116182573,0.9464161608495757,1.0,9/16,32.04%,DIP2A;ACLY;MLYCD;PPT1;CBR4;ACSS1;PPCS;GCDH;SLC25A1
prerank,negative regulation of anoikis (GO:2000811),-0.29359144714057095,-0.7988773690188307,0.7589928057553957,0.9454300435181439,1.0,2/14,6.60%,CAV1;TLE1
prerank,axonogenesis (GO:0007409),0.31035817711414093,0.7987892068321822,0.91,0.9497156747789294,1.0,45/237,17.86%,SHH;DRAXIN;NEFH;SPTBN5;PIK3CD;GRB2;PIK3CB;S100B;SLITRK1;SEMA4D;TUBB3;DOK1;CXCR4;EMB;LGR6;EFNA2;TNR;ACTB;GAB2;SH3KBP1;PRKCQ;MAP1B;SEMA4A;ARTN;CYFIP1;NRP1;PTPRO;ATL1;FYN;RANBP9;NPTN;USP9X;EFNB3;SRC;PTPRA;LAMA3;EPHA4;PTEN;HSP90AA1;EPHA8;PPP3CB;SEMA4B;RPS6KA5;SPTBN4;VLDLR
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.3444871586051035,0.7985342081430038,0.7361268403171007,0.9497032303176278,1.0,4/32,6.54%,FGF13;SNCA;ATXN7;MAPRE1
prerank,myotube cell development (GO:0014904),0.4140038488155406,0.7984296554841369,0.7288378766140603,0.9494794323545657,1.0,1/10,4.36%,SKI
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),0.38726125514581494,0.7983569780713904,0.7105263157894737,0.9492112032876225,1.0,5/13,23.93%,RAMP1;IL33;ABCA2;CHP1;IGF1
prerank,negative regulation of T cell differentiation (GO:0045581),0.41730776695561433,0.7983168028899165,0.7046109510086456,0.9488941367416254,1.0,2/10,13.89%,MDK;IRF1
prerank,electron transport chain (GO:0022900),0.3819636585388267,0.7978795065610637,0.7191601049868767,0.949102469078487,1.0,5/15,20.75%,PPARGC1A;POR;SDHB;ETFDH;SDHA
prerank,import into nucleus (GO:0051170),0.3169827777634546,0.7976255897468564,0.8033648790746583,0.9491048729661631,1.0,6/73,10.10%,MMP12;SYK;NUP62;SNRPD2;CSE1L;TPR
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.33429394973436477,0.7973050567154982,0.7566964285714286,0.9491497881240655,1.0,8/40,14.53%,BCL2L1;ABCD1;ATP5IF1;PPA2;BAK1;PRDX3;PID1;LRRK2
prerank,mitochondrion organization (GO:0007005),0.3089347024822005,0.796545471017842,0.8598598598598599,0.9498531596364729,1.0,38/165,19.75%,TSPO;RAB32;MTFR2;AIP;ATP7A;PYROXD2;BCL2L1;DNM2;MEF2A;LONP1;ATP23;CHCHD4;MSTO1;TIMM22;PPARGC1A;ATCAY;IMMP2L;MGME1;TIMM50;PRDX3;WDR81;HCFC1;TOMM40;ATAD3A;PID1;MIGA1;HK2;LRRK2;AGTPBP1;TWNK;YME1L1;PITRM1;RAB29;DNM1L;TOMM20;FIS1;MPV17;MFN1
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.3638685678680091,0.7957339512398326,0.7080820265379976,0.950577823111382,1.0,5/21,18.95%,FGF13;ATXN7;CAMSAP2;ARHGEF2;TAOK1
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.28137870655547714,-0.7956739279492375,0.7617021276595745,0.9493191113539675,1.0,7/16,17.69%,SMCHD1;KMT5B;DTX3L;KMT5C;WRAP53;KDM4D;PRKDC
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.31314049784780684,0.7955681260078024,0.8063200815494393,0.950430819334628,1.0,15/84,17.85%,ANAPC15;PTTG1;CDC23;UBE2S;PSMB10;RB1;PSMA2;FZR1;PSME3;PSMB5;PSMD8;PSMD7;PSMB9;ANAPC11;PSMD2
prerank,bile acid biosynthetic process (GO:0006699),-0.25028717463742606,-0.7955488844202675,0.8,0.9474492198358443,1.0,12/24,37.87%,OSBPL9;OSBPL1A;CYP7B1;AMACR;CYP39A1;SCP2;HSD17B4;SLC27A2;OSBPL2;CH25H;CYP46A1;HSD3B7
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.3750618339212937,0.795407333689076,0.7092866756393001,0.9502742294195441,1.0,1/15,2.22%,DAGLB
prerank,sensory perception of smell (GO:0007608),-0.3100664361720444,-0.7952785942430235,0.7345454545454545,0.945828205088698,1.0,5/11,23.15%,UBR3;BBS4;SLC24A4;DRD2;MKKS
prerank,regulation of DNA binding (GO:0051101),0.33240816851144167,0.7949159093758449,0.7684674751929438,0.9505889317614623,1.0,4/44,8.18%,TGFB1;SKI;HMGB1;DOT1L
prerank,L-serine metabolic process (GO:0006563),0.4127901480320153,0.7948272316189818,0.7206537890044576,0.9503431341713665,1.0,5/10,24.97%,CBS;PHGDH;PSAT1;SERINC3;PSPH
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.41388611519254714,0.7947919454800644,0.724822695035461,0.9500196020663768,1.0,5/11,23.68%,SNX33;NEDD4L;PICALM;LEPROTL1;GPM6B
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.3412423043957619,0.7947200059023813,0.7408256880733946,0.9497564628591987,1.0,5/35,12.11%,RASAL3;ARHGAP24;RIPOR2;FLCN;SYNGAP1
prerank,positive regulation of DNA recombination (GO:0045911),0.35571971004974495,0.794596903540077,0.7438307873090482,0.9495496107601649,1.0,6/27,19.14%,MAD2L2;MMS19;ACTR2;ERCC6;SHLD1;SHLD2
prerank,UV-damage excision repair (GO:0070914),-0.31222487198283605,-0.7944802273529334,0.7314487632508834,0.9451286564105936,1.0,5/12,20.71%,DDB2;DDB1;XPA;POLA1;ACTR5
prerank,regulation of cartilage development (GO:0061035),0.3710154918025015,0.7943536364556438,0.7030223390275953,0.9495312604060773,1.0,4/18,13.62%,MDK;TRPS1;SOX9;SOX6
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.37213215526289073,0.7943196226931013,0.7363636363636363,0.9492085558068577,1.0,6/17,20.68%,TNF;VCL;F11R;ADD1;ROCK2;ZDHHC21
prerank,regulation of RIG-I signaling pathway (GO:0039535),0.3763991841508487,0.7941399011127601,0.730423620025674,0.949072683967407,1.0,9/18,25.87%,PUM2;GPATCH3;BIRC2;BIRC3;RNF125;DDX60;C1QBP;USP15;PUM1
prerank,C4-dicarboxylate transport (GO:0015740),0.3895564362716427,0.7939936260982771,0.7146739130434783,0.9489191947067472,1.0,3/14,13.02%,LRRC8D;SLC25A18;SLC25A30
prerank,protein mono-ADP-ribosylation (GO:0140289),-0.3137592320208686,-0.7938755789600601,0.7204301075268817,0.9441044251154839,1.0,5/11,14.33%,PARP6;PARP14;PARP12;PARP11;PARP4
prerank,relaxation of cardiac muscle (GO:0055119),0.38537193852456064,0.7937280694096123,0.7112068965517241,0.9489007179135023,1.0,2/13,5.57%,SLC8A1;P2RX4
prerank,peptidyl-asparagine modification (GO:0018196),0.3453010831451135,0.7935560947522642,0.7520184544405998,0.9487703593149979,1.0,10/31,22.98%,MGAT5;OSTC;MCFD2;STT3B;DDOST;MGAT1;STT3A;TUSC3;MAGT1;DPM2
prerank,alpha-amino acid catabolic process (GO:1901606),0.34600411801744607,0.7930540892353902,0.7246207701283547,0.9490818797893416,1.0,5/29,16.86%,HAAO;KYNU;KMO;THNSL2;CBS
prerank,negative regulation of cell junction assembly (GO:1901889),0.3503083292669498,0.792829415977127,0.7463414634146341,0.9490400339830017,1.0,7/25,19.65%,TLR2;TNF;THBS1;SRC;PTEN;CORO1C;ROCK2
prerank,neural crest cell migration (GO:0001755),0.3386733007512156,0.7923300427073079,0.7582292849035187,0.9493335152602,1.0,4/36,11.23%,SHH;SEMA4D;SEMA4A;NRP1
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.2883144362925131,-0.7919673083403883,0.7125,0.9452457756853974,1.0,4/15,15.27%,BMP4;SMO;SIX1;PAX2
prerank,regulation of microtubule depolymerization (GO:0031114),0.35396029901625026,0.7915069993176865,0.7373974208675264,0.9500756599374891,1.0,6/25,18.95%,FGF13;ATXN7;MAP1B;CAMSAP2;ARHGEF2;TAOK1
prerank,protein localization to phagophore assembly site (GO:0034497),-0.3162384766529188,-0.7910827701721331,0.7266666666666667,0.944746727654811,1.0,8/11,44.28%,MFN2;WDR45B;WIPI1;WDR45;ATG9A;STX17;ATG13;WIPI2
prerank,positive regulation of heart rate (GO:0010460),-0.2728818973123053,-0.7910514782165456,0.7807017543859649,0.9427398678092305,1.0,6/17,29.71%,RYR2;EDN1;EDN3;PDE4D;ATP2A2;SCN3B
prerank,positive regulation of protein deacetylation (GO:0090312),-0.2910195466486829,-0.7909946323812795,0.7448979591836735,0.9408120336156136,1.0,2/14,4.64%,NIPBL;DYRK1A
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.37980421683956533,0.7908756683009167,0.7230359520639148,0.9505581161828364,1.0,2/14,7.90%,TRAF2;MALT1
prerank,negative regulation of JUN kinase activity (GO:0043508),0.4027060753192416,0.7907939149512087,0.7209302325581395,0.9502796411374619,1.0,2/10,10.57%,DUSP10;DUSP19
prerank,mitochondrion morphogenesis (GO:0070584),-0.308480346607761,-0.790417746474156,0.7339743589743589,0.9398177541428684,1.0,6/11,28.43%,MTM1;NUBPL;WASF1;SLIRP;MYH14;PNPT1
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),0.4033861528309006,0.7895062361041371,0.7051282051282052,0.9516692108148298,1.0,4/10,26.09%,SNCA;NOC2L;CTBP1;KLF15
prerank,negative regulation of protein localization to nucleus (GO:1900181),-0.26443497946437233,-0.7886853002128955,0.7532467532467533,0.940778203661571,1.0,4/18,10.47%,OTUD7B;LATS1;RAB23;LATS2
prerank,inorganic anion transport (GO:0015698),0.31654529116943225,0.7883290924454857,0.7756410256410257,0.9528911767834541,1.0,6/53,15.59%,SLC11A1;PACC1;CLIC1;XPR1;SLC25A30;CLCN4
prerank,interstrand cross-link repair (GO:0036297),-0.2029042592530178,-0.7882949315729227,0.8545454545454545,0.9394598335013208,1.0,28/53,34.32%,NUCKS1;FAN1;FANCM;ATRIP;XPA;FANCI;POLN;ERCC6L2;DCLRE1A;MSH6;UBC;DCLRE1B;MUS81;FAAP20;RPA3;FANCB;UBA52;FANCC;FANCD2;FANCG;NEIL3;MCM8;RPA2;EXO5;RPS27A;RAD51;RAD51AP2;CENPX
prerank,activation of protein kinase B activity (GO:0032148),0.34024851350381824,0.7881933057724532,0.7339449541284404,0.9527055698928049,1.0,7/29,17.78%,MTOR;IL18;NTF3;NRG1;GAS6;OSBPL8;PDPK1
prerank,neural crest cell development (GO:0014032),0.32929020704026696,0.7880915187065881,0.7669256381798002,0.9524587655007805,1.0,9/44,19.30%,SHH;SEMA4D;PDCD6;SEMA4A;NRG1;SEMA4B;CORO1C;TAPT1;GDNF
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.34039009700280304,0.7876517551217805,0.7735849056603774,0.9526858701792923,1.0,8/38,15.14%,NDUFA11;NDUFB8;NDUFA2;NDUFB4;NDUFV1;NDUFS6;NDUFAB1;NDUFB11
prerank,amyloid fibril formation (GO:1990000),0.32792699552099375,0.7876168002902423,0.7788671023965141,0.9523571393904129,1.0,12/51,17.02%,SNCA;TTR;TGFBI;TSPAN14;IAPP;ITM2B;SORL1;B2M;GGA2;USP9X;CD36;FURIN
prerank,glial cell differentiation (GO:0010001),0.3434241798030363,0.7875662824571823,0.7349397590361446,0.9520570980461237,1.0,4/28,14.61%,SHH;SOX9;SOX2;SOX4
prerank,cellular response to superoxide (GO:0071451),0.40553129274570704,0.7875173829749349,0.7130177514792899,0.951752487161987,1.0,3/10,12.90%,ATP7A;PRDX1;PRDX2
prerank,DNA metabolic process (GO:0006259),0.3039862992248116,0.7873928771066265,0.923923923923924,0.9515513525680602,1.0,49/270,17.05%,MCM5;EID3;ORC3;GTF2H1;UBE2V2;PTGES3;NABP1;EXO1;HMGB1;XRCC5;SAMHD1;BACH1;LIG3;POLH;LONP1;DOT1L;ENDOV;MMS19;UVRAG;RAD54L;MGMT;MCM6;MCM2;DBF4;USP7;ORC4;WDHD1;STN1;CDC34;RNASEH1;PDS5A;SMARCB1;ZNF445;DNA2;CDC6;INO80;SLX4;POLD3;ERCC5;NOC3L;REXO4;TOP2A;OGG1;SMARCAD1;RAD51B;FANCL;CBS;LRWD1;UBE2N
prerank,cilium assembly (GO:0060271),0.3050042535428841,0.7866336035426125,0.938,0.9522155616855157,1.0,56/296,18.15%,TUBB;MKS1;RAB8B;PRKAR2B;HAUS2;EXOC6;ASAP1;TUBA4A;IFT52;RP2;CNTRL;CEP192;MAPRE1;CNGB1;CEP70;SPATA6;BBS9;PLK4;ATP6V0D1;CEP76;DISC1;HAUS1;SNAP29;RAB11A;ACTR2;ACTR3;HDAC6;EXOC8;WDR11;DYNC2I1;DYNC1H1;EXOC7;EXOC1;PCM1;EXOC2;IFT80;TXNDC15;EXOC5;RPGR;FNBP1L;CEP152;EXOC3;HAUS8;JHY;CEP162;AHI1;WDR90;NINL;HSP90AA1;WDPCP;IFT27;NUDCD3;AKAP9;DYNC2LI1;CEP63;SNX10
prerank,cellular macromolecule catabolic process (GO:0044265),0.3281770749800935,0.7860899364253593,0.7833152762730228,0.9525613818510891,1.0,20/49,26.64%,SND1;OGA;CHEK2;RNASEH1;STT3B;UBE2G2;HNRNPD;IDE;PABPC4;FBXO44;RNASEH2A;PRKN;RNASE6;DNASE1L1;SIDT2;XRN2;NCBP1;DFFB;RNASE3;SUPV3L1
prerank,neural crest cell differentiation (GO:0014033),0.3631371735517,0.785775578529621,0.7220026350461133,0.9526191613312746,1.0,4/18,19.08%,MEF2C;PDCD6;NRG1;TAPT1
prerank,hexose transmembrane transport (GO:0008645),0.3526650169255747,0.7857486991281893,0.7310087173100872,0.9522817639527278,1.0,3/21,17.27%,SLC2A3;SLC2A12;PPARD
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.39963961069480797,0.7852791806497816,0.7373595505617978,0.9525404909743055,1.0,5/10,23.29%,SH2B3;NF2;PPP2CA;SOCS3;INPP5F
prerank,protein-DNA complex assembly (GO:0065004),0.30485954258574255,0.7850567865772512,0.8577235772357723,0.9524724581793343,1.0,23/116,18.25%,MCM5;ORC3;GTF2H1;PSMB10;ATRX;CDK7;MCM6;MCM2;NAP1L1;PSMA2;SOX9;ORC4;PSME3;PSMB5;CDC6;PSMD8;ERCC5;SPTY2D1;PSMD7;PSMB9;RSF1;PSMD2;GTF2H5
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",-0.21543892797625477,-0.7847294476652363,0.8301886792452831,0.9433610209726736,1.0,24/39,35.85%,RFC1;DDB2;DDB1;FAN1;RBX1;CHD1L;XPA;RFC2;GTF2H3;UBC;POLK;RPA3;GTF2H4;UBA52;POLD2;RPA2;RFC3;RPS27A;CUL4B;RFC4;PCNA;NTHL1;POLD4;POLD1
prerank,positive regulation of cyclase activity (GO:0031281),0.3893126135393851,0.7846046331547712,0.7085492227979274,0.9527285154012509,1.0,4/14,16.61%,MAPK14;AKAP5;NF1;CACNA1D
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.39725603228360173,0.7843326543557743,0.745578231292517,0.9527191014843142,1.0,5/12,22.41%,SREBF2;SEC14L2;SREBF1;ABCA2;MBTPS2
prerank,positive regulation of cell growth (GO:0030307),0.30734622565684533,0.7836423996738723,0.8189216683621566,0.9532627615084835,1.0,24/96,22.97%,SYT17;TGFBR1;SEMA4D;BRAT1;MACF1;SYT2;CSNK2A1;NEDD4L;TWF2;SDCBP;INO80;SMURF1;CXCL16;RASAL1;CDC42;PLAA;RPTOR;UNC13A;RIMS1;PABIR1;ITSN2;EXOSC2;H3-3A;GOLGA4
prerank,nucleotide metabolic process (GO:0009117),-0.24306783047747207,-0.7834641526260973,0.8011695906432749,0.94345244769185,1.0,11/23,28.82%,ME1;NUDT5;RNASEH2B;ENPP3;NMNAT1;PARK7;GUK1;AK4;CMPK2;NME2;CMPK1
prerank,transport across blood-brain barrier (GO:0150104),0.3091509987054363,0.7834377144538459,0.8180883864337102,0.9531602746336897,1.0,15/83,17.03%,SLCO2B1;ABCC3;ATP8A1;SLC7A8;SLC2A3;SLC16A2;FABP5;SLC16A1;ABCC1;ATP2A3;ATP1B2;LRP1;SLC1A4;CD36;SLC13A3
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.30416011749282723,0.7833576617846278,0.938,0.9528801628703947,1.0,62/241,21.69%,IK;SNRNP27;DHX9;BCAS2;SF3B2;SF3B1;PPIE;DHX38;SNRNP25;CWF19L1;CCAR1;DNAJC8;TFIP11;GCFC2;ZMAT5;CSTF1;CASC3;SNRPD2;CDC5L;RBM15B;CWC27;HNRNPL;RBMX2;DDX39B;SNIP1;POLR2L;CHERP;METTL3;PRPF8;TRA2B;CTNNBL1;RBM41;PCBP1;UPF3B;HNRNPD;WDR83;BUD31;CWF19L2;LSM8;CRNKL1;PCF11;PPIH;DDX41;SLU7;POLR2E;SNRNP200;HNRNPF;SRSF6;SNRPB2;SNRNP35;PNN;SRSF2;PABPN1;SF3B3;SART1;SRSF10;SRSF3;PTBP1;HNRNPA0;UBL5;PDCD7;PRCC
prerank,neuron cell-cell adhesion (GO:0007158),-0.29592492302378814,-0.7830840589106501,0.7530864197530864,0.9420711822324022,1.0,3/14,8.33%,NLGN1;ASTN1;NINJ2
prerank,protein mannosylation (GO:0035268),-0.2405357005313608,-0.7827645981453272,0.8186813186813187,0.9406003844824963,1.0,10/22,24.25%,DPM1;POMT2;RXYLT1;TMTC1;TMTC3;CRPPA;FKRP;DPM3;TMTC2;DPY19L4
prerank,phospholipid dephosphorylation (GO:0046839),-0.21216658957650325,-0.7822593839130386,0.8623853211009175,0.939457086665023,1.0,3/37,1.33%,MTM1;SACM1L;MTMR7
prerank,cellular response to leucine (GO:0071233),0.4054374604675469,0.7820789504232645,0.7373134328358208,0.9538498139719278,1.0,1/10,2.52%,MTOR
prerank,response to leucine (GO:0043201),0.4054374604675469,0.7820789504232645,0.7373134328358208,0.9538498139719278,1.0,1/10,2.52%,MTOR
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.3192301302338163,0.7820207394121925,0.7939914163090128,0.9535538416260985,1.0,6/56,12.29%,TGFB1;TGFBR1;HFE;INHBA;SNX25;SDCBP
prerank,negative regulation of stress fiber assembly (GO:0051497),0.35216102722311216,0.7819783467108374,0.7496932515337423,0.9532394011437293,1.0,6/24,13.26%,ARHGEF18;ARAP1;WASF2;F11R;PFN1;PPFIA1
prerank,regulation of mesenchymal cell proliferation (GO:0010464),0.3954437635410692,0.7815988859746144,0.7253218884120172,0.9533888857550282,1.0,3/11,11.18%,TGFBR2;LRP5;SOX9
prerank,"base-excision repair, gap-filling (GO:0006287)",-0.22269048176923728,-0.7811600850835267,0.8290598290598291,0.939295161409626,1.0,20/35,36.19%,RFC1;TDG;XRCC1;SMUG1;RFC2;POLG;LIG1;RPA3;NEIL1;POLD2;RPA2;RFC3;POLE;RFC4;MUTYH;PCNA;NTHL1;POLD4;POLD1;MPG
prerank,GTP metabolic process (GO:0046039),0.37949415176024776,0.7807841528959586,0.7402945113788487,0.9541051099427287,1.0,6/15,23.34%,GTPBP1;GNAI3;LRRK2;IMPDH2;MFN1;EFL1
prerank,protein K48-linked deubiquitination (GO:0071108),0.3507993170154882,0.7803230156588654,0.7415730337078652,0.954328449864967,1.0,5/23,14.79%,TNFAIP3;ATXN3;OTUD3;MINDY1;USP8
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.30304299200283663,0.7801874544504644,0.949,0.9541270030858662,1.0,67/264,21.69%,IK;SNRNP27;DHX9;BCAS2;SF3B2;SF3B1;PPIE;DHX38;SNRNP25;CWF19L1;SCAF11;CCAR1;DNAJC8;TFIP11;GCFC2;ZMAT5;CSTF1;SRPK3;CASC3;SNRPD2;CDC5L;RBM15B;CWC27;HNRNPL;RBMX2;DDX39B;SNIP1;POLR2L;CHERP;METTL3;PRPF8;TRA2B;CTNNBL1;RBM41;PCBP1;UPF3B;DDX1;HNRNPD;WDR83;BUD31;CWF19L2;LSM8;CRNKL1;PCF11;PPIH;DDX41;SLU7;POLR2E;SNRNP200;HNRNPF;SRSF6;SNRPB2;SNRNP35;PNN;SRSF2;CLNS1A;PABPN1;SF3B3;SART1;SRSF10;SRSF3;STRAP;PTBP1;HNRNPA0;UBL5;PDCD7;PRCC
prerank,selective autophagy (GO:0061912),0.3189131317208669,0.7801692630074668,0.7859424920127795,0.9537851555330376,1.0,23/56,27.25%,MAP1LC3B;UBE2V1;RAB7A;HDAC6;BECN1;DYNC1H1;WDR81;TEX264;RETREG1;ATG2B;UBE2N;WDFY3;ATG14;PRKN;RB1CC1;UBA5;IFT88;DYNC1LI1;NBR1;AMBRA1;DYNLL1;ATG2A;UFM1
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),-0.3161887663988851,-0.7801474886563484,0.7225806451612903,0.9389758609760149,1.0,7/10,45.23%,FMR1;CALM3;DRD2;CBARP;GPR35;CRHR1;DRD3
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.3084844808140791,0.7790805026403801,0.8338461538461538,0.9548327196808234,1.0,10/87,13.59%,CBL;GRB2;DSTYK;RAB14;CD44;FLRT1;POLR2L;CCL2;NR4A1;FIBP
prerank,protein modification process (GO:0036211),0.3096559336603382,0.7787876973335087,0.8213914849428868,0.9548578534073502,1.0,23/76,24.59%,ST8SIA4;UBE2D3;UBE2S;LOX;ST3GAL1;MAN2B1;PIGH;MCRS1;MSRA;YES1;CDC34;B4GALT7;ATG3;ERO1A;PPP4R2;CSNK1G3;UBL5;ADPRH;UBA7;UBE2I;PARP1;BAP1;ABL2
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.3258457895809491,0.7787061373666602,0.7779030439684329,0.9545978177940745,1.0,13/42,24.68%,MAD2L2;MMS19;ACTR2;SETD2;ERCC6;PPP4C;SHLD1;PPP4R2;SHLD2;SPIDR;TERF2IP;PARP1;KLHL15
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),0.3845247360340399,0.7785227937476522,0.7326869806094183,0.9544676187279907,1.0,4/13,13.27%,SEC16A;SEC16B;SORL1;SAR1A
prerank,NLS-bearing protein import into nucleus (GO:0006607),-0.2873937115278327,-0.778176129487124,0.7631578947368421,0.9401925231617656,1.0,2/13,6.00%,RANBP2;IPO5
prerank,negative regulation of cell growth (GO:0030308),0.303663716472771,0.7780739587701787,0.8527918781725888,0.9546854593448761,1.0,14/121,12.34%,TGFB1;PTPRJ;FGF13;NME6;DIP2B;CDA;TP53;FLCN;RB1;SMAD3;SIPA1;INHBA;RBBP7;PPP2CA
prerank,ribosomal subunit export from nucleus (GO:0000054),0.38599158119030325,0.777731280402157,0.7298772169167803,0.9547375481554041,1.0,3/13,13.03%,XPO1;NOP9;RRS1
prerank,regulation of chromatin organization (GO:1902275),0.3863120838234356,0.7771777222603025,0.7485795454545454,0.9550802461529806,1.0,3/14,10.19%,TLK1;METTL4;HPF1
prerank,negative regulation of centrosome duplication (GO:0010826),-0.30111454592926623,-0.7771403416847548,0.7422360248447205,0.9398041616241353,1.0,9/11,32.99%,TRIM37;CDK5RAP2;RBM14;CENATAC;NPM1;KAT2B;KAT2A;CCNF;BRCA1
prerank,mitotic nuclear division (GO:0140014),0.31385527020281373,0.7767010436249743,0.8222453222453222,0.955355389076742,1.0,14/71,17.75%,NUP62;ESPL1;BCCIP;NCAPG2;CEP192;UBE2S;CHEK2;RAB11A;STAG2;INO80;KIF2A;CENPK;MIS12;RHOA
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.33044819975717254,0.7759916556467975,0.7595505617977528,0.9558970045145132,1.0,11/35,25.52%,ALOX12;HPGD;GGTA1;FASN;ACACA;PPT2;FAR2;HMGCL;SCD;ACSS3;HSD17B8
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.3397915953971648,0.7745203448758906,0.7672811059907834,0.9570687320281926,1.0,6/29,22.16%,DBI;ACSF2;ACOT9;ACOT2;ACOT8;CROT
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.3397915953971648,0.7745203448758906,0.7672811059907834,0.9570687320281926,1.0,6/29,22.16%,DBI;ACSF2;ACOT9;ACOT2;ACOT8;CROT
prerank,replicative senescence (GO:0090399),0.38763581426134275,0.7736055892345973,0.7535211267605634,0.9578861089857539,1.0,2/12,7.97%,TP53;CHEK2
prerank,gluconeogenesis (GO:0006094),-0.22430417462067165,-0.7734716041456038,0.8627450980392157,0.9440590773990557,1.0,15/39,23.11%,SLC25A12;PGM1;MDH1;SLC25A13;PGK1;GOT1;ATF4;SLC39A14;SLC25A11;PER2;GAPDH;ALDOC;RBP4;ENO2;CRY1
prerank,negative regulation of cell-substrate junction organization (GO:0150118),-0.27392954085240495,-0.7734657799708236,0.7658730158730159,0.940100651851083,1.0,4/16,15.71%,PHLDB2;ACVRL1;ARHGAP6;DMTN
prerank,negative regulation of focal adhesion assembly (GO:0051895),-0.27392954085240495,-0.7734657799708236,0.7658730158730159,0.940100651851083,1.0,4/16,15.71%,PHLDB2;ACVRL1;ARHGAP6;DMTN
prerank,cellular response to amino acid stimulus (GO:0071230),0.3306393427694289,0.7732026162079003,0.7587768969422424,0.9580229491776026,1.0,11/33,21.78%,MTOR;CPEB3;GLRA2;FYN;LAMTOR3;CAPN2;CPEB4;LAMTOR1;RPTOR;RRAGA;RRAGB
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.3967034330914042,0.7726809974445505,0.7292576419213974,0.9583314712602832,1.0,4/10,22.86%,TFIP11;TERF2;DCLRE1C;TERF2IP
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.3740808349458807,0.772192226014966,0.7409470752089137,0.9585919898178443,1.0,2/14,8.96%,PTPN1;BAK1
prerank,regulation of rRNA processing (GO:2000232),-0.2654883780551942,-0.7720640983179721,0.7899159663865546,0.940316164318419,1.0,8/16,32.91%,RIOK2;SHQ1;UTP15;USP36;KAT2B;RIOK1;NUDT16;TRMT112
prerank,cardiac muscle cell contraction (GO:0086003),0.35638016938879485,0.7718099359202367,0.7487179487179487,0.9586999887476495,1.0,2/19,3.69%,SCN4B;PKP2
prerank,cellular response to hydroxyurea (GO:0072711),0.3979515899216499,0.7715545182496015,0.748159057437408,0.9586493326432364,1.0,2/10,9.48%,DDI2;ATRX
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.30583932231393185,0.7713304838604054,0.8322981366459627,0.9585620450088451,1.0,9/86,12.29%,TGFB1;TGFBR1;ZEB2;RNF111;HFE;FLCN;INHBA;THBS1;SDCBP
prerank,ribonucleoprotein complex assembly (GO:0022618),0.3029425218254882,0.769548998107682,0.8763819095477386,0.9604708233734243,1.0,41/132,25.15%,DHX9;PTGES3;SF3B1;SCAF11;XRCC5;GCFC2;SRPK3;SNRPD2;ERAL1;RPL6;EIF4H;DDX39B;LUC7L3;MDN1;RPS14;RRS1;DDX1;RPL11;HSP90AA1;TARBP2;CRNKL1;RPS27;SNRNP200;SRSF6;CLNS1A;SART1;RRP7A;SRSF10;STRAP;DICER1;EIF2S2;SNRPB;RPS15;GEMIN8;RPS5;DDX20;NUDT21;RPL10;NCBP1;XAB2;HSP90AB1
prerank,DNA repair (GO:0006281),0.2967330471462618,0.7692579994435561,0.939,0.9604632799444628,1.0,51/284,17.21%,EID3;FAM111A;NEIL2;GTF2H1;MAD2L2;UBE2V2;NABP1;UBE2V1;EXO1;XRCC5;BRIP1;BACH1;LIG3;ATXN3;TP53;POLH;FAAP100;CHEK2;DOT1L;ENDOV;TRIP13;MMS19;UVRAG;RAD54L;BABAM2;MGMT;SETD2;HPF1;MGME1;APTX;WDHD1;PDS5A;TEX264;PMS1;DNA2;INO80;HUWE1;SLX4;POLD3;DDX1;ALKBH5;ERCC5;REXO4;ERCC6;OGG1;RAD51B;BABAM1;FANCL;MDC1;UBE2N;FANCE
prerank,cell part morphogenesis (GO:0032990),-0.28383960571910555,-0.7692167132599176,0.7636986301369864,0.9428724393552306,1.0,6/13,28.43%,MTM1;NUBPL;WASF1;SLIRP;MYH14;PNPT1
prerank,mitotic sister chromatid cohesion (GO:0007064),0.36683342653949813,0.7687766275878694,0.7323568575233023,0.960711746102794,1.0,6/16,25.05%,RB1;PDS5A;NAA50;MAU2;SMC1A;PDS5B
prerank,regulation of DNA repair (GO:0006282),0.3193870201325871,0.7686218531352952,0.7897664071190211,0.9605312813359933,1.0,11/44,18.58%,DHX9;UBE2V2;UBE2V1;POLH;BABAM2;KAT7;ERCC6;BABAM1;UBE2N;NPAS2;TIGAR
prerank,negative regulation of telomere maintenance (GO:0032205),0.368793312104449,0.7685605550029213,0.7452574525745257,0.9602415481588898,1.0,7/15,23.59%,TNKS2;SLX4;ERCC1;TERF2;ERCC4;TERF2IP;PARP1
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),0.3765233731884125,0.7682896580514312,0.7524339360222532,0.9602081398816475,1.0,3/13,12.13%,MMS19;CIAO2A;CIAO1
prerank,regulation of mRNA 3'-end processing (GO:0031440),-0.3118061109788799,-0.7682472130767191,0.7734627831715211,0.9423699818314548,1.0,5/11,22.05%,AHCYL1;PAPOLA;PAF1;DHX36;NCBP2
prerank,aminoglycan metabolic process (GO:0006022),0.3999539667087425,0.7680134561498365,0.7540740740740741,0.9601712179810115,1.0,3/10,20.94%,XYLT1;B4GALT7;B3GAT2
prerank,protein heterotetramerization (GO:0051290),0.37603600568155815,0.7676496580183365,0.7384196185286104,0.9602691568113324,1.0,2/13,6.09%,PKD2;FARSB
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.282070646437554,-0.7676033424250771,0.7605633802816901,0.9414280595695084,1.0,4/13,17.10%,PTGIS;NAMPT;PTGS2;NNMT
prerank,mitochondrial protein processing (GO:0034982),0.3851894002079883,0.7670762410890187,0.7429378531073446,0.9606236149690024,1.0,5/11,19.72%,ATP23;IMMP2L;PMPCB;YME1L1;PMPCA
prerank,positive regulation of intracellular transport (GO:0032388),0.324635443498483,0.7669940450892304,0.7770114942528735,0.9603563976652022,1.0,7/38,12.79%,RIPOR1;KIF20B;PGAP1;TPR;DYNC1H1;PCM1;SORL1
prerank,regulation of axon extension (GO:0030516),0.3256756740821396,0.766453122059587,0.7761529808773904,0.9606775688537208,1.0,10/37,22.97%,APOE;DIP2B;MACF1;DNM2;TWF2;RTN4;GSK3B;MT3;NRCAM;GOLGA4
prerank,amide biosynthetic process (GO:0043604),0.31754222238255564,0.7653781680466362,0.793141592920354,0.9616559250460187,1.0,10/47,20.79%,CERS6;CLN8;AGK;DEGS1;ASAH1;FURIN;SGMS1;SPTSSA;SMPD1;SPTSSB
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.36517483141761264,0.765323671126446,0.7253044654939107,0.9613560548294288,1.0,5/14,21.54%,HDAC5;THBS1;RHOA;MAP2K5;MMRN2
prerank,regulation of gene expression by genetic imprinting (GO:0006349),0.39108112958759145,0.7652672739539326,0.7337278106508875,0.961057590459078,1.0,1/10,3.78%,DNMT3A
prerank,negative regulation of Rho protein signal transduction (GO:0035024),-0.2654448490156613,-0.7651026128523526,0.7821782178217822,0.9431958270284393,1.0,5/18,12.45%,KANK1;ARHGAP35;SCAI;MET;HEG1
prerank,DNA duplex unwinding (GO:0032508),0.3120051124484328,0.7648442573228214,0.80931744312026,0.9612572526349735,1.0,8/50,15.51%,GTF2H1;DHX9;ANXA1;MCM6;MCM2;MCM9;DDX1;TWNK
prerank,zinc ion homeostasis (GO:0055069),0.32936715259286703,0.7647352108890259,0.7550535077288941,0.9610205817285297,1.0,13/28,23.21%,ATP13A2;SLC39A6;PRKN;MT3;MT1G;MT1B;MT1E;MT1F;MT1A;MT1X;MT1M;MT1H;SLC30A10
prerank,peptidyl-lysine monomethylation (GO:0018026),0.39438724638568745,0.7646226573438062,0.7258064516129032,0.960789967755442,1.0,2/10,10.14%,SETD6;SETD2
prerank,protein monoubiquitination (GO:0006513),0.326668718747295,0.7644577692193529,0.7840269966254219,0.9606308004986128,1.0,12/36,23.31%,TRIM25;UBE2D3;MGRN1;LEO1;RNF40;HUWE1;FANCL;CUL3;PRKN;UBE2R2;UBE2E1;CTR9
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.3526479391220031,0.7640511597236689,0.7382465057179162,0.9607766924618213,1.0,3/19,12.48%,PYCARD;TP53;DDIT4
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),0.37201345586116996,0.7639317982932884,0.7535853976531942,0.9605679567784203,1.0,2/15,6.68%,TGFBR1;TGFBR2
prerank,central nervous system neuron axonogenesis (GO:0021955),-0.2919728017002289,-0.7638644814425934,0.7900355871886121,0.943200971557832,1.0,2/12,4.78%,ARHGAP35;EPHB2
prerank,peptidyl-lysine acetylation (GO:0018394),-0.3009824196990779,-0.7637007237581299,0.7847682119205298,0.9414871029249287,1.0,1/10,1.29%,ESCO1
prerank,protein O-linked mannosylation (GO:0035269),-0.2540613406818804,-0.7634213181130363,0.8388625592417062,0.9399630934146413,1.0,9/18,23.47%,DPM1;POMT2;RXYLT1;TMTC1;TMTC3;CRPPA;FKRP;DPM3;TMTC2
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.37829949385627704,0.7630658785479233,0.761969904240766,0.9613098728937965,1.0,5/13,23.34%,GTPBP1;GNAI3;LRRK2;MFN1;EFL1
prerank,synapse organization (GO:0050808),0.29749489794821293,0.7623656306137067,0.8699596774193549,0.9618400834331341,1.0,17/125,14.72%,CX3CR1;PCDHB6;ARHGAP39;C1QC;SLITRK1;SNCA;AGRN;C1QA;CACNB4;RAB39B;C1QB;CACNB2;CYFIP1;CACNB1;PPFIA1;LRRK2;KIRREL3
prerank,cytoplasmic sequestering of protein (GO:0051220),0.37036001753667613,0.761992102563922,0.733983286908078,0.9619313549376983,1.0,5/13,21.97%,PKD2;YWHAB;KEAP1;NFKBIE;FLNA
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.3195611315887421,0.7617193096490543,0.7888762769580022,0.9618865925012037,1.0,5/35,11.18%,AQP1;APOE;NUDT4;CAP1;SOX9
prerank,tRNA wobble uridine modification (GO:0002098),0.3740160659405056,0.76128847677005,0.7297297297297297,0.9620601836347842,1.0,3/14,11.47%,ELP1;TRMU;CTU1
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.3563315792685529,0.7606018475044939,0.7639593908629442,0.9625311312993402,1.0,2/17,3.69%,SLC8A1;PKP2
prerank,replication fork processing (GO:0031297),0.3253887111845452,0.7600744798201811,0.798196166854566,0.9628296175585127,1.0,5/38,13.34%,FAM111A;SAMHD1;ATRX;BOD1L1;DNA2
prerank,synaptic vesicle cycle (GO:0099504),0.33473200958032234,0.7599771061192127,0.7617370892018779,0.9625852363907182,1.0,4/30,9.11%,SNCA;PIP5K1C;PLD2;SYT10
prerank,dendrite self-avoidance (GO:0070593),0.3624969591374136,0.7597591949617593,0.7367741935483871,0.9624849361890407,1.0,6/16,24.11%,EMB;NPTN;VSTM2L;PALLD;CNTN4;BSG
prerank,glycosphingolipid biosynthetic process (GO:0006688),0.3626996575170197,0.7596447569392928,0.7538071065989848,0.9622568539596481,1.0,6/16,21.48%,ST8SIA4;ST6GALNAC4;ST8SIA1;LARGE1;B4GALNT1;B4GALT6
prerank,cochlea morphogenesis (GO:0090103),-0.3071659401323106,-0.7594129724774272,0.786144578313253,0.9441263955556549,1.0,3/10,15.27%,TBX18;TBX1;PAX2
prerank,organelle transport along microtubule (GO:0072384),0.3282061675018309,0.7593542296711353,0.7885264341957255,0.962237415042651,1.0,5/31,11.78%,UXT;CLN3;ARHGAP21;BORCS5;BICD2
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.33432009924227457,0.7591532746427444,0.7622950819672131,0.9621315183927223,1.0,5/29,11.42%,TLE3;CTNNB1;LEO1;RBBP5;PYGO2
prerank,positive regulation of transmembrane transport (GO:0034764),0.3664006308650666,0.7591400487847682,0.7564625850340136,0.9617850727513096,1.0,2/13,13.30%,P2RX7;BRAF
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.35073111594737283,0.7590156702001922,0.7803680981595092,0.9615844583212083,1.0,7/21,19.95%,MLXIPL;NCK2;DDIT4;PTEN;PAQR3;CNKSR3;INPP5K
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.34055910154479124,0.7587859425637701,0.7647768395657418,0.961501495969487,1.0,11/23,29.29%,HMGB1;REXO4;KPNA1;DICER1;DNASE2;DNASE1L1;DFFB;CECR2;KPNB1;HMGB2;DFFA
prerank,negative regulation of sprouting angiogenesis (GO:1903671),0.3868054356008386,0.758234840022158,0.7524613220815752,0.9618394134859152,1.0,4/11,16.53%,PIK3CB;CREB3L1;THBS1;EPN1
prerank,mitochondrial transport (GO:0006839),0.31051928170428855,0.7579697778308467,0.8118279569892473,0.9618135677248266,1.0,6/53,8.96%,TSPO;SLC25A16;AIP;BCL2L1;TIMM22;BAK1
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.3366591053060275,0.7578927464538843,0.7633209417596035,0.9615417384557896,1.0,10/23,27.37%,NABP1;PLK2;PABIR1;PRCC;INTS3;ZWINT;BUB1B;CDK5RAP3;ZWILCH;WEE1
prerank,protein ADP-ribosylation (GO:0006471),0.3288803282012081,0.7577874890882806,0.7797202797202797,0.9613093518551717,1.0,6/28,13.24%,ART4;PARP8;HPF1;PARP16;TNKS2;TIPARP
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),-0.2457653979192078,-0.757341730282657,0.7892156862745098,0.9453045262022126,1.0,10/21,28.50%,PAN2;CNOT3;SAMD4B;SAMD4A;TNKS1BP1;PAN3;PARN;CNOT6L;CNOT9;ZFP36
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.3401542679689548,0.7572741790775497,0.7714285714285715,0.9615745999422377,1.0,7/25,16.53%,ATXN3;LONP1;DERL1;HDAC6;TOR1A;STUB1;YME1L1
prerank,ERK1 and ERK2 cascade (GO:0070371),0.3442867150903851,0.7572199226977429,0.770573566084788,0.9612752200018739,1.0,10/21,27.72%,MAP2K2;SOX9;ZFP36L1;MT3;IGF1;KDR;PTGER4;MAPK1;MAPK3;CTSH
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.2986398905701595,0.7569510498173159,0.8680981595092024,0.961243815865461,1.0,20/94,17.85%,IL1A;IRAK2;UBE2V1;PSMB10;ST18;PSMA2;RPS6KA4;NOD2;PSME3;TAB2;IKBKG;NFKB1;PSMB5;PSMD8;TAB3;PSMD7;PSMB9;UBE2N;RPS6KA5;PSMD2
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),-0.28096125378606157,-0.7568530012177739,0.8095238095238095,0.9441651197104769,1.0,5/13,18.42%,SP100;RAB23;NUP153;PARK7;CABP1
prerank,postsynaptic membrane organization (GO:0001941),0.3606727203114779,0.7563655696313285,0.7526178010471204,0.9615755059623373,1.0,2/17,4.47%,APOE;CEL
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.3716158699529453,0.7560788614401199,0.7549933422103862,0.9615734810171531,1.0,7/13,28.34%,TNRC6A;CPEB3;AGO2;CNOT7;CNOT1;BTG2;TNRC6C
prerank,negative regulation of synaptic transmission (GO:0050805),-0.23377559553568042,-0.7559524628166956,0.8579881656804734,0.9434898269106619,1.0,8/23,25.87%,ATAD1;SLC24A2;SLC30A1;PRRT1;SHANK2;DRD2;ARF1;STXBP1
prerank,positive regulation of chromosome organization (GO:2001252),-0.2645454137262837,-0.7557385420773457,0.8022388059701493,0.9418609140861376,1.0,4/15,17.71%,PML;MRE11;GNL3;DHX36
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.33159838873391445,0.755563636938816,0.7638888888888888,0.9618276630106936,1.0,6/28,18.72%,GAS2L1;MAPRE1;MAP1B;CAMSAP2;MAPRE2;GBA2
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.29954383329637707,0.7552173957548823,0.849846782431052,0.961903035641593,1.0,14/88,16.29%,EDNRB;CLN8;APOE;CNOT8;CLN3;LARP1;EPRS1;CPEB3;NELL1;HDAC6;PCIF1;NFKB1;IGF2BP3;PUS7
prerank,actomyosin structure organization (GO:0031032),0.30042787386739267,0.7544972640411152,0.8243801652892562,0.962390836617785,1.0,15/75,15.27%,ITGB5;TTN;MYLK3;MYH9;FLII;TNNT3;EPB41;F11R;EPB41L2;ZYX;MYH10;CSRP1;PDLIM1;CAPN3;SRC
prerank,hemidesmosome assembly (GO:0031581),0.38680988881582784,0.754022832714956,0.7381294964028777,0.962615385126489,1.0,3/11,15.77%,ITGA6;LAMA3;DST
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.38289900450932984,0.7540191746828133,0.7496206373292867,0.9622580763303821,1.0,3/10,15.10%,HDAC5;SMARCB1;PIH1D1
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.3753893973691166,0.753969056292498,0.7564979480164159,0.9619575203043697,1.0,2/13,9.02%,PTPN1;PDCD6
prerank,regulation of cell growth (GO:0001558),0.291101954236854,0.7537650364346784,0.932,0.9618250300003225,1.0,31/204,16.18%,TGFB1;TGFBR1;PTPRJ;MAD2L2;MTOR;NME6;BRAT1;RASGRP2;CDA;CDK11B;TP53;PRKCQ;KIF14;CSNK2A1;FLCN;RB1;SMAD3;SIPA1;BCAR1;INHBA;RBBP7;SDCBP;PPP2CA;ITCH;RAB33B;INO80;ATAD3A;ARHGEF11;SGK3;CXCL16;RTN4
prerank,endothelial cell development (GO:0001885),-0.22492483667557878,-0.7529226695668259,0.8717948717948718,0.9438472736596425,1.0,8/25,17.19%,RAPGEF3;MYADM;RDX;MET;RAPGEF2;EZR;PDE2A;ROBO4
prerank,mRNA export from nucleus (GO:0006406),0.29742046226590035,0.7526691780018164,0.867274569402229,0.9627936205834889,1.0,28/102,20.95%,PCID2;NUP62;DHX38;NXF1;THOC2;SEH1L;CASC3;RBM15B;SMG1;TPR;DDX39B;NUP205;POLDIP3;UPF3B;THOC3;ALKBH5;SMG7;UPF2;SLU7;FYTTD1;SRSF6;SRSF2;SEC13;PABPN1;HHEX;SLBP;SRSF3;NUP54
prerank,histone H3-K4 trimethylation (GO:0080182),0.37987227749801894,0.7522592014084918,0.7614285714285715,0.962926782323588,1.0,5/11,23.31%,TET3;SETD1B;WDR82;TET2;CTR9
prerank,purine ribonucleotide metabolic process (GO:0009150),0.3025617646407844,0.7514872796417782,0.8459119496855346,0.9635056216705772,1.0,17/68,23.34%,DBI;SULT4A1;GTPBP1;HINT1;BPNT1;ACSF2;TPST1;GNAI3;LRRK2;ACOT9;ACOT2;MFN1;GMPR2;ACOT8;CROT;TPST2;EFL1
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.32829504529593917,0.7512811479669663,0.7804014167650531,0.9634028674020644,1.0,6/28,15.94%,HCLS1;PFN2;PFN1;COTL1;ARHGAP18;RASA1
prerank,cellular response to arsenic-containing substance (GO:0071243),0.3663262258992586,0.7502296174914193,0.7487046632124352,0.9643265608923329,1.0,3/15,16.46%,ATF3;HSF1;CPEB2
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.3479319690606383,0.7501318476637042,0.7753246753246753,0.9640819669392334,1.0,2/19,10.02%,APOE;RAPSN
prerank,glycolipid biosynthetic process (GO:0009247),0.3201376459515659,0.750098682227782,0.805094130675526,0.9637631151629684,1.0,13/38,23.19%,PIGM;PIGL;PIGV;PIGH;ST8SIA1;LARGE1;PGAP2;PIGU;PIGC;B4GALT6;PIGN;DPM2;PIGP
prerank,sulfur amino acid metabolic process (GO:0000096),0.33430531539442215,0.7497258601750159,0.7742331288343558,0.9638312232138436,1.0,5/24,16.86%,TXN2;MSRA;MMUT;MTR;CBS
prerank,regulation of cilium movement (GO:0003352),0.3888499982233947,0.7496850218959702,0.7769679300291545,0.9635161739572129,1.0,1/10,5.50%,ODAD2
prerank,neuromuscular synaptic transmission (GO:0007274),0.35355479483907526,0.7488070085131975,0.7680412371134021,0.9642007618556755,1.0,4/18,18.37%,RIMBP2;DTNA;STAC3;KIF1B
prerank,protein destabilization (GO:0031648),0.32913493674597133,0.7482321441856451,0.7888127853881278,0.9645455368899482,1.0,16/32,29.05%,SNCA;DERL1;FBXL3;CAPN3;IRGM;FBXW11;CUL3;PRKN;HTT;GGA3;CTSH;PRNP;CREBBP;SENP2;EP300;CDC73
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),-0.2454591959704304,-0.7476554915649112,0.8104265402843602,0.949398232464074,1.0,5/20,12.27%,AFG3L2;MICU1;SLC8A3;SPG7;MCUR1
prerank,regulation of protein kinase C signaling (GO:0090036),-0.28039906219231736,-0.7475255504406031,0.8065843621399177,0.9476266152844703,1.0,3/14,6.35%,WNT5A;ULK4;MYADM
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.33946651069042716,0.7474459418648993,0.7767106842737095,0.9651237389437017,1.0,6/23,19.44%,HERPUD1;SEL1L;DERL1;SEC16A;SEC13;OS9
prerank,negative regulation of protein transport (GO:0051224),0.33238074934407436,0.7471487881403377,0.8107142857142857,0.9651034652927502,1.0,2/25,4.68%,APOE;RHBDF2
prerank,regulation of autophagosome maturation (GO:1901096),0.36858103191317804,0.7467711141513046,0.7901726427622842,0.9651963074924113,1.0,3/13,16.30%,CLN3;UVRAG;IRGM
prerank,dicarboxylic acid metabolic process (GO:0043648),0.308891443686968,0.7463466782936989,0.8295819935691319,0.9653271507323541,1.0,4/52,6.93%,DGLUCY;MTHFS;HAAO;OGDH
prerank,response to growth factor (GO:0070848),0.31183519448127095,0.7453521524043,0.8057713651498335,0.9661448326809547,1.0,7/41,14.24%,TGFBR1;CTNNB1;TGFBR2;STAT5B;HDAC6;TWF2;SOX2
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),0.37863704282678945,0.7451819114404763,0.7547723935389133,0.9659862562531416,1.0,2/11,15.64%,P2RX4;GSK3A
prerank,negative regulation of mononuclear cell migration (GO:0071676),0.3749491871133147,0.7445810614657049,0.7788873038516405,0.966345208165936,1.0,1/12,1.96%,SLAMF8
prerank,nucleosome assembly (GO:0006334),0.3172850791890168,0.7441216380660991,0.792,0.9665153590811982,1.0,11/31,22.84%,ASF1B;ATRX;NAP1L1;SOX9;SPTY2D1;RSF1;UBN1;RBBP4;IPO4;SMARCA5;H3-3A
prerank,protein localization to cilium (GO:0061512),-0.21939603345098327,-0.7433042439238678,0.8897058823529411,0.9514739332324096,1.0,15/32,26.97%,ZNF423;ATP6V1D;ARL3;BBS4;ARL6;EHD1;WDR35;IFT20;TCTN2;BBS1;TUB;IFT122;WDR19;TULP2;NPHP4
prerank,cellular response to hypoxia (GO:0071456),0.2920822001253357,0.7430294100287621,0.8950554994954592,0.9674208058779499,1.0,25/126,18.91%,AQP1;ADAM8;ANGPT4;MTOR;RGCC;BACH1;TP53;PSMB10;P4HB;EPO;PSMA2;PSME3;TBL2;STUB1;PSMB5;PSMD8;PSMD7;PSMB9;HIF1A;CPEB2;SUV39H1;VHL;PSMD2;TIGAR;ELOB
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),0.2926486390707307,0.7426290016171648,0.8524251805985552,0.9675140731717733,1.0,9/75,11.42%,NEFH;S100B;SLITRK1;ACTB;MEF2A;MEF2C;RB1;MAP1B;ATL1
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.37639564550743737,0.7420843135400153,0.7829787234042553,0.9670706304259427,1.0,1/11,3.26%,SLC25A16
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.37639564550743737,0.7420843135400153,0.7829787234042553,0.9670706304259427,1.0,1/11,3.26%,SLC25A16
prerank,coenzyme A biosynthetic process (GO:0015937),0.37639564550743737,0.7420843135400153,0.7829787234042553,0.9670706304259427,1.0,1/11,3.26%,SLC25A16
prerank,mitochondrial membrane organization (GO:0007006),-0.215145839141041,-0.7414760154679976,0.8604651162790697,0.9520560572459591,1.0,11/32,22.79%,APOOL;IMMT;SLC25A4;BNIP3;SPG7;SAMM50;BAD;MFN2;MTX3;SLC25A5;APOO
prerank,regulation of cell cycle phase transition (GO:1901987),0.29204793223161857,0.7412529937361152,0.8629856850715747,0.9677224721874181,1.0,16/91,17.85%,ANAPC15;CDC23;TAF1;UBE2S;TP53;PSMB10;DBF4;PSMA2;FZR1;PSME3;PSMB5;PSMD8;PSMD7;PSMB9;ANAPC11;PSMD2
prerank,cellular response to exogenous dsRNA (GO:0071360),0.37443727063342447,0.7409107014493712,0.7722222222222223,0.9677530282206926,1.0,1/12,2.82%,DHX9
prerank,negative regulation of DNA metabolic process (GO:0051053),-0.23293186201064653,-0.7402679915495028,0.8682634730538922,0.9518113608986425,1.0,10/24,30.48%,DACH1;ACVRL1;MSH2;MSH6;H1-0;CDKN1A;BMPR2;NIBAN2;MSH3;RTEL1
prerank,cilium movement (GO:0003341),0.3108435688832244,0.7401418425651439,0.8282608695652174,0.9683011476327197,1.0,5/47,13.03%,DNAI4;ODAD2;TTC29;ODAD1;CCDC63
prerank,mitotic spindle organization (GO:0007052),0.29195719724098307,0.7399705998439347,0.9168336673346693,0.9681389733555092,1.0,30/153,19.42%,ERCC6L;CENPO;NEK6;BCCIP;XPO1;CEP192;MAPRE1;SEH1L;PLK2;CHEK2;KIF23;RAB11A;DYNC1H1;PMF1;CENPI;STAG2;KIF2A;PPP1CC;INTS13;CENPQ;PTPA;INCENP;EML4;CENPK;MIS12;RPS27;RHOA;DCTN6;TAOK1;SEC13
prerank,determination of bilateral symmetry (GO:0009855),0.33397869559759286,0.7399011471940093,0.7889022919179735,0.9678568010296072,1.0,2/24,5.50%,PKD2;ODAD2
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.3016141865650895,0.739879633592918,0.8379828326180258,0.9675220675749312,1.0,13/56,17.75%,SNX9;ESPL1;SNX33;KIF23;SON;BIN3;MYH10;USP8;PDCD6IP;RASA1;INCENP;SNX18;RHOA
prerank,chromatin organization (GO:0006325),0.2910582466242626,0.7397854448322436,0.89738430583501,0.967263653185491,1.0,34/132,19.98%,NPM3;BPTF;SPI1;HDAC5;SNAI1;RB1;ARID1A;ATRX;HDAC4;SETD2;CHD1;BAZ1A;HCFC2;SOX9;MTF2;BRDT;SMARCD3;SMARCB1;FAM50A;HCFC1;INO80;HDAC11;SOX2;PIH1D1;SMARCAD1;SUV39H1;LRWD1;RSF1;KDM4C;PHF1;TOP1;KDM5A;RBBP4;KDM5B
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),-0.2929198050285492,-0.7395759128594803,0.8104575163398693,0.9507360269182237,1.0,2/11,5.70%,GSN;CAAP1
prerank,embryonic organ development (GO:0048568),0.29709375867488697,0.7392014924541991,0.8307045215562566,0.9675843387067152,1.0,6/61,7.98%,TGFB1;TNF;TEAD1;TGFBR2;TAL1;FLT3LG
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.3254717890013411,0.7388401694403331,0.7830188679245284,0.9676354931767646,1.0,7/27,23.58%,CTPS1;TXNRD1;RRM2B;AK8;GSR;AK5;AK1
prerank,regulation of tube diameter (GO:0035296),-0.2737302568323334,-0.7376916671335291,0.8415492957746479,0.9494811358027938,1.0,4/13,12.61%,SCPEP1;ROCK1;ACE;NOS3
prerank,vascular process in circulatory system (GO:0003018),-0.2737302568323334,-0.7376916671335291,0.8415492957746479,0.9494811358027938,1.0,4/13,12.61%,SCPEP1;ROCK1;ACE;NOS3
prerank,cardiac ventricle development (GO:0003231),-0.24350846952742727,-0.7370332328363556,0.8585858585858586,0.9484099388070447,1.0,10/20,33.76%,SALL1;HES1;STRA6;PDE2A;HEY2;MATR3;DAND5;TMEM65;HEY1;DLL4
prerank,photoreceptor cell development (GO:0042461),-0.25677362235395956,-0.7368054354874205,0.8326180257510729,0.9468105769514766,1.0,5/14,21.11%,RORB;ARL3;TOPORS;RP1;MFSD2A
prerank,cellular response to hexose stimulus (GO:0071331),0.33157388400190685,0.7363483455992038,0.7766624843161857,0.970211669162829,1.0,5/23,14.61%,ERN1;TRA2B;GAS6;ADCY8;SOX4
prerank,regulation of cell death (GO:0010941),0.2895158293167189,0.7362454205215606,0.8751279426816786,0.969980120448938,1.0,22/94,22.07%,CALCR;SNCA;CTSZ;ACER3;IMPACT;BECN1;PARP16;TNFRSF1B;RRAS2;LRRK2;SOX4;LRP1;CD36;FAF1;NPAS2;SRSF6;RAB29;PRKN;CRYAB;FGF2;CHP1;MT3
prerank,response to cadmium ion (GO:0046686),0.3195185150536146,0.7354442998489001,0.8012121212121213,0.9705396944007416,1.0,11/26,22.29%,HAAO;HSF1;MT3;MT1G;MT1B;MT1E;MT1F;MT1A;MT1X;MT1M;MT1H
prerank,cardiolipin metabolic process (GO:0032048),0.35680222813299445,0.7353708609388581,0.771545827633379,0.970259757228825,1.0,7/13,25.79%,PGS1;LCLAT1;PTPMT1;PLA2G5;PLA2G6;HADHA;HADHB
prerank,cellular response to corticosteroid stimulus (GO:0071384),-0.2663960494972728,-0.7353593862542944,0.8502202643171806,0.9468607366189802,1.0,4/15,14.17%,REST;HNRNPU;UBE2L3;BCL2L11
prerank,positive regulation of behavior (GO:0048520),-0.2925287733062764,-0.7349622656742975,0.8055555555555556,0.9454801934980369,1.0,1/10,0.39%,NLGN1
prerank,DNA-dependent DNA replication (GO:0006261),0.28617511587327665,0.7345823061021052,0.9054325955734407,0.9707936478815092,1.0,23/128,15.62%,MCM5;ORC3;PSMB10;MCM6;MCM2;DBF4;MGME1;BAZ1A;PSMA2;ORC4;WDHD1;CDC34;PSME3;DNA2;MCMBP;PSMB5;CDC6;POLD3;PSMD8;NOC3L;PSMD7;TWNK;PSMB9
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.3435480064691489,0.7344292191295152,0.7742749054224464,0.9706193955578885,1.0,7/18,21.09%,VPS18;RAP1B;DTNBP1;LRRK2;RAP1A;GSK3B;RIMS1
prerank,positive regulation of binding (GO:0051099),0.29232639138761846,0.7332994533830287,0.9022633744855967,0.9715474534825581,1.0,29/84,25.13%,DHX9;APOE;SKI;HMGB1;TAF1;HFE;SPPL3;DERL1;EPB41;BAMBI;B2M;STK3;LRRK2;LRP1;IDE;RPL11;STK4;ADD1;FLOT1;DACT1;GSK3B;PRKN;PIN1;VTN;AMFR;IGF1;DDX11;PARP9;NCBP1
prerank,regulation of multicellular organism growth (GO:0040014),0.34464356656794737,0.7328139142168411,0.7941567065073041,0.971745512771571,1.0,3/15,14.18%,STAT5A;STAT5B;MBD5
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.2850305103456687,0.7325704685804021,0.9348044132397192,0.9716548550563253,1.0,33/161,18.79%,DRAXIN;TMEM131L;MAD2L2;MDK;TLE3;DKK2;APOE;TPBGL;DDIT3;PSMB10;SCYL2;AMER1;PSMA2;SOX9;PTPRU;PTPRO;CSNK1A1;PSME3;STK3;PSMB5;SOX2;PSMD8;TLE5;PSMD7;PSMB9;GSK3A;INVS;STK4;ZNRF3;PSMD2;GREM1;DACT1;IGFBP4
prerank,negative regulation of TOR signaling (GO:0032007),0.31485255614021385,0.7323853256386325,0.8365276211950394,0.9714988086137842,1.0,7/36,15.64%,FNIP1;FLCN;PDCD6;DDIT4;TMEM127;RNF152;GSK3A
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.3234959454320405,0.7323625059292556,0.802158273381295,0.9711644623525753,1.0,5/27,13.46%,CCM2;MAP3K5;IKBKG;KAT7;NFKB1
prerank,regulation of insulin secretion (GO:0050796),0.2912885929913857,0.732110459186318,0.8888888888888888,0.9710870501876009,1.0,16/101,16.82%,KCNJ11;NR1H4;TNF;CACNA1A;TFAP2B;ITPR2;ENSA;LRP5;SLC8B1;KCNA5;RAP1A;SOX4;STXBP4;CACNA1D;GCK;PPP3CB
prerank,telomere capping (GO:0016233),0.3484843202027307,0.7311830826369635,0.798140770252324,0.971786311250363,1.0,7/16,22.93%,TFIP11;STN1;TINF2;TERF2;DCLRE1C;TERF2IP;TEN1
prerank,negative regulation of dephosphorylation (GO:0035305),0.34447079542626435,0.7310567519506584,0.8023106546854942,0.9715681282451926,1.0,7/18,26.12%,YWHAB;ENSA;PTPA;INPP5K;CHP1;PPP1R16B;MFHAS1
prerank,regulation of presynapse assembly (GO:1905606),0.34381960067439743,0.7310465457171952,0.7747183979974969,0.9708577142502637,1.0,2/18,3.87%,SLITRK1;SNCA
prerank,regulation of presynapse organization (GO:0099174),0.34381960067439743,0.7310465457171952,0.7747183979974969,0.9708577142502637,1.0,2/18,3.87%,SLITRK1;SNCA
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.35620215452709264,0.7309440719665666,0.8015873015873016,0.9706215178926338,1.0,3/14,14.16%,TSEN15;RTRAF;DDX1
prerank,peptide metabolic process (GO:0006518),0.29111535843472736,0.7306049139994678,0.8613963039014374,0.9706332654085558,1.0,16/75,18.38%,GSTT4;HPGDS;SPCS2;SEC11C;SPPL3;SPCS1;NLN;NAALADL1;DNPEP;PARL;CTNS;ERAP1;IDE;FURIN;GSTM2;GSR
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.2961575479397122,0.7305476829952176,0.8709677419354839,0.9703355020924511,1.0,19/76,20.84%,LAPTM5;TANK;MALT1;DERL1;HDAC4;AMER1;STUB1;HUWE1;UBA2;WFS1;LRRK2;PIAS1;GSK3A;BIRC2;ANGPT1;DCUN1D5;RWDD3;CUL3;BIRC3
prerank,"DNA-templated transcription, termination (GO:0006353)",0.29524466407069766,0.7305167384610265,0.8654048370136698,0.9700133139935778,1.0,9/68,10.96%,GTF2H1;TAF1A;POLR1E;TTF1;CSTF1;LSM11;CDK7;POLR1B;POLR2L
prerank,regulation of axonogenesis (GO:0050770),0.3011679725633731,0.7304884069482727,0.8233369683751364,0.9696917429470283,1.0,10/51,17.75%,THY1;PLXNC1;SLITRK1;PLXNB2;ARHGDIA;EFNB3;RTN4;EPHA4;PTEN;RHOA
prerank,positive regulation of catalytic activity (GO:0043085),0.309560533636775,0.7302306190383011,0.8183856502242153,0.9696299364815878,1.0,4/37,6.62%,MAPK14;ATP7A;XRCC5;YWHAB
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.3252421780885064,0.7300932626647346,0.8188073394495413,0.9694242575630422,1.0,8/28,21.55%,MAD2L2;TFIP11;HSF1;ACTR2;ERCC6;SHLD1;SHLD2;PARP3
prerank,positive regulation of lipid biosynthetic process (GO:0046889),0.3161912401704954,0.7300207595343614,0.8191616766467066,0.9691388475154689,1.0,3/29,4.14%,MTOR;MLXIPL;APOE
prerank,calcium ion transmembrane transport (GO:0070588),0.2892763062016057,0.7297252847158202,0.8796296296296297,0.9691280260113742,1.0,21/86,19.72%,P2RX7;SLC8A1;PKD2;P2RX4;CACNA1A;ATP2C1;ATP2B1;SLC8B1;ATP2B3;PARL;GAS6;ATP2A3;TRPV3;PMPCB;YME1L1;CACNA1D;TMEM165;MICU2;MCOLN1;NALCN;PMPCA
prerank,fatty acid beta-oxidation (GO:0006635),0.29535563123348896,0.7296957246843445,0.8438864628820961,0.9687937550029007,1.0,11/51,18.65%,EHHADH;ACAD10;ACADL;ABCD1;ECHS1;ECI1;CPT2;PPARD;ABCD2;ETFDH;ECHDC1
prerank,vascular transport (GO:0010232),0.2897014688880856,0.7294941419118298,0.8725388601036269,0.9686726420421616,1.0,12/81,15.11%,SLCO2B1;ABCC3;ATP8A1;SLC7A8;SLC2A3;SLC16A2;SLC16A1;ABCC1;ATP2A3;ATP1B2;LRP1;SLC1A4
prerank,response to gamma radiation (GO:0010332),0.33321366100520167,0.7293776134963267,0.8036585365853659,0.9684514393056268,1.0,4/24,10.47%,XRCC5;TP53;HSF1;RPL26
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),-0.28669659888971705,-0.7292406279431942,0.8022388059701493,0.9510519008475266,1.0,6/12,22.20%,WAC;SDE2;PRKDC;FBXO31;CDK2;PLK5
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.35077066407480084,0.7291103055050328,0.7906666666666666,0.9683993185033667,1.0,2/15,9.18%,MLXIPL;PPARGC1A
prerank,brain development (GO:0007420),0.28667230444701497,0.7288629627714771,0.9101010101010101,0.9682988833538617,1.0,30/136,20.41%,SLC6A4;CX3CR1;EEF1AKMT4-ECE2;BPTF;CXCR4;PLXNB2;TGFBR2;NKX2-1;PAFAH1B2;SCYL2;QARS1;POMK;ADGRG1;DDIT4;SYNJ1;CTNS;SOX6;ZFHX3;MEIS1;JHY;POU6F1;NF1;PTEN;TBC1D23;PHGDH;RELN;CNTN4;CDK5R1;UTP3;FBXW11
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.3045239542634397,0.7282449669252999,0.8311111111111111,0.9686425993178748,1.0,19/45,26.62%,FOXO3;LARP1;RC3H1;TDRD7;PUM2;CYFIP1;PCIF1;PUM3;MEX3D;PER1;ATG14;ZC3H7A;NUDT21;RPL10;ZC3H7B;EIF2A;PARP9;PUM1;TSC1
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.3170158579318143,0.7282039505070333,0.7964497041420119,0.9683349132964794,1.0,6/26,18.66%,NR1H4;LRP5;ADCY8;STXBP4;PPP3CB;KLF7
prerank,positive regulation of tissue remodeling (GO:0034105),0.3755017272095855,0.7281332976855304,0.7753934191702432,0.9680670741815098,1.0,1/10,5.08%,IL18
prerank,negative regulation by host of viral process (GO:0044793),0.380558622355437,0.7277857772568973,0.7766116941529235,0.9681030781382152,1.0,1/10,3.44%,CCL8
prerank,chromatin assembly or disassembly (GO:0006333),0.3713405065286443,0.7267326808711179,0.8067226890756303,0.9689421967057148,1.0,3/11,19.59%,TP53;NOC2L;RBBP4
prerank,protein homooligomerization (GO:0051260),0.2823651647843542,0.726727404636186,0.8897876643073812,0.968591883542578,1.0,22/114,20.98%,CARD11;ALDH9A1;PKD2;PYCARD;SAMHD1;AQP11;ATL1;RNF135;B2M;NINJ1;TMEM120A;ADCY8;PDCD6IP;ACACA;USP16;ALS2;APPL2;ATL2;MCOLN1;ATL3;KCNJ2;HCN1
prerank,negative chemotaxis (GO:0050919),0.31338571124480197,0.7264715237805736,0.8222477064220184,0.968514242938646,1.0,3/33,5.21%,ITGB3;SEMA4D;LGR6
prerank,photoperiodism (GO:0009648),-0.21961715394180564,-0.7264692801032616,0.8805031446540881,0.9527787807932868,1.0,10/28,23.11%,PPP1CB;CLOCK;PML;SIK1;RBM4B;USP2;PER2;PPP1CA;RBM4;CRY1
prerank,recombinational repair (GO:0000725),0.2874217375534197,0.7260624024875613,0.8804123711340206,0.9686193327811641,1.0,22/77,23.59%,ZFYVE26;NABP1;RMI1;SAMHD1;LIG3;YY1;MCM9;INO80;SLX4;ERCC5;RAD51B;UBE2N;SWI5;RAD51D;SPIDR;SFR1;NSMCE2;ERCC4;RFWD3;SEM1;MORF4L1;PARP1
prerank,negative regulation of protein depolymerization (GO:1901880),0.32976314421795916,0.7257800422027123,0.8099762470308789,0.9685816489416145,1.0,7/24,22.71%,FGF13;ATXN7;CAMSAP2;ARHGEF2;TAOK1;PIK3CA;CLASP1
prerank,mitochondrion distribution (GO:0048311),0.3592216132124744,0.7256168694640466,0.7943786982248521,0.9684137687522311,1.0,5/12,19.49%,MEF2A;MSTO1;ATCAY;LRRK2;DNM1L
prerank,protein homotetramerization (GO:0051289),0.30155880554756875,0.7256012620476695,0.835511982570806,0.9680767073237451,1.0,11/49,21.77%,ALDH9A1;PKD2;SAMHD1;B2M;ACACA;USP16;APPL2;MCOLN1;KCNJ2;HCN1;GBP5
prerank,mitochondrial translation (GO:0032543),0.2820101973023166,0.7249377675008364,0.9112244897959184,0.9684552238035087,1.0,31/104,25.21%,MRPL46;GFM1;AURKAIP1;CHCHD1;MRPL41;GATB;ERAL1;MRPL51;MTRF1L;LARS2;MRPL19;MRPL15;MRPS25;MRPS9;MRPS21;MRPL39;MRPS14;MRPL30;MRPL3;MTIF3;MRPS26;MRPL10;MRPL54;MRPL21;MRPL18;MRPL52;MRPL12;GATC;MRPL37;MRPS34;MRPS12
prerank,regulation of cytoskeleton organization (GO:0051493),0.2829401595057515,0.7248395671300423,0.8972533062054934,0.9682041122177641,1.0,23/108,20.49%,IQGAP2;CORO1A;FZD10;PRKCD;P2RX7;MTOR;CLN3;F11R;DIAPH1;BICD2;TWF2;ARHGAP18;CAPN2;LRP1;IQGAP1;RHOA;CORO2B;TAOK1;RHOD;ROCK2;ARHGEF19;GSK3B;CRK
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),0.35293628075441874,0.7245387990999835,0.785007072135785,0.9681989698807313,1.0,2/12,8.10%,DOCK4;MEF2C
prerank,Wnt signaling pathway (GO:0016055),0.2875935781870578,0.7240370388483747,0.8945752302968271,0.9684128532540696,1.0,15/92,16.50%,FZD10;PLCG2;FZD9;FZD3;CTNNB1;CSNK1G2;STRN;LRP5;AMER1;CSNK1A1;VPS29;LRRK2;BCL9;FZD8;PTEN
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.3333988734426997,0.7240222089189929,0.8018018018018018,0.9680741557772606,1.0,7/19,23.85%,TENT4B;STN1;SRC;TINF2;TERF2;TEN1;DCP2
prerank,regulation of chromosome organization (GO:0033044),0.3270337688683795,0.723645289298836,0.8082026537997588,0.9681366397055833,1.0,4/22,14.37%,XRCC5;RB1;SMG1;HNRNPD
prerank,reticulophagy (GO:0061709),0.36502470039302487,0.7236004336973277,0.7971830985915493,0.9678331910077479,1.0,7/12,27.25%,TEX264;RETREG1;ATG2B;RB1CC1;UBA5;ATG2A;UFM1
prerank,sprouting angiogenesis (GO:0002040),0.29979617180633683,0.7235137620808407,0.836423118865867,0.9675776059010183,1.0,11/51,18.59%,PTK2B;OTULIN;VEGFB;NRP1;THBS1;CCBE1;NR4A1;NAXE;GREM1;ANGPT1;VEGFD
prerank,histone deubiquitination (GO:0016578),0.33386257832455773,0.7223725146513909,0.7558139534883721,0.968527814345057,1.0,4/18,16.00%,ATXN7;USP7;USP21;USP16
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.3046759761357158,0.7222976140415172,0.8311111111111111,0.9682620410640166,1.0,17/42,26.66%,SRCAP;ACTB;ARID1A;ARID1B;SMARCB1;INO80;SPTY2D1;ERCC6;SMARCAD1;CHD4;RBBP4;VPS72;SMARCA5;MBD2;SMARCC1;CECR2;MTA2
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.34160022662119943,0.7216933276342783,0.7961038961038961,0.9685547953092135,1.0,1/15,2.02%,PLCG2
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.3378070365414159,0.7216806644229187,0.7890724269377383,0.9682139149425677,1.0,5/19,19.92%,SS18L1;LRP8;CUX1;CUX2;RELN
prerank,C-terminal protein amino acid modification (GO:0018410),-0.2956629478464089,-0.7215776886940567,0.823321554770318,0.9568832385584302,1.0,8/11,28.45%,AGBL4;FOLH1;GPLD1;TTL;LCMT1;AGBL1;ATG5;ICMT
prerank,signal transduction by p53 class mediator (GO:0072331),0.3093673865448871,0.7213282469864659,0.8196531791907514,0.9682522236332903,1.0,4/30,9.48%,PYCARD;TP53;HINT1;ATRX
prerank,androgen receptor signaling pathway (GO:0030521),-0.2816971221069234,-0.7211313385724516,0.8272058823529411,0.9555370513280645,1.0,5/11,25.09%,AR;KDM3A;RNF14;PMEPA1;PLPP1
prerank,production of siRNA involved in RNA interference (GO:0030422),0.37073024691575157,0.7200341556951894,0.7852941176470588,0.9693599088058312,1.0,5/10,24.76%,PRKRA;TARBP2;AGO2;DICER1;DROSHA
prerank,kidney development (GO:0001822),0.29210793679355546,0.7198233450764746,0.865814696485623,0.9692529663693696,1.0,3/65,2.09%,SHH;PCSK9;TGFBR1
prerank,myelination (GO:0042552),0.2981759972167612,0.7196973664194403,0.8443960826985855,0.9690365089650018,1.0,10/46,17.99%,SKI;CXCR4;ABCD1;ACER3;EIF2B2;TNFRSF21;MPZ;DEGS1;NF1;ABCD2
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.31506161147216555,0.7196735177485541,0.8225616921269095,0.9687076651165465,1.0,10/26,22.81%,DUSP3;STAT5B;SOX9;SYAP1;PTPN12;IQGAP1;PDPK1;INPP5K;ZFP36L1;ZPR1
prerank,membrane repolarization (GO:0086009),0.33979318537886144,0.7195120107811377,0.8053691275167785,0.9685304356167864,1.0,3/15,13.76%,KCNIP2;ATP1B3;ATP1B2
prerank,positive regulation of stress fiber assembly (GO:0051496),0.3017241592002192,0.7194992216708731,0.8448471121177803,0.9681937957389416,1.0,10/44,19.65%,TGFBR1;RGCC;FHOD1;PFN2;NF2;NRP1;CD47;RHOA;CDC42;ROCK2
prerank,regulation of ossification (GO:0030278),0.30273139431845364,0.7192592327763392,0.8261851015801355,0.9681061470947647,1.0,5/36,12.22%,BMP2K;MDK;MEF2C;SOX9;CHSY1
prerank,regulation of DNA replication (GO:0006275),0.2984185253485269,0.7184595732996425,0.8456591639871383,0.9686248936590829,1.0,11/49,16.38%,ORC3;DHX9;BRPF3;STN1;PDS5A;PPP2CA;KAT7;DNA2;CDC6;BCAR3;FAF1
prerank,positive regulation of keratinocyte differentiation (GO:0045618),-0.29418799790175876,-0.7181753114798232,0.8387096774193549,0.9573311927720011,1.0,5/10,28.01%,FOXC1;TRIM16;NUMA1;NME2;ETV4
prerank,positive regulation of reproductive process (GO:2000243),0.31366439522473466,0.7179451104617054,0.8152046783625732,0.9688282643182946,1.0,5/31,17.90%,LHFPL2;INHBA;TACR1;PGAM4;AGO2
prerank,organelle disassembly (GO:1903008),-0.20767146349403104,-0.7175731994106027,0.9217391304347826,0.9561549239407783,1.0,11/33,25.32%,KIF5B;GFM2;ULK2;EIF2D;GOLGA2;KIF9;DDRGK1;PLK5;KLC1;UFL1;MRRF
prerank,cellular zinc ion homeostasis (GO:0006882),0.3152743848699347,0.71747116680256,0.8034398034398035,0.9689762704542693,1.0,12/26,23.21%,ATP13A2;SLC39A6;MT3;MT1G;MT1B;MT1E;MT1F;MT1A;MT1X;MT1M;MT1H;SLC30A10
prerank,positive regulation of insulin secretion (GO:0032024),-0.2009228131250212,-0.7165557308922056,0.9615384615384616,0.955552763879707,1.0,18/36,41.00%,MYRIP;TCF7L2;GPLD1;BAD;IRS2;RBP4;GPER1;ACSL4;CAPN10;CFTR;AACS;GLUD1;C2CD2L;ANO1;PSMD9;DOC2B;LRRC8A;NLGN2
prerank,mitochondrial translational elongation (GO:0070125),0.2808360000688614,0.7157800482261761,0.8984455958549222,0.9704708901169248,1.0,26/88,25.21%,MRPL46;GFM1;AURKAIP1;CHCHD1;MRPL41;ERAL1;MRPL51;MRPL19;MRPL15;MRPS25;MRPS9;MRPS21;MRPL39;MRPS14;MRPL30;MRPL3;MRPS26;MRPL10;MRPL54;MRPL21;MRPL18;MRPL52;MRPL12;MRPL37;MRPS34;MRPS12
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.3518317949765205,0.7157657985638041,0.8150134048257373,0.9701357703417468,1.0,3/14,15.69%,MMS19;ACTR2;ERCC6
prerank,ESCRT III complex disassembly (GO:1904903),0.3700670460925781,0.7156240979842702,0.8020527859237536,0.9695925531025295,1.0,1/10,3.66%,VTA1
prerank,ESCRT complex disassembly (GO:1904896),0.3700670460925781,0.7156240979842702,0.8020527859237536,0.9695925531025295,1.0,1/10,3.66%,VTA1
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),-0.2784764083757475,-0.7156076267135447,0.8489208633093526,0.954774391823863,1.0,3/12,16.06%,B3GNT2;B3GALT5;B3GALT1
prerank,insulin secretion (GO:0030073),0.3287915009239977,0.7152556219551691,0.811443433029909,0.9696227046399368,1.0,3/19,12.59%,ANXA1;SNX19;RAB11FIP5
prerank,intestinal absorption (GO:0050892),0.35044151805490936,0.71480659522407,0.7902777777777777,0.9697633993836348,1.0,2/13,16.04%,F11R;CD36
prerank,negative regulation of ATPase activity (GO:0032780),0.3415064902464465,0.7147407930458961,0.8018018018018018,0.9694838482710432,1.0,2/16,8.60%,TP53;ATP5IF1
prerank,positive regulation of growth (GO:0045927),0.2855454364623771,0.7144793806435691,0.8595927116827439,0.969418401638883,1.0,14/64,22.84%,RFTN1;TGFBR1;BRAT1;CSNK2A1;SDCBP;INO80;WFS1;CXCL16;CDC42;RPTOR;PABIR1;EXOSC2;ZPR1;H3-3A
prerank,telomere maintenance (GO:0000723),0.2929911255881459,0.7144182005960202,0.8373101952277657,0.9691321127211266,1.0,17/50,24.86%,PTGES3;XRCC5;STN1;DNA2;POLD3;TEP1;TINF2;RAD51D;TERF2;NSMCE2;PARP3;ERCC4;TERF2IP;TEN1;PARP1;ATR;RPA1
prerank,positive regulation of double-strand break repair (GO:2000781),0.30129268622804567,0.7135886107431808,0.8353457738748628,0.969695070559154,1.0,13/39,25.10%,MAD2L2;MMS19;MGMT;ACTR2;SLF2;ERCC6;SHLD1;SHLD2;SPIDR;PARP3;PARP1;DDX11;PARP9
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.36356489802233216,0.7126437330344005,0.7954198473282442,0.9703612966854679,1.0,2/10,13.14%,WDFY1;NINJ1
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),0.3652341199001914,0.7120764886001332,0.7985915492957747,0.970631059427047,1.0,2/11,9.58%,TIMM22;AGK
prerank,positive regulation of cell aging (GO:0090343),0.3634212585764307,0.7119675902831198,0.7913165266106442,0.9704023022090985,1.0,2/11,13.13%,YPEL3;B2M
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.36528430261702083,0.7119485008199211,0.8049490538573508,0.9700734877244311,1.0,1/10,6.29%,CTNNB1
prerank,nucleus organization (GO:0006997),0.29474525704051424,0.711526897454358,0.8506637168141593,0.9701786817182437,1.0,10/47,18.87%,ATXN7;SYNE1;SEH1L;IRAG2;TPR;NUP205;TOR1A;PDCD6IP;BIN1;TMEM170A
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.29895182731764486,0.711342185589179,0.8655737704918033,0.9700341656910083,1.0,10/46,19.61%,TSPO;AIP;CHCHD4;TIMM22;TIMM50;TOMM40;HK2;PITRM1;TOMM20;FIS1
prerank,spermatid development (GO:0007286),-0.20492240076785706,-0.709567493669374,0.9166666666666666,0.9599165810030497,1.0,8/32,24.00%,BBS4;RFX2;CEP57;ACRBP;NECTIN2;TDRD5;MKKS;NME5
prerank,response to X-ray (GO:0010165),0.3413941508101439,0.7093754126035261,0.8005464480874317,0.971812316223124,1.0,3/14,14.23%,XRCC5;ANXA1;IKBIP
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.28090869122041706,0.7088152600947745,0.9072375127420998,0.9720602130959161,1.0,22/95,21.71%,PRELP;HEXA;B4GALT1;CHSY3;FMOD;AGRN;ST3GAL1;NDST1;BCAN;XYLT1;CHSY1;B4GALT7;CHST15;PXYLP1;NDST2;CEMIP;ANGPT1;CHPF;CSPG4;SLC10A7;B4GALT6;B4GALT2
prerank,regulation of smoothened signaling pathway (GO:0008589),0.2959604519045923,0.7084128657331277,0.8606382978723405,0.9721378598231153,1.0,3/50,5.02%,SHH;RAB34;MGRN1
prerank,cell junction assembly (GO:0034329),0.27956563705918547,0.7082237446760821,0.9284984678243106,0.9719758071899663,1.0,22/100,19.64%,PCDHB6;SLITRK1;PKP2;ITGA6;ACTB;VMP1;CAPZA1;FLCN;ACTG1;CDH8;LIMS1;CDH9;CDH12;TLN1;KIRREL3;DCHS1;CDH19;PTEN;RHOA;CDC42;RAB29;FBLIM1
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.3142539100074039,0.7080894604892338,0.8291517323775388,0.9717761052215832,1.0,6/27,13.26%,ARHGEF18;ARAP1;WASF2;F11R;PFN1;PPFIA1
prerank,establishment of spindle localization (GO:0051293),0.3474128698390923,0.7077986490786847,0.8194070080862533,0.9717564277276957,1.0,4/14,22.71%,ESPL1;DYNC1H1;CFL1;CLASP1
prerank,motor neuron axon guidance (GO:0008045),-0.24709531868094808,-0.7069149478585037,0.869198312236287,0.9611372763988015,1.0,2/15,6.36%,SEMA3A;SLIT2
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),-0.24706328155756743,-0.7067826305395661,0.8744186046511628,0.9594273446332846,1.0,6/17,18.67%,MPDU1;NUS1;ALG9;SRD5A3;ALG12;ALG1
prerank,purine nucleotide biosynthetic process (GO:0006164),-0.26837043228247753,-0.7063521196440282,0.8314606741573034,0.9580528948988308,1.0,7/12,27.03%,MTHFD1;PRPS2;AMPD2;ADSL;PPAT;PRPS1;PRPS1L1
prerank,male gonad development (GO:0008584),0.2990619761904055,0.7062723721808871,0.8294392523364486,0.9730069427863797,1.0,4/34,15.49%,GATA1;INHBA;SOX9;NCOA4
prerank,regulation of cellular senescence (GO:2000772),0.3105559527337743,0.7062029004673607,0.8394919168591224,0.9727305245925384,1.0,10/28,26.36%,NEK6;YPEL3;CDK6;B2M;TERF2;NEK4;NUAK1;SLC30A10;AKT3;FBXO5
prerank,negative regulation of lipid catabolic process (GO:0050995),0.3263200070133836,0.7056538811904426,0.8120204603580563,0.9729404928416212,1.0,2/17,12.79%,TNF;SORL1
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),0.34744383158927744,0.7053154967746548,0.797768479776848,0.9729448172553715,1.0,5/12,21.24%,APOE;RANBP9;PICALM;ROCK2;ABCA2
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.3212002173680506,0.7042893019364173,0.8335419274092616,0.9736448276819419,1.0,3/22,12.34%,PPP2CB;DUSP10;PPP2CA
prerank,positive regulation of cell junction assembly (GO:1901890),0.29177391266448954,0.7041429657062808,0.861228813559322,0.9734679262638688,1.0,3/56,2.38%,CLSTN1;PTPRJ;THY1
prerank,regulation of complement activation (GO:0030449),0.2927782827050328,0.7036247508550699,0.8446389496717724,0.9736503759310816,1.0,5/40,14.90%,C1QC;C1QA;C1QB;C3AR1;C4B
prerank,telomere maintenance via recombination (GO:0000722),0.35747076677636536,0.7031662695818448,0.8,0.9737932050102547,1.0,5/11,21.92%,TEP1;ERCC1;RAD51D;NSMCE2;ERCC4
prerank,aerobic electron transport chain (GO:0019646),0.284692597809769,0.7021747105356669,0.8748696558915537,0.9744476323506557,1.0,15/68,19.52%,NDUFA11;NDUFB8;COX6C;NDUFA2;NDUFB4;NDUFV1;COX7C;NDUFS6;NDUFAB1;UQCRB;NDUFB11;COX6B1;SDHD;NDUFB9;COX4I1
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.2842036721660657,0.7020084095637296,0.8739583333333333,0.9742681151561273,1.0,15/69,19.52%,NDUFA11;NDUFB8;COX6C;NDUFA2;NDUFB4;NDUFV1;COX7C;NDUFS6;NDUFAB1;UQCRB;NDUFB11;COX6B1;SDHD;NDUFB9;COX4I1
prerank,response to steroid hormone (GO:0048545),0.3067724192354086,0.7017562786613482,0.8434285714285714,0.9741797863165556,1.0,1/31,0.90%,TGFB1
prerank,cytoplasmic translational initiation (GO:0002183),-0.23977174240223903,-0.7014657161830355,0.8577981651376146,0.9616914515533465,1.0,4/17,12.41%,EIF2B3;EIF4B;EIF2D;DHX29
prerank,icosanoid biosynthetic process (GO:0046456),-0.28972125690017725,-0.7014502309064303,0.8606271777003485,0.9598359691526125,1.0,1/10,2.21%,LTA4H
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.27181643353164814,0.7011634372703954,0.991,0.9744489939595712,1.0,88/417,21.26%,ASCL1;CIITA;TGFB1;IKZF1;BASP1;CBFA2T3;MLXIPL;YAF2;TNF;CIR1;CEBPA;DDIT3;SPI1;TSC22D4;BHLHE41;HDAC5;XRCC5;PCGF6;CTNNB1;MTA3;TP53;NKX2-1;RCOR1;CREB3L1;GCFC2;CBFA2T2;NKRF;TFAP2B;RB1;RBM15B;CIART;MDFIC;QARS1;RING1;ATF7IP;ARID4A;MIDEAS;HDAC4;PHC1;ZMYND15;LIMS1;SOX9;HDAC6;DAP;GZF1;HDAC9;MBD1;NRG1;KAT7;FOXN3;GAS6;FOXK1;IRF1;BRD7;LBH;CAPN3;TLE5;EID1;RBPJ;SBNO2;SUV39H1;PBXIP1;ZNF568;PPARD;RSF1;RPS6KA5;ZGPAT;LOXL3;SFMBT1;CIPC;CTBP2;PER1;CALCA;WWP1;INPP5K;HHEX;ENO1;ZMYND11;CDK5R1;FBXW11;POU2F1;YEATS2;HEXIM1;EED;SCMH1;TFAP4;CRYAB;PHC2
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.3473398869288745,0.7008875505907686,0.8228730822873083,0.9740521745856804,1.0,5/12,27.95%,RCAN1;GSK3B;CHP1;ATP2B4;PRNP
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.3473398869288745,0.7008875505907686,0.8228730822873083,0.9740521745856804,1.0,5/12,27.95%,RCAN1;GSK3B;CHP1;ATP2B4;PRNP
prerank,camera-type eye morphogenesis (GO:0048593),0.3617811411984392,0.7005759136613925,0.8273381294964028,0.9740347313826394,1.0,4/10,23.95%,SKI;NF1;KDM2B;VEGFA
prerank,negative regulation of mitochondrion organization (GO:0010823),0.30207684486026914,0.7001782679260137,0.8327683615819209,0.9741074607315979,1.0,10/33,24.18%,FZD9;BCL2L1;FLCN;IAPP;HUWE1;VAT1;GHITM;PRKN;IGF1;PRELID1
prerank,regulation of developmental growth (GO:0048638),0.3068157476132814,0.6992438184841685,0.833530106257379,0.9746958891592881,1.0,4/29,9.89%,STAT5A;APOE;DNM2;STAT5B
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),-0.2623918712414005,-0.6985712013425007,0.8598484848484849,0.9611771089358988,1.0,3/13,16.06%,B3GNT2;B3GALT5;B3GALT1
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.32957849007550194,0.6978778376739999,0.8444444444444444,0.9757641594600542,1.0,1/16,2.40%,MAD2L2
prerank,meiosis I (GO:0007127),0.31605210183582727,0.6974789010784489,0.8304878048780487,0.9758299417106044,1.0,2/23,12.71%,PTTG1;BRDT
prerank,histone H4 acetylation (GO:0043967),0.29009972527730976,0.6973769572795249,0.8579059829059829,0.9755976562864106,1.0,16/47,24.77%,BRD8;MSL2;EP400;MCRS1;NAA40;KAT7;HCFC1;JADE2;MEAF6;PER1;MSL1;PHF20;MORF4L2;MORF4L1;CHD5;KANSL1
prerank,secondary palate development (GO:0062009),0.33688247203773214,0.6971624519331668,0.8106267029972752,0.9754478216628293,1.0,2/14,6.68%,CHD7;TGFBR2
prerank,nuclear pore organization (GO:0006999),0.33517309639826737,0.6962334043284035,0.7980364656381487,0.9760483041067421,1.0,6/14,20.95%,SEH1L;TPR;NUP205;RTN4;TMEM170A;NUP54
prerank,nucleocytoplasmic transport (GO:0006913),0.29347682281560783,0.6961734363065614,0.8569832402234637,0.9757534194532457,1.0,6/40,11.72%,XPO1;ANP32A;SNRPD2;MALT1;RBM15B;NUP205
prerank,eye photoreceptor cell differentiation (GO:0001754),0.34807418317050537,0.6948501740100591,0.8161559888579387,0.9767614083843155,1.0,6/12,23.95%,MYO7A;AGTPBP1;NKD1;PROM1;STAT3;VEGFA
prerank,Golgi ribbon formation (GO:0090161),-0.26266332038261203,-0.6944986443414117,0.8659003831417624,0.963600069056501,1.0,3/13,11.75%,VAMP4;GCC2;GOLGA2
prerank,7-methylguanosine mRNA capping (GO:0006370),0.2976217939634146,0.6935340032368268,0.830367734282325,0.9773986894869389,1.0,5/31,18.79%,GTF2H1;CDK7;POLR2L;GTF2H5;POLR2E
prerank,7-methylguanosine RNA capping (GO:0009452),0.2976217939634146,0.6935340032368268,0.830367734282325,0.9773986894869389,1.0,5/31,18.79%,GTF2H1;CDK7;POLR2L;GTF2H5;POLR2E
prerank,endodermal cell fate commitment (GO:0001711),0.3557385599169568,0.6927299988154373,0.8069381598793364,0.9778287874635821,1.0,2/10,14.24%,LEO1;SOX2
prerank,negative regulation of viral transcription (GO:0032897),0.3433570334260233,0.6924605784385347,0.8271428571428572,0.9777349597383692,1.0,5/13,24.49%,TRIM27;MID2;TRIM62;HEXIM1;UBP1
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.29452033828256047,0.692439347814647,0.8435374149659864,0.9774031090811356,1.0,4/32,12.48%,PYCARD;TP53;HINT1;DDIT4
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),0.35898700898491,0.6923689783438852,0.8291233283803864,0.97712641951162,1.0,2/10,10.47%,NOS1AP;CACNB2
prerank,establishment of endothelial intestinal barrier (GO:0090557),0.3516873157631414,0.6920656334199187,0.8236953455571228,0.977080526794875,1.0,3/11,10.18%,RAP2B;F11R;RAB1B
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.3330724859415282,0.6920199369118829,0.8297872340425532,0.9767891477101156,1.0,5/15,24.18%,BCL2L1;GHITM;PRKN;IGF1;PRELID1
prerank,histone mRNA metabolic process (GO:0008334),-0.19812267973794012,-0.6918121670463862,0.9483870967741935,0.9645373191053801,1.0,9/27,22.05%,SSB;SNRPD3;ERI1;ATM;UPF1;TUT1;SNRPG;SNRPF;NCBP2
prerank,positive regulation of mRNA processing (GO:0050685),0.31551970013384295,0.6914566846770385,0.8475,0.9770111514887758,1.0,6/21,19.27%,CIRBP;LEO1;TRA2B;PRDX6;THRAP3;RBMXL1
prerank,lipid droplet formation (GO:0140042),0.35717174658365564,0.6911772705190864,0.8333333333333334,0.976941216709638,1.0,1/10,5.78%,CDS2
prerank,cilium organization (GO:0044782),0.26805723619146077,0.6909347382104638,0.974,0.9768318567611733,1.0,34/209,15.62%,MKS1;RAB8B;EXOC6;ASAP1;PKD2;IFT52;TTC29;RP2;CNGB1;BBS9;PLK4;ATP6V0D1;DISC1;SNAP29;RAB11A;ACTR2;ACTR3;HDAC6;EXOC8;WDR11;DYNC2I1;EXOC7;EXOC1;PCM1;EXOC2;IFT80;TXNDC15;EXOC5;RPGR;FNBP1L;EXOC3;CEP162;AHI1;WDR90
prerank,inositol phosphate-mediated signaling (GO:0048016),0.3145765725661582,0.6907922871239338,0.8489116517285531,0.9766374413798902,1.0,1/19,2.16%,NFATC1
prerank,axoneme assembly (GO:0035082),-0.20087438545013894,-0.6898463235406614,0.9444444444444444,0.9647400962429572,1.0,12/30,31.01%,SPAG1;TTC12;CCDC39;CFAP74;RP1;SPEF1;SPAG16;GAS8;CFAP46;TTLL3;DNAAF3;LRGUK
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.27717201346800613,0.6898279448379099,0.8908898305084746,0.9772306412674456,1.0,7/63,10.47%,RGCC;CNOT8;TP53;CRADD;PLK2;CHEK2;RPL26
prerank,early endosome to Golgi transport (GO:0034498),0.3483591004923393,0.6890495574516278,0.8174273858921162,0.9776810225313006,1.0,3/11,14.54%,RBSN;STX5;SNX2
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.33072759969730303,0.6874454675982029,0.8463611859838275,0.9789267596555301,1.0,7/16,25.16%,CIRBP;TRA2B;PRDX6;THRAP3;RBMXL1;NCBP1;TRA2A
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.3335933422383469,0.686856084785181,0.8333333333333334,0.9788117719906201,1.0,5/15,22.44%,CPEB3;AGO2;ZFP36L1;CNOT7;CNOT1
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.3335933422383469,0.686856084785181,0.8333333333333334,0.9788117719906201,1.0,5/15,22.44%,CPEB3;AGO2;ZFP36L1;CNOT7;CNOT1
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.3003698013608322,0.6858303183887589,0.8323281061519904,0.9794775235826361,1.0,4/26,14.53%,NFE2L2;GPR37;FYN;LRRK2
prerank,alpha-amino acid metabolic process (GO:1901605),0.285661861598753,0.6856145430989001,0.8647450110864745,0.9793355000255457,1.0,8/45,16.86%,ATP7A;ASPG;KMO;PYCR2;MMUT;DDAH1;OAT;CBS
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.3260736774105113,0.6850266717192007,0.8244274809160306,0.9795772284804363,1.0,6/16,26.35%,PHIP;IGFBP4;CDH3;IGFBP2;IGF1;IGFBP3
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.3466558813269784,0.6847642149358237,0.8290960451977402,0.9794866242164587,1.0,2/11,11.23%,BCAR1;NRP1
prerank,positive regulation of histone deacetylation (GO:0031065),0.3494377137699086,0.6846499947333369,0.8344923504867872,0.9792468104375205,1.0,5/12,23.95%,PRKD2;AKAP8L;ZBTB7B;CTBP1;VEGFA
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.26614910186348095,0.6836250850853892,0.969939879759519,0.9799341559364222,1.0,36/186,18.79%,DRAXIN;TMEM131L;NFATC1;MAD2L2;MDK;TLE3;DKK2;APOE;TPBGL;DDIT3;PSMB10;SCYL2;AMER1;PSMA2;SOX9;PTPRU;PTPRO;NLK;CSNK1A1;PSME3;STK3;PSMB5;SOX2;PSMD8;LRP1;TLE5;PSMD7;PSMB9;GSK3A;INVS;STK4;ZNRF3;PSMD2;GREM1;DACT1;IGFBP4
prerank,synaptic vesicle transport (GO:0048489),0.349597609226475,0.6835587826098705,0.8245363766048502,0.9796546966934898,1.0,3/11,13.52%,DNM2;SYNJ1;TOR1A
prerank,glucose transmembrane transport (GO:1904659),0.32135945835303514,0.6830954747083294,0.8398950131233596,0.9797729545419559,1.0,3/18,19.71%,SLC2A3;PPARD;SORT1
prerank,calcium ion import across plasma membrane (GO:0098703),0.3308712383625362,0.6822986056161343,0.8263795423956931,0.9801976150728702,1.0,2/14,13.92%,SLC8A1;TRPV3
prerank,iron ion transmembrane transport (GO:0034755),0.3533326620467628,0.6821738273536073,0.8196248196248196,0.9799721482550802,1.0,1/10,4.90%,SLC25A37
prerank,neuron migration (GO:0001764),0.28197266732715826,0.6820982822763555,0.8787234042553191,0.9796981577185416,1.0,10/48,14.18%,FGF13;LRP12;DISC1;MEF2C;PEX13;MAP1B;NRP1;DDIT4;NAV1;USP9X
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),0.305424726363833,0.6818283869727935,0.8559218559218559,0.9796106726688717,1.0,4/26,16.74%,GCH1;ACER3;SPR;ASAH1
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.3024171750314938,0.681117133357667,0.8347107438016529,0.9799716185312238,1.0,4/29,10.01%,APOE;CLN3;MCTP1;SYNGR1
prerank,cobalamin metabolic process (GO:0009235),0.31838588762541,0.680806895738737,0.8278580814717477,0.9799214797521337,1.0,6/17,24.52%,ABCC1;MMUT;CUBN;MTR;MMAA;MMAB
prerank,peptidyl-proline modification (GO:0018208),0.3043889686879433,0.6806099570133509,0.851063829787234,0.979775235739708,1.0,9/25,25.25%,PPIE;CWC27;P3H2;PPIG;PPIH;NKTR;PIN1;PPIA;PPIL3
prerank,histone H4-K8 acetylation (GO:0043982),0.3326747877588227,0.6804168230700632,0.8384512683578104,0.9792706101107562,1.0,7/15,24.77%,MCRS1;KAT7;HCFC1;JADE2;MEAF6;PHF20;KANSL1
prerank,histone H4-K5 acetylation (GO:0043981),0.3326747877588227,0.6804168230700632,0.8384512683578104,0.9792706101107562,1.0,7/15,24.77%,MCRS1;KAT7;HCFC1;JADE2;MEAF6;PHF20;KANSL1
prerank,translational elongation (GO:0006414),0.2646930237079559,0.6798950907480676,0.9295199182839632,0.9794201156295337,1.0,29/101,25.21%,MRPL46;GFM1;AURKAIP1;CHCHD1;MRPL41;GTPBP1;ERAL1;MRPL51;MRPL19;MRPL15;MRPS25;MRPS9;MRPS21;MRPL39;MRPS14;MRPL30;MRPL3;MRPS26;MRPL10;MRPL54;EEF1G;MRPL21;RACK1;MRPL18;MRPL52;MRPL12;MRPL37;MRPS34;MRPS12
prerank,histone H2B ubiquitination (GO:0033523),0.3441843972995837,0.6797761888116508,0.8102409638554217,0.9792043346618277,1.0,4/10,23.31%,LEO1;RNF40;UBE2E1;CTR9
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.23391625724117981,-0.6790512821712908,0.9071729957805907,0.973542610955269,1.0,5/17,17.47%,EMC7;EMC10;EMC4;EMC1;GET4
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.2768302667242223,0.6790219324736522,0.886411889596603,0.9795924180176823,1.0,12/54,21.97%,KCNN4;KCNIP2;KCNMA1;NOS1AP;NEDD4L;CD63;GNG2;CACNA1D;BIN1;KCNJ2;KCNJ10;FLNA
prerank,tRNA 5'-leader removal (GO:0001682),0.3337248675747998,0.6790098756627783,0.8344827586206897,0.9792558115226437,1.0,3/13,15.02%,RPP38;RPP14;PRORP
prerank,tRNA metabolic process (GO:0006399),-0.22947347848172855,-0.6774299602891252,0.8708333333333333,0.9732274159389905,1.0,8/17,32.58%,SSB;DTD2;KARS1;RPP21;YARS2;POP5;RPP30;POP1
prerank,negative regulation of histone modification (GO:0031057),0.32822242945957963,0.6772909348310406,0.8344640434192673,0.9806167500897947,1.0,6/14,29.48%,SNCA;NOC2L;CTBP1;SPHK2;JARID2;PRMT6
prerank,neuron maturation (GO:0042551),0.3180459756218999,0.6772858781149727,0.8318240620957309,0.9802760402985798,1.0,5/18,21.77%,MTCH1;C1QA;EPHA8;B4GALT6;CX3CL1
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),0.33673904205900623,0.6765831138892184,0.8127490039840638,0.9806143767602207,1.0,2/13,10.01%,CLN3;SYNGR1
prerank,mitotic spindle assembly (GO:0090307),0.285817339273971,0.6763463216550782,0.8692737430167597,0.9805020249593271,1.0,7/42,14.29%,BCCIP;CEP192;CHEK2;KIF23;RAB11A;STAG2;KIF2A
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.26773218457360043,0.6760619086616141,0.9290780141843972,0.9804305893069633,1.0,26/96,20.95%,NUP62;DHX38;NXF1;THOC2;SEH1L;CASC3;RBM15B;SMG1;TPR;DDX39B;NUP205;POLDIP3;UPF3B;THOC3;ALKBH5;SMG7;UPF2;SLU7;FYTTD1;SRSF6;SRSF2;SEC13;HHEX;SLBP;SRSF3;NUP54
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.3116100564601167,0.6758748179504038,0.8487179487179487,0.9802725010507093,1.0,2/20,8.05%,TGFBR1;SNAI1
prerank,very long-chain fatty acid metabolic process (GO:0000038),-0.19559500399410873,-0.675288812856122,0.9758064516129032,0.9734073569946708,1.0,5/30,10.66%,ABCD4;ACSL1;HACD1;ELOVL5;ACSL6
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.3440264968155293,0.6749039597381367,0.832378223495702,0.9808664070877062,1.0,1/10,3.87%,SNCA
prerank,neuromuscular junction development (GO:0007528),0.29705281560910735,0.6746482107998676,0.8448275862068966,0.9807714531158578,1.0,5/24,14.53%,AGRN;CACNB4;CACNB2;CACNB1;LRRK2
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.2694425511819601,0.674541432668807,0.9123711340206185,0.9805213871487208,1.0,15/74,18.91%,NFE2L2;BACH1;PSMB10;EPO;PSMA2;PSME3;PSMB5;PSMD8;PSMD7;PSMB9;RBPJ;HIF1A;VHL;PSMD2;ELOB
prerank,divalent inorganic cation homeostasis (GO:0072507),0.2973873084583479,0.6738506006786998,0.8610778443113772,0.9808331910514503,1.0,3/25,8.42%,SLC8A1;SNCA;TFAP2B
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.32079576204955257,0.6736048758819145,0.8496644295302014,0.9807235631659931,1.0,4/17,19.52%,COX6C;COX7C;COX6B1;COX4I1
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),-0.259395162446983,-0.6735711591338848,0.8777777777777778,0.9730969681893464,1.0,9/13,42.87%,CACNA1G;SYT4;CACNA1H;CACNA1I;KCNB1;SYT1;DOC2B;HYAL3;SCAMP5
prerank,metal ion homeostasis (GO:0055065),0.2842514721231206,0.6735450515284827,0.8755707762557078,0.9804352040690022,1.0,4/40,8.42%,SLC8A1;SLC7A8;SNCA;TFAP2B
prerank,calcium ion import into cytosol (GO:1902656),0.32154933957486176,0.673443003126897,0.8414154652686763,0.9801910131561546,1.0,2/15,13.92%,SLC8A1;TRPV3
prerank,telomere maintenance via telomere lengthening (GO:0010833),-0.18626999436588565,-0.6731233462503585,0.95,0.9716502269013955,1.0,20/33,34.86%,RFC1;MRE11;PINX1;CTC1;SHQ1;TNKS1BP1;WRAP53;CDK2;TERT;DCLRE1B;GAR1;PPP6R3;TERF1;NOP10;RTEL1;ZBTB48;ACD;RAD51;PPP6C;NHP2
prerank,histone H3-K36 demethylation (GO:0070544),0.35100473178957137,0.6729978772061798,0.8345323741007195,0.9802805827686483,1.0,4/10,21.87%,KDM7A;RIOX2;KDM4C;KDM2B
prerank,cellular response to estradiol stimulus (GO:0071392),-0.22825563731202675,-0.6728172716442011,0.8994974874371859,0.9700525090016224,1.0,2/18,7.36%,EGFR;CCDC62
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.3318472911012067,0.6726275143223202,0.8254189944134078,0.980311749917466,1.0,2/12,12.86%,METTL4;KAT7
prerank,base-excision repair (GO:0006284),0.27601371809790565,0.6724622703796,0.8794788273615635,0.9801092587371978,1.0,8/48,16.01%,NEIL2;LIG3;DNA2;HUWE1;POLD3;ERCC5;ERCC6;OGG1
prerank,positive regulation of triglyceride metabolic process (GO:0090208),0.31853153448377125,0.6723854642699851,0.8436268068331143,0.9798439326585822,1.0,1/16,2.22%,DAGLB
prerank,mismatch repair (GO:0006298),0.2958304606096971,0.6723593798809477,0.8696172248803827,0.9795233923611426,1.0,7/27,18.75%,EXO1;SETD2;MCM9;PMS1;POLD3;RNASEH2A;ERCC1
prerank,regulation of phospholipid metabolic process (GO:1903725),0.3429735300225803,0.67208834581027,0.8379160636758322,0.9794379060146191,1.0,3/10,22.42%,MTMR3;ABCA3;MTMR9
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.3457017894495628,0.6711433815255193,0.8480463096960926,0.9800027969737475,1.0,3/10,20.94%,XYLT1;PXYLP1;B3GAT2
prerank,blood vessel diameter maintenance (GO:0097746),0.2883433162721595,0.6711305484109578,0.8747099767981439,0.979667444560709,1.0,2/34,4.66%,EDNRB;ADCY6
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.3295412842813075,0.6708812430394568,0.8313570487483531,0.9795597248007983,1.0,2/14,12.34%,PPP2CB;PPP2CA
prerank,hexose biosynthetic process (GO:0019319),0.2801929104148746,0.6707632483211371,0.882091212458287,0.979319208819522,1.0,8/42,16.87%,ALDOB;SORD;ENO3;PPARGC1A;GPI;CHST15;GAPDHS;PGAM1
prerank,central nervous system development (GO:0007417),0.25945319268203576,0.6705819164226715,0.987987987987988,0.9791556843367739,1.0,49/250,20.34%,SHH;CX3CR1;S100B;EEF1AKMT4-ECE2;PKD2;BPTF;CXCR4;PLXNB2;CHD7;TGFBR2;NKX2-1;C1QA;PAFAH1B2;BCAN;SCYL2;ITGAM;QARS1;ATP6AP2;EIF2B2;SOX9;SNTG2;POMK;ADGRG1;DDIT4;SYNJ1;CTNS;SH3GL3;SOX6;ZFHX3;SOX4;MEIS1;JHY;POU6F1;AHI1;NF1;PTEN;TBC1D23;MARCKS;PHGDH;NPAS2;LOXL3;GBA2;ZIC4;WWP1;RELN;CNTN4;ANKLE2;CDK5R1;UTP3
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.26377289515562574,0.6705384194776984,0.9428571428571428,0.9788609310127449,1.0,18/104,18.40%,TGFB1;TGFBR1;UBE2D3;SKI;TGFBR2;NKX2-1;FAM89B;SMAD3;SNX25;SORL1;BAMBI;VASN;STUB1;SMURF1;LDLRAD4;PDPK1;RBPMS2;GREM1
prerank,peptidyl-arginine modification (GO:0018195),0.31914947028754087,0.670295809490703,0.8389715832205683,0.9787507740210306,1.0,1/15,3.91%,ART4
prerank,synaptonemal complex organization (GO:0070193),0.32115065320501907,0.6697462035278346,0.8450134770889488,0.9785962937535508,1.0,1/15,8.32%,TRIP13
prerank,synaptonemal complex assembly (GO:0007130),0.32115065320501907,0.6697462035278346,0.8450134770889488,0.9785962937535508,1.0,1/15,8.32%,TRIP13
prerank,autophagy of peroxisome (GO:0030242),0.33183528869496937,0.6697313511018782,0.8361111111111111,0.9782702535934895,1.0,4/12,25.46%,MAP1LC3B;PIK3R4;RB1CC1;NBR1
prerank,central nervous system neuron development (GO:0021954),0.31307332347625416,0.6694277591399844,0.8368146214099217,0.9782102513304705,1.0,8/15,28.35%,ATP7A;PTEN;HSP90AA1;GBA2;B4GALT6;HSP90AB1;B4GALT5;MAP2
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.2588698760556986,0.6691904631184952,1.0,0.97809263528357,1.0,78/497,17.36%,ASCL1;CIITA;TGFB1;IKZF1;DBI;BASP1;CBFA2T3;MLXIPL;YAF2;TNF;CIR1;CNOT8;CEBPA;DDIT3;SPI1;TSC22D4;BHLHE41;HDAC5;XRCC5;PCGF6;CTNNB1;MTA3;TP53;NKX2-1;RCOR1;CREB3L1;GCFC2;CBFA2T2;NKRF;TFAP2B;RB1;RBM15B;LARP1;CIART;MDFIC;QARS1;EPRS1;RING1;ATF7IP;ARID4A;CPEB3;MIDEAS;HDAC4;PHC1;ZMYND15;LIMS1;SOX9;HDAC6;DAP;GZF1;HDAC9;PDS5A;MBD1;NRG1;KAT7;FOXN3;GAS6;PCIF1;FOXK1;CDC6;IRF1;BRD7;LBH;CAPN3;IGF2BP3;TLE5;EID1;GSK3A;RBPJ;PUS7;SBNO2;SUV39H1;PBXIP1;ZNF568;PPARD;RSF1;RPS6KA5;ZGPAT
prerank,regulation of mRNA polyadenylation (GO:1900363),0.31653705319441855,0.6685330012033928,0.8513689700130378,0.9783799821247657,1.0,9/17,25.13%,HSF1;CPEB3;RNF40;VIRMA;ZC3H3;NELFE;CTR9;NUDT21;NCBP1
prerank,protein polyglutamylation (GO:0018095),0.33097939434968443,0.6682481297318401,0.8382559774964838,0.978312489315863,1.0,4/11,25.35%,TPGS1;TTLL1;TTLL7;TTLL4
prerank,N-terminal protein amino acid modification (GO:0031365),0.3281098426193412,0.6680128066947003,0.8517520215633423,0.9781974647965979,1.0,4/14,20.76%,NAA40;METAP2;NAA50;NAA15
prerank,melanosome transport (GO:0032402),0.31110667451702456,0.6673633039253514,0.8527918781725888,0.9781446117324468,1.0,2/18,9.82%,MYO5A;RAB11A
prerank,pigment granule transport (GO:0051904),0.31110667451702456,0.6673633039253514,0.8527918781725888,0.9781446117324468,1.0,2/18,9.82%,MYO5A;RAB11A
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),-0.2765206103344324,-0.6671607428962827,0.8644578313253012,0.9733542812544369,1.0,8/10,31.34%,IVD;ACAD11;ETFA;ETFB;ACADS;ACADVL;GCDH;ACADM
prerank,membrane repolarization during action potential (GO:0086011),0.3260475478208414,0.6671500368549532,0.84,0.9779990328032308,1.0,1/13,4.32%,KCNIP2
prerank,sulfur compound transport (GO:0072348),0.2909705675141043,0.6662433873702569,0.8573141486810552,0.9785248034306009,1.0,4/27,13.57%,LRRC8D;SLC36A1;SLC25A30;MGST1
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.2874499351476907,0.6659501704915363,0.8820809248554913,0.9784524015904915,1.0,11/32,25.24%,HDAC5;ANXA1;THBS1;HDAC9;RHOA;MAP2K5;MMRN2;FGF2;VEGFA;KDR;AKT3
prerank,protein alkylation (GO:0008213),-0.21298208652731943,-0.6657658334215798,0.9438202247191011,0.97275943752675,1.0,11/22,30.41%,FAM98B;SNRPD3;PCMT1;PRMT8;PRMT1;EEF2KMT;LCMT1;METTL22;EEF1AKMT2;CAMKMT;VCPKMT
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.32357153379323966,0.6656595510288307,0.8710990502035278,0.9783836200176446,1.0,6/15,23.58%,ENTPD1;ENTPD2;AK8;ENTPD3;AK5;AK1
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.27197406890876685,0.6651906972905344,0.8976293103448276,0.9784783300754419,1.0,5/52,8.99%,NT5C3B;CNOT8;EXOSC1;RC3H2;RC3H1
prerank,pore complex assembly (GO:0046931),0.3053239200142703,0.6647145943025031,0.8577023498694517,0.9785722607907491,1.0,6/19,18.87%,P2RX7;TPR;NUP205;PDZD11;RTN4;TMEM170A
prerank,skeletal system development (GO:0001501),0.25582142473405806,0.6647110473608323,0.9608040201005025,0.9782349773756482,1.0,20/148,14.61%,SH3PXD2B;TGFBR1;PRELP;ATP7A;CD44;CHD7;TRPS1;SULF2;BCAN;XYLT1;PRDX1;CMKLR1;CREB3L2;PAPSS1;SOX9;SOX6;RFLNA;RAB33B;ANKRD11;SOX4
prerank,nucleotide biosynthetic process (GO:0009165),0.3090781512297585,0.6642270919398591,0.8620689655172413,0.9783275014034976,1.0,5/18,16.31%,GART;PNP;NMNAT3;PRPSAP1;RRM2B
prerank,Golgi to endosome transport (GO:0006895),0.32007603203646035,0.6639435822799975,0.8545918367346939,0.978254962616054,1.0,6/16,22.22%,RAB14;EPS15;MON2;SORT1;VPS13C;VPS13A
prerank,covalent chromatin modification (GO:0016569),0.32230482892436807,0.6629303942151618,0.8456284153005464,0.9788372517744656,1.0,7/14,28.19%,CHD1;SETD5;MT3;MBD2;SIRT7;HELLS;HDAC1
prerank,smooth muscle contraction (GO:0006939),0.321490370546135,0.6622217646224876,0.8481182795698925,0.9791146532976116,1.0,3/14,19.65%,SLC8A1;SMTN;ROCK2
prerank,protein heterooligomerization (GO:0051291),0.31010373060124274,0.6621618079237279,0.8538163001293662,0.9788300984521532,1.0,3/17,13.25%,PKD2;FARSB;TMEM120A
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.3174471770930205,0.6621616422719945,0.8478260869565217,0.9784909364285636,1.0,4/15,18.96%,ATL1;RTN4;TMEM170A;ATL2
prerank,negative regulation of smooth muscle cell migration (GO:0014912),0.32351922713248693,0.662066846912229,0.8455284552845529,0.9782338322225774,1.0,3/14,15.03%,AIF1;MEF2C;LRP1
prerank,regulation of neurotransmitter secretion (GO:0046928),0.2879627960965595,0.661805813560632,0.8897727272727273,0.9781127558383214,1.0,5/32,14.53%,MCTP1;VPS18;MEF2C;DTNBP1;LRRK2
prerank,ncRNA 3'-end processing (GO:0043628),0.32013534414127515,0.6616754913330606,0.8559782608695652,0.9778893782181487,1.0,5/14,21.18%,ELAC2;INTS8;INTS6;INTS6L;TOE1
prerank,mitochondrial translational termination (GO:0070126),0.25937479174864814,0.6615048377257793,0.932920536635707,0.9777034703318762,1.0,26/88,25.21%,MRPL46;AURKAIP1;CHCHD1;MRPL41;ERAL1;MRPL51;MTRF1L;MRPL19;MRPL15;MRPS25;MRPS9;MRPS21;MRPL39;MRPS14;MRPL30;MRPL3;MRPS26;MRPL10;MRPL54;MRPL21;MRPL18;MRPL52;MRPL12;MRPL37;MRPS34;MRPS12
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.28643066674793827,0.6612623921419495,0.8669724770642202,0.977586255940513,1.0,3/33,8.10%,TNFAIP3;AIF1;MEF2C
prerank,tetrapyrrole metabolic process (GO:0033013),0.30504347261395026,0.661081196575245,0.8419689119170984,0.9774144319349369,1.0,6/18,24.52%,ABCC1;MMUT;CUBN;MTR;MMAA;MMAB
prerank,autophagy of nucleus (GO:0044804),0.31660809851062005,0.6606215004798949,0.8490813648293963,0.9774788097642049,1.0,3/16,16.36%,ATG7;ATG2B;ATG3
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.2953453099782422,0.6605856436923608,0.8934707903780069,0.9771705094817624,1.0,7/31,18.67%,RPS2;UBE2S;FZR1;ARRDC4;PTEN;UBE2N;DCUN1D5
prerank,glycoprotein biosynthetic process (GO:0009101),0.2615083368275666,0.6595951478879477,0.9311408016443987,0.9777376311293985,1.0,15/79,20.57%,GCNT1;ATP7A;ST8SIA4;NPC1;XYLT1;FUT9;B3GALNT1;ST8SIA1;B4GALT7;TMEM106A;LARGE1;DDOST;GOLPH3;MGAT1;COG7
prerank,postreplication repair (GO:0006301),0.27623139537376734,0.6591764100091568,0.884828349944629,0.9777734589800511,1.0,4/45,6.94%,TRIM25;UBE2V2;UBE2V1;POLH
prerank,global genome nucleotide-excision repair (GO:0070911),0.28917705888802103,0.6591669899777407,0.8763505402160864,0.9774451687661551,1.0,8/26,24.19%,GTF2H1;RNF111;GTF2H5;ERCC1;RAD23B;ERCC4;PARP1;XPC
prerank,regulation of phosphatase activity (GO:0010921),0.2942584899276894,0.6590700942046448,0.8576642335766423,0.977192946687409,1.0,8/24,26.62%,PPP6R1;PTPA;CHP1;MTMR9;HTT;CDK5RAP3;TIPRL;TSC1
prerank,water-soluble vitamin metabolic process (GO:0006767),0.264532984577732,0.6589345490050963,0.9055036344755971,0.9769819948571302,1.0,12/68,17.81%,SLC52A1;MTHFS;SLC2A3;ABCC1;MCCC2;CYB5A;MMUT;CUBN;PDZD11;MTR;FPGS;PCCA
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),0.32640791557598203,0.657468379072798,0.8452883263009845,0.977953355065117,1.0,5/12,20.22%,WNK1;ATP1B3;ATP1B2;WNK4;FXYD1
prerank,sensory perception of taste (GO:0050909),0.3285005962467835,0.6570183052957296,0.855072463768116,0.9780152450226032,1.0,10/10,67.17%,CD36;ASIC2;TAS1R3;GNAT3;TAS1R2;TAS1R1;ASIC3;ASIC1;PKD1L3;PKD2L1
prerank,regulation of ATP metabolic process (GO:1903578),0.26983367672294695,0.6566818867728748,0.9114194236926361,0.9779815366428826,1.0,13/54,20.95%,NUP62;ATP7A;ABCD1;SEH1L;ATP5IF1;TPR;NUP205;HIF1A;GCK;PGAM1;SEC13;FIS1;NUP54
prerank,maturation of 5.8S rRNA (GO:0000460),0.3095701156142616,0.656225408612857,0.8465473145780051,0.9780571719216754,1.0,4/17,17.61%,LAS1L;PES1;C1D;WDR12
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),0.3403510005600855,0.6558777175919283,0.8558421851289834,0.9780362042968025,1.0,2/10,14.05%,CCT8;CCT5
prerank,mRNA transport (GO:0051028),0.2588413381418263,0.6553474750016456,0.9504550050556118,0.9781425269320189,1.0,27/101,21.24%,NUP62;DHX38;NXF1;THOC2;SEH1L;CASC3;RBM15B;SMG1;TPR;DDX39B;NUP205;POLDIP3;UPF3B;THOC3;ALKBH5;SMG7;UPF2;SLU7;FYTTD1;SRSF6;SRSF2;SEC13;HHEX;SLBP;SRSF3;NUP54;ZFP36L1
prerank,detection of calcium ion (GO:0005513),0.32547721743132957,0.6552786996402433,0.8494623655913979,0.977871321482309,1.0,1/13,4.32%,KCNIP2
prerank,mitotic DNA replication (GO:1902969),0.3342649736143849,0.6544214406958666,0.8530670470756063,0.978318915883922,1.0,2/10,10.17%,MCM6;MCM2
prerank,regulation of protein neddylation (GO:2000434),0.33876004721058145,0.6539481351029423,0.8469101123595506,0.9783854753738288,1.0,4/10,18.67%,COPS9;HIF1A;RPL11;DCUN1D5
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),0.3310012687875982,0.6535811591313057,0.8447552447552448,0.9783838490012081,1.0,1/12,3.05%,DHRS3
prerank,DNA integrity checkpoint signaling (GO:0031570),0.2764768158447278,0.6510456565839887,0.8855218855218855,0.9802820772932441,1.0,10/36,21.93%,BRIP1;CHEK2;DOT1L;CDC5L;DNA2;CDC6;ERCC6;CEP63;CDC45;RAD1
prerank,kinetochore organization (GO:0051383),0.313370998116761,0.6507784801350378,0.8653061224489796,0.9801753667581947,1.0,13/13,68.69%,MIS12;CENPT;CDT1;POGZ;CENPC;CENPW;NUF2;DLGAP5;CENPA;CENPF;NDC80;CENPH;CENPE
prerank,positive regulation of developmental process (GO:0051094),0.25362402467794726,0.6500644609884177,0.9698492462311558,0.9804358831830545,1.0,28/164,19.92%,SHH;BASP1;RREB1;MAD2L2;DDHD1;MDK;TNF;APOE;CEBPB;CPEB3;SOX9;NR2C2;SORL1;LRP8;SOX6;SRC;RTN4;CORO1C;VHL;VLDLR;AGO2;SHLD1;TAPT1;SHLD2;GDNF;DNM1L;FIS1;RELN
prerank,RNA export from nucleus (GO:0006405),0.25728951430116237,0.6495250793229863,0.9513677811550152,0.9805925643985908,1.0,26/100,20.95%,NUP62;DHX38;NXF1;THOC2;SEH1L;CASC3;RBM15B;SMG1;TPR;DDX39B;NUP205;POLDIP3;UPF3B;THOC3;ALKBH5;SMG7;UPF2;SLU7;FYTTD1;SRSF6;SRSF2;SEC13;HHEX;SLBP;SRSF3;NUP54
prerank,renal system development (GO:0072001),0.2656715839013695,0.6488272429598846,0.9114470842332614,0.9808869462513087,1.0,6/52,11.42%,PCSK9;TGFBR1;MYOCD;TFAP2B;SULF2;PYGO2
prerank,cellular response to alkaloid (GO:0071312),0.3033415522905803,0.6487707674234265,0.8801546391752577,0.9805980200624402,1.0,5/17,22.31%,SLC8A1;CASP7;GSTM2;SPIDR;TGM2
prerank,negative regulation of growth (GO:0045926),0.2524214523176617,0.6481547038374741,0.9555555555555556,0.9807963971132692,1.0,12/121,12.34%,TGFB1;PTPRJ;NME6;CDA;TP53;FLCN;RB1;SMAD3;SIPA1;INHBA;RBBP7;PPP2CA
prerank,coenzyme A metabolic process (GO:0015936),0.3103834373747524,0.6479159242171878,0.873972602739726,0.9806714212221272,1.0,1/14,3.26%,SLC25A16
prerank,negative regulation of binding (GO:0051100),0.25794814323928184,0.6472552502628496,0.9351184346035015,0.980888995181742,1.0,20/81,24.73%,BAG2;PRKCD;ACTB;TFIP11;DISC1;CTSZ;PSME3IP1;SORL1;LRRK2;TLE5;RSF1;DACT1;GSK3B;TFAP4;PIN1;MITD1;RACK1;IFIT1;DDX11;ILRUN
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.2579524565281218,0.6463171780002167,0.9264705882352942,0.9813432126195163,1.0,8/72,10.47%,RGCC;CNOT8;TP53;CRADD;PLK2;CHEK2;ATRX;RPL26
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.3285212151644488,0.6462887409052747,0.8671532846715329,0.9810349286095167,1.0,11/11,67.17%,RTP4;RTP2;TAS1R3;PIGR;GNAT2;GNAT3;TAS1R2;RTP3;LPO;PKD1L3;PKD2L1
prerank,regulation of keratinocyte proliferation (GO:0010837),0.29256577953677754,0.6462838151421767,0.8879518072289156,0.9807022435224099,1.0,8/22,25.94%,MDK;CASK;STXBP4;SRSF6;ZFP36L1;CDH3;EPB41L4B;MED1
prerank,purine nucleotide metabolic process (GO:0006163),0.28529491306341187,0.645992642600482,0.8894230769230769,0.9806256673920615,1.0,4/24,14.46%,XDH;GART;PNP;PRPSAP1
prerank,negative regulation of wound healing (GO:0061045),0.2847558923400855,0.6457691323504012,0.8943661971830986,0.9804686812325291,1.0,8/28,22.71%,TNF;APOE;CASK;PTEN;CRK;FGF2;VTN;CLASP1
prerank,Notch signaling involved in heart development (GO:0061314),0.3273502819339765,0.6457415084792493,0.8755426917510853,0.9801558501156415,1.0,2/11,16.11%,SNAI1;RBPJ
prerank,peptidyl-lysine modification (GO:0018205),0.2557339353625819,0.645226527898323,0.9383838383838384,0.9802817870451992,1.0,22/99,21.51%,BCL11A;NUP62;ATP7A;SEH1L;LOX;HDAC4;TPR;HDAC6;NUP205;HDAC9;NDUFAB1;ETFBKMT;UBA2;PIAS1;VPS33B;LOXL3;SENP6;SENP7;NUP54;SIRT5;NSMCE2;EEF1AKMT1
prerank,DNA conformation change (GO:0071103),0.30840469906567575,0.6447292469647667,0.8665785997357992,0.9803574442452915,1.0,7/17,27.67%,HMGB1;TOP2A;TOP1;HHEX;NAA10;TOP3A;HMGB2
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.2799716292325173,0.6444297251984061,0.8791866028708134,0.9802712922310585,1.0,6/30,17.43%,SCN4B;PKP2;NEDD4L;KCNA5;CACNA1D;SCN5A
prerank,positive regulation of mitochondrial fission (GO:0090141),0.2996234957996448,0.6443676892235969,0.8584070796460177,0.9799922789724844,1.0,7/18,27.12%,DDHD1;DNM1L;FIS1;PRKN;KDR;MFF;MCU
prerank,receptor recycling (GO:0001881),0.3252846073678618,0.6442004117987571,0.8645533141210374,0.9798032212996797,1.0,2/10,12.79%,ARFGEF2;SORL1
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.28543979411046483,0.6436248798260001,0.8919239904988123,0.9799339709133412,1.0,6/25,23.09%,EAF1;LEO1;ELL;ZMYND11;HEXIM1;NELFE
prerank,diol metabolic process (GO:0034311),0.30070566367953044,0.6435855825714525,0.8687898089171975,0.979628027181587,1.0,3/19,16.72%,GCH1;SPR;HSP90AA1
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.3271246128315067,0.6433599417613067,0.8730822873082287,0.9794806211267746,1.0,3/10,16.41%,PIH1D1;NUFIP1;ZNHIT6
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.30166897976223517,0.6429944432486401,0.8531375166889186,0.9794600755431312,1.0,2/15,7.37%,MEF2A;SLC9A1
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",0.30465902132993045,0.6429029800940494,0.8696219035202086,0.9791983623749929,1.0,1/16,2.82%,DHX9
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.273762695486935,0.6425348549207663,0.9128491620111732,0.9791786269273677,1.0,4/40,12.54%,FAM111A;ATRX;BOD1L1;MCM9
prerank,aggrephagy (GO:0035973),0.2833853692975191,0.6424925577718724,0.8775029446407538,0.9788773101616958,1.0,9/27,24.32%,UBE2V1;HDAC6;DYNC1H1;WDR81;UBE2N;WDFY3;PRKN;IFT88;DYNC1LI1
prerank,negative regulation of hemostasis (GO:1900047),0.32329222256506057,0.6423433248796125,0.8635724331926864,0.9786779579858278,1.0,1/12,4.14%,APOE
prerank,apoptotic mitochondrial changes (GO:0008637),0.2788696941788727,0.6423215606479089,0.9001135073779796,0.978362684811401,1.0,8/32,19.61%,FZD9;BCL2L1;BAK1;TIMM50;HK2;ATG3;DNM1L;FIS1
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.2721960278510679,0.6421444139823291,0.8990011098779135,0.9781741272073982,1.0,12/40,25.04%,PYCARD;BCL2L1;TP53;BMF;TNFSF10;GHITM;DNM1L;PRKN;BID;IGF1;PRELID1;MFF
prerank,folic acid metabolic process (GO:0046655),0.30304237890789576,0.6417826528167127,0.8805194805194805,0.9781530274391023,1.0,1/18,2.77%,MTHFS
prerank,female gonad development (GO:0008585),0.2984271327471922,0.6415591897179288,0.8719590268886044,0.9779995907394201,1.0,3/19,10.54%,CEBPB;EIF2B2;INHBA
prerank,sphingoid biosynthetic process (GO:0046520),0.32195830971369377,0.641145800748048,0.8556547619047619,0.9776759307354588,1.0,4/11,25.08%,ACER3;ASAH1;ABCA2;SPHK2
prerank,sphingosine biosynthetic process (GO:0046512),0.32195830971369377,0.641145800748048,0.8556547619047619,0.9776759307354588,1.0,4/11,25.08%,ACER3;ASAH1;ABCA2;SPHK2
prerank,xenobiotic transport (GO:0042908),0.30310443703138157,0.6410461319828239,0.8761776581426649,0.9774174583693279,1.0,3/16,15.27%,ABCC3;ABCC1;ABCA3
prerank,regulation of cell morphogenesis (GO:0022604),0.28320994500163865,0.6410249439582234,0.9052023121387284,0.977102317573728,1.0,5/30,11.88%,CD44;MACF1;CAPZB;MOV10;PHIP
prerank,cellular response to dsRNA (GO:0071359),0.31122492512445793,0.6410030945359781,0.8639365918097754,0.9767884367967893,1.0,1/15,2.82%,DHX9
prerank,establishment of mitotic spindle localization (GO:0040001),-0.187656939240836,-0.6407109164284825,0.9551282051282052,0.9913799969245454,1.0,5/28,11.09%,PAFAH1B1;GPSM2;NDEL1;NDE1;CDK5RAP2
prerank,neuron projection regeneration (GO:0031102),0.32792081876352863,0.6405266093413226,0.8680057388809183,0.9768664834232613,1.0,1/10,3.71%,RTN4RL1
prerank,chromatin assembly (GO:0031497),0.2687648542860413,0.6403561926167949,0.9139664804469274,0.9766737843772133,1.0,11/38,22.84%,TP53;ATRX;NAP1L1;SOX9;NOC2L;SPTY2D1;RSF1;RBBP4;LIN54;SMARCA5;H3-3A
prerank,pyrimidine-containing compound metabolic process (GO:0072527),-0.2602348937669873,-0.6402191298290402,0.9163987138263665,0.9898446291504331,1.0,4/11,21.73%,ENPP3;SLC19A2;SLC19A3;SLC25A19
prerank,translational termination (GO:0006415),0.2494007553539442,0.6398469735901451,0.9435897435897436,0.9767542547817805,1.0,27/95,25.21%,MRPL46;AURKAIP1;CHCHD1;MRPL41;GSPT1;ERAL1;MRPL51;MTRF1L;MRPL19;MRPL15;MRPS25;MRPS9;MRPS21;MRPL39;MRPS14;MRPL30;MRPL3;MRPS26;MRPL10;MRPL54;MRPL21;MRPL18;MRPL52;MRPL12;MRPL37;MRPS34;MRPS12
prerank,nucleotide-sugar metabolic process (GO:0009225),-0.25176295731865844,-0.6394318992686183,0.9247311827956989,0.9885261349858291,1.0,3/12,14.87%,GMDS;UGP2;GFPT1
prerank,protein sumoylation (GO:0016925),0.26592913500428134,0.6392368019462005,0.911062906724512,0.9769098699772907,1.0,7/49,15.15%,BCL11A;NUP62;SEH1L;TPR;NUP205;UBA2;PIAS1
prerank,regulation of cell communication by electrical coupling (GO:0010649),0.3140456836433488,0.6391186444561985,0.8597222222222223,0.9766745449556926,1.0,1/13,3.19%,SLC8A1
prerank,membrane assembly (GO:0071709),0.2789476607561295,0.6387011329421931,0.8812572759022119,0.9766898742064248,1.0,8/34,18.50%,RFTN1;CEL;GAK;PTEN;STX2;PICALM;FLOT1;UBXN2A
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.26701108499199766,0.6386501834352067,0.9033659066232356,0.9764008756448701,1.0,10/43,21.51%,TAOK3;NABP1;BABAM2;FZR1;FOXN3;CDC6;BABAM1;TAOK1;BRSK1;PABIR1
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.30344201657827313,0.6382438093304638,0.8849104859335039,0.976408638427646,1.0,7/16,23.29%,SH2B3;NF2;ADIPOR1;PPP2CA;VHL;SOCS3;INPP5F
prerank,negative regulation of lipid metabolic process (GO:0045833),0.28488567152103145,0.6375279004928345,0.8830694275274056,0.9766388316027128,1.0,1/22,3.81%,TNF
prerank,vitamin transport (GO:0051180),0.27924327297994805,0.6372859330657403,0.8898007033997656,0.9765016268967275,1.0,1/29,1.98%,SLC52A1
prerank,dermatan sulfate biosynthetic process (GO:0030208),-0.25000337536800316,-0.6372547688889535,0.92,0.9883104589649493,1.0,3/12,16.07%,DSE;VCAN;DCN
prerank,folic acid-containing compound metabolic process (GO:0006760),0.2992952850490205,0.6369286612114586,0.8708010335917312,0.9764704478050172,1.0,3/19,17.44%,MTHFS;GGH;FPGS
prerank,positive regulation of Notch signaling pathway (GO:0045747),0.27166219309760664,0.6362574155777087,0.9073869900771775,0.9766746933531146,1.0,7/39,16.11%,BMP2K;MAML3;TSPAN14;POGLUT1;NOD2;SRC;RBPJ
prerank,protein localization to nucleus (GO:0034504),0.24892523732451916,0.6360520042967173,0.9448979591836735,0.9765251206878648,1.0,14/102,16.66%,MMP12;SYK;NUP62;MORC3;CSE1L;TPR;TAF8;RRS1;TOR1AIP2;TOR1A;INTS13;TAF3;RPL11;APPL2
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.31993597905627835,0.6359872436745875,0.8664850136239782,0.9762483119234264,1.0,4/12,14.16%,RBM15B;METTL3;CDYL;LRIF1
prerank,DNA damage checkpoint signaling (GO:0000077),0.27875662206869584,0.6359576532495257,0.8956109134045077,0.9759404737531889,1.0,4/28,8.23%,BRIP1;CHEK2;DOT1L;CDC5L
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.2989480943193079,0.6357844132815403,0.8806532663316583,0.9757465722418529,1.0,2/19,5.93%,RENBP;NAGK
prerank,cell-cell junction organization (GO:0045216),0.25344341166369005,0.6356809474705645,0.9421487603305785,0.9755028889883585,1.0,13/79,16.25%,TGFB1;CSF1R;PKP2;FLCN;SMAD3;CDH8;LIMS1;CDH9;CDH12;TLN1;CADM1;DCHS1;CDH19
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.28601430447756576,0.634907876229315,0.8802547770700637,0.9758099577263037,1.0,4/20,20.45%,BCL2L1;BAK1;GSK3A;GSK3B
prerank,response to UV-A (GO:0070141),0.304902719565487,0.6347670905687769,0.8700787401574803,0.9756059051978399,1.0,1/14,5.21%,TIMP1
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.24320741938257096,-0.6340486904499788,0.926829268292683,0.9886640237375556,1.0,6/12,36.40%,HNRNPU;LARP7;NELFB;NELFA;EAPP;RNF8
prerank,negative regulation of histone methylation (GO:0031061),0.3270974504162201,0.6339810157147655,0.87,0.9759227735966578,1.0,5/10,28.12%,MTF2;PHF1;DNMT3B;BCOR;JARID2
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.29094290121166166,0.6338241923355871,0.8797546012269939,0.9757298974485471,1.0,4/19,16.13%,NDST1;XYLT1;EXTL3;NDST2
prerank,protein tetramerization (GO:0051262),0.2550587308582122,0.6337652623103446,0.918918918918919,0.9754489132799627,1.0,5/67,6.09%,ALDH9A1;SNCA;PKD2;SAMHD1;FARSB
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.31722244566112834,0.6336132188124486,0.8631284916201117,0.9752310751454272,1.0,3/11,21.24%,ITM2B;AGO2;ABCA2
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),-0.25669546831508977,-0.6325610647531503,0.9166666666666666,0.987843819880532,1.0,2/10,8.81%,ATP1A2;FKBP1A
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.2654230180561283,0.6323679402062128,0.9053452115812918,0.9759190303822591,1.0,12/39,21.77%,ACTN4;CASK;NF2;THBS1;PTPRO;RASA1;CORO1C;RHOA;SPRY4;CORO2B;MAP4K4;CX3CL1
prerank,cardiac left ventricle morphogenesis (GO:0003214),0.3112393046890664,0.6321374508971052,0.8718291054739653,0.9757779220676506,1.0,3/13,16.11%,TGFBR2;GSK3A;RBPJ
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.3172348537235078,0.6316883249425249,0.8708751793400287,0.9758228231323068,1.0,4/10,19.44%,SVIP;UBE2G2;ERLEC1;OS9
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),0.31583211233476194,0.6315064901612907,0.8779472954230236,0.9756365883738694,1.0,1/11,6.29%,CTNNB1
prerank,protein peptidyl-prolyl isomerization (GO:0000413),0.2900352977250461,0.6309750275012387,0.8762376237623762,0.9757505733901217,1.0,8/20,25.25%,PPIE;CWC27;PPIG;PPIH;NKTR;PIN1;PPIA;PPIL3
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),0.3061770070394355,0.6308823534028427,0.8604026845637583,0.9755047657550342,1.0,4/14,20.51%,ADPRM;ENTPD1;ENTPD2;ENTPD3
prerank,regulation of TORC1 signaling (GO:1903432),0.26896326442224056,0.6305221131741865,0.9126984126984127,0.9754541053872334,1.0,9/33,21.78%,GPR137B;SEH1L;FLCN;PIP4P1;RNF152;PIH1D1;TELO2;RRAGA;RRAGB
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),-0.21241408889703062,-0.6296832837802867,0.9333333333333333,0.9880119862721771,1.0,4/17,26.87%,AKAP13;RAPGEF2;DRD2;ADRB2
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.2569128163124691,0.6286178316588342,0.92,0.9763433497887406,1.0,7/50,11.72%,NUP62;TNRC6A;SEH1L;PUM2;TPR;POLR2L;NUP205
prerank,regulation of gene silencing by RNA (GO:0060966),0.2569128163124691,0.6286178316588342,0.92,0.9763433497887406,1.0,7/50,11.72%,NUP62;TNRC6A;SEH1L;PUM2;TPR;POLR2L;NUP205
prerank,positive regulation of DNA repair (GO:0045739),0.26099639494695237,0.6286058667240455,0.9207589285714286,0.9760249305060185,1.0,11/46,20.15%,DHX9;HMGB1;BABAM2;MGMT;SLF2;ERCC6;BABAM1;UBE2N;NPAS2;TIGAR;SPIDR
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.3160097400238356,0.6281754588252101,0.8707865168539326,0.9760716957593557,1.0,2/12,17.53%,SEH1L;MIS12
prerank,tRNA 5'-end processing (GO:0099116),0.30377588573933706,0.6279557132345642,0.8994490358126722,0.9759213634196838,1.0,3/15,15.02%,RPP38;RPP14;PRORP
prerank,peptidyl-glutamic acid modification (GO:0018200),0.28227499756258057,0.6279307675902382,0.9201474201474201,0.9756106389733239,1.0,9/24,26.39%,TPGS1;AGBL5;AGTPBP1;TTLL1;NAA80;TTLL7;PARP1;TTLL4;NAA10
prerank,peptidyl-lysine dimethylation (GO:0018027),0.2966407793780444,0.6278898358967372,0.8933161953727506,0.9753156161205324,1.0,4/18,18.42%,ASH1L;SETD2;SUV39H1;SETD1B
prerank,positive regulation of axon extension (GO:0045773),0.2894210351313987,0.6277844927801866,0.8965936739659367,0.9750706965183149,1.0,4/22,13.52%,MACF1;NRP1;TWF2;MEGF8
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.28868335073923873,0.6277358093852119,0.9029850746268657,0.9747815575485721,1.0,5/21,23.52%,OSBPL10;OSBPL8;PLAAT3;PLA2G5;PLA2G4E
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),0.2944994666979376,0.6276626165759996,0.8814432989690721,0.9745228794936586,1.0,1/17,3.24%,MAML3
prerank,cranial nerve development (GO:0021545),0.31944508524527654,0.6263367110685054,0.875,0.9752288139451498,1.0,1/11,6.22%,CHD7
prerank,maturation of SSU-rRNA (GO:0030490),0.2671567639992366,0.6261348690872595,0.9221218961625283,0.9750650242674621,1.0,9/34,20.88%,NOB1;RPS16;HEATR1;RPS14;TSR1;NGDN;RIOK3;UTP3;SRFBP1
prerank,acidic amino acid transport (GO:0015800),0.2937890341576864,0.6260315431933584,0.8834437086092716,0.9748178499145141,1.0,5/17,24.22%,LRRC8D;SLC25A18;GIPC1;SLC6A6;GJA1
prerank,histone acetylation (GO:0016573),0.25266338795041476,0.6259425971025162,0.9400826446280992,0.974559506114657,1.0,17/69,24.02%,BRD8;SPI1;EP400;TADA1;BRPF3;NAA40;KAT7;JADE2;NAA50;MEAF6;PER1;BRD1;YEATS2;PHF20;MORF4L2;MORF4L1;CHD5
prerank,post-translational protein modification (GO:0043687),0.24139233868736015,0.625942381033518,0.999,0.9742333483147526,1.0,55/332,18.91%,PCSK9;WDTC1;COPS6;APOE;DNAJC3;FBXL22;SPP1;RNF7;TIMP1;FBXL18;PTP4A2;KLHL21;PSMB10;P4HB;CHML;RAB11A;RAB1B;VGF;FAM20C;LGALS1;CHGB;PSMA2;RBBP5;FBXO40;KLHL11;RBBP7;FBXO32;F5;PSME3;STT3B;SUMF2;FBXL3;COPS4;GAS6;PSMB5;WFS1;PSMD8;CCDC8;DCAF17;PSMD7;GAN;PSMB9;HIF1A;APLP2;WSB2;DCAF5;FEM1B;VHL;PSMD2;KEAP1;FBXO44;MXRA8;SPSB2;IGFBP4;ELOB
prerank,regulation of Notch signaling pathway (GO:0008593),0.25237859612499897,0.6259154571576565,0.9548717948717949,0.9739273174513826,1.0,8/76,12.25%,LFNG;BMP2K;MAML3;SREBF2;TSPAN14;POGLUT1;METTL3;NOD2
prerank,establishment of endothelial barrier (GO:0061028),0.2712621009089093,0.6252231248114792,0.8995381062355658,0.9741794346703769,1.0,7/29,17.18%,RAP1B;RAP2B;F11R;RAB1B;RAPGEF1;RAP1A;PECAM1
prerank,regulation of endocytic recycling (GO:2001135),0.3143149147659555,0.6243055195917112,0.8635014836795252,0.9745596742388516,1.0,5/11,23.52%,ARHGAP1;SORL1;EIPR1;INPP5F;PLA2G4E
prerank,organelle fusion (GO:0048284),0.28071942847443626,0.623359633717411,0.8881829733163914,0.9749715501957202,1.0,7/22,25.04%,VPS18;VPS11;MIGA1;FIS1;MFN1;EEA1;MFF
prerank,calcium ion import (GO:0070509),0.2756455003802155,0.6221332798145641,0.9143192488262911,0.9755980831836394,1.0,6/28,17.73%,SLC8A1;CACNA1A;CACNB2;CACNA1B;CACNA1D;MICU2
prerank,DNA biosynthetic process (GO:0071897),-0.21423433034036227,-0.6214337010107132,0.9262672811059908,0.9917768189085502,1.0,11/16,35.85%,WRNIP1;WRN;POLA1;TERT;TYMS;POLD2;RFC3;POLE;CDKN2D;POLD4;POLD1
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.3247030832181677,0.6208679727243288,0.8873038516405135,0.9759205131019947,1.0,2/10,18.46%,WNK1;MAP2K5
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.3247030832181677,0.6208679727243288,0.8873038516405135,0.9759205131019947,1.0,2/10,18.46%,WNK1;MAP2K5
prerank,ventricular cardiac muscle cell action potential (GO:0086005),0.2890272840955025,0.6202755903577075,0.8722826086956522,0.9760598209660399,1.0,2/17,10.05%,PKP2;NEDD4L
prerank,muscle tissue morphogenesis (GO:0060415),0.298253719512939,0.6198956858630492,0.9038961038961039,0.9760285519637485,1.0,1/16,4.28%,TTN
prerank,epithelial cell development (GO:0002064),-0.2005767836167579,-0.6194716987141814,0.9724770642201835,0.9912472758807317,1.0,13/20,49.97%,WNT5B;ACTA2;PDZD7;EXPH5;RILPL2;TMEM79;WNT7A;PKHD1;POF1B;GRHL2;WNT7B;RAB25;ROS1
prerank,amino sugar metabolic process (GO:0006040),0.31708458018532515,0.6192961316901155,0.8708272859216255,0.9761660197421348,1.0,3/10,19.34%,ST3GAL1;SLC35A3;FN3K
prerank,cellular response to misfolded protein (GO:0071218),0.2862810468533201,0.6189169224838439,0.9074074074074074,0.9761333677459975,1.0,9/20,27.32%,ATXN3;DERL1;TOR1A;STUB1;CUL3;DNAJB14;KLHL15;UGGT2;VCP
prerank,axon development (GO:0061564),0.24440700405337246,0.6188874682910054,0.9557157569515963,0.9758281676507972,1.0,15/78,20.23%,NEFH;S100B;SLITRK1;RTN4RL1;ACTB;MAP1B;ATL1;SVBP;MTR;CAMSAP2;RTN4;SPTBN4;KLF7;CNTN4;CDK5R1
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.2280057196803873,-0.6181719744364079,0.958041958041958,0.9901793536467929,1.0,6/13,36.40%,HNRNPU;LARP7;NELFB;NELFA;EAPP;RNF8
prerank,modified amino acid transport (GO:0072337),0.30078347110382175,0.6179601645821423,0.8906882591093117,0.9762281292756705,1.0,3/15,15.11%,CTNS;MGST1;SLC1A4
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.3174678582901781,0.6178287667370927,0.8775811209439528,0.9759999985137037,1.0,4/10,21.28%,EMC6;EMC2;MMGT1;EMC3
prerank,body fluid secretion (GO:0007589),0.29454087816386776,0.6173922545767858,0.8861788617886179,0.975994094241768,1.0,4/15,26.26%,PRLR;ZBTB7B;VEGFA;ERBB4
prerank,snRNA 3'-end processing (GO:0034472),0.2871706232634746,0.6173094487207963,0.9102402022756005,0.9757293070139885,1.0,7/19,22.63%,INTS8;INTS6;INTS6L;INTS1;EXOSC3;TOE1;EXOSC2
prerank,ncRNA metabolic process (GO:0034660),0.2601265334332775,0.6171175766999335,0.9234234234234234,0.9755548324209659,1.0,9/37,24.76%,TENT4B;BCDIN3D;PRKRA;TUT7;TARBP2;AGO2;DICER1;ZCCHC8;DROSHA
prerank,regulation of neurotransmitter transport (GO:0051588),0.29736685799814255,0.6168017130849854,0.8910505836575876,0.9754579517792997,1.0,2/16,8.10%,MCTP1;MEF2C
prerank,regulation of lipid metabolic process (GO:0019216),0.2443043097836037,0.6165647225097527,0.9539406345957011,0.9753178033414931,1.0,15/88,18.31%,PSAP;NPC2;SREBF2;ZFP69;TBL1XR1;TBL1X;ADIPOR1;SMARCD3;GPS2;SREBF1;FASN;ACACA;PPARD;NFYA;RXRA
prerank,DNA packaging (GO:0006323),0.2908235846451558,0.616224118057545,0.8812903225806452,0.9752418721151842,1.0,3/16,19.59%,TP53;NOC2L;RBBP4
prerank,regulation of steroid biosynthetic process (GO:0050810),0.30632727205704685,0.615948820651518,0.8896648044692738,0.9751271205618349,1.0,1/11,3.77%,NR1H4
prerank,arachidonic acid secretion (GO:0050482),0.3104689659720289,0.6158541184073733,0.9001386962552012,0.9745557377236214,1.0,1/10,6.34%,ANXA1
prerank,arachidonate transport (GO:1903963),0.3104689659720289,0.6158541184073733,0.9001386962552012,0.9745557377236214,1.0,1/10,6.34%,ANXA1
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.2825988896360239,0.6157478845867727,0.9038461538461539,0.974308822305953,1.0,6/19,21.79%,CDA;PNP;POLD3;DCK;APRT;GMPR2
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.2653369238018579,0.6146442447357703,0.9170506912442397,0.9748319847697217,1.0,9/30,23.85%,TENT4B;TP53;STN1;SRC;TINF2;TERF2;ERCC4;TEN1;DCP2
prerank,inositol phosphate catabolic process (GO:0071545),0.3121212260648438,0.61451542891242,0.8884297520661157,0.9745967153556551,1.0,5/12,23.28%,SYNJ1;PTEN;INPP5K;NUDT3;OCRL
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.29164118212966855,0.6138644200336815,0.891644908616188,0.974775739011614,1.0,3/16,15.51%,MCM6;MCM2;TWNK
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.2661182895969111,0.6137330095337905,0.9221835075493612,0.9745539113010845,1.0,9/31,22.65%,YWHAB;TP53;BAK1;CASP8;GSK3A;YWHAH;NMT1;GSK3B;BID
prerank,regulation of glucose transmembrane transport (GO:0010827),0.2870425788464353,0.6135917172683342,0.8975672215108835,0.9743417525397858,1.0,3/18,19.95%,PRKCB;BRAF;INPP5K
prerank,histone H3 acetylation (GO:0043966),0.2571327877002861,0.6135179520888411,0.9158361018826136,0.9740739817403321,1.0,9/40,20.73%,SPI1;TADA1;BRPF3;KAT7;JADE2;MEAF6;PER1;BRD1;YEATS2
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.3142958488721333,0.6129611111034496,0.8907330567081605,0.9738661320763712,1.0,1/11,4.10%,PKD2
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.3142958488721333,0.6129611111034496,0.8907330567081605,0.9738661320763712,1.0,1/11,4.10%,PKD2
prerank,histone ubiquitination (GO:0016574),0.28070383122950343,0.6126840949688224,0.9056122448979592,0.9737634991080275,1.0,7/21,23.31%,LEO1;PHC1;RNF40;HUWE1;UBE2N;UBE2E1;CTR9
prerank,positive regulation of protein ubiquitination (GO:0031398),0.24896383709234418,0.612639944831019,0.9585921325051759,0.9734718297171521,1.0,19/80,21.61%,LAPTM5;RPS2;MALT1;PDCD6;DERL1;AMER1;ARRDC4;STUB1;HUWE1;WFS1;LRRK2;GSK3A;UBE2N;BIRC2;ANGPT1;DCUN1D5;CUL3;BIRC3;PIN1
prerank,regulation of autophagosome assembly (GO:2000785),0.2645125572054663,0.6115717044889374,0.9037122969837587,0.9739562052405325,1.0,11/33,24.20%,PIP4K2A;RAB3GAP2;MTMR3;RAB1B;LRRK2;TBC1D14;TBC1D12;SEC22B;NPRL3;ADPRH;IFT88
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.28780079776383355,0.6107072363306568,0.908,0.9742770664556469,1.0,5/18,22.65%,FZD9;BAK1;GSK3A;GSK3B;BID
prerank,negative regulation of coagulation (GO:0050819),0.300121843505275,0.6098012869411155,0.8940217391304348,0.9745861838051425,1.0,1/14,4.14%,APOE
prerank,anterograde trans-synaptic signaling (GO:0098916),0.23624545271070244,0.6094186034629959,0.986986986986987,0.9745262035641447,1.0,27/224,15.78%,PCDHB6;PRKAR2B;SNCA;KCNIP2;CEL;AKAP5;NRGN;ATXN3;APBA1;PTCHD1;CACNA1A;CACNB4;GABRA5;SYT10;DTNA;RAPSN;CACNB2;GLRA2;PRKACB;SDCBP;CACNB1;CAMKK2;GABRA4;CACNA1B;MPZ;GRIA1;RPS6KA2
prerank,negative regulation of gluconeogenesis (GO:0045721),-0.24159127427892213,-0.6093173018267666,0.9256756756756757,0.9938671789696779,1.0,3/11,23.11%,SIK1;C1QTNF3;CRY1
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.2598627504915754,0.6084706897230291,0.9359550561797753,0.9748977390669846,1.0,4/36,8.53%,RAB34;RAB7A;MACF1;RAB31
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.2415403578426079,0.6084535905392117,0.9618949536560247,0.9745910255798228,1.0,14/79,18.40%,PTPN1;UBE2D3;SKI;CREB3L1;SULF2;PDCD6;CASK;THBS1;SORL1;BAMBI;SMURF1;RBPMS2;SPRY4;GREM1
prerank,positive regulation of histone modification (GO:0031058),0.2647681426998027,0.6083222137783428,0.9323394495412844,0.9743627590498546,1.0,12/33,27.11%,PPARGC1A;RPS6KA4;BRD7;AKAP8L;ZBTB7B;UBE2N;RPS6KA5;CTBP1;ARRB1;GLYR1;SART3;MAPK3
prerank,organophosphate ester transport (GO:0015748),0.2766950500459015,0.6078695029894703,0.905,0.9743841978227421,1.0,4/24,15.27%,NPC2;PRELID3B;OSBPL8;ABCA3
prerank,"synaptic transmission, GABAergic (GO:0051932)",0.31275556529397247,0.6075806669550671,0.8820960698689956,0.9742570222610589,1.0,3/10,19.04%,GABRA5;GABRA4;GABRG1
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.19286863275688293,-0.6074033740807439,0.9837837837837838,0.9930545596743419,1.0,6/21,22.53%,ATAD5;BRD4;CDK4;CDC7;NPM1;RAD51C
prerank,icosanoid secretion (GO:0032309),0.29878580914758884,0.6073865547283173,0.8993197278911564,0.9740693596069622,1.0,3/12,21.31%,ANXA1;PLA2G5;ABCC4
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.2625009471550628,0.6065360830347591,0.903448275862069,0.9743635225949151,1.0,5/30,13.79%,RAB34;MACF1;RAB31;SEC16A;GGA2
prerank,positive regulation of cartilage development (GO:0061036),0.28827342014978774,0.6060408188099845,0.9006535947712418,0.974378169605278,1.0,3/17,13.62%,MDK;SOX9;SOX6
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.3067813662123385,0.605871132944213,0.9059474412171508,0.9741788207518758,1.0,1/11,6.22%,LIG3
prerank,response to peptide hormone (GO:0043434),0.2579060605552501,0.6050406894714129,0.9375696767001115,0.9744283869308169,1.0,10/43,19.71%,STAT5A;ANXA1;STAT4;STAT5B;EIF2B2;CREB1;SRC;ZBTB7B;ROCK2;SORT1
prerank,negative regulation of inclusion body assembly (GO:0090084),-0.24920685569992052,-0.6050278351366063,0.9221183800623053,0.9925686545867287,1.0,7/10,39.13%,SACS;DNAJB2;DNAJA4;DNAJB1;HSPA1A;HSPA1B;HSPA2
prerank,intraciliary retrograde transport (GO:0035721),-0.23100633782503463,-0.6049991043567631,0.9315960912052117,0.990763041618957,1.0,6/12,29.57%,WDR35;IFT43;DYNC2I2;IFT122;WDR19;DYNC2H1
prerank,COPII-coated vesicle cargo loading (GO:0090110),0.293055620416729,0.604930127288469,0.896032831737346,0.9741811812086151,1.0,6/14,25.83%,SEC24D;SAR1A;SEC13;SEC31A;SEC24C;SEC24A
prerank,sulfur amino acid catabolic process (GO:0000098),0.30737128484025966,0.6046820587437588,0.8991477272727273,0.9740384928018756,1.0,2/10,16.86%,TXN2;CBS
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.2899585105813462,0.6042121550186604,0.8873994638069705,0.9740515346370248,1.0,4/15,18.09%,LDLRAP1;PPARD;ADM;PPM1K
prerank,fatty-acyl-CoA metabolic process (GO:0035337),-0.2027213108523878,-0.603858251516195,0.9346733668341709,0.9895720228268923,1.0,10/20,32.04%,FAR1;ACLY;PPT1;CBR4;ACSL4;ACSL3;HSD17B4;FITM2;GCDH;SLC25A1
prerank,negative regulation of endopeptidase activity (GO:0010951),0.2497013615490286,0.6026493265452924,0.9334787350054525,0.9748394561424947,1.0,2/47,5.21%,PCID2;TIMP1
prerank,cellular amino acid catabolic process (GO:0009063),0.24157649197777983,0.6021134322474291,0.9629629629629629,0.974891362544692,1.0,10/87,13.61%,CRYM;HAAO;OGDH;KYNU;KMO;QDPR;ECHS1;MCCC2;ALDH7A1;DDAH1
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.30618072964190163,0.6018125627731059,0.9030837004405287,0.9747715628672173,1.0,2/11,14.05%,CCT8;CCT5
prerank,maintenance of protein location in nucleus (GO:0051457),0.28146126688693657,0.6018064793473147,0.917312661498708,0.9744546020658911,1.0,4/20,15.92%,MORC3;SYNE1;TAF8;TAF3
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),-0.22054170540261261,-0.6011483799501304,0.9166666666666666,0.9892754888164705,1.0,2/15,6.53%,DSE;VCAN
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.2636043150964495,0.6005021882415867,0.9123222748815166,0.975039799047561,1.0,8/25,27.54%,NDST1;FUT9;B3GALNT1;NDST2;NDST4;B3GALT2;EXT2;B3GNT9
prerank,microtubule polymerization (GO:0046785),0.26458393047519146,0.6004430607327094,0.9166666666666666,0.9747569893510555,1.0,4/28,12.78%,FGF13;TUBGCP6;TUBGCP4;RANBP9
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.28039967654396564,0.6002867589344735,0.9026666666666666,0.9745306159714893,1.0,2/16,7.37%,MEF2A;SLC9A1
prerank,mitochondrial gene expression (GO:0140053),0.24982381401081574,0.6000124838937941,0.9414364640883978,0.9743929484190659,1.0,15/42,27.38%,FOXO3;GATB;MRPL51;LARS2;TWNK;MRPS21;MRPS14;TFAM;MRPL12;GATC;MRPS34;MRPS12;MRPS15;MRPL16;MRPS24
prerank,regulation of cation transmembrane transport (GO:1904062),0.2579135954211485,0.6000025321134523,0.9088757396449704,0.9740793246564535,1.0,5/29,17.43%,KCNIP2;WNK1;CD63;CACNA1D;SCN5A
prerank,peptidyl-lysine methylation (GO:0018022),0.2676836572532386,0.5996944619528453,0.9162735849056604,0.9739886687353899,1.0,5/26,16.48%,SETD6;SETD2;ETFBKMT;SMYD3;SUV39H1
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),0.2778288955903629,0.5992547851705464,0.9133663366336634,0.973977459909547,1.0,4/22,15.10%,MTOR;HEATR1;SMARCB1;PIH1D1
prerank,tyrosine metabolic process (GO:0006570),-0.23654608243520547,-0.5987451303308655,0.9388489208633094,0.9887197723002056,1.0,5/11,41.92%,FAH;GSTZ1;TYR;HGD;IL4I1
prerank,translesion synthesis (GO:0019985),0.2513442494565947,0.5987298122515047,0.9218061674008811,0.9740116559730766,1.0,3/42,6.94%,TRIM25;MAD2L2;POLH
prerank,regulation of supramolecular fiber organization (GO:1902903),0.27459475763414537,0.5981678551201252,0.9144254278728606,0.9740659997018948,1.0,6/22,21.64%,APOE;MAP1B;CAMSAP2;GBA2;AEBP1;PIK3CA
prerank,positive regulation of histone methylation (GO:0031062),0.26694996896284867,0.5976367658453023,0.9210206561360875,0.974111234270077,1.0,3/24,12.32%,PRDM12;CTNNB1;MTF2
prerank,negative regulation of DNA recombination (GO:0045910),0.24611262202716358,0.5963598913573993,0.9496644295302014,0.9746576732652483,1.0,12/43,25.84%,MAD2L2;ATRX;POLR2L;SHLD1;POLR2E;SHLD2;TINF2;TERF2;PARP3;TERF2IP;KLHL15;ZRANB3
prerank,tricarboxylic acid metabolic process (GO:0072350),0.3029554167482502,0.5959878503378071,0.9242636746143057,0.9745952164538872,1.0,2/12,11.46%,IREB2;ACO1
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.30343742025483955,0.59553272798193,0.9020979020979021,0.9745841668851386,1.0,2/12,8.14%,ATIC;GART
prerank,axonal transport (GO:0098930),0.25637527623001444,0.5954019041853879,0.9307604994324631,0.9743610139245266,1.0,9/36,20.41%,AP3D1;AP3S1;DTNBP1;DYNC1H1;DST;HIF1A;KIF1B;KIF3A;FBXW11
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),-0.21067346477357343,-0.5953519584440116,0.9615384615384616,0.9887386066224219,1.0,4/15,16.36%,CCT3;CCT6A;SHQ1;RUVBL1
prerank,dermatan sulfate metabolic process (GO:0030205),-0.2274453849628055,-0.5949795736848902,0.9548872180451128,0.9871198184420655,1.0,2/13,6.53%,DSE;VCAN
prerank,regulation of nuclear division (GO:0051783),0.27803346419929503,0.5945667077703453,0.9084249084249084,0.974604698984296,1.0,5/20,26.48%,KIF20B;CCDC8;PIN1;FBXO5;DAPK3
prerank,toxin transport (GO:1901998),0.30287840784103826,0.5939277460492794,0.8992700729927007,0.9746952829403744,1.0,3/10,24.52%,ANTXR2;RAB29;ANTXR1
prerank,establishment of melanosome localization (GO:0032401),0.27645157149778976,0.5938119325329074,0.9113924050632911,0.9744491775014128,1.0,2/19,9.82%,MYO5A;RAB11A
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.28484456728464963,0.5936762223480933,0.8983957219251337,0.9742256898894908,1.0,4/16,23.95%,THBS1;FGF2;PPP1R16B;VEGFA
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.2988676216383256,0.5932761207714403,0.9236209335219236,0.9741621766585618,1.0,2/12,9.18%,ABCD1;PPARGC1A
prerank,innate immune response in mucosa (GO:0002227),0.3042435868653639,0.5918959906815447,0.9118086696562033,0.9747609220859892,1.0,1/10,12.31%,DEFA6
prerank,regulation of primary metabolic process (GO:0080090),0.22971895435269857,0.591892664076739,0.978894472361809,0.9744458022876545,1.0,25/126,19.67%,PSAP;SREBF2;APOE;ZFP69;PSMB10;TBL1XR1;TBL1X;PSMA2;ADIPOR1;PSME3;SMARCD3;GPS2;PSMB5;PSMD8;SREBF1;FASN;PSMD7;PSMB9;ACACA;PPARD;NFYA;PSMD2;RXRA;ROCK2;C1QTNF2
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.2967632909657268,0.5918451746375033,0.9040333796940194,0.9741583369636865,1.0,2/11,12.34%,P4HB;FYN
prerank,myelination in peripheral nervous system (GO:0022011),0.28630578321791444,0.5906155549258958,0.9144079885877318,0.9746895712087216,1.0,6/13,26.46%,SKI;PRX;NF1;DICER1;CNTNAP1;LGI4
prerank,negative regulation of reproductive process (GO:2000242),0.27917686692523935,0.5905642845953285,0.9302013422818792,0.9744038864794526,1.0,2/17,9.88%,TIMP1;ARHGDIB
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.23700307658942468,0.5903421795349287,0.9720207253886011,0.9742337610729808,1.0,19/80,20.57%,KLC2;TMED3;KDELR2;KIF23;UVRAG;RAB1B;BNIP1;COPA;SCYL1;BICD2;KIF2A;LMAN2;USE1;ERGIC1;GOLPH3;SEC22B;KIF3A;ARCN1;COG7
prerank,hippo signaling (GO:0035329),0.25838628825166265,0.5900889119322886,0.9385342789598109,0.9740858107150786,1.0,8/26,20.79%,TEAD1;YWHAB;STK3;MOB1B;DCHS1;STK4;MOB1A;AMOT
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.2708483572596319,0.5898786124683653,0.9367088607594937,0.9735877416924053,1.0,7/21,24.86%,GTF2H1;ERCC5;GTF2H5;ERCC1;ERCC4;PARP1;RPA1
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.2708483572596319,0.5898786124683653,0.9367088607594937,0.9735877416924053,1.0,7/21,24.86%,GTF2H1;ERCC5;GTF2H5;ERCC1;ERCC4;PARP1;RPA1
prerank,transport along microtubule (GO:0010970),0.2879112410306418,0.589450506260719,0.8941655359565808,0.9735663902895683,1.0,3/13,11.52%,APBA1;ARHGAP21;BORCS5
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.2616988339731508,0.588840222398918,0.9399293286219081,0.9736545623491962,1.0,5/27,15.11%,SLC7A8;SLC25A38;SLC36A4;SLC25A18;SLC1A4
prerank,ribosome assembly (GO:0042255),0.24117896160197735,0.588392276527907,0.9416941694169417,0.9736211876679586,1.0,15/47,25.62%,ERAL1;RPL6;MDN1;RPS14;RRS1;RPL11;RPS27;RRP7A;EFL1;RPS15;RPS5;RPL10;EIF2A;C1QBP;RPL5
prerank,melanosome localization (GO:0032400),0.269488223916404,0.5882121569183952,0.9229813664596274,0.9734150021925149,1.0,4/21,18.15%,MYO5A;RAB11A;RAB27B;VPS33B
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.27537869991387787,0.5880633366028073,0.9160401002506265,0.9731986108826153,1.0,7/20,23.64%,CEBPA;MYOCD;PTEN;HHEX;HEXIM1;TFAP4;IPO7
prerank,cognition (GO:0050890),0.24625689304961917,0.5872177237499056,0.9453125,0.9734291652784111,1.0,12/42,21.39%,TNF;CHD7;PTCHD1;LINS1;CYFIP1;CTNS;SLC1A4;NF1;CUX2;TUSC3;SETD5;MAGT1
prerank,positive regulation of protein localization to Cajal body (GO:1904871),0.295686144862245,0.5868787549610711,0.9090909090909091,0.9730141225783037,1.0,2/11,14.05%,CCT8;CCT5
prerank,regulation of protein localization to Cajal body (GO:1904869),0.295686144862245,0.5868787549610711,0.9090909090909091,0.9730141225783037,1.0,2/11,14.05%,CCT8;CCT5
prerank,positive regulation of RNA splicing (GO:0033120),0.2576005568171647,0.5865436462840209,0.9351415094339622,0.9729200613823787,1.0,5/29,15.80%,ERN1;CIRBP;TRA2B;PRDX6;THRAP3
prerank,protein autoubiquitination (GO:0051865),0.2395701414958267,0.5861700250381378,0.9558359621451105,0.9728327213196103,1.0,8/61,13.60%,RNF19B;UBE2D3;TRAF2;RNF4;NFX1;RNF10;ITCH;STUB1
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.27953684687929886,0.5849498357380517,0.918848167539267,0.9732650880692573,1.0,8/16,28.88%,NAA40;NAA50;NAA25;NAA15;NAA80;NAA10;CREBBP;EP300
prerank,signal release from synapse (GO:0099643),0.2490434698969554,0.5848771883477061,0.9478357380688124,0.9729953250997742,1.0,9/43,21.33%,SNCA;PIP5K1C;STXBP3;SYT10;PDZD11;DNAJC5;UNC13A;RIMS1;BRSK1
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.23349552123522682,0.5846388622145228,0.9648760330578512,0.9728275370866917,1.0,6/72,13.59%,CBL;GRB2;RAB14;FLRT1;POLR2L;FIBP
prerank,negative regulation of translation (GO:0017148),0.23240205730625274,0.5844232434568061,0.9752832131822863,0.9726375755301199,1.0,23/87,23.65%,CNOT8;YTHDF3;EIF4EBP2;LARP1;EPRS1;CPEB3;TPR;METTL3;PCIF1;IGF2BP3;CPEB4;PUS7;MEX3D;CPEB2;AGO2;ROCK2;FTO;LSM14A;CNOT7;CNOT1;EIF3E;RACK1;ILF3
prerank,chemical synaptic transmission (GO:0007268),0.22570083809232167,0.583337407009226,0.993,0.9730488323132458,1.0,35/284,15.93%,PCDHB6;PRKAR2B;SNCA;APOE;KCNIP2;CEL;AKAP5;NRGN;ATXN3;RIMBP2;APBA1;PTCHD1;STXBP3;CACNA1A;CACNB4;GABRA5;SYT10;CDH8;DTNA;RAPSN;CACNB2;GLRA2;PRKACB;SDCBP;CACNB1;CAMKK2;STAC3;GABRA4;CACNA1B;PDZD11;SLC1A4;MPZ;GRIA1;RPS6KA2;DNAJC5
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.2910934055195027,0.5831934907070896,0.9212034383954155,0.9728329983372772,1.0,2/12,14.05%,CCT8;CCT5
prerank,serine family amino acid biosynthetic process (GO:0009070),0.28671530995924344,0.5823881222910076,0.8992907801418439,0.9730233122426126,1.0,6/12,24.97%,CBS;PHGDH;PSAT1;SERINC3;SEPHS2;PSPH
prerank,retinal metabolic process (GO:0042574),-0.22877096482997333,-0.582212379491759,0.9553903345724907,0.9912159248179476,1.0,1/12,5.92%,RDH10
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.2504086156078945,0.5818614191150332,0.9374275782155272,0.9730265073815845,1.0,4/31,13.52%,TGFBR1;TGFBR2;DYNC2I1;MEGF8
prerank,aminoglycan biosynthetic process (GO:0006023),0.2404303554215438,0.5812312353355806,0.9515086206896551,0.9731044080575878,1.0,8/49,16.13%,HEXA;AGRN;NDST1;XYLT1;B3GALNT1;B4GALT7;PXYLP1;NDST2
prerank,regulation of double-strand break repair (GO:2000779),0.24568807031187248,0.5811461860139915,0.9539842873176206,0.9728417018620249,1.0,13/39,26.33%,MGMT;ACTR2;SETD2;RNF169;SLF2;PPP4C;PPP4R2;SHLD2;SPIDR;TERF2IP;DDX11;SIRT7;TRIP12
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.24577345783307752,0.5810658289002278,0.9379932356257046,0.9725741883073883,1.0,10/37,23.39%,DDIT3;BCL2L1;TP53;BECN1;BMF;DNM1L;FIS1;RPS7;BID;RACK1
prerank,cellular modified amino acid biosynthetic process (GO:0042398),0.2673593340193592,0.5810347347621566,0.9163498098859315,0.9722803107927317,1.0,1/20,2.77%,MTHFS
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.2716106341471898,0.5805115270140971,0.9272030651340997,0.9722940206516427,1.0,2/18,8.96%,BCL2L1;BAK1
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.2504174940446451,0.5783334179353781,0.9291428571428572,0.9733055288156032,1.0,6/32,18.95%,TAOK3;BABAM2;FZR1;FOXN3;BABAM1;TAOK1
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.23058049877111306,0.5780425727018971,0.9691358024691358,0.9731714299810591,1.0,13/87,15.14%,NDUFA11;NDUFB8;NDUFA2;NDUFB4;FASTKD3;UQCC1;CHCHD4;NDUFV1;NDUFS6;IMMP2L;NDUFAB1;COX20;NDUFB11
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.24509967957483333,0.5774311938886018,0.9386160714285714,0.9732292307881831,1.0,1/37,0.90%,TGFB1
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.2837355416052213,0.5771627625576163,0.9285714285714286,0.9730806713920503,1.0,3/13,17.57%,ALG2;DPAGT1;ALG11
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),-0.1886091663283332,-0.5769522254393121,0.9681818181818181,0.991834566012699,1.0,7/18,28.39%,CCT3;CCT6A;SHQ1;RUVBL1;PARN;NOP10;RUVBL2
prerank,rRNA modification (GO:0000154),0.2599628675901072,0.5758752149309171,0.9276073619631902,0.9735609088905002,1.0,3/21,18.55%,FBL;ZCCHC4;NSUN4
prerank,adherens junction organization (GO:0034332),0.23848930421822917,0.5750813163099169,0.9418221734357849,0.9737264219708927,1.0,15/48,22.05%,PIP5K1C;CTNNB1;ACTB;CDH8;VCL;CDH9;CDH12;CADM1;DCHS1;CDH19;CSK;CDH20;RAMP2;CDH15;CDH3
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.2885432437647506,0.5744659413901643,0.9147727272727273,0.9738117611520912,1.0,4/12,27.57%,ADCY8;PPP3CB;PLA2G6;STX4
prerank,protein prenylation (GO:0018342),0.28911435376250927,0.5734938340349197,0.9069767441860465,0.9741001254041229,1.0,1/10,9.21%,CHML
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.25449393255953545,0.5725512091684287,0.9479418886198547,0.9743578846618676,1.0,1/23,2.04%,COPS6
prerank,RNA modification (GO:0009451),0.230991935943895,0.5689630565677224,0.9625267665952891,0.9761570987921251,1.0,10/54,18.55%,RBM15B;ADAR;CDKAL1;TRMT1;CTU1;METTL3;ADARB1;BCDIN3D;PUS7;NSUN4
prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.24852791290426973,0.5688678480667055,0.9507445589919816,0.9758936026586151,1.0,13/31,26.41%,LRP8;LZTS3;TANC2;LRRK2;EPHA4;PTEN;CUX2;RELN;CDK5R1;CFL1;EFNA1;DBNL;NGEF
prerank,inorganic anion transmembrane transport (GO:0098661),0.2311680464872553,0.5686849022041125,0.9664570230607966,0.975679494379031,1.0,7/63,13.67%,SLC37A2;GABRA5;XPR1;GLRA2;SLC20A2;SLC25A30;GABRA4
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.2463437834643301,0.5682914127403501,0.9444444444444444,0.9755860531539384,1.0,8/29,24.86%,GTF2H1;CDK7;ERCC5;GTF2H5;RAD23B;PARP1;XPC;RPA1
prerank,DNA dealkylation (GO:0035510),0.29388362476018626,0.567576856375271,0.9090909090909091,0.9753765807136515,1.0,3/10,19.68%,MGMT;ALKBH5;FTO
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.29388362476018626,0.567576856375271,0.9090909090909091,0.9753765807136515,1.0,3/10,19.68%,MGMT;ALKBH5;FTO
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.2891987174407743,0.5667305898431468,0.918194640338505,0.975563410880702,1.0,1/10,6.70%,TP53
prerank,gastrulation (GO:0007369),0.2698094000303557,0.5660646806206173,0.9184210526315789,0.9756379914910178,1.0,3/15,16.60%,LRP5;MEGF8;TASOR
prerank,leukotriene biosynthetic process (GO:0019370),-0.20820141095956046,-0.5653667518990667,0.937007874015748,0.9948150577301097,1.0,1/14,2.21%,LTA4H
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.2510292400697086,0.5632695991509644,0.9339622641509434,0.9769181877656444,1.0,5/25,19.49%,PYCARD;TP53;BMF;TNFSF10;DNM1L
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.2527150524609079,0.5631686464623379,0.9441687344913151,0.9766650117135314,1.0,1/22,2.37%,GTF2H1
prerank,DNA catabolic process (GO:0006308),0.2857928062468589,0.5620944869150076,0.9307479224376731,0.9769757296030731,1.0,4/11,25.85%,REXO4;DNASE1L1;XRN2;DFFB
prerank,regulation of membrane repolarization (GO:0060306),-0.21026771735118158,-0.5613442436350322,0.964968152866242,0.9945270668518349,1.0,1/13,1.12%,CAV1
prerank,mesenchymal cell development (GO:0014031),-0.19397428858620877,-0.5596039516068748,0.9620253164556962,0.9934026019937162,1.0,9/18,35.43%,FOXC1;PEF1;CDH2;HEY2;SOX8;TCOF1;KBTBD8;SOX11;KLHL12
prerank,regulation of mitotic spindle organization (GO:0060236),0.24014213461542294,0.5594221484812082,0.9587628865979382,0.9781498535196226,1.0,5/35,15.83%,NUP62;TPR;CLTC;DYNC1H1;PDCD6IP
prerank,male meiosis I (GO:0007141),-0.19331599469347627,-0.5591831299885499,0.961864406779661,0.9917470432895226,1.0,7/16,41.60%,ZSCAN21;MYBL1;FOXJ2;HSF2BP;SYCP3;TDRD9;DDX4
prerank,negative regulation of cation channel activity (GO:2001258),0.25380813915662237,0.5578969863008173,0.9519807923169268,0.9786758921784562,1.0,4/26,17.83%,PKD2;EPO;GNB5;GSTM2
prerank,metallo-sulfur cluster assembly (GO:0031163),0.24839016188269605,0.5529000761046657,0.9478260869565217,0.9810271017209361,1.0,4/22,13.87%,MMS19;CIAO2A;CIAO1;HSCB
prerank,neurotransmitter secretion (GO:0007269),0.2338187696917971,0.5507398356581169,0.9680264608599779,0.9818200576330214,1.0,9/44,21.33%,SNCA;PIP5K1C;STXBP3;SYT10;PDZD11;DNAJC5;UNC13A;RIMS1;BRSK1
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.25411930110982,0.5499331257768864,0.943558282208589,0.9819194145923923,1.0,7/22,23.64%,CEBPA;MYOCD;PTEN;HHEX;HEXIM1;TFAP4;IPO7
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",-0.20231234747158827,-0.5489231840482134,0.9737827715355806,0.9937815572268841,1.0,5/13,29.03%,SPRED2;ATM;EEF1E1;HIC1;PLA2R1
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.2585492860570115,0.5482664058347683,0.9464751958224543,0.9824531070439,1.0,2/17,16.95%,NOS1AP;KCNRG
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.27245799635938994,0.5475991181494615,0.9508196721311475,0.9824624526234866,1.0,4/12,23.86%,ABCD1;FADS1;ACOT8;FADS2
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),0.2319386507799807,0.5457031637893094,0.9658703071672355,0.9831011196372342,1.0,8/36,19.71%,HFE;AQP11;USP7;SDCBP;PSME3IP1;RPL11;GIPC1;TLK2
prerank,respiratory electron transport chain (GO:0022904),0.26433856708992726,0.5452106536863226,0.9387483355525965,0.9830218784352147,1.0,5/14,20.75%,PPARGC1A;SLC25A18;SDHB;ETFDH;SDHA
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.2582761269635643,0.5447745900755792,0.9442970822281167,0.982919370135545,1.0,1/16,3.66%,VTA1
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.23135761258043105,0.5447691779983032,0.9675251959686451,0.9826077907722978,1.0,10/41,20.95%,NUP62;SEH1L;TPR;NUP205;LACC1;HIF1A;GCK;PGAM1;SEC13;NUP54
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.24354167714431751,0.544086493218045,0.9593301435406698,0.9826331542105178,1.0,5/27,18.78%,FBXL22;TP53;FBXL3;PPP1CC;PER1
prerank,multivesicular body assembly (GO:0036258),0.236651735322984,0.5438056584020581,0.9595375722543352,0.9824616384057703,1.0,5/30,16.98%,VTA1;RAB11A;VPS37C;PDCD6IP;VPS28
prerank,DNA recombination (GO:0006310),0.2279311652224536,0.5421581302155797,0.9613636363636363,0.9829577125541544,1.0,7/37,21.43%,EXO1;HMGB1;RAD54L;RAD51B;ERCC1;RAD51D;RPAIN
prerank,response to interleukin-4 (GO:0070670),0.27910625745308487,0.5421305596874346,0.932761087267525,0.9826576676895012,1.0,10/10,72.11%,SHPK;XBP1;TCF7;DCSTAMP;XCL1;CITED1;RUFY4;GATA3;JAK3;LEF1
prerank,Golgi inheritance (GO:0048313),-0.21006985706540546,-0.5415247085094271,0.9757785467128027,0.994421997277138,1.0,6/11,37.39%,STK25;GOLGA2;PLK5;YWHAZ;GBF1;PLK3
prerank,protein hydroxylation (GO:0018126),0.25810194586129487,0.5396187397148893,0.9296875,0.9835575279851084,1.0,2/15,9.78%,ASPH;P3H2
prerank,aerobic respiration (GO:0009060),0.24624784952536352,0.5374673188888296,0.9540507859733979,0.9842506990647065,1.0,4/20,17.69%,MTFR2;UQCRB;ME3;SDHB
prerank,inositol phosphate dephosphorylation (GO:0046855),0.27532340341998995,0.5367171202332335,0.9361997226074896,0.9839708222850607,1.0,4/11,23.28%,SYNJ1;PTEN;INPP5K;OCRL
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.27532340341998995,0.5367171202332335,0.9361997226074896,0.9839708222850607,1.0,4/11,23.28%,SYNJ1;PTEN;INPP5K;OCRL
prerank,protein insertion into mitochondrial membrane (GO:0051204),0.2442178653947022,0.5349116445963494,0.9541062801932367,0.9844795421584878,1.0,7/23,23.68%,TIMM22;AGK;BMF;HSP90AA1;TIMM29;TIMM8B;HSPA4
prerank,protein import into peroxisome matrix (GO:0016558),0.27039001503409643,0.5323186339133689,0.9323943661971831,0.9853950585893366,1.0,2/12,11.58%,PEX13;PEX7
prerank,positive regulation of phospholipase activity (GO:0010518),0.2423159275099578,0.5312862761020055,0.9484924623115578,0.9855166198838745,1.0,7/22,24.59%,GNA13;NTF3;PDPK1;PLAA;PLA2G5;FGF2;ABL2
prerank,histone H3 deacetylation (GO:0070932),0.26110681194045404,0.530423168320798,0.9573901464713716,0.9855841389228475,1.0,4/15,18.78%,HDAC4;HDAC9;SMARCAD1;PER1
prerank,iron-sulfur cluster assembly (GO:0016226),0.23462869831939365,0.5281544169419132,0.9633251833740831,0.9862666170757353,1.0,4/24,13.87%,MMS19;CIAO2A;CIAO1;HSCB
prerank,regulation of smooth muscle cell migration (GO:0014910),0.2417575071956387,0.5277307477789741,0.9538077403245943,0.9861377437282308,1.0,8/20,26.95%,NRP1;SORL1;LRP1;VTN;IGF1;CCN4;IGFBP3;NDRG4
prerank,negative regulation of mRNA processing (GO:0050686),-0.19098442993470618,-0.5275738327868752,0.9919028340080972,0.9966821514766443,1.0,15/15,80.93%,U2AF2;RBMX;SRSF12;RNPS1;SAP18;SRSF9;SRSF7;BARD1;SFSWAP;SRSF4;PCBP4;C1QBP;PTBP1;SRSF10;SRSF6
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.24763916702261538,0.5272759046627732,0.9543147208121827,0.9860164676383337,1.0,6/18,25.24%,ANXA1;HDAC9;FGF2;VEGFA;KDR;AKT3
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),-0.1973231958160891,-0.5263688219843238,0.9807692307692307,0.9952432456066813,1.0,4/13,24.84%,HACD1;ELOVL5;ELOVL1;HACD2
prerank,semaphorin-plexin signaling pathway (GO:0071526),0.22723675950215194,0.5262821063588234,0.9740112994350283,0.986119345601341,1.0,5/35,13.58%,SEMA4D;PLXNB2;SEMA4A;NRP1;ARHGDIA
prerank,tRNA processing (GO:0008033),0.2109558996691729,0.5235194916122926,0.9797441364605544,0.9869745031318417,1.0,8/61,14.16%,TSEN15;ELAC2;CDKAL1;TRMT1;TRMT10A;CTU1;RTRAF;DDX1
prerank,NIK/NF-kappaB signaling (GO:0038061),0.2084585266313666,0.5232593193526143,0.9894625922023182,0.9867727736203262,1.0,16/72,21.10%,TRAF2;MAP3K14;PSMB10;MALT1;PSMA2;PSME3;PSMB5;PSMD8;PSMD7;PSMB9;REL;PSMD2;BIRC2;FBXW11;BIRC3;DICER1
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.25017140422438366,0.5224694658729316,0.961436170212766,0.9867754555974968,1.0,6/16,23.59%,TNKS2;SLX4;TINF2;TERF2;ERCC4;PARP1
prerank,anion transmembrane transport (GO:0098656),0.21004232412740753,0.5200643403875653,0.989517819706499,0.9874012297598623,1.0,10/67,17.03%,LRRC8D;SLC7A8;SLC25A38;SLC36A4;ABCC1;SLC25A18;SLC25A30;SLC35A3;LRRC8C;SLC13A3
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.1909724402034026,-0.5181419242575928,0.9688715953307393,0.9956846097589422,1.0,14/14,80.93%,U2AF2;RBMX;SRSF12;RNPS1;SAP18;SRSF9;SRSF7;SFSWAP;SRSF4;PCBP4;C1QBP;PTBP1;SRSF10;SRSF6
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.21001513982072065,0.5173520843172743,0.9915878023133544,0.988164230205343,1.0,13/59,26.43%,LPL;LIPC;NDUFAB1;OSBP;ACACA;OSBPL7;ACOT8;GATM;CYP27A1;OSBPL3;XBP1;HSD17B8;HOGA1
prerank,RNA biosynthetic process (GO:0032774),-0.14879608271951308,-0.5170417048935928,1.0,0.9941524049906139,1.0,7/31,21.89%,TBP;TAF13;POLA1;POLA2;TERT;PRIM1;TAF7
prerank,positive regulation of embryonic development (GO:0040019),-0.17099289542479637,-0.5163847814215707,0.981651376146789,0.9925193634818911,1.0,8/19,37.44%,WNT4;ZBED3;RBM19;NIBAN2;PLCB1;OSR1;TLE6;LHX1
prerank,P-body assembly (GO:0033962),0.2551546243171027,0.5150263319361646,0.9670487106017192,0.9887516730890644,1.0,2/12,12.21%,RC3H1;DYNC1H1
prerank,inner mitochondrial membrane organization (GO:0007007),0.21080521882143252,0.5147885425651433,0.9784714747039828,0.9885317740518909,1.0,12/47,23.67%,ATP5MC2;ATP5F1E;TIMM22;AGK;ATP5F1A;ATP5PD;ATP5MG;GHITM;ATP5MF;LETM1;TIMM29;TIMM8B
prerank,positive regulation of rRNA processing (GO:2000234),-0.20569099231822288,-0.5143210359971885,0.9839228295819936,0.9912714087764125,1.0,2/10,14.41%,RIOK2;UTP15
prerank,multivesicular body organization (GO:0036257),0.22333334539184097,0.5137557831276846,0.9721900347624566,0.9885798327823687,1.0,5/31,16.98%,VTA1;RAB11A;VPS37C;PDCD6IP;VPS28
prerank,ER-associated misfolded protein catabolic process (GO:0071712),0.2640449808301402,0.5114885678778742,0.9490806223479491,0.9891206592414201,1.0,2/11,13.52%,DERL1;TOR1A
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.24454578378308411,0.5088455059914765,0.9618008185538881,0.9897728252787255,1.0,1/15,4.36%,SKI
prerank,ribosomal large subunit assembly (GO:0000027),0.2230855165180668,0.5029512977257049,0.9719512195121951,0.9914681390928791,1.0,4/24,16.38%,RPL6;MDN1;RRS1;RPL11
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.20131511292521334,0.49946874449592216,0.9968586387434555,0.9923163389901957,1.0,19/72,25.65%,GTF2H1;PNRC2;DNA2;POLD3;DDX1;ERCC5;REXO4;OGG1;GTF2H5;ERCC1;DICER1;DCP1B;RNASE6;ERCC4;PARP1;DNASE1L1;XRN2;RPA1;DXO
prerank,amide transport (GO:0042886),0.22273800707437688,0.49944342356107113,0.9737470167064439,0.9920098498564254,1.0,3/26,10.46%,AQP11;SLC14A2;TAP1
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.19812165093283984,0.49823336634644244,0.9907597535934292,0.9920882585275678,1.0,20/84,23.93%,APOE;CNOT8;LARP1;EPRS1;CPEB3;ORMDL2;SORL1;PCIF1;RTN1;IGF2BP3;RTN4;PUS7;BIN1;LSM14A;PIN1;CNOT7;CNOT1;RACK1;ILF3;IGF1
prerank,serine family amino acid catabolic process (GO:0009071),0.25556243506005616,0.49500045863190134,0.9643387815750372,0.9927807127613673,1.0,2/10,16.86%,THNSL2;CBS
prerank,homocysteine metabolic process (GO:0050667),0.24976281775702602,0.4945311811031952,0.9656160458452722,0.9926137872702121,1.0,2/11,16.86%,MMUT;CBS
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.21528214151061942,0.49197991606197744,0.9856972586412396,0.9931051829737308,1.0,29/29,78.51%,TRIP13;SIRT7;RAD21;BAG6;RNF212;KASH5;SYCE1;SYCE3;SYCP1;TERB2;HORMAD1;ANKRD31;RNF212B;RAD21L1;IHO1;STAG3;TEX12;MEIOB;MAJIN;SYCE2;REC8;TEX11;ZCWPW1;SYCP2;FANCD2;MEI4;TERB1;P3H4;PRDM9
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.21365835979124537,0.4897536483296193,0.9794754846066135,0.9934725258553937,1.0,1/28,2.51%,LFNG
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.22203273365532175,0.48820385276820955,0.975609756097561,0.9932753060746976,1.0,4/23,15.73%,YWHAB;TP53;CASP8;YWHAH
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.22203273365532175,0.48820385276820955,0.975609756097561,0.9932753060746976,1.0,4/23,15.73%,YWHAB;TP53;CASP8;YWHAH
prerank,positive regulation of transporter activity (GO:0032411),-0.18317639673571876,-0.4878593369433941,0.9963768115942029,0.994751565447903,1.0,13/13,81.70%,NR1H3;KCTD7;STK39;SYNGR3;SGK2;TRPC6;PDZK1;PON1;ADIPOQ;KMT2A;WNK3;SGK1;RXRA
prerank,nucleoside phosphate catabolic process (GO:1901292),0.23543311780108253,0.48538162404717405,0.9743243243243244,0.9937730093544752,1.0,4/13,25.18%,ENTPD1;ENTPD2;ENTPD3;ITPA
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.25509577607883205,0.48455115259092096,0.9681620839363242,0.9936894500530893,1.0,2/10,17.51%,IMPACT;VHL
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.22478015051821548,0.4826705091452076,0.9821428571428571,0.9938932451560092,1.0,1/18,4.59%,SEL1L
prerank,adrenergic receptor signaling pathway (GO:0071875),-0.15556113797651197,-0.48212465836038165,1.0,0.9938182231007171,1.0,20/20,84.47%,AKAP13;RAPGEF2;DRD2;PDE4D;ADRB2;ADRB1;GPR101;DRD3;ADRB3;ADRA2C;ADRA2B;DRD5;DRD1;ADRA2A;ADRA1A;ADRA1D;ADRA1B;ZDHHC21;ADCY9;LMBRD2
prerank,negative regulation of transferase activity (GO:0051348),0.2125538453569684,0.4794111489193766,0.97352587244284,0.9944622462232926,1.0,7/28,21.92%,TP53;PRDX3;SRC;GSK3A;INPP5K;GSK3B;ERCC4
prerank,positive regulation of mitochondrial translation (GO:0070131),0.23401830283754738,0.47751264016203726,0.9632152588555858,0.9946439562522812,1.0,2/14,13.94%,FASTKD3;RCC1L
prerank,exit from mitosis (GO:0010458),0.24071543790576405,0.47733775513092264,0.9727891156462585,0.9943739499144266,1.0,1/12,6.58%,UBE2S
prerank,nucleic acid-templated transcription (GO:0097659),0.20003849463067583,0.47716455687246767,0.9922907488986784,0.9941067049049246,1.0,11/42,26.24%,MEF2A;MMS19;POLR2L;CREBL2;POLR2E;FUBP3;POLR3A;PAX8;PWP1;XAB2;PTMA
prerank,regulation of endopeptidase activity (GO:0052548),0.19430674395312572,0.4766364974337282,0.9916054564533053,0.9939312516554183,1.0,12/59,24.51%,VSIR;TIMP1;PSME3;PSMB9;FURIN;PICALM;BIRC2;ATP13A2;BIRC3;VTN;PRELID1;SERPINA2
prerank,engulfment of apoptotic cell (GO:0043652),0.22673302322439326,0.47252724984037175,0.9791395045632334,0.9946300996322262,1.0,4/15,22.17%,THBS1;XKR4;MEGF10;RHOG
prerank,regulation of response to stress (GO:0080134),0.24238684997396953,0.47135246519146917,0.973568281938326,0.9946014847456832,1.0,2/10,18.51%,ADCY8;CORO2B
prerank,peptidyl-methionine modification (GO:0018206),0.2329769986185564,0.46484353628421515,0.9763231197771588,0.99577774037631,1.0,3/12,20.76%,METAP2;NAA25;NAA15
prerank,response to light stimulus (GO:0009416),0.1876603110129382,0.4619423960404761,0.9967532467532467,0.9960805372854458,1.0,6/55,15.69%,CIRBP;UVSSA;USF1;UBE4B;ERCC5;ERCC6
prerank,lipid droplet organization (GO:0034389),0.20907457492034975,0.46163369221552586,0.990086741016109,0.9958313615927369,1.0,1/22,5.78%,CDS2
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.22400373964988243,0.4605212101836215,0.9837618403247632,0.9957497318190615,1.0,5/14,23.58%,PNP;NMNAT3;AK8;AK5;AK1
prerank,bile acid metabolic process (GO:0008206),0.2032279426672809,0.45983580724377343,0.9857482185273159,0.9955812548931011,1.0,7/27,23.88%,NPC1;OSBP;GBA2;OSBPL7;ACOT8;CYP27A1;OSBPL3
prerank,regulation of histone deacetylation (GO:0031063),0.226656484798043,0.45811177418898713,0.9721059972105998,0.9956102011489505,1.0,6/13,29.48%,AKAP8L;ZBTB7B;CTBP1;SPHK2;SAP30BP;PRMT6
prerank,regulation of mitochondrial translation (GO:0070129),0.20795231077154008,0.4537169377097298,0.9872286079182631,0.9961524442493805,1.0,4/21,21.55%,FASTKD3;RCC1L;MTG2;RPUSD4
prerank,proteoglycan biosynthetic process (GO:0030166),0.194495626730199,0.45061116604518825,0.990632318501171,0.9964329283422161,1.0,12/31,29.17%,XYLT1;EXTL3;B4GALT7;PXYLP1;B3GAT2;IGF1;EXT2;CHST11;BMPR1B;CHST9;HS3ST3B1;CHST12
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.21475494845074816,0.4500280902212539,0.9848293299620733,0.9962292811039536,1.0,4/16,21.45%,ADIPOR1;FOXK1;PRKN;SCARB2
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.1924224576651112,0.4437339420796276,0.9915458937198067,0.9969888519863092,1.0,10/29,26.36%,PTGES3;HSP90AA1;TINF2;TERF2;TELO2;TERF2IP;PPIA;RPA1;HSP90AB1;ANKRD28
prerank,regulation of spindle assembly (GO:0090169),0.19771214589763253,0.4426162532524696,0.9879807692307693,0.9968683459665134,1.0,5/25,19.80%,RNF4;TPR;DYNC1H1;PDCD6IP;SENP6
prerank,regulation of DNA recombination (GO:0000018),0.1857758867668374,0.43771840754271607,0.991822429906542,0.9973400405229303,1.0,8/32,22.86%,SETD2;SMARCAD1;KPNA1;PPP4C;PPP4R2;SHLD2;SPIDR;TERF2IP
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.20553167967877686,0.4334842648664736,0.9908616187989556,0.9976638568557069,1.0,2/18,14.08%,LIG3;POLD3
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.22838305794825087,0.4325022456018725,0.9878971255673222,0.9974778599948542,1.0,1/10,8.24%,DGKD
prerank,regulation of phosphate metabolic process (GO:0019220),0.2068591765954998,0.4309089867343663,0.9880636604774535,0.9973779616399774,1.0,3/16,18.58%,SMG7;PGAM1;TIGAR
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.21985815602836878,0.42672022417012884,0.9898697539797395,0.9976332125281162,1.0,10/10,78.03%,TUT7;DIS3L2;CHFR;NEDD8;UBB;TUT4;RPS27A;UBA52;ISG15;UBC
prerank,mitotic cytokinetic process (GO:1902410),0.1927400769750109,0.419713238916946,0.9962546816479401,0.9981718328618726,1.0,5/20,24.66%,CNTROB;PDCD6IP;RHOA;MITD1;CHMP1A
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.17457575562400465,0.4146153341125631,0.9977900552486187,0.9984247443710033,1.0,4/39,16.81%,RASL10B;HFE;SOX4;GCK
prerank,telomere maintenance via telomerase (GO:0007004),0.1799591137506332,0.4129423497033425,0.9975845410628019,0.9982925119298349,1.0,9/28,26.36%,PTGES3;HSP90AA1;TINF2;TERF2;TELO2;TERF2IP;RPA1;HSP90AB1;ANKRD28
prerank,cellular response to interleukin-4 (GO:0071353),0.2140882679109798,0.4077729749620826,0.9970149253731343,0.998486709659355,1.0,1/10,13.18%,SHPK
prerank,negative regulation of RNA splicing (GO:0033119),0.18530685902760455,0.3969223974177547,0.9961636828644501,0.9990857795702331,1.0,8/19,27.70%,PTBP2;SRSF6;SRSF10;PTBP1;RPS13;C1QBP;PCBP4;SRSF4
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.19624282593346223,0.39105008617074055,0.9888579387186629,0.999210844091507,1.0,5/12,27.46%,SOX9;GDNF;VEGFA;PAX8;SIX4
prerank,mitotic recombination (GO:0006312),0.18790292530064945,0.3872195957135396,0.9973333333333333,0.9991517698479213,1.0,4/15,21.34%,TEP1;ERCC1;RAD51D;NSMCE2
prerank,sphingosine metabolic process (GO:0006670),0.1798154810445893,0.3843587908293616,0.9946452476572959,0.9990150210857904,1.0,4/17,25.08%,ACER3;ASAH1;ABCA2;SPHK2
prerank,monosaccharide transmembrane transport (GO:0015749),0.1751742324354869,0.37256030203081825,0.9973262032085561,0.9993509014218521,1.0,16/16,82.50%,SLC2A12;SLC45A3;SLC2A7;SLC5A9;SLC5A2;SLC5A1;SLC5A10;SLC2A6;SLC2A10;SLC23A2;SLC23A1;SLC2A2;SLC2A9;SLC2A8;SLC5A3;SLC50A1
prerank,epithelial cell morphogenesis (GO:0003382),0.17256500611329906,0.3645901268733071,0.9961734693877551,0.9993797711578787,1.0,2/17,15.95%,SIPA1L3;COL22A1
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.1819494131676394,0.35024020121796967,0.9956958393113343,0.9995635792136562,1.0,10/10,81.82%,CDC42;ECT2;SIRT2;NEK2;CCNB1;RCC2;SPAG5;KNSTRN;RACGAP1;APC
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.15011700188504945,0.31876505492982443,1.0,0.9998136614687517,1.0,2/18,16.34%,RAB11A;RAD51B
